<SEC-DOCUMENT>0001144204-15-029130.txt : 20150511
<SEC-HEADER>0001144204-15-029130.hdr.sgml : 20150511
<ACCEPTANCE-DATETIME>20150511133127
ACCESSION NUMBER:		0001144204-15-029130
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20150331
FILED AS OF DATE:		20150511
DATE AS OF CHANGE:		20150511

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lion Biotechnologies, Inc.
		CENTRAL INDEX KEY:			0001425205
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				753254381
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36860
		FILM NUMBER:		15849867

	BUSINESS ADDRESS:	
		STREET 1:		21900 BURBANK BLVD.
		STREET 2:		THIRD FLOOR
		CITY:			WOODLAND HILLS
		STATE:			CA
		ZIP:			91367
		BUSINESS PHONE:		818-992-3126

	MAIL ADDRESS:	
		STREET 1:		21900 BURBANK BLVD.
		STREET 2:		THIRD FLOOR
		CITY:			WOODLAND HILLS
		STATE:			CA
		ZIP:			91367

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Genesis Biopharma, Inc
		DATE OF NAME CHANGE:	20100319

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FREIGHT MANAGEMENT CORP
		DATE OF NAME CHANGE:	20080128
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>v409271_10q.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>U. S. SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WASHINGTON, DC 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 10-Q</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.65in"><FONT STYLE="font-family: Wingdings">&thorn;</FONT></TD><TD>QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the quarterly period ended <B>March
31, 2015</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.65in"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the transition period from ______to
_____.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Commission File Number 000-53127</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>LION BIOTECHNOLOGIES,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of small business issuer as
specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: center"><FONT STYLE="font-size: 10pt">Nevada</FONT></TD>
    <TD STYLE="width: 50%; text-align: center"><FONT STYLE="font-size: 10pt">75-3254381</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(State or other jurisdiction of</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(I.R.S. employer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">incorporation or organization)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">identification number)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">21900 Burbank Blvd, Third Floor, Woodland
Hills, CA 91367</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices
and zip code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(818) 992-3126</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&rsquo;s telephone number, including
area code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name, if changed since last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Yes <FONT STYLE="font-family: Wingdings">&thorn;</FONT>
No <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether the registrant
has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted
and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant
was required to submit and post such files). Yes <FONT STYLE="font-family: Wingdings">&thorn;</FONT> No <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions
of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer&rdquo; and &ldquo;smaller reporting company&rdquo; in Rule 12b-2
of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 70%; padding-left: 9pt"><FONT STYLE="font-size: 10pt">Large accelerated filer <FONT STYLE="font-family: Wingdings">&uml;</FONT></FONT></TD>
    <TD NOWRAP STYLE="width: 30%"><FONT STYLE="font-size: 10pt">Accelerated filer <FONT STYLE="font-family: Wingdings">&thorn;</FONT></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="padding-left: 9pt"><FONT STYLE="font-size: 10pt">Non-accelerated filer <FONT STYLE="font-family: Wingdings">&uml;</FONT> (Do not check if a smaller reporting company)</FONT></TD>
    <TD NOWRAP><FONT STYLE="font-size: 10pt">Smaller reporting company <FONT STYLE="font-family: Wingdings">&uml;</FONT></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Yes <FONT STYLE="font-family: Wingdings">&uml;</FONT>No
<FONT STYLE="font-family: Wingdings">&thorn;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">At May 8, 2015, the issuer had 45,029,692 shares of common stock,
par value $0.000041666 per share, outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LION BIOTECHNOLOGIES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 10-Q</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the Quarter Ended March 31, 2015</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Table of Contents</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 10pt">Page</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><A HREF="#lion_001">PART I&nbsp;&nbsp;FINANCIAL INFORMATION</A></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 10%"><FONT STYLE="font-size: 10pt">Item 1.</FONT></TD>
    <TD STYLE="width: 79%"><FONT STYLE="font-size: 10pt"><A HREF="#lion_002">Condensed Financial Statements (Unaudited)</A></FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-size: 10pt">1</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">Item 2.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#lion_004">Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations</A></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">14</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">Item 3.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#lion_005">Quantitative and Qualitative Disclosures About Market Risk</A></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">17</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">Item 4T.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#lion_006">Controls and Procedures</A></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">17</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><A HREF="#lion_007">PART II&nbsp;&nbsp;OTHER INFORMATION</A></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">Item 1.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#lion_008">Legal Proceedings</A></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">18</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">Item&nbsp;1A.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#lion_009">Risk Factors</A></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">18</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">Item 2.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#lion_010">Unregistered Sales of Securities and Use of Proceeds</A></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">18</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">Item 3.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#lion_011">Defaults Upon Senior Securities</A></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">18</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">Item 4.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#lion_012">Mine Safety Disclosure</A></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">18</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">Item 5.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#lion_013">Other Information</A></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">18</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">Item 6.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#lion_014">Exhibits</A></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">19</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><A HREF="#lion_015">SIGNATURES</A></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">20</FONT></TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="lion_001"></A><B>PART I. FINANCIAL INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.75in; text-align: left"><B><A NAME="lion_002"></A>Item&nbsp;1.</B></TD><TD STYLE="text-align: justify"><B>Condensed Financial Statements</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>LION BIOTECHNOLOGIES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Condensed Balance Sheet</B>s</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">March&nbsp;31,</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">December&nbsp;31,</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2014</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">(unaudited)</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center; text-indent: -0.1in; padding-left: 0.1in">ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.1in; padding-left: 0.1in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -0.1in; padding-left: 0.1in">Current Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 74%; text-align: left; text-indent: -0.1in; padding-left: 0.1in">Cash and cash equivalents</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">111,280,443</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">44,909,147</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in">Prepaid expenses and deposits</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">128,883</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">66,134</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -0.1in; padding-left: 0.1in">Total Current Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">111,409,326</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,975,281</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.1in; padding-left: 0.1in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in">Property and
    equipment, <FONT STYLE="font-weight: normal; font-style: normal">net of accumulated depreciation of $289,672 and $104,223</FONT></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,128,260</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,531,566</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -0.1in; padding-left: 0.1in">Total Assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">113,537,586</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">46,506,847</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.1in; padding-left: 0.1in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center; text-indent: -0.1in; padding-left: 0.1in">LIABILITIES AND STOCKHOLDERS' EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.1in; padding-left: 0.1in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -0.1in; padding-left: 0.1in">Current Liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.1in; padding-left: 16.2pt">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,107,370</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,248,413</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.1in; padding-left: 16.2pt">Accrued expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">717,847</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">327,847</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 16.2pt">Accrued payable to officers and former directors</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">85,500</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">85,500</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in">Total Current Liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,910,717</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,661,760</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.1in; padding-left: 0.1in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -0.1in; padding-left: 0.1in">Commitments and contingencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.1in; padding-left: 0.1in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -0.1in; padding-left: 0.1in">Stockholders' Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.1in; padding-left: 16.2pt">Preferred stock, $0.001 par value; 50,000,000 shares authorized, 3,694 shares and 5,694 shares issued and outstanding, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.1in; padding-left: 16.2pt">Common stock, $0.000041666 par value; 150,000,000 shares authorized, 44,871,888 and 33,750,188 shares issued and outstanding, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,870</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,407</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.1in; padding-left: 16.2pt">Common stock to be issued, 303,125 shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">245,153</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">245,153</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.1in; padding-left: 16.2pt">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">193,239,795</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">121,160,415</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 16.2pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(81,859,953</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(76,561,894</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in">Total Stockholders' Equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">111,626,869</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">44,845,087</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.1in; padding-left: 0.1in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -0.1in; padding-left: 0.1in">Total Liabilities and Stockholders' Equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">113,537,586</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">46,506,847</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">The accompanying notes are an integral part of these condensed
financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>LION BIOTECHNOLOGIES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><B>Condensed Statements of Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center">For&nbsp;the&nbsp;Period&nbsp;Ended</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">March&nbsp;31,</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2014</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 1pt">Revenues</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Costs and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 74%; text-align: left; padding-left: 9pt">Operating expenses (including $1,467,753 and $919,350 of non-cash share-based compensation costs)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">3,287,026</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">1,956,852</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Research and development</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,011,033</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">302,662</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total costs and expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,298,059</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,259,514</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net Loss</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(5,298,059</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(2,259,514</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net Loss Per Share, Basic and Diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(.14</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.11</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Weighted-Average Common Shares Outstanding, Basic and Diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">37,678,662</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">20,798,229</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part
of these condensed financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LION BIOTECHNOLOGIES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Condensed Statements of Stockholders'
Equity</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the Three Months Ended March 31,
2015</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Common</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Additional</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Total</FONT></TD><TD NOWRAP STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Preferred&nbsp;Stock</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Common&nbsp;Stock</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">Stock&nbsp;to</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">Paid-In</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">Accumulated</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">Stockholders'</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Shares</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Amount</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Shares</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Amount</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Be&nbsp;Issued</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Capital</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Deficit</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Equity</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 36%; font-weight: bold"><FONT STYLE="font-size: 8pt">Balance - January 1, 2015</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-size: 8pt">5,694</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-size: 8pt">6</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-size: 8pt">33,750,188</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-size: 8pt">1,407</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-size: 8pt">245,153</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-size: 8pt">121,160,415</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-size: 8pt">(76,561,894</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 5%; text-align: right"><FONT STYLE="font-size: 8pt">44,845,087</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Fair value of vested stock options</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,017,308</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,017,308</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Common stock issued upon exercise of warrants</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">921,700</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">38</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">2,304,212</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">2,304,250</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Common stock issued upon conversion of preferred
    shares</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(2,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(2</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,000,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">42</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(40</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Common stock sold in private placement, net of
    offering costs</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">9,200,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">383</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">68,307,455</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">68,307,838</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Vesting of restricted shares issued for services</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">450,445</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">450,445</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Net loss</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">(5,298,059</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 8pt">(5,298,059</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">Balance - March 31, 2015</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">3,694</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">4</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">44,871,888</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">1,870</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">245,153</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">193,239,795</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">(81,859,953</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-size: 8pt">111,626,869</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part
of these condensed financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LION BIOTECHNOLOGIES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Condensed Statements of Cash Flows</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center">For&nbsp;the&nbsp;Three&nbsp;Months&nbsp;Ended</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">March&nbsp;31,</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2014</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Cash Flows From Operating Activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 74%; text-align: left; padding-left: 9pt">Net loss</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">(5,298,059</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">(2,259,514</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt">Adjustments to reconcile net loss to net cash used in operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">185,449</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,565</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Fair value of vested stock options</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,017,308</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">901,650</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Vesting of restricted shares issued for services</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">450,445</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,700</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt">Changes in assets and liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in">Prepaid expenses and deposits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(62,749</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,625</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Accounts payable and accrued expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">248,957</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(993,389</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Net Cash Used In Operating Activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(3,458,649</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,267,363</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Cash Flows From Investing Activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Purchases of property and equipment</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(782,143</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(3,437</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Cash Flows From Financing Activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Proceeds from the issuance of common stock upon conversion of warrants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,304,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">542,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Proceeds from the issuance of common stock, net</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">68,307,838</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 9pt">Net Cash Provided By Financing Activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">70,612,088</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">542,500</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Net Increase (Decrease) In Cash And Cash Equivalents</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">66,371,296</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,728,300</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Cash and Cash Equivalents, Beginning of Period</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">44,909,147</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">19,672,177</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Cash and Cash Equivalents, End of Period</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">111,280,443</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">17,943,877</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Supplemental Disclosures of Cash Flow Information:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in">Cash paid during the period for:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 27pt">Interest</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 27pt">Income Taxes</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part
of these condensed financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LION BIOTECHNOLOGIES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO CONDENSED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the Three Months Ended March 31,
2015 and 2014 (Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>NOTE 1. GENERAL ORGANIZATION AND BUSINESS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lion Biotechnologies, Inc. (the &ldquo;Company,&rdquo;
&ldquo;we,&rdquo; &ldquo;us&rdquo; or &ldquo;our&rdquo;) is an a clinical-stage biopharmaceutical company focused on the development
and commercialization of novel cancer immunotherapy products designed to harness the power of a patient&rsquo;s own immune system
to eradicate cancer cells. Our lead program is an adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are
T cells derived from patients&rsquo; tumors, for the treatment of metastatic melanoma. The TIL are then activated and expanded
ex vivo and then infused back into the patient to fight their tumor cells. The Company was originally incorporated under the laws
of the state of Nevada on September 17, 2007. Until March 2010, we were an inactive company known as Freight Management Corp. On
March 15, 2010, we changed our name to Genesis Biopharma, Inc., and in 2011 we commenced our current business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 26, 2013, we amended and restated
our Articles of Incorporation to, among other things, change our name to Lion Biotechnologies, Inc., effect a 1-for-100 reverse
stock split (pro-rata reduction of outstanding shares) of our common stock. After the reverse stock split we increased the number
of our authorized number of shares of common stock to 150,000,000 shares, in addition we authorized the issuance of 50,000,000
shares of &ldquo;blank check&rdquo; preferred stock, $0.001 par value per share. References in these financial statements and related
notes to numbers of shares of common stock, prices per share of common stock, and weighted average number of shares of common stock
outstanding prior to the reverse stock splits have been adjusted to reflect the reverse stock splits for all periods presented,
unless otherwise noted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Basis of Presentation of Unaudited
Condensed Financial Information</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-indent: 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The unaudited
condensed financial statements of the Company for the three months ended March 31, 2015 and 2014 have been prepared in accordance
with accounting principles generally accepted in the United States of America for interim financial information and pursuant to
the requirements for reporting on Form 10-Q and Regulation S-K. Accordingly, they do not include all the information and footnotes
required by accounting principles generally accepted in the United States of America for complete financial statements. However,
such information reflects all adjustments (consisting solely of normal recurring adjustments), which are, in the opinion of management,
necessary for the fair presentation of the financial position and the results of operations. Results shown for interim periods
are not necessarily indicative of the results to be obtained for a full fiscal year. The balance sheet information as of December
31, 2014 was derived from the audited financial statements included in the Company's financial statements as of and for the year
ended December 31, 2014 included in the Company&rsquo;s Annual Report on Form 10-K filed with the Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) on March 16, 2015. These financial statements should be read in conjunction with that report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Liquidity</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are currently engaged in the development
of therapeutics to fight cancer, we do not have any commercial products and have not yet generated any revenues from our biopharmaceutical
business. We currently do not anticipate that we will generate any revenues during 2015 from the sale or licensing of any products.
In addition, we have not generated any revenues from our prior business plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have not had any revenues and are still
in the development stage. As shown in the accompanying condensed financial statements, we have incurred a net loss of $5,298,059
for the three months ended March 31, 2015 and used $3,458,649 of cash in our operating activities during the three months ended
March 31, 2015. As of March 31, 2015, we had $111,280,443 of cash or cash equivalents on hand, stockholders&rsquo; equity of $111,626,869
and had working capital of $109,498,609.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During 2015, we expect to further ramp
up our operations, which will increase the amount of cash we will use in our operations. Our budget for 2015 includes increased
spending on research and development activities, higher payroll expenses as we increase our professional staff, the costs associated
with operating our new Tampa, Florida, research facility, as well as ongoing payments under the Cooperative Research and Development
Agreement (CRADA) we have entered into with the National Cancer Institute (NCI). Based on the funds we had available on March 31,
2015, we believe that we have sufficient capital to fund our anticipated operating expenses for at least 24 months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LION BIOTECHNOLOGIES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO CONDENSED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the Three Months Ended March 31,
2015 and 2014 (Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 3, 2015, the Company sold 9,200,000
shares of its common stock in an underwritten public offering at $8.00 per share for net proceeds of $68.3 million, after deducting
expenses of the offering. On December 22, 2014, the Company sold 6,000,000 shares of its common stock in an underwritten public
offering at $5.75 per share for net proceeds of $32.2 million after deducting expenses of the offering. On November 5, 2013, we
completed a $23.3 million private placement of our securities to various institutional and individual accredited investors. Despite
the amount of funds that we have raised, the estimated cost of completing the development of our TIL-based therapy, and of obtaining
all required regulatory approvals to market those product candidates, may be substantially greater than the amount of funds we
have available. Therefore, while we believe that our existing cash balances will be sufficient to fund our currently planned level
of operations for at least 24 months, we will have to obtain additional funds in the future to complete our development plans.
We intend to seek this additional funding through various financing sources, including possible sales of our securities, and in
the longer term through strategic alliances with other pharmaceutical or biopharmaceutical companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Net Income (Loss) Per Share</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic net income (loss) per share is computed
by dividing net income (loss) by the weighted average number of common shares outstanding for the period, excluding unvested shares
of restricted common stock. Shares of restricted stock subject to vesting are included in basic weighted average common shares
outstanding from the time they vest. Diluted earnings per share is computed by dividing the net income applicable to common stock
holders by the weighted average number of common shares outstanding plus the number of additional common shares that would have
been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares
are excluded from the computation when their effect is antidilutive. When calculating diluted net income per share, shares of restricted
stock subject to vesting are included in diluted weighted average common shares outstanding as of their grant date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At March 31, 2015 and 2014, basic
and diluted net loss per share are the same as the effect of potentially dilutive securities was antidilutive. At March 31,
2015, potentially dilutive securities include options to acquire 1,907,877 shares of common stock, warrants to acquire
10,162,726 shares of common stock, preferred stock that can be converted into 1,847,000 shares of common stock, and 507,113
shares of non-vested restricted stock. At March 31, 2014, potentially dilutive securities include options to acquire 638,750
shares of common stock, warrants to acquire 12,156,156 shares of common stock, and preferred stock that can be converted into
6,650,000 shares of common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #222222; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Fair Value Measurements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company uses various inputs in determining
the fair value of certain assets and liabilities and measures these on a recurring basis. Financial assets and liabilities recorded
at fair value in the balance sheets are categorized by the level of objectivity associated with the inputs used to measure their
fair value. Authoritative guidance provided by the Financial Accounting Standards Board (the &ldquo;FASB&rdquo;) defines the following
levels directly related to the amount of subjectivity associated with the inputs to fair valuation of these financial assets and
liabilities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Level 1&mdash;Quoted
prices in active markets for identical assets or liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Level 2&mdash;Inputs,
other than the quoted prices in active markets, that are observable either directly or indirectly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Level 3&mdash;Unobservable
inputs based on the Company&rsquo;s assumptions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At March 31, 2015 and December 31, 2014,
the fair value of cash and cash equivalents, accounts payable, and accrued expenses approximate their carrying values based on
their short term nature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Use of Estimates</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements
in conformity with accounting principles generally accepted in the United States of America requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results
could differ from those estimates. Significant estimates include accounting for potential liabilities and the assumptions made
in valuing stock instruments issued for services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LION BIOTECHNOLOGIES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO CONDENSED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the Three Months Ended March 31,
2015 and 2014 (Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Stock-Based Compensation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company periodically grants stock options
and warrants to employees and non-employees in non-capital raising transactions as compensation for services rendered. The Company
accounts for stock option grants to employees based on the authoritative guidance provided by the Financial Accounting Standards
Board where the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts
for stock option grants to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board
where the value of the stock compensation is determined based upon the measurement date at either a) the date at which a performance
commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee
stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances
where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based
compensation charge is recorded in the period of the measurement date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the Company's common
stock option grants is estimated using a Black-Scholes option pricing model, which uses certain assumptions related to risk-free
interest rates, expected volatility, expected life of the common stock options, and future dividends. Compensation expense is recorded
based upon the value derived from the Black-Scholes option pricing model, and based on actual experience. The assumptions used
in the Black-Scholes option pricing model could materially affect compensation expense recorded in future periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Research and Development</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and development costs consist
primarily of fees paid to consultants and outside service providers, patent fees and costs, and other expenses relating to the
acquisition, design, development and testing of the Company's treatments and product candidates. Research and development costs
are expensed as incurred over the life of the underlying contracts on the straight-line basis, unless the achievement of milestones,
the completion of contracted work, or other information indicates that a different expensing schedule is more appropriate. The
Company reviews the status of its research and development contracts on a quarterly basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Concentrations</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments, which potentially
subject the Company to concentrations of credit risk, consist principally of cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company maintains cash balances at
one bank. As of March 31, 2015, the Company&rsquo;s cash balances were in excess of insured limits maintained at the bank. Management
believes that the financial institution that holds the Company&rsquo;s cash is financially sound and, accordingly, minimal credit
risk exists.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Recent Accounting Pronouncements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May 2014, the Financial Accounting Standards
Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, <I>Revenue from Contracts with Customers</I>. ASU 2014-09 is
a comprehensive revenue recognition standard that will supersede nearly all existing revenue recognition guidance under current
U.S. GAAP and replace it with a principle based approach for determining revenue recognition. ASU 2014-09 will require that companies
recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require
additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts,
including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract.
ASU 2014-09 is effective for interim and annual periods beginning after December 15, 2016, however, the FASB has proposed a one-year
deferral. Early adoption is not permitted, and either full retrospective adoption or modified retrospective adoption is permitted.
The Company is in the process of evaluating the impact of ASU 2014-09 on the Company&rsquo;s financial statements and disclosures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LION BIOTECHNOLOGIES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO CONDENSED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the Three Months Ended March 31,
2015 and 2014 (Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2015, the FASB issued Accounting
Standards Update No. 2015-01 (Subtopic 225-20) - Income Statement - Extraordinary and Unusual Items. ASU 2015-01 eliminates the
concept of an extraordinary item from GAAP. As a result, an entity will no longer be required to segregate extraordinary items
from the results of ordinary operations, to separately present an extraordinary item on its income statement, net of tax, after
income from continuing operations or to disclose income taxes and earnings-per-share data applicable to an extraordinary item.
However, ASU 2015-01 will still retain the presentation and disclosure guidance for items that are unusual in nature and occur
infrequently. ASU 2015-01 is effective for periods beginning after December 15, 2015. Early adoption is permitted. The adoption
of ASU 2015-01 is not expected to have a material effect on the Company&rsquo;s consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other recent accounting pronouncements
issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities
and Exchange Commission (&ldquo;SEC&rdquo;) did not or are not believed by management to have a material impact on the Company's
present or future financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>NOTE 3. STOCKHOLDERS&rsquo; EQUITY</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Public offering</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 3, 2015, the Company completed
an underwritten public offering of 9,200,000 shares of its common stock at a price of $8.00 per share of common stock. The net
proceeds to the Company from the offering were $68.3 million, after deducting underwriting discounts and commissions and offering
expenses. The offering was made pursuant to the Company&rsquo;s existing shelf registration statement on Form S-3, including a
base prospectus, which was filed with the SEC on November 20, 2014 and declared effective on December 10, 2014, a preliminary prospectus
supplement thereunder, and a registration statement on Form S-3 filed with the SEC on February 26, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Issuance of common stock upon conversion of preferred
stock</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the three months ended March
31, 2015, the Company issued 1,000,000 shares of common stock upon the conversion of 2,000 shares of Series A Convertible
Preferred Stock. The number conversion shares issued was determined on a formula basis of 500 common shares for each Series A
Convertible Preferred Stock held.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Common stock with vesting terms</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During 2014, the Company granted 782,500
shares of its restricted common stock to nine of its employees in accordance with the terms of their employment agreements. The
782,500 shares vest over a period of three years. As these shares were granted to employees, the Company calculated the aggregate
fair value of the 782,500 shares based on the trading prices of the Company&rsquo;s stock at their grant dates and determined it
to be $4,851,590, of which $1,256,985 was expensed in 2014. The allocable portion of the fair value of the stock that vested during
the three months ended March 31, 2015 amounted to $450,445 and was recognized as expense in the accompanying statements of operations.
As of March 31, 2015, the amount of unvested compensation related to all issuances of restricted common stock was $3,144,160, which
will be recorded as expense in future periods as the shares vest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When calculating basic net income (loss)
per share, these shares are included in basic weighted average common shares outstanding from the time they vest. When calculating
diluted net income (loss) per share, these shares are included in diluted weighted average common shares outstanding from the time
they are granted, unless they are antidilutive. Shares of restricted stock granted above are subject to forfeiture to the Company
or other restrictions that will lapse in accordance with a vesting schedule determined by our Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LION BIOTECHNOLOGIES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO CONDENSED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the Three Months Ended March 31,
2015 and 2014 (Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table summarizes restricted common stock activity:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number&nbsp;of<BR> Shares</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted<BR> Average<BR> Grant&nbsp;Date<BR> Fair&nbsp;Value</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%">Non-vested shares, January 1, 2015</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">579,764</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">6.20</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in">Vested</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(72,651</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.20</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in">Forfeited</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Non-vested shares, March 31, 2015</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">507,113</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6.20</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>NOTE 4. STOCK OPTIONS AND WARRANTS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Stock Options</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A summary of the status of stock options
at March 31, 2015, and the changes during the three months then ended, is presented in the following table:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Weighted</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Weighted</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Average</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Shares</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Average</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Remaining</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Aggregate</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Under</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Exercise</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Contractual</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Intrinsic</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Option</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Price</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Life</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Value</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%">Outstanding at January 1, 2015</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">1,857,877</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">7.31</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 10pt">8.5 years</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">2,874,378</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.45</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">10 years</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">233,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Exercised</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Expired/Forfeited</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Outstanding at March 31, 2015</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,907,877</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7.47</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8.25</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">10,687,637</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">Exercisable at March 31, 2015</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">405,412</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">10.48</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">4,708,718</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the three months ended March 31,
2015, the Company granted an option to purchase 50,000 shares of common stock to a new member of the Company&rsquo;s Board of Directors.
The stock options have an exercise price of $7.45 and vest in four installments as follows: options for the purchase of 12,500
shares vest on May 15, 2015, and the remaining options to purchase shares vest evenly over the next three quarters. The fair
value of these options was determined to be $369,000 using the Black-Scholes option pricing model based on the following assumptions:
(i) volatility rate of 213%, (ii) discount rate of 1.37 %, (iii) zero expected dividend yield, and (iv) expected life of 6 years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the three months ended March
31, 2015 and 2014, the Company recorded compensation costs of $1,017,308 and $901,650, respectively, relating to the vesting
of stock options. As of March 31, 2015, the aggregate value of unvested options was $8,665,475, which will continue to be
amortized as compensation cost as the options vest over terms ranging from nine months to five years, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LION BIOTECHNOLOGIES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO CONDENSED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the Three Months Ended March 31,
2015 and 2014 (Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 29, 2010, the Company&rsquo;s
Board of Directors adopted the Genesis Biopharma, Inc. 2010<B> </B>Equity Compensation Plan (the &quot;2010 Plan&quot;) pursuant
to which the Board reserved an aggregate of 35,000 shares of common stock for future grants of stock options, rights to acquire
restricted stock, rights to acquire unrestricted stock, and stock appreciation rights. Options for the issuance of all 35,000 shares
have been granted, and no shares are available for additional grants under the 2010 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 14, 2011, the Company&rsquo;s
Board of Directors approved a 2011 Equity Incentive Plan (the &ldquo;2011 Plan&rdquo;). The Company&rsquo;s stockholders did not
approve the 2011 Plan within a required one-year period, and accordingly, the Company cannot grant incentive stock options under
the 2011 Plan. As of December 31, 2014, no shares were available for future grant under the 2011 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 19, 2014, The Company&rsquo;s
Board of Directors adopted the Lion Biotechnologies, Inc. 2014 Equity Incentive Plan (the &ldquo;2014 Plan&rdquo;). The 2014 Plan
was approved by our stockholders at the annual meeting of stockholders held in November 2014. The 2014 Plan initially authorized
the issuance up to an aggregate of 2,350,000 shares of common stock. On April 10, 2015 the Board amended the 2014 Plan, subject
to stockholder approval, to increase the total number of shares that can be issued under the 2014 Plan by 1,650,000 from 2,350,000
shares to 4,000,000 shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Warrants</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A summary of the status of stock warrants
at March 31, 2015, and the changes during the three months then ended, is presented in the following table:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP STYLE="font-weight: bold; text-align: center">Weighted</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Weighted</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP STYLE="font-weight: bold; text-align: center">Average</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Shares</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Average</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP STYLE="font-weight: bold; text-align: center">Remaining</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Aggregate</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Under</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Exercise</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP STYLE="font-weight: bold; text-align: center">Contractual</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Intrinsic</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Warrants</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Price</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Life</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Value</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%">Outstanding at December 31, 2014</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">11,084,426</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">2.51</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 12%; text-align: right">3.85 years</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">59,517,998</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: 10pt">Issued</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: 10pt">Exercised</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(921,700</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2.50</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: 10pt">Expired</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Outstanding and exercisable at March 31, 2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,162,726</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2.51</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">3.58 years</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">97,654,187</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the three months ended March 31,
2015, the Company received $2,304,250 in cash from the exercise of 921,700 warrants for the purchase of 921,700 shares of its common
stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>NOTE 5. LICENSE AND COMMITMENTS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>National Institutes of Health and the National Cancer
Institute</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective August 5, 2011, the Company signed
a Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health and the National Cancer Institute
(NCI). Under the terms of the five-year cooperative research and development agreement, the Company will work with Dr. Steven A.
Rosenberg, M.D., Ph.D., chief of NCI&rsquo;s Surgery Branch, to develop adoptive cell immunotherapies that are designed to destroy
metastatic melanoma cells using a patient&rsquo;s tumor infiltrating lymphocytes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company initially agreed to pay the
NCI $1,000,000 per year ($250,000 per quarter) under the CRADA. On January 22, 2015, the Company executed an amendment (the &ldquo;Amendment&rdquo;)
to the CRADA to include four new indications. As amended, in addition to metastatic melanoma, the CRADA now also includes the development
of TIL therapy for the treatment of patients with bladder, lung, triple-negative breast, and HPV-associated cancers. Under the
Amendment, the NCI also has agreed to provide the Company with samples of all tumors covered by the Amendment for performing studies
related to improving TIL selection and/or TIL scale-out production and process development. As amended, the annual payments the
Company is required to make to the NCI have increased from $1 million to $2 million, to be paid in quarterly installments of $500,000.
The Company paid the first quarterly installment of $500,000 in February 2015. Although the CRADA has a five year term, either
party to the CRADA has the right to terminate the CRADA upon 60 days&rsquo; notice to the other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LION BIOTECHNOLOGIES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO CONDENSED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the Three Months Ended March 31,
2015 and 2014 (Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the three months ended March 31,
2015 and 2014, the Company recognized $541,667 and $250,000, respectively, of CRADA expenses, which were recorded as part of research
and development expenses in the statement of operations. As of December 31, 2014 and March 31, 2015, $250,000 of CRADA expenses
were included in the accrued expenses on the accompanying condensed balance sheet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>National Institutes of Health</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective October 5, 2011, the Company
entered into a Patent License Agreement (the &ldquo;License Agreement&rdquo;) with the National Institutes of Health, an agency
of the United States Public Health Service within the Department of Health and Human Services (&ldquo;NIH&rdquo;). Pursuant to
the License Agreement, NIH granted to the Company a non-exclusive worldwide right and license to develop and manufacture certain
proprietary autologous tumor infiltrating lymphocyte adoptive cell therapy products for the treatment of metastatic melanoma, ovarian
cancer, breast cancer, and colorectal cancer. The License Agreement requires the Company to pay royalties of six percent (6%) of
net sales (subject to certain annual minimum royalty payments), a percentage of revenues from sublicensing arrangements, and lump
sum benchmark royalty payments on the achievement of certain clinical and regulatory milestones for each of the various indications
and other direct cost incurred by NIH pursuant to the agreement. If the Company achieves all benchmarks for metastatic melanoma,
up to and including the product&rsquo;s first commercial sale in the United States, the total amount of such benchmark payments
will be $6,050,000. The benchmark payments for the other three indications, if all benchmarks are achieved, will be $6,050,000
for ovarian cancer, $12,100,000 for breast cancer, and $12,100,000 for colorectal cancer. Accordingly, if the Company achieves
all benchmarks for all four licensed indications, the aggregate amount of benchmark royalty payments that the Company will have
to make to NIH will be $36,300,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 9, 2015, the Company entered
into an amendment to the License Agreement with the NIH pursuant to which the Company&rsquo;s non-exclusive license to melanoma
was converted into an exclusive license. In consideration for the exclusive rights granted under the amendment to the License Agreement,
the Company agreed to pay the NIH a non-refundable upfront licensing fee of $350,000, which was recognized as research and development
expense during the three months ended March 31, 2015, and included in the balance of accrued expenses at March 31, 2015. The Company
also agreed to pay customary royalties based on a percentage of net sales (which percentage is in the mid-single digits), a percentage
of revenues from sublicensing arrangements, and lump sum benchmark payments upon the successful completion of the Company&rsquo;s
first Phase 2 clinical study, the successful completion of the Company&rsquo;s first Phase 3 clinical study, the receipt of the
first FDA approval or foreign equivalent for a licensed product or process resulting from the licensed technologies, the first
commercial sale of a licensed product or process in the United States, and the first commercial sale of a licensed product or process
in any foreign country.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the three months ended March 31,
2015, there were no net sales subject to certain annual minimum royalty payments or sales that would require us to pay a percentage
of revenues from sublicensing arrangements. In addition there were no benchmarks or milestones achieved that would require payment
under the lump sum benchmark royalty payments on the achievement of certain clinical and regulatory milestones for each of the
various indications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Exclusive License Agreement</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 21, 2014, the Company entered into
an Exclusive License Agreement (the &ldquo;Moffitt License Agreement&rdquo;), effective as of June 28, 2014, with the H. Lee Moffitt
Cancer Center and Research Institute, Inc. (&ldquo;Moffitt&rdquo;) under which the Company received an exclusive, world-wide license
to Moffitt&rsquo;s rights in and to two patent-pending technologies related to methods for improving tumor-infiltrating lymphocytes
for adoptive cell therapy. Unless earlier terminated, the term of the license extends until the earlier of the expiration of the
last patent related to the licensed technology or 20 years after the effective date of the license agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LION BIOTECHNOLOGIES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO CONDENSED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the Three Months Ended March 31,
2015 and 2014 (Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Moffitt License Agreement,
the Company paid an upfront licensing fee of $25,000, which was recognized as research and development expense during 2014. A patent
issuance fee will also be payable under the Moffitt License Agreement, upon the issuance of the first U.S. patent covering the
subject technology. In addition, the Company agreed to pay milestone license fees upon completion of specified milestones, customary
royalties based on a specified percentage of net sales (which percentage is in the low single digits) and sublicensing payments,
as applicable, and annual minimum royalties beginning with the first sale of products based on the licensed technologies, which
minimum royalties will be credited against the percentage royalty payments otherwise payable in that year. The Company will also
be responsible for all costs associated with the preparation, filing, maintenance and prosecution of the patent applications and
patents covered by the Moffitt License Agreement related to the treatment of any cancers in the United States, Europe and Japan
and in other countries selected that the Company and Moffitt agreed to.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the three months ended March 31,
2015, there were no net sales subject to certain annual minimum royalty payments or sales that would require us to pay a percentage
of revenues from sublicensing arrangements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Exclusive Patent License Agreement</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 10, 2015, the Company entered
into an exclusive Patent License Agreement with the NIH under which the Company received an exclusive, world-wide license to the
NIH&rsquo;s rights in and to two patent-pending technologies related to methods for improving tumor-infiltrating lymphocytes for
adoptive cell therapy. The licensed technologies relate to the more potent and efficient production of TIL from melanoma tumors
by selecting for T-cell populations that express various inhibitory receptors. Unless terminated sooner, the license shall remain
in effect until the last licensed patent right expires.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In consideration for the exclusive rights
granted under the exclusive Patent License Agreement, the Company agreed to pay the NIH a non-refundable upfront licensing fee
of $40,000, which was recognized as research and development expense during the three months ended March 31, 2015, and included
in the balance of accrued expenses at March 31, 2015. The Company also agreed to pay customary royalties based on a percentage
of net sales (which percentage is in the mid-single digits), a percentage of revenues from sublicensing arrangements, and lump
sum benchmark payments upon the successful completion of the Company&rsquo;s first Phase 2 clinical study, the successful completion
of the Company&rsquo;s first Phase 3 clinical study, the receipt of the first FDA approval or foreign equivalent for a licensed
product or process resulting from the licensed technologies, the first commercial sale of a licensed product or process in the
United States, and the first commercial sale of a licensed product or process in any foreign country.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the three months ended March 31,
2015, there were no net sales subject to certain annual minimum royalty payments or sales that would require us to pay a percentage
of revenues from sublicensing arrangements. In addition there were no benchmarks or milestones achieved that would require payment
under the lump sum benchmark royalty payments on the achievement of certain clinical and regulatory milestones for each of the
various indications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Manufacturing Service Agreement</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2011, the Company entered into
a Manufacturing Services Agreement with Lonza Walkersville, Inc. (Lonza) pursuant to which Lonza has agreed to manufacture, package,
ship and perform quality assurance and quality control of our TIL therapy. Lonza has commenced developing a commercial-scale manufacturing
process for the TIL therapy. The goal is to develop and establish a manufacturing process for the large-scale production of TIL
that is in accord with current Good Manufacturing Practices (cGMP).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 1, 2014 we issued a new statement
of work (SOW) to Lonza under the Manufacturing Services Agreement. The total cost for services to be provided under the SOW is
approximately $738,000. During 2014, the Company recognized $890,684 of expenses under the Manufacturing Services Agreement with
Lonza, which included a $100,000 in upfront costs required under the SOW, and were recorded as part of research and development
expenses in 2014. During the three months ended March 31, 2015, the Company recognized $298,071 of expenses under the Manufacturing
Services Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LION BIOTECHNOLOGIES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO CONDENSED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the Three Months Ended March 31,
2015 and 2014 (Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Research Collaboration Agreement
</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In September, 2014, we entered into a research
collaboration agreement with the H. Lee Moffitt Cancer Center and Research Institute, Inc. to jointly engage in transitional research
and development of adoptive tumor-infiltrating lymphocyte cell therapy with improved anti-tumor properties and process. The total
obligation under the agreement was $1,432,797, of which $358,199 was paid in 2014. During the three-month period ended March 31,
2015, the Company did not record any expenses related to this research collaboration agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>NOTE 6. LEGAL PROCEEDINGS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 23, 2014, the
Company received a subpoena from the Securities Exchange Commission (the &ldquo;SEC&rdquo;) that stated that the staff of the
SEC is conducting an investigation <I><U>In the Matter of Galena Biopharma, Inc. File No. HO 12356</U></I> <I>(now known
as &ldquo;<U>In the Matter of Certain Stock Promotions</U>&rdquo;) </I>and that the subpoena was issued to the Company as
part of the foregoing investigation. The SEC&rsquo;s subpoena and accompanying letter do not indicate whether the Company is,
or is not, under investigation. We have fully cooperated with the SEC and as of November 2014, we had completed production
of documents in response to the subpoena. To date, The SEC has not requested any further action from the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The subpoena requires the Company to give
the SEC, among other materials, all communications between anyone at the Company and certain persons and entities (which include
investor-relations firms and persons associated with the investor-relations firms), all documents related to the listed persons
and entities, all articles regarding the Company posted on certain equity research or other financial websites, and documents and
communications related to individuals who post or have posted articles regarding the Company on equity research or other financial
websites.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no other pending legal proceedings
to which the Company is a party or of which its property is the subject.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>NOTE 7. SUBSEQUENT EVENTS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Share Issuances</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the second quarter of 2015, the Company has received $394,510
in cash from the exercise of warrants for the purchase of 157,804 shares of its common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 6, 2015, certain stockholders of
the Company, including certain members of Board of Directors of the Company and their affiliates, sold 4,750,000 shares of the
Company&rsquo;s common stock in an underwritten secondary offering at a price of $10.00 per share. The Company did not sell any
shares in the offering and will not receive any of the proceeds from the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">.</P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 13%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B><A NAME="lion_004"></A>Item 2. </B></FONT></TD>
    <TD STYLE="width: 87%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>This management&rsquo;s
discussion and analysis of financial condition as of March 31, 2015 and results of operations for the three months ended March
31, 2015 and 2014, respectively, should be read in conjunction with management&rsquo;s discussion and analysis of financial condition
and results of operations included in our Annual Report on Form 10-K for the year ended December&nbsp;31, 2014 which was filed
with the SEC on March&nbsp;16, 2015.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Our discussion includes
forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives,
expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking
statements as a result of a number of factors. We use words such as &ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo; &ldquo;plan,&rdquo;
&ldquo;project,&rdquo; &ldquo;continuing,&rdquo; &ldquo;ongoing,&rdquo; &ldquo;expect,&rdquo; &ldquo;believe,&rdquo; &ldquo;intend,&rdquo;
&ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;could,&rdquo; and similar expressions to identify forward-looking
statements. All forward-looking statements included in this Quarterly Report are based on information available to us on the date
hereof and, except as required by law, we assume no obligation to update any such forward-looking statements. For a discussion
of some of the factors that may cause actual results to differ materially from those suggested by the forward-looking statements,
please read carefully the information in the &ldquo;Risk Factors&rdquo; section in our Form 10-K for the year ended December&nbsp;31,
2014. The identification in this Quarterly Report of factors that may affect future performance and the accuracy of forward-looking
statements is meant to be illustrative and by no means exhaustive. All forward-looking statements should be evaluated with the
understanding of their inherent uncertainty. </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Background on the Company and Recent Events Affecting our
Financial Condition and Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a clinical-stage
biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products designed to harness
the power of a patient&rsquo;s own immune system to eradicate cancer cells. Our lead program is an adoptive cell therapy utilizing
tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients&rsquo; tumors, for the treatment of metastatic melanoma.
TIL therapy is being developed in collaboration with the National Cancer Institute (NCI). A patient's immune system, particularly
their TIL, plays an important role in identifying and killing cancer cells. TIL consist of a heterogeneous population of T cells
that can recognize a wide variety of cancer-specific mutations and can overcome tumor escape mechanisms. TIL therapy involves growing
a patient&rsquo;s TIL in special culture conditions outside the patient&rsquo;s body, or ex vivo, and then infusing the T cells
back into the patient in combination with interleukin-2 (IL-2). By taking TIL away from the immune-suppressive tumor microenvironment
in the patient, the T cells can rapidly proliferate. Billions of TIL, when infused back into the patient, are more able to search
out and eradicate the tumor. In most cases, only a single treatment of TIL is administered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2011, we acquired
from the National Institutes of Health (NIH) a non-exclusive, worldwide right and license to certain NIH patents and patent applications
to develop and manufacture autologous TIL for the treatment of metastatic melanoma, ovarian, breast, and colorectal cancers. Under
a Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Health and Human Services, as represented
by the NCI, we support the in vitro development of improved methods for the generation and selection of TIL, the development of
large-scale production of TIL, and clinical trials using these improved methods of generating TIL. On January 22, 2015, we executed
an amendment to the CRADA to include four new indications. On February 9, 2015, the NIH granted us an exclusive, worldwide license
to treat metastatic melanoma with TIL therapy. On February 10, 2015, the NIH granted us a worldwide license to the NIH&rsquo;s
rights in and to two patent-pending technologies related to methods for improving TIL therapy. In addition to our CRADA, we also
conduct research and development on TIL technology at our research facility in Tampa, Florida.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Recent Developments</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 3, 2015 we
closed an underwritten public offering of 9,200,000 shares of our common stock, including shares sold pursuant to the exercise
in full of the underwriters' option to purchase additional shares, at a price of $8.00 per share. The net proceeds to us from that
public offering were approximately $68.3 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Results of Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Revenues</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a development stage
company that is currently engaged in the development of novel cancer immunotherapy products, we have not yet generated any revenues
from our biopharmaceutical business or otherwise since our formation. We currently do not anticipate that we will generate any
revenues during 2015 from the sale or licensing of any products. Our ability to generate revenues in the future will depend on
our ability to complete the development of our product candidates and to obtain regulatory approval for them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Operating Expenses</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Operating expenses
include compensation-related costs for our employees engaged to general and administrative activities (other than employees engaged
in research and development), legal fees, audit and tax fees, consultants and professional services, and general corporate expenses.
Our operating expenses increased by 68% from $1,957,000 for the three months ended March 31, 2014 (&ldquo;fiscal 2014 quarter&rdquo;)
to $3,287,000 for the three months ended March 31, 2015 (&ldquo;fiscal 2015 quarter&rdquo;). Our operating expenses during the
fiscal 2015 quarter increased by $1,330,000 compared with the fiscal 2014 quarter due to the increase in our overall business activities,
including an increase in expense related to obtaining and maintaining our NASDAQ listing, compliance with SEC requirements, and
increases in insurance and investor relations. In addition, in the fiscal 2015 quarter, we incurred $1,468,000 of non-cash share
based compensation costs, compared to $919,000 of such costs incurred in the fiscal 2014 quarter. Share based compensation includes
stock and options granted to our executive officers, our employees, our directors, and our consultants and advisors. As a result
of our increased operating activities, our larger payroll and our planned Florida facilities, our operating expenses in the future
are expected to continue to increase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Research and Development</U>.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and development
expenses consist of expenses incurred in performing research and development activities, including compensation and benefits for
research and development employees and consultants, rent at our new research and development facility in Tampa, Florida, cost of
laboratory supplies, manufacturing expenses, and fees paid to third parties, including the NCI and Lonza Walkersville, Inc., a
third party contractor that will process and manufacture LN-144 for our clinical trials in patients. Research and development expenses
also included amounts paid (i) the National Institutes of Health under terms of our license agreement, and (ii) NCI under the CRADA.
Research and development costs increased by 563.7% from $303,000 in the fiscal 2014 quarter to $2,011,000 in the fiscal 2015 quarter
mostly due to the establishment of our Tampa, Florida, research facility in the fourth quarter of 2014. We have hired nine new
employees (including our Chief Scientific Officer) since the end of the fiscal 2014 quarter, and have opened the Tampa, Florida,
research and development laboratory. None of these expenses were incurred in the fiscal 2014 quarter. Research and development
expenses in 2015 and 2014 fiscal quarters included the $500,000 and $250,000 quarterly payments, respectively, we made under the
CRADA as well as the $350,000 upfront licensing fees for the amendment to the NIH license signed February 9, 2015, $40,000 upfront
licensing fee for the exclusive license to next-generation TIL technologies signed February 10, 2015 and the $20,000 annual minimum
payments to the NIH under the original licensing agreement. We anticipate that our research and development costs will continue
to increase in the future as we increase our research and development activities and accelerate the development of our technologies
and product candidates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Net Loss</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We had a net loss of
$5,298,000 and $2,260,000 for the three months ended March 31, 2015 and 2014, respectively, an increase of 134%. Our net loss for
the fiscal 2015 quarter increased because of the $1,330,000 increase in operating expenses and the $1,708,000 increase in research
and development. We anticipate that we will continue to incur net losses in the future because we do not expect to generate any
revenues in the near term, while our research and development activities are expected to increase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Liquidity and Capital Resources</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 3, 2015, we
closed an underwritten public offering. The net proceeds to us from the public offering were $68.3 million, after deducting underwriting
discounts and commissions and estimated offering expenses payable by us. In addition, during the fiscal quarter ended Mach 31,
2015, holders of our common stock purchase warrants exercised warrants to purchase a total of 921,700 shares for an aggregate purchase
price of $2,304,000. As a result, as of March 31, 2015, we had $111.3 million in cash and cash equivalents. Cash in excess of immediate
requirements is invested in accordance with our investment policy, primarily with a view to liquidity and capital preservation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the remainder
of 2015, we expect to further ramp up our operations and our research and development efforts, which will increase the amount of
cash we will use in our operations. Our budget for the remainder of 2015 includes increased spending on research and development
activities (including costs associated with a Phase 2 multicenter clinical trial to treat about 20 patients with refractory metastatic
melanoma that we expect to initiate), higher payroll expenses as we increase our professional staff, increased expenses for operating
a new research and development facility in Tampa, Florida, as well as ongoing payments under the CRADA. Based on the funds we had
available on March 31, 2015, we believe that we have sufficient capital to fund our anticipated operating expenses for at least
24 months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of March 31, 2015,
we had no long-term debt obligations or other similar long-term liabilities other than various obligations under our CRADA
and our license agreements. We have no financial guarantees, debt or lease agreements or other arrangements that could trigger
a requirement for an early payment or that could change the value of our assets. We do not have any bank credit lines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Cash Flow </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I><U>Net Cash Used
in Operating Activities</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net cash used in operating
activities was $3,459,000 for the three months ended March&nbsp;31, 2015, compared with $2,267,000 for the three months ended March
31, 2014. The increase in cash used in operating activities of approximately $1,192,000 resulted from the $3,038,000 increase in
our net loss. Net cash used in operating activities was less than our net loss due to a $1,017,000 non-cash charge in the fiscal
2015 quarter related to the fair value of vested stock option and warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I><U>Net Cash Flow
from Investing Activities</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net cash used in investing
activities was $782,000 for the three months ended March 31, 2015, compared with $3,000 for the three months ended March 31, 2014.
The increase was due to our purchase of lab equipment and furniture for our Tampa, Florida, laboratory.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I><U>Net Cash Flow
from Financing Activities</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net cash provided by
financing activities was $70,612,000 for the three months ended March 31, 2015, compared with $543,000 for the three months ended
March 31, 2014. The increase was due to net proceeds of $68,307,000 received from the March 3, 2015 public offering of our common
stock, and $2,304,000 received from common stock warrant exercises. We received $543,000 of net proceeds from common stock warrant
exercises in the three months ended March 31, 2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Off-Balance Sheet Arrangements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have not entered
into any off-balance sheet financing arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Critical Accounting Policies and Estimates</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In our Annual Report
on Form 10-K for the year ended December 31, 2014, we disclosed our critical accounting policies and estimates upon which our financial
statements are derived. There have been no changes to these policies since December&nbsp;31, 2014 that are not included in Note
1 of the accompanying condensed consolidated financial statements for the three months ended March 31, 2015. Readers are encouraged
to read our Annual Report on Form 10-K in conjunction with this report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Inflation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Inflation and changing
prices have had no effect on our continuing operations over our two most recent fiscal years.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 84px; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B><A NAME="lion_005"></A>Item 3.</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Quantitative and Qualitative Disclosures About Market Risk</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The primary objective
of our investment activities is to preserve capital. We do not utilize hedging contracts or similar instruments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are exposed to certain
market risks relating primarily to interest rate risk on our cash and cash equivalents and risks relating to the financial viability
of the institutions which hold our capital and through which we have invested our funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 84px; font-size: 10pt; text-align: justify"><A NAME="lion_006"></A><FONT STYLE="font-size: 10pt"><B>Item 4.</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Controls and Procedures</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Evaluation of Disclosure Controls and Procedures </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">As of the end of the period covered by this
quarterly report on Form 10-Q, our principal executive officer and our principal accounting officer (the &ldquo;Certifying Officers&rdquo;),
evaluated the effectiveness of our disclosure controls and procedures. Disclosure controls and procedures are controls and procedures
designed to reasonably assure that information required to be disclosed in our reports filed under the Securities Exchange Act
of 1934 (the &ldquo;Exchange Act&rdquo;), such as this quarterly report on Form 10-Q, is recorded, processed, summarized and reported
within the time periods specified in the SEC rules and forms. Disclosure controls and procedures are also designed to reasonably
assure that such information is accumulated and communicated to our management, including the Certifying Officers, as appropriate
to allow timely decisions regarding required disclosure. Based on these evaluations, the Certifying Officers have concluded, that,
as of the end of the period covered by this quarterly report on Form 10-Q, our disclosure controls and procedures were not effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Changes in Controls over Financial Reporting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There has been no change
in the Company&rsquo;s internal control over financial reporting during the quarter ended March 31, 2015 that has materially affected,
or is reasonably likely to materially affect, the Company&rsquo;s internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="lion_007"></A><B>PART II. OTHER INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 13%; font-size: 10pt; text-align: justify"><A NAME="lion_008"></A><FONT STYLE="font-size: 10pt"><B>Item 1.</B></FONT></TD>
    <TD STYLE="width: 87%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Legal Proceedings</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are no other
pending legal proceedings to which the Company is a party or of which its property is the subject.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 13%; font-size: 10pt; text-align: justify"><A NAME="lion_009"></A><FONT STYLE="font-size: 10pt"><B>Item 1A.</B></FONT></TD>
    <TD STYLE="width: 87%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Risk Factors</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Information regarding
risk factors appears under &ldquo;Risk Factors&rdquo; included in Item 1A, Part I, and under Item 7, Management&rsquo;s Discussion
and Analysis of Financial Condition and Results of Operations, of our Annual Report on Form 10-K for the year ended December 31,
2014. There have been no material changes from the risk factors previously disclosed in the above-mentioned periodic report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 13%; font-size: 10pt; text-align: justify"><A NAME="lion_010"></A><FONT STYLE="font-size: 10pt"><B>Item 2.</B></FONT></TD>
    <TD STYLE="width: 87%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Unregistered Sales of Securities and Use of Proceeds.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the fiscal quarter
ended March 31, 2015, 41 accredited investors who held warrants that we sold to them in the November 2013 in a private placement,
exercised warrants to purchase 921,700 shares of common stock at an exercise price of $2.50 per share (for a total amount of $2304,250).
These shares were issued pursuant to an exemption available under Section 4(a)(2) of the Securities Act of 1933, as amended. No commissions
were paid with respect to these warrants exercises.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the three months
ended March&nbsp;31, 2015, we granted options to a new director to purchase an aggregate of 50,000 shares of common stock at an
exercise price of $7.45 per share. The options are exercisable for a period of ten years from the grant date. The grant was exempt
from registration in reliance on Section&nbsp;4(a)(2)&nbsp;of the Securities Act as transactions not involving any public offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 13%; font-size: 10pt; text-align: justify"><A NAME="lion_011"></A><FONT STYLE="font-size: 10pt"><B>Item 3.</B></FONT></TD>
    <TD STYLE="width: 87%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Defaults Upon Senior Securities.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nothing to report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 13%; font-size: 10pt; text-align: justify"><A NAME="lion_012"></A><FONT STYLE="font-size: 10pt"><B>Item 4.</B></FONT></TD>
    <TD STYLE="width: 87%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Mine Safety Disclosures</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nothing to report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 13%; font-size: 10pt"><A NAME="lion_013"></A><FONT STYLE="font-size: 10pt"><B>Item 5.</B></FONT></TD>
    <TD STYLE="width: 87%; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Other Information.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nothing to report</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 13%; font-size: 10pt"><A NAME="lion_014"></A><FONT STYLE="font-size: 10pt"><B>Item 6.</B></FONT></TD>
    <TD STYLE="width: 87%; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Exhibits</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="vertical-align: top; width: 11%; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Exhibit</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><B>Number</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 89%; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Description of Exhibit</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">31.1</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Certification of Principal Executive Officer pursuant to Rule 13a-14 and Rule 15d-14(a), promulgated under the Securities and Exchange Act of 1934, as amended.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">31.2</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Certification of Principal Financial Officer pursuant to Rule 13a-14 and Rule 15d 14(a), promulgated under the Securities and Exchange Act of 1934, as amended.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">32.1</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chief Executive Officer).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">32.2</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chief Financial Officer).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">101.INS</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">XBRL Instance Document</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">101.SCH</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">XBRL Taxonomy Extension Schema</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">101.CAL</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">XBRL Taxonomy Extension Calculation Linkbase</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">101.DEF</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">XBRL Taxonomy Extension Definition Linkbase</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">101.LAB</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">XBRL Taxonomy Extension Label Linkbase</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">101.PRE</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">XBRL Extension Presentation Linkbase</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="lion_015"></A><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-decoration: underline"><FONT STYLE="font-size: 10pt"><B><U>Lion Biotechnologies, Inc.</U></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 46%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">May 11, 2015</FONT></TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Elma Hawkins</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Elma Hawkins</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Chief Executive Officer (Principal Executive Officer)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">May 11, 2015</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Michael Handelman</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Michael Handelman</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Chief Financial Officer (Principal Financial and<BR>
 Accounting Officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>v409271_ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">I, Elma Hawkins, Chief Executive Officer
of Lion Biotechnologies, Inc., certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD>I have reviewed this Quarterly Report on Form 10-Q of Lion Biotechnologies, Inc.;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with
respect to the period covered by this report;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in
all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
presented in this report;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD>I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
registrant and have:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">a)</TD><TD>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my
supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during the period in which this report is being prepared;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">b)</TD><TD>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">c)</TD><TD>Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report my conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on
such evaluation; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">d)</TD><TD>Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during
the registrant&rsquo;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the
registrant&rsquo;s internal control over financial reporting; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD>I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s
auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">a)</TD><TD>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial
information; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">b)</TD><TD>Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; padding-bottom: 1.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Dated:&nbsp;&nbsp;May 11, 2015</FONT></TD>
    <TD STYLE="width: 4%; padding-bottom: 1.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 36%; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Elma Hawkins</FONT></TD>
    <TD STYLE="width: 9%; padding-bottom: 1.25pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Elma Hawkins</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>v409271_ex31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">I, Michael Handelman, Chief Financial Officer
of Lion Biotechnologies, Inc., certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD>I have reviewed this Quarterly Report on Form 10-Q of Lion Biotechnologies, Inc.;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with
respect to the period covered by this report;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in
all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
presented in this report;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD>I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
registrant and have:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">a)</TD><TD>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my
supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during the period in which this report is being prepared;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">b)</TD><TD>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">c)</TD><TD>Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report my conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on
such evaluation; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">d)</TD><TD>Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during
the registrant&rsquo;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the
registrant&rsquo;s internal control over financial reporting; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD>I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s
auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">a)</TD><TD>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial
information; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">b)</TD><TD>Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; padding-bottom: 1.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Dated: May 11, 2015</FONT></TD>
    <TD STYLE="width: 4%; padding-bottom: 1.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 36%; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Michael Handelman</FONT></TD>
    <TD STYLE="width: 9%; padding-bottom: 1.25pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Michael Handelman</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>v409271_ex32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C. SECTION 1350,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the Quarterly Report
on Form 10-Q of Lion Biotechnologies, Inc. (the &ldquo;Company&rdquo;) for the quarter ended March 31, 2015, as filed with the
Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), Elma Hawkins, Chief Executive Officer of the
Company, hereby certifies, pursuant to 18 U.S.C. &sect;1350, as adopted pursuant to &sect;906 of the Sarbanes-Oxley Act of 2002,
that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(1) The Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(2) The information contained in the Report fairly presents,
in all material respects, the financial condition and results of operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; padding-bottom: 1.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Dated:&nbsp;&nbsp;May 11, 2015</FONT></TD>
    <TD STYLE="width: 4%; padding-bottom: 1.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 36%; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Elma Hawkins</FONT></TD>
    <TD STYLE="width: 9%; padding-bottom: 1.25pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Elma Hawkins</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This certification accompanies each Report pursuant to &sect;
906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed
filed by the Company for purposes of &sect;18 of the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A signed original of this written statement required by Section
906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission
or its staff upon request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>v409271_ex32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 32.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C. SECTION 1350,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the Quarterly Report
on Form 10-Q of Lion Biotechnologies, Inc. (the &ldquo;Company&rdquo;) for the quarter ended March 31, 2015, as filed with the
Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), Michael Handelman, Chief Financial Officer of
the Company, hereby certifies, pursuant to 18 U.S.C. &sect;1350, as adopted pursuant to &sect;906 of the Sarbanes-Oxley Act of
2002, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(1) The Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(2) The information contained in the Report fairly presents,
in all material respects, the financial condition and results of operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; padding-bottom: 1.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Dated:&nbsp;&nbsp;May 11, 2015</FONT></TD>
    <TD STYLE="width: 4%; padding-bottom: 1.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 36%; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Michael Handelman</FONT></TD>
    <TD STYLE="width: 9%; padding-bottom: 1.25pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Michael Handelman</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This certification accompanies each Report
pursuant to &sect; 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act
of 2002, be deemed filed by the Company for purposes of &sect;18 of the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A signed original of this written statement
required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and
Exchange Commission or its staff upon request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>6
<FILENAME>lbio-20150331.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--Created by IRIS, Powered by IRIS Carbon-->
<xbrli:xbrl xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2014-01-31" xmlns:lbio="http://www.lbio.com/20150331">
  <link:schemaRef xlink:type="simple" xlink:href="lbio-20150331.xsd" />
  <xbrli:context id="C680990">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C680991">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-01-01</xbrli:startDate>
      <xbrli:endDate>2014-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C681022">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C681023">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C681024">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C681025">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C681029">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C681030">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C681031">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lbio:CommonStockToBeIssuedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C681032">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C681033">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C681034">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C681035">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C681037">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C681038">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C681039">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C681040">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C681041">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">lbio:CommonStockToBeIssuedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C681042">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C681043">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C713287">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C713288">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C713290">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C714310">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C714311">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C714341">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C714347">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C714366">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C714945">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-01-01</xbrli:startDate>
      <xbrli:endDate>2014-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C787614">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-01-01</xbrli:startDate>
      <xbrli:endDate>2014-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C787615">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-11-01</xbrli:startDate>
      <xbrli:endDate>2013-11-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C787616">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-09-01</xbrli:startDate>
      <xbrli:endDate>2013-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C787703">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lbio:SeriesConvertiblePreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C787721">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-01-01</xbrli:startDate>
      <xbrli:endDate>2014-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C788559">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">lbio:CradaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">lbio:PerQuarterMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C788560">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">lbio:CradaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">lbio:PerYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C788561">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">lbio:NCIMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">lbio:PerYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-01-01</xbrli:startDate>
      <xbrli:endDate>2014-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C788562">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">lbio:NCIMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">lbio:PerYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C788563">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">lbio:NCIMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">lbio:PerQuarterMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C788564">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">lbio:CradaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C788565">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">lbio:CradaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-01-01</xbrli:startDate>
      <xbrli:endDate>2014-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C788566">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">lbio:CradaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C788568">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">lbio:NIHMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C788569">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">lbio:MelanomaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C788570">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">lbio:OvarianCancerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C788571">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">lbio:BreastCancerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C788572">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">lbio:ColorectalCancerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C788577">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">lbio:NIHMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C788582">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">lbio:ManufacturingServiceAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C788583">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">lbio:ManufacturingServiceAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-01-01</xbrli:startDate>
      <xbrli:endDate>2014-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C788584">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">lbio:ManufacturingServiceAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C788611">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-12-01</xbrli:startDate>
      <xbrli:endDate>2014-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800532">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800533">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800534">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800535">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800536">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-01-01</xbrli:startDate>
      <xbrli:endDate>2014-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800537">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-01-01</xbrli:startDate>
      <xbrli:endDate>2014-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800538">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-01-01</xbrli:startDate>
      <xbrli:endDate>2014-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800557">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-01-01</xbrli:startDate>
      <xbrli:endDate>2014-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800558">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800559">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800560">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800566">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800567">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:VestingAxis">lbio:VestingFirstMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800568">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lbio:PlanOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-03-29</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800569">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lbio:PlanTwoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-11-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800570">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lbio:PlanTwoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-04-10</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800571">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lbio:PlanTwoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800572">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800573">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">lbio:CradaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-02-01</xbrli:startDate>
      <xbrli:endDate>2015-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800574">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-01-01</xbrli:startDate>
      <xbrli:endDate>2014-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800575">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800577">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-04-01</xbrli:startDate>
      <xbrli:endDate>2015-05-11</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800578">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-04-01</xbrli:startDate>
      <xbrli:endDate>2015-05-11</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800579">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-05-06</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800580">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-05-08</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C800581">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001425205</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-09-01</xbrli:startDate>
      <xbrli:endDate>2014-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:unit id="USD">
    <xbrli:measure>iso4217:USD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="USDPerShare">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <xbrli:unit id="Shares">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="Pure">
    <xbrli:measure>xbrli:pure</xbrli:measure>
  </xbrli:unit>
  <us-gaap:StockholdersEquity id="Tag1" contextRef="C681022" unitRef="USD" decimals="0">44845087</us-gaap:StockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity id="Tag2" contextRef="C681024" unitRef="USD" decimals="0">113537586</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity id="Tag3" contextRef="C681022" unitRef="USD" decimals="0">46506847</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="Tag4" contextRef="C681022" unitRef="USDPerShare" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized id="Tag5" contextRef="C681022" unitRef="Shares" decimals="INF">50000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued id="Tag6" contextRef="C681024" unitRef="Shares" decimals="INF">3694</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding id="Tag7" contextRef="C681024" unitRef="Shares" decimals="INF">3694</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding id="Tag8" contextRef="C681022" unitRef="Shares" decimals="INF">5694</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:CommonStockParOrStatedValuePerShare id="Tag9" contextRef="C681022" unitRef="USDPerShare" decimals="9">0.000041666</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized id="Tag10" contextRef="C681022" unitRef="Shares" decimals="INF">150000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued id="Tag11" contextRef="C681024" unitRef="Shares" decimals="INF">44871888</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding id="Tag12" contextRef="C681024" unitRef="Shares" decimals="INF">44871888</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding id="Tag13" contextRef="C681022" unitRef="Shares" decimals="INF">33750188</us-gaap:CommonStockSharesOutstanding>
  <lbio:CommonStockToBeIssuedShares id="Tag14" contextRef="C681022" unitRef="Shares" decimals="INF">303125</lbio:CommonStockToBeIssuedShares>
  <us-gaap:CommitmentsAndContingencies id="Tag15" contextRef="C681024" unitRef="USD" xsi:nil="true" />
  <us-gaap:CommitmentsAndContingencies id="Tag16" contextRef="C681022" unitRef="USD" xsi:nil="true" />
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Tag17" contextRef="C681024" unitRef="USD" decimals="0">111280443</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Tag18" contextRef="C681022" unitRef="USD" decimals="0">44909147</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="Tag19" contextRef="C681024" unitRef="USD" decimals="0">128883</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="Tag20" contextRef="C681022" unitRef="USD" decimals="0">66134</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:AssetsCurrent id="Tag21" contextRef="C681024" unitRef="USD" decimals="0">111409326</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent id="Tag22" contextRef="C681022" unitRef="USD" decimals="0">44975281</us-gaap:AssetsCurrent>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="Tag23" contextRef="C681024" unitRef="USD" decimals="0">289672</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="Tag24" contextRef="C681022" unitRef="USD" decimals="0">104223</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:PropertyPlantAndEquipmentNet id="Tag25" contextRef="C681024" unitRef="USD" decimals="0">2128260</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet id="Tag26" contextRef="C681022" unitRef="USD" decimals="0">1531566</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:Assets id="Tag27" contextRef="C681024" unitRef="USD" decimals="0">113537586</us-gaap:Assets>
  <us-gaap:Assets id="Tag28" contextRef="C681022" unitRef="USD" decimals="0">46506847</us-gaap:Assets>
  <us-gaap:AccountsPayableCurrent id="Tag29" contextRef="C681024" unitRef="USD" decimals="0">1107370</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent id="Tag30" contextRef="C681022" unitRef="USD" decimals="0">1248413</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccruedLiabilitiesCurrent id="Tag31" contextRef="C681024" unitRef="USD" decimals="0">717847</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent id="Tag32" contextRef="C681022" unitRef="USD" decimals="0">327847</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccountsPayableRelatedPartiesCurrent id="Tag33" contextRef="C681024" unitRef="USD" decimals="0">85500</us-gaap:AccountsPayableRelatedPartiesCurrent>
  <us-gaap:AccountsPayableRelatedPartiesCurrent id="Tag34" contextRef="C681022" unitRef="USD" decimals="0">85500</us-gaap:AccountsPayableRelatedPartiesCurrent>
  <us-gaap:LiabilitiesCurrent id="Tag35" contextRef="C681024" unitRef="USD" decimals="0">1910717</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent id="Tag36" contextRef="C681022" unitRef="USD" decimals="0">1661760</us-gaap:LiabilitiesCurrent>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="Tag37" contextRef="C681024" unitRef="USDPerShare" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized id="Tag38" contextRef="C681024" unitRef="Shares" decimals="INF">50000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued id="Tag39" contextRef="C681022" unitRef="Shares" decimals="INF">5694</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockValue id="Tag40" contextRef="C681024" unitRef="USD" decimals="0">4</us-gaap:PreferredStockValue>
  <us-gaap:PreferredStockValue id="Tag41" contextRef="C681022" unitRef="USD" decimals="0">6</us-gaap:PreferredStockValue>
  <us-gaap:CommonStockParOrStatedValuePerShare id="Tag42" contextRef="C681024" unitRef="USDPerShare" decimals="9">0.000041666</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized id="Tag43" contextRef="C681024" unitRef="Shares" decimals="INF">150000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued id="Tag44" contextRef="C681022" unitRef="Shares" decimals="INF">33750188</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="Tag45" contextRef="C681024" unitRef="USD" decimals="0">1870</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue id="Tag46" contextRef="C681022" unitRef="USD" decimals="0">1407</us-gaap:CommonStockValue>
  <lbio:CommonStockToBeIssuedShares id="Tag47" contextRef="C681024" unitRef="Shares" decimals="INF">303125</lbio:CommonStockToBeIssuedShares>
  <lbio:CommonStockToBeIssuedValue id="Tag48" contextRef="C681024" unitRef="USD" decimals="0">245153</lbio:CommonStockToBeIssuedValue>
  <lbio:CommonStockToBeIssuedValue id="Tag49" contextRef="C681022" unitRef="USD" decimals="0">245153</lbio:CommonStockToBeIssuedValue>
  <us-gaap:AdditionalPaidInCapital id="Tag50" contextRef="C681024" unitRef="USD" decimals="0">193239795</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AdditionalPaidInCapital id="Tag51" contextRef="C681022" unitRef="USD" decimals="0">121160415</us-gaap:AdditionalPaidInCapital>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="Tag52" contextRef="C681024" unitRef="USD" decimals="0">-81859953</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="Tag53" contextRef="C681022" unitRef="USD" decimals="0">-76561894</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockholdersEquity id="Tag54" contextRef="C681024" unitRef="USD" decimals="0">111626869</us-gaap:StockholdersEquity>
  <us-gaap:Revenues id="Tag55" contextRef="C680990" unitRef="USD" xsi:nil="true" />
  <us-gaap:Revenues id="Tag56" contextRef="C680991" unitRef="USD" xsi:nil="true" />
  <us-gaap:ShareBasedCompensation id="Tag57" contextRef="C680990" unitRef="USD" decimals="0">1467753</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="Tag58" contextRef="C680991" unitRef="USD" decimals="0">919350</us-gaap:ShareBasedCompensation>
  <us-gaap:OperatingCostsAndExpenses id="Tag59" contextRef="C680990" unitRef="USD" decimals="0">3287026</us-gaap:OperatingCostsAndExpenses>
  <us-gaap:OperatingCostsAndExpenses id="Tag60" contextRef="C680991" unitRef="USD" decimals="0">1956852</us-gaap:OperatingCostsAndExpenses>
  <us-gaap:ResearchAndDevelopmentExpense id="Tag61" contextRef="C680990" unitRef="USD" decimals="0">2011033</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="Tag62" contextRef="C680991" unitRef="USD" decimals="0">302662</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:OperatingExpenses id="Tag63" contextRef="C680990" unitRef="USD" decimals="0">5298059</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses id="Tag64" contextRef="C680991" unitRef="USD" decimals="0">2259514</us-gaap:OperatingExpenses>
  <us-gaap:NetIncomeLoss id="Tag65" contextRef="C680990" unitRef="USD" decimals="0">-5298059</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="Tag66" contextRef="C680991" unitRef="USD" decimals="0">-2259514</us-gaap:NetIncomeLoss>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Tag67" contextRef="C680991" unitRef="USDPerShare" decimals="2">-0.11</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Tag68" contextRef="C680990" unitRef="Shares" decimals="INF">37678662</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Tag69" contextRef="C680991" unitRef="Shares" decimals="INF">20798229</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Tag70" contextRef="C680990" unitRef="USDPerShare" decimals="2">-0.14</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:SharesOutstanding id="Tag71" contextRef="C681029" unitRef="Shares" decimals="INF">5694</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity id="Tag72" contextRef="C681029" unitRef="USD" decimals="0">6</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="Tag73" contextRef="C681030" unitRef="Shares" decimals="INF">33750188</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity id="Tag74" contextRef="C681030" unitRef="USD" decimals="0">1407</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag75" contextRef="C681031" unitRef="USD" decimals="0">245153</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag76" contextRef="C681032" unitRef="USD" decimals="0">121160415</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag77" contextRef="C681033" unitRef="USD" decimals="0">-76561894</us-gaap:StockholdersEquity>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket id="Tag78" contextRef="C681037" unitRef="USD" decimals="0">1017308</us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket id="Tag79" contextRef="C680990" unitRef="USD" decimals="0">1017308</us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket>
  <lbio:CommonStockIssuedUponExerciseOfWarrantsShares id="Tag80" contextRef="C681035" unitRef="Shares" decimals="INF">921700</lbio:CommonStockIssuedUponExerciseOfWarrantsShares>
  <lbio:CommonStockIssuedUponExerciseOfWarrantsAmount id="Tag81" contextRef="C681035" unitRef="USD" decimals="0">38</lbio:CommonStockIssuedUponExerciseOfWarrantsAmount>
  <lbio:CommonStockIssuedUponExerciseOfWarrantsAmount id="Tag82" contextRef="C681037" unitRef="USD" decimals="0">2304212</lbio:CommonStockIssuedUponExerciseOfWarrantsAmount>
  <lbio:CommonStockIssuedUponExerciseOfWarrantsAmount id="Tag83" contextRef="C680990" unitRef="USD" decimals="0">2304250</lbio:CommonStockIssuedUponExerciseOfWarrantsAmount>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities id="Tag84" contextRef="C681034" unitRef="Shares" decimals="INF">-2000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="Tag85" contextRef="C681034" unitRef="USD" decimals="0">-2</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities id="Tag86" contextRef="C681035" unitRef="Shares" decimals="INF">1000000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="Tag87" contextRef="C681035" unitRef="USD" decimals="0">42</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="Tag88" contextRef="C681037" unitRef="USD" decimals="0">-40</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="Tag89" contextRef="C680990" unitRef="USD" xsi:nil="true" />
  <us-gaap:StockIssuedDuringPeriodSharesOther id="Tag90" contextRef="C681035" unitRef="Shares" decimals="INF">9200000</us-gaap:StockIssuedDuringPeriodSharesOther>
  <us-gaap:StockIssuedDuringPeriodValueOther id="Tag91" contextRef="C681035" unitRef="USD" decimals="0">383</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:StockIssuedDuringPeriodValueOther id="Tag92" contextRef="C681037" unitRef="USD" decimals="0">68307455</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:StockIssuedDuringPeriodValueOther id="Tag93" contextRef="C680990" unitRef="USD" decimals="0">68307838</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition id="Tag94" contextRef="C681037" unitRef="USD" decimals="0">450445</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition id="Tag95" contextRef="C680990" unitRef="USD" decimals="0">450445</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
  <us-gaap:NetIncomeLoss id="Tag96" contextRef="C681038" unitRef="USD" decimals="0">-5298059</us-gaap:NetIncomeLoss>
  <us-gaap:SharesOutstanding id="Tag97" contextRef="C681039" unitRef="Shares" decimals="INF">3694</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity id="Tag98" contextRef="C681039" unitRef="USD" decimals="0">4</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="Tag99" contextRef="C681040" unitRef="Shares" decimals="INF">44871888</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity id="Tag100" contextRef="C681040" unitRef="USD" decimals="0">1870</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag101" contextRef="C681041" unitRef="USD" decimals="0">245153</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag102" contextRef="C681042" unitRef="USD" decimals="0">193239795</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag103" contextRef="C681043" unitRef="USD" decimals="0">-81859953</us-gaap:StockholdersEquity>
  <us-gaap:DepreciationAndAmortization id="Tag104" contextRef="C680990" unitRef="USD" decimals="0">185449</us-gaap:DepreciationAndAmortization>
  <us-gaap:DepreciationAndAmortization id="Tag105" contextRef="C680991" unitRef="USD" decimals="0">16565</us-gaap:DepreciationAndAmortization>
  <us-gaap:StockOptionPlanExpense id="Tag106" contextRef="C680990" unitRef="USD" decimals="0">1017308</us-gaap:StockOptionPlanExpense>
  <us-gaap:StockOptionPlanExpense id="Tag107" contextRef="C680991" unitRef="USD" decimals="0">901650</us-gaap:StockOptionPlanExpense>
  <lbio:FairValueOfVestedWarrantsGrantedForServices id="Tag108" contextRef="C680990" unitRef="USD" decimals="0">450445</lbio:FairValueOfVestedWarrantsGrantedForServices>
  <lbio:FairValueOfVestedWarrantsGrantedForServices id="Tag109" contextRef="C680991" unitRef="USD" decimals="0">17700</lbio:FairValueOfVestedWarrantsGrantedForServices>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="Tag110" contextRef="C680990" unitRef="USD" decimals="0">62749</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="Tag111" contextRef="C680991" unitRef="USD" decimals="0">-49625</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities id="Tag112" contextRef="C680990" unitRef="USD" decimals="0">248957</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities id="Tag113" contextRef="C680991" unitRef="USD" decimals="0">-993389</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations id="Tag114" contextRef="C680990" unitRef="USD" decimals="0">-3458649</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations id="Tag115" contextRef="C680991" unitRef="USD" decimals="0">-2267363</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="Tag116" contextRef="C680990" unitRef="USD" decimals="0">782143</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="Tag117" contextRef="C680991" unitRef="USD" decimals="0">3437</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <lbio:ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants id="Tag118" contextRef="C680990" unitRef="USD" decimals="0">2304250</lbio:ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants>
  <lbio:ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants id="Tag119" contextRef="C680991" unitRef="USD" decimals="0">542500</lbio:ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="Tag120" contextRef="C680990" unitRef="USD" decimals="0">68307838</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations id="Tag121" contextRef="C680990" unitRef="USD" decimals="0">70612088</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations id="Tag122" contextRef="C680991" unitRef="USD" decimals="0">542500</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="Tag123" contextRef="C680990" unitRef="USD" decimals="0">66371296</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="Tag124" contextRef="C680991" unitRef="USD" decimals="0">-1728300</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Tag125" contextRef="C681023" unitRef="USD" decimals="0">19672177</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Tag126" contextRef="C681025" unitRef="USD" decimals="0">17943877</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:InterestPaid id="Tag127" contextRef="C680990" unitRef="USD" xsi:nil="true" />
  <us-gaap:InterestPaid id="Tag128" contextRef="C680991" unitRef="USD" xsi:nil="true" />
  <us-gaap:IncomeTaxesPaid id="Tag129" contextRef="C680990" unitRef="USD" xsi:nil="true" />
  <us-gaap:IncomeTaxesPaid id="Tag130" contextRef="C680991" unitRef="USD" xsi:nil="true" />
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="Tag131" contextRef="C788611" unitRef="USD" decimals="-5">32200000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfPrivatePlacement id="Tag132" contextRef="C787615" unitRef="USD" decimals="-5">23300000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
  <us-gaap:StockholdersEquityReverseStockSplit id="Tag133" contextRef="C787616">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;1-for-100&lt;/div&gt;</us-gaap:StockholdersEquityReverseStockSplit>
  <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock id="Tag134" contextRef="C680990">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;
&lt;p style="margin: 0pt; font-family: 'times new roman';"&gt;&lt;br/&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;b&gt;&lt;font style="text-decoration: underline;"&gt;NOTE 1. GENERAL ORGANIZATION AND BUSINESS&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"&gt;Lion Biotechnologies, Inc. (the &amp;#147;Company,&amp;#148; &amp;#147;we,&amp;#148; &amp;#147;us&amp;#148; or &amp;#147;our&amp;#148;) is an a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells. Our lead program is an adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors, for the treatment of metastatic melanoma. The TIL are then activated and expanded ex vivo and then infused back into the patient to fight their tumor cells. The Company was originally incorporated under the laws of the state of Nevada on September 17, 2007. Until March 2010, we were an inactive company known as Freight Management Corp. On March 15, 2010, we changed our name to Genesis Biopharma, Inc., and in 2011 we commenced our current business.&lt;/p&gt;
&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"&gt;On September 26, 2013, we amended and restated our Articles of Incorporation to, among other things, change our name to Lion Biotechnologies, Inc., effect a &lt;font&gt;1-for-100&lt;/font&gt; reverse stock split (pro-rata reduction of outstanding shares) of our common stock. After the reverse stock split we increased the number of our authorized number of shares of common stock to &lt;font&gt;150,000,000&lt;/font&gt; shares, in addition we authorized the issuance of &lt;font&gt;50,000,000&lt;/font&gt; shares of &amp;#147;blank check&amp;#148; preferred stock, $&lt;font&gt;0.001&lt;/font&gt; par value per share. References in these financial statements and related notes to numbers of shares of common stock, prices per share of common stock, and weighted average number of shares of common stock outstanding prior to the reverse stock splits have been adjusted to reflect the reverse stock splits for all periods presented, unless otherwise noted.&lt;/p&gt;
&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"&gt;&lt;b&gt;&lt;i&gt;Basis of Presentation of Unaudited Condensed Financial Information&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-indent: 0px; font-size-adjust: none; font-stretch: normal; background-color: white;"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal; background-color: white;"&gt;The unaudited condensed financial statements of the Company for the three months ended March 31, 2015 and 2014 have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Regulation S-K. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. However, such information reflects all adjustments (consisting solely of normal recurring adjustments), which are, in the opinion of management, necessary for the fair presentation of the financial position and the results of operations. Results shown for interim periods are not necessarily indicative of the results to be obtained for a full fiscal year. The balance sheet information as of December 31, 2014 was derived from the audited financial statements included in the Company's financial statements as of and for the year ended December 31, 2014 included in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission (the &amp;#147;SEC&amp;#148;) on March 16, 2015. These financial statements should be read in conjunction with that report.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;b&gt;&lt;i&gt;Liquidity&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;We are currently engaged in the development of therapeutics to fight cancer, we do not have any commercial products and have not yet generated any revenues from our biopharmaceutical business. We currently do not anticipate that we will generate any revenues during 2015 from the sale or licensing of any products. In addition, we have not generated any revenues from our prior business plans.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;We have not had any revenues and are still in the development stage. As shown in the accompanying condensed financial statements, we have incurred a net loss of $&lt;font&gt;5,298,059&lt;/font&gt; for the three months ended March 31, 2015 and used $&lt;font&gt;3,458,649&lt;/font&gt;&amp;#160;of cash in our operating activities during the three months ended March 31, 2015. As of March 31, 2015, we had $&lt;font&gt;111,280,443&lt;/font&gt; of cash or cash equivalents on hand, stockholders' equity of $&lt;font&gt;111,626,869&lt;/font&gt; and had working capital of $&lt;font&gt;109,498,609&lt;/font&gt;.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;During 2015, we expect to further ramp up our operations, which will increase the amount of cash we will use in our operations. Our budget for 2015 includes increased spending on research and development activities, higher payroll expenses as we increase our professional staff, the costs associated with operating our new Tampa, Florida, research facility, as well as ongoing payments under the Cooperative Research and Development Agreement (CRADA) we have entered into with the National Cancer Institute (NCI). Based on the funds we had available on March 31, 2015, we believe that we have sufficient capital to fund our anticipated operating expenses for at least 24 months.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On March 3, 2015, the Company sold &lt;font&gt;9,200,000&lt;/font&gt; shares of its common stock in an underwritten public offering at $&lt;font&gt;8.00&lt;/font&gt; per share for net proceeds of $&lt;font&gt;68.3&lt;/font&gt; million, after deducting expenses of the offering. On December 22, 2014, the Company sold &lt;font&gt;6,000,000&lt;/font&gt; shares of its common stock in an underwritten public offering at $&lt;font&gt;5.75&lt;/font&gt; per share for net proceeds of $&lt;font&gt;32.2&lt;/font&gt; million after deducting expenses of the offering. On November 5, 2013, we completed a $&lt;font&gt;23.3&lt;/font&gt; million private placement of our securities to various institutional and individual accredited investors. Despite the amount of funds that we have raised, the estimated cost of completing the development of our TIL-based therapy, and of obtaining all required regulatory approvals to market those product candidates, may be substantially greater than the amount of funds we have available. Therefore, while we believe that our existing cash balances will be sufficient to fund our currently planned level of operations for at least 24 months, we will have to obtain additional funds in the future to complete our development plans. We intend to seek this additional funding through various financing sources, including possible sales of our securities, and in the longer term through strategic alliances with other pharmaceutical or biopharmaceutical companies.&lt;/p&gt;
&lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="Tag135" contextRef="C680990" unitRef="USD" decimals="0">3458649</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <lbio:WorkingCapital id="Tag136" contextRef="C681024" unitRef="USD" decimals="0">109498609</lbio:WorkingCapital>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Tag137" contextRef="C680990" unitRef="Shares" decimals="INF">9200000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SharePrice id="Tag138" contextRef="C681024" unitRef="USDPerShare" decimals="2">8.00</us-gaap:SharePrice>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="Tag139" contextRef="C787614" unitRef="USD" decimals="-5">68300000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Tag140" contextRef="C787614" unitRef="Shares" decimals="INF">6000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SharePrice id="Tag141" contextRef="C681022" unitRef="USDPerShare" decimals="2">5.75</us-gaap:SharePrice>
  <us-gaap:SignificantAccountingPoliciesTextBlock id="Tag142" contextRef="C680990">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt; &lt;p style="margin: 0pt; font-family: 'times new roman';"&gt;&lt;br/&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;b&gt;&lt;font style="text-decoration: underline;"&gt;NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES&lt;/font&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;div&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;b&gt;&lt;i&gt;Net Income (Loss) Per Share&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period, excluding unvested shares of restricted common stock. Shares of restricted stock subject to vesting are included in basic weighted average common shares outstanding from the time they vest. Diluted earnings per share is computed by dividing the net income applicable to common stock holders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation when their effect is antidilutive. When calculating diluted net income per share, shares of restricted stock subject to vesting are included in diluted weighted average common shares outstanding as of their grant date.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;At March 31, 2015 and 2014, basic and diluted net loss per share are the same as the effect of potentially dilutive securities was antidilutive. At March 31, 2015, potentially dilutive securities include options to acquire &lt;font&gt;1,907,877&lt;/font&gt; shares of common stock, warrants to acquire &lt;font&gt;10,162,726&lt;/font&gt; shares of common stock, preferred stock that can be converted into &lt;font&gt;1,847,000&lt;/font&gt; shares of common stock, and &lt;font&gt;507,113&lt;/font&gt; shares of non-vested restricted stock. At March 31, 2014, potentially dilutive securities include options to acquire &lt;font&gt;638,750&lt;/font&gt; shares of common stock, warrants to acquire &lt;font&gt;12,156,156&lt;/font&gt; shares of common stock, and preferred stock that can be converted into &lt;font&gt;6,650,000&lt;/font&gt; shares of common stock.&lt;/p&gt;&lt;/div&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #222222; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt; &lt;div&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;b&gt;&lt;i&gt;Fair Value Measurements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company uses various inputs in determining the fair value of certain assets and liabilities and measures these on a recurring basis. Financial assets and liabilities recorded at fair value in the balance sheets are categorized by the level of objectivity associated with the inputs used to measure their fair value. Authoritative guidance provided by the Financial Accounting Standards Board (the &amp;#147;FASB&amp;#148;) defines the following levels directly related to the amount of subjectivity associated with the inputs to fair valuation of these financial assets and liabilities:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;Level 1&amp;#151;Quoted prices in active markets for identical assets or liabilities.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;Level 2&amp;#151;Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;Level 3&amp;#151;Unobservable inputs based on the Company's assumptions.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;At March 31, 2015 and December 31, 2014, the fair value of cash and cash equivalents, accounts payable, and accrued expenses approximate their carrying values based on their short term nature.&lt;/p&gt;&lt;/div&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;div&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;b&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include accounting for potential liabilities and the assumptions made in valuing stock instruments issued for services.&lt;/p&gt;&lt;/div&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;div&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;b&gt;&lt;i&gt;Stock-Based Compensation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company periodically grants stock options and warrants to employees and non-employees in non-capital raising transactions as compensation for services rendered. The Company accounts for stock option grants to employees based on the authoritative guidance provided by the Financial Accounting Standards Board where the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option grants to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board where the value of the stock compensation is determined based upon the measurement date at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The fair value of the Company's common stock option grants is estimated using a Black-Scholes option pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the common stock options, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes option pricing model, and based on actual experience. The assumptions used in the Black-Scholes option pricing model could materially affect compensation expense recorded in future periods.&lt;/p&gt;&lt;/div&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;div&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;b&gt;&lt;i&gt;Research and Development&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Research and development costs consist primarily of fees paid to consultants and outside service providers, patent fees and costs, and other expenses relating to the acquisition, design, development and testing of the Company's treatments and product candidates. Research and development costs are expensed as incurred over the life of the underlying contracts on the straight-line basis, unless the achievement of milestones, the completion of contracted work, or other information indicates that a different expensing schedule is more appropriate. The Company reviews the status of its research and development contracts on a quarterly basis.&lt;/p&gt;&lt;/div&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;div&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;b&gt;&lt;i&gt;Concentrations&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company maintains cash balances at one bank. As of March 31, 2015, the Company's cash balances were in excess of insured limits maintained at the bank. Management believes that the financial institution that holds the Company's cash is financially sound and, accordingly, minimal credit risk exists.&lt;/p&gt;&lt;/div&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;div&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;b&gt;&lt;i&gt;Recent Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;. ASU 2014-09 is a comprehensive revenue recognition standard that will supersede nearly all existing revenue recognition guidance under current U.S. GAAP and replace it with a principle based approach for determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. ASU 2014-09 is effective for interim and annual periods beginning after December 15, 2016, however, the FASB has proposed a one-year deferral. Early adoption is not permitted, and either full retrospective adoption or modified retrospective adoption is permitted. The Company is in the process of evaluating the impact of ASU 2014-09 on the Company's financial statements and disclosures.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In January 2015, the FASB issued Accounting Standards Update No. 2015-01 (Subtopic 225-20) - Income Statement - Extraordinary and Unusual Items. ASU 2015-01 eliminates the concept of an extraordinary item from GAAP. As a result, an entity will no longer be required to segregate extraordinary items from the results of ordinary operations, to separately present an extraordinary item on its income statement, net of tax, after income from continuing operations or to disclose income taxes and earnings-per-share data applicable to an extraordinary item. However, ASU 2015-01 will still retain the presentation and disclosure guidance for items that are unusual in nature and occur infrequently. ASU 2015-01 is effective for periods beginning after December 15, 2015. Early adoption is permitted. The adoption of ASU 2015-01 is not expected to have a material effect on the Company's consolidated financial statements.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission (&amp;#147;SEC&amp;#148;) did not or are not believed by management to have a material impact on the Company's present or future financial statements.&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Tag143" contextRef="C800532" unitRef="Shares" decimals="INF">1907877</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Tag144" contextRef="C800533" unitRef="Shares" decimals="INF">10162726</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Tag145" contextRef="C800534" unitRef="Shares" decimals="INF">1847000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Tag146" contextRef="C800535" unitRef="Shares" decimals="INF">507113</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Tag147" contextRef="C800536" unitRef="Shares" decimals="INF">638750</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Tag148" contextRef="C800537" unitRef="Shares" decimals="INF">12156156</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Tag149" contextRef="C800538" unitRef="Shares" decimals="INF">6650000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:EarningsPerSharePolicyTextBlock id="Tag150" contextRef="C680990">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;b&gt;&lt;i&gt;Net Income (Loss) Per Share&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period, excluding unvested shares of restricted common stock. Shares of restricted stock subject to vesting are included in basic weighted average common shares outstanding from the time they vest. Diluted earnings per share is computed by dividing the net income applicable to common stock holders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation when their effect is antidilutive. When calculating diluted net income per share, shares of restricted stock subject to vesting are included in diluted weighted average common shares outstanding as of their grant date.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;At March 31, 2015 and 2014, basic and diluted net loss per share are the same as the effect of potentially dilutive securities was antidilutive. At March 31, 2015, potentially dilutive securities include options to acquire &lt;font&gt;1,907,877&lt;/font&gt; shares of common stock, warrants to acquire &lt;font&gt;10,162,726&lt;/font&gt; shares of common stock, preferred stock that can be converted into &lt;font&gt;1,847,000&lt;/font&gt; shares of common stock, and &lt;font&gt;507,113&lt;/font&gt; shares of non-vested restricted stock. At March 31, 2014, potentially dilutive securities include options to acquire &lt;font&gt;638,750&lt;/font&gt; shares of common stock, warrants to acquire &lt;font&gt;12,156,156&lt;/font&gt; shares of common stock, and preferred stock that can be converted into &lt;font&gt;6,650,000&lt;/font&gt; shares of common stock.&lt;/p&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:FairValueOfFinancialInstrumentsPolicy id="Tag151" contextRef="C680990">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;b&gt;&lt;i&gt;Fair Value Measurements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company uses various inputs in determining the fair value of certain assets and liabilities and measures these on a recurring basis. Financial assets and liabilities recorded at fair value in the balance sheets are categorized by the level of objectivity associated with the inputs used to measure their fair value. Authoritative guidance provided by the Financial Accounting Standards Board (the &amp;#147;FASB&amp;#148;) defines the following levels directly related to the amount of subjectivity associated with the inputs to fair valuation of these financial assets and liabilities:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;Level 1&amp;#151;Quoted prices in active markets for identical assets or liabilities.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;Level 2&amp;#151;Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;Level 3&amp;#151;Unobservable inputs based on the Company's assumptions.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;At March 31, 2015 and December 31, 2014, the fair value of cash and cash equivalents, accounts payable, and accrued expenses approximate their carrying values based on their short term nature.&lt;/p&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
  <us-gaap:UseOfEstimates id="Tag152" contextRef="C680990">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;b&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include accounting for potential liabilities and the assumptions made in valuing stock instruments issued for services.&lt;/p&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy id="Tag153" contextRef="C680990">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;b&gt;&lt;i&gt;Stock-Based Compensation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company periodically grants stock options and warrants to employees and non-employees in non-capital raising transactions as compensation for services rendered. The Company accounts for stock option grants to employees based on the authoritative guidance provided by the Financial Accounting Standards Board where the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option grants to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board where the value of the stock compensation is determined based upon the measurement date at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The fair value of the Company's common stock option grants is estimated using a Black-Scholes option pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the common stock options, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes option pricing model, and based on actual experience. The assumptions used in the Black-Scholes option pricing model could materially affect compensation expense recorded in future periods.&lt;/p&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
  <us-gaap:ResearchAndDevelopmentExpensePolicy id="Tag154" contextRef="C680990">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;b&gt;&lt;i&gt;Research and Development&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Research and development costs consist primarily of fees paid to consultants and outside service providers, patent fees and costs, and other expenses relating to the acquisition, design, development and testing of the Company's treatments and product candidates. Research and development costs are expensed as incurred over the life of the underlying contracts on the straight-line basis, unless the achievement of milestones, the completion of contracted work, or other information indicates that a different expensing schedule is more appropriate. The Company reviews the status of its research and development contracts on a quarterly basis.&lt;/p&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
  <us-gaap:ConcentrationRiskCreditRisk id="Tag155" contextRef="C680990">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;b&gt;&lt;i&gt;Concentrations&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company maintains cash balances at one bank. As of March 31, 2015, the Company's cash balances were in excess of insured limits maintained at the bank. Management believes that the financial institution that holds the Company's cash is financially sound and, accordingly, minimal credit risk exists.&lt;/p&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="Tag156" contextRef="C680990" unitRef="USDPerShare" xsi:nil="true" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod id="Tag157" contextRef="C680990" unitRef="Shares" decimals="INF">72651</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue id="Tag158" contextRef="C680990" unitRef="USDPerShare" decimals="2">6.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock id="Tag159" contextRef="C680990">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;b&gt;&lt;i&gt;Recent Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;. ASU 2014-09 is a comprehensive revenue recognition standard that will supersede nearly all existing revenue recognition guidance under current U.S. GAAP and replace it with a principle based approach for determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. ASU 2014-09 is effective for interim and annual periods beginning after December 15, 2016, however, the FASB has proposed a one-year deferral. Early adoption is not permitted, and either full retrospective adoption or modified retrospective adoption is permitted. The Company is in the process of evaluating the impact of ASU 2014-09 on the Company's financial statements and disclosures.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In January 2015, the FASB issued Accounting Standards Update No. 2015-01 (Subtopic 225-20) - Income Statement - Extraordinary and Unusual Items. ASU 2015-01 eliminates the concept of an extraordinary item from GAAP. As a result, an entity will no longer be required to segregate extraordinary items from the results of ordinary operations, to separately present an extraordinary item on its income statement, net of tax, after income from continuing operations or to disclose income taxes and earnings-per-share data applicable to an extraordinary item. However, ASU 2015-01 will still retain the presentation and disclosure guidance for items that are unusual in nature and occur infrequently. ASU 2015-01 is effective for periods beginning after December 15, 2015. Early adoption is permitted. The adoption of ASU 2015-01 is not expected to have a material effect on the Company's consolidated financial statements.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission (&amp;#147;SEC&amp;#148;) did not or are not believed by management to have a material impact on the Company's present or future financial statements.&lt;/p&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod id="Tag160" contextRef="C680990" unitRef="Shares" xsi:nil="true" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue id="Tag161" contextRef="C680990" unitRef="USDPerShare" xsi:nil="true" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="Tag162" contextRef="C681024" unitRef="Shares" decimals="INF">507113</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue id="Tag163" contextRef="C681024" unitRef="USDPerShare" decimals="2">6.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="Tag164" contextRef="C800557" unitRef="Shares" decimals="INF">782500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 id="Tag165" contextRef="C800557">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested id="Tag166" contextRef="C800558" unitRef="USD" decimals="0">4851590</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Tag167" contextRef="C800557" unitRef="USD" decimals="0">1256985</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue id="Tag168" contextRef="C800559" unitRef="USD" decimals="0">450445</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions id="Tag169" contextRef="C800560" unitRef="USD" decimals="0">3144160</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="Tag170" contextRef="C714310" unitRef="USDPerShare" decimals="2">7.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock id="Tag171" contextRef="C680990">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;
&lt;p style="margin: 0pt; font-family: 'times new roman';"&gt;&lt;br/&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;b&gt;&lt;font style="text-decoration: underline;"&gt;NOTE 3. STOCKHOLDERS' EQUITY&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;b&gt;&lt;i&gt;Public offering&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On March 3, 2015, the Company completed an underwritten public offering of &lt;font&gt;9,200,000&lt;/font&gt; shares of its common stock at a price of $&lt;font&gt;8.00&lt;/font&gt; per share of common stock. The net proceeds to the Company from the offering were $&lt;font&gt;68.3&lt;/font&gt; million, after deducting underwriting discounts and commissions and offering expenses. The offering was made pursuant to the Company's existing shelf registration statement on Form S-3, including a base prospectus, which was filed with the SEC on November 20, 2014 and declared effective on December 10, 2014, a preliminary prospectus supplement thereunder, and a registration statement on Form S-3 filed with the SEC on February 26, 2015.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;b&gt;&lt;i&gt;Issuance of common stock upon conversion of preferred stock&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;During the three months ended March 31, 2015, the Company issued &lt;font&gt;1,000,000&lt;/font&gt; shares of common stock upon the conversion of &lt;font&gt;2,000&lt;/font&gt; shares of Series A Convertible Preferred Stock. The number conversion shares issued was determined on a formula basis of &lt;font&gt;500&lt;/font&gt; common shares for each Series A Convertible Preferred Stock held.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;br/&gt;&lt;/p&gt;
&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"&gt;&lt;b&gt;&lt;i&gt;Common stock with vesting terms&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"&gt;During 2014, the Company granted &lt;font&gt;782,500&lt;/font&gt; shares of its restricted common stock to nine of its employees in accordance with the terms of their employment agreements. The 782,500 shares vest over a period of &lt;font&gt;three&lt;/font&gt; years. As these shares were granted to employees, the Company calculated the aggregate fair value of the 782,500 shares based on the trading prices of the Company's stock at their grant dates and determined it to be $&lt;font&gt;4,851,590&lt;/font&gt;, of which $&lt;font&gt;1,256,985&lt;/font&gt; was expensed in 2014. The allocable portion of the fair value of the stock that vested during the three months ended March 31, 2015 amounted to $&lt;font&gt;450,445&lt;/font&gt; and was recognized as expense in the accompanying statements of operations. As of March 31, 2015, the amount of unvested compensation related to all issuances of restricted common stock was $&lt;font&gt;3,144,160&lt;/font&gt;, which will be recorded as expense in future periods as the shares vest.&lt;/p&gt;
&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; font-size-adjust: none; font-stretch: normal;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"&gt;When calculating basic net income (loss) per share, these shares are included in basic weighted average common shares outstanding from the time they vest. When calculating diluted net income (loss) per share, these shares are included in diluted weighted average common shares outstanding from the time they are granted, unless they are antidilutive. Shares of restricted stock granted above are subject to forfeiture to the Company or other restrictions that will lapse in accordance with a vesting schedule determined by our Board.&lt;/p&gt;
&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; font-size-adjust: none; font-stretch: normal;"&gt;The following table summarizes restricted common stock activity:&lt;/p&gt;&lt;div&gt;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; font-size-adjust: none; font-stretch: normal;"&gt;
&lt;/p&gt;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; font-size-adjust: none; font-stretch: normal;"&gt;&amp;#160;&lt;/p&gt;
&lt;table align="center" style="font: 10pt/normal Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;" cellspacing="0" cellpadding="0"&gt;

&lt;tr style="vertical-align: bottom;"&gt;
&lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td nowrap="nowrap" style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td nowrap="nowrap" style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2"&gt;Number&amp;#160;of&lt;br/&gt; Shares&lt;/td&gt;
&lt;td nowrap="nowrap" style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td nowrap="nowrap" style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td nowrap="nowrap" style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Grant&amp;#160;Date&lt;br/&gt; Fair&amp;#160;Value&lt;/td&gt;
&lt;td nowrap="nowrap" style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;
&lt;td style="width: 74%;"&gt;Non-vested shares, January 1, 2015&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 10%; text-align: right;"&gt;&lt;font&gt;579,764&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 10%; text-align: right;"&gt;&lt;font&gt;6.20&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white;"&gt;
&lt;td style="padding-left: 0.125in;"&gt;Granted&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;
&lt;td style="padding-left: 0.125in;"&gt;Vested&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font&gt;(72,651&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font&gt;6.20&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white;"&gt;
&lt;td style="padding-left: 0.125in;"&gt;Forfeited&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"&gt;&lt;font&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"&gt;&lt;font&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;Non-vested shares, March 31, 2015&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"&gt;&lt;font&gt;507,113&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"&gt;&lt;font&gt;6.20&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; text-indent: 0.5in; font-size-adjust: none; font-stretch: normal;"&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;
&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:ConversionOfStockSharesIssued1 id="Tag172" contextRef="C680990" unitRef="Shares" decimals="INF">1000000</us-gaap:ConversionOfStockSharesIssued1>
  <us-gaap:ConversionOfStockSharesConverted1 id="Tag173" contextRef="C680990" unitRef="Shares" decimals="INF">2000</us-gaap:ConversionOfStockSharesConverted1>
  <us-gaap:ConversionOfStockSharesConverted1 id="Tag174" contextRef="C787703" unitRef="Shares" decimals="INF">500</us-gaap:ConversionOfStockSharesConverted1>
  <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock id="Tag175" contextRef="C680990">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; font-size-adjust: none; font-stretch: normal;"&gt;
&lt;/p&gt;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; font-size-adjust: none; font-stretch: normal;"&gt;&amp;#160;&lt;/p&gt;
&lt;table align="center" style="font: 10pt/normal Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;" cellspacing="0" cellpadding="0"&gt;

&lt;tr style="vertical-align: bottom;"&gt;
&lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td nowrap="nowrap" style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td nowrap="nowrap" style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2"&gt;Number&amp;#160;of&lt;br/&gt; Shares&lt;/td&gt;
&lt;td nowrap="nowrap" style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td nowrap="nowrap" style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td nowrap="nowrap" style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Grant&amp;#160;Date&lt;br/&gt; Fair&amp;#160;Value&lt;/td&gt;
&lt;td nowrap="nowrap" style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;
&lt;td style="width: 74%;"&gt;Non-vested shares, January 1, 2015&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 10%; text-align: right;"&gt;&lt;font&gt;579,764&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 10%; text-align: right;"&gt;&lt;font&gt;6.20&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white;"&gt;
&lt;td style="padding-left: 0.125in;"&gt;Granted&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;
&lt;td style="padding-left: 0.125in;"&gt;Vested&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font&gt;(72,651&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&lt;font&gt;6.20&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white;"&gt;
&lt;td style="padding-left: 0.125in;"&gt;Forfeited&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"&gt;&lt;font&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"&gt;&lt;font&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt; font-weight: bold;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;Non-vested shares, March 31, 2015&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"&gt;&lt;font&gt;507,113&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"&gt;&lt;font&gt;6.20&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; text-indent: 0.5in; font-size-adjust: none; font-stretch: normal;"&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="Tag176" contextRef="C681022" unitRef="Shares" decimals="INF">579764</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue id="Tag177" contextRef="C681022" unitRef="USDPerShare" decimals="2">6.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="Tag178" contextRef="C680990" unitRef="Shares" xsi:nil="true" />
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock id="Tag179" contextRef="C680990">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;
&lt;p style="margin: 0pt; font-family: 'times new roman';"&gt;&amp;#160;&lt;br/&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;b&gt;&lt;font style="text-decoration: underline;"&gt;NOTE 4. STOCK OPTIONS AND WARRANTS&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;b&gt;&lt;i&gt;Stock Options&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;A summary of the status of stock options at March 31, 2015, and the changes during the three months then ended, is presented in the following table:&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;
&lt;div class="CursorPointer"&gt;
&lt;div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 100%;"&gt;

&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="13" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;br/&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Weighted Average&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Shares&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Remaining&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Aggregate&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Under&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Exercise&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Contractual&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Intrinsic&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"&gt;&lt;strong&gt;Option&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"&gt;&lt;strong&gt;Price&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"&gt;&lt;strong&gt;Life&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"&gt;&lt;strong&gt;Value&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px;" width="100%"&gt;Outstanding at January 1, 2015&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;1,857,877&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;7.31&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;8.5&lt;/font&gt; years&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;2,874,378&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white;"&gt;
&lt;td style="font-family: 'Times New Roman';" width="100%"&gt;Granted&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;50,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;7.45&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;10&lt;/font&gt; years&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;233,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;
&lt;td style="font-family: 'Times New Roman';" width="100%"&gt;Exercised&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white;"&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px;" width="100%"&gt;Expired/Forfeited&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 1pt solid !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px;" width="100%"&gt;Outstanding at March 31, 2015&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;1,907,877&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 2.80pt double !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;7.47&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 2.80pt double !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;8.25&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 1pt solid !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;10,687,637&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 1pt solid !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white;"&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px;" width="100%"&gt;Exercisable at March 31, 2015&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;405,412&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 2.80pt double !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;10.48&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 2.80pt double !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;4,708,718&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;During the three months ended March 31, 2015, the Company granted an option to purchase &lt;font&gt;50,000&lt;/font&gt; shares of common stock to a new member of the Company's Board of Directors. The stock options have an exercise price of $&lt;font&gt;7.45&lt;/font&gt; and vest in four installments as follows: options for the purchase of &lt;font&gt;12,500&lt;/font&gt; shares vest on May 15, 2015, and the remaining options to purchase shares vest evenly over the next three quarters. The fair value of these options was determined to be $&lt;font&gt;369,000&lt;/font&gt; using the Black-Scholes option pricing model based on the following assumptions: (i) volatility rate of &lt;font&gt;213&lt;/font&gt;%, (ii) discount rate of &lt;font&gt;1.37&lt;/font&gt; %, (iii) &lt;font&gt;zero&lt;/font&gt; expected dividend yield, and (iv) expected life of &lt;font&gt;6&lt;/font&gt; years.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;During the three months ended March 31, 2015 and 2014, the Company recorded compensation costs of $&lt;font&gt;1,017,308&lt;/font&gt; and $&lt;font&gt;901,650&lt;/font&gt;, respectively, relating to the vesting of stock options. As of March 31, 2015, the aggregate value of unvested options was $&lt;font&gt;8,665,475&lt;/font&gt;, which will continue to be amortized as compensation cost as the options vest over terms ranging from &lt;font&gt;nine&lt;/font&gt; months to &lt;font&gt;five&lt;/font&gt; years, as applicable.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On March 29, 2010, the Company's Board of Directors adopted the Genesis Biopharma, Inc. 2010&lt;b&gt; &lt;/b&gt;Equity Compensation Plan (the "2010 Plan") pursuant to which the Board reserved an aggregate of &lt;font&gt;35,000&lt;/font&gt; shares of common stock for future grants of stock options, rights to acquire restricted stock, rights to acquire unrestricted stock, and stock appreciation rights. Options for the issuance of all 35,000 shares have been granted, and no shares are available for additional grants under the 2010 Plan.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On October 14, 2011, the Company's Board of Directors approved a 2011 Equity Incentive Plan (the &amp;#147;2011 Plan&amp;#148;). The Company's stockholders did not approve the 2011 Plan within a required one-year period, and accordingly, the Company cannot grant incentive stock options under the 2011 Plan. As of December 31, 2014, no shares were available for future grant under the 2011 Plan.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On September 19, 2014, The Company's Board of Directors adopted the Lion Biotechnologies, Inc. 2014 Equity Incentive Plan (the &amp;#147;2014 Plan&amp;#148;). The 2014 Plan was approved by our stockholders at the annual meeting of stockholders held in November 2014. The 2014 Plan initially authorized the issuance up to an aggregate of &lt;font&gt;2,350,000&lt;/font&gt; shares of common stock. On April 10, 2015 the Board amended the 2014 Plan, subject to stockholder approval, to increase the total number of shares that can be issued under the 2014 Plan by &lt;font&gt;1,650,000&lt;/font&gt; from 2,350,000 shares to &lt;font&gt;4,000,000&lt;/font&gt; shares.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;b&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;A summary of the status of stock warrants at March 31, 2015, and the changes during the three months then ended, is presented in the following table:&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&amp;#160;&lt;/p&gt;
&lt;div class="CursorPointer"&gt;
&lt;div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 100%;"&gt;

&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" colspan="3" align="center"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" colspan="3" align="center"&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="15" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt;"&gt;&lt;br/&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" colspan="3" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" colspan="3" align="center"&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="3" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt;"&gt;&lt;strong&gt;Weighted Average&lt;/strong&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" colspan="3" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="4" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Shares&lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="3" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt;"&gt;&lt;strong&gt;Remaining&lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Aggregate&lt;/strong&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="4" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Under&lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Exercise&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="3" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt;"&gt;&lt;strong&gt;Contractual&lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Intrinsic&lt;/strong&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="4" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"&gt;&lt;strong&gt;Warrants&lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"&gt;&lt;strong&gt;Price&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="3" align="center" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; font-size: 10.0pt;"&gt;&lt;strong&gt;Life&lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"&gt;&lt;strong&gt;Value&lt;/strong&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="vertical-align: top; text-align: left;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="3" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="3" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="3" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="3" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px;" width="100%"&gt;Outstanding at December 31, 2014&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;11,084,426&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;$&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;2.51&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;3.85&lt;/font&gt; years&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;$&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;59,517,998&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white;"&gt;
&lt;td style="text-indent: 10pt; font-family: 'times new roman'; padding: 0px;" width="100%"&gt;Issued&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;
&lt;td style="text-indent: 10pt; font-family: 'times new roman'; padding: 0px;" width="100%"&gt;Exercised&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;(921,700&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;)&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;$&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;2.50&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white;"&gt;
&lt;td style="text-indent: 10pt; font-family: 'times new roman'; padding: 0px;" width="100%"&gt;Expired&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px;" width="100%"&gt;Outstanding and exercisable at March 31, 2015&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;10,162,726&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;$&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;2.51&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;3.58&lt;/font&gt; years&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;$&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;97,654,187&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;During the three months ended March 31, 2015, the Company received $&lt;font&gt;2,304,250&lt;/font&gt; in cash from the exercise of 921,700 warrants for the purchase of &lt;font&gt;921,700&lt;/font&gt; shares of its common stock.&lt;/p&gt;
&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="Tag180" contextRef="C714347" unitRef="Shares" decimals="INF">1857877</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="Tag181" contextRef="C714347" unitRef="USDPerShare" decimals="2">7.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="Tag182" contextRef="C714945">P8Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue id="Tag183" contextRef="C714347" unitRef="USD" decimals="0">2874378</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="Tag184" contextRef="C714311" unitRef="Shares" decimals="INF">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="Tag185" contextRef="C714311" unitRef="USDPerShare" decimals="2">7.45</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <lbio:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm id="Tag186" contextRef="C714311">P10Y</lbio:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue id="Tag187" contextRef="C714311" unitRef="USD" decimals="0">233000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="Tag188" contextRef="C714311" unitRef="Shares" xsi:nil="true" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod id="Tag189" contextRef="C714311" unitRef="Shares" xsi:nil="true" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="Tag190" contextRef="C714310" unitRef="Shares" decimals="INF">1907877</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="Tag191" contextRef="C714311">P8Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue id="Tag192" contextRef="C714310" unitRef="USD" decimals="0">10687637</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber id="Tag193" contextRef="C714310" unitRef="Shares" decimals="INF">405412</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice id="Tag194" contextRef="C714310" unitRef="USDPerShare" decimals="2">10.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue id="Tag195" contextRef="C714310" unitRef="USD" decimals="0">4708718</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="Tag196" contextRef="C800566" unitRef="Shares" decimals="INF">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="Tag197" contextRef="C800566" unitRef="USDPerShare" decimals="2">7.45</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="Tag198" contextRef="C800567" unitRef="Shares" decimals="INF">12500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 id="Tag199" contextRef="C800566" unitRef="USD" decimals="0">369000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate id="Tag200" contextRef="C800566" unitRef="Pure" decimals="2">2.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate id="Tag201" contextRef="C800566" unitRef="Pure" decimals="4">0.0137</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate id="Tag202" contextRef="C800566" unitRef="Pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="Tag203" contextRef="C800566">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Tag204" contextRef="C680990" unitRef="USD" decimals="0">1017308</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Tag205" contextRef="C680991" unitRef="USD" decimals="0">901650</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized id="Tag206" contextRef="C681024" unitRef="USD" decimals="0">8665475</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 id="Tag207" contextRef="C713287">P9M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 id="Tag208" contextRef="C713288">P5Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized id="Tag209" contextRef="C800568" unitRef="Shares" decimals="INF">35000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized id="Tag210" contextRef="C800569" unitRef="Shares" decimals="INF">2350000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized id="Tag211" contextRef="C800571" unitRef="Shares" decimals="INF">1650000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized id="Tag212" contextRef="C800570" unitRef="Shares" decimals="INF">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="Tag213" contextRef="C714366" unitRef="Shares" decimals="INF">11084426</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="Tag214" contextRef="C714366" unitRef="USDPerShare" decimals="2">2.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="Tag215" contextRef="C787721">P3Y10M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue id="Tag216" contextRef="C714366" unitRef="USD" decimals="0">59517998</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="Tag217" contextRef="C713290" unitRef="Shares" xsi:nil="true" />
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="Tag218" contextRef="C713290" unitRef="Shares" decimals="INF">921700</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice id="Tag219" contextRef="C713290" unitRef="USDPerShare" decimals="2">2.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="Tag220" contextRef="C714341" unitRef="Shares" decimals="INF">10162726</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="Tag221" contextRef="C714341" unitRef="USDPerShare" decimals="2">2.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="Tag222" contextRef="C713290">P3Y6M29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue id="Tag223" contextRef="C714341" unitRef="USD" decimals="0">97654187</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
  <us-gaap:ProceedsFromWarrantExercises id="Tag224" contextRef="C680990" unitRef="USD" decimals="0">2304250</us-gaap:ProceedsFromWarrantExercises>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="Tag225" contextRef="C800572" unitRef="Shares" decimals="INF">921700</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber id="Tag226" contextRef="C714341" unitRef="Shares" decimals="INF">10162726</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice id="Tag227" contextRef="C714341" unitRef="USDPerShare" decimals="2">2.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 id="Tag228" contextRef="C713290">P3Y6M29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock id="Tag229" contextRef="C680990">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;
&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 100%;"&gt;

&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="13" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;br/&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Weighted Average&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Shares&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Remaining&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Aggregate&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Under&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Exercise&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Contractual&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Intrinsic&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"&gt;&lt;strong&gt;Option&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"&gt;&lt;strong&gt;Price&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"&gt;&lt;strong&gt;Life&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"&gt;&lt;strong&gt;Value&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px;" width="100%"&gt;Outstanding at January 1, 2015&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;1,857,877&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;7.31&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;8.5&lt;/font&gt; years&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;2,874,378&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white;"&gt;
&lt;td style="font-family: 'Times New Roman';" width="100%"&gt;Granted&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;50,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;7.45&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;10&lt;/font&gt; years&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;233,000&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;
&lt;td style="font-family: 'Times New Roman';" width="100%"&gt;Exercised&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white;"&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px;" width="100%"&gt;Expired/Forfeited&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 1pt solid !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px;" width="100%"&gt;Outstanding at March 31, 2015&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;1,907,877&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 2.80pt double !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;7.47&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 2.80pt double !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;8.25&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 1pt solid !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;10,687,637&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 1pt solid !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white;"&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px;" width="100%"&gt;Exercisable at March 31, 2015&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;405,412&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 2.80pt double !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;10.48&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 2.80pt double !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"&gt;&lt;font&gt;4,708,718&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ResearchAndDevelopmentExpense id="Tag230" contextRef="C800573" unitRef="USD" decimals="0">500000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="Tag231" contextRef="C788564" unitRef="USD" decimals="0">541667</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock id="Tag232" contextRef="C680990">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;
&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 100%;"&gt;

&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" colspan="3" align="center"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" colspan="3" align="center"&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="15" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt;"&gt;&lt;br/&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" colspan="3" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" colspan="3" align="center"&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="3" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt;"&gt;&lt;strong&gt;Weighted Average&lt;/strong&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" colspan="3" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="4" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Shares&lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="3" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt;"&gt;&lt;strong&gt;Remaining&lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Aggregate&lt;/strong&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="4" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Under&lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Exercise&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="3" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt;"&gt;&lt;strong&gt;Contractual&lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;Intrinsic&lt;/strong&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="4" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"&gt;&lt;strong&gt;Warrants&lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"&gt;&lt;strong&gt;Price&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" colspan="3" align="center" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; font-size: 10.0pt;"&gt;&lt;strong&gt;Life&lt;/strong&gt;&lt;/td&gt;
&lt;td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"&gt;&lt;strong&gt;Value&lt;/strong&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="vertical-align: top; text-align: left;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="3" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="3" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="3" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="3" align="center"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px;" width="100%"&gt;Outstanding at December 31, 2014&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;11,084,426&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;$&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;2.51&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;3.85&lt;/font&gt; years&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;$&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;59,517,998&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white;"&gt;
&lt;td style="text-indent: 10pt; font-family: 'times new roman'; padding: 0px;" width="100%"&gt;Issued&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;
&lt;td style="text-indent: 10pt; font-family: 'times new roman'; padding: 0px;" width="100%"&gt;Exercised&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;(921,700&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;)&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;$&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;2.50&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white;"&gt;
&lt;td style="text-indent: 10pt; font-family: 'times new roman'; padding: 0px;" width="100%"&gt;Expired&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;
&lt;td style="text-align: left; font-family: 'times new roman'; padding: 0px;" width="100%"&gt;Outstanding and exercisable at March 31, 2015&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;10,162,726&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'Times New Roman';"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;$&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;2.51&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;3.58&lt;/font&gt; years&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;$&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"&gt;&lt;font&gt;97,654,187&lt;/font&gt;&lt;/td&gt;
&lt;td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"&gt;&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock id="Tag233" contextRef="C680990">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt; &lt;p style="margin: 0pt; font-family: 'times new roman';"&gt;&lt;br/&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;b&gt;&lt;font style="text-decoration: underline;"&gt;NOTE 5. LICENSE AND COMMITMENTS&lt;/font&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;b&gt;&lt;i&gt;National Institutes of Health and the National Cancer Institute&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Effective August 5, 2011, the Company signed a Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health and the National Cancer Institute (NCI). Under the terms of the five-year cooperative research and development agreement, the Company will work with Dr. Steven A. Rosenberg, M.D., Ph.D., chief of NCI's Surgery Branch, to develop adoptive cell immunotherapies that are designed to destroy metastatic melanoma cells using a patient's tumor infiltrating lymphocytes.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company initially agreed to pay the NCI $&lt;font&gt;1,000,000&lt;/font&gt; per year ($&lt;font&gt;250,000&lt;/font&gt; per quarter) under the CRADA. On January 22, 2015, the Company executed an amendment (the &amp;#147;Amendment&amp;#148;) to the CRADA to include four new indications. As amended, in addition to metastatic melanoma, the CRADA now also includes the development of TIL therapy for the treatment of patients with bladder, lung, triple-negative breast, and HPV-associated cancers. Under the Amendment, the NCI also has agreed to provide the Company with samples of all tumors covered by the Amendment for performing studies related to improving TIL selection and/or TIL scale-out production and process development. As amended, the annual payments the Company is required to make to the NCI have increased from $&lt;font&gt;1&lt;/font&gt; million to $&lt;font&gt;2&lt;/font&gt; million, to be paid in quarterly installments of $&lt;font&gt;500,000&lt;/font&gt;. The Company paid the first quarterly installment of $&lt;font&gt;500,000&lt;/font&gt; in February 2015. Although the CRADA has a five year term, either party to the CRADA has the right to terminate the CRADA upon 60 days' notice to the other party.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;During the three months ended March 31, 2015 and 2014, the Company recognized $&lt;font&gt;541,667&lt;/font&gt; and $&lt;font&gt;250,000&lt;/font&gt;, respectively, of CRADA expenses, which were recorded as part of research and development expenses in the statement of operations. As of December 31, 2014 and March 31, 2015, $&lt;font&gt;250,000&lt;/font&gt; of CRADA expenses were included in the accrued expenses on the accompanying condensed balance sheet.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;b&gt;&lt;i&gt;National Institutes of Health&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Effective October 5, 2011, the Company entered into a Patent License Agreement (the &amp;#147;License Agreement&amp;#148;) with the National Institutes of Health, an agency of the United States Public Health Service within the Department of Health and Human Services (&amp;#147;NIH&amp;#148;). Pursuant to the License Agreement, NIH granted to the Company a non-exclusive worldwide right and license to develop and manufacture certain proprietary autologous tumor infiltrating lymphocyte adoptive cell therapy products for the treatment of metastatic melanoma, ovarian cancer, breast cancer, and colorectal cancer. The License Agreement requires the Company to pay royalties of six percent (&lt;font&gt;6&lt;/font&gt;%) of net sales (subject to certain annual minimum royalty payments), a percentage of revenues from sublicensing arrangements, and lump sum benchmark royalty payments on the achievement of certain clinical and regulatory milestones for each of the various indications and other direct cost incurred by NIH pursuant to the agreement. If the Company achieves all benchmarks for metastatic melanoma, up to and including the product's first commercial sale in the United States, the total amount of such benchmark payments will be $&lt;font&gt;6,050,000&lt;/font&gt;. The benchmark payments for the other three indications, if all benchmarks are achieved, will be $&lt;font&gt;6,050,000&lt;/font&gt; for ovarian cancer, $&lt;font&gt;12,100,000&lt;/font&gt; for breast cancer, and $&lt;font&gt;12,100,000&lt;/font&gt; for colorectal cancer. Accordingly, if the Company achieves all benchmarks for all four licensed indications, the aggregate amount of benchmark royalty payments that the Company will have to make to NIH will be $&lt;font&gt;36,300,000&lt;/font&gt;.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On February 9, 2015, the Company entered into an amendment to the License Agreement with the NIH pursuant to which the Company's non-exclusive license to melanoma was converted into an exclusive license. In consideration for the exclusive rights granted under the amendment to the License Agreement, the Company agreed to pay the NIH a non-refundable upfront licensing fee of $&lt;font&gt;350,000&lt;/font&gt;, which was recognized as research and development expense during the three months ended March 31, 2015, and included in the balance of accrued expenses at March 31, 2015. The Company also agreed to pay customary royalties based on a percentage of net sales (which percentage is in the mid-single digits), a percentage of revenues from sublicensing arrangements, and lump sum benchmark payments upon the successful completion of the Company's first Phase 2 clinical study, the successful completion of the Company's first Phase 3 clinical study, the receipt of the first FDA approval or foreign equivalent for a licensed product or process resulting from the licensed technologies, the first commercial sale of a licensed product or process in the United States, and the first commercial sale of a licensed product or process in any foreign country.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;During the three months ended March 31, 2015, there were no net sales subject to certain annual minimum royalty payments or sales that would require us to pay a percentage of revenues from sublicensing arrangements. In addition there were no benchmarks or milestones achieved that would require payment under the lump sum benchmark royalty payments on the achievement of certain clinical and regulatory milestones for each of the various indications.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;b&gt;&lt;i&gt;Exclusive License Agreement&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On July 21, 2014, the Company entered into an Exclusive License Agreement (the &amp;#147;Moffitt License Agreement&amp;#148;), effective as of June 28, 2014, with the H. Lee Moffitt Cancer Center and Research Institute, Inc. (&amp;#147;Moffitt&amp;#148;) under which the Company received an exclusive, world-wide license to Moffitt's rights in and to two patent-pending technologies related to methods for improving tumor-infiltrating lymphocytes for adoptive cell therapy. Unless earlier terminated, the term of the license extends until the earlier of the expiration of the last patent related to the licensed technology or 20 years after the effective date of the license agreement.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Pursuant to the Moffitt License Agreement, the Company paid an upfront licensing fee of $&lt;font&gt;25,000&lt;/font&gt;, which was recognized as research and development expense during 2014. A patent issuance fee will also be payable under the Moffitt License Agreement, upon the issuance of the first U.S. patent covering the subject technology. In addition, the Company agreed to pay milestone license fees upon completion of specified milestones, customary royalties based on a specified percentage of net sales (which percentage is in the low single digits) and sublicensing payments, as applicable, and annual minimum royalties beginning with the first sale of products based on the licensed technologies, which minimum royalties will be credited against the percentage royalty payments otherwise payable in that year. The Company will also be responsible for all costs associated with the preparation, filing, maintenance and prosecution of the patent applications and patents covered by the Moffitt License Agreement related to the treatment of any cancers in the United States, Europe and Japan and in other countries selected that the Company and Moffitt agreed to.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;During the three months ended March 31, 2015, there were no net sales subject to certain annual minimum royalty payments or sales that would require us to pay a percentage of revenues from sublicensing arrangements&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;b&gt;&lt;i&gt;Exclusive Patent License Agreement&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On February 10, 2015, the Company entered into an exclusive Patent License Agreement with the NIH under which the Company received an exclusive, world-wide license to the NIH's rights in and to two patent-pending technologies related to methods for improving tumor-infiltrating lymphocytes for adoptive cell therapy. The licensed technologies relate to the more potent and efficient production of TIL from melanoma tumors by selecting for T-cell populations that express various inhibitory receptors. Unless terminated sooner, the license shall remain in effect until the last licensed patent right expires.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In consideration for the exclusive rights granted under the exclusive Patent License Agreement, the Company agreed to pay the NIH a non-refundable upfront licensing fee of $&lt;font&gt;40,000&lt;/font&gt;, which was recognized as research and development expense during the three months ended March 31, 2015, and included in the balance of accrued expenses at March 31, 2015. The Company also agreed to pay customary royalties based on a percentage of net sales (which percentage is in the mid-single digits), a percentage of revenues from sublicensing arrangements, and lump sum benchmark payments upon the successful completion of the Company's first Phase 2 clinical study, the successful completion of the Company's first Phase 3 clinical study, the receipt of the first FDA approval or foreign equivalent for a licensed product or process resulting from the licensed technologies, the first commercial sale of a licensed product or process in the United States, and the first commercial sale of a licensed product or process in any foreign country.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;During the three months ended March 31, 2015, there were no net sales subject to certain annual minimum royalty payments or sales that would require us to pay a percentage of revenues from sublicensing arrangements. In addition there were no benchmarks or milestones achieved that would require payment under the lump sum benchmark royalty payments on the achievement of certain clinical and regulatory milestones for each of the various indications.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;b&gt;&lt;i&gt;Manufacturing Service Agreement&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In December 2011, the Company entered into a Manufacturing Services Agreement with Lonza Walkersville, Inc. (Lonza) pursuant to which Lonza has agreed to manufacture, package, ship and perform quality assurance and quality control of our TIL therapy. Lonza has commenced developing a commercial-scale manufacturing process for the TIL therapy. The goal is to develop and establish a manufacturing process for the large-scale production of TIL that is in accord with current Good Manufacturing Practices (cGMP).&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On June 1, 2014 we issued a new statement of work (SOW) to Lonza under the Manufacturing Services Agreement. The total cost for services to be provided under the SOW is approximately $&lt;font&gt;738,000&lt;/font&gt;. During 2014, the Company recognized $&lt;font&gt;890,684&lt;/font&gt; of expenses under the Manufacturing Services Agreement with Lonza, which included a $&lt;font&gt;100,000&lt;/font&gt; in upfront costs required under the SOW, and were recorded as part of research and development expenses in 2014. During the three months ended March 31, 2015, the Company recognized $&lt;font&gt;298,071&lt;/font&gt; of expenses under the Manufacturing Services Agreement.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;b&gt;&lt;i&gt;Research Collaboration Agreement &lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In September, 2014, we entered into a research collaboration agreement with the H. Lee Moffitt Cancer Center and Research Institute, Inc. to jointly engage in transitional research and development of adoptive tumor-infiltrating lymphocyte cell therapy with improved anti-tumor properties and process. The total obligation under the agreement was $&lt;font&gt;1,432,797&lt;/font&gt;, of which $&lt;font&gt;358,199&lt;/font&gt; was paid in 2014. During the three-month period ended March 31, 2015, the Company did not record any expenses related to this research collaboration agreement.&lt;/p&gt; &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:LongTermPurchaseCommitmentAmount id="Tag234" contextRef="C788560" unitRef="USD" decimals="0">1000000</us-gaap:LongTermPurchaseCommitmentAmount>
  <us-gaap:LongTermPurchaseCommitmentAmount id="Tag235" contextRef="C788559" unitRef="USD" decimals="0">250000</us-gaap:LongTermPurchaseCommitmentAmount>
  <us-gaap:LongTermPurchaseCommitmentAmount id="Tag236" contextRef="C788561" unitRef="USD" decimals="-6">1000000</us-gaap:LongTermPurchaseCommitmentAmount>
  <us-gaap:LongTermPurchaseCommitmentAmount id="Tag237" contextRef="C788562" unitRef="USD" decimals="-6">2000000</us-gaap:LongTermPurchaseCommitmentAmount>
  <us-gaap:LongTermPurchaseCommitmentAmount id="Tag238" contextRef="C788563" unitRef="USD" decimals="0">500000</us-gaap:LongTermPurchaseCommitmentAmount>
  <us-gaap:ResearchAndDevelopmentExpense id="Tag239" contextRef="C788565" unitRef="USD" decimals="0">250000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:AccruedLiabilitiesCurrent id="Tag240" contextRef="C788566" unitRef="USD" decimals="0">250000</us-gaap:AccruedLiabilitiesCurrent>
  <lbio:PercentageOfRoyaltyOnSales id="Tag241" contextRef="C788568" unitRef="Pure" decimals="2">0.06</lbio:PercentageOfRoyaltyOnSales>
  <lbio:EstimatedBenchmarkPaymentsForProducts id="Tag242" contextRef="C788569" unitRef="USD" decimals="0">6050000</lbio:EstimatedBenchmarkPaymentsForProducts>
  <lbio:EstimatedBenchmarkPaymentsForProducts id="Tag243" contextRef="C788570" unitRef="USD" decimals="0">6050000</lbio:EstimatedBenchmarkPaymentsForProducts>
  <lbio:EstimatedBenchmarkPaymentsForProducts id="Tag244" contextRef="C788571" unitRef="USD" decimals="0">12100000</lbio:EstimatedBenchmarkPaymentsForProducts>
  <lbio:EstimatedBenchmarkPaymentsForProducts id="Tag245" contextRef="C788572" unitRef="USD" decimals="0">12100000</lbio:EstimatedBenchmarkPaymentsForProducts>
  <lbio:EstimatedBenchmarkPaymentsForProducts id="Tag246" contextRef="C681024" unitRef="USD" decimals="0">36300000</lbio:EstimatedBenchmarkPaymentsForProducts>
  <lbio:UpfrontLicenseFee id="Tag247" contextRef="C788577" unitRef="USD" decimals="0">350000</lbio:UpfrontLicenseFee>
  <us-gaap:ResearchAndDevelopmentExpense id="Tag248" contextRef="C800574" unitRef="USD" decimals="0">25000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="Tag249" contextRef="C788568" unitRef="USD" decimals="0">40000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:LongTermPurchaseCommitmentAmount id="Tag250" contextRef="C788582" unitRef="USD" decimals="0">738000</us-gaap:LongTermPurchaseCommitmentAmount>
  <us-gaap:ResearchAndDevelopmentExpense id="Tag251" contextRef="C788583" unitRef="USD" decimals="0">890684</us-gaap:ResearchAndDevelopmentExpense>
  <lbio:UpfrontLicenseFee id="Tag252" contextRef="C788584" unitRef="USD" decimals="0">100000</lbio:UpfrontLicenseFee>
  <us-gaap:ResearchAndDevelopmentExpense id="Tag253" contextRef="C788582" unitRef="USD" decimals="0">298071</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:LongTermPurchaseCommitmentAmount id="Tag254" contextRef="C800575" unitRef="USD" decimals="0">1432797</us-gaap:LongTermPurchaseCommitmentAmount>
  <us-gaap:ResearchAndDevelopmentExpense id="Tag255" contextRef="C800581" unitRef="USD" decimals="0">358199</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:SubsequentEventsTextBlock id="Tag256" contextRef="C680990">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt; &lt;p style="margin: 0pt; font-family: 'times new roman';"&gt;&lt;br/&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;b&gt;&lt;font style="text-decoration: underline;"&gt;NOTE 7. SUBSEQUENT EVENTS&lt;/font&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&lt;b&gt;&lt;i&gt;Share Issuances&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;In the second quarter of 2015, the Company has received $&lt;font&gt;394,510&lt;/font&gt; in cash from the exercise of warrants for the purchase of &lt;font&gt;157,804&lt;/font&gt; shares of its common stock.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On May 6, 2015, certain stockholders of the Company, including certain members of Board of Directors of the Company and their affiliates, sold &lt;font&gt;4,750,000&lt;/font&gt; shares of the Company's common stock in an underwritten secondary offering at a price of $&lt;font&gt;10.00&lt;/font&gt; per share. The Company did not sell any shares in the offering and will not receive any of the proceeds from the offering.&lt;/p&gt; &lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:ProceedsFromWarrantExercises id="Tag257" contextRef="C800577" unitRef="USD" decimals="0">394510</us-gaap:ProceedsFromWarrantExercises>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="Tag258" contextRef="C800578" unitRef="Shares" decimals="INF">157804</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Tag259" contextRef="C800577" unitRef="Shares" decimals="INF">4750000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SaleOfStockPricePerShare id="Tag260" contextRef="C800579" unitRef="USDPerShare" decimals="2">10.00</us-gaap:SaleOfStockPricePerShare>
  <dei:AmendmentFlag id="Tag261" contextRef="C680990">false</dei:AmendmentFlag>
  <dei:CurrentFiscalYearEndDate id="Tag262" contextRef="C680990">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:DocumentPeriodEndDate id="Tag263" contextRef="C680990">2015-03-31</dei:DocumentPeriodEndDate>
  <dei:EntityFilerCategory id="Tag264" contextRef="C680990">Accelerated Filer</dei:EntityFilerCategory>
  <dei:EntityRegistrantName id="Tag265" contextRef="C680990">Lion Biotechnologies, Inc.</dei:EntityRegistrantName>
  <dei:EntityCentralIndexKey id="Tag266" contextRef="C680990">0001425205</dei:EntityCentralIndexKey>
  <dei:EntityCommonStockSharesOutstanding id="Tag267" contextRef="C800580" unitRef="Shares" decimals="INF">45029692</dei:EntityCommonStockSharesOutstanding>
  <dei:DocumentFiscalYearFocus id="Tag268" contextRef="C680990">2015</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus id="Tag269" contextRef="C680990">Q1</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentType id="Tag270" contextRef="C680990">10-Q</dei:DocumentType>
  <us-gaap:LossContingencyDisclosures id="Tag271" contextRef="C680990">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;br/&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;b&gt;&lt;font style="text-decoration: underline;"&gt;NOTE 6. LEGAL PROCEEDINGS&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;On April 23, 2014, the Company received a subpoena from the Securities Exchange Commission (the &amp;#147;SEC&amp;#148;) that stated that the staff of the SEC is conducting an investigation &lt;i&gt;&lt;font style="text-decoration: underline;"&gt;In the Matter of Galena Biopharma, Inc. File No. HO 12356&lt;/font&gt;&lt;/i&gt; &lt;i&gt;(now known as &amp;#147;&lt;font style="text-decoration: underline;"&gt;In the Matter of Certain Stock Promotions&lt;/font&gt;&amp;#148;) &lt;/i&gt;and that the subpoena was issued to the Company as part of the foregoing investigation. The SEC's subpoena and accompanying letter do not indicate whether the Company is, or is not, under investigation. We have fully cooperated with the SEC and as of November 2014, we had completed production of documents in response to the subpoena. To date, The SEC has not requested any further action from the Company.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The subpoena requires the Company to give the SEC, among other materials, all communications between anyone at the Company and certain persons and entities (which include investor-relations firms and persons associated with the investor-relations firms), all documents related to the listed persons and entities, all articles regarding the Company posted on certain equity research or other financial websites, and documents and communications related to individuals who post or have posted articles regarding the Company on equity research or other financial websites.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;There are no other pending legal proceedings to which the Company is a party or of which its property is the subject.&lt;/p&gt;
&lt;/div&gt;</us-gaap:LossContingencyDisclosures>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>lbio-20150331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--Created by IRIS, Powered by IRIS Carbon-->
<xsd:schema xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:lbio="http://www.lbio.com/20150331" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2014-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.lbio.com/20150331">
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="lbio-20150331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="lbio-20150331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="lbio-20150331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="lbio-20150331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://www.lbio.com/role/Ibio-dei" id="Ibio-dei">
        <link:definition>001 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Ibio-cbs" id="Ibio-cbs">
        <link:definition>002 - Statement - Condensed Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Ibio-cbsp" id="Ibio-cbsp">
        <link:definition>003 - Statement - Condensed Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Ibio-csoo" id="Ibio-csoo">
        <link:definition>004 - Statement - Condensed Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Ibio-csose" id="Ibio-csose">
        <link:definition>006 - Statement - Condensed Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Ibio-csocf" id="Ibio-csocf">
        <link:definition>008 - Statement - Condensed Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Ibio-goab" id="Ibio-goab">
        <link:definition>101 - Disclosure - GENERAL ORGANIZATION AND BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Ibio-sosap" id="Ibio-sosap">
        <link:definition>102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Ibio-se" id="Ibio-se">
        <link:definition>103 - Statement - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Ibio-soaw" id="Ibio-soaw">
        <link:definition>104 - Disclosure - STOCK OPTIONS AND WARRANTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Disclosure-LICENSEANDCOMMITMENTS" id="Disclosure-LICENSEANDCOMMITMENTS">
        <link:definition>105 - Disclosure - LICENSE AND COMMITMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Ibio-se1" id="Ibio-se1">
        <link:definition>107 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Ibio-sosapp" id="Ibio-sosapp">
        <link:definition>202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Ibio-soawt" id="Ibio-soawt">
        <link:definition>304 - Disclosure - STOCK OPTIONS AND WARRANTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Ibio-goabd" id="Ibio-goabd">
        <link:definition>40101 - Disclosure - GENERAL ORGANIZATION AND BUSINESS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Ibio-sosapd" id="Ibio-sosapd">
        <link:definition>40201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Disclosure-STOCKHOLDERSEQUITYNarrativeDetails" id="Disclosure-STOCKHOLDERSEQUITYNarrativeDetails">
        <link:definition>40301 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Ibio-soawnd" id="Ibio-soawnd">
        <link:definition>40401 - Disclosure - STOCK OPTIONS AND WARRANTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Ibio-soawsososod" id="Ibio-soawsososod">
        <link:definition>40402 - Disclosure - STOCK OPTIONS AND WARRANTS (Schedule of Status of Stock Options) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Disclosure-STOCKOPTIONSANDWARRANTSScheduleofStatusofStockWarrantsDetails" id="Disclosure-STOCKOPTIONSANDWARRANTSScheduleofStatusofStockWarrantsDetails">
        <link:definition>40403 - Disclosure - STOCK OPTIONS AND WARRANTS (Schedule of Status of Stock Warrants) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Disclosure-LICENSEANDCOMMITMENTSDetails" id="Disclosure-LICENSEANDCOMMITMENTSDetails">
        <link:definition>40501 - Disclosure - LICENSE AND COMMITMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Statement-CondensedStatementsofStockholdersEquityParenthetical" id="Statement-CondensedStatementsofStockholdersEquityParenthetical">
        <link:definition>007 - Statement - Condensed Statements of Stockholders' Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Disclosure-LEGALPROCEEDINGS" id="Disclosure-LEGALPROCEEDINGS">
        <link:definition>106 - Disclosure - LEGAL PROCEEDINGS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Statement-CondensedStatementsofOperationsParenthetical" id="Statement-CondensedStatementsofOperationsParenthetical">
        <link:definition>005 - Statement - Condensed Statements of Operations (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Disclosure-STOCKHOLDERSEQUITYTables" id="Disclosure-STOCKHOLDERSEQUITYTables">
        <link:definition>303 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Disclosure-STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityDetails" id="Disclosure-STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityDetails">
        <link:definition>40302 - Disclosure - STOCKHOLDER'S EQUITY (Schedule of Restricted Stock Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.lbio.com/role/Disclosure-SUBSEQUENTEVENTSDetails" id="Disclosure-SUBSEQUENTEVENTSDetails">
        <link:definition>40801 - Disclosure - SUBSEQUENT EVENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2006/ref" schemaLocation="http://www.xbrl.org/2006/ref-2006-02-27.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/XLink" schemaLocation="http://www.xbrl.org/2003/xl-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2014-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd" />
  <xsd:element name="CostToInduceExchangeTransaction" id="lbio_CostToInduceExchangeTransaction" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" id="lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="FairValueOfVestedWarrantsGrantedForServices" id="lbio_FairValueOfVestedWarrantsGrantedForServices" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="CommonStockIssuedToOfficerForServices" id="lbio_CommonStockIssuedToOfficerForServices" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="CommonStockIssuedToInduceConversionOfWarrants" id="lbio_CommonStockIssuedToInduceConversionOfWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="CommonStockIssuedToInduceExchangeTransaction" id="lbio_CommonStockIssuedToInduceExchangeTransaction" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="FairValueOfCommonStockTransferredToOfficerAndDirector" id="lbio_FairValueOfCommonStockTransferredToOfficerAndDirector" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="WriteOffOfAdvancesToRelatedParty" id="lbio_WriteOffOfAdvancesToRelatedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="ProceedsFromIssuanceOfSecuredPromissoryNotesNet" id="lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants" id="lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="DerivativeLiabilityRecordedAsPrivatePlacementCost" id="lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount" id="lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="SettlementOfAccountsPayableThroughIssuanceOfCommonStock" id="lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="CommonStockIssuedUponExerciseOfWarrantsShares" id="lbio_CommonStockIssuedUponExerciseOfWarrantsShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="CommonStockIssuedUponExerciseOfWarrantsAmount" id="lbio_CommonStockIssuedUponExerciseOfWarrantsAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="CommonStockToBeIssuedMember" id="lbio_CommonStockToBeIssuedMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="CommonStockToBeIssuedValue" id="lbio_CommonStockToBeIssuedValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="CommonStockToBeIssuedShares" id="lbio_CommonStockToBeIssuedShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xsd:element name="VestedOnOneYearAnniversaryMember" id="lbio_VestedOnOneYearAnniversaryMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember" id="lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments" id="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="NumberOfConsultantsIntoConsultingAgreements" id="lbio_NumberOfConsultantsIntoConsultingAgreements" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedPaymentOptionValuationAssumptionForfeitureRate" id="lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="AccruedCompensationPayableInSharesOfStockDisclosureTextBlock" id="lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="AccruedCompensationPayableInSharesOfStockDisclosureAbstract" id="lbio_AccruedCompensationPayableInSharesOfStockDisclosureAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="VestOnThirtySeptemberTwoThousandFourteenMember" id="lbio_VestOnThirtySeptemberTwoThousandFourteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="VestOnThirtySeptemberTwoThousandFifteenMember" id="lbio_VestOnThirtySeptemberTwoThousandFifteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="VestOnThirtySeptemberTwoThousandSixteenMember" id="lbio_VestOnThirtySeptemberTwoThousandSixteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="PrivatePlacementCosts" id="lbio_PrivatePlacementCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="DocumentAndEntityInformationAbstract" id="lbio_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities" id="lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities" id="lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="EffectiveIncomeTaxRateReconciliationExpectedRateTotal1" id="lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="GeneralOrganizationAndBusinessTable" id="lbio_GeneralOrganizationAndBusinessTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="LoanNeitherRepaidNorConverted" id="lbio_LoanNeitherRepaidNorConverted" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="WorkingCapital" id="lbio_WorkingCapital" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="CommonStockCancelledAndExchangedValue" id="lbio_CommonStockCancelledAndExchangedValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" id="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" id="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="AggregateIntrinsicValueAbstract" id="lbio_AggregateIntrinsicValueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="AgreementAxis" id="lbio_AgreementAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="SecuredPromissoryNotesMember" id="lbio_SecuredPromissoryNotesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="SeniorSecuredNotesMember" id="lbio_SeniorSecuredNotesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="NotesAndCertainOtherIndebtednessMember" id="lbio_NotesAndCertainOtherIndebtednessMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="SecuredNotes2012Member" id="lbio_SecuredNotes2012Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="StockIssuedAxis" id="lbio_StockIssuedAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="AgreementDomain" id="lbio_AgreementDomain" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="ExchangeAgreementMember" id="lbio_ExchangeAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="StockPurchaseAndExchangeAgreementMember" id="lbio_StockPurchaseAndExchangeAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="CertainCreditorsAndCertainPlacementAgentsMember" id="lbio_CertainCreditorsAndCertainPlacementAgentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="StockIssuedDomain" id="lbio_StockIssuedDomain" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="InvestorsMember" id="lbio_InvestorsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="InvestorsAndOtherPartiesMember" id="lbio_InvestorsAndOtherPartiesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="TheoremGroupLlcMember" id="lbio_TheoremGroupLlcMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="StockPurchaseAgreementMember" id="lbio_StockPurchaseAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="AyerCapitalPartnersMasterFundLpMember" id="lbio_AyerCapitalPartnersMasterFundLpMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="BristolInvestmentFundLtdMember" id="lbio_BristolInvestmentFundLtdMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="LionAgreementMember" id="lbio_LionAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="PercentageOfOutstandingVotingEquityInterests" id="lbio_PercentageOfOutstandingVotingEquityInterests" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="PercentageOfOutstandingVotingEquityInterestsAfterRestructuring" id="lbio_PercentageOfOutstandingVotingEquityInterestsAfterRestructuring" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="BristolCapitalLlcMember" id="lbio_BristolCapitalLlcMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="PercentageOfRoyaltyOnSales" id="lbio_PercentageOfRoyaltyOnSales" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="EstimatedBenchmarkPaymentsForProduct1" id="lbio_EstimatedBenchmarkPaymentsForProduct1" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="AnnualBaseSalary" id="lbio_AnnualBaseSalary" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="PercentageOfPotentialBonus" id="lbio_PercentageOfPotentialBonus" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="CommonStockToBeIssued" id="lbio_CommonStockToBeIssued" type="num:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xsd:element name="EstimatedBenchmarkPaymentsForProduct2" id="lbio_EstimatedBenchmarkPaymentsForProduct2" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="EstimatedBenchmarkPaymentsForProduct3" id="lbio_EstimatedBenchmarkPaymentsForProduct3" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="EstimatedBenchmarkPaymentsForProduct4" id="lbio_EstimatedBenchmarkPaymentsForProduct4" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="EstimatedBenchmarkPaymentsForProducts" id="lbio_EstimatedBenchmarkPaymentsForProducts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="TampaLeaseMember" id="lbio_TampaLeaseMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="FormerChiefExecutiveOfficerMember" id="lbio_FormerChiefExecutiveOfficerMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="EmmesGroupConsultingLlcMember" id="lbio_EmmesGroupConsultingLlcMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="CompensationPaidInCash" id="lbio_CompensationPaidInCash" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="CompensationPaidInKind" id="lbio_CompensationPaidInKind" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="ManufacturingServiceAgreementMember" id="lbio_ManufacturingServiceAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm" id="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="NonemployeeMember" id="lbio_NonemployeeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="EmployeesMember" id="lbio_EmployeesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="IssuanceOfCommonStockUponConversionOfPreferredStockMember" id="lbio_IssuanceOfCommonStockUponConversionOfPreferredStockMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="ConsultantMember" id="lbio_ConsultantMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="SettlementOfOutstandingObligationsMember" id="lbio_SettlementOfOutstandingObligationsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="NewEmployeeMember" id="lbio_NewEmployeeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="SecondEmployeeMember" id="lbio_SecondEmployeeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="LionBiotechnologiesIncMember" id="lbio_LionBiotechnologiesIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="AggregateIntrinsicValueAbstract1Abstract" id="lbio_AggregateIntrinsicValueAbstract1Abstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="EmployeesAndDirectorsMember" id="lbio_EmployeesAndDirectorsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="ConsultantsMember" id="lbio_ConsultantsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="EquityIncentivePlan2011Member" id="lbio_EquityIncentivePlan2011Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="AwardAgreementMember" id="lbio_AwardAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="MatrixGroupInternationalIncMember" id="lbio_MatrixGroupInternationalIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="RestructuringAndRelatedCostExpectedCostQuarterlyPayments" id="lbio_RestructuringAndRelatedCostExpectedCostQuarterlyPayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="TermOfLease" id="lbio_TermOfLease" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="PercentageOfIncreaseInLeaseRent" id="lbio_PercentageOfIncreaseInLeaseRent" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="TermOfLicense" id="lbio_TermOfLicense" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="WarrantExpirationPeriod" id="lbio_WarrantExpirationPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="GeneralOrganizationAndBusinessLineItems" id="lbio_GeneralOrganizationAndBusinessLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="SeriesConvertiblePreferredStockMember" id="lbio_SeriesConvertiblePreferredStockMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="WarrantIssuance1Member" id="lbio_WarrantIssuance1Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="WarrantIssuance2Member" id="lbio_WarrantIssuance2Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="PlacementAgentsMember" id="lbio_PlacementAgentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="ProceedsFromIssuanceOfPrivatePlacementNet" id="lbio_ProceedsFromIssuanceOfPrivatePlacementNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="DescriptionOnAggregateBeneficialOwnershipPercentageOfCommonStockUponConversion" id="lbio_DescriptionOnAggregateBeneficialOwnershipPercentageOfCommonStockUponConversion" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="DepartmentOfHealthAndHumanServicesMember" id="lbio_DepartmentOfHealthAndHumanServicesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="LonzaWalkersvilleIncMember" id="lbio_LonzaWalkersvilleIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="PatentLicenseAgreementMember" id="lbio_PatentLicenseAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="PreferredStockSharesExercised" id="lbio_PreferredStockSharesExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="CommonStockIssuedToInduceExchangeTransactionShares" id="lbio_CommonStockIssuedToInduceExchangeTransactionShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="StockIssuedDuringPeriodValueToDirectors" id="lbio_StockIssuedDuringPeriodValueToDirectors" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="StockIssuedDuringPeriodSharesToDirectors" id="lbio_StockIssuedDuringPeriodSharesToDirectors" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="PreferredStockSoldInPrivatePlacementValue" id="lbio_PreferredStockSoldInPrivatePlacementValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="PreferredStockSoldInPrivatePlacementShares" id="lbio_PreferredStockSoldInPrivatePlacementShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="StockIssuedDuringPeriodSharesForSettlementOfPayable" id="lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="StockIssuedDuringPeriodValueForSettlementOfPayable" id="lbio_StockIssuedDuringPeriodValueForSettlementOfPayable" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="PercentageOfContractualObligation" id="lbio_PercentageOfContractualObligation" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" id="lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1" id="lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="AnticipatedBudgetedExpenditures" id="lbio_AnticipatedBudgetedExpenditures" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="VestOnSixJanuaryTwoThousandFifteenMember" id="lbio_VestOnSixJanuaryTwoThousandFifteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="ScheduleOfEstimatedUsefulLivesTableTextBlock" id="lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="MaximumBeneficialOwnershipPercentageByHolder" id="lbio_MaximumBeneficialOwnershipPercentageByHolder" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xsd:element name="MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue" id="lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xsd:element name="CradaMember" id="lbio_CradaMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="NCIMember" id="lbio_NCIMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="PerQuarterMember" id="lbio_PerQuarterMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="PerYearMember" id="lbio_PerYearMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="NIHMember" id="lbio_NIHMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="OvarianCancerMember" id="lbio_OvarianCancerMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="BreastCancerMember" id="lbio_BreastCancerMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="ColorectalCancerMember" id="lbio_ColorectalCancerMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="UpfrontLicenseFee" id="lbio_UpfrontLicenseFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="MelanomaMember" id="lbio_MelanomaMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="LongTermPurchaseCommitmentPercentage" id="lbio_LongTermPurchaseCommitmentPercentage" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xsd:element name="UnpaidRentMember" id="lbio_UnpaidRentMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="LoanAgreementMember" id="lbio_LoanAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="VestingFirstMember" id="lbio_VestingFirstMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="PlanOneMember" id="lbio_PlanOneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="PlanTwoMember" id="lbio_PlanTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>lbio-20150331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--Created by IRIS, Powered by IRIS Carbon-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-cbs" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-cbs" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-csoo" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-csoo" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-csocf" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-csocf" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-cbs">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xlink:title="us-gaap_AssetsCurrent" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="Calculation : us-gaap_AssetsCurrent to us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xlink:title="us-gaap_LiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesCurrent" xlink:title="Calculation : us-gaap_LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesCurrent" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Deposits" xlink:label="us-gaap_Deposits" xlink:title="us-gaap_Deposits" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_Deposits" xlink:title="Calculation : us-gaap_AssetsCurrent to us-gaap_Deposits" order="2" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:title="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:title="Calculation : us-gaap_AssetsCurrent to us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:title="us-gaap_StockholdersEquity" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" xlink:title="Calculation : us-gaap_LiabilitiesAndStockholdersEquity to us-gaap_StockholdersEquity" order="3" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:title="us-gaap_Assets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" xlink:title="Calculation : us-gaap_Assets to us-gaap_AssetsCurrent" order="10" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" xlink:title="us-gaap_AccountsPayableCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" xlink:title="Calculation : us-gaap_LiabilitiesCurrent to us-gaap_AccountsPayableCurrent" order="10" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" xlink:title="us-gaap_PreferredStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" xlink:title="Calculation : us-gaap_StockholdersEquity to us-gaap_PreferredStockValue" order="10" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:title="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:title="Calculation : us-gaap_Assets to us-gaap_PropertyPlantAndEquipmentNet" order="20" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:title="us-gaap_AccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" xlink:title="Calculation : us-gaap_LiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent" order="20" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xlink:title="us-gaap_CommonStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" xlink:title="Calculation : us-gaap_StockholdersEquity to us-gaap_CommonStockValue" order="20" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:title="us-gaap_AccountsPayableRelatedPartiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:title="Calculation : us-gaap_LiabilitiesCurrent to us-gaap_AccountsPayableRelatedPartiesCurrent" order="30" weight="1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockToBeIssuedValue" xlink:label="lbio_CommonStockToBeIssuedValue" xlink:title="lbio_CommonStockToBeIssuedValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="lbio_CommonStockToBeIssuedValue" xlink:title="Calculation : us-gaap_StockholdersEquity to lbio_CommonStockToBeIssuedValue" order="30" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:title="us-gaap_AdditionalPaidInCapital" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" xlink:title="Calculation : us-gaap_StockholdersEquity to us-gaap_AdditionalPaidInCapital" order="40" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:title="Calculation : us-gaap_StockholdersEquity to us-gaap_RetainedEarningsAccumulatedDeficit" order="50" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:title="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:title="Calculation : us-gaap_LiabilitiesAndStockholdersEquity to us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" order="13" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:title="us-gaap_CommitmentsAndContingencies" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" xlink:title="Calculation : us-gaap_LiabilitiesAndStockholdersEquity to us-gaap_CommitmentsAndContingencies" order="23" weight="1" use="optional" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-csoo">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" xlink:title="us-gaap_OperatingExpenses" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:title="us-gaap_OperatingCostsAndExpenses" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses" xlink:title="Calculation : us-gaap_OperatingExpenses to us-gaap_OperatingCostsAndExpenses" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:title="us-gaap_OtherNonoperatingIncomeExpense" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" xlink:title="us-gaap_InterestExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_InterestExpense" xlink:title="Calculation : us-gaap_OtherNonoperatingIncomeExpense to us-gaap_InterestExpense" order="1" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NoncashMergerRelatedCosts" xlink:label="us-gaap_NoncashMergerRelatedCosts" xlink:title="us-gaap_NoncashMergerRelatedCosts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_NoncashMergerRelatedCosts" xlink:title="Calculation : us-gaap_OperatingExpenses to us-gaap_NoncashMergerRelatedCosts" order="2" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:label="us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:title="us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:title="Calculation : us-gaap_OtherNonoperatingIncomeExpense to us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" order="2" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xlink:title="us-gaap_AmortizationOfDebtDiscountPremium" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" xlink:title="Calculation : us-gaap_OtherNonoperatingIncomeExpense to us-gaap_AmortizationOfDebtDiscountPremium" order="3" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:title="us-gaap_ResearchAndDevelopmentExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" xlink:title="Calculation : us-gaap_OperatingExpenses to us-gaap_ResearchAndDevelopmentExpense" order="3" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:title="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:title="Calculation : us-gaap_OperatingExpenses to us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="4" weight="1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CostToInduceExchangeTransaction" xlink:label="lbio_CostToInduceExchangeTransaction" xlink:title="lbio_CostToInduceExchangeTransaction" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lbio_CostToInduceExchangeTransaction" xlink:title="Calculation : us-gaap_OtherNonoperatingIncomeExpense to lbio_CostToInduceExchangeTransaction" order="4" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts" xlink:title="us-gaap_AmortizationOfFinancingCosts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_AmortizationOfFinancingCosts" xlink:title="Calculation : us-gaap_OtherNonoperatingIncomeExpense to us-gaap_AmortizationOfFinancingCosts" order="5" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:title="us-gaap_NetIncomeLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLoss" xlink:title="Calculation : us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic to us-gaap_NetIncomeLoss" order="10" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xlink:title="us-gaap_OperatingIncomeLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" xlink:title="Calculation : us-gaap_NetIncomeLoss to us-gaap_OperatingIncomeLoss" order="10" weight="1" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" xlink:title="Calculation : us-gaap_OperatingIncomeLoss to us-gaap_OperatingExpenses" order="20" weight="-1" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" xlink:title="Calculation : us-gaap_NetIncomeLoss to us-gaap_OtherNonoperatingIncomeExpense" order="20" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherPreferredStockDividendsAndAdjustments" xlink:label="us-gaap_OtherPreferredStockDividendsAndAdjustments" xlink:title="us-gaap_OtherPreferredStockDividendsAndAdjustments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_OtherPreferredStockDividendsAndAdjustments" xlink:title="Calculation : us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic to us-gaap_OtherPreferredStockDividendsAndAdjustments" order="20" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" xlink:title="us-gaap_Revenues" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_Revenues" xlink:title="Calculation : us-gaap_OperatingIncomeLoss to us-gaap_Revenues" order="10" weight="1" use="optional" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-csocf">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations to us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:title="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:title="Calculation : us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease to us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" order="3" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:label="us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:title="us-gaap_PaymentsToFundLongtermLoansToRelatedParties" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations to us-gaap_PaymentsToFundLongtermLoansToRelatedParties" order="2" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:title="us-gaap_ProceedsFromConvertibleDebt" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromConvertibleDebt" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to us-gaap_ProceedsFromConvertibleDebt" order="11" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to us-gaap_ProceedsFromIssuanceOfCommonStock" order="41" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:title="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="51" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" xlink:title="us-gaap_ProceedsFromRelatedPartyDebt" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to us-gaap_ProceedsFromRelatedPartyDebt" order="61" weight="1" use="optional" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:title="Calculation : us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease to us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" order="4" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:title="us-gaap_ProceedsFromIssuanceOfSecuredDebt" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to us-gaap_ProceedsFromIssuanceOfSecuredDebt" order="71" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:title="us-gaap_NetIncomeLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetIncomeLoss" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_NetIncomeLoss" order="16" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" xlink:title="us-gaap_DepreciationAndAmortization" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_DepreciationAndAmortization" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_DepreciationAndAmortization" order="26" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:title="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="36" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="us-gaap_StockOptionPlanExpense" xlink:title="us-gaap_StockOptionPlanExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_StockOptionPlanExpense" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_StockOptionPlanExpense" order="46" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" xlink:label="lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" xlink:title="lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" order="56" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_FairValueOfVestedWarrantsGrantedForServices" xlink:label="lbio_FairValueOfVestedWarrantsGrantedForServices" xlink:title="lbio_FairValueOfVestedWarrantsGrantedForServices" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="lbio_FairValueOfVestedWarrantsGrantedForServices" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to lbio_FairValueOfVestedWarrantsGrantedForServices" order="66" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:title="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="76" weight="-1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PrivatePlacementCosts" xlink:label="lbio_PrivatePlacementCosts" xlink:title="lbio_PrivatePlacementCosts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="lbio_PrivatePlacementCosts" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to lbio_PrivatePlacementCosts" order="86" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="96" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:title="us-gaap_DerivativeGainLossOnDerivativeNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_DerivativeGainLossOnDerivativeNet" order="106" weight="-1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:title="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_StockIssuedDuringPeriodValueIssuedForServices" order="116" weight="-1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockIssuedToInduceConversionOfWarrants" xlink:label="lbio_CommonStockIssuedToInduceConversionOfWarrants" xlink:title="lbio_CommonStockIssuedToInduceConversionOfWarrants" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="lbio_CommonStockIssuedToInduceConversionOfWarrants" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to lbio_CommonStockIssuedToInduceConversionOfWarrants" order="126" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockIssuedToInduceExchangeTransaction" xlink:label="lbio_CommonStockIssuedToInduceExchangeTransaction" xlink:title="lbio_CommonStockIssuedToInduceExchangeTransaction" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="lbio_CommonStockIssuedToInduceExchangeTransaction" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to lbio_CommonStockIssuedToInduceExchangeTransaction" order="136" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NoncashMergerRelatedCosts" xlink:label="us-gaap_NoncashMergerRelatedCosts" xlink:title="us-gaap_NoncashMergerRelatedCosts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NoncashMergerRelatedCosts" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_NoncashMergerRelatedCosts" order="146" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1" xlink:title="us-gaap_StockIssued1" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_StockIssued1" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_StockIssued1" order="156" weight="-1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:title="us-gaap_AdjustmentOfWarrantsGrantedForServices" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_AdjustmentOfWarrantsGrantedForServices" order="166" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_WriteOffOfAdvancesToRelatedParty" xlink:label="lbio_WriteOffOfAdvancesToRelatedParty" xlink:title="lbio_WriteOffOfAdvancesToRelatedParty" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="lbio_WriteOffOfAdvancesToRelatedParty" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to lbio_WriteOffOfAdvancesToRelatedParty" order="167" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="168" weight="-1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:title="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" order="169" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:label="us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:title="us-gaap_IncreaseDecreaseInDeferredCompensation" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_IncreaseDecreaseInDeferredCompensation" order="170" weight="1" use="optional" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:title="Calculation : us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease to us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" order="2" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:title="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" order="180" weight="1" use="optional" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" xlink:label="lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" xlink:title="lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" order="81" weight="1" use="optional" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>lbio-20150331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--Created by IRIS, Powered by IRIS Carbon-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-dei" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-dei" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-soawsososod" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-soawsososod" />
  <link:roleRef roleURI="http://www.lbio.com/role/Disclosure-STOCKOPTIONSANDWARRANTSScheduleofStatusofStockWarrantsDetails" xlink:type="simple" xlink:href="lbio-20150331.xsd#Disclosure-STOCKOPTIONSANDWARRANTSScheduleofStatusofStockWarrantsDetails" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-csose" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-csose" />
  <link:roleRef roleURI="http://www.lbio.com/role/Disclosure-LICENSEANDCOMMITMENTSDetails" xlink:type="simple" xlink:href="lbio-20150331.xsd#Disclosure-LICENSEANDCOMMITMENTSDetails" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-sosapd" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-sosapd" />
  <link:roleRef roleURI="http://www.lbio.com/role/Disclosure-STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="lbio-20150331.xsd#Disclosure-STOCKHOLDERSEQUITYNarrativeDetails" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-soawnd" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-soawnd" />
  <link:roleRef roleURI="http://www.lbio.com/role/Disclosure-SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="lbio-20150331.xsd#Disclosure-SUBSEQUENTEVENTSDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-dei">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:title="dei_DocumentInformationLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:title="dei_DocumentInformationTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:title="Definition : dei_DocumentInformationLineItems to dei_DocumentInformationTable" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:title="us-gaap_StatementClassOfStockAxis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:title="Definition : dei_DocumentInformationTable to us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:title="us-gaap_ClassOfStockDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:title="Definition : us-gaap_StatementClassOfStockAxis to us-gaap_ClassOfStockDomain" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_1" xlink:title="us-gaap_ClassOfStockDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_1" xlink:title="Definition : us-gaap_StatementClassOfStockAxis to us-gaap_ClassOfStockDomain" xlink:type="arc" order="4" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:title="dei_EntityRegistrantName" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:title="Definition : dei_DocumentInformationLineItems to dei_EntityRegistrantName" xlink:type="arc" order="5" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:title="dei_EntityCentralIndexKey" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:title="Definition : dei_DocumentInformationLineItems to dei_EntityCentralIndexKey" xlink:type="arc" order="6" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:title="dei_CurrentFiscalYearEndDate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" xlink:title="Definition : dei_DocumentInformationLineItems to dei_CurrentFiscalYearEndDate" xlink:type="arc" order="7" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:title="dei_EntityFilerCategory" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" xlink:title="Definition : dei_DocumentInformationLineItems to dei_EntityFilerCategory" xlink:type="arc" order="8" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:title="dei_EntityCommonStockSharesOutstanding" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" xlink:title="Definition : dei_DocumentInformationLineItems to dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="9" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:title="dei_DocumentType" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:title="Definition : dei_DocumentInformationLineItems to dei_DocumentType" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:title="dei_AmendmentFlag" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:title="Definition : dei_DocumentInformationLineItems to dei_AmendmentFlag" xlink:type="arc" order="11" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:title="dei_DocumentPeriodEndDate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:title="Definition : dei_DocumentInformationLineItems to dei_DocumentPeriodEndDate" xlink:type="arc" order="12" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:title="dei_DocumentFiscalPeriodFocus" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="Definition : dei_DocumentInformationLineItems to dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="13" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xlink:title="dei_DocumentFiscalYearFocus" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="Definition : dei_DocumentInformationLineItems to dei_DocumentFiscalYearFocus" xlink:type="arc" order="14" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:title="dei_EntityWellKnownSeasonedIssuer" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" xlink:title="Definition : dei_DocumentInformationLineItems to dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="15" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" xlink:title="dei_EntityVoluntaryFilers" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" xlink:title="Definition : dei_DocumentInformationLineItems to dei_EntityVoluntaryFilers" xlink:type="arc" order="16" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xlink:title="dei_EntityCurrentReportingStatus" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" xlink:title="Definition : dei_DocumentInformationLineItems to dei_EntityCurrentReportingStatus" xlink:type="arc" order="17" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" xlink:title="dei_EntityPublicFloat" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" xlink:title="Definition : dei_DocumentInformationLineItems to dei_EntityPublicFloat" xlink:type="arc" order="18" xbrldt:closed="false" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-soawsososod">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:title="us-gaap_AwardTypeAxis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" xlink:title="Definition : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_AwardTypeAxis" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="Definition : us-gaap_AwardTypeAxis to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:title="Definition : us-gaap_AwardTypeAxis to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="4" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:label="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:title="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:type="arc" order="4" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:title="us-gaap_EmployeeStockOptionMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="4" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_AggregateIntrinsicValueAbstract" xlink:label="lbio_AggregateIntrinsicValueAbstract" xlink:title="lbio_AggregateIntrinsicValueAbstract" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lbio_AggregateIntrinsicValueAbstract" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to lbio_AggregateIntrinsicValueAbstract" xlink:type="arc" order="5" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="7" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="8" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="9" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="12" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="14" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="15" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="16" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="18" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="Definition : lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="20" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:label="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:title="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:to="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:title="Definition : lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract to lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:type="arc" order="21" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm" xlink:label="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm" xlink:title="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:to="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm" xlink:title="Definition : lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract to lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm" xlink:type="arc" order="22" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="Definition : lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="23" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbio_AggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:title="Definition : lbio_AggregateIntrinsicValueAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="25" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbio_AggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="Definition : lbio_AggregateIntrinsicValueAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="27" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbio_AggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="Definition : lbio_AggregateIntrinsicValueAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" use="optional" order="37" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Disclosure-STOCKOPTIONSANDWARRANTSScheduleofStatusofStockWarrantsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:title="us-gaap_StatementEquityComponentsAxis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:title="Definition : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:title="us-gaap_EquityComponentDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:title="Definition : us-gaap_StatementEquityComponentsAxis to us-gaap_EquityComponentDomain" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_1" xlink:title="us-gaap_EquityComponentDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_1" xlink:title="Definition : us-gaap_StatementEquityComponentsAxis to us-gaap_EquityComponentDomain" xlink:type="arc" order="4" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:title="us-gaap_WarrantMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" xlink:title="Definition : us-gaap_EquityComponentDomain to us-gaap_WarrantMember" xlink:type="arc" order="5" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="6" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="7" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="8" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="9" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="11" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="12" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="13" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="14" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="15" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="16" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:label="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:title="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:type="arc" order="17" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="Definition : lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="18" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="Definition : lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="19" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_AggregateIntrinsicValueAbstract1Abstract" xlink:label="lbio_AggregateIntrinsicValueAbstract1Abstract" xlink:title="lbio_AggregateIntrinsicValueAbstract1Abstract" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lbio_AggregateIntrinsicValueAbstract1Abstract" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to lbio_AggregateIntrinsicValueAbstract1Abstract" xlink:type="arc" order="20" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbio_AggregateIntrinsicValueAbstract1Abstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:title="Definition : lbio_AggregateIntrinsicValueAbstract1Abstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="21" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbio_AggregateIntrinsicValueAbstract1Abstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="Definition : lbio_AggregateIntrinsicValueAbstract1Abstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="22" xbrldt:closed="false" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-csose">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:title="us-gaap_StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:title="us-gaap_StatementTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_StatementTable" xlink:type="arc" order="8011" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:title="us-gaap_StockholdersEquity" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_StockholdersEquity" xlink:type="arc" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:title="us-gaap_StatementEquityComponentsAxis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:title="Definition : us-gaap_StatementTable to us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" xlink:title="us-gaap_SharesOutstanding" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_SharesOutstanding" xlink:type="arc" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:title="us-gaap_EquityComponentDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:title="Definition : us-gaap_StatementEquityComponentsAxis to us-gaap_EquityComponentDomain" xlink:type="arc" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:type="arc" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" xlink:title="us-gaap_PreferredStockMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" xlink:title="Definition : us-gaap_EquityComponentDomain to us-gaap_PreferredStockMember" xlink:type="arc" order="4" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockIssuedUponExerciseOfWarrantsAmount" xlink:label="lbio_CommonStockIssuedUponExerciseOfWarrantsAmount" xlink:title="lbio_CommonStockIssuedUponExerciseOfWarrantsAmount" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="lbio_CommonStockIssuedUponExerciseOfWarrantsAmount" xlink:title="Definition : us-gaap_StatementLineItems to lbio_CommonStockIssuedUponExerciseOfWarrantsAmount" xlink:type="arc" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:title="us-gaap_CommonStockMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" xlink:title="Definition : us-gaap_EquityComponentDomain to us-gaap_CommonStockMember" xlink:type="arc" order="5" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockIssuedUponExerciseOfWarrantsShares" xlink:label="lbio_CommonStockIssuedUponExerciseOfWarrantsShares" xlink:title="lbio_CommonStockIssuedUponExerciseOfWarrantsShares" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="lbio_CommonStockIssuedUponExerciseOfWarrantsShares" xlink:title="Definition : us-gaap_StatementLineItems to lbio_CommonStockIssuedUponExerciseOfWarrantsShares" xlink:type="arc" order="5" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockToBeIssuedMember" xlink:label="lbio_CommonStockToBeIssuedMember" xlink:title="lbio_CommonStockToBeIssuedMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lbio_CommonStockToBeIssuedMember" xlink:title="Definition : us-gaap_EquityComponentDomain to lbio_CommonStockToBeIssuedMember" xlink:type="arc" order="6" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:title="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="6" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:title="us-gaap_AdditionalPaidInCapitalMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" xlink:title="Definition : us-gaap_EquityComponentDomain to us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="7" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:title="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="7" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" xlink:title="us-gaap_RetainedEarningsMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" xlink:title="Definition : us-gaap_EquityComponentDomain to us-gaap_RetainedEarningsMember" xlink:type="arc" order="8" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:title="us-gaap_StockIssuedDuringPeriodValueOther" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodValueOther" xlink:type="arc" order="8" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:title="us-gaap_StockIssuedDuringPeriodSharesOther" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodSharesOther" xlink:type="arc" order="9" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:title="us-gaap_NetIncomeLoss" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_NetIncomeLoss" xlink:type="arc" order="12" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_1" xlink:title="us-gaap_EquityComponentDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_1" xlink:title="Definition : us-gaap_StatementEquityComponentsAxis to us-gaap_EquityComponentDomain" xlink:type="arc" use="optional" order="13" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:type="arc" use="optional" order="8021" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Disclosure-LICENSEANDCOMMITMENTSDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="us-gaap_OtherCommitmentsLineItems" xlink:title="us-gaap_OtherCommitmentsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCommitmentsTable" xlink:label="us-gaap_OtherCommitmentsTable" xlink:title="us-gaap_OtherCommitmentsTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OtherCommitmentsTable" xlink:title="Definition : us-gaap_OtherCommitmentsLineItems to us-gaap_OtherCommitmentsTable" xlink:type="arc" order="8048" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:title="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:title="Definition : us-gaap_OtherCommitmentsTable to us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:type="arc" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:title="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis to us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:type="arc" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseArrangementTypeAxis" xlink:label="us-gaap_LeaseArrangementTypeAxis" xlink:title="us-gaap_LeaseArrangementTypeAxis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_LeaseArrangementTypeAxis" xlink:title="Definition : us-gaap_OtherCommitmentsTable to us-gaap_LeaseArrangementTypeAxis" xlink:type="arc" order="5" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="us-gaap_LeaseArrangementTypeDomain" xlink:title="us-gaap_LeaseArrangementTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LeaseArrangementTypeAxis" xlink:to="us-gaap_LeaseArrangementTypeDomain" xlink:title="Definition : us-gaap_LeaseArrangementTypeAxis to us-gaap_LeaseArrangementTypeDomain" xlink:type="arc" order="6" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LicensingAgreementsMember" xlink:label="us-gaap_LicensingAgreementsMember" xlink:title="us-gaap_LicensingAgreementsMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseArrangementTypeDomain" xlink:to="us-gaap_LicensingAgreementsMember" xlink:title="Definition : us-gaap_LeaseArrangementTypeDomain to us-gaap_LicensingAgreementsMember" xlink:type="arc" order="8" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:title="us-gaap_StatementScenarioAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:title="us-gaap_ScenarioUnspecifiedDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:title="Definition : us-gaap_StatementScenarioAxis to us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PerQuarterMember" xlink:label="lbio_PerQuarterMember" xlink:title="lbio_PerQuarterMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="lbio_PerQuarterMember" xlink:title="Definition : us-gaap_ScenarioUnspecifiedDomain to lbio_PerQuarterMember" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CradaMember" xlink:label="lbio_CradaMember" xlink:title="lbio_CradaMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="lbio_CradaMember" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to lbio_CradaMember" xlink:type="arc" use="optional" order="14" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ManufacturingServiceAgreementMember" xlink:label="lbio_ManufacturingServiceAgreementMember" xlink:title="lbio_ManufacturingServiceAgreementMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseArrangementTypeDomain" xlink:to="lbio_ManufacturingServiceAgreementMember" xlink:title="Definition : us-gaap_LeaseArrangementTypeDomain to lbio_ManufacturingServiceAgreementMember" xlink:type="arc" use="optional" order="18" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PerYearMember" xlink:label="lbio_PerYearMember" xlink:title="lbio_PerYearMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="lbio_PerYearMember" xlink:title="Definition : us-gaap_ScenarioUnspecifiedDomain to lbio_PerYearMember" xlink:type="arc" use="optional" order="20" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:title="Definition : us-gaap_OtherCommitmentsTable to us-gaap_StatementScenarioAxis" xlink:type="arc" use="optional" order="22" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount" xlink:title="us-gaap_LongTermPurchaseCommitmentAmount" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount" xlink:title="Definition : us-gaap_OtherCommitmentsLineItems to us-gaap_LongTermPurchaseCommitmentAmount" xlink:type="arc" use="optional" order="24" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_NCIMember" xlink:label="lbio_NCIMember" xlink:title="lbio_NCIMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="lbio_NCIMember" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to lbio_NCIMember" xlink:type="arc" use="optional" order="24" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AreaOfLand" xlink:label="us-gaap_AreaOfLand" xlink:title="us-gaap_AreaOfLand" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_AreaOfLand" xlink:title="Definition : us-gaap_OtherCommitmentsLineItems to us-gaap_AreaOfLand" xlink:type="arc" order="26" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:title="us-gaap_AccruedLiabilitiesCurrent" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_AccruedLiabilitiesCurrent" xlink:title="Definition : us-gaap_OtherCommitmentsLineItems to us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="27" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_OvarianCancerMember" xlink:label="lbio_OvarianCancerMember" xlink:title="lbio_OvarianCancerMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="lbio_OvarianCancerMember" xlink:title="Definition : us-gaap_ScenarioUnspecifiedDomain to lbio_OvarianCancerMember" xlink:type="arc" use="optional" order="30" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PercentageOfRoyaltyOnSales" xlink:label="lbio_PercentageOfRoyaltyOnSales" xlink:title="lbio_PercentageOfRoyaltyOnSales" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="lbio_PercentageOfRoyaltyOnSales" xlink:title="Definition : us-gaap_OtherCommitmentsLineItems to lbio_PercentageOfRoyaltyOnSales" xlink:type="arc" order="32" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_NIHMember" xlink:label="lbio_NIHMember" xlink:title="lbio_NIHMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="lbio_NIHMember" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to lbio_NIHMember" xlink:type="arc" use="optional" order="34" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_BreastCancerMember" xlink:label="lbio_BreastCancerMember" xlink:title="lbio_BreastCancerMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="lbio_BreastCancerMember" xlink:title="Definition : us-gaap_ScenarioUnspecifiedDomain to lbio_BreastCancerMember" xlink:type="arc" use="optional" order="40" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ColorectalCancerMember" xlink:label="lbio_ColorectalCancerMember" xlink:title="lbio_ColorectalCancerMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="lbio_ColorectalCancerMember" xlink:title="Definition : us-gaap_ScenarioUnspecifiedDomain to lbio_ColorectalCancerMember" xlink:type="arc" use="optional" order="50" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_MelanomaMember" xlink:label="lbio_MelanomaMember" xlink:title="lbio_MelanomaMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="lbio_MelanomaMember" xlink:title="Definition : us-gaap_ScenarioUnspecifiedDomain to lbio_MelanomaMember" xlink:type="arc" use="optional" order="60" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:title="us-gaap_ResearchAndDevelopmentExpense" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" xlink:title="Definition : us-gaap_OtherCommitmentsLineItems to us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="8001" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_EstimatedBenchmarkPaymentsForProducts" xlink:label="lbio_EstimatedBenchmarkPaymentsForProducts" xlink:title="lbio_EstimatedBenchmarkPaymentsForProducts" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="lbio_EstimatedBenchmarkPaymentsForProducts" xlink:title="Definition : us-gaap_OtherCommitmentsLineItems to lbio_EstimatedBenchmarkPaymentsForProducts" xlink:type="arc" order="8002" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:title="us-gaap_LeaseAndRentalExpense" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" xlink:title="Definition : us-gaap_OtherCommitmentsLineItems to us-gaap_LeaseAndRentalExpense" xlink:type="arc" order="8003" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PercentageOfIncreaseInLeaseRent" xlink:label="lbio_PercentageOfIncreaseInLeaseRent" xlink:title="lbio_PercentageOfIncreaseInLeaseRent" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="lbio_PercentageOfIncreaseInLeaseRent" xlink:title="Definition : us-gaap_OtherCommitmentsLineItems to lbio_PercentageOfIncreaseInLeaseRent" xlink:type="arc" order="8018" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_UpfrontLicenseFee" xlink:label="lbio_UpfrontLicenseFee" xlink:title="lbio_UpfrontLicenseFee" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="lbio_UpfrontLicenseFee" xlink:title="Definition : us-gaap_OtherCommitmentsLineItems to lbio_UpfrontLicenseFee" xlink:type="arc" use="optional" order="8028" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_LongTermPurchaseCommitmentPercentage" xlink:label="lbio_LongTermPurchaseCommitmentPercentage" xlink:title="lbio_LongTermPurchaseCommitmentPercentage" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="lbio_LongTermPurchaseCommitmentPercentage" xlink:title="Definition : us-gaap_OtherCommitmentsLineItems to lbio_LongTermPurchaseCommitmentPercentage" xlink:type="arc" use="optional" order="8038" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="us-gaap_LeaseArrangementTypeDomain_1" xlink:title="us-gaap_LeaseArrangementTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LeaseArrangementTypeAxis" xlink:to="us-gaap_LeaseArrangementTypeDomain_1" xlink:title="Definition : us-gaap_LeaseArrangementTypeAxis to us-gaap_LeaseArrangementTypeDomain" xlink:type="arc" use="optional" order="16" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_1" xlink:title="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_1" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis to us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:type="arc" use="optional" order="13" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain_1" xlink:title="us-gaap_ScenarioUnspecifiedDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_1" xlink:title="Definition : us-gaap_StatementScenarioAxis to us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc" use="optional" order="20" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-sosapd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="Definition : us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="29" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="Definition : us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockOptionMember" xlink:label="us-gaap_StockOptionMember" xlink:title="us-gaap_StockOptionMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_StockOptionMember" xlink:title="Definition : us-gaap_AntidilutiveSecuritiesNameDomain to us-gaap_StockOptionMember" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="Definition : us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="19" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:title="us-gaap_WarrantMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" xlink:title="Definition : us-gaap_AntidilutiveSecuritiesNameDomain to us-gaap_WarrantMember" xlink:type="arc" use="optional" order="20" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:title="us-gaap_ConvertiblePreferredStockMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" xlink:title="Definition : us-gaap_AntidilutiveSecuritiesNameDomain to us-gaap_ConvertiblePreferredStockMember" xlink:type="arc" use="optional" order="30" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:title="us-gaap_RestrictedStockMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" xlink:title="Definition : us-gaap_AntidilutiveSecuritiesNameDomain to us-gaap_RestrictedStockMember" xlink:type="arc" use="optional" order="40" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="Definition : us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" use="optional" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_1" xlink:title="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_1" xlink:title="Definition : us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" use="optional" order="20" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Disclosure-STOCKHOLDERSEQUITYNarrativeDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" xlink:title="us-gaap_ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" xlink:title="us-gaap_ScheduleOfStockByClassTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" xlink:title="Definition : us-gaap_ClassOfStockLineItems to us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="8123" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:title="us-gaap_StatementClassOfStockAxis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:title="Definition : us-gaap_ScheduleOfStockByClassTable to us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:title="us-gaap_ClassOfStockDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:title="Definition : us-gaap_StatementClassOfStockAxis to us-gaap_ClassOfStockDomain" xlink:type="arc" order="3" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_SeriesConvertiblePreferredStockMember" xlink:label="lbio_SeriesConvertiblePreferredStockMember" xlink:title="lbio_SeriesConvertiblePreferredStockMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="lbio_SeriesConvertiblePreferredStockMember" xlink:title="Definition : us-gaap_ClassOfStockDomain to lbio_SeriesConvertiblePreferredStockMember" xlink:type="arc" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:title="us-gaap_AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="Definition : us-gaap_AwardTypeAxis to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:title="us-gaap_RestrictedStockMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_RestrictedStockMember" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="Definition : us-gaap_ClassOfStockLineItems to us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" use="optional" order="20" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_AwardTypeAxis" xlink:title="Definition : us-gaap_ScheduleOfStockByClassTable to us-gaap_AwardTypeAxis" xlink:type="arc" use="optional" order="36" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" xlink:title="us-gaap_SharePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharePrice" xlink:title="Definition : us-gaap_ClassOfStockLineItems to us-gaap_SharePrice" xlink:type="arc" order="8006" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="Definition : us-gaap_ClassOfStockLineItems to us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" use="optional" order="8023" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1" xlink:title="us-gaap_ConversionOfStockSharesIssued1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConversionOfStockSharesIssued1" xlink:title="Definition : us-gaap_ClassOfStockLineItems to us-gaap_ConversionOfStockSharesIssued1" xlink:type="arc" order="8033" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1" xlink:title="us-gaap_ConversionOfStockSharesConverted1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" xlink:title="Definition : us-gaap_ClassOfStockLineItems to us-gaap_ConversionOfStockSharesConverted1" xlink:type="arc" order="8043" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="Definition : us-gaap_ClassOfStockLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" use="optional" order="8053" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="Definition : us-gaap_ClassOfStockLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" use="optional" order="8063" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:title="Definition : us-gaap_ClassOfStockLineItems to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:type="arc" use="optional" order="8073" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="Definition : us-gaap_ClassOfStockLineItems to us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" use="optional" order="8093" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:title="Definition : us-gaap_ClassOfStockLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" use="optional" order="8103" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="Definition : us-gaap_ClassOfStockLineItems to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" use="optional" order="8113" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_1" xlink:title="us-gaap_ClassOfStockDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_1" xlink:title="Definition : us-gaap_StatementClassOfStockAxis to us-gaap_ClassOfStockDomain" xlink:type="arc" use="optional" order="13" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:title="Definition : us-gaap_AwardTypeAxis to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" use="optional" order="20" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-soawnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="161" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" xlink:title="us-gaap_VestingAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain" xlink:title="us-gaap_VestingDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" xlink:title="Definition : us-gaap_VestingAxis to us-gaap_VestingDomain" xlink:type="arc" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="Definition : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:title="us-gaap_RangeAxis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_RangeAxis" xlink:title="Definition : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_RangeAxis" xlink:type="arc" order="3" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" xlink:title="Definition : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_VestingAxis" xlink:type="arc" order="6" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xlink:title="us-gaap_RelatedPartyDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" xlink:title="Definition : us-gaap_RelatedPartyTransactionsByRelatedPartyAxis to us-gaap_RelatedPartyDomain" xlink:type="arc" order="6" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:title="us-gaap_PlanNameAxis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" xlink:title="Definition : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_PlanNameAxis" xlink:type="arc" use="optional" order="7" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:title="us-gaap_RangeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:title="Definition : us-gaap_RangeAxis to us-gaap_RangeMember" xlink:type="arc" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:title="us-gaap_PlanNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" xlink:title="Definition : us-gaap_PlanNameAxis to us-gaap_PlanNameDomain" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PlanOneMember" xlink:label="lbio_PlanOneMember" xlink:title="lbio_PlanOneMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="lbio_PlanOneMember" xlink:title="Definition : us-gaap_PlanNameDomain to lbio_PlanOneMember" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:title="us-gaap_AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="Definition : us-gaap_AwardTypeAxis to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:title="us-gaap_WarrantMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_WarrantMember" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_WarrantMember" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:title="us-gaap_MinimumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:title="Definition : us-gaap_RangeMember to us-gaap_MinimumMember" xlink:type="arc" order="11" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_VestingFirstMember" xlink:label="lbio_VestingFirstMember" xlink:title="lbio_VestingFirstMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="lbio_VestingFirstMember" xlink:title="Definition : us-gaap_VestingDomain to lbio_VestingFirstMember" xlink:type="arc" use="optional" order="11" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:title="us-gaap_MaximumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:title="Definition : us-gaap_RangeMember to us-gaap_MaximumMember" xlink:type="arc" order="12" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DirectorMember" xlink:label="us-gaap_DirectorMember" xlink:title="us-gaap_DirectorMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_DirectorMember" xlink:title="Definition : us-gaap_RelatedPartyDomain to us-gaap_DirectorMember" xlink:type="arc" use="optional" order="13" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" use="optional" order="17" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" xlink:title="Definition : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_AwardTypeAxis" xlink:type="arc" use="optional" order="17" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="19" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PlanTwoMember" xlink:label="lbio_PlanTwoMember" xlink:title="lbio_PlanTwoMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="lbio_PlanTwoMember" xlink:title="Definition : us-gaap_PlanNameDomain to lbio_PlanTwoMember" xlink:type="arc" use="optional" order="20" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" use="optional" order="41" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="51" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="61" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="71" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises" xlink:title="us-gaap_ProceedsFromWarrantExercises" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromWarrantExercises" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ProceedsFromWarrantExercises" xlink:type="arc" order="91" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" use="optional" order="101" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" use="optional" order="111" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" use="optional" order="121" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" use="optional" order="131" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" use="optional" order="141" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" use="optional" order="151" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_1" xlink:title="us-gaap_RelatedPartyDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_1" xlink:title="Definition : us-gaap_RelatedPartyTransactionsByRelatedPartyAxis to us-gaap_RelatedPartyDomain" xlink:type="arc" use="optional" order="16" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember_1" xlink:title="us-gaap_RangeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember_1" xlink:title="Definition : us-gaap_RangeAxis to us-gaap_RangeMember" xlink:type="arc" use="optional" order="20" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain_1" xlink:title="us-gaap_VestingDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain_1" xlink:title="Definition : us-gaap_VestingAxis to us-gaap_VestingDomain" xlink:type="arc" use="optional" order="11" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_1" xlink:title="us-gaap_PlanNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_1" xlink:title="Definition : us-gaap_PlanNameAxis to us-gaap_PlanNameDomain" xlink:type="arc" use="optional" order="20" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:title="Definition : us-gaap_AwardTypeAxis to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" use="optional" order="20" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Disclosure-SUBSEQUENTEVENTSDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" xlink:title="us-gaap_SubsequentEventLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" xlink:title="us-gaap_SubsequentEventTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" xlink:title="Definition : us-gaap_SubsequentEventLineItems to us-gaap_SubsequentEventTable" xlink:type="arc" use="optional" order="50" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:title="us-gaap_SubsequentEventTypeAxis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" xlink:title="Definition : us-gaap_SubsequentEventTable to us-gaap_SubsequentEventTypeAxis" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:title="us-gaap_SubsequentEventTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" xlink:title="Definition : us-gaap_SubsequentEventTypeAxis to us-gaap_SubsequentEventTypeDomain" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:title="us-gaap_SubsequentEventMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" xlink:title="Definition : us-gaap_SubsequentEventTypeDomain to us-gaap_SubsequentEventMember" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises" xlink:title="us-gaap_ProceedsFromWarrantExercises" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromWarrantExercises" xlink:title="Definition : us-gaap_SubsequentEventLineItems to us-gaap_ProceedsFromWarrantExercises" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:title="us-gaap_AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="Definition : us-gaap_AwardTypeAxis to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:title="us-gaap_WarrantMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_WarrantMember" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_WarrantMember" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="Definition : us-gaap_SubsequentEventLineItems to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" use="optional" order="20" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_AwardTypeAxis" xlink:title="Definition : us-gaap_SubsequentEventTable to us-gaap_AwardTypeAxis" xlink:type="arc" use="optional" order="20" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="Definition : us-gaap_SubsequentEventLineItems to us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" use="optional" order="30" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:title="us-gaap_SaleOfStockPricePerShare" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" xlink:title="Definition : us-gaap_SubsequentEventLineItems to us-gaap_SaleOfStockPricePerShare" xlink:type="arc" use="optional" order="40" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_1" xlink:title="us-gaap_SubsequentEventTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_1" xlink:title="Definition : us-gaap_SubsequentEventTypeAxis to us-gaap_SubsequentEventTypeDomain" xlink:type="arc" use="optional" order="20" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:title="Definition : us-gaap_AwardTypeAxis to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" use="optional" order="20" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>lbio-20150331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--Created by IRIS, Powered by IRIS Carbon-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CostToInduceExchangeTransaction" xlink:label="lbio_CostToInduceExchangeTransaction" xlink:title="lbio_CostToInduceExchangeTransaction" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CostToInduceExchangeTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_CostToInduceExchangeTransaction" xml:lang="en-US" id="label_lbio_CostToInduceExchangeTransaction">The amount of exchange transaction inducement costs capitalized during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CostToInduceExchangeTransaction" xlink:to="label_lbio_CostToInduceExchangeTransaction" xlink:title="Label : lbio_CostToInduceExchangeTransaction to label_lbio_CostToInduceExchangeTransaction" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CostToInduceExchangeTransaction_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_CostToInduceExchangeTransaction_1" xml:lang="en-US" id="label_lbio_CostToInduceExchangeTransaction_1">Cost To Induce Exchange Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CostToInduceExchangeTransaction" xlink:to="label_lbio_CostToInduceExchangeTransaction_1" xlink:title="Label : lbio_CostToInduceExchangeTransaction to label_lbio_CostToInduceExchangeTransaction_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CostToInduceExchangeTransaction_2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_lbio_CostToInduceExchangeTransaction_2" xml:lang="en-US" id="label_lbio_CostToInduceExchangeTransaction_2">Cost to induce exchange transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CostToInduceExchangeTransaction" xlink:to="label_lbio_CostToInduceExchangeTransaction_2" xlink:title="Label : lbio_CostToInduceExchangeTransaction to label_lbio_CostToInduceExchangeTransaction_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" xlink:label="lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" xlink:title="lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" />
    <link:label xlink:type="resource" xlink:label="label_lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" xml:lang="en-US" id="label_lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts">Represents the fair value of common stock and warrants accounted for as financing costs during the reporting period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" xlink:to="label_lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" xlink:title="Label : lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts to label_lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" />
    <link:label xlink:type="resource" xlink:label="label_lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts_1" xml:lang="en-US" id="label_lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts_1">Fair Value of Common Stock and Warrants Accounted for as Financing Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" xlink:to="label_lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts_1" xlink:title="Label : lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts to label_lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts_2" xml:lang="en-US" id="label_lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts_2">Fair value of common stock and warrants accounted for as financing costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" xlink:to="label_lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts_2" xlink:title="Label : lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts to label_lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_FairValueOfVestedWarrantsGrantedForServices" xlink:label="lbio_FairValueOfVestedWarrantsGrantedForServices" xlink:title="lbio_FairValueOfVestedWarrantsGrantedForServices" />
    <link:label xlink:type="resource" xlink:label="label_lbio_FairValueOfVestedWarrantsGrantedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_FairValueOfVestedWarrantsGrantedForServices" xml:lang="en-US" id="label_lbio_FairValueOfVestedWarrantsGrantedForServices">Fair Value of Vested Warrants Granted for Services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_FairValueOfVestedWarrantsGrantedForServices" xlink:to="label_lbio_FairValueOfVestedWarrantsGrantedForServices" xlink:title="Label : lbio_FairValueOfVestedWarrantsGrantedForServices to label_lbio_FairValueOfVestedWarrantsGrantedForServices" />
    <link:label xlink:type="resource" xlink:label="label_lbio_FairValueOfVestedWarrantsGrantedForServices_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_FairValueOfVestedWarrantsGrantedForServices_1" xml:lang="en-US" id="label_lbio_FairValueOfVestedWarrantsGrantedForServices_1">Vesting of restricted shares issued for services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_FairValueOfVestedWarrantsGrantedForServices" xlink:to="label_lbio_FairValueOfVestedWarrantsGrantedForServices_1" xlink:title="Label : lbio_FairValueOfVestedWarrantsGrantedForServices to label_lbio_FairValueOfVestedWarrantsGrantedForServices_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockIssuedToOfficerForServices" xlink:label="lbio_CommonStockIssuedToOfficerForServices" xlink:title="lbio_CommonStockIssuedToOfficerForServices" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockIssuedToOfficerForServices" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_CommonStockIssuedToOfficerForServices" xml:lang="en-US" id="label_lbio_CommonStockIssuedToOfficerForServices">Custom Element</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockIssuedToOfficerForServices" xlink:to="label_lbio_CommonStockIssuedToOfficerForServices" xlink:title="Label : lbio_CommonStockIssuedToOfficerForServices to label_lbio_CommonStockIssuedToOfficerForServices" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockIssuedToOfficerForServices_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_CommonStockIssuedToOfficerForServices_1" xml:lang="en-US" id="label_lbio_CommonStockIssuedToOfficerForServices_1">Common Stock Issued to Officer for Services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockIssuedToOfficerForServices" xlink:to="label_lbio_CommonStockIssuedToOfficerForServices_1" xlink:title="Label : lbio_CommonStockIssuedToOfficerForServices to label_lbio_CommonStockIssuedToOfficerForServices_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockIssuedToOfficerForServices_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_CommonStockIssuedToOfficerForServices_2" xml:lang="en-US" id="label_lbio_CommonStockIssuedToOfficerForServices_2">Common stock issued to officer for services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockIssuedToOfficerForServices" xlink:to="label_lbio_CommonStockIssuedToOfficerForServices_2" xlink:title="Label : lbio_CommonStockIssuedToOfficerForServices to label_lbio_CommonStockIssuedToOfficerForServices_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockIssuedToInduceConversionOfWarrants" xlink:label="lbio_CommonStockIssuedToInduceConversionOfWarrants" xlink:title="lbio_CommonStockIssuedToInduceConversionOfWarrants" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockIssuedToInduceConversionOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_CommonStockIssuedToInduceConversionOfWarrants" xml:lang="en-US" id="label_lbio_CommonStockIssuedToInduceConversionOfWarrants">Value of common stock issued to induce conversion of warrants.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockIssuedToInduceConversionOfWarrants" xlink:to="label_lbio_CommonStockIssuedToInduceConversionOfWarrants" xlink:title="Label : lbio_CommonStockIssuedToInduceConversionOfWarrants to label_lbio_CommonStockIssuedToInduceConversionOfWarrants" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockIssuedToInduceConversionOfWarrants_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_CommonStockIssuedToInduceConversionOfWarrants_1" xml:lang="en-US" id="label_lbio_CommonStockIssuedToInduceConversionOfWarrants_1">Common Stock Issued To Induce Conversion Of Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockIssuedToInduceConversionOfWarrants" xlink:to="label_lbio_CommonStockIssuedToInduceConversionOfWarrants_1" xlink:title="Label : lbio_CommonStockIssuedToInduceConversionOfWarrants to label_lbio_CommonStockIssuedToInduceConversionOfWarrants_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockIssuedToInduceConversionOfWarrants_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_CommonStockIssuedToInduceConversionOfWarrants_2" xml:lang="en-US" id="label_lbio_CommonStockIssuedToInduceConversionOfWarrants_2">Common stock issued to induce conversion of warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockIssuedToInduceConversionOfWarrants" xlink:to="label_lbio_CommonStockIssuedToInduceConversionOfWarrants_2" xlink:title="Label : lbio_CommonStockIssuedToInduceConversionOfWarrants to label_lbio_CommonStockIssuedToInduceConversionOfWarrants_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockIssuedToInduceExchangeTransaction" xlink:label="lbio_CommonStockIssuedToInduceExchangeTransaction" xlink:title="lbio_CommonStockIssuedToInduceExchangeTransaction" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockIssuedToInduceExchangeTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_CommonStockIssuedToInduceExchangeTransaction" xml:lang="en-US" id="label_lbio_CommonStockIssuedToInduceExchangeTransaction">The amount of exchange transaction inducement costs capitalized during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockIssuedToInduceExchangeTransaction" xlink:to="label_lbio_CommonStockIssuedToInduceExchangeTransaction" xlink:title="Label : lbio_CommonStockIssuedToInduceExchangeTransaction to label_lbio_CommonStockIssuedToInduceExchangeTransaction" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockIssuedToInduceExchangeTransaction_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_CommonStockIssuedToInduceExchangeTransaction_1" xml:lang="en-US" id="label_lbio_CommonStockIssuedToInduceExchangeTransaction_1">Common Stock Issued To Induce Exchange Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockIssuedToInduceExchangeTransaction" xlink:to="label_lbio_CommonStockIssuedToInduceExchangeTransaction_1" xlink:title="Label : lbio_CommonStockIssuedToInduceExchangeTransaction to label_lbio_CommonStockIssuedToInduceExchangeTransaction_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockIssuedToInduceExchangeTransaction_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_CommonStockIssuedToInduceExchangeTransaction_2" xml:lang="en-US" id="label_lbio_CommonStockIssuedToInduceExchangeTransaction_2">Common stock issued to induce exchange transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockIssuedToInduceExchangeTransaction" xlink:to="label_lbio_CommonStockIssuedToInduceExchangeTransaction_2" xlink:title="Label : lbio_CommonStockIssuedToInduceExchangeTransaction to label_lbio_CommonStockIssuedToInduceExchangeTransaction_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_FairValueOfCommonStockTransferredToOfficerAndDirector" xlink:label="lbio_FairValueOfCommonStockTransferredToOfficerAndDirector" xlink:title="lbio_FairValueOfCommonStockTransferredToOfficerAndDirector" />
    <link:label xlink:type="resource" xlink:label="label_lbio_FairValueOfCommonStockTransferredToOfficerAndDirector" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_FairValueOfCommonStockTransferredToOfficerAndDirector" xml:lang="en-US" id="label_lbio_FairValueOfCommonStockTransferredToOfficerAndDirector">Custom Element</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_FairValueOfCommonStockTransferredToOfficerAndDirector" xlink:to="label_lbio_FairValueOfCommonStockTransferredToOfficerAndDirector" xlink:title="Label : lbio_FairValueOfCommonStockTransferredToOfficerAndDirector to label_lbio_FairValueOfCommonStockTransferredToOfficerAndDirector" />
    <link:label xlink:type="resource" xlink:label="label_lbio_FairValueOfCommonStockTransferredToOfficerAndDirector_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_FairValueOfCommonStockTransferredToOfficerAndDirector_1" xml:lang="en-US" id="label_lbio_FairValueOfCommonStockTransferredToOfficerAndDirector_1">Fair Value of Common Stock Transferred to Officer and Director</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_FairValueOfCommonStockTransferredToOfficerAndDirector" xlink:to="label_lbio_FairValueOfCommonStockTransferredToOfficerAndDirector_1" xlink:title="Label : lbio_FairValueOfCommonStockTransferredToOfficerAndDirector to label_lbio_FairValueOfCommonStockTransferredToOfficerAndDirector_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_FairValueOfCommonStockTransferredToOfficerAndDirector_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_FairValueOfCommonStockTransferredToOfficerAndDirector_2" xml:lang="en-US" id="label_lbio_FairValueOfCommonStockTransferredToOfficerAndDirector_2">Fair value of common stock transferred to officer and director</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_FairValueOfCommonStockTransferredToOfficerAndDirector" xlink:to="label_lbio_FairValueOfCommonStockTransferredToOfficerAndDirector_2" xlink:title="Label : lbio_FairValueOfCommonStockTransferredToOfficerAndDirector to label_lbio_FairValueOfCommonStockTransferredToOfficerAndDirector_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_WriteOffOfAdvancesToRelatedParty" xlink:label="lbio_WriteOffOfAdvancesToRelatedParty" xlink:title="lbio_WriteOffOfAdvancesToRelatedParty" />
    <link:label xlink:type="resource" xlink:label="label_lbio_WriteOffOfAdvancesToRelatedParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_WriteOffOfAdvancesToRelatedParty" xml:lang="en-US" id="label_lbio_WriteOffOfAdvancesToRelatedParty">Represents the amount write-off of advances to related party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_WriteOffOfAdvancesToRelatedParty" xlink:to="label_lbio_WriteOffOfAdvancesToRelatedParty" xlink:title="Label : lbio_WriteOffOfAdvancesToRelatedParty to label_lbio_WriteOffOfAdvancesToRelatedParty" />
    <link:label xlink:type="resource" xlink:label="label_lbio_WriteOffOfAdvancesToRelatedParty_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_WriteOffOfAdvancesToRelatedParty_1" xml:lang="en-US" id="label_lbio_WriteOffOfAdvancesToRelatedParty_1">Write Off of Advances to Related Party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_WriteOffOfAdvancesToRelatedParty" xlink:to="label_lbio_WriteOffOfAdvancesToRelatedParty_1" xlink:title="Label : lbio_WriteOffOfAdvancesToRelatedParty to label_lbio_WriteOffOfAdvancesToRelatedParty_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_WriteOffOfAdvancesToRelatedParty_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_WriteOffOfAdvancesToRelatedParty_2" xml:lang="en-US" id="label_lbio_WriteOffOfAdvancesToRelatedParty_2">Write off of advances to related party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_WriteOffOfAdvancesToRelatedParty" xlink:to="label_lbio_WriteOffOfAdvancesToRelatedParty_2" xlink:title="Label : lbio_WriteOffOfAdvancesToRelatedParty to label_lbio_WriteOffOfAdvancesToRelatedParty_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet" xlink:label="lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet" xlink:title="lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet" xml:lang="en-US" id="label_lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet">Custom Element</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet" xlink:to="label_lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet" xlink:title="Label : lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet to label_lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet_1" xml:lang="en-US" id="label_lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet_1">Proceeds from Issuance of Secured Promissory Notes Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet" xlink:to="label_lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet_1" xlink:title="Label : lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet to label_lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet_2" xml:lang="en-US" id="label_lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet_2">Proceeds from the issuance of secured promissory notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet" xlink:to="label_lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet_2" xlink:title="Label : lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet to label_lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants" xlink:label="lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants" xlink:title="lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants" />
    <link:label xlink:type="resource" xlink:label="label_lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants" xml:lang="en-US" id="label_lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants">Custom Element</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants" xlink:to="label_lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants" xlink:title="Label : lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants to label_lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants" />
    <link:label xlink:type="resource" xlink:label="label_lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants_1" xml:lang="en-US" id="label_lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants_1">Derivative Liability Recorded Upon Issuance of Convertible Notes and Attached Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants" xlink:to="label_lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants_1" xlink:title="Label : lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants to label_lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants_2" xml:lang="en-US" id="label_lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants_2">Derivative liability recorded upon issuance of convertible notes and warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants" xlink:to="label_lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants_2" xlink:title="Label : lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants to label_lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:title="dei_AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="label_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_AmendmentFlag" xml:lang="en-US" id="label_dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="label_dei_AmendmentFlag" xlink:title="Label : dei_AmendmentFlag to label_dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost" xlink:label="lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost" xlink:title="lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost" />
    <link:label xlink:type="resource" xlink:label="label_lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost" xml:lang="en-US" id="label_lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost">Represents the derivative liability recorded as offering cost in noncash investing or financing transactions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost" xlink:to="label_lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost" xlink:title="Label : lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost to label_lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost" />
    <link:label xlink:type="resource" xlink:label="label_lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost_1" xml:lang="en-US" id="label_lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost_1">Derivative Liability Recorded as Private Placement Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost" xlink:to="label_lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost_1" xlink:title="Label : lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost to label_lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost_2" xml:lang="en-US" id="label_lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost_2">Derivative liability recorded as offering cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost" xlink:to="label_lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost_2" xlink:title="Label : lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost to label_lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount" xlink:label="lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount" xlink:title="lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount" />
    <link:label xlink:type="resource" xlink:label="label_lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount" xml:lang="en-US" id="label_lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount">Represents the fair value of common stock issued with notes payable recorded as a note discount in noncash investing or financing transactions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount" xlink:to="label_lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount" xlink:title="Label : lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount to label_lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount" />
    <link:label xlink:type="resource" xlink:label="label_lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount_1" xml:lang="en-US" id="label_lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount_1">Fair Value of Common Stock Issued with Notes Payable Recorded as Note Discount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount" xlink:to="label_lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount_1" xlink:title="Label : lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount to label_lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount_2" xml:lang="en-US" id="label_lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount_2">Fair value of common stock issued with notes payable recorded as a note discount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount" xlink:to="label_lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount_2" xlink:title="Label : lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount to label_lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock" xlink:label="lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock" xlink:title="lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="label_lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock" xml:lang="en-US" id="label_lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock">Settlement of accounts payable through issuance of common stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock" xlink:to="label_lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock" xlink:title="Label : lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock to label_lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="label_lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock_1" xml:lang="en-US" id="label_lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock_1">Settlement Of Accounts Payable Through Issuance Of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock" xlink:to="label_lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock_1" xlink:title="Label : lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock to label_lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock_2" xml:lang="en-US" id="label_lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock_2">Settlement of accounts payable through issuance of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock" xlink:to="label_lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock_2" xlink:title="Label : lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock to label_lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockIssuedUponExerciseOfWarrantsShares" xlink:label="lbio_CommonStockIssuedUponExerciseOfWarrantsShares" xlink:title="lbio_CommonStockIssuedUponExerciseOfWarrantsShares" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockIssuedUponExerciseOfWarrantsShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_CommonStockIssuedUponExerciseOfWarrantsShares" xml:lang="en-US" id="label_lbio_CommonStockIssuedUponExerciseOfWarrantsShares">Number of shares issued upon exercise of warrant.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockIssuedUponExerciseOfWarrantsShares" xlink:to="label_lbio_CommonStockIssuedUponExerciseOfWarrantsShares" xlink:title="Label : lbio_CommonStockIssuedUponExerciseOfWarrantsShares to label_lbio_CommonStockIssuedUponExerciseOfWarrantsShares" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockIssuedUponExerciseOfWarrantsShares_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_CommonStockIssuedUponExerciseOfWarrantsShares_1" xml:lang="en-US" id="label_lbio_CommonStockIssuedUponExerciseOfWarrantsShares_1">Common Stock Issued Upon Exercise Of Warrants Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockIssuedUponExerciseOfWarrantsShares" xlink:to="label_lbio_CommonStockIssuedUponExerciseOfWarrantsShares_1" xlink:title="Label : lbio_CommonStockIssuedUponExerciseOfWarrantsShares to label_lbio_CommonStockIssuedUponExerciseOfWarrantsShares_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockIssuedUponExerciseOfWarrantsShares_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_CommonStockIssuedUponExerciseOfWarrantsShares_2" xml:lang="en-US" id="label_lbio_CommonStockIssuedUponExerciseOfWarrantsShares_2">Common stock issued upon exercise of warrants (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockIssuedUponExerciseOfWarrantsShares" xlink:to="label_lbio_CommonStockIssuedUponExerciseOfWarrantsShares_2" xlink:title="Label : lbio_CommonStockIssuedUponExerciseOfWarrantsShares to label_lbio_CommonStockIssuedUponExerciseOfWarrantsShares_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockIssuedUponExerciseOfWarrantsAmount" xlink:label="lbio_CommonStockIssuedUponExerciseOfWarrantsAmount" xlink:title="lbio_CommonStockIssuedUponExerciseOfWarrantsAmount" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockIssuedUponExerciseOfWarrantsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_CommonStockIssuedUponExerciseOfWarrantsAmount" xml:lang="en-US" id="label_lbio_CommonStockIssuedUponExerciseOfWarrantsAmount">The amount of exchange transaction inducement costs capitalized during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockIssuedUponExerciseOfWarrantsAmount" xlink:to="label_lbio_CommonStockIssuedUponExerciseOfWarrantsAmount" xlink:title="Label : lbio_CommonStockIssuedUponExerciseOfWarrantsAmount to label_lbio_CommonStockIssuedUponExerciseOfWarrantsAmount" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockIssuedUponExerciseOfWarrantsAmount_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_CommonStockIssuedUponExerciseOfWarrantsAmount_1" xml:lang="en-US" id="label_lbio_CommonStockIssuedUponExerciseOfWarrantsAmount_1">Common Stock Issued Upon Exercise Of Warrants Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockIssuedUponExerciseOfWarrantsAmount" xlink:to="label_lbio_CommonStockIssuedUponExerciseOfWarrantsAmount_1" xlink:title="Label : lbio_CommonStockIssuedUponExerciseOfWarrantsAmount to label_lbio_CommonStockIssuedUponExerciseOfWarrantsAmount_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockIssuedUponExerciseOfWarrantsAmount_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_CommonStockIssuedUponExerciseOfWarrantsAmount_2" xml:lang="en-US" id="label_lbio_CommonStockIssuedUponExerciseOfWarrantsAmount_2">Common stock issued upon exercise of warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockIssuedUponExerciseOfWarrantsAmount" xlink:to="label_lbio_CommonStockIssuedUponExerciseOfWarrantsAmount_2" xlink:title="Label : lbio_CommonStockIssuedUponExerciseOfWarrantsAmount to label_lbio_CommonStockIssuedUponExerciseOfWarrantsAmount_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockToBeIssuedMember" xlink:label="lbio_CommonStockToBeIssuedMember" xlink:title="lbio_CommonStockToBeIssuedMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockToBeIssuedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_CommonStockToBeIssuedMember" xml:lang="en-US" id="label_lbio_CommonStockToBeIssuedMember">Common Stock To Be Issued [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockToBeIssuedMember" xlink:to="label_lbio_CommonStockToBeIssuedMember" xlink:title="Label : lbio_CommonStockToBeIssuedMember to label_lbio_CommonStockToBeIssuedMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockToBeIssuedMember_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_CommonStockToBeIssuedMember_1" xml:lang="en-US" id="label_lbio_CommonStockToBeIssuedMember_1">Common Stock To Be Issued [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockToBeIssuedMember" xlink:to="label_lbio_CommonStockToBeIssuedMember_1" xlink:title="Label : lbio_CommonStockToBeIssuedMember to label_lbio_CommonStockToBeIssuedMember_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockToBeIssuedValue" xlink:label="lbio_CommonStockToBeIssuedValue" xlink:title="lbio_CommonStockToBeIssuedValue" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockToBeIssuedValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_CommonStockToBeIssuedValue" xml:lang="en-US" id="label_lbio_CommonStockToBeIssuedValue">Value of common stock to be issued as of balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockToBeIssuedValue" xlink:to="label_lbio_CommonStockToBeIssuedValue" xlink:title="Label : lbio_CommonStockToBeIssuedValue to label_lbio_CommonStockToBeIssuedValue" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockToBeIssuedValue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_CommonStockToBeIssuedValue_1" xml:lang="en-US" id="label_lbio_CommonStockToBeIssuedValue_1">Common Stock To Be Issued Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockToBeIssuedValue" xlink:to="label_lbio_CommonStockToBeIssuedValue_1" xlink:title="Label : lbio_CommonStockToBeIssuedValue to label_lbio_CommonStockToBeIssuedValue_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockToBeIssuedValue_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_CommonStockToBeIssuedValue_2" xml:lang="en-US" id="label_lbio_CommonStockToBeIssuedValue_2">Common stock to be issued, 303,125 shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockToBeIssuedValue" xlink:to="label_lbio_CommonStockToBeIssuedValue_2" xlink:title="Label : lbio_CommonStockToBeIssuedValue to label_lbio_CommonStockToBeIssuedValue_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockToBeIssuedShares" xlink:label="lbio_CommonStockToBeIssuedShares" xlink:title="lbio_CommonStockToBeIssuedShares" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockToBeIssuedShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_CommonStockToBeIssuedShares" xml:lang="en-US" id="label_lbio_CommonStockToBeIssuedShares">Number of shares of common stock to be issued.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockToBeIssuedShares" xlink:to="label_lbio_CommonStockToBeIssuedShares" xlink:title="Label : lbio_CommonStockToBeIssuedShares to label_lbio_CommonStockToBeIssuedShares" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockToBeIssuedShares_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_CommonStockToBeIssuedShares_1" xml:lang="en-US" id="label_lbio_CommonStockToBeIssuedShares_1">Common Stock To Be Issued Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockToBeIssuedShares" xlink:to="label_lbio_CommonStockToBeIssuedShares_1" xlink:title="Label : lbio_CommonStockToBeIssuedShares to label_lbio_CommonStockToBeIssuedShares_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockToBeIssuedShares_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_CommonStockToBeIssuedShares_2" xml:lang="en-US" id="label_lbio_CommonStockToBeIssuedShares_2">Common stock to be issued shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockToBeIssuedShares" xlink:to="label_lbio_CommonStockToBeIssuedShares_2" xlink:title="Label : lbio_CommonStockToBeIssuedShares to label_lbio_CommonStockToBeIssuedShares_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_VestedOnOneYearAnniversaryMember" xlink:label="lbio_VestedOnOneYearAnniversaryMember" xlink:title="lbio_VestedOnOneYearAnniversaryMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_VestedOnOneYearAnniversaryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_VestedOnOneYearAnniversaryMember" xml:lang="en-US" id="label_lbio_VestedOnOneYearAnniversaryMember">Represents the information pertaining to option vest on the one year anniversary.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_VestedOnOneYearAnniversaryMember" xlink:to="label_lbio_VestedOnOneYearAnniversaryMember" xlink:title="Label : lbio_VestedOnOneYearAnniversaryMember to label_lbio_VestedOnOneYearAnniversaryMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_VestedOnOneYearAnniversaryMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_VestedOnOneYearAnniversaryMember_1" xml:lang="en-US" id="label_lbio_VestedOnOneYearAnniversaryMember_1">Vested on One Year Anniversary [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_VestedOnOneYearAnniversaryMember" xlink:to="label_lbio_VestedOnOneYearAnniversaryMember_1" xlink:title="Label : lbio_VestedOnOneYearAnniversaryMember to label_lbio_VestedOnOneYearAnniversaryMember_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_VestedOnOneYearAnniversaryMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_VestedOnOneYearAnniversaryMember_2" xml:lang="en-US" id="label_lbio_VestedOnOneYearAnniversaryMember_2">Vested on the one year anniversary [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_VestedOnOneYearAnniversaryMember" xlink:to="label_lbio_VestedOnOneYearAnniversaryMember_2" xlink:title="Label : lbio_VestedOnOneYearAnniversaryMember to label_lbio_VestedOnOneYearAnniversaryMember_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember" xlink:label="lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember" xlink:title="lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember" xml:lang="en-US" id="label_lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember">Represents the information pertaining to option vest in equal quarterly installments over the remaining two-year of the agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember" xlink:to="label_lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember" xlink:title="Label : lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember to label_lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember_1" xml:lang="en-US" id="label_lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember_1">Vest in Equal Quarterly Installments Over Remaining Two Year of Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember" xlink:to="label_lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember_1" xlink:title="Label : lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember to label_lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember_2" xml:lang="en-US" id="label_lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember_2">Vest in equal quarterly installments over the remaining two-year of the agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember" xlink:to="label_lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember_2" xlink:title="Label : lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember to label_lbio_VestInEqualQuarterlyInstallmentsOverRemainingTwoYearOfAgreementMember_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments" xlink:label="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments" xlink:title="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments" />
    <link:label xlink:type="resource" xlink:label="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments" xml:lang="en-US" id="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments">Represents the number of installments for option vest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments" xlink:to="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments" xlink:title="Label : lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments to label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments" />
    <link:label xlink:type="resource" xlink:label="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments_1" xml:lang="en-US" id="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments_1">Sharebased Compensation Arrangement by Sharebased Payment Award Options Vested Number of Installments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments" xlink:to="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments_1" xlink:title="Label : lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments to label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments_2" xml:lang="en-US" id="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments_2">Option vest number of installments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments" xlink:to="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments_2" xlink:title="Label : lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments to label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfInstallments_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_NumberOfConsultantsIntoConsultingAgreements" xlink:label="lbio_NumberOfConsultantsIntoConsultingAgreements" xlink:title="lbio_NumberOfConsultantsIntoConsultingAgreements" />
    <link:label xlink:type="resource" xlink:label="label_lbio_NumberOfConsultantsIntoConsultingAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_NumberOfConsultantsIntoConsultingAgreements" xml:lang="en-US" id="label_lbio_NumberOfConsultantsIntoConsultingAgreements">Represents the number of consultants into consulting agreements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_NumberOfConsultantsIntoConsultingAgreements" xlink:to="label_lbio_NumberOfConsultantsIntoConsultingAgreements" xlink:title="Label : lbio_NumberOfConsultantsIntoConsultingAgreements to label_lbio_NumberOfConsultantsIntoConsultingAgreements" />
    <link:label xlink:type="resource" xlink:label="label_lbio_NumberOfConsultantsIntoConsultingAgreements_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_NumberOfConsultantsIntoConsultingAgreements_1" xml:lang="en-US" id="label_lbio_NumberOfConsultantsIntoConsultingAgreements_1">Number of Consultants into Consulting Agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_NumberOfConsultantsIntoConsultingAgreements" xlink:to="label_lbio_NumberOfConsultantsIntoConsultingAgreements_1" xlink:title="Label : lbio_NumberOfConsultantsIntoConsultingAgreements to label_lbio_NumberOfConsultantsIntoConsultingAgreements_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_NumberOfConsultantsIntoConsultingAgreements_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_NumberOfConsultantsIntoConsultingAgreements_2" xml:lang="en-US" id="label_lbio_NumberOfConsultantsIntoConsultingAgreements_2">Number of consultants into consulting agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_NumberOfConsultantsIntoConsultingAgreements" xlink:to="label_lbio_NumberOfConsultantsIntoConsultingAgreements_2" xlink:title="Label : lbio_NumberOfConsultantsIntoConsultingAgreements to label_lbio_NumberOfConsultantsIntoConsultingAgreements_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate" xlink:label="lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate" xlink:title="lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate" xml:lang="en-US" id="label_lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate">Represents the forfeiture rate assumption that is used in valuing an option on its own shares.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate" xlink:to="label_lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate" xlink:title="Label : lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate to label_lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate_1" xml:lang="en-US" id="label_lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate_1">Share Based Payment Option Valuation Assumption Forfeiture Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate" xlink:to="label_lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate_1" xlink:title="Label : lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate to label_lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate_2" xml:lang="en-US" id="label_lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate_2">Forfeiture rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate" xlink:to="label_lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate_2" xlink:title="Label : lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate to label_lbio_ShareBasedPaymentOptionValuationAssumptionForfeitureRate_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock" xlink:label="lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock" xlink:title="lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock" xml:lang="en-US" id="label_lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock">Represents the entire disclosure for accrued compensation payable in shares of stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock" xlink:to="label_lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock" xlink:title="Label : lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock to label_lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock_1" xml:lang="en-US" id="label_lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock_1">Accrued Compensation Payable in Shares of Stock Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock" xlink:to="label_lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock_1" xlink:title="Label : lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock to label_lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock_2" xml:lang="en-US" id="label_lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock_2">ACCRUED COMPENSATION PAYABLE IN SHARES OF STOCK</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock" xlink:to="label_lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock_2" xlink:title="Label : lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock to label_lbio_AccruedCompensationPayableInSharesOfStockDisclosureTextBlock_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_AccruedCompensationPayableInSharesOfStockDisclosureAbstract" xlink:label="lbio_AccruedCompensationPayableInSharesOfStockDisclosureAbstract" xlink:title="lbio_AccruedCompensationPayableInSharesOfStockDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_lbio_AccruedCompensationPayableInSharesOfStockDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_AccruedCompensationPayableInSharesOfStockDisclosureAbstract" xml:lang="en-US" id="label_lbio_AccruedCompensationPayableInSharesOfStockDisclosureAbstract">ACCRUED COMPENSATION PAYABLE IN SHARES OF STOCK [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_AccruedCompensationPayableInSharesOfStockDisclosureAbstract" xlink:to="label_lbio_AccruedCompensationPayableInSharesOfStockDisclosureAbstract" xlink:title="Label : lbio_AccruedCompensationPayableInSharesOfStockDisclosureAbstract to label_lbio_AccruedCompensationPayableInSharesOfStockDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_VestOnThirtySeptemberTwoThousandFourteenMember" xlink:label="lbio_VestOnThirtySeptemberTwoThousandFourteenMember" xlink:title="lbio_VestOnThirtySeptemberTwoThousandFourteenMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_VestOnThirtySeptemberTwoThousandFourteenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_VestOnThirtySeptemberTwoThousandFourteenMember" xml:lang="en-US" id="label_lbio_VestOnThirtySeptemberTwoThousandFourteenMember">Represents information pertaining to shares vested on September 30, 2014.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_VestOnThirtySeptemberTwoThousandFourteenMember" xlink:to="label_lbio_VestOnThirtySeptemberTwoThousandFourteenMember" xlink:title="Label : lbio_VestOnThirtySeptemberTwoThousandFourteenMember to label_lbio_VestOnThirtySeptemberTwoThousandFourteenMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_VestOnThirtySeptemberTwoThousandFourteenMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_VestOnThirtySeptemberTwoThousandFourteenMember_1" xml:lang="en-US" id="label_lbio_VestOnThirtySeptemberTwoThousandFourteenMember_1">Vest on Thirty September Two Thousand Fourteen [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_VestOnThirtySeptemberTwoThousandFourteenMember" xlink:to="label_lbio_VestOnThirtySeptemberTwoThousandFourteenMember_1" xlink:title="Label : lbio_VestOnThirtySeptemberTwoThousandFourteenMember to label_lbio_VestOnThirtySeptemberTwoThousandFourteenMember_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_VestOnThirtySeptemberTwoThousandFourteenMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_VestOnThirtySeptemberTwoThousandFourteenMember_2" xml:lang="en-US" id="label_lbio_VestOnThirtySeptemberTwoThousandFourteenMember_2">Vest on September 30, 2014 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_VestOnThirtySeptemberTwoThousandFourteenMember" xlink:to="label_lbio_VestOnThirtySeptemberTwoThousandFourteenMember_2" xlink:title="Label : lbio_VestOnThirtySeptemberTwoThousandFourteenMember to label_lbio_VestOnThirtySeptemberTwoThousandFourteenMember_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:title="dei_CurrentFiscalYearEndDate" />
    <link:label xlink:type="resource" xlink:label="label_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_CurrentFiscalYearEndDate" xml:lang="en-US" id="label_dei_CurrentFiscalYearEndDate">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="label_dei_CurrentFiscalYearEndDate" xlink:title="Label : dei_CurrentFiscalYearEndDate to label_dei_CurrentFiscalYearEndDate" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_VestOnThirtySeptemberTwoThousandFifteenMember" xlink:label="lbio_VestOnThirtySeptemberTwoThousandFifteenMember" xlink:title="lbio_VestOnThirtySeptemberTwoThousandFifteenMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_VestOnThirtySeptemberTwoThousandFifteenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_VestOnThirtySeptemberTwoThousandFifteenMember" xml:lang="en-US" id="label_lbio_VestOnThirtySeptemberTwoThousandFifteenMember">Represents information pertaining to shares vesting on September 30, 2015.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_VestOnThirtySeptemberTwoThousandFifteenMember" xlink:to="label_lbio_VestOnThirtySeptemberTwoThousandFifteenMember" xlink:title="Label : lbio_VestOnThirtySeptemberTwoThousandFifteenMember to label_lbio_VestOnThirtySeptemberTwoThousandFifteenMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_VestOnThirtySeptemberTwoThousandFifteenMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_VestOnThirtySeptemberTwoThousandFifteenMember_1" xml:lang="en-US" id="label_lbio_VestOnThirtySeptemberTwoThousandFifteenMember_1">Vest on Thirty September Two Thousand Fifteen [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_VestOnThirtySeptemberTwoThousandFifteenMember" xlink:to="label_lbio_VestOnThirtySeptemberTwoThousandFifteenMember_1" xlink:title="Label : lbio_VestOnThirtySeptemberTwoThousandFifteenMember to label_lbio_VestOnThirtySeptemberTwoThousandFifteenMember_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_VestOnThirtySeptemberTwoThousandFifteenMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_VestOnThirtySeptemberTwoThousandFifteenMember_2" xml:lang="en-US" id="label_lbio_VestOnThirtySeptemberTwoThousandFifteenMember_2">Vest on September 30, 2015 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_VestOnThirtySeptemberTwoThousandFifteenMember" xlink:to="label_lbio_VestOnThirtySeptemberTwoThousandFifteenMember_2" xlink:title="Label : lbio_VestOnThirtySeptemberTwoThousandFifteenMember to label_lbio_VestOnThirtySeptemberTwoThousandFifteenMember_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_VestOnThirtySeptemberTwoThousandSixteenMember" xlink:label="lbio_VestOnThirtySeptemberTwoThousandSixteenMember" xlink:title="lbio_VestOnThirtySeptemberTwoThousandSixteenMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_VestOnThirtySeptemberTwoThousandSixteenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_VestOnThirtySeptemberTwoThousandSixteenMember" xml:lang="en-US" id="label_lbio_VestOnThirtySeptemberTwoThousandSixteenMember">Represents information pertaining to shares vesting on September 30, 2016.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_VestOnThirtySeptemberTwoThousandSixteenMember" xlink:to="label_lbio_VestOnThirtySeptemberTwoThousandSixteenMember" xlink:title="Label : lbio_VestOnThirtySeptemberTwoThousandSixteenMember to label_lbio_VestOnThirtySeptemberTwoThousandSixteenMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_VestOnThirtySeptemberTwoThousandSixteenMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_VestOnThirtySeptemberTwoThousandSixteenMember_1" xml:lang="en-US" id="label_lbio_VestOnThirtySeptemberTwoThousandSixteenMember_1">Vest on Thirty September Two Thousand Sixteen [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_VestOnThirtySeptemberTwoThousandSixteenMember" xlink:to="label_lbio_VestOnThirtySeptemberTwoThousandSixteenMember_1" xlink:title="Label : lbio_VestOnThirtySeptemberTwoThousandSixteenMember to label_lbio_VestOnThirtySeptemberTwoThousandSixteenMember_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_VestOnThirtySeptemberTwoThousandSixteenMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_VestOnThirtySeptemberTwoThousandSixteenMember_2" xml:lang="en-US" id="label_lbio_VestOnThirtySeptemberTwoThousandSixteenMember_2">Vest on September 30, 2016 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_VestOnThirtySeptemberTwoThousandSixteenMember" xlink:to="label_lbio_VestOnThirtySeptemberTwoThousandSixteenMember_2" xlink:title="Label : lbio_VestOnThirtySeptemberTwoThousandSixteenMember to label_lbio_VestOnThirtySeptemberTwoThousandSixteenMember_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AreaOfLand" xlink:label="us-gaap_AreaOfLand" xlink:title="us-gaap_AreaOfLand" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AreaOfLand" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AreaOfLand" xml:lang="en-US" id="label_us-gaap_AreaOfLand">Area of Land</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfLand" xlink:to="label_us-gaap_AreaOfLand" xlink:title="Label : us-gaap_AreaOfLand to label_us-gaap_AreaOfLand" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AreaOfLand_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AreaOfLand_1" xml:lang="en-US" id="label_us-gaap_AreaOfLand_1">Area of land</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfLand" xlink:to="label_us-gaap_AreaOfLand_1" xlink:title="Label : us-gaap_AreaOfLand to label_us-gaap_AreaOfLand_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PrivatePlacementCosts" xlink:label="lbio_PrivatePlacementCosts" xlink:title="lbio_PrivatePlacementCosts" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PrivatePlacementCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_PrivatePlacementCosts" xml:lang="en-US" id="label_lbio_PrivatePlacementCosts">Represents the cost incurred directly with the issuance of an equity security.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PrivatePlacementCosts" xlink:to="label_lbio_PrivatePlacementCosts" xlink:title="Label : lbio_PrivatePlacementCosts to label_lbio_PrivatePlacementCosts" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PrivatePlacementCosts_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_PrivatePlacementCosts_1" xml:lang="en-US" id="label_lbio_PrivatePlacementCosts_1">Private Placement Costs 1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PrivatePlacementCosts" xlink:to="label_lbio_PrivatePlacementCosts_1" xlink:title="Label : lbio_PrivatePlacementCosts to label_lbio_PrivatePlacementCosts_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PrivatePlacementCosts_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_PrivatePlacementCosts_2" xml:lang="en-US" id="label_lbio_PrivatePlacementCosts_2">Private placement costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PrivatePlacementCosts" xlink:to="label_lbio_PrivatePlacementCosts_2" xlink:title="Label : lbio_PrivatePlacementCosts to label_lbio_PrivatePlacementCosts_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_DocumentAndEntityInformationAbstract" xlink:label="lbio_DocumentAndEntityInformationAbstract" xlink:title="lbio_DocumentAndEntityInformationAbstract" />
    <link:label xlink:type="resource" xlink:label="label_lbio_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_DocumentAndEntityInformationAbstract" xml:lang="en-US" id="label_lbio_DocumentAndEntityInformationAbstract">Document And Entity Information [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_DocumentAndEntityInformationAbstract" xlink:to="label_lbio_DocumentAndEntityInformationAbstract" xlink:title="Label : lbio_DocumentAndEntityInformationAbstract to label_lbio_DocumentAndEntityInformationAbstract" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities" xlink:label="lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities" xlink:title="lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="label_lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities" xml:lang="en-US" id="label_lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities">Number of shares of stock issued during period for the settlement of notes payable and accrued liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities" xlink:to="label_lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities" xlink:title="Label : lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities to label_lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="label_lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities_1" xml:lang="en-US" id="label_lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities_1">Stock Issued During Period Value For Settlement Of Notes Payable And Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities" xlink:to="label_lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities_1" xlink:title="Label : lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities to label_lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities_2" xml:lang="en-US" id="label_lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities_2">Common stock issued upon conversion of accrued interest and penalty</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities" xlink:to="label_lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities_2" xlink:title="Label : lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities to label_lbio_StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities" xlink:label="lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities" xlink:title="lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities" xml:lang="en-US" id="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities">Value of stock issued during period for the settlement of notes payable and accrued liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities" xlink:to="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities" xlink:title="Label : lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities to label_lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities_1" xml:lang="en-US" id="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities_1">Stock Issued During Period Shares For Settlement Of Notes Payable And Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities" xlink:to="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities_1" xlink:title="Label : lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities to label_lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities_2" xml:lang="en-US" id="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities_2">Common stock issued in settlement of notes payable and accrued interest and penalty (Shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities" xlink:to="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities_2" xlink:title="Label : lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities to label_lbio_StockIssuedDuringPeriodSharesForSettlementOfNotesPayableAndAccruedLiabilities_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1" xlink:label="lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1" xlink:title="lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1" xml:lang="en-US" id="label_lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1">Represents the sum of Federal Statutory tax rate and State tax net of federal benefit.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1" xlink:to="label_lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1" xlink:title="Label : lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1 to label_lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1_1" xml:lang="en-US" id="label_lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1_1">Effective Income Tax Rate Reconciliation Expected Rate Total1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1" xlink:to="label_lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1_1" xlink:title="Label : lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1 to label_lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1_2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1_2" xml:lang="en-US" id="label_lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1_2">Effective Income Tax Rate Reconciliation Expected Rate Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1" xlink:to="label_lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1_2" xlink:title="Label : lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1 to label_lbio_EffectiveIncomeTaxRateReconciliationExpectedRateTotal1_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:title="dei_DocumentInformationLineItems" />
    <link:label xlink:type="resource" xlink:label="label_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_DocumentInformationLineItems" xml:lang="en-US" id="label_dei_DocumentInformationLineItems">Document Information [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="label_dei_DocumentInformationLineItems" xlink:title="Label : dei_DocumentInformationLineItems to label_dei_DocumentInformationLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:title="us-gaap_AwardTypeAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AwardTypeAxis" xml:lang="en-US" id="label_us-gaap_AwardTypeAxis">Award Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="label_us-gaap_AwardTypeAxis" xlink:title="Label : us-gaap_AwardTypeAxis to label_us-gaap_AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_GeneralOrganizationAndBusinessTable" xlink:label="lbio_GeneralOrganizationAndBusinessTable" xlink:title="lbio_GeneralOrganizationAndBusinessTable" />
    <link:label xlink:type="resource" xlink:label="label_lbio_GeneralOrganizationAndBusinessTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_GeneralOrganizationAndBusinessTable" xml:lang="en-US" id="label_lbio_GeneralOrganizationAndBusinessTable">It represents general organization and business.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_GeneralOrganizationAndBusinessTable" xlink:to="label_lbio_GeneralOrganizationAndBusinessTable" xlink:title="Label : lbio_GeneralOrganizationAndBusinessTable to label_lbio_GeneralOrganizationAndBusinessTable" />
    <link:label xlink:type="resource" xlink:label="label_lbio_GeneralOrganizationAndBusinessTable_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_GeneralOrganizationAndBusinessTable_1" xml:lang="en-US" id="label_lbio_GeneralOrganizationAndBusinessTable_1">General Organization And Business [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_GeneralOrganizationAndBusinessTable" xlink:to="label_lbio_GeneralOrganizationAndBusinessTable_1" xlink:title="Label : lbio_GeneralOrganizationAndBusinessTable to label_lbio_GeneralOrganizationAndBusinessTable_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:title="dei_DocumentInformationTable" />
    <link:label xlink:type="resource" xlink:label="label_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_DocumentInformationTable" xml:lang="en-US" id="label_dei_DocumentInformationTable">Document Information [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="label_dei_DocumentInformationTable" xlink:title="Label : dei_DocumentInformationTable to label_dei_DocumentInformationTable" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_LoanNeitherRepaidNorConverted" xlink:label="lbio_LoanNeitherRepaidNorConverted" xlink:title="lbio_LoanNeitherRepaidNorConverted" />
    <link:label xlink:type="resource" xlink:label="label_lbio_LoanNeitherRepaidNorConverted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_LoanNeitherRepaidNorConverted" xml:lang="en-US" id="label_lbio_LoanNeitherRepaidNorConverted">It represents the value of loan neither repaid nor converted.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_LoanNeitherRepaidNorConverted" xlink:to="label_lbio_LoanNeitherRepaidNorConverted" xlink:title="Label : lbio_LoanNeitherRepaidNorConverted to label_lbio_LoanNeitherRepaidNorConverted" />
    <link:label xlink:type="resource" xlink:label="label_lbio_LoanNeitherRepaidNorConverted_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_LoanNeitherRepaidNorConverted_1" xml:lang="en-US" id="label_lbio_LoanNeitherRepaidNorConverted_1">Loan Neither Repaid Nor Converted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_LoanNeitherRepaidNorConverted" xlink:to="label_lbio_LoanNeitherRepaidNorConverted_1" xlink:title="Label : lbio_LoanNeitherRepaidNorConverted to label_lbio_LoanNeitherRepaidNorConverted_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_WorkingCapital" xlink:label="lbio_WorkingCapital" xlink:title="lbio_WorkingCapital" />
    <link:label xlink:type="resource" xlink:label="label_lbio_WorkingCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_WorkingCapital" xml:lang="en-US" id="label_lbio_WorkingCapital">Represents the value of working capital which is the difference between current assets and current liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_WorkingCapital" xlink:to="label_lbio_WorkingCapital" xlink:title="Label : lbio_WorkingCapital to label_lbio_WorkingCapital" />
    <link:label xlink:type="resource" xlink:label="label_lbio_WorkingCapital_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_WorkingCapital_1" xml:lang="en-US" id="label_lbio_WorkingCapital_1">Working Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_WorkingCapital" xlink:to="label_lbio_WorkingCapital_1" xlink:title="Label : lbio_WorkingCapital to label_lbio_WorkingCapital_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockCancelledAndExchangedValue" xlink:label="lbio_CommonStockCancelledAndExchangedValue" xlink:title="lbio_CommonStockCancelledAndExchangedValue" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockCancelledAndExchangedValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_CommonStockCancelledAndExchangedValue" xml:lang="en-US" id="label_lbio_CommonStockCancelledAndExchangedValue">It represents common stock cancelled and exchanged value.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockCancelledAndExchangedValue" xlink:to="label_lbio_CommonStockCancelledAndExchangedValue" xlink:title="Label : lbio_CommonStockCancelledAndExchangedValue to label_lbio_CommonStockCancelledAndExchangedValue" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockCancelledAndExchangedValue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_CommonStockCancelledAndExchangedValue_1" xml:lang="en-US" id="label_lbio_CommonStockCancelledAndExchangedValue_1">Common Stock Cancelled And Exchanged Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockCancelledAndExchangedValue" xlink:to="label_lbio_CommonStockCancelledAndExchangedValue_1" xlink:title="Label : lbio_CommonStockCancelledAndExchangedValue to label_lbio_CommonStockCancelledAndExchangedValue_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:title="dei_DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="label_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_DocumentPeriodEndDate" xml:lang="en-US" id="label_dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="label_dei_DocumentPeriodEndDate" xlink:title="Label : dei_DocumentPeriodEndDate to label_dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:label="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:title="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xml:lang="en-US" id="label_lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract">Share Based Compensation Arrangement By Share Based Payment Award Options Additional Disclosures Abstract1 [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:to="label_lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:title="Label : lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract to label_lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract_1" xml:lang="en-US" id="label_lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract_1">Weighted Average Remaining Contractual Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:to="label_lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract_1" xlink:title="Label : lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract to label_lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:label="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:title="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" />
    <link:label xlink:type="resource" xlink:label="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xml:lang="en-US" id="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm">Weighted average remaining contractual term for option awards grants in period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:to="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:title="Label : lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm to label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" />
    <link:label xlink:type="resource" xlink:label="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_1" xml:lang="en-US" id="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:to="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_1" xlink:title="Label : lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm to label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_2" xml:lang="en-US" id="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_2">Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:to="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_2" xlink:title="Label : lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm to label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_AggregateIntrinsicValueAbstract" xlink:label="lbio_AggregateIntrinsicValueAbstract" xlink:title="lbio_AggregateIntrinsicValueAbstract" />
    <link:label xlink:type="resource" xlink:label="label_lbio_AggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_AggregateIntrinsicValueAbstract" xml:lang="en-US" id="label_lbio_AggregateIntrinsicValueAbstract">Aggregate Intrinsic Value [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_AggregateIntrinsicValueAbstract" xlink:to="label_lbio_AggregateIntrinsicValueAbstract" xlink:title="Label : lbio_AggregateIntrinsicValueAbstract to label_lbio_AggregateIntrinsicValueAbstract" />
    <link:label xlink:type="resource" xlink:label="label_lbio_AggregateIntrinsicValueAbstract_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_AggregateIntrinsicValueAbstract_1" xml:lang="en-US" id="label_lbio_AggregateIntrinsicValueAbstract_1">Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_AggregateIntrinsicValueAbstract" xlink:to="label_lbio_AggregateIntrinsicValueAbstract_1" xlink:title="Label : lbio_AggregateIntrinsicValueAbstract to label_lbio_AggregateIntrinsicValueAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_AgreementAxis" xlink:label="lbio_AgreementAxis" xlink:title="lbio_AgreementAxis" />
    <link:label xlink:type="resource" xlink:label="label_lbio_AgreementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_AgreementAxis" xml:lang="en-US" id="label_lbio_AgreementAxis">Agreement [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_AgreementAxis" xlink:to="label_lbio_AgreementAxis" xlink:title="Label : lbio_AgreementAxis to label_lbio_AgreementAxis" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_SecuredPromissoryNotesMember" xlink:label="lbio_SecuredPromissoryNotesMember" xlink:title="lbio_SecuredPromissoryNotesMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_SecuredPromissoryNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_SecuredPromissoryNotesMember" xml:lang="en-US" id="label_lbio_SecuredPromissoryNotesMember">Secured Promissory Notes [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_SecuredPromissoryNotesMember" xlink:to="label_lbio_SecuredPromissoryNotesMember" xlink:title="Label : lbio_SecuredPromissoryNotesMember to label_lbio_SecuredPromissoryNotesMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_SeniorSecuredNotesMember" xlink:label="lbio_SeniorSecuredNotesMember" xlink:title="lbio_SeniorSecuredNotesMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_SeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_SeniorSecuredNotesMember" xml:lang="en-US" id="label_lbio_SeniorSecuredNotesMember">Senior Secured Notes [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_SeniorSecuredNotesMember" xlink:to="label_lbio_SeniorSecuredNotesMember" xlink:title="Label : lbio_SeniorSecuredNotesMember to label_lbio_SeniorSecuredNotesMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_NotesAndCertainOtherIndebtednessMember" xlink:label="lbio_NotesAndCertainOtherIndebtednessMember" xlink:title="lbio_NotesAndCertainOtherIndebtednessMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_NotesAndCertainOtherIndebtednessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_NotesAndCertainOtherIndebtednessMember" xml:lang="en-US" id="label_lbio_NotesAndCertainOtherIndebtednessMember">Notes And Certain Other Indebtedness [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_NotesAndCertainOtherIndebtednessMember" xlink:to="label_lbio_NotesAndCertainOtherIndebtednessMember" xlink:title="Label : lbio_NotesAndCertainOtherIndebtednessMember to label_lbio_NotesAndCertainOtherIndebtednessMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_SecuredNotes2012Member" xlink:label="lbio_SecuredNotes2012Member" xlink:title="lbio_SecuredNotes2012Member" />
    <link:label xlink:type="resource" xlink:label="label_lbio_SecuredNotes2012Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_SecuredNotes2012Member" xml:lang="en-US" id="label_lbio_SecuredNotes2012Member">Secured Notes 2012 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_SecuredNotes2012Member" xlink:to="label_lbio_SecuredNotes2012Member" xlink:title="Label : lbio_SecuredNotes2012Member to label_lbio_SecuredNotes2012Member" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_StockIssuedAxis" xlink:label="lbio_StockIssuedAxis" xlink:title="lbio_StockIssuedAxis" />
    <link:label xlink:type="resource" xlink:label="label_lbio_StockIssuedAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_StockIssuedAxis" xml:lang="en-US" id="label_lbio_StockIssuedAxis">Stock Issued [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_StockIssuedAxis" xlink:to="label_lbio_StockIssuedAxis" xlink:title="Label : lbio_StockIssuedAxis to label_lbio_StockIssuedAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:title="dei_EntityDomain" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityDomain" xml:lang="en-US" id="label_dei_EntityDomain">Entity [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="label_dei_EntityDomain" xlink:title="Label : dei_EntityDomain to label_dei_EntityDomain" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_AgreementDomain" xlink:label="lbio_AgreementDomain" xlink:title="lbio_AgreementDomain" />
    <link:label xlink:type="resource" xlink:label="label_lbio_AgreementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_AgreementDomain" xml:lang="en-US" id="label_lbio_AgreementDomain">Agreement [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_AgreementDomain" xlink:to="label_lbio_AgreementDomain" xlink:title="Label : lbio_AgreementDomain to label_lbio_AgreementDomain" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ExchangeAgreementMember" xlink:label="lbio_ExchangeAgreementMember" xlink:title="lbio_ExchangeAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ExchangeAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_ExchangeAgreementMember" xml:lang="en-US" id="label_lbio_ExchangeAgreementMember">Exchange agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ExchangeAgreementMember" xlink:to="label_lbio_ExchangeAgreementMember" xlink:title="Label : lbio_ExchangeAgreementMember to label_lbio_ExchangeAgreementMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_StockPurchaseAndExchangeAgreementMember" xlink:label="lbio_StockPurchaseAndExchangeAgreementMember" xlink:title="lbio_StockPurchaseAndExchangeAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_StockPurchaseAndExchangeAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_StockPurchaseAndExchangeAgreementMember" xml:lang="en-US" id="label_lbio_StockPurchaseAndExchangeAgreementMember">Stock Purchase And Exchange Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_StockPurchaseAndExchangeAgreementMember" xlink:to="label_lbio_StockPurchaseAndExchangeAgreementMember" xlink:title="Label : lbio_StockPurchaseAndExchangeAgreementMember to label_lbio_StockPurchaseAndExchangeAgreementMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CertainCreditorsAndCertainPlacementAgentsMember" xlink:label="lbio_CertainCreditorsAndCertainPlacementAgentsMember" xlink:title="lbio_CertainCreditorsAndCertainPlacementAgentsMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CertainCreditorsAndCertainPlacementAgentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_CertainCreditorsAndCertainPlacementAgentsMember" xml:lang="en-US" id="label_lbio_CertainCreditorsAndCertainPlacementAgentsMember">Certain Creditors And Certain Placement Agents [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CertainCreditorsAndCertainPlacementAgentsMember" xlink:to="label_lbio_CertainCreditorsAndCertainPlacementAgentsMember" xlink:title="Label : lbio_CertainCreditorsAndCertainPlacementAgentsMember to label_lbio_CertainCreditorsAndCertainPlacementAgentsMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_StockIssuedDomain" xlink:label="lbio_StockIssuedDomain" xlink:title="lbio_StockIssuedDomain" />
    <link:label xlink:type="resource" xlink:label="label_lbio_StockIssuedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_StockIssuedDomain" xml:lang="en-US" id="label_lbio_StockIssuedDomain">Stock Issued [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_StockIssuedDomain" xlink:to="label_lbio_StockIssuedDomain" xlink:title="Label : lbio_StockIssuedDomain to label_lbio_StockIssuedDomain" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_InvestorsMember" xlink:label="lbio_InvestorsMember" xlink:title="lbio_InvestorsMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_InvestorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_InvestorsMember" xml:lang="en-US" id="label_lbio_InvestorsMember">Investors [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_InvestorsMember" xlink:to="label_lbio_InvestorsMember" xlink:title="Label : lbio_InvestorsMember to label_lbio_InvestorsMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_InvestorsAndOtherPartiesMember" xlink:label="lbio_InvestorsAndOtherPartiesMember" xlink:title="lbio_InvestorsAndOtherPartiesMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_InvestorsAndOtherPartiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_InvestorsAndOtherPartiesMember" xml:lang="en-US" id="label_lbio_InvestorsAndOtherPartiesMember">Investors And Other Parties [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_InvestorsAndOtherPartiesMember" xlink:to="label_lbio_InvestorsAndOtherPartiesMember" xlink:title="Label : lbio_InvestorsAndOtherPartiesMember to label_lbio_InvestorsAndOtherPartiesMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_TheoremGroupLlcMember" xlink:label="lbio_TheoremGroupLlcMember" xlink:title="lbio_TheoremGroupLlcMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_TheoremGroupLlcMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_TheoremGroupLlcMember" xml:lang="en-US" id="label_lbio_TheoremGroupLlcMember">Theorem Group, LLC [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_TheoremGroupLlcMember" xlink:to="label_lbio_TheoremGroupLlcMember" xlink:title="Label : lbio_TheoremGroupLlcMember to label_lbio_TheoremGroupLlcMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_StockPurchaseAgreementMember" xlink:label="lbio_StockPurchaseAgreementMember" xlink:title="lbio_StockPurchaseAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_StockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_StockPurchaseAgreementMember" xml:lang="en-US" id="label_lbio_StockPurchaseAgreementMember">Stock Purchase Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_StockPurchaseAgreementMember" xlink:to="label_lbio_StockPurchaseAgreementMember" xlink:title="Label : lbio_StockPurchaseAgreementMember to label_lbio_StockPurchaseAgreementMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_AyerCapitalPartnersMasterFundLpMember" xlink:label="lbio_AyerCapitalPartnersMasterFundLpMember" xlink:title="lbio_AyerCapitalPartnersMasterFundLpMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_AyerCapitalPartnersMasterFundLpMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_AyerCapitalPartnersMasterFundLpMember" xml:lang="en-US" id="label_lbio_AyerCapitalPartnersMasterFundLpMember">Ayer Capital Partners Master Fund, L.P [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_AyerCapitalPartnersMasterFundLpMember" xlink:to="label_lbio_AyerCapitalPartnersMasterFundLpMember" xlink:title="Label : lbio_AyerCapitalPartnersMasterFundLpMember to label_lbio_AyerCapitalPartnersMasterFundLpMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_BristolInvestmentFundLtdMember" xlink:label="lbio_BristolInvestmentFundLtdMember" xlink:title="lbio_BristolInvestmentFundLtdMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_BristolInvestmentFundLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_BristolInvestmentFundLtdMember" xml:lang="en-US" id="label_lbio_BristolInvestmentFundLtdMember">Bristol Investment Fund, Ltd [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_BristolInvestmentFundLtdMember" xlink:to="label_lbio_BristolInvestmentFundLtdMember" xlink:title="Label : lbio_BristolInvestmentFundLtdMember to label_lbio_BristolInvestmentFundLtdMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_LionAgreementMember" xlink:label="lbio_LionAgreementMember" xlink:title="lbio_LionAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_LionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_LionAgreementMember" xml:lang="en-US" id="label_lbio_LionAgreementMember">Lion Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_LionAgreementMember" xlink:to="label_lbio_LionAgreementMember" xlink:title="Label : lbio_LionAgreementMember to label_lbio_LionAgreementMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PercentageOfOutstandingVotingEquityInterests" xlink:label="lbio_PercentageOfOutstandingVotingEquityInterests" xlink:title="lbio_PercentageOfOutstandingVotingEquityInterests" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PercentageOfOutstandingVotingEquityInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_PercentageOfOutstandingVotingEquityInterests" xml:lang="en-US" id="label_lbio_PercentageOfOutstandingVotingEquityInterests">Represents the percentage of outstanding voting equity interests.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PercentageOfOutstandingVotingEquityInterests" xlink:to="label_lbio_PercentageOfOutstandingVotingEquityInterests" xlink:title="Label : lbio_PercentageOfOutstandingVotingEquityInterests to label_lbio_PercentageOfOutstandingVotingEquityInterests" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PercentageOfOutstandingVotingEquityInterests_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_PercentageOfOutstandingVotingEquityInterests_1" xml:lang="en-US" id="label_lbio_PercentageOfOutstandingVotingEquityInterests_1">Percentage of Outstanding Voting Equity Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PercentageOfOutstandingVotingEquityInterests" xlink:to="label_lbio_PercentageOfOutstandingVotingEquityInterests_1" xlink:title="Label : lbio_PercentageOfOutstandingVotingEquityInterests to label_lbio_PercentageOfOutstandingVotingEquityInterests_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PercentageOfOutstandingVotingEquityInterestsAfterRestructuring" xlink:label="lbio_PercentageOfOutstandingVotingEquityInterestsAfterRestructuring" xlink:title="lbio_PercentageOfOutstandingVotingEquityInterestsAfterRestructuring" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PercentageOfOutstandingVotingEquityInterestsAfterRestructuring" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_PercentageOfOutstandingVotingEquityInterestsAfterRestructuring" xml:lang="en-US" id="label_lbio_PercentageOfOutstandingVotingEquityInterestsAfterRestructuring">Represents the percentage of outstanding voting equity interests after restructuring.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PercentageOfOutstandingVotingEquityInterestsAfterRestructuring" xlink:to="label_lbio_PercentageOfOutstandingVotingEquityInterestsAfterRestructuring" xlink:title="Label : lbio_PercentageOfOutstandingVotingEquityInterestsAfterRestructuring to label_lbio_PercentageOfOutstandingVotingEquityInterestsAfterRestructuring" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PercentageOfOutstandingVotingEquityInterestsAfterRestructuring_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_PercentageOfOutstandingVotingEquityInterestsAfterRestructuring_1" xml:lang="en-US" id="label_lbio_PercentageOfOutstandingVotingEquityInterestsAfterRestructuring_1">Percentage of Outstanding Voting Equity Interests After Restructuring</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PercentageOfOutstandingVotingEquityInterestsAfterRestructuring" xlink:to="label_lbio_PercentageOfOutstandingVotingEquityInterestsAfterRestructuring_1" xlink:title="Label : lbio_PercentageOfOutstandingVotingEquityInterestsAfterRestructuring to label_lbio_PercentageOfOutstandingVotingEquityInterestsAfterRestructuring_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_BristolCapitalLlcMember" xlink:label="lbio_BristolCapitalLlcMember" xlink:title="lbio_BristolCapitalLlcMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_BristolCapitalLlcMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_BristolCapitalLlcMember" xml:lang="en-US" id="label_lbio_BristolCapitalLlcMember">Bristol Capital, LLC [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_BristolCapitalLlcMember" xlink:to="label_lbio_BristolCapitalLlcMember" xlink:title="Label : lbio_BristolCapitalLlcMember to label_lbio_BristolCapitalLlcMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PercentageOfRoyaltyOnSales" xlink:label="lbio_PercentageOfRoyaltyOnSales" xlink:title="lbio_PercentageOfRoyaltyOnSales" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PercentageOfRoyaltyOnSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_PercentageOfRoyaltyOnSales" xml:lang="en-US" id="label_lbio_PercentageOfRoyaltyOnSales">It represents the percentage of royalty paid on net sales.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PercentageOfRoyaltyOnSales" xlink:to="label_lbio_PercentageOfRoyaltyOnSales" xlink:title="Label : lbio_PercentageOfRoyaltyOnSales to label_lbio_PercentageOfRoyaltyOnSales" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PercentageOfRoyaltyOnSales_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_PercentageOfRoyaltyOnSales_1" xml:lang="en-US" id="label_lbio_PercentageOfRoyaltyOnSales_1">Percentage Of Royalty On Sales</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PercentageOfRoyaltyOnSales" xlink:to="label_lbio_PercentageOfRoyaltyOnSales_1" xlink:title="Label : lbio_PercentageOfRoyaltyOnSales to label_lbio_PercentageOfRoyaltyOnSales_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PercentageOfRoyaltyOnSales_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_PercentageOfRoyaltyOnSales_2" xml:lang="en-US" id="label_lbio_PercentageOfRoyaltyOnSales_2">Percentage of royalty on sales</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PercentageOfRoyaltyOnSales" xlink:to="label_lbio_PercentageOfRoyaltyOnSales_2" xlink:title="Label : lbio_PercentageOfRoyaltyOnSales to label_lbio_PercentageOfRoyaltyOnSales_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_EstimatedBenchmarkPaymentsForProduct1" xlink:label="lbio_EstimatedBenchmarkPaymentsForProduct1" xlink:title="lbio_EstimatedBenchmarkPaymentsForProduct1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EstimatedBenchmarkPaymentsForProduct1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_EstimatedBenchmarkPaymentsForProduct1" xml:lang="en-US" id="label_lbio_EstimatedBenchmarkPaymentsForProduct1">Estimated amount of benchmark payment to develop and manufacture certain proprietary autologous tumor infiltrating lymphocyte adoptive cell therapy products.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EstimatedBenchmarkPaymentsForProduct1" xlink:to="label_lbio_EstimatedBenchmarkPaymentsForProduct1" xlink:title="Label : lbio_EstimatedBenchmarkPaymentsForProduct1 to label_lbio_EstimatedBenchmarkPaymentsForProduct1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EstimatedBenchmarkPaymentsForProduct1_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_EstimatedBenchmarkPaymentsForProduct1_1" xml:lang="en-US" id="label_lbio_EstimatedBenchmarkPaymentsForProduct1_1">Estimated Benchmark Payments For Product 1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EstimatedBenchmarkPaymentsForProduct1" xlink:to="label_lbio_EstimatedBenchmarkPaymentsForProduct1_1" xlink:title="Label : lbio_EstimatedBenchmarkPaymentsForProduct1 to label_lbio_EstimatedBenchmarkPaymentsForProduct1_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EstimatedBenchmarkPaymentsForProduct1_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_EstimatedBenchmarkPaymentsForProduct1_2" xml:lang="en-US" id="label_lbio_EstimatedBenchmarkPaymentsForProduct1_2">Estimated Benchmark Payments For Metastatic Melanoma</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EstimatedBenchmarkPaymentsForProduct1" xlink:to="label_lbio_EstimatedBenchmarkPaymentsForProduct1_2" xlink:title="Label : lbio_EstimatedBenchmarkPaymentsForProduct1 to label_lbio_EstimatedBenchmarkPaymentsForProduct1_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_AnnualBaseSalary" xlink:label="lbio_AnnualBaseSalary" xlink:title="lbio_AnnualBaseSalary" />
    <link:label xlink:type="resource" xlink:label="label_lbio_AnnualBaseSalary" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_AnnualBaseSalary" xml:lang="en-US" id="label_lbio_AnnualBaseSalary">Amount of annual base salary payable to officers as part of employment agreements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_AnnualBaseSalary" xlink:to="label_lbio_AnnualBaseSalary" xlink:title="Label : lbio_AnnualBaseSalary to label_lbio_AnnualBaseSalary" />
    <link:label xlink:type="resource" xlink:label="label_lbio_AnnualBaseSalary_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_AnnualBaseSalary_1" xml:lang="en-US" id="label_lbio_AnnualBaseSalary_1">Annual Base Salary</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_AnnualBaseSalary" xlink:to="label_lbio_AnnualBaseSalary_1" xlink:title="Label : lbio_AnnualBaseSalary to label_lbio_AnnualBaseSalary_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PercentageOfPotentialBonus" xlink:label="lbio_PercentageOfPotentialBonus" xlink:title="lbio_PercentageOfPotentialBonus" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PercentageOfPotentialBonus" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_PercentageOfPotentialBonus" xml:lang="en-US" id="label_lbio_PercentageOfPotentialBonus">Percentage of Potential Bonus.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PercentageOfPotentialBonus" xlink:to="label_lbio_PercentageOfPotentialBonus" xlink:title="Label : lbio_PercentageOfPotentialBonus to label_lbio_PercentageOfPotentialBonus" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PercentageOfPotentialBonus_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_PercentageOfPotentialBonus_1" xml:lang="en-US" id="label_lbio_PercentageOfPotentialBonus_1">Percentage of Potential Bonus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PercentageOfPotentialBonus" xlink:to="label_lbio_PercentageOfPotentialBonus_1" xlink:title="Label : lbio_PercentageOfPotentialBonus to label_lbio_PercentageOfPotentialBonus_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockToBeIssued" xlink:label="lbio_CommonStockToBeIssued" xlink:title="lbio_CommonStockToBeIssued" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockToBeIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_CommonStockToBeIssued" xml:lang="en-US" id="label_lbio_CommonStockToBeIssued">Number of shares of common stock to be issued as of balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockToBeIssued" xlink:to="label_lbio_CommonStockToBeIssued" xlink:title="Label : lbio_CommonStockToBeIssued to label_lbio_CommonStockToBeIssued" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockToBeIssued_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_CommonStockToBeIssued_1" xml:lang="en-US" id="label_lbio_CommonStockToBeIssued_1">Common Stock To Be Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockToBeIssued" xlink:to="label_lbio_CommonStockToBeIssued_1" xlink:title="Label : lbio_CommonStockToBeIssued to label_lbio_CommonStockToBeIssued_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_EstimatedBenchmarkPaymentsForProduct2" xlink:label="lbio_EstimatedBenchmarkPaymentsForProduct2" xlink:title="lbio_EstimatedBenchmarkPaymentsForProduct2" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EstimatedBenchmarkPaymentsForProduct2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_EstimatedBenchmarkPaymentsForProduct2" xml:lang="en-US" id="label_lbio_EstimatedBenchmarkPaymentsForProduct2">Estimated amount of benchmark payment to develop and manufacture certain proprietary autologous tumor infiltrating lymphocyte adoptive cell therapy products.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EstimatedBenchmarkPaymentsForProduct2" xlink:to="label_lbio_EstimatedBenchmarkPaymentsForProduct2" xlink:title="Label : lbio_EstimatedBenchmarkPaymentsForProduct2 to label_lbio_EstimatedBenchmarkPaymentsForProduct2" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EstimatedBenchmarkPaymentsForProduct2_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_EstimatedBenchmarkPaymentsForProduct2_1" xml:lang="en-US" id="label_lbio_EstimatedBenchmarkPaymentsForProduct2_1">Estimated Benchmark Payments For Product 2</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EstimatedBenchmarkPaymentsForProduct2" xlink:to="label_lbio_EstimatedBenchmarkPaymentsForProduct2_1" xlink:title="Label : lbio_EstimatedBenchmarkPaymentsForProduct2 to label_lbio_EstimatedBenchmarkPaymentsForProduct2_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EstimatedBenchmarkPaymentsForProduct2_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_EstimatedBenchmarkPaymentsForProduct2_2" xml:lang="en-US" id="label_lbio_EstimatedBenchmarkPaymentsForProduct2_2">Estimated Benchmark Payments For Ovarian Cancer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EstimatedBenchmarkPaymentsForProduct2" xlink:to="label_lbio_EstimatedBenchmarkPaymentsForProduct2_2" xlink:title="Label : lbio_EstimatedBenchmarkPaymentsForProduct2 to label_lbio_EstimatedBenchmarkPaymentsForProduct2_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_EstimatedBenchmarkPaymentsForProduct3" xlink:label="lbio_EstimatedBenchmarkPaymentsForProduct3" xlink:title="lbio_EstimatedBenchmarkPaymentsForProduct3" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EstimatedBenchmarkPaymentsForProduct3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_EstimatedBenchmarkPaymentsForProduct3" xml:lang="en-US" id="label_lbio_EstimatedBenchmarkPaymentsForProduct3">Estimated amount of benchmark payment to develop and manufacture certain proprietary autologous tumor infiltrating lymphocyte adoptive cell therapy products.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EstimatedBenchmarkPaymentsForProduct3" xlink:to="label_lbio_EstimatedBenchmarkPaymentsForProduct3" xlink:title="Label : lbio_EstimatedBenchmarkPaymentsForProduct3 to label_lbio_EstimatedBenchmarkPaymentsForProduct3" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EstimatedBenchmarkPaymentsForProduct3_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_EstimatedBenchmarkPaymentsForProduct3_1" xml:lang="en-US" id="label_lbio_EstimatedBenchmarkPaymentsForProduct3_1">Estimated Benchmark Payments For Product 3</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EstimatedBenchmarkPaymentsForProduct3" xlink:to="label_lbio_EstimatedBenchmarkPaymentsForProduct3_1" xlink:title="Label : lbio_EstimatedBenchmarkPaymentsForProduct3 to label_lbio_EstimatedBenchmarkPaymentsForProduct3_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EstimatedBenchmarkPaymentsForProduct3_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_EstimatedBenchmarkPaymentsForProduct3_2" xml:lang="en-US" id="label_lbio_EstimatedBenchmarkPaymentsForProduct3_2">Estimated Benchmark Payments For Breast Cancer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EstimatedBenchmarkPaymentsForProduct3" xlink:to="label_lbio_EstimatedBenchmarkPaymentsForProduct3_2" xlink:title="Label : lbio_EstimatedBenchmarkPaymentsForProduct3 to label_lbio_EstimatedBenchmarkPaymentsForProduct3_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_EstimatedBenchmarkPaymentsForProduct4" xlink:label="lbio_EstimatedBenchmarkPaymentsForProduct4" xlink:title="lbio_EstimatedBenchmarkPaymentsForProduct4" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EstimatedBenchmarkPaymentsForProduct4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_EstimatedBenchmarkPaymentsForProduct4" xml:lang="en-US" id="label_lbio_EstimatedBenchmarkPaymentsForProduct4">Estimated amount of benchmark payment to develop and manufacture certain proprietary autologous tumor infiltrating lymphocyte adoptive cell therapy products.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EstimatedBenchmarkPaymentsForProduct4" xlink:to="label_lbio_EstimatedBenchmarkPaymentsForProduct4" xlink:title="Label : lbio_EstimatedBenchmarkPaymentsForProduct4 to label_lbio_EstimatedBenchmarkPaymentsForProduct4" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EstimatedBenchmarkPaymentsForProduct4_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_EstimatedBenchmarkPaymentsForProduct4_1" xml:lang="en-US" id="label_lbio_EstimatedBenchmarkPaymentsForProduct4_1">Estimated Benchmark Payments For Product 4</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EstimatedBenchmarkPaymentsForProduct4" xlink:to="label_lbio_EstimatedBenchmarkPaymentsForProduct4_1" xlink:title="Label : lbio_EstimatedBenchmarkPaymentsForProduct4 to label_lbio_EstimatedBenchmarkPaymentsForProduct4_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EstimatedBenchmarkPaymentsForProduct4_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_EstimatedBenchmarkPaymentsForProduct4_2" xml:lang="en-US" id="label_lbio_EstimatedBenchmarkPaymentsForProduct4_2">Estimated Benchmark Payments For Colorectal Cancer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EstimatedBenchmarkPaymentsForProduct4" xlink:to="label_lbio_EstimatedBenchmarkPaymentsForProduct4_2" xlink:title="Label : lbio_EstimatedBenchmarkPaymentsForProduct4 to label_lbio_EstimatedBenchmarkPaymentsForProduct4_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_EstimatedBenchmarkPaymentsForProducts" xlink:label="lbio_EstimatedBenchmarkPaymentsForProducts" xlink:title="lbio_EstimatedBenchmarkPaymentsForProducts" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EstimatedBenchmarkPaymentsForProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_EstimatedBenchmarkPaymentsForProducts" xml:lang="en-US" id="label_lbio_EstimatedBenchmarkPaymentsForProducts">Aggregate amount of benchmark royalty payments to develop and manufacture certain proprietary autologous tumor infiltrating lymphocyte adoptive cell therapy products.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EstimatedBenchmarkPaymentsForProducts" xlink:to="label_lbio_EstimatedBenchmarkPaymentsForProducts" xlink:title="Label : lbio_EstimatedBenchmarkPaymentsForProducts to label_lbio_EstimatedBenchmarkPaymentsForProducts" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EstimatedBenchmarkPaymentsForProducts_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_EstimatedBenchmarkPaymentsForProducts_1" xml:lang="en-US" id="label_lbio_EstimatedBenchmarkPaymentsForProducts_1">Estimated Benchmark Payments For Products</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EstimatedBenchmarkPaymentsForProducts" xlink:to="label_lbio_EstimatedBenchmarkPaymentsForProducts_1" xlink:title="Label : lbio_EstimatedBenchmarkPaymentsForProducts to label_lbio_EstimatedBenchmarkPaymentsForProducts_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EstimatedBenchmarkPaymentsForProducts_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_EstimatedBenchmarkPaymentsForProducts_2" xml:lang="en-US" id="label_lbio_EstimatedBenchmarkPaymentsForProducts_2">Estimated benchmark payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EstimatedBenchmarkPaymentsForProducts" xlink:to="label_lbio_EstimatedBenchmarkPaymentsForProducts_2" xlink:title="Label : lbio_EstimatedBenchmarkPaymentsForProducts to label_lbio_EstimatedBenchmarkPaymentsForProducts_2" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EstimatedBenchmarkPaymentsForProducts_3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_EstimatedBenchmarkPaymentsForProducts_3" xml:lang="en-US" id="label_lbio_EstimatedBenchmarkPaymentsForProducts_3">Estimated Benchmark Payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EstimatedBenchmarkPaymentsForProducts" xlink:to="label_lbio_EstimatedBenchmarkPaymentsForProducts_3" xlink:title="Label : lbio_EstimatedBenchmarkPaymentsForProducts to label_lbio_EstimatedBenchmarkPaymentsForProducts_3" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_TampaLeaseMember" xlink:label="lbio_TampaLeaseMember" xlink:title="lbio_TampaLeaseMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_TampaLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_TampaLeaseMember" xml:lang="en-US" id="label_lbio_TampaLeaseMember">Tampa Lease [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_TampaLeaseMember" xlink:to="label_lbio_TampaLeaseMember" xlink:title="Label : lbio_TampaLeaseMember to label_lbio_TampaLeaseMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_FormerChiefExecutiveOfficerMember" xlink:label="lbio_FormerChiefExecutiveOfficerMember" xlink:title="lbio_FormerChiefExecutiveOfficerMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_FormerChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_FormerChiefExecutiveOfficerMember" xml:lang="en-US" id="label_lbio_FormerChiefExecutiveOfficerMember">Former Chief Executive Officer [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_FormerChiefExecutiveOfficerMember" xlink:to="label_lbio_FormerChiefExecutiveOfficerMember" xlink:title="Label : lbio_FormerChiefExecutiveOfficerMember to label_lbio_FormerChiefExecutiveOfficerMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_FormerChiefExecutiveOfficerMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_FormerChiefExecutiveOfficerMember_1" xml:lang="en-US" id="label_lbio_FormerChiefExecutiveOfficerMember_1">Mr Cataldo [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_FormerChiefExecutiveOfficerMember" xlink:to="label_lbio_FormerChiefExecutiveOfficerMember_1" xlink:title="Label : lbio_FormerChiefExecutiveOfficerMember to label_lbio_FormerChiefExecutiveOfficerMember_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_EmmesGroupConsultingLlcMember" xlink:label="lbio_EmmesGroupConsultingLlcMember" xlink:title="lbio_EmmesGroupConsultingLlcMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EmmesGroupConsultingLlcMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_EmmesGroupConsultingLlcMember" xml:lang="en-US" id="label_lbio_EmmesGroupConsultingLlcMember">Emmes Group Consulting LLC [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EmmesGroupConsultingLlcMember" xlink:to="label_lbio_EmmesGroupConsultingLlcMember" xlink:title="Label : lbio_EmmesGroupConsultingLlcMember to label_lbio_EmmesGroupConsultingLlcMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CompensationPaidInCash" xlink:label="lbio_CompensationPaidInCash" xlink:title="lbio_CompensationPaidInCash" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CompensationPaidInCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_CompensationPaidInCash" xml:lang="en-US" id="label_lbio_CompensationPaidInCash">Amount of cash paid to employees after deducting federal and state income and employment taxes under settlement agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CompensationPaidInCash" xlink:to="label_lbio_CompensationPaidInCash" xlink:title="Label : lbio_CompensationPaidInCash to label_lbio_CompensationPaidInCash" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CompensationPaidInCash_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_CompensationPaidInCash_1" xml:lang="en-US" id="label_lbio_CompensationPaidInCash_1">Compensation Paid In Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CompensationPaidInCash" xlink:to="label_lbio_CompensationPaidInCash_1" xlink:title="Label : lbio_CompensationPaidInCash to label_lbio_CompensationPaidInCash_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CompensationPaidInKind" xlink:label="lbio_CompensationPaidInKind" xlink:title="lbio_CompensationPaidInKind" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CompensationPaidInKind" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_CompensationPaidInKind" xml:lang="en-US" id="label_lbio_CompensationPaidInKind">Amount of securities given to employees after deducting federal and state income and employment taxes under settlement agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CompensationPaidInKind" xlink:to="label_lbio_CompensationPaidInKind" xlink:title="Label : lbio_CompensationPaidInKind to label_lbio_CompensationPaidInKind" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CompensationPaidInKind_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_CompensationPaidInKind_1" xml:lang="en-US" id="label_lbio_CompensationPaidInKind_1">Compensation Paid In Kind</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CompensationPaidInKind" xlink:to="label_lbio_CompensationPaidInKind_1" xlink:title="Label : lbio_CompensationPaidInKind to label_lbio_CompensationPaidInKind_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ManufacturingServiceAgreementMember" xlink:label="lbio_ManufacturingServiceAgreementMember" xlink:title="lbio_ManufacturingServiceAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ManufacturingServiceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_ManufacturingServiceAgreementMember" xml:lang="en-US" id="label_lbio_ManufacturingServiceAgreementMember">Manufacturing Service Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ManufacturingServiceAgreementMember" xlink:to="label_lbio_ManufacturingServiceAgreementMember" xlink:title="Label : lbio_ManufacturingServiceAgreementMember to label_lbio_ManufacturingServiceAgreementMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm" xlink:label="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm" xlink:title="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm" />
    <link:label xlink:type="resource" xlink:label="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm" xml:lang="en-US" id="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm">Weighted average remaining contractual term for option awards forfeitures and expirations in period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm" xlink:to="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm" xlink:title="Label : lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm to label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm" />
    <link:label xlink:type="resource" xlink:label="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm_1" xml:lang="en-US" id="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm" xlink:to="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm_1" xlink:title="Label : lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm to label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm_2" xml:lang="en-US" id="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm_2">Expired/Forfeited</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm" xlink:to="label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm_2" xlink:title="Label : lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm to label_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_NonemployeeMember" xlink:label="lbio_NonemployeeMember" xlink:title="lbio_NonemployeeMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_NonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_NonemployeeMember" xml:lang="en-US" id="label_lbio_NonemployeeMember">Nonemployee [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_NonemployeeMember" xlink:to="label_lbio_NonemployeeMember" xlink:title="Label : lbio_NonemployeeMember to label_lbio_NonemployeeMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_EmployeesMember" xlink:label="lbio_EmployeesMember" xlink:title="lbio_EmployeesMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EmployeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_EmployeesMember" xml:lang="en-US" id="label_lbio_EmployeesMember">Employees [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EmployeesMember" xlink:to="label_lbio_EmployeesMember" xlink:title="Label : lbio_EmployeesMember to label_lbio_EmployeesMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_IssuanceOfCommonStockUponConversionOfPreferredStockMember" xlink:label="lbio_IssuanceOfCommonStockUponConversionOfPreferredStockMember" xlink:title="lbio_IssuanceOfCommonStockUponConversionOfPreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_IssuanceOfCommonStockUponConversionOfPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_IssuanceOfCommonStockUponConversionOfPreferredStockMember" xml:lang="en-US" id="label_lbio_IssuanceOfCommonStockUponConversionOfPreferredStockMember">Issuance Of Common Stock Upon Conversion Of Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_IssuanceOfCommonStockUponConversionOfPreferredStockMember" xlink:to="label_lbio_IssuanceOfCommonStockUponConversionOfPreferredStockMember" xlink:title="Label : lbio_IssuanceOfCommonStockUponConversionOfPreferredStockMember to label_lbio_IssuanceOfCommonStockUponConversionOfPreferredStockMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ConsultantMember" xlink:label="lbio_ConsultantMember" xlink:title="lbio_ConsultantMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ConsultantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_ConsultantMember" xml:lang="en-US" id="label_lbio_ConsultantMember">Consultant [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ConsultantMember" xlink:to="label_lbio_ConsultantMember" xlink:title="Label : lbio_ConsultantMember to label_lbio_ConsultantMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_SettlementOfOutstandingObligationsMember" xlink:label="lbio_SettlementOfOutstandingObligationsMember" xlink:title="lbio_SettlementOfOutstandingObligationsMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_SettlementOfOutstandingObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_SettlementOfOutstandingObligationsMember" xml:lang="en-US" id="label_lbio_SettlementOfOutstandingObligationsMember">Settlement Of Outstanding Obligations [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_SettlementOfOutstandingObligationsMember" xlink:to="label_lbio_SettlementOfOutstandingObligationsMember" xlink:title="Label : lbio_SettlementOfOutstandingObligationsMember to label_lbio_SettlementOfOutstandingObligationsMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_NewEmployeeMember" xlink:label="lbio_NewEmployeeMember" xlink:title="lbio_NewEmployeeMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_NewEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_NewEmployeeMember" xml:lang="en-US" id="label_lbio_NewEmployeeMember">New Employee [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_NewEmployeeMember" xlink:to="label_lbio_NewEmployeeMember" xlink:title="Label : lbio_NewEmployeeMember to label_lbio_NewEmployeeMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_SecondEmployeeMember" xlink:label="lbio_SecondEmployeeMember" xlink:title="lbio_SecondEmployeeMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_SecondEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_SecondEmployeeMember" xml:lang="en-US" id="label_lbio_SecondEmployeeMember">Second Employee [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_SecondEmployeeMember" xlink:to="label_lbio_SecondEmployeeMember" xlink:title="Label : lbio_SecondEmployeeMember to label_lbio_SecondEmployeeMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_LionBiotechnologiesIncMember" xlink:label="lbio_LionBiotechnologiesIncMember" xlink:title="lbio_LionBiotechnologiesIncMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_LionBiotechnologiesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_LionBiotechnologiesIncMember" xml:lang="en-US" id="label_lbio_LionBiotechnologiesIncMember">Lion Biotechnologies, Inc [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_LionBiotechnologiesIncMember" xlink:to="label_lbio_LionBiotechnologiesIncMember" xlink:title="Label : lbio_LionBiotechnologiesIncMember to label_lbio_LionBiotechnologiesIncMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_AggregateIntrinsicValueAbstract1Abstract" xlink:label="lbio_AggregateIntrinsicValueAbstract1Abstract" xlink:title="lbio_AggregateIntrinsicValueAbstract1Abstract" />
    <link:label xlink:type="resource" xlink:label="label_lbio_AggregateIntrinsicValueAbstract1Abstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_AggregateIntrinsicValueAbstract1Abstract" xml:lang="en-US" id="label_lbio_AggregateIntrinsicValueAbstract1Abstract">Aggregate Intrinsic Value Abstract1 [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_AggregateIntrinsicValueAbstract1Abstract" xlink:to="label_lbio_AggregateIntrinsicValueAbstract1Abstract" xlink:title="Label : lbio_AggregateIntrinsicValueAbstract1Abstract to label_lbio_AggregateIntrinsicValueAbstract1Abstract" />
    <link:label xlink:type="resource" xlink:label="label_lbio_AggregateIntrinsicValueAbstract1Abstract_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_AggregateIntrinsicValueAbstract1Abstract_1" xml:lang="en-US" id="label_lbio_AggregateIntrinsicValueAbstract1Abstract_1">Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_AggregateIntrinsicValueAbstract1Abstract" xlink:to="label_lbio_AggregateIntrinsicValueAbstract1Abstract_1" xlink:title="Label : lbio_AggregateIntrinsicValueAbstract1Abstract to label_lbio_AggregateIntrinsicValueAbstract1Abstract_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_EmployeesAndDirectorsMember" xlink:label="lbio_EmployeesAndDirectorsMember" xlink:title="lbio_EmployeesAndDirectorsMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EmployeesAndDirectorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_EmployeesAndDirectorsMember" xml:lang="en-US" id="label_lbio_EmployeesAndDirectorsMember">Employees and Directors [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EmployeesAndDirectorsMember" xlink:to="label_lbio_EmployeesAndDirectorsMember" xlink:title="Label : lbio_EmployeesAndDirectorsMember to label_lbio_EmployeesAndDirectorsMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ConsultantsMember" xlink:label="lbio_ConsultantsMember" xlink:title="lbio_ConsultantsMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ConsultantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_ConsultantsMember" xml:lang="en-US" id="label_lbio_ConsultantsMember">Consultants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ConsultantsMember" xlink:to="label_lbio_ConsultantsMember" xlink:title="Label : lbio_ConsultantsMember to label_lbio_ConsultantsMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_EquityIncentivePlan2011Member" xlink:label="lbio_EquityIncentivePlan2011Member" xlink:title="lbio_EquityIncentivePlan2011Member" />
    <link:label xlink:type="resource" xlink:label="label_lbio_EquityIncentivePlan2011Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_EquityIncentivePlan2011Member" xml:lang="en-US" id="label_lbio_EquityIncentivePlan2011Member">Equity Incentive Plan 2011 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_EquityIncentivePlan2011Member" xlink:to="label_lbio_EquityIncentivePlan2011Member" xlink:title="Label : lbio_EquityIncentivePlan2011Member to label_lbio_EquityIncentivePlan2011Member" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_AwardAgreementMember" xlink:label="lbio_AwardAgreementMember" xlink:title="lbio_AwardAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_AwardAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_AwardAgreementMember" xml:lang="en-US" id="label_lbio_AwardAgreementMember">Award Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_AwardAgreementMember" xlink:to="label_lbio_AwardAgreementMember" xlink:title="Label : lbio_AwardAgreementMember to label_lbio_AwardAgreementMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:title="dei_EntityWellKnownSeasonedIssuer" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityWellKnownSeasonedIssuer" xml:lang="en-US" id="label_dei_EntityWellKnownSeasonedIssuer">Entity Well-known Seasoned Issuer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="label_dei_EntityWellKnownSeasonedIssuer" xlink:title="Label : dei_EntityWellKnownSeasonedIssuer to label_dei_EntityWellKnownSeasonedIssuer" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_MatrixGroupInternationalIncMember" xlink:label="lbio_MatrixGroupInternationalIncMember" xlink:title="lbio_MatrixGroupInternationalIncMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_MatrixGroupInternationalIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_MatrixGroupInternationalIncMember" xml:lang="en-US" id="label_lbio_MatrixGroupInternationalIncMember">Matrix Group International, Inc [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_MatrixGroupInternationalIncMember" xlink:to="label_lbio_MatrixGroupInternationalIncMember" xlink:title="Label : lbio_MatrixGroupInternationalIncMember to label_lbio_MatrixGroupInternationalIncMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" xlink:title="dei_EntityVoluntaryFilers" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityVoluntaryFilers" xml:lang="en-US" id="label_dei_EntityVoluntaryFilers">Entity Voluntary Filers</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="label_dei_EntityVoluntaryFilers" xlink:title="Label : dei_EntityVoluntaryFilers to label_dei_EntityVoluntaryFilers" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_RestructuringAndRelatedCostExpectedCostQuarterlyPayments" xlink:label="lbio_RestructuringAndRelatedCostExpectedCostQuarterlyPayments" xlink:title="lbio_RestructuringAndRelatedCostExpectedCostQuarterlyPayments" />
    <link:label xlink:type="resource" xlink:label="label_lbio_RestructuringAndRelatedCostExpectedCostQuarterlyPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_RestructuringAndRelatedCostExpectedCostQuarterlyPayments" xml:lang="en-US" id="label_lbio_RestructuringAndRelatedCostExpectedCostQuarterlyPayments">Represents the quarterly payment of the expected cost of restructuring and related costs for the reporting period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_RestructuringAndRelatedCostExpectedCostQuarterlyPayments" xlink:to="label_lbio_RestructuringAndRelatedCostExpectedCostQuarterlyPayments" xlink:title="Label : lbio_RestructuringAndRelatedCostExpectedCostQuarterlyPayments to label_lbio_RestructuringAndRelatedCostExpectedCostQuarterlyPayments" />
    <link:label xlink:type="resource" xlink:label="label_lbio_RestructuringAndRelatedCostExpectedCostQuarterlyPayments_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_RestructuringAndRelatedCostExpectedCostQuarterlyPayments_1" xml:lang="en-US" id="label_lbio_RestructuringAndRelatedCostExpectedCostQuarterlyPayments_1">Restructuring And Related Cost Expected Cost Quarterly Payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_RestructuringAndRelatedCostExpectedCostQuarterlyPayments" xlink:to="label_lbio_RestructuringAndRelatedCostExpectedCostQuarterlyPayments_1" xlink:title="Label : lbio_RestructuringAndRelatedCostExpectedCostQuarterlyPayments to label_lbio_RestructuringAndRelatedCostExpectedCostQuarterlyPayments_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xlink:title="dei_EntityCurrentReportingStatus" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityCurrentReportingStatus" xml:lang="en-US" id="label_dei_EntityCurrentReportingStatus">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="label_dei_EntityCurrentReportingStatus" xlink:title="Label : dei_EntityCurrentReportingStatus to label_dei_EntityCurrentReportingStatus" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_TermOfLease" xlink:label="lbio_TermOfLease" xlink:title="lbio_TermOfLease" />
    <link:label xlink:type="resource" xlink:label="label_lbio_TermOfLease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_TermOfLease" xml:lang="en-US" id="label_lbio_TermOfLease">It represents the term of lease.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_TermOfLease" xlink:to="label_lbio_TermOfLease" xlink:title="Label : lbio_TermOfLease to label_lbio_TermOfLease" />
    <link:label xlink:type="resource" xlink:label="label_lbio_TermOfLease_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_TermOfLease_1" xml:lang="en-US" id="label_lbio_TermOfLease_1">Term Of Lease</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_TermOfLease" xlink:to="label_lbio_TermOfLease_1" xlink:title="Label : lbio_TermOfLease to label_lbio_TermOfLease_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:title="dei_EntityFilerCategory" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityFilerCategory" xml:lang="en-US" id="label_dei_EntityFilerCategory">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="label_dei_EntityFilerCategory" xlink:title="Label : dei_EntityFilerCategory to label_dei_EntityFilerCategory" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PercentageOfIncreaseInLeaseRent" xlink:label="lbio_PercentageOfIncreaseInLeaseRent" xlink:title="lbio_PercentageOfIncreaseInLeaseRent" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PercentageOfIncreaseInLeaseRent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_PercentageOfIncreaseInLeaseRent" xml:lang="en-US" id="label_lbio_PercentageOfIncreaseInLeaseRent">It represents the percentage of increase in lease rentals annually.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PercentageOfIncreaseInLeaseRent" xlink:to="label_lbio_PercentageOfIncreaseInLeaseRent" xlink:title="Label : lbio_PercentageOfIncreaseInLeaseRent to label_lbio_PercentageOfIncreaseInLeaseRent" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PercentageOfIncreaseInLeaseRent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_PercentageOfIncreaseInLeaseRent_1" xml:lang="en-US" id="label_lbio_PercentageOfIncreaseInLeaseRent_1">Percentage Of Increase In Lease Rent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PercentageOfIncreaseInLeaseRent" xlink:to="label_lbio_PercentageOfIncreaseInLeaseRent_1" xlink:title="Label : lbio_PercentageOfIncreaseInLeaseRent to label_lbio_PercentageOfIncreaseInLeaseRent_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PercentageOfIncreaseInLeaseRent_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_PercentageOfIncreaseInLeaseRent_2" xml:lang="en-US" id="label_lbio_PercentageOfIncreaseInLeaseRent_2">Percentage of increase in rent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PercentageOfIncreaseInLeaseRent" xlink:to="label_lbio_PercentageOfIncreaseInLeaseRent_2" xlink:title="Label : lbio_PercentageOfIncreaseInLeaseRent to label_lbio_PercentageOfIncreaseInLeaseRent_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" xlink:title="dei_EntityPublicFloat" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityPublicFloat" xml:lang="en-US" id="label_dei_EntityPublicFloat">Entity Public Float</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="label_dei_EntityPublicFloat" xlink:title="Label : dei_EntityPublicFloat to label_dei_EntityPublicFloat" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_TermOfLicense" xlink:label="lbio_TermOfLicense" xlink:title="lbio_TermOfLicense" />
    <link:label xlink:type="resource" xlink:label="label_lbio_TermOfLicense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_TermOfLicense" xml:lang="en-US" id="label_lbio_TermOfLicense">It represents the term of license.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_TermOfLicense" xlink:to="label_lbio_TermOfLicense" xlink:title="Label : lbio_TermOfLicense to label_lbio_TermOfLicense" />
    <link:label xlink:type="resource" xlink:label="label_lbio_TermOfLicense_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_TermOfLicense_1" xml:lang="en-US" id="label_lbio_TermOfLicense_1">Term of License</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_TermOfLicense" xlink:to="label_lbio_TermOfLicense_1" xlink:title="Label : lbio_TermOfLicense to label_lbio_TermOfLicense_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:title="dei_EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityRegistrantName" xml:lang="en-US" id="label_dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="label_dei_EntityRegistrantName" xlink:title="Label : dei_EntityRegistrantName to label_dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_WarrantExpirationPeriod" xlink:label="lbio_WarrantExpirationPeriod" xlink:title="lbio_WarrantExpirationPeriod" />
    <link:label xlink:type="resource" xlink:label="label_lbio_WarrantExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_WarrantExpirationPeriod" xml:lang="en-US" id="label_lbio_WarrantExpirationPeriod">Represents the warrant expiration period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_WarrantExpirationPeriod" xlink:to="label_lbio_WarrantExpirationPeriod" xlink:title="Label : lbio_WarrantExpirationPeriod to label_lbio_WarrantExpirationPeriod" />
    <link:label xlink:type="resource" xlink:label="label_lbio_WarrantExpirationPeriod_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_WarrantExpirationPeriod_1" xml:lang="en-US" id="label_lbio_WarrantExpirationPeriod_1">Warrant Expiration Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_WarrantExpirationPeriod" xlink:to="label_lbio_WarrantExpirationPeriod_1" xlink:title="Label : lbio_WarrantExpirationPeriod to label_lbio_WarrantExpirationPeriod_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:title="dei_EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityCentralIndexKey" xml:lang="en-US" id="label_dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="label_dei_EntityCentralIndexKey" xlink:title="Label : dei_EntityCentralIndexKey to label_dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_GeneralOrganizationAndBusinessLineItems" xlink:label="lbio_GeneralOrganizationAndBusinessLineItems" xlink:title="lbio_GeneralOrganizationAndBusinessLineItems" />
    <link:label xlink:type="resource" xlink:label="label_lbio_GeneralOrganizationAndBusinessLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_GeneralOrganizationAndBusinessLineItems" xml:lang="en-US" id="label_lbio_GeneralOrganizationAndBusinessLineItems">It represents general organization and business.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_GeneralOrganizationAndBusinessLineItems" xlink:to="label_lbio_GeneralOrganizationAndBusinessLineItems" xlink:title="Label : lbio_GeneralOrganizationAndBusinessLineItems to label_lbio_GeneralOrganizationAndBusinessLineItems" />
    <link:label xlink:type="resource" xlink:label="label_lbio_GeneralOrganizationAndBusinessLineItems_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_GeneralOrganizationAndBusinessLineItems_1" xml:lang="en-US" id="label_lbio_GeneralOrganizationAndBusinessLineItems_1">General Organization And Business [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_GeneralOrganizationAndBusinessLineItems" xlink:to="label_lbio_GeneralOrganizationAndBusinessLineItems_1" xlink:title="Label : lbio_GeneralOrganizationAndBusinessLineItems to label_lbio_GeneralOrganizationAndBusinessLineItems_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_SeriesConvertiblePreferredStockMember" xlink:label="lbio_SeriesConvertiblePreferredStockMember" xlink:title="lbio_SeriesConvertiblePreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_SeriesConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_SeriesConvertiblePreferredStockMember" xml:lang="en-US" id="label_lbio_SeriesConvertiblePreferredStockMember">Series A Convertible Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_SeriesConvertiblePreferredStockMember" xlink:to="label_lbio_SeriesConvertiblePreferredStockMember" xlink:title="Label : lbio_SeriesConvertiblePreferredStockMember to label_lbio_SeriesConvertiblePreferredStockMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_WarrantIssuance1Member" xlink:label="lbio_WarrantIssuance1Member" xlink:title="lbio_WarrantIssuance1Member" />
    <link:label xlink:type="resource" xlink:label="label_lbio_WarrantIssuance1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_WarrantIssuance1Member" xml:lang="en-US" id="label_lbio_WarrantIssuance1Member">Warrant Issuance1 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_WarrantIssuance1Member" xlink:to="label_lbio_WarrantIssuance1Member" xlink:title="Label : lbio_WarrantIssuance1Member to label_lbio_WarrantIssuance1Member" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_WarrantIssuance2Member" xlink:label="lbio_WarrantIssuance2Member" xlink:title="lbio_WarrantIssuance2Member" />
    <link:label xlink:type="resource" xlink:label="label_lbio_WarrantIssuance2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_WarrantIssuance2Member" xml:lang="en-US" id="label_lbio_WarrantIssuance2Member">Warrant Issuance2 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_WarrantIssuance2Member" xlink:to="label_lbio_WarrantIssuance2Member" xlink:title="Label : lbio_WarrantIssuance2Member to label_lbio_WarrantIssuance2Member" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:title="dei_EntityCommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityCommonStockSharesOutstanding" xml:lang="en-US" id="label_dei_EntityCommonStockSharesOutstanding">Entity Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="label_dei_EntityCommonStockSharesOutstanding" xlink:title="Label : dei_EntityCommonStockSharesOutstanding to label_dei_EntityCommonStockSharesOutstanding" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PlacementAgentsMember" xlink:label="lbio_PlacementAgentsMember" xlink:title="lbio_PlacementAgentsMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PlacementAgentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_PlacementAgentsMember" xml:lang="en-US" id="label_lbio_PlacementAgentsMember">Placement Agents [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PlacementAgentsMember" xlink:to="label_lbio_PlacementAgentsMember" xlink:title="Label : lbio_PlacementAgentsMember to label_lbio_PlacementAgentsMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ProceedsFromIssuanceOfPrivatePlacementNet" xlink:label="lbio_ProceedsFromIssuanceOfPrivatePlacementNet" xlink:title="lbio_ProceedsFromIssuanceOfPrivatePlacementNet" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ProceedsFromIssuanceOfPrivatePlacementNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_ProceedsFromIssuanceOfPrivatePlacementNet" xml:lang="en-US" id="label_lbio_ProceedsFromIssuanceOfPrivatePlacementNet">Proceeds from issuance of private placement net.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ProceedsFromIssuanceOfPrivatePlacementNet" xlink:to="label_lbio_ProceedsFromIssuanceOfPrivatePlacementNet" xlink:title="Label : lbio_ProceedsFromIssuanceOfPrivatePlacementNet to label_lbio_ProceedsFromIssuanceOfPrivatePlacementNet" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ProceedsFromIssuanceOfPrivatePlacementNet_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_ProceedsFromIssuanceOfPrivatePlacementNet_1" xml:lang="en-US" id="label_lbio_ProceedsFromIssuanceOfPrivatePlacementNet_1">Proceeds From Issuance Of Private Placement Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ProceedsFromIssuanceOfPrivatePlacementNet" xlink:to="label_lbio_ProceedsFromIssuanceOfPrivatePlacementNet_1" xlink:title="Label : lbio_ProceedsFromIssuanceOfPrivatePlacementNet to label_lbio_ProceedsFromIssuanceOfPrivatePlacementNet_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_DescriptionOnAggregateBeneficialOwnershipPercentageOfCommonStockUponConversion" xlink:label="lbio_DescriptionOnAggregateBeneficialOwnershipPercentageOfCommonStockUponConversion" xlink:title="lbio_DescriptionOnAggregateBeneficialOwnershipPercentageOfCommonStockUponConversion" />
    <link:label xlink:type="resource" xlink:label="label_lbio_DescriptionOnAggregateBeneficialOwnershipPercentageOfCommonStockUponConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_DescriptionOnAggregateBeneficialOwnershipPercentageOfCommonStockUponConversion" xml:lang="en-US" id="label_lbio_DescriptionOnAggregateBeneficialOwnershipPercentageOfCommonStockUponConversion">Description on aggregate beneficial ownership percentage of common stock upon conversion.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_DescriptionOnAggregateBeneficialOwnershipPercentageOfCommonStockUponConversion" xlink:to="label_lbio_DescriptionOnAggregateBeneficialOwnershipPercentageOfCommonStockUponConversion" xlink:title="Label : lbio_DescriptionOnAggregateBeneficialOwnershipPercentageOfCommonStockUponConversion to label_lbio_DescriptionOnAggregateBeneficialOwnershipPercentageOfCommonStockUponConversion" />
    <link:label xlink:type="resource" xlink:label="label_lbio_DescriptionOnAggregateBeneficialOwnershipPercentageOfCommonStockUponConversion_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_DescriptionOnAggregateBeneficialOwnershipPercentageOfCommonStockUponConversion_1" xml:lang="en-US" id="label_lbio_DescriptionOnAggregateBeneficialOwnershipPercentageOfCommonStockUponConversion_1">Description on Aggregate Beneficial Ownership Percentage of Common Stock Upon Conversion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_DescriptionOnAggregateBeneficialOwnershipPercentageOfCommonStockUponConversion" xlink:to="label_lbio_DescriptionOnAggregateBeneficialOwnershipPercentageOfCommonStockUponConversion_1" xlink:title="Label : lbio_DescriptionOnAggregateBeneficialOwnershipPercentageOfCommonStockUponConversion to label_lbio_DescriptionOnAggregateBeneficialOwnershipPercentageOfCommonStockUponConversion_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_DepartmentOfHealthAndHumanServicesMember" xlink:label="lbio_DepartmentOfHealthAndHumanServicesMember" xlink:title="lbio_DepartmentOfHealthAndHumanServicesMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_DepartmentOfHealthAndHumanServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_DepartmentOfHealthAndHumanServicesMember" xml:lang="en-US" id="label_lbio_DepartmentOfHealthAndHumanServicesMember">Department of Health and Human Services [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_DepartmentOfHealthAndHumanServicesMember" xlink:to="label_lbio_DepartmentOfHealthAndHumanServicesMember" xlink:title="Label : lbio_DepartmentOfHealthAndHumanServicesMember to label_lbio_DepartmentOfHealthAndHumanServicesMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_LonzaWalkersvilleIncMember" xlink:label="lbio_LonzaWalkersvilleIncMember" xlink:title="lbio_LonzaWalkersvilleIncMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_LonzaWalkersvilleIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_LonzaWalkersvilleIncMember" xml:lang="en-US" id="label_lbio_LonzaWalkersvilleIncMember">Lonza Walkersville, Inc [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_LonzaWalkersvilleIncMember" xlink:to="label_lbio_LonzaWalkersvilleIncMember" xlink:title="Label : lbio_LonzaWalkersvilleIncMember to label_lbio_LonzaWalkersvilleIncMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PatentLicenseAgreementMember" xlink:label="lbio_PatentLicenseAgreementMember" xlink:title="lbio_PatentLicenseAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PatentLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_PatentLicenseAgreementMember" xml:lang="en-US" id="label_lbio_PatentLicenseAgreementMember">Patent License Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PatentLicenseAgreementMember" xlink:to="label_lbio_PatentLicenseAgreementMember" xlink:title="Label : lbio_PatentLicenseAgreementMember to label_lbio_PatentLicenseAgreementMember" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PreferredStockSharesExercised" xlink:label="lbio_PreferredStockSharesExercised" xlink:title="lbio_PreferredStockSharesExercised" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PreferredStockSharesExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_PreferredStockSharesExercised" xml:lang="en-US" id="label_lbio_PreferredStockSharesExercised">Number of preferred stock shares exercised during the reporting period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PreferredStockSharesExercised" xlink:to="label_lbio_PreferredStockSharesExercised" xlink:title="Label : lbio_PreferredStockSharesExercised to label_lbio_PreferredStockSharesExercised" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PreferredStockSharesExercised_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_PreferredStockSharesExercised_1" xml:lang="en-US" id="label_lbio_PreferredStockSharesExercised_1">Preferred Stock Shares Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PreferredStockSharesExercised" xlink:to="label_lbio_PreferredStockSharesExercised_1" xlink:title="Label : lbio_PreferredStockSharesExercised to label_lbio_PreferredStockSharesExercised_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockIssuedToInduceExchangeTransactionShares" xlink:label="lbio_CommonStockIssuedToInduceExchangeTransactionShares" xlink:title="lbio_CommonStockIssuedToInduceExchangeTransactionShares" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockIssuedToInduceExchangeTransactionShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_CommonStockIssuedToInduceExchangeTransactionShares" xml:lang="en-US" id="label_lbio_CommonStockIssuedToInduceExchangeTransactionShares">Number of shares of stock issued to induce exchange transaction during the reporting period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockIssuedToInduceExchangeTransactionShares" xlink:to="label_lbio_CommonStockIssuedToInduceExchangeTransactionShares" xlink:title="Label : lbio_CommonStockIssuedToInduceExchangeTransactionShares to label_lbio_CommonStockIssuedToInduceExchangeTransactionShares" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockIssuedToInduceExchangeTransactionShares_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_CommonStockIssuedToInduceExchangeTransactionShares_1" xml:lang="en-US" id="label_lbio_CommonStockIssuedToInduceExchangeTransactionShares_1">Common Stock Issued To Induce Exchange Transaction Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockIssuedToInduceExchangeTransactionShares" xlink:to="label_lbio_CommonStockIssuedToInduceExchangeTransactionShares_1" xlink:title="Label : lbio_CommonStockIssuedToInduceExchangeTransactionShares to label_lbio_CommonStockIssuedToInduceExchangeTransactionShares_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CommonStockIssuedToInduceExchangeTransactionShares_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_CommonStockIssuedToInduceExchangeTransactionShares_2" xml:lang="en-US" id="label_lbio_CommonStockIssuedToInduceExchangeTransactionShares_2">Common stock issued to induce exchange transaction (Shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CommonStockIssuedToInduceExchangeTransactionShares" xlink:to="label_lbio_CommonStockIssuedToInduceExchangeTransactionShares_2" xlink:title="Label : lbio_CommonStockIssuedToInduceExchangeTransactionShares to label_lbio_CommonStockIssuedToInduceExchangeTransactionShares_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_StockIssuedDuringPeriodValueToDirectors" xlink:label="lbio_StockIssuedDuringPeriodValueToDirectors" xlink:title="lbio_StockIssuedDuringPeriodValueToDirectors" />
    <link:label xlink:type="resource" xlink:label="label_lbio_StockIssuedDuringPeriodValueToDirectors" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_StockIssuedDuringPeriodValueToDirectors" xml:lang="en-US" id="label_lbio_StockIssuedDuringPeriodValueToDirectors">Value of stock issued during period to directors for services rendered.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_StockIssuedDuringPeriodValueToDirectors" xlink:to="label_lbio_StockIssuedDuringPeriodValueToDirectors" xlink:title="Label : lbio_StockIssuedDuringPeriodValueToDirectors to label_lbio_StockIssuedDuringPeriodValueToDirectors" />
    <link:label xlink:type="resource" xlink:label="label_lbio_StockIssuedDuringPeriodValueToDirectors_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_StockIssuedDuringPeriodValueToDirectors_1" xml:lang="en-US" id="label_lbio_StockIssuedDuringPeriodValueToDirectors_1">Stock Issued During Period Value To Directors</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_StockIssuedDuringPeriodValueToDirectors" xlink:to="label_lbio_StockIssuedDuringPeriodValueToDirectors_1" xlink:title="Label : lbio_StockIssuedDuringPeriodValueToDirectors to label_lbio_StockIssuedDuringPeriodValueToDirectors_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_StockIssuedDuringPeriodValueToDirectors_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_StockIssuedDuringPeriodValueToDirectors_2" xml:lang="en-US" id="label_lbio_StockIssuedDuringPeriodValueToDirectors_2">Common stock issued to directors</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_StockIssuedDuringPeriodValueToDirectors" xlink:to="label_lbio_StockIssuedDuringPeriodValueToDirectors_2" xlink:title="Label : lbio_StockIssuedDuringPeriodValueToDirectors to label_lbio_StockIssuedDuringPeriodValueToDirectors_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_StockIssuedDuringPeriodSharesToDirectors" xlink:label="lbio_StockIssuedDuringPeriodSharesToDirectors" xlink:title="lbio_StockIssuedDuringPeriodSharesToDirectors" />
    <link:label xlink:type="resource" xlink:label="label_lbio_StockIssuedDuringPeriodSharesToDirectors" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_StockIssuedDuringPeriodSharesToDirectors" xml:lang="en-US" id="label_lbio_StockIssuedDuringPeriodSharesToDirectors">Number of shares of stock issued during period to directors for services rendered.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_StockIssuedDuringPeriodSharesToDirectors" xlink:to="label_lbio_StockIssuedDuringPeriodSharesToDirectors" xlink:title="Label : lbio_StockIssuedDuringPeriodSharesToDirectors to label_lbio_StockIssuedDuringPeriodSharesToDirectors" />
    <link:label xlink:type="resource" xlink:label="label_lbio_StockIssuedDuringPeriodSharesToDirectors_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_StockIssuedDuringPeriodSharesToDirectors_1" xml:lang="en-US" id="label_lbio_StockIssuedDuringPeriodSharesToDirectors_1">Stock Issued During Period Shares To Directors</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_StockIssuedDuringPeriodSharesToDirectors" xlink:to="label_lbio_StockIssuedDuringPeriodSharesToDirectors_1" xlink:title="Label : lbio_StockIssuedDuringPeriodSharesToDirectors to label_lbio_StockIssuedDuringPeriodSharesToDirectors_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_StockIssuedDuringPeriodSharesToDirectors_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_StockIssuedDuringPeriodSharesToDirectors_2" xml:lang="en-US" id="label_lbio_StockIssuedDuringPeriodSharesToDirectors_2">Common stock issued to directors (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_StockIssuedDuringPeriodSharesToDirectors" xlink:to="label_lbio_StockIssuedDuringPeriodSharesToDirectors_2" xlink:title="Label : lbio_StockIssuedDuringPeriodSharesToDirectors to label_lbio_StockIssuedDuringPeriodSharesToDirectors_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PreferredStockSoldInPrivatePlacementValue" xlink:label="lbio_PreferredStockSoldInPrivatePlacementValue" xlink:title="lbio_PreferredStockSoldInPrivatePlacementValue" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PreferredStockSoldInPrivatePlacementValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_PreferredStockSoldInPrivatePlacementValue" xml:lang="en-US" id="label_lbio_PreferredStockSoldInPrivatePlacementValue">Value of preferred stock sold in private placement net of offering costs.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PreferredStockSoldInPrivatePlacementValue" xlink:to="label_lbio_PreferredStockSoldInPrivatePlacementValue" xlink:title="Label : lbio_PreferredStockSoldInPrivatePlacementValue to label_lbio_PreferredStockSoldInPrivatePlacementValue" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PreferredStockSoldInPrivatePlacementValue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_PreferredStockSoldInPrivatePlacementValue_1" xml:lang="en-US" id="label_lbio_PreferredStockSoldInPrivatePlacementValue_1">Preferred Stock Sold In Private Placement Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PreferredStockSoldInPrivatePlacementValue" xlink:to="label_lbio_PreferredStockSoldInPrivatePlacementValue_1" xlink:title="Label : lbio_PreferredStockSoldInPrivatePlacementValue to label_lbio_PreferredStockSoldInPrivatePlacementValue_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PreferredStockSoldInPrivatePlacementValue_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_PreferredStockSoldInPrivatePlacementValue_2" xml:lang="en-US" id="label_lbio_PreferredStockSoldInPrivatePlacementValue_2">Preferred stock sold in private placement at $2.00 per share, November 2013, net of offering costs of $1,091,240</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PreferredStockSoldInPrivatePlacementValue" xlink:to="label_lbio_PreferredStockSoldInPrivatePlacementValue_2" xlink:title="Label : lbio_PreferredStockSoldInPrivatePlacementValue to label_lbio_PreferredStockSoldInPrivatePlacementValue_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PreferredStockSoldInPrivatePlacementShares" xlink:label="lbio_PreferredStockSoldInPrivatePlacementShares" xlink:title="lbio_PreferredStockSoldInPrivatePlacementShares" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PreferredStockSoldInPrivatePlacementShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_PreferredStockSoldInPrivatePlacementShares" xml:lang="en-US" id="label_lbio_PreferredStockSoldInPrivatePlacementShares">Number of shares of preferred stock sold in private placement net of offering costs.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PreferredStockSoldInPrivatePlacementShares" xlink:to="label_lbio_PreferredStockSoldInPrivatePlacementShares" xlink:title="Label : lbio_PreferredStockSoldInPrivatePlacementShares to label_lbio_PreferredStockSoldInPrivatePlacementShares" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PreferredStockSoldInPrivatePlacementShares_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_PreferredStockSoldInPrivatePlacementShares_1" xml:lang="en-US" id="label_lbio_PreferredStockSoldInPrivatePlacementShares_1">Preferred Stock Sold In Private Placement Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PreferredStockSoldInPrivatePlacementShares" xlink:to="label_lbio_PreferredStockSoldInPrivatePlacementShares_1" xlink:title="Label : lbio_PreferredStockSoldInPrivatePlacementShares to label_lbio_PreferredStockSoldInPrivatePlacementShares_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PreferredStockSoldInPrivatePlacementShares_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_PreferredStockSoldInPrivatePlacementShares_2" xml:lang="en-US" id="label_lbio_PreferredStockSoldInPrivatePlacementShares_2">Preferred stock sold in private placement at $2.00 per share, November 2013, net of offering costs of $1,091,240 (Shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PreferredStockSoldInPrivatePlacementShares" xlink:to="label_lbio_PreferredStockSoldInPrivatePlacementShares_2" xlink:title="Label : lbio_PreferredStockSoldInPrivatePlacementShares to label_lbio_PreferredStockSoldInPrivatePlacementShares_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable" xlink:label="lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable" xlink:title="lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable" />
    <link:label xlink:type="resource" xlink:label="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable" xml:lang="en-US" id="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable">Value of stock issued during period for settlement of payable.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable" xlink:to="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable" xlink:title="Label : lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable to label_lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable" />
    <link:label xlink:type="resource" xlink:label="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable_1" xml:lang="en-US" id="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable_1">Stock Issued During Period Shares For Settlement Of Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable" xlink:to="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable_1" xlink:title="Label : lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable to label_lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable_2" xml:lang="en-US" id="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable_2">Common stock issued for settlement of payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable" xlink:to="label_lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable_2" xlink:title="Label : lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable to label_lbio_StockIssuedDuringPeriodSharesForSettlementOfPayable_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_StockIssuedDuringPeriodValueForSettlementOfPayable" xlink:label="lbio_StockIssuedDuringPeriodValueForSettlementOfPayable" xlink:title="lbio_StockIssuedDuringPeriodValueForSettlementOfPayable" />
    <link:label xlink:type="resource" xlink:label="label_lbio_StockIssuedDuringPeriodValueForSettlementOfPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_StockIssuedDuringPeriodValueForSettlementOfPayable" xml:lang="en-US" id="label_lbio_StockIssuedDuringPeriodValueForSettlementOfPayable">Number of shares of stock issued during period for settlement of payable.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_StockIssuedDuringPeriodValueForSettlementOfPayable" xlink:to="label_lbio_StockIssuedDuringPeriodValueForSettlementOfPayable" xlink:title="Label : lbio_StockIssuedDuringPeriodValueForSettlementOfPayable to label_lbio_StockIssuedDuringPeriodValueForSettlementOfPayable" />
    <link:label xlink:type="resource" xlink:label="label_lbio_StockIssuedDuringPeriodValueForSettlementOfPayable_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_StockIssuedDuringPeriodValueForSettlementOfPayable_1" xml:lang="en-US" id="label_lbio_StockIssuedDuringPeriodValueForSettlementOfPayable_1">Stock Issued During Period Value For Settlement Of Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_StockIssuedDuringPeriodValueForSettlementOfPayable" xlink:to="label_lbio_StockIssuedDuringPeriodValueForSettlementOfPayable_1" xlink:title="Label : lbio_StockIssuedDuringPeriodValueForSettlementOfPayable to label_lbio_StockIssuedDuringPeriodValueForSettlementOfPayable_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_StockIssuedDuringPeriodValueForSettlementOfPayable_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_StockIssuedDuringPeriodValueForSettlementOfPayable_2" xml:lang="en-US" id="label_lbio_StockIssuedDuringPeriodValueForSettlementOfPayable_2">Common stock issued for settlement of payable (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_StockIssuedDuringPeriodValueForSettlementOfPayable" xlink:to="label_lbio_StockIssuedDuringPeriodValueForSettlementOfPayable_2" xlink:title="Label : lbio_StockIssuedDuringPeriodValueForSettlementOfPayable to label_lbio_StockIssuedDuringPeriodValueForSettlementOfPayable_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PercentageOfContractualObligation" xlink:label="lbio_PercentageOfContractualObligation" xlink:title="lbio_PercentageOfContractualObligation" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PercentageOfContractualObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_PercentageOfContractualObligation" xml:lang="en-US" id="label_lbio_PercentageOfContractualObligation">Represents the percentage of contractual obligation incurred during the reporting period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PercentageOfContractualObligation" xlink:to="label_lbio_PercentageOfContractualObligation" xlink:title="Label : lbio_PercentageOfContractualObligation to label_lbio_PercentageOfContractualObligation" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PercentageOfContractualObligation_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_PercentageOfContractualObligation_1" xml:lang="en-US" id="label_lbio_PercentageOfContractualObligation_1">Percentage Of Contractual Obligation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PercentageOfContractualObligation" xlink:to="label_lbio_PercentageOfContractualObligation_1" xlink:title="Label : lbio_PercentageOfContractualObligation to label_lbio_PercentageOfContractualObligation_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" xlink:label="lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" xlink:title="lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" xml:lang="en-US" id="label_lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants">Represents the cash inflow from the issuance of common stock upon conversion of warrants during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" xlink:to="label_lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" xlink:title="Label : lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants to label_lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants_1" xml:lang="en-US" id="label_lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants_1">Proceeds from Issuance of Common Stock Upon Conversion of Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" xlink:to="label_lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants_1" xlink:title="Label : lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants to label_lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants_2" xml:lang="en-US" id="label_lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants_2">Proceeds from issuance of common stock upon conversion of warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" xlink:to="label_lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants_2" xlink:title="Label : lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants to label_lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1" xlink:label="lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1" xlink:title="lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1" xml:lang="en-US" id="label_lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1">Represents the aggregate purchase price of warrants to purchase shares of common stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1" xlink:to="label_lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1" xlink:title="Label : lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1 to label_lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1_1" xml:lang="en-US" id="label_lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1_1">Class of Warrant or Right Aggregate Purchase Price of Warrants or Rights 1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1" xlink:to="label_lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1_1" xlink:title="Label : lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1 to label_lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1_2" xml:lang="en-US" id="label_lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1_2">Aggregate purchase price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1" xlink:to="label_lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1_2" xlink:title="Label : lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1 to label_lbio_ClassOfWarrantOrRightAggregatePurchasePriceOfWarrantsOrRights1_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xlink:title="dei_DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="label_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_DocumentFiscalYearFocus" xml:lang="en-US" id="label_dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="label_dei_DocumentFiscalYearFocus" xlink:title="Label : dei_DocumentFiscalYearFocus to label_dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_AnticipatedBudgetedExpenditures" xlink:label="lbio_AnticipatedBudgetedExpenditures" xlink:title="lbio_AnticipatedBudgetedExpenditures" />
    <link:label xlink:type="resource" xlink:label="label_lbio_AnticipatedBudgetedExpenditures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_AnticipatedBudgetedExpenditures" xml:lang="en-US" id="label_lbio_AnticipatedBudgetedExpenditures">Represents the amount of budgeted expenditures.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_AnticipatedBudgetedExpenditures" xlink:to="label_lbio_AnticipatedBudgetedExpenditures" xlink:title="Label : lbio_AnticipatedBudgetedExpenditures to label_lbio_AnticipatedBudgetedExpenditures" />
    <link:label xlink:type="resource" xlink:label="label_lbio_AnticipatedBudgetedExpenditures_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_AnticipatedBudgetedExpenditures_1" xml:lang="en-US" id="label_lbio_AnticipatedBudgetedExpenditures_1">Anticipated Budgeted Expenditures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_AnticipatedBudgetedExpenditures" xlink:to="label_lbio_AnticipatedBudgetedExpenditures_1" xlink:title="Label : lbio_AnticipatedBudgetedExpenditures to label_lbio_AnticipatedBudgetedExpenditures_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_AnticipatedBudgetedExpenditures_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_AnticipatedBudgetedExpenditures_2" xml:lang="en-US" id="label_lbio_AnticipatedBudgetedExpenditures_2">Anticipated budgeted expenditures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_AnticipatedBudgetedExpenditures" xlink:to="label_lbio_AnticipatedBudgetedExpenditures_2" xlink:title="Label : lbio_AnticipatedBudgetedExpenditures to label_lbio_AnticipatedBudgetedExpenditures_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:title="dei_DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="label_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="label_dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="label_dei_DocumentFiscalPeriodFocus" xlink:title="Label : dei_DocumentFiscalPeriodFocus to label_dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_VestOnSixJanuaryTwoThousandFifteenMember" xlink:label="lbio_VestOnSixJanuaryTwoThousandFifteenMember" xlink:title="lbio_VestOnSixJanuaryTwoThousandFifteenMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_VestOnSixJanuaryTwoThousandFifteenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_VestOnSixJanuaryTwoThousandFifteenMember" xml:lang="en-US" id="label_lbio_VestOnSixJanuaryTwoThousandFifteenMember">Represents the information pertaining to option vest on January 6, 2015.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_VestOnSixJanuaryTwoThousandFifteenMember" xlink:to="label_lbio_VestOnSixJanuaryTwoThousandFifteenMember" xlink:title="Label : lbio_VestOnSixJanuaryTwoThousandFifteenMember to label_lbio_VestOnSixJanuaryTwoThousandFifteenMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_VestOnSixJanuaryTwoThousandFifteenMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_VestOnSixJanuaryTwoThousandFifteenMember_1" xml:lang="en-US" id="label_lbio_VestOnSixJanuaryTwoThousandFifteenMember_1">Vest on Six January Two Thousand Fifteen [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_VestOnSixJanuaryTwoThousandFifteenMember" xlink:to="label_lbio_VestOnSixJanuaryTwoThousandFifteenMember_1" xlink:title="Label : lbio_VestOnSixJanuaryTwoThousandFifteenMember to label_lbio_VestOnSixJanuaryTwoThousandFifteenMember_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_VestOnSixJanuaryTwoThousandFifteenMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_VestOnSixJanuaryTwoThousandFifteenMember_2" xml:lang="en-US" id="label_lbio_VestOnSixJanuaryTwoThousandFifteenMember_2">Vest on January 6, 2015 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_VestOnSixJanuaryTwoThousandFifteenMember" xlink:to="label_lbio_VestOnSixJanuaryTwoThousandFifteenMember_2" xlink:title="Label : lbio_VestOnSixJanuaryTwoThousandFifteenMember to label_lbio_VestOnSixJanuaryTwoThousandFifteenMember_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock" xlink:label="lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock" xlink:title="lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock" xml:lang="en-US" id="label_lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock">Tabular disclosure of estimated useful lives for property, plant and equipment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock" xlink:to="label_lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock" xlink:title="Label : lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock to label_lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock_1" xml:lang="en-US" id="label_lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock_1">Schedule Of Estimated Useful Lives [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock" xlink:to="label_lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock_1" xlink:title="Label : lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock to label_lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock_2" xml:lang="en-US" id="label_lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock_2">Schedule of Estimated Useful Lives</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock" xlink:to="label_lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock_2" xlink:title="Label : lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock to label_lbio_ScheduleOfEstimatedUsefulLivesTableTextBlock_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_MaximumBeneficialOwnershipPercentageByHolder" xlink:label="lbio_MaximumBeneficialOwnershipPercentageByHolder" xlink:title="lbio_MaximumBeneficialOwnershipPercentageByHolder" />
    <link:label xlink:type="resource" xlink:label="label_lbio_MaximumBeneficialOwnershipPercentageByHolder" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_MaximumBeneficialOwnershipPercentageByHolder" xml:lang="en-US" id="label_lbio_MaximumBeneficialOwnershipPercentageByHolder">The maximum beneficial ownership percentage by holder.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_MaximumBeneficialOwnershipPercentageByHolder" xlink:to="label_lbio_MaximumBeneficialOwnershipPercentageByHolder" xlink:title="Label : lbio_MaximumBeneficialOwnershipPercentageByHolder to label_lbio_MaximumBeneficialOwnershipPercentageByHolder" />
    <link:label xlink:type="resource" xlink:label="label_lbio_MaximumBeneficialOwnershipPercentageByHolder_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_MaximumBeneficialOwnershipPercentageByHolder_1" xml:lang="en-US" id="label_lbio_MaximumBeneficialOwnershipPercentageByHolder_1">Maximum Beneficial Ownership Percentage By Holder</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_MaximumBeneficialOwnershipPercentageByHolder" xlink:to="label_lbio_MaximumBeneficialOwnershipPercentageByHolder_1" xlink:title="Label : lbio_MaximumBeneficialOwnershipPercentageByHolder to label_lbio_MaximumBeneficialOwnershipPercentageByHolder_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_MaximumBeneficialOwnershipPercentageByHolder_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_MaximumBeneficialOwnershipPercentageByHolder_2" xml:lang="en-US" id="label_lbio_MaximumBeneficialOwnershipPercentageByHolder_2">Maximum beneficial ownership percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_MaximumBeneficialOwnershipPercentageByHolder" xlink:to="label_lbio_MaximumBeneficialOwnershipPercentageByHolder_2" xlink:title="Label : lbio_MaximumBeneficialOwnershipPercentageByHolder to label_lbio_MaximumBeneficialOwnershipPercentageByHolder_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue" xlink:label="lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue" xlink:title="lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue" />
    <link:label xlink:type="resource" xlink:label="label_lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue" xml:lang="en-US" id="label_lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue">The percentage of fair market value for those possessing more than the maximum beneficial ownership percentage.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue" xlink:to="label_lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue" xlink:title="Label : lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue to label_lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue" />
    <link:label xlink:type="resource" xlink:label="label_lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue_1" xml:lang="en-US" id="label_lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue_1">Maximum Beneficial Ownership Percentage By Holder Percentage Of Fair Market Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue" xlink:to="label_lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue_1" xlink:title="Label : lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue to label_lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue_2" xml:lang="en-US" id="label_lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue_2">Percentage of fair market value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue" xlink:to="label_lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue_2" xlink:title="Label : lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue to label_lbio_MaximumBeneficialOwnershipPercentageByHolderPercentageOfFairMarketValue_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CradaMember" xlink:label="lbio_CradaMember" xlink:title="lbio_CradaMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CradaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_CradaMember" xml:lang="en-US" id="label_lbio_CradaMember">Crada [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CradaMember" xlink:to="label_lbio_CradaMember" xlink:title="Label : lbio_CradaMember to label_lbio_CradaMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_CradaMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_CradaMember_1" xml:lang="en-US" id="label_lbio_CradaMember_1">Crada [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_CradaMember" xlink:to="label_lbio_CradaMember_1" xlink:title="Label : lbio_CradaMember to label_lbio_CradaMember_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_NCIMember" xlink:label="lbio_NCIMember" xlink:title="lbio_NCIMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_NCIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_NCIMember" xml:lang="en-US" id="label_lbio_NCIMember">NCI [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_NCIMember" xlink:to="label_lbio_NCIMember" xlink:title="Label : lbio_NCIMember to label_lbio_NCIMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_NCIMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_NCIMember_1" xml:lang="en-US" id="label_lbio_NCIMember_1">NCI [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_NCIMember" xlink:to="label_lbio_NCIMember_1" xlink:title="Label : lbio_NCIMember to label_lbio_NCIMember_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PerQuarterMember" xlink:label="lbio_PerQuarterMember" xlink:title="lbio_PerQuarterMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PerQuarterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_PerQuarterMember" xml:lang="en-US" id="label_lbio_PerQuarterMember">Per Quarter [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PerQuarterMember" xlink:to="label_lbio_PerQuarterMember" xlink:title="Label : lbio_PerQuarterMember to label_lbio_PerQuarterMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PerQuarterMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_PerQuarterMember_1" xml:lang="en-US" id="label_lbio_PerQuarterMember_1">Per Quarter [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PerQuarterMember" xlink:to="label_lbio_PerQuarterMember_1" xlink:title="Label : lbio_PerQuarterMember to label_lbio_PerQuarterMember_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PerYearMember" xlink:label="lbio_PerYearMember" xlink:title="lbio_PerYearMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PerYearMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_PerYearMember" xml:lang="en-US" id="label_lbio_PerYearMember">Per Year [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PerYearMember" xlink:to="label_lbio_PerYearMember" xlink:title="Label : lbio_PerYearMember to label_lbio_PerYearMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PerYearMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_PerYearMember_1" xml:lang="en-US" id="label_lbio_PerYearMember_1">Per Year [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PerYearMember" xlink:to="label_lbio_PerYearMember_1" xlink:title="Label : lbio_PerYearMember to label_lbio_PerYearMember_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_NIHMember" xlink:label="lbio_NIHMember" xlink:title="lbio_NIHMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_NIHMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_NIHMember" xml:lang="en-US" id="label_lbio_NIHMember">NIH [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_NIHMember" xlink:to="label_lbio_NIHMember" xlink:title="Label : lbio_NIHMember to label_lbio_NIHMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_NIHMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_NIHMember_1" xml:lang="en-US" id="label_lbio_NIHMember_1">NIH [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_NIHMember" xlink:to="label_lbio_NIHMember_1" xlink:title="Label : lbio_NIHMember to label_lbio_NIHMember_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_OvarianCancerMember" xlink:label="lbio_OvarianCancerMember" xlink:title="lbio_OvarianCancerMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_OvarianCancerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_OvarianCancerMember" xml:lang="en-US" id="label_lbio_OvarianCancerMember">Ovarian Cancer [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_OvarianCancerMember" xlink:to="label_lbio_OvarianCancerMember" xlink:title="Label : lbio_OvarianCancerMember to label_lbio_OvarianCancerMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_OvarianCancerMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_OvarianCancerMember_1" xml:lang="en-US" id="label_lbio_OvarianCancerMember_1">Ovarian Cancer [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_OvarianCancerMember" xlink:to="label_lbio_OvarianCancerMember_1" xlink:title="Label : lbio_OvarianCancerMember to label_lbio_OvarianCancerMember_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_BreastCancerMember" xlink:label="lbio_BreastCancerMember" xlink:title="lbio_BreastCancerMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_BreastCancerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_BreastCancerMember" xml:lang="en-US" id="label_lbio_BreastCancerMember">Breast Cancer [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_BreastCancerMember" xlink:to="label_lbio_BreastCancerMember" xlink:title="Label : lbio_BreastCancerMember to label_lbio_BreastCancerMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_BreastCancerMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_BreastCancerMember_1" xml:lang="en-US" id="label_lbio_BreastCancerMember_1">Breast Cancer [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_BreastCancerMember" xlink:to="label_lbio_BreastCancerMember_1" xlink:title="Label : lbio_BreastCancerMember to label_lbio_BreastCancerMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:title="dei_LegalEntityAxis" />
    <link:label xlink:type="resource" xlink:label="label_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_LegalEntityAxis" xml:lang="en-US" id="label_dei_LegalEntityAxis">Legal Entity [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="label_dei_LegalEntityAxis" xlink:title="Label : dei_LegalEntityAxis to label_dei_LegalEntityAxis" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ColorectalCancerMember" xlink:label="lbio_ColorectalCancerMember" xlink:title="lbio_ColorectalCancerMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ColorectalCancerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_ColorectalCancerMember" xml:lang="en-US" id="label_lbio_ColorectalCancerMember">Colorectal Cancer [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ColorectalCancerMember" xlink:to="label_lbio_ColorectalCancerMember" xlink:title="Label : lbio_ColorectalCancerMember to label_lbio_ColorectalCancerMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_ColorectalCancerMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_ColorectalCancerMember_1" xml:lang="en-US" id="label_lbio_ColorectalCancerMember_1">Colorectal Cancer [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_ColorectalCancerMember" xlink:to="label_lbio_ColorectalCancerMember_1" xlink:title="Label : lbio_ColorectalCancerMember to label_lbio_ColorectalCancerMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:title="dei_DocumentType" />
    <link:label xlink:type="resource" xlink:label="label_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_DocumentType" xml:lang="en-US" id="label_dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="label_dei_DocumentType" xlink:title="Label : dei_DocumentType to label_dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_UpfrontLicenseFee" xlink:label="lbio_UpfrontLicenseFee" xlink:title="lbio_UpfrontLicenseFee" />
    <link:label xlink:type="resource" xlink:label="label_lbio_UpfrontLicenseFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_UpfrontLicenseFee" xml:lang="en-US" id="label_lbio_UpfrontLicenseFee">Upfront License Fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_UpfrontLicenseFee" xlink:to="label_lbio_UpfrontLicenseFee" xlink:title="Label : lbio_UpfrontLicenseFee to label_lbio_UpfrontLicenseFee" />
    <link:label xlink:type="resource" xlink:label="label_lbio_UpfrontLicenseFee_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_UpfrontLicenseFee_1" xml:lang="en-US" id="label_lbio_UpfrontLicenseFee_1">Upfront License Fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_UpfrontLicenseFee" xlink:to="label_lbio_UpfrontLicenseFee_1" xlink:title="Label : lbio_UpfrontLicenseFee to label_lbio_UpfrontLicenseFee_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_UpfrontLicenseFee_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_UpfrontLicenseFee_2" xml:lang="en-US" id="label_lbio_UpfrontLicenseFee_2">Upfront license fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_UpfrontLicenseFee" xlink:to="label_lbio_UpfrontLicenseFee_2" xlink:title="Label : lbio_UpfrontLicenseFee to label_lbio_UpfrontLicenseFee_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_MelanomaMember" xlink:label="lbio_MelanomaMember" xlink:title="lbio_MelanomaMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_MelanomaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_MelanomaMember" xml:lang="en-US" id="label_lbio_MelanomaMember">Melanoma [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_MelanomaMember" xlink:to="label_lbio_MelanomaMember" xlink:title="Label : lbio_MelanomaMember to label_lbio_MelanomaMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_MelanomaMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_MelanomaMember_1" xml:lang="en-US" id="label_lbio_MelanomaMember_1">Melanoma [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_MelanomaMember" xlink:to="label_lbio_MelanomaMember_1" xlink:title="Label : lbio_MelanomaMember to label_lbio_MelanomaMember_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_LongTermPurchaseCommitmentPercentage" xlink:label="lbio_LongTermPurchaseCommitmentPercentage" xlink:title="lbio_LongTermPurchaseCommitmentPercentage" />
    <link:label xlink:type="resource" xlink:label="label_lbio_LongTermPurchaseCommitmentPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_LongTermPurchaseCommitmentPercentage" xml:lang="en-US" id="label_lbio_LongTermPurchaseCommitmentPercentage">The percentage of the purchase commitment to be paid upfront.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_LongTermPurchaseCommitmentPercentage" xlink:to="label_lbio_LongTermPurchaseCommitmentPercentage" xlink:title="Label : lbio_LongTermPurchaseCommitmentPercentage to label_lbio_LongTermPurchaseCommitmentPercentage" />
    <link:label xlink:type="resource" xlink:label="label_lbio_LongTermPurchaseCommitmentPercentage_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_LongTermPurchaseCommitmentPercentage_1" xml:lang="en-US" id="label_lbio_LongTermPurchaseCommitmentPercentage_1">Long Term Purchase Commitment Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_LongTermPurchaseCommitmentPercentage" xlink:to="label_lbio_LongTermPurchaseCommitmentPercentage_1" xlink:title="Label : lbio_LongTermPurchaseCommitmentPercentage to label_lbio_LongTermPurchaseCommitmentPercentage_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_LongTermPurchaseCommitmentPercentage_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_LongTermPurchaseCommitmentPercentage_2" xml:lang="en-US" id="label_lbio_LongTermPurchaseCommitmentPercentage_2">Percentage to be paid up-front</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_LongTermPurchaseCommitmentPercentage" xlink:to="label_lbio_LongTermPurchaseCommitmentPercentage_2" xlink:title="Label : lbio_LongTermPurchaseCommitmentPercentage to label_lbio_LongTermPurchaseCommitmentPercentage_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_UnpaidRentMember" xlink:label="lbio_UnpaidRentMember" xlink:title="lbio_UnpaidRentMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_UnpaidRentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_UnpaidRentMember" xml:lang="en-US" id="label_lbio_UnpaidRentMember">Unpaid Rent [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_UnpaidRentMember" xlink:to="label_lbio_UnpaidRentMember" xlink:title="Label : lbio_UnpaidRentMember to label_lbio_UnpaidRentMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_UnpaidRentMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_UnpaidRentMember_1" xml:lang="en-US" id="label_lbio_UnpaidRentMember_1">Unpaid Rent [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_UnpaidRentMember" xlink:to="label_lbio_UnpaidRentMember_1" xlink:title="Label : lbio_UnpaidRentMember to label_lbio_UnpaidRentMember_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_LoanAgreementMember" xlink:label="lbio_LoanAgreementMember" xlink:title="lbio_LoanAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_LoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_LoanAgreementMember" xml:lang="en-US" id="label_lbio_LoanAgreementMember">Loan Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_LoanAgreementMember" xlink:to="label_lbio_LoanAgreementMember" xlink:title="Label : lbio_LoanAgreementMember to label_lbio_LoanAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_LoanAgreementMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_LoanAgreementMember_1" xml:lang="en-US" id="label_lbio_LoanAgreementMember_1">Loan Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_LoanAgreementMember" xlink:to="label_lbio_LoanAgreementMember_1" xlink:title="Label : lbio_LoanAgreementMember to label_lbio_LoanAgreementMember_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_VestingFirstMember" xlink:label="lbio_VestingFirstMember" xlink:title="lbio_VestingFirstMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_VestingFirstMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_VestingFirstMember" xml:lang="en-US" id="label_lbio_VestingFirstMember">Vesting First [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_VestingFirstMember" xlink:to="label_lbio_VestingFirstMember" xlink:title="Label : lbio_VestingFirstMember to label_lbio_VestingFirstMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_VestingFirstMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_VestingFirstMember_1" xml:lang="en-US" id="label_lbio_VestingFirstMember_1">Vesting First [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_VestingFirstMember" xlink:to="label_lbio_VestingFirstMember_1" xlink:title="Label : lbio_VestingFirstMember to label_lbio_VestingFirstMember_1" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PlanOneMember" xlink:label="lbio_PlanOneMember" xlink:title="lbio_PlanOneMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PlanOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_PlanOneMember" xml:lang="en-US" id="label_lbio_PlanOneMember">Plan One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PlanOneMember" xlink:to="label_lbio_PlanOneMember" xlink:title="Label : lbio_PlanOneMember to label_lbio_PlanOneMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PlanOneMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_PlanOneMember_1" xml:lang="en-US" id="label_lbio_PlanOneMember_1">Plan One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PlanOneMember" xlink:to="label_lbio_PlanOneMember_1" xlink:title="Label : lbio_PlanOneMember to label_lbio_PlanOneMember_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PlanOneMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_PlanOneMember_2" xml:lang="en-US" id="label_lbio_PlanOneMember_2">2010 Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PlanOneMember" xlink:to="label_lbio_PlanOneMember_2" xlink:title="Label : lbio_PlanOneMember to label_lbio_PlanOneMember_2" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PlanTwoMember" xlink:label="lbio_PlanTwoMember" xlink:title="lbio_PlanTwoMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PlanTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_lbio_PlanTwoMember" xml:lang="en-US" id="label_lbio_PlanTwoMember">Plan Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PlanTwoMember" xlink:to="label_lbio_PlanTwoMember" xlink:title="Label : lbio_PlanTwoMember to label_lbio_PlanTwoMember" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PlanTwoMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_lbio_PlanTwoMember_1" xml:lang="en-US" id="label_lbio_PlanTwoMember_1">Plan Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PlanTwoMember" xlink:to="label_lbio_PlanTwoMember_1" xlink:title="Label : lbio_PlanTwoMember to label_lbio_PlanTwoMember_1" />
    <link:label xlink:type="resource" xlink:label="label_lbio_PlanTwoMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_lbio_PlanTwoMember_2" xml:lang="en-US" id="label_lbio_PlanTwoMember_2">2014 Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbio_PlanTwoMember" xlink:to="label_lbio_PlanTwoMember_2" xlink:title="Label : lbio_PlanTwoMember to label_lbio_PlanTwoMember_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:title="us-gaap_AccountingPoliciesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccountingPoliciesAbstract" xml:lang="en-US" id="label_us-gaap_AccountingPoliciesAbstract">SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="label_us-gaap_AccountingPoliciesAbstract" xlink:title="Label : us-gaap_AccountingPoliciesAbstract to label_us-gaap_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:title="us-gaap_AccountsPayableRelatedPartiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccountsPayableRelatedPartiesCurrent" xml:lang="en-US" id="label_us-gaap_AccountsPayableRelatedPartiesCurrent">Accounts Payable, Related Parties, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:to="label_us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:title="Label : us-gaap_AccountsPayableRelatedPartiesCurrent to label_us-gaap_AccountsPayableRelatedPartiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccountsPayableRelatedPartiesCurrent_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_AccountsPayableRelatedPartiesCurrent_1" xml:lang="en-US" id="label_us-gaap_AccountsPayableRelatedPartiesCurrent_1">Accrued payable to officers and former directors</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:to="label_us-gaap_AccountsPayableRelatedPartiesCurrent_1" xlink:title="Label : us-gaap_AccountsPayableRelatedPartiesCurrent to label_us-gaap_AccountsPayableRelatedPartiesCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" xlink:title="us-gaap_AccountsPayableCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccountsPayableCurrent" xml:lang="en-US" id="label_us-gaap_AccountsPayableCurrent">Accounts Payable, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="label_us-gaap_AccountsPayableCurrent" xlink:title="Label : us-gaap_AccountsPayableCurrent to label_us-gaap_AccountsPayableCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccountsPayableCurrent_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_AccountsPayableCurrent_1" xml:lang="en-US" id="label_us-gaap_AccountsPayableCurrent_1">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="label_us-gaap_AccountsPayableCurrent_1" xlink:title="Label : us-gaap_AccountsPayableCurrent to label_us-gaap_AccountsPayableCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:title="us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xml:lang="en-US" id="label_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis">Legal Entity of Counterparty, Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:to="label_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:title="Label : us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis to label_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_1" xml:lang="en-US" id="label_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_1">Legal Entity of Counterparty, Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis" xlink:to="label_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_1" xlink:title="Label : us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis to label_us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:title="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xml:lang="en-US" id="label_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="label_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:title="Label : us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments to label_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_1" xml:lang="en-US" id="label_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_1">Amortization of discount on convertible notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="label_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_1" xlink:title="Label : us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments to label_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:title="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xml:lang="en-US" id="label_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent">Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="label_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:title="Label : us-gaap_AccruedLiabilitiesCurrentAndNoncurrent to label_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_1" xml:lang="en-US" id="label_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_1">Accrued compensation payable in shares of stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="label_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_1" xlink:title="Label : us-gaap_AccruedLiabilitiesCurrentAndNoncurrent to label_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:title="us-gaap_AccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccruedLiabilitiesCurrent" xml:lang="en-US" id="label_us-gaap_AccruedLiabilitiesCurrent">Accrued Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="label_us-gaap_AccruedLiabilitiesCurrent" xlink:title="Label : us-gaap_AccruedLiabilitiesCurrent to label_us-gaap_AccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccruedLiabilitiesCurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AccruedLiabilitiesCurrent_1" xml:lang="en-US" id="label_us-gaap_AccruedLiabilitiesCurrent_1">Accrued liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="label_us-gaap_AccruedLiabilitiesCurrent_1" xlink:title="Label : us-gaap_AccruedLiabilitiesCurrent to label_us-gaap_AccruedLiabilitiesCurrent_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccruedLiabilitiesCurrent_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_AccruedLiabilitiesCurrent_2" xml:lang="en-US" id="label_us-gaap_AccruedLiabilitiesCurrent_2">Accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="label_us-gaap_AccruedLiabilitiesCurrent_2" xlink:title="Label : us-gaap_AccruedLiabilitiesCurrent to label_us-gaap_AccruedLiabilitiesCurrent_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="us-gaap_AccruedBonusesCurrent" xlink:title="us-gaap_AccruedBonusesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccruedBonusesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccruedBonusesCurrent" xml:lang="en-US" id="label_us-gaap_AccruedBonusesCurrent">Accrued Bonuses, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedBonusesCurrent" xlink:to="label_us-gaap_AccruedBonusesCurrent" xlink:title="Label : us-gaap_AccruedBonusesCurrent to label_us-gaap_AccruedBonusesCurrent" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US" id="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="Label : us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1" xml:lang="en-US" id="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1">Property and equipment, accumulated depreciation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1" xlink:title="Label : us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2" xml:lang="en-US" id="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2">Less: Accumulated depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2" xlink:title="Label : us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:title="us-gaap_AdditionalPaidInCapital" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AdditionalPaidInCapital" xml:lang="en-US" id="label_us-gaap_AdditionalPaidInCapital">Additional Paid in Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="label_us-gaap_AdditionalPaidInCapital" xlink:title="Label : us-gaap_AdditionalPaidInCapital to label_us-gaap_AdditionalPaidInCapital" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdditionalPaidInCapital_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_AdditionalPaidInCapital_1" xml:lang="en-US" id="label_us-gaap_AdditionalPaidInCapital_1">Additional paid-in capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="label_us-gaap_AdditionalPaidInCapital_1" xlink:title="Label : us-gaap_AdditionalPaidInCapital to label_us-gaap_AdditionalPaidInCapital_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:title="us-gaap_AdditionalPaidInCapitalMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US" id="label_us-gaap_AdditionalPaidInCapitalMember">Additional Paid-in Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="label_us-gaap_AdditionalPaidInCapitalMember" xlink:title="Label : us-gaap_AdditionalPaidInCapitalMember to label_us-gaap_AdditionalPaidInCapitalMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdditionalPaidInCapitalMember_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_AdditionalPaidInCapitalMember_1" xml:lang="en-US" id="label_us-gaap_AdditionalPaidInCapitalMember_1">Additional Paid-In Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="label_us-gaap_AdditionalPaidInCapitalMember_1" xlink:title="Label : us-gaap_AdditionalPaidInCapitalMember to label_us-gaap_AdditionalPaidInCapitalMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:title="us-gaap_AdjustmentOfWarrantsGrantedForServices" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AdjustmentOfWarrantsGrantedForServices" xml:lang="en-US" id="label_us-gaap_AdjustmentOfWarrantsGrantedForServices">Adjustment of Warrants Granted for Services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:to="label_us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:title="Label : us-gaap_AdjustmentOfWarrantsGrantedForServices to label_us-gaap_AdjustmentOfWarrantsGrantedForServices" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentOfWarrantsGrantedForServices_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AdjustmentOfWarrantsGrantedForServices_1" xml:lang="en-US" id="label_us-gaap_AdjustmentOfWarrantsGrantedForServices_1">Fair value of common stock transferred to officer and director</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:to="label_us-gaap_AdjustmentOfWarrantsGrantedForServices_1" xlink:title="Label : us-gaap_AdjustmentOfWarrantsGrantedForServices to label_us-gaap_AdjustmentOfWarrantsGrantedForServices_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xml:lang="en-US" id="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket">Adjustments to Additional Paid in Capital, Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:to="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:title="Label : us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket to label_us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket_1" xml:lang="en-US" id="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket_1">Fair value of vested stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:to="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket_1" xlink:title="Label : us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket to label_us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US" id="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="Label : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1" xml:lang="en-US" id="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:title="Label : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xml:lang="en-US" id="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">Adjustments to Additional Paid in Capital, Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:title="Label : us-gaap_AdjustmentsToAdditionalPaidInCapitalOther to label_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_1" xml:lang="en-US" id="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_1">Deemed dividend on beneficial conversion feature of preferred stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_1" xlink:title="Label : us-gaap_AdjustmentsToAdditionalPaidInCapitalOther to label_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xml:lang="en-US" id="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition">Adjustments to Additional Paid in Capital, Share-based Compensation, Restricted Stock Unit or Restricted Stock Award, Requisite Service Period Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:to="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:title="Label : us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition to label_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_1" xml:lang="en-US" id="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_1">Vesting of restricted shares issued for services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:to="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_1" xlink:title="Label : us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition to label_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AllOtherSegmentsMember" xlink:label="us-gaap_AllOtherSegmentsMember" xlink:title="us-gaap_AllOtherSegmentsMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AllOtherSegmentsMember" xml:lang="en-US" id="label_us-gaap_AllOtherSegmentsMember">Other Segments [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllOtherSegmentsMember" xlink:to="label_us-gaap_AllOtherSegmentsMember" xlink:title="Label : us-gaap_AllOtherSegmentsMember to label_us-gaap_AllOtherSegmentsMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AllocatedShareBasedCompensationExpense" xml:lang="en-US" id="label_us-gaap_AllocatedShareBasedCompensationExpense">Allocated Share-based Compensation Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="label_us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="Label : us-gaap_AllocatedShareBasedCompensationExpense to label_us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AllocatedShareBasedCompensationExpense_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AllocatedShareBasedCompensationExpense_1" xml:lang="en-US" id="label_us-gaap_AllocatedShareBasedCompensationExpense_1">Allocable portion of the fair value that vested recognized as expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="label_us-gaap_AllocatedShareBasedCompensationExpense_1" xlink:title="Label : us-gaap_AllocatedShareBasedCompensationExpense to label_us-gaap_AllocatedShareBasedCompensationExpense_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AllocatedShareBasedCompensationExpense_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_AllocatedShareBasedCompensationExpense_2" xml:lang="en-US" id="label_us-gaap_AllocatedShareBasedCompensationExpense_2">Share-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="label_us-gaap_AllocatedShareBasedCompensationExpense_2" xlink:title="Label : us-gaap_AllocatedShareBasedCompensationExpense to label_us-gaap_AllocatedShareBasedCompensationExpense_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts" xlink:title="us-gaap_AmortizationOfFinancingCosts" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AmortizationOfFinancingCosts" xml:lang="en-US" id="label_us-gaap_AmortizationOfFinancingCosts">Amortization of Financing Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="label_us-gaap_AmortizationOfFinancingCosts" xlink:title="Label : us-gaap_AmortizationOfFinancingCosts to label_us-gaap_AmortizationOfFinancingCosts" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AmortizationOfFinancingCosts_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_AmortizationOfFinancingCosts_1" xml:lang="en-US" id="label_us-gaap_AmortizationOfFinancingCosts_1">Financing costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="label_us-gaap_AmortizationOfFinancingCosts_1" xlink:title="Label : us-gaap_AmortizationOfFinancingCosts to label_us-gaap_AmortizationOfFinancingCosts_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xlink:title="us-gaap_AmortizationOfDebtDiscountPremium" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AmortizationOfDebtDiscountPremium" xml:lang="en-US" id="label_us-gaap_AmortizationOfDebtDiscountPremium">Amortization of Debt Discount (Premium)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="label_us-gaap_AmortizationOfDebtDiscountPremium" xlink:title="Label : us-gaap_AmortizationOfDebtDiscountPremium to label_us-gaap_AmortizationOfDebtDiscountPremium" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AmortizationOfDebtDiscountPremium_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_AmortizationOfDebtDiscountPremium_1" xml:lang="en-US" id="label_us-gaap_AmortizationOfDebtDiscountPremium_1">Amortization of discount on convertible notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="label_us-gaap_AmortizationOfDebtDiscountPremium_1" xlink:title="Label : us-gaap_AmortizationOfDebtDiscountPremium to label_us-gaap_AmortizationOfDebtDiscountPremium_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xml:lang="en-US" id="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">Antidilutive Securities [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="Label : us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xml:lang="en-US" id="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="Label : us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AntidilutiveSecuritiesNameDomain" xml:lang="en-US" id="label_us-gaap_AntidilutiveSecuritiesNameDomain">Antidilutive Securities, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="label_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="Label : us-gaap_AntidilutiveSecuritiesNameDomain to label_us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xml:lang="en-US" id="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="Label : us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount to label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:title="us-gaap_Assets" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_Assets" xml:lang="en-US" id="label_us-gaap_Assets">Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="label_us-gaap_Assets" xlink:title="Label : us-gaap_Assets to label_us-gaap_Assets" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_Assets_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_Assets_1" xml:lang="en-US" id="label_us-gaap_Assets_1">Total Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="label_us-gaap_Assets_1" xlink:title="Label : us-gaap_Assets to label_us-gaap_Assets_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:title="us-gaap_AssetsCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AssetsCurrentAbstract" xml:lang="en-US" id="label_us-gaap_AssetsCurrentAbstract">Assets, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="label_us-gaap_AssetsCurrentAbstract" xlink:title="Label : us-gaap_AssetsCurrentAbstract to label_us-gaap_AssetsCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AssetsCurrentAbstract_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_AssetsCurrentAbstract_1" xml:lang="en-US" id="label_us-gaap_AssetsCurrentAbstract_1">Current Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="label_us-gaap_AssetsCurrentAbstract_1" xlink:title="Label : us-gaap_AssetsCurrentAbstract to label_us-gaap_AssetsCurrentAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" xlink:title="us-gaap_AssetsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AssetsAbstract" xml:lang="en-US" id="label_us-gaap_AssetsAbstract">Assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="label_us-gaap_AssetsAbstract" xlink:title="Label : us-gaap_AssetsAbstract to label_us-gaap_AssetsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AssetsAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AssetsAbstract_1" xml:lang="en-US" id="label_us-gaap_AssetsAbstract_1">ASSETS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="label_us-gaap_AssetsAbstract_1" xlink:title="Label : us-gaap_AssetsAbstract to label_us-gaap_AssetsAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xlink:title="us-gaap_AssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AssetsCurrent" xml:lang="en-US" id="label_us-gaap_AssetsCurrent">Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="label_us-gaap_AssetsCurrent" xlink:title="Label : us-gaap_AssetsCurrent to label_us-gaap_AssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AssetsCurrent_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_AssetsCurrent_1" xml:lang="en-US" id="label_us-gaap_AssetsCurrent_1">Total Current Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="label_us-gaap_AssetsCurrent_1" xlink:title="Label : us-gaap_AssetsCurrent to label_us-gaap_AssetsCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:title="us-gaap_BusinessAcquisitionAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_BusinessAcquisitionAxis" xml:lang="en-US" id="label_us-gaap_BusinessAcquisitionAxis">Business Acquisition [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="label_us-gaap_BusinessAcquisitionAxis" xlink:title="Label : us-gaap_BusinessAcquisitionAxis to label_us-gaap_BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:title="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_BusinessAcquisitionAcquireeDomain" xml:lang="en-US" id="label_us-gaap_BusinessAcquisitionAcquireeDomain">Business Acquisition, Acquiree [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="label_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:title="Label : us-gaap_BusinessAcquisitionAcquireeDomain to label_us-gaap_BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:title="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xml:lang="en-US" id="label_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="label_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:title="Label : us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock to label_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_1" xml:lang="en-US" id="label_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_1">GENERAL ORGANIZATION AND BUSINESS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="label_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_1" xlink:title="Label : us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock to label_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:title="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:title="Label : us-gaap_CashAndCashEquivalentsPolicyTextBlock to label_us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1">Cash and Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1" xlink:title="Label : us-gaap_CashAndCashEquivalentsPolicyTextBlock to label_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:title="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="label_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:title="Label : us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease to label_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_1" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_1">Net Increase (Decrease) In Cash And Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="label_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_1" xlink:title="Label : us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease to label_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsAtCarryingValue">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="label_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="Label : us-gaap_CashAndCashEquivalentsAtCarryingValue to label_us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_1">Cash and Cash Equivalents, End of Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" xlink:title="Label : us-gaap_CashAndCashEquivalentsAtCarryingValue to label_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_2" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_2">Cash and Cash Equivalents, Beginning of Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_2" xlink:title="Label : us-gaap_CashAndCashEquivalentsAtCarryingValue to label_us-gaap_CashAndCashEquivalentsAtCarryingValue_2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_3" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_3">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_3" xlink:title="Label : us-gaap_CashAndCashEquivalentsAtCarryingValue to label_us-gaap_CashAndCashEquivalentsAtCarryingValue_3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="us-gaap_ChiefExecutiveOfficerMember" xlink:title="us-gaap_ChiefExecutiveOfficerMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ChiefExecutiveOfficerMember" xml:lang="en-US" id="label_us-gaap_ChiefExecutiveOfficerMember">Chief Executive Officer [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChiefExecutiveOfficerMember" xlink:to="label_us-gaap_ChiefExecutiveOfficerMember" xlink:title="Label : us-gaap_ChiefExecutiveOfficerMember to label_us-gaap_ChiefExecutiveOfficerMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" xlink:title="us-gaap_ClassOfStockLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ClassOfStockLineItems" xml:lang="en-US" id="label_us-gaap_ClassOfStockLineItems">Class of Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="label_us-gaap_ClassOfStockLineItems" xlink:title="Label : us-gaap_ClassOfStockLineItems to label_us-gaap_ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xml:lang="en-US" id="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="Label : us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 to label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US" id="label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="Label : us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights to label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:title="us-gaap_ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ClassOfStockDomain" xml:lang="en-US" id="label_us-gaap_ClassOfStockDomain">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="label_us-gaap_ClassOfStockDomain" xlink:title="Label : us-gaap_ClassOfStockDomain to label_us-gaap_ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xml:lang="en-US" id="label_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">LICENSE AND COMMITMENTS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="label_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:title="Label : us-gaap_CommitmentsAndContingenciesDisclosureAbstract to label_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:title="us-gaap_CommitmentsAndContingencies" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommitmentsAndContingencies" xml:lang="en-US" id="label_us-gaap_CommitmentsAndContingencies">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="label_us-gaap_CommitmentsAndContingencies" xlink:title="Label : us-gaap_CommitmentsAndContingencies to label_us-gaap_CommitmentsAndContingencies" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommitmentsAndContingencies_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_CommitmentsAndContingencies_1" xml:lang="en-US" id="label_us-gaap_CommitmentsAndContingencies_1">Commitments and contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="label_us-gaap_CommitmentsAndContingencies_1" xlink:title="Label : us-gaap_CommitmentsAndContingencies to label_us-gaap_CommitmentsAndContingencies_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">LICENSE AND COMMITMENTS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="Label : us-gaap_CommitmentsAndContingenciesDisclosureTextBlock to label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:title="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US" id="label_us-gaap_CommonStockParOrStatedValuePerShare">Common Stock, Par or Stated Value Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="label_us-gaap_CommonStockParOrStatedValuePerShare" xlink:title="Label : us-gaap_CommonStockParOrStatedValuePerShare to label_us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockParOrStatedValuePerShare_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_CommonStockParOrStatedValuePerShare_1" xml:lang="en-US" id="label_us-gaap_CommonStockParOrStatedValuePerShare_1">Common stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="label_us-gaap_CommonStockParOrStatedValuePerShare_1" xlink:title="Label : us-gaap_CommonStockParOrStatedValuePerShare to label_us-gaap_CommonStockParOrStatedValuePerShare_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:title="us-gaap_CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommonStockMember" xml:lang="en-US" id="label_us-gaap_CommonStockMember">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="label_us-gaap_CommonStockMember" xlink:title="Label : us-gaap_CommonStockMember to label_us-gaap_CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockMember_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_CommonStockMember_1" xml:lang="en-US" id="label_us-gaap_CommonStockMember_1">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="label_us-gaap_CommonStockMember_1" xlink:title="Label : us-gaap_CommonStockMember to label_us-gaap_CommonStockMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xlink:title="us-gaap_CommonStockValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommonStockValue" xml:lang="en-US" id="label_us-gaap_CommonStockValue">Common Stock, Value, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="label_us-gaap_CommonStockValue" xlink:title="Label : us-gaap_CommonStockValue to label_us-gaap_CommonStockValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockValue_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_CommonStockValue_1" xml:lang="en-US" id="label_us-gaap_CommonStockValue_1">Common stock, $0.000041666 par value; 150,000,000 shares authorized, 44,871,888 and 33,750,188 shares issued and outstanding, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="label_us-gaap_CommonStockValue_1" xlink:title="Label : us-gaap_CommonStockValue to label_us-gaap_CommonStockValue_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" xlink:title="us-gaap_CommonStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommonStockSharesIssued" xml:lang="en-US" id="label_us-gaap_CommonStockSharesIssued">Common Stock, Shares, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="label_us-gaap_CommonStockSharesIssued" xlink:title="Label : us-gaap_CommonStockSharesIssued to label_us-gaap_CommonStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesIssued_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CommonStockSharesIssued_1" xml:lang="en-US" id="label_us-gaap_CommonStockSharesIssued_1">Common stock, shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="label_us-gaap_CommonStockSharesIssued_1" xlink:title="Label : us-gaap_CommonStockSharesIssued to label_us-gaap_CommonStockSharesIssued_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:title="us-gaap_CommonStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US" id="label_us-gaap_CommonStockSharesAuthorized">Common Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="label_us-gaap_CommonStockSharesAuthorized" xlink:title="Label : us-gaap_CommonStockSharesAuthorized to label_us-gaap_CommonStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesAuthorized_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CommonStockSharesAuthorized_1" xml:lang="en-US" id="label_us-gaap_CommonStockSharesAuthorized_1">Common stock, shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="label_us-gaap_CommonStockSharesAuthorized_1" xlink:title="Label : us-gaap_CommonStockSharesAuthorized to label_us-gaap_CommonStockSharesAuthorized_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:title="us-gaap_CommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US" id="label_us-gaap_CommonStockSharesOutstanding">Common Stock, Shares, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="label_us-gaap_CommonStockSharesOutstanding" xlink:title="Label : us-gaap_CommonStockSharesOutstanding to label_us-gaap_CommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesOutstanding_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CommonStockSharesOutstanding_1" xml:lang="en-US" id="label_us-gaap_CommonStockSharesOutstanding_1">Common stock, shares outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="label_us-gaap_CommonStockSharesOutstanding_1" xlink:title="Label : us-gaap_CommonStockSharesOutstanding to label_us-gaap_CommonStockSharesOutstanding_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" xlink:title="us-gaap_ComputerEquipmentMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ComputerEquipmentMember" xml:lang="en-US" id="label_us-gaap_ComputerEquipmentMember">Computer Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="label_us-gaap_ComputerEquipmentMember" xlink:title="Label : us-gaap_ComputerEquipmentMember to label_us-gaap_ComputerEquipmentMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:title="us-gaap_ConcentrationRiskCreditRisk" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ConcentrationRiskCreditRisk" xml:lang="en-US" id="label_us-gaap_ConcentrationRiskCreditRisk">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="label_us-gaap_ConcentrationRiskCreditRisk" xlink:title="Label : us-gaap_ConcentrationRiskCreditRisk to label_us-gaap_ConcentrationRiskCreditRisk" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConcentrationRiskCreditRisk_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ConcentrationRiskCreditRisk_1" xml:lang="en-US" id="label_us-gaap_ConcentrationRiskCreditRisk_1">Concentrations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="label_us-gaap_ConcentrationRiskCreditRisk_1" xlink:title="Label : us-gaap_ConcentrationRiskCreditRisk to label_us-gaap_ConcentrationRiskCreditRisk_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:label="us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:title="us-gaap_ContractualObligationDueInNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ContractualObligationDueInNextTwelveMonths" xml:lang="en-US" id="label_us-gaap_ContractualObligationDueInNextTwelveMonths">Contractual Obligation, Due in Next Twelve Months</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:to="label_us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:title="Label : us-gaap_ContractualObligationDueInNextTwelveMonths to label_us-gaap_ContractualObligationDueInNextTwelveMonths" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ContractualObligation" xlink:label="us-gaap_ContractualObligation" xlink:title="us-gaap_ContractualObligation" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ContractualObligation" xml:lang="en-US" id="label_us-gaap_ContractualObligation">Contractual Obligation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractualObligation" xlink:to="label_us-gaap_ContractualObligation" xlink:title="Label : us-gaap_ContractualObligation to label_us-gaap_ContractualObligation" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConversionOfStockTypeOfStockConverted" xlink:label="us-gaap_ConversionOfStockTypeOfStockConverted" xlink:title="us-gaap_ConversionOfStockTypeOfStockConverted" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConversionOfStockTypeOfStockConverted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ConversionOfStockTypeOfStockConverted" xml:lang="en-US" id="label_us-gaap_ConversionOfStockTypeOfStockConverted">Conversion of Stock, Type of Stock Converted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockTypeOfStockConverted" xlink:to="label_us-gaap_ConversionOfStockTypeOfStockConverted" xlink:title="Label : us-gaap_ConversionOfStockTypeOfStockConverted to label_us-gaap_ConversionOfStockTypeOfStockConverted" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1" xlink:title="us-gaap_ConversionOfStockSharesIssued1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConversionOfStockSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ConversionOfStockSharesIssued1" xml:lang="en-US" id="label_us-gaap_ConversionOfStockSharesIssued1">Conversion of Stock, Shares Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="label_us-gaap_ConversionOfStockSharesIssued1" xlink:title="Label : us-gaap_ConversionOfStockSharesIssued1 to label_us-gaap_ConversionOfStockSharesIssued1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:label="us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:title="us-gaap_ConversionOfStockByUniqueDescriptionAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xml:lang="en-US" id="label_us-gaap_ConversionOfStockByUniqueDescriptionAxis">Stock Conversion Description [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:to="label_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:title="Label : us-gaap_ConversionOfStockByUniqueDescriptionAxis to label_us-gaap_ConversionOfStockByUniqueDescriptionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConversionOfStockDescription" xlink:label="us-gaap_ConversionOfStockDescription" xlink:title="us-gaap_ConversionOfStockDescription" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConversionOfStockDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ConversionOfStockDescription" xml:lang="en-US" id="label_us-gaap_ConversionOfStockDescription">Conversion of Stock, Description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockDescription" xlink:to="label_us-gaap_ConversionOfStockDescription" xlink:title="Label : us-gaap_ConversionOfStockDescription to label_us-gaap_ConversionOfStockDescription" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1" xlink:title="us-gaap_ConversionOfStockSharesConverted1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConversionOfStockSharesConverted1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ConversionOfStockSharesConverted1" xml:lang="en-US" id="label_us-gaap_ConversionOfStockSharesConverted1">Conversion of Stock, Shares Converted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="label_us-gaap_ConversionOfStockSharesConverted1" xlink:title="Label : us-gaap_ConversionOfStockSharesConverted1 to label_us-gaap_ConversionOfStockSharesConverted1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConversionOfStockNameDomain" xlink:label="us-gaap_ConversionOfStockNameDomain" xlink:title="us-gaap_ConversionOfStockNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ConversionOfStockNameDomain" xml:lang="en-US" id="label_us-gaap_ConversionOfStockNameDomain">Conversion of Stock, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockNameDomain" xlink:to="label_us-gaap_ConversionOfStockNameDomain" xlink:title="Label : us-gaap_ConversionOfStockNameDomain to label_us-gaap_ConversionOfStockNameDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:title="us-gaap_ConvertiblePreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ConvertiblePreferredStockMember" xml:lang="en-US" id="label_us-gaap_ConvertiblePreferredStockMember">Convertible Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="label_us-gaap_ConvertiblePreferredStockMember" xlink:title="Label : us-gaap_ConvertiblePreferredStockMember to label_us-gaap_ConvertiblePreferredStockMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CostOfServicesLicensesAndServices" xlink:label="us-gaap_CostOfServicesLicensesAndServices" xlink:title="us-gaap_CostOfServicesLicensesAndServices" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CostOfServicesLicensesAndServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CostOfServicesLicensesAndServices" xml:lang="en-US" id="label_us-gaap_CostOfServicesLicensesAndServices">Cost of Services, Licenses and Services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfServicesLicensesAndServices" xlink:to="label_us-gaap_CostOfServicesLicensesAndServices" xlink:title="Label : us-gaap_CostOfServicesLicensesAndServices to label_us-gaap_CostOfServicesLicensesAndServices" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1" xlink:title="us-gaap_DebtConversionOriginalDebtAmount1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtConversionOriginalDebtAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtConversionOriginalDebtAmount1" xml:lang="en-US" id="label_us-gaap_DebtConversionOriginalDebtAmount1">Debt Conversion, Original Debt, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionOriginalDebtAmount1" xlink:to="label_us-gaap_DebtConversionOriginalDebtAmount1" xlink:title="Label : us-gaap_DebtConversionOriginalDebtAmount1 to label_us-gaap_DebtConversionOriginalDebtAmount1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtConversionOriginalDebtAmount1_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_DebtConversionOriginalDebtAmount1_1" xml:lang="en-US" id="label_us-gaap_DebtConversionOriginalDebtAmount1_1">Common stock issued upon conversion of convertible notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionOriginalDebtAmount1" xlink:to="label_us-gaap_DebtConversionOriginalDebtAmount1_1" xlink:title="Label : us-gaap_DebtConversionOriginalDebtAmount1 to label_us-gaap_DebtConversionOriginalDebtAmount1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:title="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xml:lang="en-US" id="label_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="label_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:title="Label : us-gaap_DebtConversionConvertedInstrumentSharesIssued1 to label_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:title="us-gaap_DebtConversionByUniqueDescriptionAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtConversionByUniqueDescriptionAxis" xml:lang="en-US" id="label_us-gaap_DebtConversionByUniqueDescriptionAxis">Debt Conversion Description [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="label_us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:title="Label : us-gaap_DebtConversionByUniqueDescriptionAxis to label_us-gaap_DebtConversionByUniqueDescriptionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:title="us-gaap_DebtDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtDisclosureAbstract" xml:lang="en-US" id="label_us-gaap_DebtDisclosureAbstract">Debt Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="label_us-gaap_DebtDisclosureAbstract" xlink:title="Label : us-gaap_DebtDisclosureAbstract to label_us-gaap_DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentDecreaseForgiveness" xlink:label="us-gaap_DebtInstrumentDecreaseForgiveness" xlink:title="us-gaap_DebtInstrumentDecreaseForgiveness" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentDecreaseForgiveness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtInstrumentDecreaseForgiveness" xml:lang="en-US" id="label_us-gaap_DebtInstrumentDecreaseForgiveness">Debt Instrument, Decrease, Forgiveness</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDecreaseForgiveness" xlink:to="label_us-gaap_DebtInstrumentDecreaseForgiveness" xlink:title="Label : us-gaap_DebtInstrumentDecreaseForgiveness to label_us-gaap_DebtInstrumentDecreaseForgiveness" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentDecreaseForgiveness_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DebtInstrumentDecreaseForgiveness_1" xml:lang="en-US" id="label_us-gaap_DebtInstrumentDecreaseForgiveness_1">Forgiveness of debt by director, treated as contribution of capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDecreaseForgiveness" xlink:to="label_us-gaap_DebtInstrumentDecreaseForgiveness_1" xlink:title="Label : us-gaap_DebtInstrumentDecreaseForgiveness to label_us-gaap_DebtInstrumentDecreaseForgiveness_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:title="us-gaap_DebtConversionConvertedInstrumentAmount1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtConversionConvertedInstrumentAmount1" xml:lang="en-US" id="label_us-gaap_DebtConversionConvertedInstrumentAmount1">Debt Conversion, Converted Instrument, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="label_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:title="Label : us-gaap_DebtConversionConvertedInstrumentAmount1 to label_us-gaap_DebtConversionConvertedInstrumentAmount1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtConversionConvertedInstrumentAmount1_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_DebtConversionConvertedInstrumentAmount1_1" xml:lang="en-US" id="label_us-gaap_DebtConversionConvertedInstrumentAmount1_1">Common stock issued upon conversion of accrued interest and penalty</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="label_us-gaap_DebtConversionConvertedInstrumentAmount1_1" xlink:title="Label : us-gaap_DebtConversionConvertedInstrumentAmount1 to label_us-gaap_DebtConversionConvertedInstrumentAmount1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:title="us-gaap_DebtDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_DebtDisclosureTextBlock">Debt Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="label_us-gaap_DebtDisclosureTextBlock" xlink:title="Label : us-gaap_DebtDisclosureTextBlock to label_us-gaap_DebtDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DebtDisclosureTextBlock_1" xml:lang="en-US" id="label_us-gaap_DebtDisclosureTextBlock_1">Debt Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="label_us-gaap_DebtDisclosureTextBlock_1" xlink:title="Label : us-gaap_DebtDisclosureTextBlock to label_us-gaap_DebtDisclosureTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtConversionNameDomain" xlink:label="us-gaap_DebtConversionNameDomain" xlink:title="us-gaap_DebtConversionNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtConversionNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtConversionNameDomain" xml:lang="en-US" id="label_us-gaap_DebtConversionNameDomain">Debt Conversion, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionNameDomain" xlink:to="label_us-gaap_DebtConversionNameDomain" xlink:title="Label : us-gaap_DebtConversionNameDomain to label_us-gaap_DebtConversionNameDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:title="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtInstrumentConvertibleConversionPrice1" xml:lang="en-US" id="label_us-gaap_DebtInstrumentConvertibleConversionPrice1">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="label_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:title="Label : us-gaap_DebtInstrumentConvertibleConversionPrice1 to label_us-gaap_DebtInstrumentConvertibleConversionPrice1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentConvertibleConversionPrice1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DebtInstrumentConvertibleConversionPrice1_1" xml:lang="en-US" id="label_us-gaap_DebtInstrumentConvertibleConversionPrice1_1">Conversion price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="label_us-gaap_DebtInstrumentConvertibleConversionPrice1_1" xlink:title="Label : us-gaap_DebtInstrumentConvertibleConversionPrice1 to label_us-gaap_DebtInstrumentConvertibleConversionPrice1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:title="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtInstrumentInterestRateStatedPercentage" xml:lang="en-US" id="label_us-gaap_DebtInstrumentInterestRateStatedPercentage">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="label_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:title="Label : us-gaap_DebtInstrumentInterestRateStatedPercentage to label_us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:title="us-gaap_DeferredTaxAssetsNet" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredTaxAssetsNet" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsNet">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="label_us-gaap_DeferredTaxAssetsNet" xlink:title="Label : us-gaap_DeferredTaxAssetsNet to label_us-gaap_DeferredTaxAssetsNet" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsNet_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_DeferredTaxAssetsNet_1" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsNet_1">Net deferred income tax asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="label_us-gaap_DeferredTaxAssetsNet_1" xlink:title="Label : us-gaap_DeferredTaxAssetsNet to label_us-gaap_DeferredTaxAssetsNet_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract" xlink:title="us-gaap_DeferredTaxAssetsNetAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredTaxAssetsNetAbstract" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsNetAbstract">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="label_us-gaap_DeferredTaxAssetsNetAbstract" xlink:title="Label : us-gaap_DeferredTaxAssetsNetAbstract to label_us-gaap_DeferredTaxAssetsNetAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsNetAbstract_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_DeferredTaxAssetsNetAbstract_1" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsNetAbstract_1">Deferred income tax asset:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="label_us-gaap_DeferredTaxAssetsNetAbstract_1" xlink:title="Label : us-gaap_DeferredTaxAssetsNetAbstract to label_us-gaap_DeferredTaxAssetsNetAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="Label : us-gaap_DeferredTaxAssetsOperatingLossCarryforwards to label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1">Net operating loss carry forward</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1" xlink:title="Label : us-gaap_DeferredTaxAssetsOperatingLossCarryforwards to label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:title="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredTaxAssetsValuationAllowance" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsValuationAllowance">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="label_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:title="Label : us-gaap_DeferredTaxAssetsValuationAllowance to label_us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsValuationAllowance_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_DeferredTaxAssetsValuationAllowance_1" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsValuationAllowance_1">Valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="label_us-gaap_DeferredTaxAssetsValuationAllowance_1" xlink:title="Label : us-gaap_DeferredTaxAssetsValuationAllowance to label_us-gaap_DeferredTaxAssetsValuationAllowance_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:label="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:title="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xml:lang="en-US" id="label_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="label_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:title="Label : us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent to label_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_1" xml:lang="en-US" id="label_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_1">Accrued compensation payable in shares of stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="label_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_1" xlink:title="Label : us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent to label_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Deposits" xlink:label="us-gaap_Deposits" xlink:title="us-gaap_Deposits" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_Deposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_Deposits" xml:lang="en-US" id="label_us-gaap_Deposits">Deposits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Deposits" xlink:to="label_us-gaap_Deposits" xlink:title="Label : us-gaap_Deposits to label_us-gaap_Deposits" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_Deposits_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_Deposits_1" xml:lang="en-US" id="label_us-gaap_Deposits_1">Deposits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Deposits" xlink:to="label_us-gaap_Deposits_1" xlink:title="Label : us-gaap_Deposits to label_us-gaap_Deposits_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" xlink:title="us-gaap_DepreciationAndAmortization" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DepreciationAndAmortization" xml:lang="en-US" id="label_us-gaap_DepreciationAndAmortization">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="label_us-gaap_DepreciationAndAmortization" xlink:title="Label : us-gaap_DepreciationAndAmortization to label_us-gaap_DepreciationAndAmortization" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DepreciationAndAmortization_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_DepreciationAndAmortization_1" xml:lang="en-US" id="label_us-gaap_DepreciationAndAmortization_1">Depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="label_us-gaap_DepreciationAndAmortization_1" xlink:title="Label : us-gaap_DepreciationAndAmortization to label_us-gaap_DepreciationAndAmortization_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" xlink:title="us-gaap_Depreciation" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_Depreciation" xml:lang="en-US" id="label_us-gaap_Depreciation">Depreciation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="label_us-gaap_Depreciation" xlink:title="Label : us-gaap_Depreciation to label_us-gaap_Depreciation" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:label="us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:title="us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xml:lang="en-US" id="label_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="label_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:title="Label : us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet to label_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_1" xml:lang="en-US" id="label_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_1">Change in fair value of derivative liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="label_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_1" xlink:title="Label : us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet to label_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" xlink:title="us-gaap_DerivativeInstrumentRiskAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DerivativeInstrumentRiskAxis" xml:lang="en-US" id="label_us-gaap_DerivativeInstrumentRiskAxis">Derivative Instrument [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="label_us-gaap_DerivativeInstrumentRiskAxis" xlink:title="Label : us-gaap_DerivativeInstrumentRiskAxis to label_us-gaap_DerivativeInstrumentRiskAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:title="us-gaap_DerivativeGainLossOnDerivativeNet" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DerivativeGainLossOnDerivativeNet" xml:lang="en-US" id="label_us-gaap_DerivativeGainLossOnDerivativeNet">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="label_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:title="Label : us-gaap_DerivativeGainLossOnDerivativeNet to label_us-gaap_DerivativeGainLossOnDerivativeNet" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DerivativeGainLossOnDerivativeNet_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_DerivativeGainLossOnDerivativeNet_1" xml:lang="en-US" id="label_us-gaap_DerivativeGainLossOnDerivativeNet_1">Change in fair value of derivative liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="label_us-gaap_DerivativeGainLossOnDerivativeNet_1" xlink:title="Label : us-gaap_DerivativeGainLossOnDerivativeNet to label_us-gaap_DerivativeGainLossOnDerivativeNet_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain" xlink:title="us-gaap_DerivativeContractTypeDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DerivativeContractTypeDomain" xml:lang="en-US" id="label_us-gaap_DerivativeContractTypeDomain">Derivative Contract [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="label_us-gaap_DerivativeContractTypeDomain" xlink:title="Label : us-gaap_DerivativeContractTypeDomain to label_us-gaap_DerivativeContractTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock" xlink:title="us-gaap_DerivativesPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DerivativesPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_DerivativesPolicyTextBlock">Derivatives, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="label_us-gaap_DerivativesPolicyTextBlock" xlink:title="Label : us-gaap_DerivativesPolicyTextBlock to label_us-gaap_DerivativesPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DerivativesPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DerivativesPolicyTextBlock_1" xml:lang="en-US" id="label_us-gaap_DerivativesPolicyTextBlock_1">Derivatives, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="label_us-gaap_DerivativesPolicyTextBlock_1" xlink:title="Label : us-gaap_DerivativesPolicyTextBlock to label_us-gaap_DerivativesPolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DirectorMember" xlink:label="us-gaap_DirectorMember" xlink:title="us-gaap_DirectorMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DirectorMember" xml:lang="en-US" id="label_us-gaap_DirectorMember">Director [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DirectorMember" xlink:to="label_us-gaap_DirectorMember" xlink:title="Label : us-gaap_DirectorMember to label_us-gaap_DirectorMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xml:lang="en-US" id="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="Label : us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock to label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1" xml:lang="en-US" id="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1">STOCK OPTIONS AND WARRANTS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1" xlink:title="Label : us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock to label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xml:lang="en-US" id="label_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">STOCK OPTIONS AND WARRANTS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="label_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="Label : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to label_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent" xlink:label="us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent" xlink:title="us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent" xml:lang="en-US" id="label_us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent">Due to Officers or Stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent" xlink:to="label_us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent" xlink:title="Label : us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent to label_us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:title="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xml:lang="en-US" id="label_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">Due to Related Parties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="label_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:title="Label : us-gaap_DueToRelatedPartiesCurrentAndNoncurrent to label_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:title="us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US" id="label_us-gaap_EarningsPerShareBasicAndDiluted">Earnings Per Share, Basic and Diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="label_us-gaap_EarningsPerShareBasicAndDiluted" xlink:title="Label : us-gaap_EarningsPerShareBasicAndDiluted to label_us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EarningsPerShareBasicAndDiluted_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EarningsPerShareBasicAndDiluted_1" xml:lang="en-US" id="label_us-gaap_EarningsPerShareBasicAndDiluted_1">Net Loss Per Share, Basic and Diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="label_us-gaap_EarningsPerShareBasicAndDiluted_1" xlink:title="Label : us-gaap_EarningsPerShareBasicAndDiluted to label_us-gaap_EarningsPerShareBasicAndDiluted_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:title="us-gaap_EarningsPerSharePolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US" id="label_us-gaap_EarningsPerSharePolicyTextBlock">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="label_us-gaap_EarningsPerSharePolicyTextBlock" xlink:title="Label : us-gaap_EarningsPerSharePolicyTextBlock to label_us-gaap_EarningsPerSharePolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EarningsPerSharePolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EarningsPerSharePolicyTextBlock_1" xml:lang="en-US" id="label_us-gaap_EarningsPerSharePolicyTextBlock_1">Net Income (Loss) Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="label_us-gaap_EarningsPerSharePolicyTextBlock_1" xlink:title="Label : us-gaap_EarningsPerSharePolicyTextBlock to label_us-gaap_EarningsPerSharePolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:title="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xml:lang="en-US" id="label_us-gaap_EffectiveIncomeTaxRateContinuingOperations">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="label_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:title="Label : us-gaap_EffectiveIncomeTaxRateContinuingOperations to label_us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1" xml:lang="en-US" id="label_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1">Effective tax rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="label_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1" xlink:title="Label : us-gaap_EffectiveIncomeTaxRateContinuingOperations to label_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xml:lang="en-US" id="label_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="label_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="Label : us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance to label_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_1" xml:lang="en-US" id="label_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_1">Valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="label_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_1" xlink:title="Label : us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance to label_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xml:lang="en-US" id="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="Label : us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate to label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1" xml:lang="en-US" id="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1">Federal Statutory tax rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1" xlink:title="Label : us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate to label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal" xml:lang="en-US" id="label_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal">Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal" xlink:to="label_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal" xlink:title="Label : us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal to label_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal_1" xml:lang="en-US" id="label_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal_1">State tax, net of federal benefit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal" xlink:to="label_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal_1" xlink:title="Label : us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal to label_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:title="us-gaap_EmployeeStockOptionMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EmployeeStockOptionMember" xml:lang="en-US" id="label_us-gaap_EmployeeStockOptionMember">Employee Stock Option [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="label_us-gaap_EmployeeStockOptionMember" xlink:title="Label : us-gaap_EmployeeStockOptionMember to label_us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xml:lang="en-US" id="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="Label : us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions to label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_1" xml:lang="en-US" id="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_1">Unrecognized compensation cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_1" xlink:title="Label : us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions to label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xml:lang="en-US" id="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="Label : us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized to label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1" xml:lang="en-US" id="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1">Unrecognized compensation cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1" xlink:title="Label : us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized to label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xml:lang="en-US" id="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="Label : us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 to label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1" xml:lang="en-US" id="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1">Unrecognized compensation cost, period for recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1" xlink:title="Label : us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 to label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember" xlink:title="us-gaap_EquipmentMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EquipmentMember" xml:lang="en-US" id="label_us-gaap_EquipmentMember">Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="label_us-gaap_EquipmentMember" xlink:title="Label : us-gaap_EquipmentMember to label_us-gaap_EquipmentMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:title="us-gaap_EquityComponentDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EquityComponentDomain" xml:lang="en-US" id="label_us-gaap_EquityComponentDomain">Equity Component [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="label_us-gaap_EquityComponentDomain" xlink:title="Label : us-gaap_EquityComponentDomain to label_us-gaap_EquityComponentDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:title="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueOfFinancialInstrumentsPolicy" xml:lang="en-US" id="label_us-gaap_FairValueOfFinancialInstrumentsPolicy">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="label_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:title="Label : us-gaap_FairValueOfFinancialInstrumentsPolicy to label_us-gaap_FairValueOfFinancialInstrumentsPolicy" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueOfFinancialInstrumentsPolicy_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FairValueOfFinancialInstrumentsPolicy_1" xml:lang="en-US" id="label_us-gaap_FairValueOfFinancialInstrumentsPolicy_1">Fair Value Measurements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="label_us-gaap_FairValueOfFinancialInstrumentsPolicy_1" xlink:title="Label : us-gaap_FairValueOfFinancialInstrumentsPolicy to label_us-gaap_FairValueOfFinancialInstrumentsPolicy_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:title="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xml:lang="en-US" id="label_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="label_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:title="Label : us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill to label_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1" xml:lang="en-US" id="label_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1">Impairment of intangible asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="label_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1" xlink:title="Label : us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill to label_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" xlink:title="us-gaap_IncomeStatementAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeStatementAbstract" xml:lang="en-US" id="label_us-gaap_IncomeStatementAbstract">Condensed Statements of Operations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="label_us-gaap_IncomeStatementAbstract" xlink:title="Label : us-gaap_IncomeStatementAbstract to label_us-gaap_IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:title="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxDisclosureAbstract" xml:lang="en-US" id="label_us-gaap_IncomeTaxDisclosureAbstract">Income Tax Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="label_us-gaap_IncomeTaxDisclosureAbstract" xlink:title="Label : us-gaap_IncomeTaxDisclosureAbstract to label_us-gaap_IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="us-gaap_IncomeTaxContingencyLineItems" xlink:title="us-gaap_IncomeTaxContingencyLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxContingencyLineItems" xml:lang="en-US" id="label_us-gaap_IncomeTaxContingencyLineItems">Income Tax Contingency [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="label_us-gaap_IncomeTaxContingencyLineItems" xlink:title="Label : us-gaap_IncomeTaxContingencyLineItems to label_us-gaap_IncomeTaxContingencyLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="us-gaap_IncomeTaxContingencyTable" xlink:title="us-gaap_IncomeTaxContingencyTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxContingencyTable" xml:lang="en-US" id="label_us-gaap_IncomeTaxContingencyTable">Income Tax Contingency [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxContingencyTable" xlink:to="label_us-gaap_IncomeTaxContingencyTable" xlink:title="Label : us-gaap_IncomeTaxContingencyTable to label_us-gaap_IncomeTaxContingencyTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:title="us-gaap_IncomeTaxDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_IncomeTaxDisclosureTextBlock">Income Tax Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="label_us-gaap_IncomeTaxDisclosureTextBlock" xlink:title="Label : us-gaap_IncomeTaxDisclosureTextBlock to label_us-gaap_IncomeTaxDisclosureTextBlock" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" xlink:title="us-gaap_IncomeTaxesPaid" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxesPaid" xml:lang="en-US" id="label_us-gaap_IncomeTaxesPaid">Income Taxes Paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="label_us-gaap_IncomeTaxesPaid" xlink:title="Label : us-gaap_IncomeTaxesPaid to label_us-gaap_IncomeTaxesPaid" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxesPaid_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncomeTaxesPaid_1" xml:lang="en-US" id="label_us-gaap_IncomeTaxesPaid_1">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="label_us-gaap_IncomeTaxesPaid_1" xlink:title="Label : us-gaap_IncomeTaxesPaid to label_us-gaap_IncomeTaxesPaid_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:label="us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:title="us-gaap_IncreaseDecreaseInDeferredCompensation" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncreaseDecreaseInDeferredCompensation" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInDeferredCompensation">Increase (Decrease) in Deferred Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:to="label_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:title="Label : us-gaap_IncreaseDecreaseInDeferredCompensation to label_us-gaap_IncreaseDecreaseInDeferredCompensation" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInDeferredCompensation_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncreaseDecreaseInDeferredCompensation_1" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInDeferredCompensation_1">Accrued compensation payable in shares of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:to="label_us-gaap_IncreaseDecreaseInDeferredCompensation_1" xlink:title="Label : us-gaap_IncreaseDecreaseInDeferredCompensation to label_us-gaap_IncreaseDecreaseInDeferredCompensation_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:title="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties">Increase (Decrease) in Accounts Payable, Related Parties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:to="label_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:title="Label : us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties to label_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_1" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_1">Accounts payable to officers and former directors</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:to="label_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_1" xlink:title="Label : us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties to label_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:title="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities">Increase (Decrease) in Other Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:to="label_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:title="Label : us-gaap_IncreaseDecreaseInOtherAccruedLiabilities to label_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_1" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_1">Accrued interest and penalty</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:to="label_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_1" xlink:title="Label : us-gaap_IncreaseDecreaseInOtherAccruedLiabilities to label_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="Label : us-gaap_IncreaseDecreaseInOperatingCapitalAbstract to label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1">Changes in assets and liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1" xlink:title="Label : us-gaap_IncreaseDecreaseInOperatingCapitalAbstract to label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:title="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">Increase (Decrease) in Other Accounts Payable and Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="label_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:title="Label : us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities to label_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_1" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_1">Accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="label_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_1" xlink:title="Label : us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities to label_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders" xlink:label="us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders" xlink:title="us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders">Increase (Decrease) in Due to Officers and Stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders" xlink:to="label_us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders" xlink:title="Label : us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders to label_us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders_1" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders_1">Due to director</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders" xlink:to="label_us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders_1" xlink:title="Label : us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders to label_us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:title="us-gaap_IncreaseDecreaseInDueToRelatedParties" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncreaseDecreaseInDueToRelatedParties" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInDueToRelatedParties">Increase (Decrease) in Due to Related Parties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:to="label_us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:title="Label : us-gaap_IncreaseDecreaseInDueToRelatedParties to label_us-gaap_IncreaseDecreaseInDueToRelatedParties" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="Label : us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets to label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1">Prepaid expenses and deposits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1" xlink:title="Label : us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets to label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" xlink:title="us-gaap_InterestExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_InterestExpense" xml:lang="en-US" id="label_us-gaap_InterestExpense">Interest Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="label_us-gaap_InterestExpense" xlink:title="Label : us-gaap_InterestExpense to label_us-gaap_InterestExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestExpense_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_InterestExpense_1" xml:lang="en-US" id="label_us-gaap_InterestExpense_1">Interest expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="label_us-gaap_InterestExpense_1" xlink:title="Label : us-gaap_InterestExpense to label_us-gaap_InterestExpense_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" xlink:title="us-gaap_InterestPaid" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_InterestPaid" xml:lang="en-US" id="label_us-gaap_InterestPaid">Interest Paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="label_us-gaap_InterestPaid" xlink:title="Label : us-gaap_InterestPaid to label_us-gaap_InterestPaid" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestPaid_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_InterestPaid_1" xml:lang="en-US" id="label_us-gaap_InterestPaid_1">Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="label_us-gaap_InterestPaid_1" xlink:title="Label : us-gaap_InterestPaid to label_us-gaap_InterestPaid_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember" xlink:title="us-gaap_InvestmentTypeCategorizationMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_InvestmentTypeCategorizationMember" xml:lang="en-US" id="label_us-gaap_InvestmentTypeCategorizationMember">Investments [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="label_us-gaap_InvestmentTypeCategorizationMember" xlink:title="Label : us-gaap_InvestmentTypeCategorizationMember to label_us-gaap_InvestmentTypeCategorizationMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember" xlink:title="us-gaap_IPOMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IPOMember" xml:lang="en-US" id="label_us-gaap_IPOMember">IPO [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="label_us-gaap_IPOMember" xlink:title="Label : us-gaap_IPOMember to label_us-gaap_IPOMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xml:lang="en-US" id="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">Issuance of Stock and Warrants for Services or Claims</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="Label : us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims to label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_1" xml:lang="en-US" id="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_1">Common stock issued to officer for services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_1" xlink:title="Label : us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims to label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" xlink:title="us-gaap_LongtermDebtTypeAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LongtermDebtTypeAxis" xml:lang="en-US" id="label_us-gaap_LongtermDebtTypeAxis">Long-term Debt, Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="label_us-gaap_LongtermDebtTypeAxis" xlink:title="Label : us-gaap_LongtermDebtTypeAxis to label_us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain" xlink:title="us-gaap_LongtermDebtTypeDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LongtermDebtTypeDomain" xml:lang="en-US" id="label_us-gaap_LongtermDebtTypeDomain">Long-term Debt, Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="label_us-gaap_LongtermDebtTypeDomain" xlink:title="Label : us-gaap_LongtermDebtTypeDomain to label_us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:title="us-gaap_LeaseAndRentalExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LeaseAndRentalExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LeaseAndRentalExpense" xml:lang="en-US" id="label_us-gaap_LeaseAndRentalExpense">Operating Leases, Rent Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="label_us-gaap_LeaseAndRentalExpense" xlink:title="Label : us-gaap_LeaseAndRentalExpense to label_us-gaap_LeaseAndRentalExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LeaseAndRentalExpense_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LeaseAndRentalExpense_1" xml:lang="en-US" id="label_us-gaap_LeaseAndRentalExpense_1">Monthly rent expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="label_us-gaap_LeaseAndRentalExpense_1" xlink:title="Label : us-gaap_LeaseAndRentalExpense to label_us-gaap_LeaseAndRentalExpense_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="us-gaap_LeaseArrangementTypeDomain" xlink:title="us-gaap_LeaseArrangementTypeDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LeaseArrangementTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LeaseArrangementTypeDomain" xml:lang="en-US" id="label_us-gaap_LeaseArrangementTypeDomain">Lease Arrangement, Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseArrangementTypeDomain" xlink:to="label_us-gaap_LeaseArrangementTypeDomain" xlink:title="Label : us-gaap_LeaseArrangementTypeDomain to label_us-gaap_LeaseArrangementTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseArrangementTypeAxis" xlink:label="us-gaap_LeaseArrangementTypeAxis" xlink:title="us-gaap_LeaseArrangementTypeAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LeaseArrangementTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LeaseArrangementTypeAxis" xml:lang="en-US" id="label_us-gaap_LeaseArrangementTypeAxis">Lease Arrangement, Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseArrangementTypeAxis" xlink:to="label_us-gaap_LeaseArrangementTypeAxis" xlink:title="Label : us-gaap_LeaseArrangementTypeAxis to label_us-gaap_LeaseArrangementTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:title="us-gaap_LeaseholdImprovementsMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LeaseholdImprovementsMember" xml:lang="en-US" id="label_us-gaap_LeaseholdImprovementsMember">Leasehold Improvements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="label_us-gaap_LeaseholdImprovementsMember" xlink:title="Label : us-gaap_LeaseholdImprovementsMember to label_us-gaap_LeaseholdImprovementsMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock" xlink:label="us-gaap_LegalMattersAndContingenciesTextBlock" xlink:title="us-gaap_LegalMattersAndContingenciesTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LegalMattersAndContingenciesTextBlock" xml:lang="en-US" id="label_us-gaap_LegalMattersAndContingenciesTextBlock">Legal Matters and Contingencies [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="label_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:title="Label : us-gaap_LegalMattersAndContingenciesTextBlock to label_us-gaap_LegalMattersAndContingenciesTextBlock" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LegalFees" xlink:label="us-gaap_LegalFees" xlink:title="us-gaap_LegalFees" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LegalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LegalFees" xml:lang="en-US" id="label_us-gaap_LegalFees">Legal Fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="label_us-gaap_LegalFees" xlink:title="Label : us-gaap_LegalFees to label_us-gaap_LegalFees" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LegalEntityTypeOfCounterpartyDomain" xlink:label="us-gaap_LegalEntityTypeOfCounterpartyDomain" xlink:title="us-gaap_LegalEntityTypeOfCounterpartyDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LegalEntityTypeOfCounterpartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LegalEntityTypeOfCounterpartyDomain" xml:lang="en-US" id="label_us-gaap_LegalEntityTypeOfCounterpartyDomain">Legal Entity Type of Counterparty [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalEntityTypeOfCounterpartyDomain" xlink:to="label_us-gaap_LegalEntityTypeOfCounterpartyDomain" xlink:title="Label : us-gaap_LegalEntityTypeOfCounterpartyDomain to label_us-gaap_LegalEntityTypeOfCounterpartyDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LegalEntityTypeOfCounterpartyDomain_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_LegalEntityTypeOfCounterpartyDomain_1" xml:lang="en-US" id="label_us-gaap_LegalEntityTypeOfCounterpartyDomain_1">Legal Entity Type of Counterparty [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalEntityTypeOfCounterpartyDomain" xlink:to="label_us-gaap_LegalEntityTypeOfCounterpartyDomain_1" xlink:title="Label : us-gaap_LegalEntityTypeOfCounterpartyDomain to label_us-gaap_LegalEntityTypeOfCounterpartyDomain_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xlink:title="us-gaap_LiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LiabilitiesCurrent" xml:lang="en-US" id="label_us-gaap_LiabilitiesCurrent">Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="label_us-gaap_LiabilitiesCurrent" xlink:title="Label : us-gaap_LiabilitiesCurrent to label_us-gaap_LiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesCurrent_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_LiabilitiesCurrent_1" xml:lang="en-US" id="label_us-gaap_LiabilitiesCurrent_1">Total Current Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="label_us-gaap_LiabilitiesCurrent_1" xlink:title="Label : us-gaap_LiabilitiesCurrent to label_us-gaap_LiabilitiesCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US" id="label_us-gaap_LiabilitiesAndStockholdersEquity">Liabilities and Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="label_us-gaap_LiabilitiesAndStockholdersEquity" xlink:title="Label : us-gaap_LiabilitiesAndStockholdersEquity to label_us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesAndStockholdersEquity_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_LiabilitiesAndStockholdersEquity_1" xml:lang="en-US" id="label_us-gaap_LiabilitiesAndStockholdersEquity_1">Total Liabilities and Stockholders' Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="label_us-gaap_LiabilitiesAndStockholdersEquity_1" xlink:title="Label : us-gaap_LiabilitiesAndStockholdersEquity to label_us-gaap_LiabilitiesAndStockholdersEquity_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:title="us-gaap_LiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US" id="label_us-gaap_LiabilitiesCurrentAbstract">Liabilities, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="label_us-gaap_LiabilitiesCurrentAbstract" xlink:title="Label : us-gaap_LiabilitiesCurrentAbstract to label_us-gaap_LiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesCurrentAbstract_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_LiabilitiesCurrentAbstract_1" xml:lang="en-US" id="label_us-gaap_LiabilitiesCurrentAbstract_1">Current Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="label_us-gaap_LiabilitiesCurrentAbstract_1" xlink:title="Label : us-gaap_LiabilitiesCurrentAbstract to label_us-gaap_LiabilitiesCurrentAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US" id="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract">Liabilities and Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:title="Label : us-gaap_LiabilitiesAndStockholdersEquityAbstract to label_us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1" xml:lang="en-US" id="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1" xlink:title="Label : us-gaap_LiabilitiesAndStockholdersEquityAbstract to label_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LicenseAgreementTermsMember" xlink:label="us-gaap_LicenseAgreementTermsMember" xlink:title="us-gaap_LicenseAgreementTermsMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LicenseAgreementTermsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LicenseAgreementTermsMember" xml:lang="en-US" id="label_us-gaap_LicenseAgreementTermsMember">License Agreement Terms [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicenseAgreementTermsMember" xlink:to="label_us-gaap_LicenseAgreementTermsMember" xlink:title="Label : us-gaap_LicenseAgreementTermsMember to label_us-gaap_LicenseAgreementTermsMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LicenseCosts" xlink:label="us-gaap_LicenseCosts" xlink:title="us-gaap_LicenseCosts" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LicenseCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LicenseCosts" xml:lang="en-US" id="label_us-gaap_LicenseCosts">License Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicenseCosts" xlink:to="label_us-gaap_LicenseCosts" xlink:title="Label : us-gaap_LicenseCosts to label_us-gaap_LicenseCosts" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LicensingAgreementsMember" xlink:label="us-gaap_LicensingAgreementsMember" xlink:title="us-gaap_LicensingAgreementsMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LicensingAgreementsMember" xml:lang="en-US" id="label_us-gaap_LicensingAgreementsMember">Licensing Agreements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicensingAgreementsMember" xlink:to="label_us-gaap_LicensingAgreementsMember" xlink:title="Label : us-gaap_LicensingAgreementsMember to label_us-gaap_LicensingAgreementsMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LicensingAgreementsMember_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_LicensingAgreementsMember_1" xml:lang="en-US" id="label_us-gaap_LicensingAgreementsMember_1">Moffitt License Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicensingAgreementsMember" xlink:to="label_us-gaap_LicensingAgreementsMember_1" xlink:title="Label : us-gaap_LicensingAgreementsMember to label_us-gaap_LicensingAgreementsMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:title="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xml:lang="en-US" id="label_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain">Long-term Purchase Commitment, Category of Item Purchased [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="label_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:title="Label : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to label_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_1" xml:lang="en-US" id="label_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_1">Long-term Purchase Commitment, Category of Item Purchased [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="label_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_1" xlink:title="Label : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to label_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount" xlink:title="us-gaap_LongTermPurchaseCommitmentAmount" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermPurchaseCommitmentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LongTermPurchaseCommitmentAmount" xml:lang="en-US" id="label_us-gaap_LongTermPurchaseCommitmentAmount">Long-term Purchase Commitment, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentAmount" xlink:to="label_us-gaap_LongTermPurchaseCommitmentAmount" xlink:title="Label : us-gaap_LongTermPurchaseCommitmentAmount to label_us-gaap_LongTermPurchaseCommitmentAmount" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermPurchaseCommitmentAmount_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LongTermPurchaseCommitmentAmount_1" xml:lang="en-US" id="label_us-gaap_LongTermPurchaseCommitmentAmount_1">Purchase commitment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentAmount" xlink:to="label_us-gaap_LongTermPurchaseCommitmentAmount_1" xlink:title="Label : us-gaap_LongTermPurchaseCommitmentAmount to label_us-gaap_LongTermPurchaseCommitmentAmount_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:title="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xml:lang="en-US" id="label_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">Category of Item Purchased [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="label_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:title="Label : us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis to label_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_1" xml:lang="en-US" id="label_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_1">Category of Item Purchased [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="label_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_1" xlink:title="Label : us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis to label_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LossContingencyDisclosures" xlink:label="us-gaap_LossContingencyDisclosures" xlink:title="us-gaap_LossContingencyDisclosures" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LossContingencyDisclosures" xml:lang="en-US" id="label_us-gaap_LossContingencyDisclosures">Contingencies Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDisclosures" xlink:to="label_us-gaap_LossContingencyDisclosures" xlink:title="Label : us-gaap_LossContingencyDisclosures to label_us-gaap_LossContingencyDisclosures" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LossContingencyDisclosures_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LossContingencyDisclosures_1" xml:lang="en-US" id="label_us-gaap_LossContingencyDisclosures_1">LEGAL PROCEEDINGS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDisclosures" xlink:to="label_us-gaap_LossContingencyDisclosures_1" xlink:title="Label : us-gaap_LossContingencyDisclosures to label_us-gaap_LossContingencyDisclosures_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="us-gaap_LossContingencyDamagesPaidValue" xlink:title="us-gaap_LossContingencyDamagesPaidValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LossContingencyDamagesPaidValue" xml:lang="en-US" id="label_us-gaap_LossContingencyDamagesPaidValue">Loss Contingency, Damages Paid, Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesPaidValue" xlink:to="label_us-gaap_LossContingencyDamagesPaidValue" xlink:title="Label : us-gaap_LossContingencyDamagesPaidValue to label_us-gaap_LossContingencyDamagesPaidValue" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LossContingencyAbstract" xlink:label="us-gaap_LossContingencyAbstract" xlink:title="us-gaap_LossContingencyAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LossContingencyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LossContingencyAbstract" xml:lang="en-US" id="label_us-gaap_LossContingencyAbstract">LEGAL PROCEEDINGS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyAbstract" xlink:to="label_us-gaap_LossContingencyAbstract" xlink:title="Label : us-gaap_LossContingencyAbstract to label_us-gaap_LossContingencyAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable" xlink:title="us-gaap_LossContingenciesTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LossContingenciesTable" xml:lang="en-US" id="label_us-gaap_LossContingenciesTable">Loss Contingencies [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesTable" xlink:to="label_us-gaap_LossContingenciesTable" xlink:title="Label : us-gaap_LossContingenciesTable to label_us-gaap_LossContingenciesTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="us-gaap_LossContingencyDamagesSoughtValue" xlink:title="us-gaap_LossContingencyDamagesSoughtValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LossContingencyDamagesSoughtValue" xml:lang="en-US" id="label_us-gaap_LossContingencyDamagesSoughtValue">Loss Contingency, Damages Sought, Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesSoughtValue" xlink:to="label_us-gaap_LossContingencyDamagesSoughtValue" xlink:title="Label : us-gaap_LossContingencyDamagesSoughtValue to label_us-gaap_LossContingencyDamagesSoughtValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LossContingencyDamagesSoughtValue_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LossContingencyDamagesSoughtValue_1" xml:lang="en-US" id="label_us-gaap_LossContingencyDamagesSoughtValue_1">Damages sought</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesSoughtValue" xlink:to="label_us-gaap_LossContingencyDamagesSoughtValue_1" xlink:title="Label : us-gaap_LossContingencyDamagesSoughtValue to label_us-gaap_LossContingencyDamagesSoughtValue_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems" xlink:title="us-gaap_LossContingenciesLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LossContingenciesLineItems" xml:lang="en-US" id="label_us-gaap_LossContingenciesLineItems">Loss Contingencies [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="label_us-gaap_LossContingenciesLineItems" xlink:title="Label : us-gaap_LossContingenciesLineItems to label_us-gaap_LossContingenciesLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue" xlink:title="us-gaap_LossContingencyAccrualAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LossContingencyAccrualAtCarryingValue" xml:lang="en-US" id="label_us-gaap_LossContingencyAccrualAtCarryingValue">Loss Contingency Accrual</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="label_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:title="Label : us-gaap_LossContingencyAccrualAtCarryingValue to label_us-gaap_LossContingencyAccrualAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LossContingencyAccrualAtCarryingValue_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LossContingencyAccrualAtCarryingValue_1" xml:lang="en-US" id="label_us-gaap_LossContingencyAccrualAtCarryingValue_1">Accrual for legal settlement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="label_us-gaap_LossContingencyAccrualAtCarryingValue_1" xlink:title="Label : us-gaap_LossContingencyAccrualAtCarryingValue to label_us-gaap_LossContingencyAccrualAtCarryingValue_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:title="us-gaap_LossContingenciesByNatureOfContingencyAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LossContingenciesByNatureOfContingencyAxis" xml:lang="en-US" id="label_us-gaap_LossContingenciesByNatureOfContingencyAxis">Loss Contingency Nature [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="label_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:title="Label : us-gaap_LossContingenciesByNatureOfContingencyAxis to label_us-gaap_LossContingenciesByNatureOfContingencyAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="us-gaap_LossContingencyNatureDomain" xlink:title="us-gaap_LossContingencyNatureDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LossContingencyNatureDomain" xml:lang="en-US" id="label_us-gaap_LossContingencyNatureDomain">Loss Contingency, Nature [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="label_us-gaap_LossContingencyNatureDomain" xlink:title="Label : us-gaap_LossContingencyNatureDomain to label_us-gaap_LossContingencyNatureDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:title="us-gaap_MaximumMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_MaximumMember" xml:lang="en-US" id="label_us-gaap_MaximumMember">Maximum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="label_us-gaap_MaximumMember" xlink:title="Label : us-gaap_MaximumMember to label_us-gaap_MaximumMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:title="us-gaap_MinimumMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_MinimumMember" xml:lang="en-US" id="label_us-gaap_MinimumMember">Minimum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="label_us-gaap_MinimumMember" xlink:title="Label : us-gaap_MinimumMember to label_us-gaap_MinimumMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:title="Label : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1">Cash Flows From Financing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1" xlink:title="Label : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:title="us-gaap_NetIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetIncomeLoss" xml:lang="en-US" id="label_us-gaap_NetIncomeLoss">Net Income (Loss) Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="label_us-gaap_NetIncomeLoss" xlink:title="Label : us-gaap_NetIncomeLoss to label_us-gaap_NetIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetIncomeLoss_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_NetIncomeLoss_1" xml:lang="en-US" id="label_us-gaap_NetIncomeLoss_1">Net Loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="label_us-gaap_NetIncomeLoss_1" xlink:title="Label : us-gaap_NetIncomeLoss to label_us-gaap_NetIncomeLoss_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetIncomeLoss_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_NetIncomeLoss_2" xml:lang="en-US" id="label_us-gaap_NetIncomeLoss_2">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="label_us-gaap_NetIncomeLoss_2" xlink:title="Label : us-gaap_NetIncomeLoss to label_us-gaap_NetIncomeLoss_2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetIncomeLoss_3" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_NetIncomeLoss_3" xml:lang="en-US" id="label_us-gaap_NetIncomeLoss_3">Net Income (Loss) Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="label_us-gaap_NetIncomeLoss_3" xlink:title="Label : us-gaap_NetIncomeLoss to label_us-gaap_NetIncomeLoss_3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:title="Label : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract to label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1">Cash Flows From Operating Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1" xlink:title="Label : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract to label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xml:lang="en-US" id="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="Label : us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic to label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1" xml:lang="en-US" id="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1">Net Loss Attributable to Common Stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1" xlink:title="Label : us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic to label_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:title="Label : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_1" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_1">Net Cash Used In Operating Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_1" xlink:title="Label : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations to label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations">Net Cash Provided by (Used in) Financing Activities, Continuing Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:title="Label : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_1" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_1">Net Cash Provided By Financing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_1" xlink:title="Label : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations to label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">Net Cash Provided by (Used in) Investing Activities, Continuing Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:title="Label : us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations to label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_1" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_1">Net Cash Used In Investing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_1" xlink:title="Label : us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations to label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:title="Label : us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_1" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_1">Cash Flows From Investing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_1" xlink:title="Label : us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInOperatingActivities">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="label_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:title="Label : us-gaap_NetCashProvidedByUsedInOperatingActivities to label_us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="Label : us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock to label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1" xml:lang="en-US" id="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1">Recent Accounting Pronouncements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1" xlink:title="Label : us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock to label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NoncashMergerRelatedCosts" xlink:label="us-gaap_NoncashMergerRelatedCosts" xlink:title="us-gaap_NoncashMergerRelatedCosts" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NoncashMergerRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NoncashMergerRelatedCosts" xml:lang="en-US" id="label_us-gaap_NoncashMergerRelatedCosts">Noncash Merger Related Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashMergerRelatedCosts" xlink:to="label_us-gaap_NoncashMergerRelatedCosts" xlink:title="Label : us-gaap_NoncashMergerRelatedCosts to label_us-gaap_NoncashMergerRelatedCosts" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NoncashMergerRelatedCosts_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_NoncashMergerRelatedCosts_1" xml:lang="en-US" id="label_us-gaap_NoncashMergerRelatedCosts_1">Cost of Lion transaction - related party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashMergerRelatedCosts" xlink:to="label_us-gaap_NoncashMergerRelatedCosts_1" xlink:title="Label : us-gaap_NoncashMergerRelatedCosts to label_us-gaap_NoncashMergerRelatedCosts_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NoncashMergerRelatedCosts_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_NoncashMergerRelatedCosts_2" xml:lang="en-US" id="label_us-gaap_NoncashMergerRelatedCosts_2">Common stock issued for Lion transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashMergerRelatedCosts" xlink:to="label_us-gaap_NoncashMergerRelatedCosts_2" xlink:title="Label : us-gaap_NoncashMergerRelatedCosts to label_us-gaap_NoncashMergerRelatedCosts_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:title="us-gaap_NonoperatingIncomeExpenseAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NonoperatingIncomeExpenseAbstract" xml:lang="en-US" id="label_us-gaap_NonoperatingIncomeExpenseAbstract">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="label_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:title="Label : us-gaap_NonoperatingIncomeExpenseAbstract to label_us-gaap_NonoperatingIncomeExpenseAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NonoperatingIncomeExpenseAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_NonoperatingIncomeExpenseAbstract_1" xml:lang="en-US" id="label_us-gaap_NonoperatingIncomeExpenseAbstract_1">Other income (expense)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="label_us-gaap_NonoperatingIncomeExpenseAbstract_1" xlink:title="Label : us-gaap_NonoperatingIncomeExpenseAbstract to label_us-gaap_NonoperatingIncomeExpenseAbstract_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NonoperatingIncomeExpenseAbstract_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_NonoperatingIncomeExpenseAbstract_2" xml:lang="en-US" id="label_us-gaap_NonoperatingIncomeExpenseAbstract_2">Other income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="label_us-gaap_NonoperatingIncomeExpenseAbstract_2" xlink:title="Label : us-gaap_NonoperatingIncomeExpenseAbstract to label_us-gaap_NonoperatingIncomeExpenseAbstract_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" xlink:title="us-gaap_NotesPayable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NotesPayable" xml:lang="en-US" id="label_us-gaap_NotesPayable">Notes Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="label_us-gaap_NotesPayable" xlink:title="Label : us-gaap_NotesPayable to label_us-gaap_NotesPayable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NotesIssued1" xlink:label="us-gaap_NotesIssued1" xlink:title="us-gaap_NotesIssued1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NotesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NotesIssued1" xml:lang="en-US" id="label_us-gaap_NotesIssued1">Notes Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesIssued1" xlink:to="label_us-gaap_NotesIssued1" xlink:title="Label : us-gaap_NotesIssued1 to label_us-gaap_NotesIssued1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NotesIssued1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_NotesIssued1_1" xml:lang="en-US" id="label_us-gaap_NotesIssued1_1">Derivative liability recorded upon issuance of convertible notes and warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesIssued1" xlink:to="label_us-gaap_NotesIssued1_1" xlink:title="Label : us-gaap_NotesIssued1 to label_us-gaap_NotesIssued1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember" xlink:title="us-gaap_OfficeEquipmentMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OfficeEquipmentMember" xml:lang="en-US" id="label_us-gaap_OfficeEquipmentMember">Office Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="label_us-gaap_OfficeEquipmentMember" xlink:title="Label : us-gaap_OfficeEquipmentMember to label_us-gaap_OfficeEquipmentMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:title="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_1" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_1">2019</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_1" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_2" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_2">2019</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_2" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:title="us-gaap_OperatingExpensesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingExpensesAbstract" xml:lang="en-US" id="label_us-gaap_OperatingExpensesAbstract">Operating Expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="label_us-gaap_OperatingExpensesAbstract" xlink:title="Label : us-gaap_OperatingExpensesAbstract to label_us-gaap_OperatingExpensesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingExpensesAbstract_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_OperatingExpensesAbstract_1" xml:lang="en-US" id="label_us-gaap_OperatingExpensesAbstract_1">Costs and expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="label_us-gaap_OperatingExpensesAbstract_1" xlink:title="Label : us-gaap_OperatingExpensesAbstract to label_us-gaap_OperatingExpensesAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" xlink:title="us-gaap_OperatingExpenses" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingExpenses" xml:lang="en-US" id="label_us-gaap_OperatingExpenses">Operating Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="label_us-gaap_OperatingExpenses" xlink:title="Label : us-gaap_OperatingExpenses to label_us-gaap_OperatingExpenses" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingExpenses_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_OperatingExpenses_1" xml:lang="en-US" id="label_us-gaap_OperatingExpenses_1">Total costs and expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="label_us-gaap_OperatingExpenses_1" xlink:title="Label : us-gaap_OperatingExpenses to label_us-gaap_OperatingExpenses_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:title="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_1" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_1">2018</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_1" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_2" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_2">2018</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_2" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:title="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1">2017</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2">2017</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:title="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1">2016</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_2" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_2">2016</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_2" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xlink:title="us-gaap_OperatingIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingIncomeLoss" xml:lang="en-US" id="label_us-gaap_OperatingIncomeLoss">Operating Income (Loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="label_us-gaap_OperatingIncomeLoss" xlink:title="Label : us-gaap_OperatingIncomeLoss to label_us-gaap_OperatingIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingIncomeLoss_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_OperatingIncomeLoss_1" xml:lang="en-US" id="label_us-gaap_OperatingIncomeLoss_1">Loss from operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="label_us-gaap_OperatingIncomeLoss_1" xlink:title="Label : us-gaap_OperatingIncomeLoss to label_us-gaap_OperatingIncomeLoss_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:title="us-gaap_OperatingCostsAndExpenses" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingCostsAndExpenses" xml:lang="en-US" id="label_us-gaap_OperatingCostsAndExpenses">Operating Costs and Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="label_us-gaap_OperatingCostsAndExpenses" xlink:title="Label : us-gaap_OperatingCostsAndExpenses to label_us-gaap_OperatingCostsAndExpenses" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingCostsAndExpenses_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_OperatingCostsAndExpenses_1" xml:lang="en-US" id="label_us-gaap_OperatingCostsAndExpenses_1">Operating expenses (including $0 and $1,070,707 of non-cash share-based compensation costs)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="label_us-gaap_OperatingCostsAndExpenses_1" xlink:title="Label : us-gaap_OperatingCostsAndExpenses to label_us-gaap_OperatingCostsAndExpenses_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:title="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1">2015</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_2" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_2">2015</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_2" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:title="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">Operating Leases, Future Minimum Payments Due</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDue to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDue to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xml:lang="en-US" id="label_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">GENERAL ORGANIZATION AND BUSINESS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="label_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="Label : us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to label_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCommitmentsTable" xlink:label="us-gaap_OtherCommitmentsTable" xlink:title="us-gaap_OtherCommitmentsTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherCommitmentsTable" xml:lang="en-US" id="label_us-gaap_OtherCommitmentsTable">Other Commitments [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="label_us-gaap_OtherCommitmentsTable" xlink:title="Label : us-gaap_OtherCommitmentsTable to label_us-gaap_OtherCommitmentsTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherCommitmentsTable_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_OtherCommitmentsTable_1" xml:lang="en-US" id="label_us-gaap_OtherCommitmentsTable_1">License And Commitments [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="label_us-gaap_OtherCommitmentsTable_1" xlink:title="Label : us-gaap_OtherCommitmentsTable to label_us-gaap_OtherCommitmentsTable_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="us-gaap_OtherCommitmentsLineItems" xlink:title="us-gaap_OtherCommitmentsLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherCommitmentsLineItems" xml:lang="en-US" id="label_us-gaap_OtherCommitmentsLineItems">Other Commitments [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="label_us-gaap_OtherCommitmentsLineItems" xlink:title="Label : us-gaap_OtherCommitmentsLineItems to label_us-gaap_OtherCommitmentsLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherCommitmentsLineItems_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_OtherCommitmentsLineItems_1" xml:lang="en-US" id="label_us-gaap_OtherCommitmentsLineItems_1">License And Commitments [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="label_us-gaap_OtherCommitmentsLineItems_1" xlink:title="Label : us-gaap_OtherCommitmentsLineItems to label_us-gaap_OtherCommitmentsLineItems_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:title="us-gaap_OtherNonoperatingIncomeExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherNonoperatingIncomeExpense" xml:lang="en-US" id="label_us-gaap_OtherNonoperatingIncomeExpense">Other Nonoperating Income (Expense)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="label_us-gaap_OtherNonoperatingIncomeExpense" xlink:title="Label : us-gaap_OtherNonoperatingIncomeExpense to label_us-gaap_OtherNonoperatingIncomeExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherNonoperatingIncomeExpense_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_OtherNonoperatingIncomeExpense_1" xml:lang="en-US" id="label_us-gaap_OtherNonoperatingIncomeExpense_1">Total other income (expense)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="label_us-gaap_OtherNonoperatingIncomeExpense_1" xlink:title="Label : us-gaap_OtherNonoperatingIncomeExpense to label_us-gaap_OtherNonoperatingIncomeExpense_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherLoansPayable" xlink:label="us-gaap_OtherLoansPayable" xlink:title="us-gaap_OtherLoansPayable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherLoansPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherLoansPayable" xml:lang="en-US" id="label_us-gaap_OtherLoansPayable">Other Loans Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLoansPayable" xlink:to="label_us-gaap_OtherLoansPayable" xlink:title="Label : us-gaap_OtherLoansPayable to label_us-gaap_OtherLoansPayable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherPreferredStockDividendsAndAdjustments" xlink:label="us-gaap_OtherPreferredStockDividendsAndAdjustments" xlink:title="us-gaap_OtherPreferredStockDividendsAndAdjustments" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherPreferredStockDividendsAndAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherPreferredStockDividendsAndAdjustments" xml:lang="en-US" id="label_us-gaap_OtherPreferredStockDividendsAndAdjustments">Other Preferred Stock Dividends and Adjustments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPreferredStockDividendsAndAdjustments" xlink:to="label_us-gaap_OtherPreferredStockDividendsAndAdjustments" xlink:title="Label : us-gaap_OtherPreferredStockDividendsAndAdjustments to label_us-gaap_OtherPreferredStockDividendsAndAdjustments" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherPreferredStockDividendsAndAdjustments_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_OtherPreferredStockDividendsAndAdjustments_1" xml:lang="en-US" id="label_us-gaap_OtherPreferredStockDividendsAndAdjustments_1">Deemed dividend related to beneficial conversion feature of convertible preferred stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPreferredStockDividendsAndAdjustments" xlink:to="label_us-gaap_OtherPreferredStockDividendsAndAdjustments_1" xlink:title="Label : us-gaap_OtherPreferredStockDividendsAndAdjustments to label_us-gaap_OtherPreferredStockDividendsAndAdjustments_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:label="us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:title="us-gaap_PaymentsToFundLongtermLoansToRelatedParties" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xml:lang="en-US" id="label_us-gaap_PaymentsToFundLongtermLoansToRelatedParties">Payments to Fund Long-term Loans to Related Parties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:to="label_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:title="Label : us-gaap_PaymentsToFundLongtermLoansToRelatedParties to label_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_1" xml:lang="en-US" id="label_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_1">Advances to related party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:to="label_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_1" xlink:title="Label : us-gaap_PaymentsToFundLongtermLoansToRelatedParties to label_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsForLegalSettlements" xlink:label="us-gaap_PaymentsForLegalSettlements" xlink:title="us-gaap_PaymentsForLegalSettlements" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PaymentsForLegalSettlements" xml:lang="en-US" id="label_us-gaap_PaymentsForLegalSettlements">Payments for Legal Settlements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForLegalSettlements" xlink:to="label_us-gaap_PaymentsForLegalSettlements" xlink:title="Label : us-gaap_PaymentsForLegalSettlements to label_us-gaap_PaymentsForLegalSettlements" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US" id="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="Label : us-gaap_PaymentsToAcquirePropertyPlantAndEquipment to label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1" xml:lang="en-US" id="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1">Purchases of property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1" xlink:title="Label : us-gaap_PaymentsToAcquirePropertyPlantAndEquipment to label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:title="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PaymentsOfStockIssuanceCosts" xml:lang="en-US" id="label_us-gaap_PaymentsOfStockIssuanceCosts">Payments of Stock Issuance Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="label_us-gaap_PaymentsOfStockIssuanceCosts" xlink:title="Label : us-gaap_PaymentsOfStockIssuanceCosts to label_us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsOfStockIssuanceCosts_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PaymentsOfStockIssuanceCosts_1" xml:lang="en-US" id="label_us-gaap_PaymentsOfStockIssuanceCosts_1">Offering costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="label_us-gaap_PaymentsOfStockIssuanceCosts_1" xlink:title="Label : us-gaap_PaymentsOfStockIssuanceCosts to label_us-gaap_PaymentsOfStockIssuanceCosts_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts" xlink:title="us-gaap_PaymentsOfFinancingCosts" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PaymentsOfFinancingCosts" xml:lang="en-US" id="label_us-gaap_PaymentsOfFinancingCosts">Payments of Financing Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfFinancingCosts" xlink:to="label_us-gaap_PaymentsOfFinancingCosts" xlink:title="Label : us-gaap_PaymentsOfFinancingCosts to label_us-gaap_PaymentsOfFinancingCosts" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToEmployees" xlink:label="us-gaap_PaymentsToEmployees" xlink:title="us-gaap_PaymentsToEmployees" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsToEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PaymentsToEmployees" xml:lang="en-US" id="label_us-gaap_PaymentsToEmployees">Payments to Employees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToEmployees" xlink:to="label_us-gaap_PaymentsToEmployees" xlink:title="Label : us-gaap_PaymentsToEmployees to label_us-gaap_PaymentsToEmployees" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:title="us-gaap_PlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PlanNameDomain" xml:lang="en-US" id="label_us-gaap_PlanNameDomain">Plan Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="label_us-gaap_PlanNameDomain" xlink:title="Label : us-gaap_PlanNameDomain to label_us-gaap_PlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:title="us-gaap_PlanNameAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PlanNameAxis" xml:lang="en-US" id="label_us-gaap_PlanNameAxis">Plan Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="label_us-gaap_PlanNameAxis" xlink:title="Label : us-gaap_PlanNameAxis to label_us-gaap_PlanNameAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:title="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US" id="label_us-gaap_PreferredStockParOrStatedValuePerShare">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="label_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:title="Label : us-gaap_PreferredStockParOrStatedValuePerShare to label_us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockParOrStatedValuePerShare_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_PreferredStockParOrStatedValuePerShare_1" xml:lang="en-US" id="label_us-gaap_PreferredStockParOrStatedValuePerShare_1">Preferred stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="label_us-gaap_PreferredStockParOrStatedValuePerShare_1" xlink:title="Label : us-gaap_PreferredStockParOrStatedValuePerShare to label_us-gaap_PreferredStockParOrStatedValuePerShare_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" xlink:title="us-gaap_PreferredStockValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PreferredStockValue" xml:lang="en-US" id="label_us-gaap_PreferredStockValue">Preferred Stock, Value, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="label_us-gaap_PreferredStockValue" xlink:title="Label : us-gaap_PreferredStockValue to label_us-gaap_PreferredStockValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockValue_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_PreferredStockValue_1" xml:lang="en-US" id="label_us-gaap_PreferredStockValue_1">Preferred stock, $0.001 par value; 50,000,000 shares authorized, 3,694 shares and 5,694 shares issued and outstanding, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="label_us-gaap_PreferredStockValue_1" xlink:title="Label : us-gaap_PreferredStockValue to label_us-gaap_PreferredStockValue_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:title="us-gaap_PreferredStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PreferredStockSharesIssued" xml:lang="en-US" id="label_us-gaap_PreferredStockSharesIssued">Preferred Stock, Shares Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="label_us-gaap_PreferredStockSharesIssued" xlink:title="Label : us-gaap_PreferredStockSharesIssued to label_us-gaap_PreferredStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockSharesIssued_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PreferredStockSharesIssued_1" xml:lang="en-US" id="label_us-gaap_PreferredStockSharesIssued_1">Preferred stock, shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="label_us-gaap_PreferredStockSharesIssued_1" xlink:title="Label : us-gaap_PreferredStockSharesIssued to label_us-gaap_PreferredStockSharesIssued_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:title="us-gaap_PreferredStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US" id="label_us-gaap_PreferredStockSharesAuthorized">Preferred Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="label_us-gaap_PreferredStockSharesAuthorized" xlink:title="Label : us-gaap_PreferredStockSharesAuthorized to label_us-gaap_PreferredStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockSharesAuthorized_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PreferredStockSharesAuthorized_1" xml:lang="en-US" id="label_us-gaap_PreferredStockSharesAuthorized_1">Preferred stock, shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="label_us-gaap_PreferredStockSharesAuthorized_1" xlink:title="Label : us-gaap_PreferredStockSharesAuthorized to label_us-gaap_PreferredStockSharesAuthorized_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:title="us-gaap_PreferredStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US" id="label_us-gaap_PreferredStockSharesOutstanding">Preferred Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="label_us-gaap_PreferredStockSharesOutstanding" xlink:title="Label : us-gaap_PreferredStockSharesOutstanding to label_us-gaap_PreferredStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockSharesOutstanding_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PreferredStockSharesOutstanding_1" xml:lang="en-US" id="label_us-gaap_PreferredStockSharesOutstanding_1">Preferred stock, shares outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="label_us-gaap_PreferredStockSharesOutstanding_1" xlink:title="Label : us-gaap_PreferredStockSharesOutstanding to label_us-gaap_PreferredStockSharesOutstanding_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" xlink:title="us-gaap_PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PreferredStockMember" xml:lang="en-US" id="label_us-gaap_PreferredStockMember">Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="label_us-gaap_PreferredStockMember" xlink:title="Label : us-gaap_PreferredStockMember to label_us-gaap_PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PreferredStockMember_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_PreferredStockMember_1" xml:lang="en-US" id="label_us-gaap_PreferredStockMember_1">Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="label_us-gaap_PreferredStockMember_1" xlink:title="Label : us-gaap_PreferredStockMember to label_us-gaap_PreferredStockMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:title="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US" id="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">Prepaid Expense and Other Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:title="Label : us-gaap_PrepaidExpenseAndOtherAssetsCurrent to label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1" xml:lang="en-US" id="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1">Prepaid expenses and deposits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1" xlink:title="Label : us-gaap_PrepaidExpenseAndOtherAssetsCurrent to label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" xlink:title="us-gaap_PrivatePlacementMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PrivatePlacementMember" xml:lang="en-US" id="label_us-gaap_PrivatePlacementMember">Private Placement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="label_us-gaap_PrivatePlacementMember" xlink:title="Label : us-gaap_PrivatePlacementMember to label_us-gaap_PrivatePlacementMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises" xlink:title="us-gaap_ProceedsFromWarrantExercises" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProceedsFromWarrantExercises" xml:lang="en-US" id="label_us-gaap_ProceedsFromWarrantExercises">Proceeds from Warrant Exercises</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="label_us-gaap_ProceedsFromWarrantExercises" xlink:title="Label : us-gaap_ProceedsFromWarrantExercises to label_us-gaap_ProceedsFromWarrantExercises" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromWarrantExercises_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ProceedsFromWarrantExercises_1" xml:lang="en-US" id="label_us-gaap_ProceedsFromWarrantExercises_1">Proceeds from warrant exercises</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="label_us-gaap_ProceedsFromWarrantExercises_1" xlink:title="Label : us-gaap_ProceedsFromWarrantExercises to label_us-gaap_ProceedsFromWarrantExercises_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromWarrantExercises_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ProceedsFromWarrantExercises_2" xml:lang="en-US" id="label_us-gaap_ProceedsFromWarrantExercises_2">Proceeds from the issuance of common stock upon exercise of warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="label_us-gaap_ProceedsFromWarrantExercises_2" xlink:title="Label : us-gaap_ProceedsFromWarrantExercises to label_us-gaap_ProceedsFromWarrantExercises_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:title="us-gaap_ProceedsFromConvertibleDebt" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProceedsFromConvertibleDebt" xml:lang="en-US" id="label_us-gaap_ProceedsFromConvertibleDebt">Proceeds from Convertible Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="label_us-gaap_ProceedsFromConvertibleDebt" xlink:title="Label : us-gaap_ProceedsFromConvertibleDebt to label_us-gaap_ProceedsFromConvertibleDebt" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromConvertibleDebt_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ProceedsFromConvertibleDebt_1" xml:lang="en-US" id="label_us-gaap_ProceedsFromConvertibleDebt_1">Proceeds from the issuance of convertible notes, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="label_us-gaap_ProceedsFromConvertibleDebt_1" xlink:title="Label : us-gaap_ProceedsFromConvertibleDebt to label_us-gaap_ProceedsFromConvertibleDebt_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:title="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">Proceeds from Issuance or Sale of Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="label_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:title="Label : us-gaap_ProceedsFromIssuanceOrSaleOfEquity to label_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" xlink:title="us-gaap_ProceedsFromRelatedPartyDebt" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProceedsFromRelatedPartyDebt" xml:lang="en-US" id="label_us-gaap_ProceedsFromRelatedPartyDebt">Proceeds from Related Party Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="label_us-gaap_ProceedsFromRelatedPartyDebt" xlink:title="Label : us-gaap_ProceedsFromRelatedPartyDebt to label_us-gaap_ProceedsFromRelatedPartyDebt" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromRelatedPartyDebt_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ProceedsFromRelatedPartyDebt_1" xml:lang="en-US" id="label_us-gaap_ProceedsFromRelatedPartyDebt_1">Due to director</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="label_us-gaap_ProceedsFromRelatedPartyDebt_1" xlink:title="Label : us-gaap_ProceedsFromRelatedPartyDebt to label_us-gaap_ProceedsFromRelatedPartyDebt_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:title="us-gaap_ProceedsFromIssuanceOfSecuredDebt" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOfSecuredDebt">Proceeds from Issuance of Secured Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:to="label_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:title="Label : us-gaap_ProceedsFromIssuanceOfSecuredDebt to label_us-gaap_ProceedsFromIssuanceOfSecuredDebt" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromIssuanceOfSecuredDebt_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ProceedsFromIssuanceOfSecuredDebt_1" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOfSecuredDebt_1">Proceeds from the issuance of secured promissory notes, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:to="label_us-gaap_ProceedsFromIssuanceOfSecuredDebt_1" xlink:title="Label : us-gaap_ProceedsFromIssuanceOfSecuredDebt to label_us-gaap_ProceedsFromIssuanceOfSecuredDebt_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:title="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">Proceeds from Issuance of Preferred Stock and Preference Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="label_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:title="Label : us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock to label_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_1" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_1">Proceeds from the issuance of preferred stock, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="label_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_1" xlink:title="Label : us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock to label_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:title="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">Proceeds from Issuance of Private Placement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="label_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:title="Label : us-gaap_ProceedsFromIssuanceOfPrivatePlacement to label_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProceedsFromIssuanceOfCommonStock" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOfCommonStock">Proceeds from Issuance of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="label_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="Label : us-gaap_ProceedsFromIssuanceOfCommonStock to label_us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromIssuanceOfCommonStock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ProceedsFromIssuanceOfCommonStock_1" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOfCommonStock_1">Proceeds from the issuance of common stock, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="label_us-gaap_ProceedsFromIssuanceOfCommonStock_1" xlink:title="Label : us-gaap_ProceedsFromIssuanceOfCommonStock to label_us-gaap_ProceedsFromIssuanceOfCommonStock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" xlink:title="us-gaap_ProfitLoss" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProfitLoss" xml:lang="en-US" id="label_us-gaap_ProfitLoss">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="label_us-gaap_ProfitLoss" xlink:title="Label : us-gaap_ProfitLoss to label_us-gaap_ProfitLoss" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProfitLoss_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ProfitLoss_1" xml:lang="en-US" id="label_us-gaap_ProfitLoss_1">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="label_us-gaap_ProfitLoss_1" xlink:title="Label : us-gaap_ProfitLoss to label_us-gaap_ProfitLoss_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentPolicyTextBlock to label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1">Property and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentPolicyTextBlock to label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:title="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentUsefulLife" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentUsefulLife">Property, Plant and Equipment, Useful Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="label_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentUsefulLife to label_us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:title="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentGross" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentGross">Property, Plant and Equipment, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="label_us-gaap_PropertyPlantAndEquipmentGross" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentGross to label_us-gaap_PropertyPlantAndEquipmentGross" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:title="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:title="label_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentNet">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="label_us-gaap_PropertyPlantAndEquipmentNet" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentNet to label_us-gaap_PropertyPlantAndEquipmentNet" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentNet_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentNet_1" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentNet_1">Property, Plant and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="label_us-gaap_PropertyPlantAndEquipmentNet_1" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentNet to label_us-gaap_PropertyPlantAndEquipmentNet_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentNet_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_PropertyPlantAndEquipmentNet_2" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentNet_2">Property and equipment, net of accumulated depreciation of $289,672 and $104,223</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="label_us-gaap_PropertyPlantAndEquipmentNet_2" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentNet to label_us-gaap_PropertyPlantAndEquipmentNet_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:title="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">Property, Plant and Equipment, Estimated Useful Lives</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="label_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives to label_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:title="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentAbstract" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentAbstract">Property, Plant and Equipment [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="label_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentAbstract to label_us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:title="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentTextBlock" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentTextBlock">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="label_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentTextBlock to label_us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentTypeDomain" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentTypeDomain">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="label_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentTypeDomain to label_us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentByTypeAxis">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="label_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentByTypeAxis to label_us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock to label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:title="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentLineItems" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentLineItems">Property, Plant and Equipment [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="label_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentLineItems to label_us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:title="us-gaap_RangeAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RangeAxis" xml:lang="en-US" id="label_us-gaap_RangeAxis">Range [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeAxis" xlink:to="label_us-gaap_RangeAxis" xlink:title="Label : us-gaap_RangeAxis to label_us-gaap_RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:title="us-gaap_RangeMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RangeMember" xml:lang="en-US" id="label_us-gaap_RangeMember">Range [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeMember" xlink:to="label_us-gaap_RangeMember" xlink:title="Label : us-gaap_RangeMember to label_us-gaap_RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:title="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">RELATED PARTY TRANSACTIONS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="label_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:title="Label : us-gaap_RelatedPartyTransactionsDisclosureTextBlock to label_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:title="us-gaap_RelatedPartyTransactionLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RelatedPartyTransactionLineItems" xml:lang="en-US" id="label_us-gaap_RelatedPartyTransactionLineItems">Related Party Transaction [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="label_us-gaap_RelatedPartyTransactionLineItems" xlink:title="Label : us-gaap_RelatedPartyTransactionLineItems to label_us-gaap_RelatedPartyTransactionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xml:lang="en-US" id="label_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis">Related Party [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="label_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="Label : us-gaap_RelatedPartyTransactionsByRelatedPartyAxis to label_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xml:lang="en-US" id="label_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1">Related Party [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="label_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:title="Label : us-gaap_RelatedPartyTransactionsByRelatedPartyAxis to label_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xlink:title="us-gaap_RelatedPartyDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RelatedPartyDomain" xml:lang="en-US" id="label_us-gaap_RelatedPartyDomain">Related Party [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="label_us-gaap_RelatedPartyDomain" xlink:title="Label : us-gaap_RelatedPartyDomain to label_us-gaap_RelatedPartyDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RelatedPartyDomain_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_RelatedPartyDomain_1" xml:lang="en-US" id="label_us-gaap_RelatedPartyDomain_1">Related Party [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="label_us-gaap_RelatedPartyDomain_1" xlink:title="Label : us-gaap_RelatedPartyDomain to label_us-gaap_RelatedPartyDomain_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:title="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RelatedPartyTransactionsAbstract" xml:lang="en-US" id="label_us-gaap_RelatedPartyTransactionsAbstract">RELATED PARTY TRANSACTIONS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="label_us-gaap_RelatedPartyTransactionsAbstract" xlink:title="Label : us-gaap_RelatedPartyTransactionsAbstract to label_us-gaap_RelatedPartyTransactionsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementMember" xlink:label="us-gaap_ResearchAndDevelopmentArrangementMember" xlink:title="us-gaap_ResearchAndDevelopmentArrangementMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ResearchAndDevelopmentArrangementMember" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentArrangementMember">Research and Development Arrangement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementMember" xlink:to="label_us-gaap_ResearchAndDevelopmentArrangementMember" xlink:title="Label : us-gaap_ResearchAndDevelopmentArrangementMember to label_us-gaap_ResearchAndDevelopmentArrangementMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentArrangementMember_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ResearchAndDevelopmentArrangementMember_1" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentArrangementMember_1">Research and Development Arrangement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementMember" xlink:to="label_us-gaap_ResearchAndDevelopmentArrangementMember_1" xlink:title="Label : us-gaap_ResearchAndDevelopmentArrangementMember to label_us-gaap_ResearchAndDevelopmentArrangementMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:title="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:title="Label : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis to label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:title="us-gaap_ResearchAndDevelopmentExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ResearchAndDevelopmentExpense" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentExpense">Research and Development Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="label_us-gaap_ResearchAndDevelopmentExpense" xlink:title="Label : us-gaap_ResearchAndDevelopmentExpense to label_us-gaap_ResearchAndDevelopmentExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentExpense_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ResearchAndDevelopmentExpense_1" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentExpense_1">Research and development expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="label_us-gaap_ResearchAndDevelopmentExpense_1" xlink:title="Label : us-gaap_ResearchAndDevelopmentExpense to label_us-gaap_ResearchAndDevelopmentExpense_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentExpense_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ResearchAndDevelopmentExpense_2" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentExpense_2">Research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="label_us-gaap_ResearchAndDevelopmentExpense_2" xlink:title="Label : us-gaap_ResearchAndDevelopmentExpense to label_us-gaap_ResearchAndDevelopmentExpense_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:title="us-gaap_ResearchAndDevelopmentExpensePolicy" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ResearchAndDevelopmentExpensePolicy" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentExpensePolicy">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="label_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:title="Label : us-gaap_ResearchAndDevelopmentExpensePolicy to label_us-gaap_ResearchAndDevelopmentExpensePolicy" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentExpensePolicy_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ResearchAndDevelopmentExpensePolicy_1" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentExpensePolicy_1">Research and Development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="label_us-gaap_ResearchAndDevelopmentExpensePolicy_1" xlink:title="Label : us-gaap_ResearchAndDevelopmentExpensePolicy to label_us-gaap_ResearchAndDevelopmentExpensePolicy_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:title="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:title="Label : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain to label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms" xlink:title="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms">Research and Development Arrangement, Contract to Perform for Others, Description and Terms</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms" xlink:to="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms" xlink:title="Label : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms to label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross" xlink:title="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross">Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross" xlink:to="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross" xlink:title="Label : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross to label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:title="us-gaap_RestrictedStockMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RestrictedStockMember" xml:lang="en-US" id="label_us-gaap_RestrictedStockMember">Restricted Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="label_us-gaap_RestrictedStockMember" xlink:title="Label : us-gaap_RestrictedStockMember to label_us-gaap_RestrictedStockMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RestrictedStockMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_RestrictedStockMember_1" xml:lang="en-US" id="label_us-gaap_RestrictedStockMember_1">Restricted common stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="label_us-gaap_RestrictedStockMember_1" xlink:title="Label : us-gaap_RestrictedStockMember to label_us-gaap_RestrictedStockMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:label="us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:title="us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xml:lang="en-US" id="label_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1">Restructuring and Related Cost, Expected Cost Remaining</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:to="label_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:title="Label : us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1 to label_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:title="us-gaap_RestructuringAndRelatedActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RestructuringAndRelatedActivitiesAbstract" xml:lang="en-US" id="label_us-gaap_RestructuringAndRelatedActivitiesAbstract">Restructuring and Related Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="label_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:title="Label : us-gaap_RestructuringAndRelatedActivitiesAbstract to label_us-gaap_RestructuringAndRelatedActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:title="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="label_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:title="Label : us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock to label_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems" xlink:title="us-gaap_RestructuringCostAndReserveLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RestructuringCostAndReserveLineItems" xml:lang="en-US" id="label_us-gaap_RestructuringCostAndReserveLineItems">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="label_us-gaap_RestructuringCostAndReserveLineItems" xlink:title="Label : us-gaap_RestructuringCostAndReserveLineItems to label_us-gaap_RestructuringCostAndReserveLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US" id="label_us-gaap_RetainedEarningsAccumulatedDeficit">Retained Earnings (Accumulated Deficit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="label_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:title="Label : us-gaap_RetainedEarningsAccumulatedDeficit to label_us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RetainedEarningsAccumulatedDeficit_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_RetainedEarningsAccumulatedDeficit_1" xml:lang="en-US" id="label_us-gaap_RetainedEarningsAccumulatedDeficit_1">Accumulated deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="label_us-gaap_RetainedEarningsAccumulatedDeficit_1" xlink:title="Label : us-gaap_RetainedEarningsAccumulatedDeficit to label_us-gaap_RetainedEarningsAccumulatedDeficit_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" xlink:title="us-gaap_RetainedEarningsMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RetainedEarningsMember" xml:lang="en-US" id="label_us-gaap_RetainedEarningsMember">Retained Earnings [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="label_us-gaap_RetainedEarningsMember" xlink:title="Label : us-gaap_RetainedEarningsMember to label_us-gaap_RetainedEarningsMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RetainedEarningsMember_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_RetainedEarningsMember_1" xml:lang="en-US" id="label_us-gaap_RetainedEarningsMember_1">Accumulated Deficit [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="label_us-gaap_RetainedEarningsMember_1" xlink:title="Label : us-gaap_RetainedEarningsMember to label_us-gaap_RetainedEarningsMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" xlink:title="us-gaap_Revenues" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_Revenues" xml:lang="en-US" id="label_us-gaap_Revenues">Revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="label_us-gaap_Revenues" xlink:title="Label : us-gaap_Revenues to label_us-gaap_Revenues" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_Revenues_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_Revenues_1" xml:lang="en-US" id="label_us-gaap_Revenues_1">Revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="label_us-gaap_Revenues_1" xlink:title="Label : us-gaap_Revenues to label_us-gaap_Revenues_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1">Fair value of options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1">Expected life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_1">Nonvested, fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_1" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">Vested (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1">Exercisable ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2">Exercisable ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3">Exercisable ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1">Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2">Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3">Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:title="us-gaap_SaleOfStockPricePerShare" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SaleOfStockPricePerShare" xml:lang="en-US" id="label_us-gaap_SaleOfStockPricePerShare">Sale of Stock, Price Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="label_us-gaap_SaleOfStockPricePerShare" xlink:title="Label : us-gaap_SaleOfStockPricePerShare to label_us-gaap_SaleOfStockPricePerShare" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SaleOfStockPricePerShare_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SaleOfStockPricePerShare_1" xml:lang="en-US" id="label_us-gaap_SaleOfStockPricePerShare_1">Price per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="label_us-gaap_SaleOfStockPricePerShare_1" xlink:title="Label : us-gaap_SaleOfStockPricePerShare to label_us-gaap_SaleOfStockPricePerShare_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:title="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SaleOfStockNameOfTransactionDomain" xml:lang="en-US" id="label_us-gaap_SaleOfStockNameOfTransactionDomain">Sale of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="label_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:title="Label : us-gaap_SaleOfStockNameOfTransactionDomain to label_us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:title="us-gaap_ScenarioUnspecifiedDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScenarioUnspecifiedDomain" xml:lang="en-US" id="label_us-gaap_ScenarioUnspecifiedDomain">Scenario, Unspecified [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="label_us-gaap_ScenarioUnspecifiedDomain" xlink:title="Label : us-gaap_ScenarioUnspecifiedDomain to label_us-gaap_ScenarioUnspecifiedDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xml:lang="en-US" id="label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="Label : us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">Schedule of Status of Stock Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="Label : us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock to label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="Label : us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock to label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1">Schedule of fair value of each option award estimated on the date of grant using the Black-Scholes option pricing model</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1" xlink:title="Label : us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock to label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="Label : us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock to label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="Label : us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock to label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:title="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="label_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:title="Label : us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock to label_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_1" xml:lang="en-US" id="label_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_1">Schedule of Restricted Stock Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="label_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_1" xlink:title="Label : us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock to label_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:title="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="label_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:title="Label : us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock to label_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_1" xml:lang="en-US" id="label_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_1">Schedule of Minimum Lease Payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="label_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_1" xlink:title="Label : us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock to label_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:title="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="label_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:title="Label : us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock to label_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xml:lang="en-US" id="label_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="label_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="Label : us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to label_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:title="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xml:lang="en-US" id="label_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="label_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:title="Label : us-gaap_ScheduleOfRestructuringAndRelatedCostsTable to label_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xml:lang="en-US" id="label_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable">Property, Plant and Equipment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="label_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="Label : us-gaap_ScheduleOfPropertyPlantAndEquipmentTable to label_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" xlink:title="us-gaap_ScheduleOfStockByClassTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfStockByClassTable" xml:lang="en-US" id="label_us-gaap_ScheduleOfStockByClassTable">Schedule of Stock by Class [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="label_us-gaap_ScheduleOfStockByClassTable" xlink:title="Label : us-gaap_ScheduleOfStockByClassTable to label_us-gaap_ScheduleOfStockByClassTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable" xlink:title="us-gaap_ScheduleOfShortTermDebtTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfShortTermDebtTable" xml:lang="en-US" id="label_us-gaap_ScheduleOfShortTermDebtTable">Schedule of Short-term Debt [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="label_us-gaap_ScheduleOfShortTermDebtTable" xlink:title="Label : us-gaap_ScheduleOfShortTermDebtTable to label_us-gaap_ScheduleOfShortTermDebtTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="label_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="Label : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to label_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:title="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">Schedule of Status of Stock Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="label_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:title="Label : us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock to label_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:title="us-gaap_SeriesAPreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SeriesAPreferredStockMember" xml:lang="en-US" id="label_us-gaap_SeriesAPreferredStockMember">Series A Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="label_us-gaap_SeriesAPreferredStockMember" xlink:title="Label : us-gaap_SeriesAPreferredStockMember to label_us-gaap_SeriesAPreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SeriesAPreferredStockMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SeriesAPreferredStockMember_1" xml:lang="en-US" id="label_us-gaap_SeriesAPreferredStockMember_1">Series A Convertible Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="label_us-gaap_SeriesAPreferredStockMember_1" xlink:title="Label : us-gaap_SeriesAPreferredStockMember to label_us-gaap_SeriesAPreferredStockMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1">Number of Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1">Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1">Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1">Granted, exercise price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2">Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3">Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1">Non-vested shares, March 31, 2015</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2">Non-vested shares, January 1, 2015</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" xlink:title="us-gaap_ShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensation" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensation">Share-based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="label_us-gaap_ShareBasedCompensation" xlink:title="Label : us-gaap_ShareBasedCompensation to label_us-gaap_ShareBasedCompensation" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_1">Number of additional shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1">Vested (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2">Vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1">Vesting period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1">Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1">Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2">Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1">Accrued compensation payable in shares of stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1">Non-vested shares, March 31, 2015</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2">Non-vested shares, January 1, 2015</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" xlink:title="us-gaap_SharePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharePrice" xml:lang="en-US" id="label_us-gaap_SharePrice">Share Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="label_us-gaap_SharePrice" xlink:title="Label : us-gaap_SharePrice to label_us-gaap_SharePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharePrice_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SharePrice_1" xml:lang="en-US" id="label_us-gaap_SharePrice_1">Share price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="label_us-gaap_SharePrice_1" xlink:title="Label : us-gaap_SharePrice to label_us-gaap_SharePrice_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1">Forfeited</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1">Forfeited</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1">Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2">Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1">Exercisable ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1">Expected dividend yield</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1">Aggregate fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_2" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_2">Vested, fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_2" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1">Expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1">Vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1">Exercisable ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1">Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2">Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1">Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1">Expected volatility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1">Number of shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1">Discount rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1">Expired/Forfeited</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1">Expired/Forfeited</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1">Outstanding ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2">Outstanding beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_1">Exercisable ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_2" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_2">Exercisable Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_2" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="Label : us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy to label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1">Stock-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1" xlink:title="Label : us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy to label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1">Outstanding ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2">Outstanding beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1">Shares Under Option</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2">Shares Under Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain">Equity Award [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1">Outstanding ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2">Outstanding beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" xlink:title="us-gaap_SharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharesOutstanding" xml:lang="en-US" id="label_us-gaap_SharesOutstanding">Shares, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="label_us-gaap_SharesOutstanding" xlink:title="Label : us-gaap_SharesOutstanding to label_us-gaap_SharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharesOutstanding_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_SharesOutstanding_1" xml:lang="en-US" id="label_us-gaap_SharesOutstanding_1">Balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="label_us-gaap_SharesOutstanding_1" xlink:title="Label : us-gaap_SharesOutstanding to label_us-gaap_SharesOutstanding_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharesOutstanding_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_SharesOutstanding_2" xml:lang="en-US" id="label_us-gaap_SharesOutstanding_2">Balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="label_us-gaap_SharesOutstanding_2" xlink:title="Label : us-gaap_SharesOutstanding to label_us-gaap_SharesOutstanding_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems" xlink:title="us-gaap_ShortTermDebtLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShortTermDebtLineItems" xml:lang="en-US" id="label_us-gaap_ShortTermDebtLineItems">Short-term Debt [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="label_us-gaap_ShortTermDebtLineItems" xlink:title="Label : us-gaap_ShortTermDebtLineItems to label_us-gaap_ShortTermDebtLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:title="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SignificantAccountingPoliciesTextBlock" xml:lang="en-US" id="label_us-gaap_SignificantAccountingPoliciesTextBlock">Significant Accounting Policies [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="label_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:title="Label : us-gaap_SignificantAccountingPoliciesTextBlock to label_us-gaap_SignificantAccountingPoliciesTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SignificantAccountingPoliciesTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SignificantAccountingPoliciesTextBlock_1" xml:lang="en-US" id="label_us-gaap_SignificantAccountingPoliciesTextBlock_1">SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="label_us-gaap_SignificantAccountingPoliciesTextBlock_1" xlink:title="Label : us-gaap_SignificantAccountingPoliciesTextBlock to label_us-gaap_SignificantAccountingPoliciesTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:title="us-gaap_StatementScenarioAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StatementScenarioAxis" xml:lang="en-US" id="label_us-gaap_StatementScenarioAxis">Scenario [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="label_us-gaap_StatementScenarioAxis" xlink:title="Label : us-gaap_StatementScenarioAxis to label_us-gaap_StatementScenarioAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:title="us-gaap_StatementTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StatementTable" xml:lang="en-US" id="label_us-gaap_StatementTable">Statement [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="label_us-gaap_StatementTable" xlink:title="Label : us-gaap_StatementTable to label_us-gaap_StatementTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:title="us-gaap_StatementLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StatementLineItems" xml:lang="en-US" id="label_us-gaap_StatementLineItems">Statement [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="label_us-gaap_StatementLineItems" xlink:title="Label : us-gaap_StatementLineItems to label_us-gaap_StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:title="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StatementOfStockholdersEquityAbstract" xml:lang="en-US" id="label_us-gaap_StatementOfStockholdersEquityAbstract">Condensed Statements of Stockholders' Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="label_us-gaap_StatementOfStockholdersEquityAbstract" xlink:title="Label : us-gaap_StatementOfStockholdersEquityAbstract to label_us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:title="us-gaap_StatementOfCashFlowsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StatementOfCashFlowsAbstract" xml:lang="en-US" id="label_us-gaap_StatementOfCashFlowsAbstract">Condensed Statements of Cash Flows [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="label_us-gaap_StatementOfCashFlowsAbstract" xlink:title="Label : us-gaap_StatementOfCashFlowsAbstract to label_us-gaap_StatementOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:title="us-gaap_StatementEquityComponentsAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StatementEquityComponentsAxis" xml:lang="en-US" id="label_us-gaap_StatementEquityComponentsAxis">Equity Components [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="label_us-gaap_StatementEquityComponentsAxis" xlink:title="Label : us-gaap_StatementEquityComponentsAxis to label_us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:title="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StatementOfFinancialPositionAbstract" xml:lang="en-US" id="label_us-gaap_StatementOfFinancialPositionAbstract">Condensed Balance Sheets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="label_us-gaap_StatementOfFinancialPositionAbstract" xlink:title="Label : us-gaap_StatementOfFinancialPositionAbstract to label_us-gaap_StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:title="us-gaap_StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StatementClassOfStockAxis" xml:lang="en-US" id="label_us-gaap_StatementClassOfStockAxis">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="label_us-gaap_StatementClassOfStockAxis" xlink:title="Label : us-gaap_StatementClassOfStockAxis to label_us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">Stock Issued During Period, Shares, Issued for Services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesIssuedForServices to label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_1">Common stock issued to consultants for services (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesIssuedForServices to label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2">Common stock issued for services (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesIssuedForServices to label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:title="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesAcquisitions to label_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_1">Common stock issued for Lion transaction (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesAcquisitions to label_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockSplits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockSplits" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockSplits" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesStockSplits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesStockSplits" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesStockSplits">Stock Issued During Period, Shares, Stock Splits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockSplits" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesStockSplits" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesStockSplits to label_us-gaap_StockIssuedDuringPeriodSharesStockSplits" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesStockSplits_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesStockSplits_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesStockSplits_1">Stock Issued During Period, Shares, Stock Splits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockSplits" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesStockSplits_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesStockSplits to label_us-gaap_StockIssuedDuringPeriodSharesStockSplits_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:label="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:title="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued">Stock Issued During Period, Shares, Treasury Stock Reissued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued to label_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_1">Purchase of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued to label_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:title="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueIssuedForCash">Development Stage Entities, Stock Issued, Value, Issued for Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueIssuedForCash to label_us-gaap_StockIssuedDuringPeriodValueIssuedForCash" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueIssuedForCash_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueIssuedForCash_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueIssuedForCash_1">Common stock issued for cash under the restructuring, net of offering costs of $109,990</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueIssuedForCash_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueIssuedForCash to label_us-gaap_StockIssuedDuringPeriodValueIssuedForCash_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration" xlink:title="us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration">Development Stage Entities, Stock Issued, Shares, Issued for Noncash Consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration to label_us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration_1">Fair value of common stock issued for cancellation of outstanding warrants (Shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration to label_us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:title="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueAcquisitions">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueAcquisitions to label_us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueAcquisitions_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueAcquisitions_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueAcquisitions_1">Common stock issued for Lion transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueAcquisitions_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueAcquisitions to label_us-gaap_StockIssuedDuringPeriodValueAcquisitions_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:title="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities to label_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1">Common stock issued upon conversion of preferred shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities to label_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:title="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">Stock Issued During Period, Value, Issued for Services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueIssuedForServices to label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_1">Common stock issued for services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueIssuedForServices to label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_2" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_2">Common stock issued for services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_2" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueIssuedForServices to label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:title="us-gaap_StockIssuedDuringPeriodSharesOther" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesOther" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesOther">Stock Issued During Period, Shares, Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesOther to label_us-gaap_StockIssuedDuringPeriodSharesOther" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesOther_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesOther_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesOther_1">Common stock sold in private placement, net of offering costs (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesOther_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesOther to label_us-gaap_StockIssuedDuringPeriodSharesOther_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1" xlink:title="us-gaap_StockIssued1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssued1" xml:lang="en-US" id="label_us-gaap_StockIssued1">Stock Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="label_us-gaap_StockIssued1" xlink:title="Label : us-gaap_StockIssued1 to label_us-gaap_StockIssued1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssued1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssued1_1" xml:lang="en-US" id="label_us-gaap_StockIssued1_1">Common stock issued for intellectual property</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="label_us-gaap_StockIssued1_1" xlink:title="Label : us-gaap_StockIssued1 to label_us-gaap_StockIssued1_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssued1_2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_StockIssued1_2" xml:lang="en-US" id="label_us-gaap_StockIssued1_2">Common stock issued to directors</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="label_us-gaap_StockIssued1_2" xlink:title="Label : us-gaap_StockIssued1 to label_us-gaap_StockIssued1_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="us-gaap_StockOptionPlanExpense" xlink:title="us-gaap_StockOptionPlanExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockOptionPlanExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockOptionPlanExpense" xml:lang="en-US" id="label_us-gaap_StockOptionPlanExpense">Stock or Unit Option Plan Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="label_us-gaap_StockOptionPlanExpense" xlink:title="Label : us-gaap_StockOptionPlanExpense to label_us-gaap_StockOptionPlanExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockOptionPlanExpense_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockOptionPlanExpense_1" xml:lang="en-US" id="label_us-gaap_StockOptionPlanExpense_1">Fair value of vested stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="label_us-gaap_StockOptionPlanExpense_1" xlink:title="Label : us-gaap_StockOptionPlanExpense to label_us-gaap_StockOptionPlanExpense_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockOptionPlanExpense_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockOptionPlanExpense_2" xml:lang="en-US" id="label_us-gaap_StockOptionPlanExpense_2">Fair value of vested stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="label_us-gaap_StockOptionPlanExpense_2" xlink:title="Label : us-gaap_StockOptionPlanExpense to label_us-gaap_StockOptionPlanExpense_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised to label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1">Purchase of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised to label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2">Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised to label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3">Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised to label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations" xlink:title="us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations">Development Stage Entities, Stock Issued, Value, Issued for Noncash Consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations to label_us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations_1">Fair value of common stock issued for cancellation of outstanding warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations to label_us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues">Stock Issued During Period, Shares, New Issues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesNewIssues to label_us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1">Shares issued during period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesNewIssues to label_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:title="us-gaap_StockIssuedDuringPeriodValueOther" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueOther" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueOther">Stock Issued During Period, Value, Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueOther" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueOther to label_us-gaap_StockIssuedDuringPeriodValueOther" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueOther_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueOther_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueOther_1">Common stock sold in private placement, net of offering costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueOther_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueOther to label_us-gaap_StockIssuedDuringPeriodValueOther_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockOptionMember" xlink:label="us-gaap_StockOptionMember" xlink:title="us-gaap_StockOptionMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockOptionMember" xml:lang="en-US" id="label_us-gaap_StockOptionMember">Equity Option [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="label_us-gaap_StockOptionMember" xlink:title="Label : us-gaap_StockOptionMember to label_us-gaap_StockOptionMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:title="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash">Development Stage Entities, Stock Issued, Shares, Issued for Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesIssuedForCash to label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash_1">Common stock issued for cash under the restructuring, net of offering costs of $109,990 (Shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesIssuedForCash to label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:title="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities to label_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1">Common stock issued upon conversion of preferred shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities to label_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:title="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueNewIssues">Stock Issued During Period, Value, New Issues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueNewIssues to label_us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:title="us-gaap_StockholdersEquityReverseStockSplit" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquityReverseStockSplit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockholdersEquityReverseStockSplit" xml:lang="en-US" id="label_us-gaap_StockholdersEquityReverseStockSplit">Stockholders' Equity, Reverse Stock Split</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="label_us-gaap_StockholdersEquityReverseStockSplit" xlink:title="Label : us-gaap_StockholdersEquityReverseStockSplit to label_us-gaap_StockholdersEquityReverseStockSplit" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:title="us-gaap_StockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockholdersEquityAbstract" xml:lang="en-US" id="label_us-gaap_StockholdersEquityAbstract">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="label_us-gaap_StockholdersEquityAbstract" xlink:title="Label : us-gaap_StockholdersEquityAbstract to label_us-gaap_StockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquityAbstract_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockholdersEquityAbstract_1" xml:lang="en-US" id="label_us-gaap_StockholdersEquityAbstract_1">Stockholders' Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="label_us-gaap_StockholdersEquityAbstract_1" xlink:title="Label : us-gaap_StockholdersEquityAbstract to label_us-gaap_StockholdersEquityAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:title="us-gaap_StockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockholdersEquity" xml:lang="en-US" id="label_us-gaap_StockholdersEquity">Stockholders' Equity Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="label_us-gaap_StockholdersEquity" xlink:title="Label : us-gaap_StockholdersEquity to label_us-gaap_StockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquity_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_StockholdersEquity_1" xml:lang="en-US" id="label_us-gaap_StockholdersEquity_1">Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="label_us-gaap_StockholdersEquity_1" xlink:title="Label : us-gaap_StockholdersEquity to label_us-gaap_StockholdersEquity_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquity_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_StockholdersEquity_2" xml:lang="en-US" id="label_us-gaap_StockholdersEquity_2">Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="label_us-gaap_StockholdersEquity_2" xlink:title="Label : us-gaap_StockholdersEquity to label_us-gaap_StockholdersEquity_2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquity_3" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_StockholdersEquity_3" xml:lang="en-US" id="label_us-gaap_StockholdersEquity_3">Total Stockholders' Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="label_us-gaap_StockholdersEquity_3" xlink:title="Label : us-gaap_StockholdersEquity to label_us-gaap_StockholdersEquity_3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:title="us-gaap_StockholdersEquityNoteAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockholdersEquityNoteAbstract" xml:lang="en-US" id="label_us-gaap_StockholdersEquityNoteAbstract">STOCKHOLDERS' EQUITY [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="label_us-gaap_StockholdersEquityNoteAbstract" xlink:title="Label : us-gaap_StockholdersEquityNoteAbstract to label_us-gaap_StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:title="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_StockholdersEquityNoteDisclosureTextBlock">STOCKHOLDERS' EQUITY</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="label_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:title="Label : us-gaap_StockholdersEquityNoteDisclosureTextBlock to label_us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:title="us-gaap_SubsequentEventsTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SubsequentEventsTextBlock" xml:lang="en-US" id="label_us-gaap_SubsequentEventsTextBlock">SUBSEQUENT EVENTS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="label_us-gaap_SubsequentEventsTextBlock" xlink:title="Label : us-gaap_SubsequentEventsTextBlock to label_us-gaap_SubsequentEventsTextBlock" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:title="us-gaap_SubsequentEventsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SubsequentEventsAbstract" xml:lang="en-US" id="label_us-gaap_SubsequentEventsAbstract">SUBSEQUENT EVENTS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="label_us-gaap_SubsequentEventsAbstract" xlink:title="Label : us-gaap_SubsequentEventsAbstract to label_us-gaap_SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" xlink:title="us-gaap_SubsequentEventTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SubsequentEventTable" xml:lang="en-US" id="label_us-gaap_SubsequentEventTable">Subsequent Event [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="label_us-gaap_SubsequentEventTable" xlink:title="Label : us-gaap_SubsequentEventTable to label_us-gaap_SubsequentEventTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" xlink:title="us-gaap_SubsequentEventLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SubsequentEventLineItems" xml:lang="en-US" id="label_us-gaap_SubsequentEventLineItems">Subsequent Event [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="label_us-gaap_SubsequentEventLineItems" xlink:title="Label : us-gaap_SubsequentEventLineItems to label_us-gaap_SubsequentEventLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:title="us-gaap_SubsequentEventMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SubsequentEventMember" xml:lang="en-US" id="label_us-gaap_SubsequentEventMember">Subsequent Event [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="label_us-gaap_SubsequentEventMember" xlink:title="Label : us-gaap_SubsequentEventMember to label_us-gaap_SubsequentEventMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:title="us-gaap_SubsequentEventTypeDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SubsequentEventTypeDomain" xml:lang="en-US" id="label_us-gaap_SubsequentEventTypeDomain">Subsequent Event Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="label_us-gaap_SubsequentEventTypeDomain" xlink:title="Label : us-gaap_SubsequentEventTypeDomain to label_us-gaap_SubsequentEventTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:title="us-gaap_SubsequentEventTypeAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SubsequentEventTypeAxis" xml:lang="en-US" id="label_us-gaap_SubsequentEventTypeAxis">Subsequent Event Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="label_us-gaap_SubsequentEventTypeAxis" xlink:title="Label : us-gaap_SubsequentEventTypeAxis to label_us-gaap_SubsequentEventTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:title="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SubsidiarySaleOfStockAxis" xml:lang="en-US" id="label_us-gaap_SubsidiarySaleOfStockAxis">Sale of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="label_us-gaap_SubsidiarySaleOfStockAxis" xlink:title="Label : us-gaap_SubsidiarySaleOfStockAxis to label_us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" xlink:title="us-gaap_SupplementalCashFlowElementsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SupplementalCashFlowElementsAbstract" xml:lang="en-US" id="label_us-gaap_SupplementalCashFlowElementsAbstract">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="label_us-gaap_SupplementalCashFlowElementsAbstract" xlink:title="Label : us-gaap_SupplementalCashFlowElementsAbstract to label_us-gaap_SupplementalCashFlowElementsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SupplementalCashFlowElementsAbstract_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_SupplementalCashFlowElementsAbstract_1" xml:lang="en-US" id="label_us-gaap_SupplementalCashFlowElementsAbstract_1">Supplemental Disclosures of Cash Flow Information:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="label_us-gaap_SupplementalCashFlowElementsAbstract_1" xlink:title="Label : us-gaap_SupplementalCashFlowElementsAbstract to label_us-gaap_SupplementalCashFlowElementsAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount" xlink:title="us-gaap_TaxCreditCarryforwardAmount" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_TaxCreditCarryforwardAmount" xml:lang="en-US" id="label_us-gaap_TaxCreditCarryforwardAmount">Tax Credit Carryforward, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="label_us-gaap_TaxCreditCarryforwardAmount" xlink:title="Label : us-gaap_TaxCreditCarryforwardAmount to label_us-gaap_TaxCreditCarryforwardAmount" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis" xlink:title="us-gaap_TitleOfIndividualAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_TitleOfIndividualAxis" xml:lang="en-US" id="label_us-gaap_TitleOfIndividualAxis">Title of Individual [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="label_us-gaap_TitleOfIndividualAxis" xlink:title="Label : us-gaap_TitleOfIndividualAxis to label_us-gaap_TitleOfIndividualAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xml:lang="en-US" id="label_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain">Relationship to Entity [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="label_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="Label : us-gaap_TitleOfIndividualWithRelationshipToEntityDomain to label_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" xlink:title="us-gaap_UseOfEstimates" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_UseOfEstimates" xml:lang="en-US" id="label_us-gaap_UseOfEstimates">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="label_us-gaap_UseOfEstimates" xlink:title="Label : us-gaap_UseOfEstimates to label_us-gaap_UseOfEstimates" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_UseOfEstimates_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_UseOfEstimates_1" xml:lang="en-US" id="label_us-gaap_UseOfEstimates_1">Use of Estimates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="label_us-gaap_UseOfEstimates_1" xlink:title="Label : us-gaap_UseOfEstimates to label_us-gaap_UseOfEstimates_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" xlink:title="us-gaap_VestingAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_VestingAxis" xml:lang="en-US" id="label_us-gaap_VestingAxis">Vesting [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="label_us-gaap_VestingAxis" xlink:title="Label : us-gaap_VestingAxis to label_us-gaap_VestingAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain" xlink:title="us-gaap_VestingDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_VestingDomain" xml:lang="en-US" id="label_us-gaap_VestingDomain">Vesting [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingDomain" xlink:to="label_us-gaap_VestingDomain" xlink:title="Label : us-gaap_VestingDomain to label_us-gaap_VestingDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VicePresidentMember" xlink:label="us-gaap_VicePresidentMember" xlink:title="us-gaap_VicePresidentMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_VicePresidentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_VicePresidentMember" xml:lang="en-US" id="label_us-gaap_VicePresidentMember">James G. Bender [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VicePresidentMember" xlink:to="label_us-gaap_VicePresidentMember" xlink:title="Label : us-gaap_VicePresidentMember to label_us-gaap_VicePresidentMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:title="us-gaap_WarrantMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_WarrantMember" xml:lang="en-US" id="label_us-gaap_WarrantMember">Warrant [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="label_us-gaap_WarrantMember" xlink:title="Label : us-gaap_WarrantMember to label_us-gaap_WarrantMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_WarrantMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_WarrantMember_1" xml:lang="en-US" id="label_us-gaap_WarrantMember_1">Warrant [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="label_us-gaap_WarrantMember_1" xlink:title="Label : us-gaap_WarrantMember to label_us-gaap_WarrantMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xml:lang="en-US" id="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="Label : us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted to label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1" xml:lang="en-US" id="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1">Weighted-Average Common Shares Outstanding, Basic and Diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1" xlink:title="Label : us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted to label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>lbio-20150331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--Created by IRIS, Powered by IRIS Carbon-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-dei" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-dei" />
  <link:roleRef roleURI="http://www.lbio.com/role/Disclosure-STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="lbio-20150331.xsd#Disclosure-STOCKHOLDERSEQUITYNarrativeDetails" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-soawnd" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-soawnd" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-soawsososod" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-soawsososod" />
  <link:roleRef roleURI="http://www.lbio.com/role/Disclosure-SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="lbio-20150331.xsd#Disclosure-SUBSEQUENTEVENTSDetails" />
  <link:roleRef roleURI="http://www.lbio.com/role/Disclosure-STOCKOPTIONSANDWARRANTSScheduleofStatusofStockWarrantsDetails" xlink:type="simple" xlink:href="lbio-20150331.xsd#Disclosure-STOCKOPTIONSANDWARRANTSScheduleofStatusofStockWarrantsDetails" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-sosapp" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-sosapp" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-sosapd" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-sosapd" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-sosap" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-sosap" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-csocf" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-csocf" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-cbs" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-cbs" />
  <link:roleRef roleURI="http://www.lbio.com/role/Disclosure-LICENSEANDCOMMITMENTS" xlink:type="simple" xlink:href="lbio-20150331.xsd#Disclosure-LICENSEANDCOMMITMENTS" />
  <link:roleRef roleURI="http://www.lbio.com/role/Disclosure-LICENSEANDCOMMITMENTSDetails" xlink:type="simple" xlink:href="lbio-20150331.xsd#Disclosure-LICENSEANDCOMMITMENTSDetails" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-soaw" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-soaw" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-soawt" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-soawt" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-csose" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-csose" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-csoo" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-csoo" />
  <link:roleRef roleURI="http://www.lbio.com/role/Statement-CondensedStatementsofOperationsParenthetical" xlink:type="simple" xlink:href="lbio-20150331.xsd#Statement-CondensedStatementsofOperationsParenthetical" />
  <link:roleRef roleURI="http://www.lbio.com/role/Disclosure-LEGALPROCEEDINGS" xlink:type="simple" xlink:href="lbio-20150331.xsd#Disclosure-LEGALPROCEEDINGS" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-goabd" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-goabd" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-goab" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-goab" />
  <link:roleRef roleURI="http://www.lbio.com/role/Disclosure-STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityDetails" xlink:type="simple" xlink:href="lbio-20150331.xsd#Disclosure-STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityDetails" />
  <link:roleRef roleURI="http://www.lbio.com/role/Statement-CondensedStatementsofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="lbio-20150331.xsd#Statement-CondensedStatementsofStockholdersEquityParenthetical" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-cbsp" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-cbsp" />
  <link:roleRef roleURI="http://www.lbio.com/role/Disclosure-STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="lbio-20150331.xsd#Disclosure-STOCKHOLDERSEQUITYTables" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-se" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-se" />
  <link:roleRef roleURI="http://www.lbio.com/role/Ibio-se1" xlink:type="simple" xlink:href="lbio-20150331.xsd#Ibio-se1" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-dei">
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_DocumentAndEntityInformationAbstract" xlink:label="lbio_DocumentAndEntityInformationAbstract" xlink:title="lbio_DocumentAndEntityInformationAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:title="dei_DocumentInformationTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbio_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" xlink:title="Presentation : lbio_DocumentAndEntityInformationAbstract to dei_DocumentInformationTable" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:title="dei_DocumentInformationLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:title="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:title="Presentation : dei_DocumentInformationLineItems to dei_AmendmentFlag" order="11" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:title="dei_CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" xlink:title="Presentation : dei_DocumentInformationLineItems to dei_CurrentFiscalYearEndDate" order="7" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:title="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:title="Presentation : dei_DocumentInformationLineItems to dei_DocumentPeriodEndDate" order="12" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:title="dei_EntityWellKnownSeasonedIssuer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" xlink:title="Presentation : dei_DocumentInformationLineItems to dei_EntityWellKnownSeasonedIssuer" order="15" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" xlink:title="dei_EntityVoluntaryFilers" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" xlink:title="Presentation : dei_DocumentInformationLineItems to dei_EntityVoluntaryFilers" order="16" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xlink:title="dei_EntityCurrentReportingStatus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" xlink:title="Presentation : dei_DocumentInformationLineItems to dei_EntityCurrentReportingStatus" order="17" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:title="dei_EntityFilerCategory" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" xlink:title="Presentation : dei_DocumentInformationLineItems to dei_EntityFilerCategory" order="8" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" xlink:title="dei_EntityPublicFloat" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" xlink:title="Presentation : dei_DocumentInformationLineItems to dei_EntityPublicFloat" order="18" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:title="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:title="Presentation : dei_DocumentInformationLineItems to dei_EntityRegistrantName" order="5" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:title="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:title="Presentation : dei_DocumentInformationLineItems to dei_EntityCentralIndexKey" order="6" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:title="dei_EntityCommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" xlink:title="Presentation : dei_DocumentInformationLineItems to dei_EntityCommonStockSharesOutstanding" order="9" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xlink:title="dei_DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="Presentation : dei_DocumentInformationLineItems to dei_DocumentFiscalYearFocus" order="14" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:title="dei_DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="Presentation : dei_DocumentInformationLineItems to dei_DocumentFiscalPeriodFocus" order="13" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:title="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:title="Presentation : dei_DocumentInformationLineItems to dei_DocumentType" order="10" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:title="Presentation : dei_DocumentInformationTable to dei_DocumentInformationLineItems" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:title="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:title="Presentation : dei_DocumentInformationTable to us-gaap_StatementClassOfStockAxis" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:title="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:title="Presentation : us-gaap_StatementClassOfStockAxis to us-gaap_ClassOfStockDomain" order="3" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Disclosure-STOCKHOLDERSEQUITYNarrativeDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:title="us-gaap_AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="Presentation : us-gaap_AwardTypeAxis to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" xlink:title="us-gaap_ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="Presentation : us-gaap_ClassOfStockLineItems to us-gaap_AllocatedShareBasedCompensationExpense" use="optional" priority="0" order="8093" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1" xlink:title="us-gaap_ConversionOfStockSharesIssued1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConversionOfStockSharesIssued1" xlink:title="Presentation : us-gaap_ClassOfStockLineItems to us-gaap_ConversionOfStockSharesIssued1" order="8033" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1" xlink:title="us-gaap_ConversionOfStockSharesConverted1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" xlink:title="Presentation : us-gaap_ClassOfStockLineItems to us-gaap_ConversionOfStockSharesConverted1" order="8043" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="Presentation : us-gaap_ClassOfStockLineItems to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" use="optional" priority="0" order="8113" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="Presentation : us-gaap_ClassOfStockLineItems to us-gaap_ProceedsFromIssuanceOfCommonStock" use="optional" priority="0" order="8023" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:title="Presentation : us-gaap_ClassOfStockLineItems to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" use="optional" priority="0" order="8073" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="Presentation : us-gaap_ClassOfStockLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" use="optional" priority="0" order="8053" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="Presentation : us-gaap_ClassOfStockLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" use="optional" priority="0" order="8063" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" xlink:title="us-gaap_SharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharePrice" xlink:title="Presentation : us-gaap_ClassOfStockLineItems to us-gaap_SharePrice" order="8006" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:title="Presentation : us-gaap_ClassOfStockLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" use="optional" priority="0" order="8103" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="Presentation : us-gaap_ClassOfStockLineItems to us-gaap_StockIssuedDuringPeriodSharesNewIssues" use="optional" priority="0" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:title="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_SeriesConvertiblePreferredStockMember" xlink:label="lbio_SeriesConvertiblePreferredStockMember" xlink:title="lbio_SeriesConvertiblePreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="lbio_SeriesConvertiblePreferredStockMember" xlink:title="Presentation : us-gaap_ClassOfStockDomain to lbio_SeriesConvertiblePreferredStockMember" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" xlink:title="us-gaap_ScheduleOfStockByClassTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_AwardTypeAxis" xlink:title="Presentation : us-gaap_ScheduleOfStockByClassTable to us-gaap_AwardTypeAxis" use="optional" priority="0" order="36" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" xlink:title="Presentation : us-gaap_ScheduleOfStockByClassTable to us-gaap_ClassOfStockLineItems" order="46" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:title="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:title="Presentation : us-gaap_ScheduleOfStockByClassTable to us-gaap_StatementClassOfStockAxis" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:title="us-gaap_RestrictedStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_RestrictedStockMember" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:title="Presentation : us-gaap_StatementClassOfStockAxis to us-gaap_ClassOfStockDomain" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:title="us-gaap_StockholdersEquityNoteAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" xlink:title="Presentation : us-gaap_StockholdersEquityNoteAbstract to us-gaap_ScheduleOfStockByClassTable" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-soawnd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:title="us-gaap_AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="Presentation : us-gaap_AwardTypeAxis to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:title="us-gaap_PlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PlanOneMember" xlink:label="lbio_PlanOneMember" xlink:title="lbio_PlanOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="lbio_PlanOneMember" xlink:title="Presentation : us-gaap_PlanNameDomain to lbio_PlanOneMember" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PlanTwoMember" xlink:label="lbio_PlanTwoMember" xlink:title="lbio_PlanTwoMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="lbio_PlanTwoMember" xlink:title="Presentation : us-gaap_PlanNameDomain to lbio_PlanTwoMember" use="optional" priority="0" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:title="us-gaap_PlanNameAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" xlink:title="Presentation : us-gaap_PlanNameAxis to us-gaap_PlanNameDomain" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:title="us-gaap_RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:title="us-gaap_RangeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:title="Presentation : us-gaap_RangeAxis to us-gaap_RangeMember" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:title="us-gaap_MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MaximumMember" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:title="us-gaap_MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MinimumMember" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xlink:title="us-gaap_RelatedPartyDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" xlink:title="Presentation : us-gaap_RelatedPartyTransactionsByRelatedPartyAxis to us-gaap_RelatedPartyDomain" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DirectorMember" xlink:label="us-gaap_DirectorMember" xlink:title="us-gaap_DirectorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_DirectorMember" xlink:title="Presentation : us-gaap_RelatedPartyDomain to us-gaap_DirectorMember" use="optional" priority="0" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_AwardTypeAxis" use="optional" priority="0" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_PlanNameAxis" use="optional" priority="0" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_RangeAxis" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_RangeAxis" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="27" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" xlink:title="us-gaap_VestingAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_VestingAxis" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_AllocatedShareBasedCompensationExpense" order="51" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="61" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="71" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises" xlink:title="us-gaap_ProceedsFromWarrantExercises" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromWarrantExercises" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ProceedsFromWarrantExercises" order="91" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" use="optional" priority="0" order="111" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" use="optional" priority="0" order="151" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" use="optional" priority="0" order="41" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" use="optional" priority="0" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="19" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" use="optional" priority="0" order="141" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" use="optional" priority="0" order="121" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" use="optional" priority="0" order="131" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" use="optional" priority="0" order="101" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:title="us-gaap_WarrantMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_WarrantMember" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_WarrantMember" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain" xlink:title="us-gaap_VestingDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" xlink:title="Presentation : us-gaap_VestingAxis to us-gaap_VestingDomain" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_VestingFirstMember" xlink:label="lbio_VestingFirstMember" xlink:title="lbio_VestingFirstMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="lbio_VestingFirstMember" xlink:title="Presentation : us-gaap_VestingDomain to lbio_VestingFirstMember" use="optional" priority="0" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-soawsososod">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:title="us-gaap_AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="Presentation : us-gaap_AwardTypeAxis to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:label="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:title="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:label="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:title="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:to="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" xlink:title="Presentation : lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract to lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm" xlink:label="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm" xlink:title="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:to="lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm" xlink:title="Presentation : lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract to lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageRemainingContractualTerm" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="Presentation : lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="23" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="Presentation : lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="20" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_AggregateIntrinsicValueAbstract" xlink:label="lbio_AggregateIntrinsicValueAbstract" xlink:title="lbio_AggregateIntrinsicValueAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbio_AggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="Presentation : lbio_AggregateIntrinsicValueAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" use="optional" priority="0" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbio_AggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="Presentation : lbio_AggregateIntrinsicValueAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" order="37" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbio_AggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:title="Presentation : lbio_AggregateIntrinsicValueAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="27" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbio_AggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1" xlink:title="Presentation : lbio_AggregateIntrinsicValueAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="25" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_AwardTypeAxis" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lbio_AggregateIntrinsicValueAbstract" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to lbio_AggregateIntrinsicValueAbstract" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="18" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="17" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="14" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="12" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="11" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="7" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:title="us-gaap_EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_EmployeeStockOptionMember" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Disclosure-SUBSEQUENTEVENTSDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:title="us-gaap_AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="Presentation : us-gaap_AwardTypeAxis to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:title="us-gaap_WarrantMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_WarrantMember" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_WarrantMember" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:title="us-gaap_SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" xlink:title="us-gaap_SubsequentEventTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable" xlink:title="Presentation : us-gaap_SubsequentEventsAbstract to us-gaap_SubsequentEventTable" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_AwardTypeAxis" xlink:title="Presentation : us-gaap_SubsequentEventTable to us-gaap_AwardTypeAxis" use="optional" priority="0" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" xlink:title="us-gaap_SubsequentEventLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" xlink:title="Presentation : us-gaap_SubsequentEventTable to us-gaap_SubsequentEventLineItems" use="optional" priority="0" order="30" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:title="us-gaap_SubsequentEventTypeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" xlink:title="Presentation : us-gaap_SubsequentEventTable to us-gaap_SubsequentEventTypeAxis" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises" xlink:title="us-gaap_ProceedsFromWarrantExercises" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromWarrantExercises" xlink:title="Presentation : us-gaap_SubsequentEventLineItems to us-gaap_ProceedsFromWarrantExercises" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:title="us-gaap_SaleOfStockPricePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" xlink:title="Presentation : us-gaap_SubsequentEventLineItems to us-gaap_SaleOfStockPricePerShare" use="optional" priority="0" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="Presentation : us-gaap_SubsequentEventLineItems to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" use="optional" priority="0" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="Presentation : us-gaap_SubsequentEventLineItems to us-gaap_StockIssuedDuringPeriodSharesNewIssues" use="optional" priority="0" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:title="us-gaap_SubsequentEventTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:title="us-gaap_SubsequentEventMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" xlink:title="Presentation : us-gaap_SubsequentEventTypeDomain to us-gaap_SubsequentEventMember" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" xlink:title="Presentation : us-gaap_SubsequentEventTypeAxis to us-gaap_SubsequentEventTypeDomain" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Disclosure-STOCKOPTIONSANDWARRANTSScheduleofStatusofStockWarrantsDetails">
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:label="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:title="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="Presentation : lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="Presentation : lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_AggregateIntrinsicValueAbstract1Abstract" xlink:label="lbio_AggregateIntrinsicValueAbstract1Abstract" xlink:title="lbio_AggregateIntrinsicValueAbstract1Abstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbio_AggregateIntrinsicValueAbstract1Abstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="Presentation : lbio_AggregateIntrinsicValueAbstract1Abstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" order="25" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbio_AggregateIntrinsicValueAbstract1Abstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:title="Presentation : lbio_AggregateIntrinsicValueAbstract1Abstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="24" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbio_AggregateIntrinsicValueAbstract1Abstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1" xlink:title="Presentation : lbio_AggregateIntrinsicValueAbstract1Abstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="23" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:title="us-gaap_EquityComponentDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:title="us-gaap_WarrantMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" xlink:title="Presentation : us-gaap_EquityComponentDomain to us-gaap_WarrantMember" order="4" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="5" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:title="us-gaap_StatementEquityComponentsAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_StatementEquityComponentsAxis" order="2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract" order="19" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lbio_AggregateIntrinsicValueAbstract1Abstract" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to lbio_AggregateIntrinsicValueAbstract1Abstract" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="18" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="17" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="14" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="12" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="11" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="7" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:title="Presentation : us-gaap_StatementEquityComponentsAxis to us-gaap_EquityComponentDomain" order="3" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-sosapp">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:title="us-gaap_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:title="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:title="us-gaap_ConcentrationRiskCreditRisk" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_ConcentrationRiskCreditRisk" order="8003" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:title="us-gaap_EarningsPerSharePolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_EarningsPerSharePolicyTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:title="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_FairValueOfFinancialInstrumentsPolicy" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="8004" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="8001" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:title="us-gaap_ResearchAndDevelopmentExpensePolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_ResearchAndDevelopmentExpensePolicy" order="8002" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" xlink:title="us-gaap_UseOfEstimates" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_UseOfEstimates" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-sosapd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:title="us-gaap_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="Presentation : us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to us-gaap_AntidilutiveSecuritiesNameDomain" use="optional" priority="0" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="Presentation : us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="19" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:title="us-gaap_ConvertiblePreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" xlink:title="Presentation : us-gaap_AntidilutiveSecuritiesNameDomain to us-gaap_ConvertiblePreferredStockMember" use="optional" priority="0" order="30" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xlink:title="us-gaap_RestrictedStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" xlink:title="Presentation : us-gaap_AntidilutiveSecuritiesNameDomain to us-gaap_RestrictedStockMember" use="optional" priority="0" order="40" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockOptionMember" xlink:label="us-gaap_StockOptionMember" xlink:title="us-gaap_StockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_StockOptionMember" xlink:title="Presentation : us-gaap_AntidilutiveSecuritiesNameDomain to us-gaap_StockOptionMember" use="optional" priority="0" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:title="us-gaap_WarrantMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" xlink:title="Presentation : us-gaap_AntidilutiveSecuritiesNameDomain to us-gaap_WarrantMember" use="optional" priority="0" order="20" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="Presentation : us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" use="optional" priority="0" order="8000" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="Presentation : us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="8010" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-sosap">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:title="us-gaap_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:title="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_SignificantAccountingPoliciesTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-csocf">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" xlink:label="lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" xlink:title="lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to lbio_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_FairValueOfVestedWarrantsGrantedForServices" xlink:label="lbio_FairValueOfVestedWarrantsGrantedForServices" xlink:title="lbio_FairValueOfVestedWarrantsGrantedForServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lbio_FairValueOfVestedWarrantsGrantedForServices" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to lbio_FairValueOfVestedWarrantsGrantedForServices" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockIssuedToOfficerForServices" xlink:label="lbio_CommonStockIssuedToOfficerForServices" xlink:title="lbio_CommonStockIssuedToOfficerForServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lbio_CommonStockIssuedToOfficerForServices" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to lbio_CommonStockIssuedToOfficerForServices" order="8001" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockIssuedToInduceConversionOfWarrants" xlink:label="lbio_CommonStockIssuedToInduceConversionOfWarrants" xlink:title="lbio_CommonStockIssuedToInduceConversionOfWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lbio_CommonStockIssuedToInduceConversionOfWarrants" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to lbio_CommonStockIssuedToInduceConversionOfWarrants" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockIssuedToInduceExchangeTransaction" xlink:label="lbio_CommonStockIssuedToInduceExchangeTransaction" xlink:title="lbio_CommonStockIssuedToInduceExchangeTransaction" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lbio_CommonStockIssuedToInduceExchangeTransaction" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to lbio_CommonStockIssuedToInduceExchangeTransaction" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_FairValueOfCommonStockTransferredToOfficerAndDirector" xlink:label="lbio_FairValueOfCommonStockTransferredToOfficerAndDirector" xlink:title="lbio_FairValueOfCommonStockTransferredToOfficerAndDirector" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lbio_FairValueOfCommonStockTransferredToOfficerAndDirector" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to lbio_FairValueOfCommonStockTransferredToOfficerAndDirector" order="8002" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_WriteOffOfAdvancesToRelatedParty" xlink:label="lbio_WriteOffOfAdvancesToRelatedParty" xlink:title="lbio_WriteOffOfAdvancesToRelatedParty" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lbio_WriteOffOfAdvancesToRelatedParty" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to lbio_WriteOffOfAdvancesToRelatedParty" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PrivatePlacementCosts" xlink:label="lbio_PrivatePlacementCosts" xlink:title="lbio_PrivatePlacementCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lbio_PrivatePlacementCosts" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to lbio_PrivatePlacementCosts" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:title="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:title="us-gaap_AdjustmentOfWarrantsGrantedForServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AdjustmentOfWarrantsGrantedForServices" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" xlink:title="us-gaap_DepreciationAndAmortization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_DepreciationAndAmortization" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:title="us-gaap_DerivativeGainLossOnDerivativeNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_DerivativeGainLossOnDerivativeNet" order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:title="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NoncashMergerRelatedCosts" xlink:label="us-gaap_NoncashMergerRelatedCosts" xlink:title="us-gaap_NoncashMergerRelatedCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NoncashMergerRelatedCosts" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_NoncashMergerRelatedCosts" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:title="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_StockIssuedDuringPeriodValueIssuedForServices" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1" xlink:title="us-gaap_StockIssued1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_StockIssued1" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_StockIssued1" order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="us-gaap_StockOptionPlanExpense" xlink:title="us-gaap_StockOptionPlanExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_StockOptionPlanExpense" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_StockOptionPlanExpense" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:label="us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:title="us-gaap_IncreaseDecreaseInDeferredCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:title="Presentation : us-gaap_IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInDeferredCompensation" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:title="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:title="Presentation : us-gaap_IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" order="8001" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:title="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:title="Presentation : us-gaap_IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:title="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:title="Presentation : us-gaap_IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="Presentation : us-gaap_IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet" xlink:label="lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet" xlink:title="lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to lbio_ProceedsFromIssuanceOfSecuredPromissoryNotesNet" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" xlink:label="lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" xlink:title="lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders" xlink:label="us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders" xlink:title="us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders" order="8001" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:title="us-gaap_ProceedsFromConvertibleDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromConvertibleDebt" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap_ProceedsFromConvertibleDebt" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" xlink:title="us-gaap_ProceedsFromRelatedPartyDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap_ProceedsFromRelatedPartyDebt" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:title="us-gaap_ProceedsFromIssuanceOfSecuredDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap_ProceedsFromIssuanceOfSecuredDebt" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:title="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract to us-gaap_ProceedsFromIssuanceOfCommonStock" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract to us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:title="us-gaap_NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetIncomeLoss" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract to us-gaap_NetIncomeLoss" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" order="16" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:label="us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:title="us-gaap_PaymentsToFundLongtermLoansToRelatedParties" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to us-gaap_PaymentsToFundLongtermLoansToRelatedParties" order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract to us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:title="us-gaap_StatementOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:title="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_CashAndCashEquivalentsAtCarryingValue" order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_1" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_1" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_CashAndCashEquivalentsAtCarryingValue" order="5" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" xlink:title="us-gaap_SupplementalCashFlowElementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_SupplementalCashFlowElementsAbstract" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants" xlink:label="lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants" xlink:title="lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants" xlink:title="Presentation : us-gaap_SupplementalCashFlowElementsAbstract to lbio_DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost" xlink:label="lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost" xlink:title="lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost" xlink:title="Presentation : us-gaap_SupplementalCashFlowElementsAbstract to lbio_DerivativeLiabilityRecordedAsPrivatePlacementCost" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount" xlink:label="lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount" xlink:title="lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount" xlink:title="Presentation : us-gaap_SupplementalCashFlowElementsAbstract to lbio_FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock" xlink:label="lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock" xlink:title="lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock" xlink:title="Presentation : us-gaap_SupplementalCashFlowElementsAbstract to lbio_SettlementOfAccountsPayableThroughIssuanceOfCommonStock" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1" xlink:title="us-gaap_DebtConversionOriginalDebtAmount1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_DebtConversionOriginalDebtAmount1" xlink:title="Presentation : us-gaap_SupplementalCashFlowElementsAbstract to us-gaap_DebtConversionOriginalDebtAmount1" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentDecreaseForgiveness" xlink:label="us-gaap_DebtInstrumentDecreaseForgiveness" xlink:title="us-gaap_DebtInstrumentDecreaseForgiveness" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_DebtInstrumentDecreaseForgiveness" xlink:title="Presentation : us-gaap_SupplementalCashFlowElementsAbstract to us-gaap_DebtInstrumentDecreaseForgiveness" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:title="us-gaap_DebtConversionConvertedInstrumentAmount1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:title="Presentation : us-gaap_SupplementalCashFlowElementsAbstract to us-gaap_DebtConversionConvertedInstrumentAmount1" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" xlink:title="us-gaap_IncomeTaxesPaid" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_IncomeTaxesPaid" xlink:title="Presentation : us-gaap_SupplementalCashFlowElementsAbstract to us-gaap_IncomeTaxesPaid" use="optional" priority="0" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" xlink:title="us-gaap_InterestPaid" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_InterestPaid" xlink:title="Presentation : us-gaap_SupplementalCashFlowElementsAbstract to us-gaap_InterestPaid" use="optional" priority="0" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NotesIssued1" xlink:label="us-gaap_NotesIssued1" xlink:title="us-gaap_NotesIssued1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_NotesIssued1" xlink:title="Presentation : us-gaap_SupplementalCashFlowElementsAbstract to us-gaap_NotesIssued1" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1_1" xlink:title="us-gaap_StockIssued1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_StockIssued1_1" xlink:title="Presentation : us-gaap_SupplementalCashFlowElementsAbstract to us-gaap_StockIssued1" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-cbs">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:title="us-gaap_AssetsCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xlink:title="us-gaap_AssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" xlink:title="Presentation : us-gaap_AssetsCurrentAbstract to us-gaap_AssetsCurrent" order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="Presentation : us-gaap_AssetsCurrentAbstract to us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Deposits" xlink:label="us-gaap_Deposits" xlink:title="us-gaap_Deposits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Deposits" xlink:title="Presentation : us-gaap_AssetsCurrentAbstract to us-gaap_Deposits" order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:title="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:title="Presentation : us-gaap_AssetsCurrentAbstract to us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" xlink:title="us-gaap_AssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:title="us-gaap_Assets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" xlink:title="Presentation : us-gaap_AssetsAbstract to us-gaap_Assets" order="16" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" xlink:title="Presentation : us-gaap_AssetsAbstract to us-gaap_AssetsCurrentAbstract" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:title="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:title="Presentation : us-gaap_AssetsAbstract to us-gaap_PropertyPlantAndEquipmentNet" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:title="us-gaap_LiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:title="us-gaap_AccountsPayableRelatedPartiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:title="Presentation : us-gaap_LiabilitiesCurrentAbstract to us-gaap_AccountsPayableRelatedPartiesCurrent" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" xlink:title="us-gaap_AccountsPayableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" xlink:title="Presentation : us-gaap_LiabilitiesCurrentAbstract to us-gaap_AccountsPayableCurrent" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:title="us-gaap_AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" xlink:title="Presentation : us-gaap_LiabilitiesCurrentAbstract to us-gaap_AccruedLiabilitiesCurrent" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xlink:title="us-gaap_LiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" xlink:title="Presentation : us-gaap_LiabilitiesCurrentAbstract to us-gaap_LiabilitiesCurrent" order="8000" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:title="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:title="Presentation : us-gaap_LiabilitiesAndStockholdersEquityAbstract to us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" use="optional" priority="0" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:title="us-gaap_CommitmentsAndContingencies" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" xlink:title="Presentation : us-gaap_LiabilitiesAndStockholdersEquityAbstract to us-gaap_CommitmentsAndContingencies" order="36" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" xlink:title="Presentation : us-gaap_LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquity" order="47" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" xlink:title="Presentation : us-gaap_LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesCurrentAbstract" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:title="us-gaap_StockholdersEquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" xlink:title="Presentation : us-gaap_LiabilitiesAndStockholdersEquityAbstract to us-gaap_StockholdersEquityAbstract" order="37" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:title="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_AssetsAbstract" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockToBeIssuedValue" xlink:label="lbio_CommonStockToBeIssuedValue" xlink:title="lbio_CommonStockToBeIssuedValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="lbio_CommonStockToBeIssuedValue" xlink:title="Presentation : us-gaap_StockholdersEquityAbstract to lbio_CommonStockToBeIssuedValue" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:title="us-gaap_AdditionalPaidInCapital" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" xlink:title="Presentation : us-gaap_StockholdersEquityAbstract to us-gaap_AdditionalPaidInCapital" order="23" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xlink:title="us-gaap_CommonStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" xlink:title="Presentation : us-gaap_StockholdersEquityAbstract to us-gaap_CommonStockValue" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" xlink:title="us-gaap_PreferredStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" xlink:title="Presentation : us-gaap_StockholdersEquityAbstract to us-gaap_PreferredStockValue" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:title="Presentation : us-gaap_StockholdersEquityAbstract to us-gaap_RetainedEarningsAccumulatedDeficit" order="24" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:title="us-gaap_StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" xlink:title="Presentation : us-gaap_StockholdersEquityAbstract to us-gaap_StockholdersEquity" order="25" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Disclosure-LICENSEANDCOMMITMENTS">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="Presentation : us-gaap_CommitmentsAndContingenciesDisclosureAbstract to us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Disclosure-LICENSEANDCOMMITMENTSDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCommitmentsTable" xlink:label="us-gaap_OtherCommitmentsTable" xlink:title="us-gaap_OtherCommitmentsTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OtherCommitmentsTable" xlink:title="Presentation : us-gaap_CommitmentsAndContingenciesDisclosureAbstract to us-gaap_OtherCommitmentsTable" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="us-gaap_LeaseArrangementTypeDomain" xlink:title="us-gaap_LeaseArrangementTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ManufacturingServiceAgreementMember" xlink:label="lbio_ManufacturingServiceAgreementMember" xlink:title="lbio_ManufacturingServiceAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseArrangementTypeDomain" xlink:to="lbio_ManufacturingServiceAgreementMember" xlink:title="Presentation : us-gaap_LeaseArrangementTypeDomain to lbio_ManufacturingServiceAgreementMember" use="optional" priority="0" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LicensingAgreementsMember" xlink:label="us-gaap_LicensingAgreementsMember" xlink:title="us-gaap_LicensingAgreementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseArrangementTypeDomain" xlink:to="us-gaap_LicensingAgreementsMember" xlink:title="Presentation : us-gaap_LeaseArrangementTypeDomain to us-gaap_LicensingAgreementsMember" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseArrangementTypeAxis" xlink:label="us-gaap_LeaseArrangementTypeAxis" xlink:title="us-gaap_LeaseArrangementTypeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseArrangementTypeAxis" xlink:to="us-gaap_LeaseArrangementTypeDomain" xlink:title="Presentation : us-gaap_LeaseArrangementTypeAxis to us-gaap_LeaseArrangementTypeDomain" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:title="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CradaMember" xlink:label="lbio_CradaMember" xlink:title="lbio_CradaMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="lbio_CradaMember" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to lbio_CradaMember" use="optional" priority="0" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_NCIMember" xlink:label="lbio_NCIMember" xlink:title="lbio_NCIMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="lbio_NCIMember" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to lbio_NCIMember" use="optional" priority="0" order="24" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_NIHMember" xlink:label="lbio_NIHMember" xlink:title="lbio_NIHMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="lbio_NIHMember" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to lbio_NIHMember" use="optional" priority="0" order="34" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:title="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis to us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_LeaseArrangementTypeAxis" xlink:title="Presentation : us-gaap_OtherCommitmentsTable to us-gaap_LeaseArrangementTypeAxis" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:title="Presentation : us-gaap_OtherCommitmentsTable to us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="us-gaap_OtherCommitmentsLineItems" xlink:title="us-gaap_OtherCommitmentsLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_OtherCommitmentsLineItems" xlink:title="Presentation : us-gaap_OtherCommitmentsTable to us-gaap_OtherCommitmentsLineItems" order="32" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:title="us-gaap_StatementScenarioAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:title="Presentation : us-gaap_OtherCommitmentsTable to us-gaap_StatementScenarioAxis" use="optional" priority="0" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AreaOfLand" xlink:label="us-gaap_AreaOfLand" xlink:title="us-gaap_AreaOfLand" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_AreaOfLand" xlink:title="Presentation : us-gaap_OtherCommitmentsLineItems to us-gaap_AreaOfLand" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PercentageOfRoyaltyOnSales" xlink:label="lbio_PercentageOfRoyaltyOnSales" xlink:title="lbio_PercentageOfRoyaltyOnSales" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="lbio_PercentageOfRoyaltyOnSales" xlink:title="Presentation : us-gaap_OtherCommitmentsLineItems to lbio_PercentageOfRoyaltyOnSales" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_EstimatedBenchmarkPaymentsForProducts" xlink:label="lbio_EstimatedBenchmarkPaymentsForProducts" xlink:title="lbio_EstimatedBenchmarkPaymentsForProducts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="lbio_EstimatedBenchmarkPaymentsForProducts" xlink:title="Presentation : us-gaap_OtherCommitmentsLineItems to lbio_EstimatedBenchmarkPaymentsForProducts" order="8002" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PercentageOfIncreaseInLeaseRent" xlink:label="lbio_PercentageOfIncreaseInLeaseRent" xlink:title="lbio_PercentageOfIncreaseInLeaseRent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="lbio_PercentageOfIncreaseInLeaseRent" xlink:title="Presentation : us-gaap_OtherCommitmentsLineItems to lbio_PercentageOfIncreaseInLeaseRent" order="8018" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_UpfrontLicenseFee" xlink:label="lbio_UpfrontLicenseFee" xlink:title="lbio_UpfrontLicenseFee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="lbio_UpfrontLicenseFee" xlink:title="Presentation : us-gaap_OtherCommitmentsLineItems to lbio_UpfrontLicenseFee" use="optional" priority="0" order="8028" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_LongTermPurchaseCommitmentPercentage" xlink:label="lbio_LongTermPurchaseCommitmentPercentage" xlink:title="lbio_LongTermPurchaseCommitmentPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="lbio_LongTermPurchaseCommitmentPercentage" xlink:title="Presentation : us-gaap_OtherCommitmentsLineItems to lbio_LongTermPurchaseCommitmentPercentage" use="optional" priority="0" order="8038" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:title="us-gaap_AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_AccruedLiabilitiesCurrent" xlink:title="Presentation : us-gaap_OtherCommitmentsLineItems to us-gaap_AccruedLiabilitiesCurrent" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:title="us-gaap_LeaseAndRentalExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" xlink:title="Presentation : us-gaap_OtherCommitmentsLineItems to us-gaap_LeaseAndRentalExpense" order="8003" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount" xlink:title="us-gaap_LongTermPurchaseCommitmentAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount" xlink:title="Presentation : us-gaap_OtherCommitmentsLineItems to us-gaap_LongTermPurchaseCommitmentAmount" use="optional" priority="0" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:title="us-gaap_ResearchAndDevelopmentExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" xlink:title="Presentation : us-gaap_OtherCommitmentsLineItems to us-gaap_ResearchAndDevelopmentExpense" order="8001" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:title="us-gaap_ScenarioUnspecifiedDomain" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PerQuarterMember" xlink:label="lbio_PerQuarterMember" xlink:title="lbio_PerQuarterMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="lbio_PerQuarterMember" xlink:title="Presentation : us-gaap_ScenarioUnspecifiedDomain to lbio_PerQuarterMember" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_PerYearMember" xlink:label="lbio_PerYearMember" xlink:title="lbio_PerYearMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="lbio_PerYearMember" xlink:title="Presentation : us-gaap_ScenarioUnspecifiedDomain to lbio_PerYearMember" use="optional" priority="0" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_OvarianCancerMember" xlink:label="lbio_OvarianCancerMember" xlink:title="lbio_OvarianCancerMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="lbio_OvarianCancerMember" xlink:title="Presentation : us-gaap_ScenarioUnspecifiedDomain to lbio_OvarianCancerMember" use="optional" priority="0" order="30" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_BreastCancerMember" xlink:label="lbio_BreastCancerMember" xlink:title="lbio_BreastCancerMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="lbio_BreastCancerMember" xlink:title="Presentation : us-gaap_ScenarioUnspecifiedDomain to lbio_BreastCancerMember" use="optional" priority="0" order="40" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_ColorectalCancerMember" xlink:label="lbio_ColorectalCancerMember" xlink:title="lbio_ColorectalCancerMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="lbio_ColorectalCancerMember" xlink:title="Presentation : us-gaap_ScenarioUnspecifiedDomain to lbio_ColorectalCancerMember" use="optional" priority="0" order="50" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_MelanomaMember" xlink:label="lbio_MelanomaMember" xlink:title="lbio_MelanomaMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="lbio_MelanomaMember" xlink:title="Presentation : us-gaap_ScenarioUnspecifiedDomain to lbio_MelanomaMember" use="optional" priority="0" order="60" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:title="Presentation : us-gaap_StatementScenarioAxis to us-gaap_ScenarioUnspecifiedDomain" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-soaw">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-soawt">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:title="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-csose">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:title="us-gaap_EquityComponentDomain" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockToBeIssuedMember" xlink:label="lbio_CommonStockToBeIssuedMember" xlink:title="lbio_CommonStockToBeIssuedMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="lbio_CommonStockToBeIssuedMember" xlink:title="Presentation : us-gaap_EquityComponentDomain to lbio_CommonStockToBeIssuedMember" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:title="us-gaap_AdditionalPaidInCapitalMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" xlink:title="Presentation : us-gaap_EquityComponentDomain to us-gaap_AdditionalPaidInCapitalMember" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:title="us-gaap_CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" xlink:title="Presentation : us-gaap_EquityComponentDomain to us-gaap_CommonStockMember" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" xlink:title="us-gaap_PreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" xlink:title="Presentation : us-gaap_EquityComponentDomain to us-gaap_PreferredStockMember" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" xlink:title="us-gaap_RetainedEarningsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" xlink:title="Presentation : us-gaap_EquityComponentDomain to us-gaap_RetainedEarningsMember" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:title="us-gaap_StatementTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:title="us-gaap_StatementLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:title="Presentation : us-gaap_StatementTable to us-gaap_StatementLineItems" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:title="us-gaap_StatementEquityComponentsAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:title="Presentation : us-gaap_StatementTable to us-gaap_StatementEquityComponentsAxis" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockIssuedUponExerciseOfWarrantsShares" xlink:label="lbio_CommonStockIssuedUponExerciseOfWarrantsShares" xlink:title="lbio_CommonStockIssuedUponExerciseOfWarrantsShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="lbio_CommonStockIssuedUponExerciseOfWarrantsShares" xlink:title="Presentation : us-gaap_StatementLineItems to lbio_CommonStockIssuedUponExerciseOfWarrantsShares" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockIssuedUponExerciseOfWarrantsAmount" xlink:label="lbio_CommonStockIssuedUponExerciseOfWarrantsAmount" xlink:title="lbio_CommonStockIssuedUponExerciseOfWarrantsAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="lbio_CommonStockIssuedUponExerciseOfWarrantsAmount" xlink:title="Presentation : us-gaap_StatementLineItems to lbio_CommonStockIssuedUponExerciseOfWarrantsAmount" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" use="optional" priority="0" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:title="us-gaap_NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_NetIncomeLoss" order="8000" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" xlink:title="us-gaap_SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_SharesOutstanding" order="8011" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_1" xlink:title="us-gaap_SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_1" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_SharesOutstanding" order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:title="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:title="us-gaap_StockIssuedDuringPeriodSharesOther" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodSharesOther" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:title="us-gaap_StockIssuedDuringPeriodValueOther" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodValueOther" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:title="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:title="us-gaap_StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_StockholdersEquity" order="8001" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_1" xlink:title="us-gaap_StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_1" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_StockholdersEquity" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:title="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" xlink:title="Presentation : us-gaap_StatementOfStockholdersEquityAbstract to us-gaap_StatementTable" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:title="Presentation : us-gaap_StatementEquityComponentsAxis to us-gaap_EquityComponentDomain" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-csoo">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" xlink:title="us-gaap_IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:title="us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_EarningsPerShareBasicAndDiluted" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:title="us-gaap_NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_NetIncomeLoss" order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:title="us-gaap_NonoperatingIncomeExpenseAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_NonoperatingIncomeExpenseAbstract" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:title="us-gaap_OperatingExpensesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_OperatingExpensesAbstract" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xlink:title="us-gaap_OperatingIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_OperatingIncomeLoss" order="2.5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherPreferredStockDividendsAndAdjustments" xlink:label="us-gaap_OtherPreferredStockDividendsAndAdjustments" xlink:title="us-gaap_OtherPreferredStockDividendsAndAdjustments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherPreferredStockDividendsAndAdjustments" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_OtherPreferredStockDividendsAndAdjustments" order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" xlink:title="us-gaap_Revenues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_Revenues" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CostToInduceExchangeTransaction" xlink:label="lbio_CostToInduceExchangeTransaction" xlink:title="lbio_CostToInduceExchangeTransaction" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lbio_CostToInduceExchangeTransaction" xlink:title="Presentation : us-gaap_NonoperatingIncomeExpenseAbstract to lbio_CostToInduceExchangeTransaction" order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts" xlink:title="us-gaap_AmortizationOfFinancingCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_AmortizationOfFinancingCosts" xlink:title="Presentation : us-gaap_NonoperatingIncomeExpenseAbstract to us-gaap_AmortizationOfFinancingCosts" order="14.1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xlink:title="us-gaap_AmortizationOfDebtDiscountPremium" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium" xlink:title="Presentation : us-gaap_NonoperatingIncomeExpenseAbstract to us-gaap_AmortizationOfDebtDiscountPremium" order="13.2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:label="us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:title="us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:title="Presentation : us-gaap_NonoperatingIncomeExpenseAbstract to us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" order="13.1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" xlink:title="us-gaap_InterestExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpense" xlink:title="Presentation : us-gaap_NonoperatingIncomeExpenseAbstract to us-gaap_InterestExpense" order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:title="us-gaap_OtherNonoperatingIncomeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" xlink:title="Presentation : us-gaap_NonoperatingIncomeExpenseAbstract to us-gaap_OtherNonoperatingIncomeExpense" order="15" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:title="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:title="Presentation : us-gaap_OperatingExpensesAbstract to us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="9.2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NoncashMergerRelatedCosts" xlink:label="us-gaap_NoncashMergerRelatedCosts" xlink:title="us-gaap_NoncashMergerRelatedCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_NoncashMergerRelatedCosts" xlink:title="Presentation : us-gaap_OperatingExpensesAbstract to us-gaap_NoncashMergerRelatedCosts" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" xlink:title="us-gaap_OperatingExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" xlink:title="Presentation : us-gaap_OperatingExpensesAbstract to us-gaap_OperatingExpenses" order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses" xlink:title="us-gaap_OperatingCostsAndExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingCostsAndExpenses" xlink:title="Presentation : us-gaap_OperatingExpensesAbstract to us-gaap_OperatingCostsAndExpenses" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:title="us-gaap_ResearchAndDevelopmentExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" xlink:title="Presentation : us-gaap_OperatingExpensesAbstract to us-gaap_ResearchAndDevelopmentExpense" order="9.1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Statement-CondensedStatementsofOperationsParenthetical">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" xlink:title="us-gaap_IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" xlink:title="us-gaap_ShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ShareBasedCompensation" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_ShareBasedCompensation" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Disclosure-LEGALPROCEEDINGS">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LossContingencyAbstract" xlink:label="us-gaap_LossContingencyAbstract" xlink:title="us-gaap_LossContingencyAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LossContingencyDisclosures" xlink:label="us-gaap_LossContingencyDisclosures" xlink:title="us-gaap_LossContingencyDisclosures" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingencyAbstract" xlink:to="us-gaap_LossContingencyDisclosures" xlink:title="Presentation : us-gaap_LossContingencyAbstract to us-gaap_LossContingencyDisclosures" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-goabd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_WorkingCapital" xlink:label="lbio_WorkingCapital" xlink:title="lbio_WorkingCapital" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lbio_WorkingCapital" xlink:title="Presentation : us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to lbio_WorkingCapital" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="Presentation : us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to us-gaap_CashAndCashEquivalentsAtCarryingValue" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:title="us-gaap_CommonStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" xlink:title="Presentation : us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to us-gaap_CommonStockSharesAuthorized" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:title="us-gaap_NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NetIncomeLoss" xlink:title="Presentation : us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to us-gaap_NetIncomeLoss" order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:title="Presentation : us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivities" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:title="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:title="Presentation : us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to us-gaap_PreferredStockParOrStatedValuePerShare" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:title="us-gaap_PreferredStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" xlink:title="Presentation : us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to us-gaap_PreferredStockSharesAuthorized" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:title="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:title="Presentation : us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="Presentation : us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to us-gaap_ProceedsFromIssuanceOfCommonStock" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" xlink:title="us-gaap_SharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_SharePrice" xlink:title="Presentation : us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to us-gaap_SharePrice" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="Presentation : us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to us-gaap_StockIssuedDuringPeriodSharesNewIssues" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:title="us-gaap_StockholdersEquityReverseStockSplit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" xlink:title="Presentation : us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to us-gaap_StockholdersEquityReverseStockSplit" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:title="us-gaap_StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_StockholdersEquity" xlink:title="Presentation : us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to us-gaap_StockholdersEquity" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-goab">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:title="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:title="Presentation : us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Disclosure-STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" use="optional" priority="0" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" use="optional" priority="0" order="50" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" use="optional" priority="0" order="30" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" use="optional" priority="0" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" use="optional" priority="0" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" use="optional" priority="0" order="50" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" use="optional" priority="0" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" use="optional" priority="0" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:title="us-gaap_StockholdersEquityNoteAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="Presentation : us-gaap_StockholdersEquityNoteAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="Presentation : us-gaap_StockholdersEquityNoteAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" use="optional" priority="0" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Statement-CondensedStatementsofStockholdersEquityParenthetical">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:title="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:title="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" xlink:title="Presentation : us-gaap_StatementOfStockholdersEquityAbstract to us-gaap_PaymentsOfStockIssuanceCosts" use="optional" priority="0" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:title="us-gaap_SaleOfStockPricePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_SaleOfStockPricePerShare" xlink:title="Presentation : us-gaap_StatementOfStockholdersEquityAbstract to us-gaap_SaleOfStockPricePerShare" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-cbsp">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:title="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="lbio-20150331.xsd#lbio_CommonStockToBeIssuedShares" xlink:label="lbio_CommonStockToBeIssuedShares" xlink:title="lbio_CommonStockToBeIssuedShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lbio_CommonStockToBeIssuedShares" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to lbio_CommonStockToBeIssuedShares" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:title="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_CommonStockParOrStatedValuePerShare" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" xlink:title="us-gaap_CommonStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_CommonStockSharesIssued" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:title="us-gaap_CommonStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_CommonStockSharesAuthorized" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:title="us-gaap_CommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_CommonStockSharesOutstanding" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:title="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_PreferredStockParOrStatedValuePerShare" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:title="us-gaap_PreferredStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_PreferredStockSharesIssued" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:title="us-gaap_PreferredStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_PreferredStockSharesAuthorized" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:title="us-gaap_PreferredStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_PreferredStockSharesOutstanding" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Disclosure-STOCKHOLDERSEQUITYTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:title="us-gaap_StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:title="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:title="Presentation : us-gaap_StockholdersEquityNoteAbstract to us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-se">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:title="us-gaap_StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:title="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:title="Presentation : us-gaap_StockholdersEquityNoteAbstract to us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.lbio.com/role/Ibio-se1">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:title="us-gaap_SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:title="us-gaap_SubsequentEventsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" xlink:title="Presentation : us-gaap_SubsequentEventsAbstract to us-gaap_SubsequentEventsTextBlock" order="1" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0`!@`(````(0!S7WC=T0$``&D2```3``@"6T-O;G1E;G1?5'EP97-=
M+GAM;""B!`(HH``"````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````#,F-%NVC`4AN\G[1TBWT[$
MV-LZ-A&X8-UEA[3N`3S[0"(<V[(-A;?O26A153$0*E+/3:S$/N?_8BF_XG\\
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M4'%62<59)15GE52<55)Q5DG%62459Y7OY:P9#]+`^^O;OY>^S9F37,H["^G*
M?U_[IN>4:Q7!_,D1(X>K`[SL?89#*ZMG-9Z]K[P)A[ZG]#$0F$<?$D8C$2X'
M>,X^NNI!P$80<P.'].-8BG!0Q%CE<L%7,09TP8T!<T2;]T'1Y!$``/__`P!0
M2P,$%``&``@````A`+55,"/U````3`(```L`"`)?<F5L<R\N<F5L<R"B!`(H
MH``"````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````",DL].PS`,QN](O$/D^^IN2`BAI;M,2+LA
M5![`).X?M8VC)$#W]H0#@DICV]'VY\\_6][NYFE4'QQB+T[#NBA!L3-B>]=J
M>*V?5@^@8B)G:13'&HX<85?=WFQ?>*24FV+7^ZBRBXL:NI3\(V(T'4\4"_'L
M<J61,%'*86C1DQFH9=R4Y3V&OQY0+3S5P6H(!WL'JC[Z//FRMS1-;W@OYGUB
METZ,0)X3.\MVY4-F"ZG/VZB:0LM)@Q7SG-,1R?LB8P.>)MI<3_3_MCAQ(DN)
MT$C@\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A363X8<'%#U1?````__\#`%!+`P04
M``8`"````"$`FBV37+@!```J$0``&@`(`7AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS(*($`2B@``$`````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
MO%C+:L,P$+P7^@]&]T;>S;O$R:&ED&N;?H"P%=O$EHVD/O+W%2:U&PC;B]F+
M02N\&F9W1V-O=M]U%7UJZ\K&)`(FL8BT29NL-'DBW@\O#RL1.:],IJK&Z$2<
MM1.[[?W=YE57RH>77%&V+@I9C$M$X7W[**5+"UTK-VE:;<+.L;&U\F%I<]FJ
M]*1R+3&.%]+^S2&V5SFC?98(N\_"^8=S&T[^/W=S/):I?F[2CUH;?^,(^=78
MDRNT]B&ILKGVB>A#3G8[JTE`+.1M,#!E1@-3$@XW.4"R@PMF=G!!L<-=*[)4
M"-S<`,7-DAG-D@(#R(P&D(3#30Z0[."<F1V<4^QPUXHN%;?B`*DX&&Y/ULL*
M8[)4ZS'AN$)9G;UY&ZR!"XDO]^=5F$+#+8"D_G'W#=DVP$X-R0W.QFR;WE\-
M+=.'+I8+9U3?<,L?J7[`C09(.,CM<9`V.:/Z4>?/5?C:&)2F6U.M`MSZ"Z3^
MPJCZVT_-P$@?N@P2K"EVN,>:G&IN:DAF@)L:(+E!=H]%FBP<U0_[\&M`#RW<
M+67W)"^EZ:BCG:HJ?2I4:08@?>AWA.35'X[M#P```/__`P!02P,$%``&``@`
M```A`(%AVG8<`P``[@@```\```!X;"]W;W)K8F]O:RYX;6R4EE%OHD`0Q]\O
MN>]`>+\B:'MM4VT0T9)3\`3;]%XV6UC+IK@06&O[[6_`DXY"&^])!YS?SOSG
MO[O>W+ZM$^65Y05/15_5SSJJPD281EP\]]5E,/YQJ2J%I"*B22I87WUGA7H[
M^/[M9IOF+T]I^J(`0!1]-98RN]:T(HS9FA9G:<8$O%FE^9I*"/-GK<AR1J,B
M9DRN$\WH="ZT->5"W1&N\U,8Z6K%0S9*P\V:";F#Y"RA$LHO8IX5ZN!FQ1-V
MO^M(H5GFTC74_9:H2D(+:4=<LJBOGD.8;MG!@WR3#3<\@;=7W4Y7U09UD_-<
MB=B*;A(90'M[.NAE]`SCHOQE*<4]9]OB(ZD,E;<'+J)T6_X4I'VOHRX4L*U>
M/?!(QO"^T^G4S^X8?X[E_B'@-<2O%(1UJD]%5.WM%2&FB(@M))?OQ!$[]7D*
M(RQ5=Z`S757R:PY?<B?2R\(QQ4I%Q$3!(C*D"14A(WZ95Z!\`^4;I^:3.<T9
M#+JNHHLHE=#M5?B22I!;R(*D*^)E+*<247J(TON\EC8*R%`7`ZK7DIR?BO%E
M&K[$B'*!*)4C3FG)HD5,QHCR$U%^'M<RL5U[84Z)MYB8KO/'#!S/):8[(L.E
M[[B(8F#,Y3'&7\YFYN*1>&/B.Q/7&3N6Z0;$M"QOZ088`WN_5N:J@0D\Z]>=
M-QW9"Y_8OY=.\(ASKU"NWFE-)MZ\;,&O>G@P%PLHPT>,+NR8>GV]X=:I8]FN
M;U?9EC>;.<',/@(<N+UAUZD]`37G"\^R[9'C3@[6QD;7&Q[UET,?>H;UB'U_
MO"IVM]XPYM?R8V-VL<'UAC7]Y@!(0)\2.*$_S%V>,Q\:-HQ9,5KG4*(P!_M;
M_T]KXJ9T;"H(CHZ@K]6!H=3;5C]PV"GV)"[-X03AKXP@3GDNUPI!<%Q0B\I^
M&+-HDS""3U8#FPV"-DZ[TE`6K@<[SVB8]HN)05F8@VUH-!U<]M5>#W#PQ`QL
M0PB.&OMD&Y(1DY3#K5L/S,!6A."(T]A2_PC8S7#7HEE5;M8J/ER'(4U"N*?+
MC^JBZYU?[*:@[?^J#/X"``#__P,`4$L#!!0`!@`(````(0#*[KBF5P,```L*
M```8````>&PO=V]R:W-H965T<R]S:&5E=#0N>&ULE)9=;]HP%(;O)^T_1+Z'
M?)$$$*$J5-TJ;=(T[>/:)`:L)G%DF]+^^YT30TA,&S$N@#BO7S_G',<GB[O7
MLG!>F%1<5"GQQQYQ6)6)G%>[E/S^]3B:$D=I6N6T$!5+R1M3Y&[Y^=/B*.2S
MVC.F'7"H5$KV6M=SUU79GI54C47-*KBS%;*D&B[ESE6U9#1O)I6%&WA>[):4
M5\0XS.4M'F*[Y1E[$-FA9)4V)I(55`._VO-:G=W*[!:[DLKG0SW*1%F#Q887
M7+\UIL0IL_G3KA*2;@J(^]6?T.SLW5Q<V9<\DT*)K1Z#G6M`KV.>N3,7G):+
MG$,$F'9'LFU*[OWYVO>)NUPT"?K#V5%U_CMJ+XY?),^_\8I!MJ%.6(&-$,\H
M?<IQ"":[5[,?FPK\D$[.MO10Z)_B^)7QW5Y#N2.("`.;YV\/3&604;`9!Q$Z
M9:(``/AV2HY;`S)"7YO?(\_U/B5A/(X2+_1![FR8TH\<+8F3'906Y5\C:B)J
M38*320CTI_O!K2:N`6KB>Z":+A=2'!W8-+"DJBEN07\.QN?`#$8;ZD>10HAH
M<H\N*9D1!X)04)Z7910NW!?(:':2K*XE?E^Q/BNP$$#7(D+<7<3W<WXF03&2
M8`T0;64&P+M%"ZQUKQ71I)7T2"!!71),5@A[:9@()Z4$RMP"1%%K;QB-)&ZA
MUYV!'L"D#S"\,(I3`M^7A6-K82.).Y+0SLZ@I`<'(7:S,PR'8BLKB05G))VL
M=`9Z"P-_=V$LRP2TPP`XR<K.U`(PDJ39SV$P3;S`RM^ZJ_!G43R-+NGK(29]
MQ&$T%%MH,PO-2`Q:X/F^%UK/V[JK"($\_H`,6U3G`!@F0W&?+/8L,B,Q9%$P
MFWJ1Q;[N*H(@FD7^!X\;G">WHZ'80K,.F)61^%Y3T-'[<'W-(!X8_0=?H[8`
M+R4QY\!)`YT,C]"1-_8G7N]C1;2^GG!1]/8?6/98;SNZFED6L[7/5B?-Z2E)
MXF3:W6I-7-B:L3CG[9K,ID%PV14&U/1>TYM*)G=LS8I".9DX8%\-("/M:-OS
M[P,\,JWQ%;X+X+C;WH!67-,=^T[ECE?**=@6++UQ`H>$-,W<7&A1-QUQ(S0T
MX>;O'EZZ&/01;PSBK1#Z?($+M*]QRW\```#__P,`4$L#!!0`!@`(````(0#]
M6TX/%`0``,,.```9````>&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;)17T6ZK
M.!!]7VG_`?F]`4,20A1RU5!U]TI[I=5J]]YG`DZ""AAATK1_OS,8B&W2EO2!
M!CC,G#DS/N#-M[<BMUY9+3)>AH3.'&*Q,N%I5AY#\M^_SP\K8HDF+M,XYR4+
MR3L3Y-OV]]\V%UZ_B!-CC0412A&24]-4:]L6R8D5L9CQBI5PY\#K(F[@M#[:
MHJI9G+8/%;GM.L[2+N*L)#+"NIX2@Q\.6<*>>'(N6-G((#7+XP;XBU-6B3Y:
MD4P)5\3UR[EZ2'A108A]EF?->QN46$6R_GXL>1WO<ZC[C<[CI(_=GHS"%UE2
M<\$/S0S"V9+HN.;`#FR(M-VD&52`LELU.X3DD:XCUR'V=M,*]#-C%Z'\ML2)
M7_ZHL_2OK&2@-O0).[#G_`6AWU.\!`_;HZ>?VP[\75LI.\3GO/F'7_YDV?'4
M0+L74!$6MD[?GYA(0%$(,W,7&"GA.1"`HU5D.!J@2/S6_K]D:7,*B;><+7S'
MHP"W]DPTSQF&)%9R%@TO?DD0[4+)(&X7Q`/V\KX+/S]_V)9$VKJ>XB;>;FI^
ML6!8()6H8AP]NH8H6)`'LLCT0XD?50BE89!'C!*2@%CPN("VO&X]-]C8KR!E
MTF%V$@/'`4-U1#1&N`MGP-C`>*`-&JBT;^O?LT,PLL-^(-V=O*!2<8<T+2(:
M(^BU'HT)B#:="8)#,E<T<'TC]4YBE@/;2+F@988PTS,C."0P9(/ZGG?55LHB
M,4IFY8*6&<),SXQ@O69/T5)FEAB_G1Q*G=5\[BZ-CDA(2T[CLKR'"X)U+JYC
M3.%.8N!X5<IH4=1#T"K4J?3OX8)@G0M=K?2B=Q(C=7D(7.H[1L\BB1C+@F\<
M95U_OD`0K%/Q7"/13F*Z%CET"8-KMDB#F%W4A`*GF,X.P28[LVD2\RD["1DK
M1<'NII-IT<9"<HWYV'4@926I5S0E*)K>Y$:U:$.+T6+J0/`/C=B=+9Q`_3-F
M+.K@-X2YRV2IM$RPC&'=C.>Y`UVIZ?,>=?=O<+G+9NG89\<#W8&N7+Z02<;\
M&JZW%RUT>GNEX:H:>JXYZE2"OB8BWV0=_(:DAHOWK_[/K0*_=F`UPG%HL^=Z
M>AMW'4B=_X_LFZ*73A=(.J\NT-S,WMNS0M$S5(S:O"$!Z+4.[[J.]2;>Y>MT
M;.PWFMC[MII^Q+$'F>\9>I>[MVBS9;XIFC1OM67*%5V.N]R;WK#OL65)$+@D
M6M8B6%`_"$9&]9&#PQ?_'3/4H@T/';WM.E!'*/"7BSE=&9KA3@/7PD>LI6AR
M+R&_N0M6'UG$\EQ8"3_C/@$]>K@Z[&$>7?SZLX<;L(6HXB/[$=?'K!16S@[P
MJ#/S85'5<A,B3QI>M5_T>][`YJ']>8+-(H-O7F<&X`/G37^""8;MY_9_````
M__\#`%!+`P04``8`"````"$`E86`8&8$``!_$```&0```'AL+W=O<FMS:&5E
M=',O<VAE970R,RYX;6R4F-V.HS@0A>]7VG=`W`]@?@*)DHPZM'IWI!UIM=J=
MN2;$25`#CC#I=+_]5F&'&)MI05\D`3[*QU7E`^[UU_>JM-YHPPM6;VSB>+9%
MZYP=BOJTL?_[]^5+8EN\S>I#5K*:;NP/RNVOV]]_6]]8\\K/E+861*CYQCZW
M[67ENCP_TRKC#KO0&JX<65-E+1PV)Y=?&IH=NINJTO4];^%665';(L*JF1*#
M'8]%3I]9?JUHW8H@#2VS%O3S<W'A]VA5/B5<E36OU\N7G%47"+$ORJ+]Z(+:
M5I6OOIUJUF3[$N;]3L(LO\?N#HSP59$WC+-CZT`X5P@UY[QTERY$VJX/!<P`
MTVXU]+BQG\@J]0/;W:Z[!/THZ(TKORU^9K<_FN+P5U%3R#;4"2NP9^P5T6\'
M/`4WN\;=+UT%_FZL`SUFU[+]A]W^I,7IW$*Y(Y@13FQU^'BF/(>,0AC'CS!2
MSDH0`)]656!K0$:R]^[[5AS:\\8.%DX4>P$!W-I3WKX4&-*V\BMO6?530$2&
M$D%\&02^91`2.4D4A8LDGAXED%'@^QYEX81^%"<3M+AB7EV:GK,VVZX;=K.@
M]T`YOV38R60%D3$_(6@2L^DS]JN$0:8PR!-&V=A+VX+;.53Y;1N0Q=I]@\KD
MDMD)!CY[A@R)U"3\R.L9%Q3WLB&5JNSQ<M[5(8SJL+PH=R=.J%+\?IB.2$V"
M+'MDH`22-ET)PI!@)0<!B?NX0IQ@%KW:5#DQ&!G"3!\9X8T-E>VS'Y!$&UDP
MRLC*B<'($&;ZR`CK<W[D4LQ9,''7.22!EHZUK*2"Z+0-I"SF2$%X*(4LM";<
M"49(B3SX&R8I%==-(?$<(0AK0A*]&H*!X1X5T[OTCJ`#JJL#GU[*HOY\=2"L
M:]'K(YA/M=P170N8PG0M"`^U!+Y6@)U@9*\LO9%>&1!:-PWR1.!Y,EU<1^OJ
M]/:1D)`7>E%(]*))PNP@@OXWN6P=K:UH7QMK)R%E2:MGAKF89:E$&"08Q*,[
M%8<4JUI","0^$6(GT)*52F`D%;-<E9BV:JYK"?5BPDA;V!(8$8,V.+TNPC0'
MF3%ZF`CH(4:W.QU04C>LVBPKQC<?8WUI1=E)2&HCGA-JSI1*8B13:(Y*IO!M
M(H`U]KD!$6&IH.W12WXPK,Y.0FHGB]M&5,RR8F)Z<>"'^NAWIU4E&@TT!CW>
M@H9UFV719,2CC0>7A%23)HG15[^R:3++ISM:-Q]MK)V$U)()9S9+YL\RXH[6
MC-@P'PF!VZ+Y^$D<!K'>R)(9T3/+BGWQXJHN>=-_)"0>#'X0F&\6DAA1,\N:
M_1%K-@Q(0O(IZL%&9!%H]4L'C)[`03?##FZP[C]?[QVME<_72K.3D"Q?&'M)
MK+^OXL81[4Q)F-@'B@U.19L336E9<BMG5]SCX7.H/]OO/Y]\?-5V^PNP_;MD
M)_H]:TY%S:V2'N%6S\&=6B,VD.*@99=N^[1G+6S\NI]GV.A3V&!X#L!'QMK[
M`0[0_^M@^S\```#__P,`4$L#!!0`!@`(````(0"0,A5%FP8``+L=```9````
M>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;)Q978_;-A!\+]#_(.@]EBCYXWPX
M7Q!)9%N@!8JB'\\Z6SX+L2U#TN62?]^E2$O+7<>6\Y*+QZ/U#+GDT.;3QZ^'
MO?>EJ)NR.JY\,0E]KSBNJTUY?%WY__RM/CSX7M/FQTV^KX[%RO]6-/['YY]_
M>GJOZL_-KBA:#RH<FY6_:]O38Q`TZUUQR)M)=2J.\,ZVJ@]Y"R_KUZ`YU46^
MZ1XZ[(,H#.?!(2^/OJGP6(^I46VWY;K(JO7;H3BVIDA=[/,6]#>[\M2<JQW6
M8\H=\OKSV^G#NCJ<H,1+N2_;;UU1WSNL'W][/59U_K('WU_%-%^?:W<O6/E#
MN:ZKIMJV$R@7&*'<\S)8!E#I^6E3@@,][%Y=;%?^)_&HXJD?/#]U`_1O6;PW
MZ/]>LZO>?ZG+S>_EL8#1AGG2,_!259\U];>-AN#A@#VMNAGXL_8VQ39_V[=_
M5>^_%N7KKH7IGH$C;>QQ\RTKFC6,*)291#-=:5WM00#\ZQU*W1HP(OG7[N][
MN6EW*S^>3V:+,!9`]UZ*IE6E+NE[Z[>FK0[_&9*PI4R1R!:9@GK[?G1W$?BX
M3@G\'8J(:3B_0\C<UH"_0XV1;@(S,MU`9WF;/S_5U;L'W0O>FU.NUX)XA,+G
M$3;CT8_Y]X8<QEH7^:2KK/RE[\%H-M`G7YZCI7@*OL#<KBTGX1S"2,\,/9&Z
M;&8`,QT:D!10"`C`46\+)@W;NMPP9_6:K-6?/S<Q`-0>[+AF4LZ835U*QBG1
M,G(Y\A(G=CGJ$F?X+,=U[+K6DSG][G(YN]</K7R@#6:7,U=#8CCS?H12"F04
MD!10"'!$P[H:/U6:#*:PV`?21HGAB+#K0Q&*11P^N'Y2A[(,Q7P6NHS,,`;'
MD@(*`8X?&,GQ?C29^IF[4A+#671V'N;SV71!IB<UC$%L1@%)`84`1SWL`>/5
M:S)1OZ3J#<>HC^)P&M&A3@T#J:>`I(!"@*-^<8]Z32;J%V2!)H8S:$LID%%`
M4D`AP!&K3REDZ[V]6O5#MU:KX2#1%,@H("F@$."(ACT>B[Z^L6HR&>'E@G2W
MX9C^6$9B$9*5F!K"X":C@*2`0H`C'O:$.]1W;"J?["2))0WR4H9D#)$,41AQ
M->N(N[M-A`E&6.57=G5+PMK-8P.2,8YDB,*(JUUG%])^O5N$23K85Y'F)6D7
M2QH4I@S)+&)Z*IZ%M*4D>T1AQ+6@8VN\!1-RV$),/ST1*`F[<T[*D(PADB$*
M(ZYF'4U(\[AS@#"!=J-E#`D//T4R6VC@2(8HC+C:=3`A[3=:QL082+C6,H8T
MZ$GU=PC8F`8D8XBTB&FB*?00:R/E4**NT8;-RW6E`PNYTC,2PV9TPYV).>PN
M#NEI1QB2T:D/,DQG:BG8+@K0K@4EXRB,N&9TH"$S-TR8^'--T)@5*"/MDJ!(
MQCB2(0HCKF:=9TCSR"5A4A"Z!;47.7PE`D6EU4Z1C'$D0Q1&7.TZSHCV$<UC
M0M`==_+=(A'GI!P,PA'-W7+3GG3^?I0Q1#)$8<2Q$]T5PAW;#>$XI%-@24.#
MIPS)&"(9HC#B:OZA$([&A+`E8>TLA!E',D1AQ-5.0GC<WA/Q,(Y#VCZ6!)M)
MOS[BD'P!2'M2WSX,D0Q1&''MW!7(T:5`ID=02\)30",Z8QS)$(415S.L0KJ"
M;Q_U(_W4K;.^)6'MYK$!R1A',D1AQ-6NLQ+M/M=W>_US%CGRBSF-+$LRD74I
ML"P!6Z")+1E'8<2UH--NO`63C>[&28_]D2'!R5?_V+683,F6E%H"MF`>&1#)
M.`HCKH6[,C>ZE+GT)&U)\,5#6XCG2WYPL)1!<L80R1"%$=<$">$;K612U)D'
M,9RONJA-(ANU#YV):"+(%I6>"?U/5QE#)$,41EP+)(MO6+B0P8*M!IO!QH*8
MQ`OY@9R/TNB<T\,>2A').`HCC@M]>AB_(#HVB6!!%":6-#<NR#2EYW>'66"(
M9(C"B*N?Q/'U68A-GKJ-1/HDL218HT.4"7H2ZDG]-#!$,D1AQ+7Q0\D<7TAF
M0;:?Q)*&E9LR)&.(9(C"B*N=Q/"X`W5L<O7Z@=J2L'86QXPC&:(PXFK7"3DZ
M#^""ZW:D69+]%@:_<;(58*H,IC+[R(!(ANC+M?Z+JK%@[LK,%<ZAJ%^+M-CO
M&V]=O>E[L`BVP1[M[^@^17K=$3P1CVEWLQ+T;\#5V2E_+?[(Z]?RV'C[8@LE
MP\D"IJLVEV_F15N=NHNCEZJ%2[/NOSNX)"W@AB:<`'E;5>WY!7QPT%^[/O\/
M``#__P,`4$L#!!0`!@`(````(0"#O(/?(P,```,*```9````>&PO=V]R:W-H
M965T<R]S:&5E=#(Q+GAM;)1676^;,!1]G[3_8/F]@$D"2112M:NZ5=JD:=K'
MLP,F6`6,;*=I__VN;4((;5KRPN?Q.??<>[EF=?U<E>B)2<5%G6#B!1BQ.A49
MK[<)_O/[_FJ.D=*TSF@I:I;@%Z;P]?KSI]5>R$=5,*81,-0JP876S=+W55JP
MBBI/-*R&-[F0%=5P*[>^:B2CF5U4E7X8!)%?45YCQ["48SA$GO.4W8ET5[%:
M.Q+)2JHA?E7P1AW8JG0,747EXZZY2D75`,6&EUR_6%*,JG3YL*V%I)L2?#^3
M*4T/W/;F%7W%4RF4R+4'=+X+]+7GA;_P@6F]RC@X,&E'DN4)OB'+6S+%_GIE
M$_27L[WJ72-5B/U7R;/OO&:0;:B3J<!&B$<#?<C,(UCLOUI];ROP4Z*,Y717
MZE]B_XWQ;:&AW#-P9(PMLY<[IE+(*-!XX<PPI:*$`."(*FY:`S)"G^UYSS-=
M)'@2>;,XF!"`HPU3^IX;2HS2G=*B^N=`I*5R)&%+`N>6A,R\:3B+YR-8?!>1
M-7A'-5VOI-@CZ!K05`TU/4B6P&R<32`_+H[.ZSFKX-&0W!B6!"\P@N4*ZO.T
M#N?SE?\$.4U;S*W#P+'#D`[A0S1=2!!&/Z2WDWQ0-F"C;))N0KEU#_HRX=LR
MDTMD##C!4*PN^'"^Z'B=LL-$MI/Z?J:7"!EP@N'8"9$H&`@Y3&SS/(L7<33M
M`">)A'#')]*`A\+'`CF'#A/U@IN<22Y@QDL;\%!ZTEERT@[C/%_%830[QG;B
M.;Y$V("'PM%`V&'&>#;3OO<IO=^W!CR4C@?2#M/6.8@).2;EQ#-\=WWAPS?\
M?@!FT:"C%\-&<YC7'4U@0O05WU>RZ*'7H50+(L1V=>2=Z2MX?XFRFSFG7].Q
M<5QG6<H$CZDPN6@T6?30][&$K7H[KS[R?=&T(FX4G?H>-G8+&N7;3)S1K0T[
M\<>]W8+.UMOMQ6ZKJIC<LB^L+!5*Q<[LLR9;W=/N'^`FM+.W>P%;<$.W[`>5
M6UXK5+(<E@9>#&-,NDW<W6C1V(UP(S1LOO:R@)\M!MM)X`$X%T(?;LQO0O?[
MMOX/``#__P,`4$L#!!0`!@`(````(0":6-KM_P0```H3```9````>&PO=V]R
M:W-H965T<R]S:&5E=#(P+GAM;)186V^K1A!^K]3_@'@_A@5SL67[*`;2'JF5
MJJJ79X+7-@JP%I`XY]]W=H?+7G)2D@<[_OAF^&9V=@9V]_6MKJQ7VG8E:_8V
M6;FV19N"G<KFLK?__NOQ2VQ;79\WI[QB#=W;WVEG?SW\_-/NSMKG[DII;X&'
MIMO;U[Z_;1VG*ZZTSKL5N]$&KIQ96^<]_&PO3G=K:7X21G7E>*X;.G5>-C9Z
MV+9+?+#SN2QHRHJ7FC8].FEIE?>@O[N6MV[T5A=+W-5Y^_QR^U*P^@8NGLJJ
M[+\+I[95%]MOEX:U^5,%<;^1=5Z,OL4/PWU=%BWKV+E?@3L'A9HQ;YR-`YX.
MNU,)$?"T6RT][^T'LLT\8CN'G4C0/R6]=]+_5G=E]U_:\O1;V5#(-JP37X$G
MQIXY]=N)0V#L&-:/8@7^:*T3/><O5?\GN_]*R\NUA^4.("(>V/;T/:5=`1D%
M-RLOX)X*5H$`^+3JDI<&9"1_$]_W\M1?][8?KH+(]0G0K2?:]8\E=VE;Q4O7
ML_I?)(F()B?>X`2^!R<D6*V]((H_X\4?O*QG+]ZGI8!H$0]\CU+"Q5(<3([(
M=9KW^6'7LKL%!0SA=[><;P>R!<]CDC$E4]I_E'5(-W?RP+WL[8UM04([*)77
M@Q<%.^<5EK<8.$?DP.?,66]43F+Z(2HC'1E\O?FMLW?<!NYDY$"84ZRPB'*L
M[Q?2&!(G\Y#&&QT1D/437;Y)\28E0FUJ,H*U2LE,BG0?)1XHJ^7Q</+>AB6>
MTQ^%ZJV/R`FGF!,=2'4@DP!%&Y3Z<FV<O+?A4](6:=J0(VE#(!+5MH'>#'^J
M2:J;9+))*"QF$T4]I&FY>D[6U<>JE"-R"!%J@Y6^.9+ANBNN:\8I7IQ#SW[L
M38DB5*/@>]N'-OQQW7,C-9J-OA1((2C6]][+?:)PPMAWH]C7XT*.%)=AI"RJ
M$ENDQO9Q3)RLQN1%VMX](F<6DR"`]46T8L'-K)MD$J"(Y8\D4I/]6"PG:V+C
MN4S%G8_(D<0B@&+Y>JCEE^K\3`(4I=#"EROE9%4I";5^?42.I'0$YKWNZTUR
MI(RM-Y,`12V4X"?D"K:JUXMUO0-)$CP@8R&0R'?U0E8H&Y>$T@0:IA17NK>%
M6S4$/K\6UP8T$#WE7J0-D.-`DD-`LQE)#4XF(ZI"/I"6*\3Q!1U*ZN7ZG"%(
MFO4D!I(:2"8CJD(^A)8KQ)$%LV!2:)8MD>::6,'$0%(#R08$2R6*O4#:B*IB
M/HF6*\:Y)2OV8FW3'`F2Y)SJ2&IPL@F9D^'%_M0]5-%\["P7C4-*%6V4*I(P
M8>LX(,%&:UT)?^0?=PZV70/)!N1]-VH,?,0LCP$'DAJ#T3'T,980'4D-)!N0
MH:MX0;B)YP=F53*?*LLEXPQ2)<^><7P0:5`-U8W(D,'`7:\UF]2PR61$5<RG
MRW+%.(M4Q4;'D`;6H!@1:+W\=<,GZS4)M=I)B6Z5R8BJF<\82?.RAR6"DTG5
MKC\N#21Y9TH#;:AI'<ED*T6I]ZFA)]C_]]P_D"2%!I(:2"8CJL)/S33OG9EF
M//`,)%GA.-/X\LN-%A-J&/"SBJF1H%P\>L#7X9JV%YK0JNJL@KWP8P4/"FM"
MIR./!X^_'6EX0K;P8@JX,UV`DXA;?J&_Y^VE;#JKHF=PZ<*#OVVU>):!/WIV
M$R_A3ZR',PCQ[Q7.G"B\VKHK()\9Z\<?_`;3*=;A/P```/__`P!02P,$%``&
M``@````A`#?2LY3^!P``5B@``!D```!X;"]W;W)K<VAE971S+W-H965T,C4N
M>&ULE)I;;^.Z%87?"_0_&'X_MFZ^)(AS,!;)]@`M4!2]/#NVD@AC6X:D3&;^
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MF"KRJ\*M"%=6`;!?;V63[($>I'LTBXAJ3(\&U9G;H;B-AUTV>#SZE^RU;2=V
M;5\-;P$0P]1*+A6+C$J4E*0ITVBIB=G`&"E)T\7MOR)-VW-D>--.O)G:M7R;
ME#1=WNIV$[<%S?(V,#D'B@/-@4&`F+7GXG"S3KR9VJ_([(J9!4T<=>MV%:_6
M&5/DH`CM*`XTJ9$FLH9!AY!V[$`.;\>)>3MKU@YH5ETW213'$3\3<ZQ(HV2Y
M3&@)!8+0K^;`($"ZL5O(\&Z<F'?#5O$6--!-NDPC]X^ZS4$2W"H.-`<&`6)_
M-<:^$S/[&?.V!4WPEG.@.-`<&`2(67>YA+;N^UN5$W]UUH(&F>5`<:`Y,`@0
MLS8;AIMU8C:R*5\8H(&%L8P6/>L"%*$=Q8'FP"!`W-O-883]3LW\9RSLMEX4
M[.6"*$&T(`83ZMFEWN#U$4-&VO,:[91\6_<B[!D."T0)C1;$8$(]N]`:[ADB
MSNZLR#-?)S&(8*'$2=RW@W@-[@*."D0+C<&$=N&B:W@7$'2DBXSMR-L8I6$7
ML;D@2A`MB,&$>G;Y--PSI-D7JP5$80SSF!,EB!;$8$(]NQ0:[ADRRUJXMUI`
M='^U@";TI=S-C=VP`M&"&$QH%RZ,AG<!T46ZR,2E-LHWOUHX43$G6A"#"?7L
M,FFX9T@P.TAHY,7>@F+.>^9$Q9QH00PFU+.+IN&>(<C(.(L,BD%T+X2\)"P-
M)8@6Q&!"FW`)-;P)R#/21,9N);8Q"CT_\)PHH=&"&$R(YV14>';JKZY4O"B,
M:BZ($D0+8C"AGD>%9P(I2,<YW&MUH[KU(K^U9/8FX8'?9WA):$L)H@4QF-`F
M1J5ITI>F_.;"BX+#7!#E"32:+M;Q`\MD312)NW:CE_0&%Z4ML6AUSRM2N[[N
M7_PF?1'+-R`OPJWQT%5"HP4QF%#O=GT,/W<3I_[R/``1]LR)\H6"1@MB,*&>
M7;(-WF_<XSE^X9Z)\P!$L#Q6Z5K,?N[+!,=*$"V(P83VX))N>`^0BW8845B)
MTP!$T$/RL(Y6[/(^3WB\*D&T)U!E_1`MUVQO-O@8VI-+PN$]06Z2GOA#CFW"
MPS471`FB/8$>^BZN#3Z&]C`JD).>0,[$O(`HK)S<'Q:($D0+8C"AGD?E;P)!
M>O_"QXN"PUP0)8@6Q&!"/+O]<?A:Z=3LYC5E0;7U(K_^^VZ^O2)TI031@AA,
M:`^C\CCMR>.4KQ4O@AX66;Q<LBYSHNABBN64\HK0I1;$D"K=4(4JM$<6U\.R
M+>V);?1P&ZX]O"CXS`51@FA!#";4.\OE^WF<0K#>/R^\"'L6>2PT6A"#"?7L
MHG+P'II"L-(]E&>;%]T[+Z!,Z$KY8P+1@AA,:`\N3(?W`-%+>N`?EFQ3$`4_
MN2!*$"V(P81Z'I7'*03I%VN%IVWN#PM=*$&T(`83ZGE4WJ9]>2O6"HAP<H:-
M`6[$?!W<!`]I+30&$]K$J,!->P)WP2YSMEX4'.:"*$&T(`83ZGE4X*9#`M>+
ML&<X+!`E-%H0@PGQG(T*W$[-`E=<-'N1#ZN^9YA>@7H01`MB,*$]C`K<K"=P
M%_P9IA<%A[D@2A`MB,&$>F8!>C^$,@C.^QN+%V'/<%@@2FBT(`83ZGE4<&:0
M@&0#EVL%1#Z$NK7"-Q9?!S?!LU5[S9W]R>`RM"N7<H-C*8-,)%TM^#--+PJ6
M<T&4(%H0@PGU[')ON&=(R2]6#XBP9TY4QHD6Q&!"/8^*T@Q2DHXSN^7<>M%R
MW7V`',TB]IPDOPIN'^XK0;0@!A/:PJADS7J255S9>Q&LW,R=`/3Q4NX%85Z4
M(%H0@PEM852NVC>OY$,2=NNQ]2+[X5[W,DW?'9:7X":@<B!::-Q[7[>/*J`)
M>(T+7@HZ%?5;D1?'8S/95Q_N%:W$&KC1V^MCWQ(W^XQOX\>\>P=K?ON#?:OK
MLGLK_KZKW\IS,SD6K[9D-%O9-5_#>V'P2UM=NE>17JK6OL_5_?ANW]\K[$M`
MT<R*7ZNJO?YB_^/Y[8W`Y_\!``#__P,`4$L#!!0`!@`(````(0"9]\&1*@0`
M``\/```9````>&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;)Q778^K-A!]K]3_
M@'B_@"&$)0JYVL1L>Z56JJI^/!-P$K2`$2:;W7_?L4W`-K==TCQ`.#F<G!F/
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M;`AD&\:)C\"1TE=._59P"%YV9V^_B!'XK;,*<LJN5?\[O?U,RO.EA^$.(2(>
MV*;XP(3ED%&0<?R0*^6T`@-PM>J2EP9D)'L7]UM9])?$#M9.&'D!`KIU)*Q_
M*;FD;>57UM/Z;TE"@Y04\0<1N`\B*'16?A@]/:(2#"IPOZNL'U=9#2IPOZO\
M#R\0NT@+W`>5V/&?0A2N/T^+*U,L1@QG?;;;=O1FP32`)+(VXY,*;?YUB&!L
M./>9DQ,[MBW(/H.Z>ML%8;AUWZ`6\H&SEQRXCARD,PYSAA]Z.@=_A[.*=4YZ
MY_!2A&C&D&#$EX?$R3PD7H4\QKT$5/^^_K^'.0,9UK"D!")%*Q\%1I)2\_<I
M?"T2J+KED7!R8L,8CHD/PK5N?2\Y8NJ+:`\F@$T@50#-&]3R<F^<G-AP';WY
ML>E-<I`GDN8''LS5*2W2K:1,]K$)I`J@N86T+'?+R8;;*#(R*3F1,!M#?X&/
MSCBHC+4@&`PL&5,XJ0)H[M>/N.=DT[U1PGO)F?[Y8`+8!%(%T+Q%CWCCY,]J
M5'(4;R:`32!5`,T;WU`L7MPXV<A;;(ZZY-Q''46S09>$R3PV@50!-*^PJB[W
MRLFZUR`TO4K.9.5@`M@$4@70O,&D?,"<8'\VR@-)L3=#\`Q)541WR)O!XJ%&
MLG7`8O$?Z]%`4AW*UR8$#QRP)9IAO`J1,<E354:WS)O`<LNR96B69XL2DJ3)
MX&&&X`&1-;R*POG*E:HOZ99Y,UAN6;8.U7(0/NFKY!XI_44N\C,$SY!T0(:\
M*SG7[?)NH-CE^]``2OG[^]!QD\/?,B>7T>#W2)+43)L(GG%2%=&=\I5?<?J)
M0]DGX#J6[[S5\PTWA*$Z-!$\XZ0JHCODZ_]RA[);0$I&A_YL,84CB.G01/#`
MD=6*8//NK?0"X@>9444ZEN<2N<NM27<F!U)5S,KIE9\Y$$S5$1W/0\^^.-&,
M/\!QI,W.Y->L.Y<-LRIR@E<])X(4=O)`(Q]ZVHH]])'V<!`17R]P\"2PD_0<
M()\H[>\/?)\Z'F5W_P```/__`P!02P,$%``&``@````A`/MBI6V4!@``IQL`
M`!,```!X;"]T:&5M92]T:&5M93$N>&UL[%E/;]LV%+\/V'<@=&]M)[8;!W6*
MV+&;K4T;Q&Z''FF9EEA3HD#227T;VN.``<.Z89<!N^TP;"O0`KMTGR9;AZT#
M^A7V2$JR&,M+T@8;UM6'1")_?/_?XR-U]=J#B*%#(B3E<=NK7:YZB,0^'],X
M:'MWAOU+&QZ2"L=CS'A,VMZ<2._:UOOO7<6;*B010;`^EINX[85*)9N5BO1A
M&,O+/"$QS$VXB+""5Q%4Q@(?`=V(5=:JU68EPC3V4(PC('M[,J$^04--TMO*
MB/<8O,9*Z@&?B8$F39P5!CN>UC1"SF67"72(6=L#/F-^-"0/E(<8E@HFVE[5
M_+S*UM4*WDP7,;5B;6%=W_S2=>F"\73-\!3!*&=:Z]=;5W9R^@;`U#*NU^MU
M>[6<G@%@WP=-K2Q%FO7^1JV3T2R`[.,R[6ZU4:V[^`+]]2696YU.I]%*9;%$
M#<@^UI?P&]5F?7O-P1N0Q3>6\/7.=K?;=/`&9/'-)7S_2JM9=_$&%#(:3Y?0
MVJ']?DH]ATPXVRV%;P!\HYK"%RB(ACRZ-(L)C]6J6(OP?2[Z`-!`AA6-D9HG
M9()]B.(NCD:"8LT`;Q)<F+%#OEP:TKR0]`5-5-O[,,&0$0MZKYY__^KY4_3J
M^9/CA\^.'_YT_.C1\<,?+2UGX2Z.@^+"E]]^]N?7'Z,_GG[S\O$7Y7A9Q/_Z
MPR>__/QY.1`R:"'1BR^?_/;LR8NO/OW]N\<E\&V!1T7XD$9$HEOD"!WP"'0S
MAG$E)R-QOA7#$%-G!0Z!=@GIG@H=X*TY9F6X#G&-=U=`\2@#7I_==V0=A&*F
M:`GG&V'D`/<X9QTN2@UP0_,J6'@XBX-RYF)6Q!U@?%C&NXMCQ[6]60)5,PM*
MQ_;=D#AB[C,<*QR0F"BDY_B4D!+M[E'JV'6/^H)+/E'H'D4=3$M-,J0C)Y`6
MBW9I!'Z9E^D,KG9LLW<7=3@KTWJ''+I(2`C,2H0?$N:8\3J>*1R5D1SBB!4-
M?A.KL$S(P5SX15Q/*O!T0!A'O3&1LFS-;0'Z%IQ^`T.]*G7['IM'+E(H.BVC
M>1-S7D3N\&DWQ%%2AAW0."QB/Y!3"%&,]KDJ@^]Q-T/T._@!QRO=?9<2Q]VG
M%X([-'!$6@2(GIF)$E]>)]R)W\&<33`Q509*NE.I(QK_7=EF%.JVY?"N;+>]
M;=C$RI)G]T2Q7H7[#Y;H'3R+]PEDQ?(6]:Y"OZO0WEM?H5?E\L77Y44IABJM
M&Q+;:YO..UK9>$\H8P,U9^2F-+VWA`UHW(=!O<X<.DE^$$M">-29#`P<7""P
M68,$5Q]1%0Y"G$#?7O,TD4"FI`.)$B[AO&B&2VEK//3^RIXV&_H<8BN'Q&J/
MC^WPNA[.CALY&2-58,ZT&:-U3>"LS-:OI$1!M]=A5M-"G9E;S8AFBJ+#+5=9
MF]B<R\'DN6HPF%L3.AL$_1!8N0G'?LT:SCN8D;&VN_51YA;CA8MTD0SQF*0^
MTGHO^ZAFG)3%RI(B6@\;#/KL>(K5"MQ:FNP;<#N+DXKLZBO89=Y[$R]E$;SP
M$E`[F8XL+B8GB]%1VVLUUAH>\G'2]B9P5(;'*`&O2]U,8A;`?9.OA`W[4Y/9
M9/G"FZU,,3<):G#[8>V^I+!3!Q(AU0Z6H0T-,Y6&`(LU)RO_6@/,>E$*E%2C
MLTFQO@'!\*])`79T74LF$^*KHK,+(]IV]C4MI7RFB!B$XR,T8C-Q@,'].E1!
MGS&5<.-A*H)^@>LY;6TSY1;G-.F*EV(&9\<Q2T*<EEN=HEDF6[@I2+D,YJT@
M'NA6*KM1[ORJF)2_(%6*8?P_4T7O)W`%L3[6'O#A=EA@I#.E[7&A0@Y5*`FI
MWQ?0.)C:`=$"5[PP#4$%=]3FOR"'^K_-.4O#I#6<)-4!#9"@L!^I4!"R#V7)
M1-\IQ&KIWF5)LI20B:B"N#*Q8H_((6%#70.;>F_W4`BA;JI)6@8,[F3\N>]I
M!HT"W>04\\VI9/G>:W/@G^Y\;#*#4FX=-@U-9O]<Q+P]6.RJ=KU9GNV]147T
MQ*+-JF=9`<P*6T$K3?O7%.&<6ZVM6$L:KS4RX<"+RQK#8-X0)7"1A/0?V/^H
M\)G]X*$WU"$_@-J*X/N%)@9A`U%]R38>2!=(.SB"QLD.VF#2I*QIT]9)6RW;
MK"^XT\WYGC"VENPL_CZGL?/FS&7GY.)%&CNUL&-K.[;2U.#9DRD*0Y/L(&,<
M8[Z4%3]F\=%]</0.?#:8,25-,,&G*H&AAQZ8/(#DMQS-TJV_````__\#`%!+
M`P04``8`"````"$`)FVAJ6H$```@$```&````'AL+W=O<FMS:&5E=',O<VAE
M970R+GAM;)Q778^C-A1]K]3_@'B?@&T^HR2K#:-I5VJEJNINGPEQ$C0!1YB9
MS/S[7G,=P&8FF_1E,L#A^/C<ZV.\^/)6'9U7WLA2U$N7S'S7X74AMF6]7[K?
M_WEZ2%Q'MGF]S8^BYDOWG4OWR^K77Q9GT3S+`^>M`PRU7+J'MCW-/4\6!U[E
M<B9.O(8G.]%4>0N7S=Z3IX;GV^ZEZNA1WX^\*B]K%QGFS2T<8K<K"_XHBI>*
MURV2-/R8MZ!?'LJ3O+!5Q2UT5=X\OYP>"E&=@&)3'LOVO2-UG:J8?]O7HLDW
M1YCW&PGRXL+=74SHJ[)HA!2[=@9T'@J=SCGU4@^85HMM"3-0MCL-WRW=KV2>
M4>)ZJT5GT(^2G^7H?T<>Q/FWIMS^4=8<W(8ZJ0ILA'A6T&];=0M>]B9O/W45
M^*MQMGR7OQS;O\7Y=U[N#RV4.X09J8G-M^^/7!;@*-#,:*B8"G$$`?#7J4K5
M&N!(_M;]GLMM>UBZ+)J%L<\(P)T-E^U3J2A=IWB1K:C^15`WHYZ$:A+XU22$
MWDW"-`G\#B0T"4D8_5R*A]/J7'K,VWRU:,39@=8#X?*4JT8F<V#^V!;P0V&_
M*G#W"LQ80BU?5R19>*]@?Z$AZRF$FHALBB!I#_%`5J\-[+I=FP(O7:A)KXWZ
M/6TG?XV0J*NRFD\VNF$,#$;</K`"+]U@/#"Q!D8(\=$R0FCB!P$S09D!"H+4
M3TD0]QA#'PQVNSX%MO19)5DC)$9Y-$D26]L8$$6$!1_K`O=OUZ7`EBYKV#5"
MM"Y"`C]E-.J'[HJ:C3'@6AS29+#?<"TRU:DD".#MZRVO7K)4#I/'MD((JJ10
M6QI9C9>-$21DL&*'61@28U/B=6D*;$D+37/6"+D8R$(6A\DP-!HXQ@11Z$?)
M9VVG]L2;LT*!K?5HC;Q&R&@]CFX8MJ3W#*S`EBW#,L**(>1BBQ^SV*Z8@:!!
M$I"A-PUIL*CO,*5#6^(F":H8ERZJBTD\+@=63+,@@E$#88JSTEVU/`/ZZWU%
M,*%AS0]1.B0T.J@Q*"$)0]\V\`K`E'A7R!-,[+$T9HV\UAA=W93XX*&Y+#(3
M`H$6CY:L*>^NK8!,]P(VA)%V#C$0";V[S,KC3/-\@C$%JFB^>5$2#')(O6'P
MH;&U0,2,EJ5^J[MC#J["=S2XZJ_HY_V%D6T4T<Y4]8D&BR#JMB3K868\'$+%
ME*8R]WYIF-2&-#M3"6)T?R63Z#"?!_[0?*9`*^MO7)O3T&>#`[J`XT2G`7P@
M6B7.R!6$*?*NR">8WX9[P^RU.,1<5B>C+(U3R^),$VD0)23R`S*`3(EW;0YD
MNCNP20"/P_\A(4F8IE,+#5`<A1%)TJ%1#8GTKCVB0YM[!+/C5V.T0>`/C9+(
M`F4&*(`]+/23H1RFPO^U4=#I1A'8::PQ_;?OQ]\@)NJ3KQ`\X^'IY93O^9]Y
MLR]KZ1SY#G+'G\60&0V>\/"B%:?NM+(1+9S,NG\/<!+G\.GOSP"\$Z*]7*@S
M9'^V7_T'``#__P,`4$L#!!0`!@`(````(0"?Q.980`,``-,*```8````>&PO
M=V]R:W-H965T<R]S:&5E=#,N>&ULE)9=;YLP&(7O)^T_(.X#F`1(HI"JH>U6
M:9.F:1_7#CB)5<`(.TW[[_?:I@EV%MKD(H1P?/SXO,;VXN:E*IUGTG+*ZM1%
M7N`ZI,Y90>MMZO[^]3":N@X7N"YPR6J2NJ^$NS?+SY\6!]8^\1TAP@&'FJ?N
M3HAF[OL\WY$*<X\UI(8G&]966,!MN_5YTQ)<J$95Z8=!$/L5IK6K'>;M1SS8
M9D-S<L?R?45JH4U:4F(!_'Q'&_[F5N4?L:MP^[1O1CFK&K!8TY**5V7J.E4^
M?]S6K,7K$L;]@B8X?_-6-V?V%<U;QME&>&#G:]#S,<_\F0].RT5!800R=J<E
MF]2]1?,,A:Z_7*B`_E!RX+W?#M^QPY>6%M]H32!MJ).LP)JQ)RE]+.1?T-@_
M:_V@*O"C=0JRP?M2_&2'KX1N=P+*'<&(Y,#FQ>L=X3DD"C9>&$FGG)4``-].
M1>74@$3PB[H>:"%VJ3N.O2@)Q@CDSIIP\4"EI>OD>RY8]5>+4&>E3<+.!*Z=
M"0JO-AEW)G`]F833"$7Q^RB^'I9*Z0X+O%RT[.#`U`-PWF`YD=$<G&4\8PCY
M__%`+K+-K6RDFH*:0TV?EQ.T\)^A#'DG69U+0E.1G2O0["CQ`>_("+'U&8?9
MI#AUH38G-JOGE9;$JD1R/%GO#Z-C"*3?\<?"D8U2=]('&!_'I?);:0D*5'3A
M=!8G%F)F*%`P"<.3AX$(_5R/*!M9B!,+44L04HCH?G3J7@TAN_S<P(,Z]/&&
M2R?%%E9D86E)HJBB0'],238H,>#B:^"DV(*+S9Y76J+AQO',BC3K/X[ZCPVH
MY!HH*;:@$@M*2RY"]1]?AI*[X=6KA&QDP4TM."WI9MG$0W$<S4Z?Y'YDU3^[
MHH&1ZLP<P/`\E&(+_+0RZ3=82W2JZ,)$'-88>+`4&`$/\RFU"1@%5K*=1A-.
M)M,$3:=6^IFA&8^3*`#1T<<$M/:)=P#UV@YKQ'$1CLXV"*T9!NQKW@&\:I.`
M$X==XLA:@E>=IGMSU(9_S$:O@4,*G9X^EN@-M\%;\AVW6UISIR0;2";P$EBL
M6GTHT3>"-6IC73,!APGU<P>'1P*[5."!>,.8>+N1QY[C<73Y#P``__\#`%!+
M`P04``8`"````"$`1KX<UBT\``#=O```%````'AL+W-H87)E9%-T<FEN9W,N
M>&UL[)W9;AQ)EJ;O!YAW<`AL-`4$F0RN4DUF-I@4I6251+%$*A/=A;YP1CC)
M*`4CHF*1Q+RJA^C+&:">I1ZEGF2^_QPS\RV"I')I-!H-U"*&NVW'SO*?Q<R_
M_I?/M\/L8S&=#<:C;YYT-[>>9,6H-^X/1M??/'E_\7+CV9-L-L]'_7PX'A7?
M/+DK9D_^Y=O__;^^GLWF&6U'LV^>W,SGD]]]]=6L=U/<YK/-\:08\>1J/+W-
MY_PYO?YJ-ID6>7]V4Q3SV^%7VUM;^U_=YH/1DZPW7HSFWSPYZ.X]R1:CP5\6
MQ9'_LK._]>3;KV>#;[^>?_MBW%O<%J-Y=CCJ9\>C^6!^EYV,O'^F_?57\V^_
M_DJO^NL[V9OQ:'XSX]5^T6\^?9-/-[.=;B?;WNKN-1^FD2K=9W]Z/1@5V<F\
MN)W]>[-!F,V[XGHPFT]SYGB:WQ;-MUXSR^R[P7A>]&Y&X^'X>E#,.BRAM]E\
M,_1WQ&JG^9!7^L7G[`_%7?.]H\5TRCO9R\&LQWO_6N13+3=[D<];HX<^7PZ&
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M-7Z=A/=,]`C9&<Q%.^^XAYI"9-"W2U;U][_]_6_-F9K4W8R'?:;VS]DQ.S%O
M"3*[?U6@'/JH;9/1M:W-K:TNQ)EF,,RB^#_9WE9G:\O^F\U<@//%_&8\'?Q4
M]#O93F?_^6YZP([O57\8S&:BI3AA7$I])T,-3"#/X&,Q;$U)ZX8=JO/9VMKM
M[N_O5V?5O7]:N[N=9P?=SK-GSVSPG9W.`0VZ_!G6\$MGIGV_+#+O!C)L[72Z
MVWNA]^9.'/;[\.)XA.Q(UC8&(\1R,D"66F_6I`.V&LR;KS@#/69S_<T*BQDM
M'M-RM:(Z0X5C+HOY`$OR=)7B6MG^3X>7LGR]><LVKE(;J_1%DRPM3DXLG*U#
M[_YX.,P14523;U)+V;8Z:''[@T/6>.NQ;U<$H]FD+@I?NJ!ZZP=7L_1UY^_[
MYQ5Z?N0Z:H*S0EY*]CF?8RA<!V(?WK)[9BQ66LPJ7FM;S&1^5W:[FC_?%1^+
MT:)M3X[&LZ"@5UF,,.O1=;(IXLC><"'8G*UMF52N=3M;!UN=@ZT#&<+1>+1A
MAMMHNW&9"S/TQK<RT6XM>QJVQ</OBAG8KN>6O\^,AV.SOLT-=,U@?=CHJZ9^
MBLU^/9ZUC%C\/0,I.:SK`&EF@Y[U]F(P7(`,FX/^6`RN;_A]XQ`/(K\NLL!Q
MYRU8^(C.'L,BC]-5-GP@,3-*)&Y.?]6(R_3I*KUH=&]V7"H>ZRK[TYOB]K*8
MMC1D))<,]>->NAAGW^&+N!%>U6W%.)W).)V,@/UFG%8.`D9*&.Y%859JY;L1
MZ>;S[,5]<#:^)V7M&N5I]E";E_D@P!0)S<=B)G]D9O093V1P6XP;:.CO!`RP
MF``WBL_%M#>8%>KH4SZ5<_;+&IO5"0MI[OC*6?3&H^!=:QZ3$IR9B/Q*W3QZ
M9C.P8\9V3*8X#_,BFPSSGBGC!.9!OGA6:#%3)??.[TL[NV^6/[#3&A4:@23G
MTT'/-M[U2-A5<'@V*Z8?0>:MC93Z&BY1:Y$'X;NJ(=EK+BR^U^#5>]NL4A]'
M\L]>#L>?5MJTRALOI^/;:`59_Z$@]'(OI__GQ2PX#R!5?)$Q?L.P,"],2Y<9
MED=F5F8A\\)&RW'#O-`S""WT_+OFXE]4G38A^_QV/)T/?C*[U'SYZ";'99FI
M\]S\5#,0P](]:W7?],^L`2#P7J=,&VID>J^5G(P>1:,F74^0/>>KU70]6V!=
ML<8SE\]EGFZ+!.4&V_:]'(QP_47D>X:9CGM%T9]E5]IP<;1%"^#W7L4[RDQS
MU77&*MT%O*[T"(!?V:L)=W,1B<#T\W'0A\C?W1'Y>7@E:DCHBH`>NG4="V#_
M>JH],OH?PD#V#_FG*T(4]ER<UGP1G$`H;30*N@`P0I2G.?5[6BL>!$V7MSM?
M3"9#4W>X;2^(G"$V"\6O:&%]2FA91XHLMECY9#0OI)^:,X(>X]LBN\@_MU73
MJ^/3XW>'K[.W[UX=GI[\V^'%R=O3[/#T1?;=^_.3T^/S\V9G#S;(5F/:T[<7
MQUEW,WNPC^:@JT.4V;IXZQ]__;_8N$D^NNO\XZ__3W]^*N*_%C/]A';FU_%B
MRA]/X47$/,NSWG`PDF.Y08`0@'@Y&$]0ZK>8G84YG(:!Z36[4F@.+L1R:[P*
MU#5](2F1/<^'02]ITT9C\#`*C[C;-!O<WBY&8]I.\\D=%F[<7_3`\?UB-K@>
MT3'JD9%'A30E`TS&GVA$)SD>/&&ET?R?881/(^^GR&9W8(];M:+#/DO`7(:1
MB)0.9YM$/:?9D+"VQKJ>YI)J6W-?2.4C;_.:AK+YL%IF+K:>+]"N!`RN!D/\
M9M/-P[O;R<VX=S>'%]<O3EX_[62?;@8"_5.8RCK20C#:K,,42)@R42#K;M:!
M?E-;UQQQ-#.AM=T6\QS"0VG^27QR?)MO9A>LGD&L<Z;'+LDT6/A.(HGGP/\Q
M$)'GCX./8R._O<><;8LN<^#J8`1I^#E23Y2ZDCN@'P%Q-B^?N@\9V`<L!IVG
M`Z0\'P[OZ*<WGD[&'GE>,+`O8YAC/EF!1M`*#,:=%A_S?BX6.2\F[`Z8.NL>
M*)2_=;"9O2>:-I29AW`$][<@8L%_("&<R&A:);OB7)Q]&&FSF<O+J7DQ-!S!
MH19Y/F)&[.\H=-;=LVR!=XBQP/XI^C7-1L3ZM>Y7!6S%[A/B=^[VX'['2(>A
M9#9=3<:8&&;UUKT0VKQ<S$@PS&:M9``3*->YO6^3V+%5,:YMD?9+^L@V3S,Z
MQ&[WAJ[2I)2<L@K&SL=,AS`<&`N:BL@P(WSCZZDM9[4NZ&0%^+`W1VBZ&W#<
M1G=KBPD(X6J;Y,;,)D1ILW5D8H,]S7DJ.0SAX$I$(;D$;+)F+MHP3>MD,SN\
M0M':YB_K'5+"-F9WD&LX9+0P7@A=E=',RH.98TE>J8ZDW6L''CMTG^4AQ*>-
MJ_2HX:KFNQVU9`@4X27B]@'J%KT/THZ3$ODO#\N6<:S-[)U"N(2%V4<FPHA0
M]\I-,Y;+MKN,(D\1;(%E=!_OLQXGADG/\D5WA/_5.>#0MT&25B6+<^ZGX-YG
M.1LL[5V2>7G'U9"PQI!*<B6Q9!=GJ&/D\;*0!C)PRR)X'4(-Q6(B]-)FTG2H
M#LT><,`JD`#4MV+7BQ&\S\II._TDWT]$Z;<$2X$-H\^9-S6@*QJ\'^7$<$3-
M$MP'3`3A*\B@:3XOF.PB-0;`A:S0TEUC("WN*&BBI+EOID61(03*7;I\NS*+
MV4I3)^B2W0KE6#Q11"8LCB41,NT;KOPTF&,]/#$BH\-F@%!!/[.,?`.[*=7+
M<ZE1:ZL)O1_9TL^E3HP\Y.)@E-QL"_J>/VXK?(@YL!2O9%N*:+*8"M6R<W'/
M`8#3$.O3(IFJ_`JIH%'VDK:9$H#6E@2J,DCJZGSC#\B_+857AW<=$>N.<*\V
M4W)/F`V)=-O*W_5)7(W'<Y>$J3)5HLREK50IHE^'$@@*A,0B+=O<S>Q[@`7R
MTLEF"PQ1=7Z!LT$)3-Y9WL5X'8:!(VU^>-6D4,2,(U%W"-5D*#3U2I,J0C!M
MI?T;3\!:4)"VM\F8"?PCZ[-\*HSE.O5*418X1V*3>%\]E"NR;&'<63WB[<40
M/$7GP:EDSE)5_O/L1N94`T1&B>(I#*.=B],8F-$W1"5['(0A=@_O7/+CY3S'
M)@)V).O9U0*"77FJ^XYPJ`.*RY!QM;*"&J&%,*X4G'*($.1GUZ!'#49I85'B
MR[57%&Q@MR0B06:!BDM?]X$E#)'4FFX0YO9\5O=^.!HMV/MW)C%5<?D#`P\A
MC`FXIG\N]K"(@0G2\>=@T)GI+79*6Q@!_/GQD6%S?G+%TG5,L6?T7&5CV-D%
M42-V!8-KA(!;_[P8N5$/\R"^XM+=TK6O*>H8H%-;6<$?(3VL$5`03%&,KC$R
MB=15#\"9!"!M7H-9.<>:CL@-$P4%849%#@5B&CP&6#TX`]H9>T$,>8<CZ\I0
M.E!-9&Z4$7",+532]E<26LM80#GY,#KJCPP?Z!Q<>`-1P`Z?!C!O'*<^3)^=
M0ZY5B>)#:D-G9/7E3`TQT6@%:4N<%&875[$I5SNB$UMZ6E(<9M5RW";')2C\
MAPQ_W:B?85VIPQMVO$8945#;AK)B68Y.:LX:PG-=H,!G(`MSI]R?DRTR]U$+
MNM\^EDM"/H21&;&,<D&,M;W.]O-GG:V]YTG,YH^RG>:]K.UT=O>>=?9WG__]
M;W364S"'=6BWET7+LK!)VIH'1[%UTVG=;H<%];.U;K?;V7ZVU=G=W=&NVMAL
MM?V_S%4(ETC@<3,`-`:'4\9?KU"&(1*HIWU\@F?[S]D@<34Z83S]8.0-P7Y[
M;^MY9Q=B[6\];VWTBY+];(K*&0EXX<@MIJP7BYW?3HA)58F#UN=E\TZ-L]DC
M`^(&:7`P,+-I:9'[H7N#Q&8[WDK`%OUKY%#JTL0@J$0!WPCP*2P8]4T.1K)"
M2]-A[L.:&NQD-[BA3)YZCBDYXC)'AW9F1K%C6Q0R=85Q1$NB;6'=JRN#&W"H
MY0!GL[&*6:*^+?E#W#(J/A'Q@:D[BO9.!WW^D>9WE1.<9;-`TAJ5:<@VC*['
M6@@S<\-?^KM'X]`Y)A&;6B[R19GSRPZO08AJF:T?O3M\<?A4ZS%9Y3<\!NE.
M=B_9AE,S[JSLR$,D)R/$=DXF+UL_/3IYNJD,'XW@-G'W%;,Q"IG0?\P'0U73
MZ.D2=KXLA@-FEK2<S6*V4-V,8BFPM"><C)G@3Q&L5([\#3Q@=A`C9BK=UA/&
M)[`XS[9W`Q)N<>W;-!^OX?,-"X8YLZ3$\PX1`=6X!"=3#$GM4\W%$4,2%[`=
M^(0!G>.&3!:7:%W>QOW2U%#@:\^HGJDX2F)41=EA'(^^2LCVGVWN9+<H1/B(
M#3??M>]^;W6!O"HZQ^XMPI!`P?:V+6=WR7+VF^4ZOV`Y>YL'>P\M9V=[<SLN
MY\M6<TI`SCQQCYCLF%J1XA=>EAI?V]XI2041&VDH;90X95:"&ACH8XZCMY!*
M</9U:976&Z`8"%X+*F%@$`!S8`86]J=2:Q,,.(,/Q::@C:2<G-.C@3;6G>:X
MBRA<O:B<`:6K3%AJ0',*2Q!/Z(4&--&,":B%C#,O*.(''XCM68]A66,GM$#R
M2J;N\5"*F>43N`G5;[CF-I]^@+^HQT)I!I./-+'0OMRR#M#^3F!LMJ#N1A)E
MKAR*@:="]_#TLL5&19%'N3;,AT<RGA:FSY%TWJF)M=95?`Y^B=FH`+G1$K+^
M-HLD\55)+W&1((:`_%!JS,CA@H\!6"'PQC/6OVT,W3H%$^1ALWT#`_JX6LP7
M(!)>C)QF/%3=)`<Z0FSR3M@77IX5Q0=(I:!M6<RECGV7I^/%]4UBO8#VV?\9
M5,&?DM,5"S[PE68#J4I!-W,]ZCSLK!!F2QGUM3:JP/T%3]@H*J"B+%?%%N@0
MZ6I1&`_>0W63>L0<#=2&I5IZ/J*.L*4OS]^_>7/X[E^SMR^S\Y-7IR<O3XX.
M3R^RPZ.CM^]/+TY.7V5G[PZ/+DZ.CEN9B"]H^E!.8GLS^X+>FI`TY)R48UE7
M]<K3LDRE^:H7K4A%LT'60,G1IQ6=QXZ+6BIH46S`-(CVO-V&IY*E>^)@=&11
MRQ!<+"LB$S)U-YC`Z>?(+@M33PQ>!M&`#3'G'7M4E!":I:AEY940:%U<_CG`
MM9CE%#!WMJ1W^.W2"GA:TX]#+)FTDI-:,@K0E.:=U6"@1[T`*`.7*#=7#1VN
M(J>ZJ9`4)8=M-43ADIJBO5G`M]J,GTWNR1`#84.F4'!%K.LK=L5O7JVI&`M!
M5D/3`QPN]%M?BU:,8D(4T32M&*>RWP)*UM@K%(@_FK]F!!0H7J#<?;-(Q-R,
M^YO9V8J>M'/.(>R<97C4":/!IAZA^:1,#3\2N0DQ>&DN9A5GN9G]J%?(M?4L
ME`9'VR,ZK&P#[.A\AV_QBW@K]OT%W"4$;!"(-9`P`R7*I+44UJ'5:A`[:\4]
M.X&C95GC^%J;E3^DE<7$%NH8)F90D3+0C/'39A)RB+2K`@[EI^IT;4V(`'K<
MQQ6=!"D$YEK1DNQ-WL-[8YN[G>=;!]0R'U0V(+*5IP9BQK_6BEKG_>W.P?;^
MRF83K'FE\IME@U]!#K+3>-S$)*7QS$.@CGKWH`&0ZW,0B?>89[>[4QE058Q2
M-O33U$>XOHU]`\K^`C+M[SQ3A7=E\/H$EQ)IN]/=V]=_5S;3NKZ`4/N=?4_P
MK.BPQ;PO%5K]077VV1O3`![_;EJI"UCRR$SV'4H#<U]B7"3>TCY](//TEHAN
M`)T6M`4ETK,0*;M)B!3VUED1PYJ5&AS[^];'-_X'2^+'*1LG:*8N91L`R"]3
M6FE%3RHTFO;9<)BI,H6`9FHQ6*8!?RM3S@DC'2:(&KT$?V:R5(<$ZFTXUY+2
MP<A6#T4,HH45!+57C@ZO^8$%Z4;T\S411DM["$=;+4LP)>7JE%!8H"U9^;D=
M9YOBZWXWSJ?]%!Y]>7C^G<5'^Q1`DI`UO7%%!&'\2<UL$:3A[1@(8A_S;HBV
MIEYZ%R!S&>8'5TG#M"37\:X=:X'8Y;O2*DQY;?"Z^X^__L<?%TIYR;42BA2'
M:"KDE<RO<-`-B2`%EB*R#Y"RPCTMIO;>M^G]Q#:HD\4<<O`V_G+_H'*K8!]Q
MQ_A2)7P&`PH0+M8H$91)R)^#X>;#NQ5SV&$.[T>53@+'P,TL.@0R@F`1I(=Z
MBUM7P:T.F^IJSX0F^>,Q:>`N8=HH%S[%#*5)FH$[D+[S&0#)#R,Y]I=S6CV"
MY"[?9_,R`W?W*%&]$Y^9B,\DGVE%J!2"J5.\0GD-HUS^3FL][R7C5]EQ<%Y;
M)9)2.6B^2:ZX"Y3BW>#5P`>XDK$J'Y;!6N`7<E;ISMV0L"C-[I<E$H/W.ZOD
MIV3D;O,/I=?MRJRR<X%YO/!`HN:9!JCC,F>H8KF<V";U4Z67*<YXZ`I^7*$[
MY7WCY$,1-="_EQ)*#+!J.B&38..G`%<EDNQ+,((2:A(RI'1080S,JJ79T%8D
M7?H#A:(B(%1$(,8F4-WGU#4-B+<)2*6?$:&0("T5GF)6R1)7!=VFIR54J7V;
M]Z6(C0\U00>PBKU,%QZU=+1K'DZLQVUQX[F@S,9WQL22QWC,X3Y#Z*Z2]!+J
MU0`B203UDV"42%XU_`61I?%=@:+3$Z&3\A>6X(<N/!"I`(^6@ZO-B0MTHB(0
M0#U019I<;4ELA:J1*!^PBJEHK9.`BZK5V<49P\_E)*I2'*M(?A6CA3N`-M7>
M)4A@&PEUP'@(F!O_I!,C-SON%K5DV&$@F6FB=IX8CHZD[\27+[RU`Z)6M23!
MYKC<=@=1>Y3)7K%ZWX[:CD**"*18J&^'%=EJ)H%(%E$W`F&D@E7*GY9*@%]#
M.9ZB"-*,!C88)QSG%,'Q]RCV(8((6UP^%5K2"+%7;Z]?8AJ<?%ZE+S$-KK6U
M"5F>NL09GRJ*NIF=5MC<.7#I<2*\.]5I5\H]8!@TIBJ[5^^YPT0%I%3+MT'U
M)D%!AXHG&(:`.GN#*>=%%'^T4%7D10W`?T=*(%E,KKK$H/M=A01\5N47*&>6
M.LJ1>J*FDY@NBAB%$/R.J'7G=G#9=GSU\GUC`H!%(6@#G+>C9F^R0$N17="D
M;OW52=`&0`QQ`=9TF2:`*Z)>[H?00)Y]QY&+#QOG/8(>[$Y8LM":E-/MN%\,
M8WK-_()(\:J&KB#/Z6#V8>-*=4-6=L%PY.PL3.S)/#;ZXWB(P?=<5/IQ.+A*
MQFW)"@AOBLYA%_N*L:,,L3E:=U3E,7-3(W)#PEPYH4:!H)7`QF.(H`DD]8G"
MEG74_*?DEWJ(@3:F2A5S&L(>/]P_^R8#JS#_U$/HY/X43H,:[14F)XC^2]96
M]5F+7]X5RY-W3<-7>Z\:J_;4(Q!,%4'"6R!WU<P(K\G2V=E^](7>`"I@_=WZ
M*8#%-L4C,K0T7VC*7DY8)2#!FHNL-H1OL0/Y!%&,M<Q,!J]&00ON#;#$5M]*
MJ3NU](>)H[@<[@T:7#Q"S0"RD6J1?8;M;(;5#Y6YSC89I`3"Y(![EA7VBH!D
MLJJ<3/"^F`X-14,==)@*P(-3L$2EI7I!233:6PE-LP4LA&P>J^+*$\BGQV(+
MU&\`SK%W>%I)=U/Z3LEJO9>\&7G#\B2Q!WF`<]H*7Y.(IEM3^@N2!S+:)&/<
M-6#;:5@WP&#*0?')W5+A]84!7^4U`8VKB%BA0I[]99$3`X)"0:4W>?*((T7,
MSAV$E@-16N:*:8K**N%+.@\.L-$M,(-0/D2K]"YN\8Q=)B5&(7+)\2I5-!"H
M=_"U6D(FV8\]ZR(9A4)0Q7++4HH*BK-]_#WZL*HL0QM;<FN]N16.(^Y$9:VD
ME`PR\J8<^W"`V9<+X^/R2S#V/E2ECCQDT\+^:[32D1`-E8L71QE[*`KNF]N8
M$HR1FHFZQ#$84M4ACJ[@(E5)*E2D>L$*49D\.F29CM)&6)'EPF,B9]/QB'[]
M,&!CYZ?<P:.K?GXWFW!LXYLG$[';]&/QY-L3I>+O5+A!K$_+*UGDL'0_6O$6
M!5IT0L1NDECZXON)`:?UP_/W3\$[FS;$!J4LF;,L4])_SOB?P5?<^_.34##7
M%VT]X:\>-^P8G+UELEW],GV)-O!7+DALS+)32C?><1ABI*=7.<(.OK`>],-7
MUO'\VW?H`\K!W/U"-H)"L<S<T0+M0'U9H%5E0K_19.#A\_>1#E(6G*U!)TT+
M@OXS!7BBRQEPO3&6$%I?'H%QF"559PM,**$%(=%<JD"9CI3E7=9)BJZ9>HTU
M;]G[S7/.&1T>GAE4P*'565+*+$+(H(P4!"MN66ZTK#E9$9-+`RX9L[Y8FW>`
MC[X2K=RRG30.7DSJ)F$&,63I',GM"^'QZ['*QN6^A=.DLBR\C8WE&+2B4,;,
M*"3;<=?"HCXI>E77E&G\:NJX$F;(+S'&UH?':I!4JSU`2-`=+%E64])F,5RO
MZ(I4T"/31%=V@A3;;VZKY80X(65,)UWIS%A-0^N<4XP'_)FR*D?:UE]Y9K/^
M($1`$A$#1',(0B3!;2VZ.Z3@H1FUN%2@#HW](GT:G.FY%O&D?&0#IA2.:R+4
M`@C&.00GQI7.^GG-3`J^A1,WE*=20X@44DUMZ@7%0;V32O[')-VE>:7C-ZS(
MEJ@MV8]\N)D=.U_;.2RT*[(RHMR30=';Q$8=^`0_STJ+I\5\.H[WU["G`94S
M>0`Y)&6@%:_0=^JW;JUY$OB(R483POFEX0(T#@MH/0.X&,B)E:M2,`"6T@HD
M[8^7`2HH][5DN:CCT4.5F]#0S[_/H3AI2!7758CX".4;U.[>!I<'K9\O+N>4
ME_>R[>V]C>VMI]E&=N+I=;2[3XF?CC_#E?C[Y!084AO^?K3@3`!')W@']R$L
MT_JD@`Q9"/#(,E0ZC2!BY+*ZU9ZHX.'@@7+3TC=FS97*$/S59F88,X]5PI<X
MGZ'$XE(ZT7)NZ#_5>U`D<\UX2SH/%;_:$^_6H%5:22A6`Z!`0O5D050YI1/9
M0FS+\BF+^4`*")(*$=+FI</V\_PS\[=RL?".BSG2/1@MQ"7ER-)7C!VV7/Z>
M=4H7V#.1&FUNJ?D-&'+#<KN*/N3"DY7$^]*)5@XM5'?([06^H\*2EFT2@<*2
M/8BL@4LN+!,Q)OC:<_A<T!=<NPBL@%2X5K191XV+#\OE?R-%_FM<@AC5U<EC
M=<?>,CW0D-52TI,$&FL&C2&0;O<00'<K%,B3OYCRR6XJ2ED5BAT/K58+99J2
M:VGOHZ"6UQ6^A:@Z&V.03(@N0#+41@621;@4$UMHPJKN%YL=`T<X57GMUX/,
MJ$V=?=`QFQX%7MJX<)IGA.0Z]+0(P!%&R%7<F5<_!D`FO](UI=H^YI0!A][B
M"0.*U4SGPK,>$)JCZZU@U'*"Y>D4L723M%$K-DD;98U.@P_^*/J>7[P]^L/W
M;U^_.'YWSJ5I?WQ_<O&O3<=GV3L/533M$(%_1->!JK'HLSGRVWNK61'Q6#KY
M0*DJ:O-15:_FA^)=`M5HTJQNY2>&3/$LMVBJL#`;INL+V"_Q0V#XF)E09UA?
M,9_Y30]4Q!J05-&M&DA]B.==BVEXC)-'YU$NJ=\8HO`YI9]5K6$9B^;ILS!#
MHA`)W')0:*C[1?RNS@B0@_5"5R,KMQP_VZD*5F[H5>LW?+!`)D+Q.P,WC^(<
M'RG:D(I@MSDQ+-_(%%V_Z'%=&4BB5&>\6R*>\"XB)PWKMA$C6@Z,6XTF]P"%
M5$9A5'01E35\:%4K9ONRN)PZ0HB'@9HL>O(%EU4P]0"R+2#:[.K%PGA$'/3@
M60I76I'1`F#A3JU69;=8!E+:@'Z!AOI'$8,;[?P37+W=*'8Y5QAQEAW"R%88
M8^6;9VGRYUY]=T$_X<QKI;M0-Q5F)`:,W@R[RT3LO*0NQ!3K8$H8?H\:\CA-
MK[J2@53&`,WZ\$PR&+=]BA72E.LVIS2F;XCQW#:<>&[1==J7SGHDK:6$F/K!
ML^V.)EK6A878TK+21"D"X(9I$;U6IKRP[[)BS:R/S4FT8'-4PV:9.XNVY?%4
MP\QENS$/+<HS5$@&Q.+65^M%06\!?UH=FOM&=C1,W7107!8339.K\U0LE6/M
MXIC\.@+$=KR_,:>:CPE2!?%::ES9$%]BU)#H'V=,CQ'5*M]<XU68!^>9V8);
MU[CL<J_;V7N.5J`_USA<*+=-==/S9WMVD#&%12&X-M6)AS<_]BK+B3(]L&.8
M3WM-/B_#9R&W4DE0/RB>P:45[<;,ERJIW=T]TW22B(I'R5]AJM$A$GM8B%A4
M*Y&19EKB7=M5?FF>/;&=2I7\J996/:;$A$6Q?6:*;DA2/5-%?P#VI?RL67,T
MK,L]H]U]7?50'G$R1R)60=564\\%A#!"Y$(1M16Y;-5H2D?TJA6:ZXUZ9>/9
MDK>%I\#^.@3]*]?XMJ96+;$,[L873B[V\`5%HJGXM2Q!UI*#-%=#]GB8/*B7
M:IZOKFF-^H#@#)$)-4UQ:O*5X^D5$0'BNTV$@Y[VR'YD'(,F93QMF$_8G"5*
M+[>,I;%X#/%71!T<KT,"5H'68A+9G;+P;&[54A0R*1'T$QHFS@0&@.U+&Z"J
M!I76M:K#3JTF6L<=FP;9Z=7\]<=P\4/S]W#-8_/G5\36YG__VPM\Z^:CEY1#
M_OUO/ZAJL?E(:>R@=UQM=U*P8L7M[#9.^Q;*C6;//R!X[=?6#[8IYFS=]=VZ
M<1,4*%9H=[!DPG7EU)S'6O,'\Q>RMV>Z`NK<[H#Z\?#=N\/3B_/'O_F06X(=
M^()AK+KFK5?(->=PB("(YRSU*+4K5;TP`^>FP\-D6+%&X2^!)L4%U*07(H^K
M+`OO*'R#+@-T*ZYGX137;&K?D((69T=.S5:PYCN^2&`EM*W%16/??/!>.<3F
MC\>?_2[)YN^@1XO#$N)J/CKA"3F>0:_YP*G=_/5,+EGSQ]=DZ9N_+96EMY6#
M)^Q&#/JMD*-GFWN.G)I]=[>6_QZ7W[J)[?CS1%=L?+529AH3NU]>PC"F[EH\
MU9QK@+-BD@>Q2AWV)4,`-O**$Q`,[B.\BB:_M]Q;QD%GT3]1.A1O'-(,`I0&
M['E),3CCA16RVB'$"]ZH2XR'/!3F=+Z"\:-'?K`98)1TH^S*E>R$LH5`F1#Z
M516ORI)GOPLKT`]>P976P12Z-3QO_8$'E;$+\?6*H')/BPM*ZK%*%%?09M`R
M)<6(?*8$_(A8;=B"D%\..+Z%.*%N5!D-KXFQ+D&]._O/S4\KC]$\HI"CAL5+
M?5$I#?D=-X\^K=3!6(F,T.9V=^>?.CSD:8Q"I&?=S9V#S)_R^*=BBAL1XX&Q
M(":[&^"8N;9;'WQ\6KX1JQ+V@XOR2[C7E&G;;1/$ML+\&O3UU`UKT_73W8/.
MSM8S:[_V?(L+`V!NH8=T4[_^&H9\A`=VQ"7"+/108]E[X7C4I66Z+>'RZH:O
M<0W!_EYG]P"^J\!K7&N%NPUYP05EB1J(O+6VB+%CO\[5>/I6&PTVXG8VS=]@
MI#FHX"-=J`2+72DE92XC6X;92H'Q!@`CB3+_]FT,S&V3=8;Z4.XA2??,D?P.
M!/[5\COAK"OGADK.^)*L\V^3-UZ>N&^GT7^;T;\])O]"?E/Z,7EG9QP)]D,7
M3T373'\_X8!FY?HHYPZ1T?6I8`$5!WU8N>*FPZ,[>XW`#@Q3`F(IQ>"BF=)O
M8Q<$0'6.QA[Q@%8%7IL(+'MG,6J_)<SC,J-4=_H*B@_`87]'64E31Z]4HB8O
MM;Z4\F!B,%>N9<AN!5ULOL_'>$F#5EHY[QA6:Q%"X\9$Z,#J]3PAO/ZV-Q_;
M=8J[QNT@AX>YG55B!=@4,74W?(]$>4'R.!*U<J-)#=@K^D5';#Q6(:[P0C$C
M6SP&&I,'5C!`-YI(:FW5!?*VT%PAMY<RP!X=<D)Y"`I-$"X0BR::W/IH1#;8
M*"1'.LS5-RYJE1KANK:0J`!3Q+8\(%)NB@6>TA%[V^HJ__EM$_4%-72/*9[R
MUL>N*Q\VY0(JE`1KPXR:\EE]@Z,HN?OP5NW:FLNMLE:VG[+<86<LEV-'W>5&
MQ.WS0!>2:JG^6[Z&5+4G\2U%-(5N*L'R&,(JQP*YA_L-5EW`R-TT@F0-K;#=
MV;D7QMG-&X=@KB$WT!F_[]FF.%4Y-2J')&Z3DX+CLN5YZPJ[!EKD5.TR$?BI
MO`S'*Y1;=R9:Z"`<RPPQY!J[^7@Z.N<&6]>8F#5KK8H!=QOQ\!8W_;CBYOL'
MG;MTS**%Q%W`))6_M7?7\!Y:HM=$53N;Q$;-P#>?G%BQ6?/7]>?;73[0L=7\
M/;@US9]KTT'9!_3^.']E9W/OV?*Y_7Q/1DEC%"T72\$;^K86YV61*2\?BD?Y
MDX^!G0GK+<_0+',;XDO!T-!,`?ZJ86UQV6MNCS@]/[:0QM';-V].+MX<+XEJ
MK'CMH9`&J?P5+9L[=&I5";FNZ@PI;C/YWQ?Y4/=AAJ!$>NM(4>%I^7*SNV,K
M"9<I.UQ<+W#'`*ZR1#7CF(7[I7/4<PA?T^`=B"5]M^4%/E/X;LNR.YQTTX?$
M*<WKY\T^"Y<ZO5<$PSJLYEP,_7JE5*\R3R&K-,]J_77*RM07:S4AJGGV,K\7
MW,5X/I=+F!U2S$U-U@@4<=W)WFR^V.QD9S?V?RJM)K9_E7'K%#[R^8*3*825
MO@.L]VY,<8:10^T5]+/+LZM7>BM=EVI)O!)=.IJ*&#R6Z?@.C[QUU[5?/YV.
M7E`&'^[Y]LNIJ=5>>@=WB[TKMA?Y2C9)>2N;`F<]?0./3LSO"BE*\(A)?+:^
MAF0:4-5/P4M^6D$#=IN76:48NMGVZZ!@.'%&,/S2.#V[MT063V;*$FCQ?D<*
M//P7.\4,::RI+@H+MLEN3K5X@D(8H3Q=\6P#-\'N*?N=L*0:+B%LF)5US3W:
M7AB)\=,`EHNKG1%@XW7?.+.QJ]"CSDFG`\0986_"O3>70\"LJOZ&BQ',1"2-
MS/?&2.5;DL9+&=FYVZ'OSW[8P->/][1A6!%I%E1*02*+SQH>]/FJD-"XW/?0
MCTO4R&U)56Z18'#3(X+I?M\ZZA"?D]W'3(O*:0S#?.PRB[1*S]F<"X5I74E)
M4=^BL7!21949G]TD;D]@!O7T%3#>?B0U66R,*2+EU7A_MM07?UHM8452ZWNG
MR<0JRWC+G+&!8VT%61-PUM[JY&W@%!'&W(Z(8D(UZ%HW70;&FVOI:C#(:6$;
M.Y`"SY2G"VK1*C9WC;2RV+\&^\-!%N9[-9BB6Y<V%VO$UN++LEJ!>D96CEJW
M&Y1LB<:.MJNEJV]A`6[?\;/F$\X_L&%5R=#[:FUNFCVR6Q=4)UAV:B<&][<H
MJ+OCROW1F,/SB6R>';*>6XKC2TR[F2=A7V?3*/*53.K:WBZ0</_`WHPJI1G0
M@6"F32P6I<]_IE@+_,K>EWE,35GT76D"0MHV%;*F5*U:M3.U+7AF\ZR'?#OP
M3U"%K8EZZ5#0(N8<:`-PY.I'YY&4\+NSM`2)$!('U%007+N0HK4?]UK8U=8_
M.L=+S3\.I&D"ZIP5'#Z#<R@(?0V',*&JN=>L<81;3TQ;FZK1&_=.42H/G56,
M>BDI4[^T.U2;!<!#;8F^EA1]9G7/MW[8=C,;;$`%&'V_H"I/U2CV?:5LG9F>
MGGSO'N!9)32C3EI+Z&2\&W.T2;Z"RB%@KA.KNO_*#BJ`'H;]3SJJYC(GO4:%
MJI$+$B8HP,],:<%-FG/E95'K5H.*"L1SP]B#('`+]3EE70YXKTEOX`K68)8H
M*-<R>EXS24OM'O?T<31+&%MVA@N)S!2E/[46.W^"3@>&^ENN]EI$BXK8]4^4
M=R@@.`&B`;/*<K!-L\%GE;XH5I&M[__34_VFJKR9W3>W7O%,(Y&B]ZTS08O;
MT!O59,$D/(618H^PDVN!ZMW'=.E;(NDR%](_C8$VL>U:<"\LV4&B]B`X<H0?
M6D.H$DJ\TCA7%R<8OPMCW5&\IBNK=!=B>>[.+*F52+%:]51>D6/'ZBP/K\FX
M`O:+0R"^94W"R06LLQBS&EJT.<6*(ZY2]KXC]<-L`0:8^K0X9Y"E_!`#$-)7
M@C^BEX8(K`7:=>O6(RZI7`],H5V3+=-K->EUQ>]A`S\P8INO:^335-(6^CD4
MXN5K7`_J*M7Y;,FK$7$YI3Q=5D%_(#X/0::FK!^)"\3H8T'"=8_E6+8[36%8
M(^/$%T$,Z6K,)<+1?&6)L!Q:]1B$5.B.F8E.C]D?;9F!VZ!,M"6)4YRV98E7
M2=^TZ#8+F[]1'=[H8!@),8W821R6"+2SCR?N8*=I3XBR)OCB8;TFNJ]9DBK"
M9S1-HZU"2K/18/,R@AY(!R?6U7"@DK1U_#:0U95YI2/U#Y"/9^BZ4G6'-G8#
M.>_IO'&X32:R6/EN"*R'\'7%V3$_PRS0JF75$5`%HT<_B\6Z5:%B<\$)-UV^
MN9@0)4-!^APEAYQWE@"MA6!@`D(@O@JJLK]6.,$!`7W1'>"N(9LP)N(2YM-"
M-*T(6QTGVZFS.A'\()@L8&DG4AZTJ=DKEL*Y(I@2*7[<@:");OE0J$Z:0<D^
M'V?B4[2_OHV(YJ>LTN4;&?)G.(6%YJZ>L*Y(7=*A9Y:@WT[?%"/;LNBC(_3N
MS^AH9VE'%E/S<TCJU[7W2UQH#WJCOY54XJ`VI^TRI2`XTB6[+`'((XXQ1TU^
MFU[&%)C/!L[FP)(Q9HS-!7G"`2UZ-R-!&2R^+VBYV1#[W#O(<KLB,UFNIFF+
M'M.I/@(05VWE^M/V%5U?XNW8(K$QEC$A@5(RZ9>C&1'9H9"7Y=G-#L'+)?@C
M#2=(U92+<.(2"ZWM6(EX:I];$!4KLTZV`YC&8<%T9T`RG;R/='^JS2A(044C
M#O^+P*F6OW2<0/OKIC^SQ+K]?D%="!%URS'5=7C=21IQ4C!Z`ZV.TWU\;SCD
MP8'-MM634X)+GX*S:'!8^/<+JM&WG\71DV7\GN@QAB#V%F*^1S8C0Y\I5)O"
MKO[Y-O.!0C/ST;`TA.]:EE7&Q,/P55N)M9&?LV&.3I!S<6+H$*46#"02:^*)
MB?\D1I7[R!F^<`]U12\P#B#9(XY@4>Z3=5Q:QI/,!]I8%=9T%;7LZX2*EA'B
MHK29D[,#!8]C#`3L)[VAOT5C_3NNA;(?)CF#C3DA:$]BZ_`BQG-0WC5G376S
MOZ^PNIA*KQ5-B(>K;T)XSB2<DM2;Y;YSO-$,?*6]!_0$+EJ\W'1B(T.T&+#.
MN1;=8F-7PXMMJT'XY>A"L1]"6I%`J3Y`,,;PI0$!$#\*Q!%/"O3?LY9TV57J
M+VR/&Q@[Q1^VQ&*:LD\B:%+#D0,YF'D"JX:[TNM$JJ.3I`<3K]C-,S:3NI57
M)9(?/DQM,'\/H)NR407(L*C2A*S?@W/TB=<ZSC'QJZG_B%-`0);LAN5%<$=V
M2UUK.>J7Z31[TCU.8W/XF&#P">MW.T8:53C?,(`O@1ARQ8'7*-'32%\[R*]S
MQ5MMTRH$<6!8NOSN)MM'\2+_&%;`/"EC6H><-78#MTR$]06R#>7@9WF9627N
MGI8\*:^8Y*.DW#NE`+[=E5+HV\**3ALZTB<>JN=3`@^"LD1M/8'T>M44HO*/
MM8#[2HYO*I9:2$<H)F0((NYM>.#'"\)+/LG?YQ/D7G.`4.XZ._+1-GC87LI8
M!EX"$_PL:Q!GE^2BI8W^>V*E)B@HS?R9;6/;EC=;5)WD6)M1US5FN)=ZIZO&
M0&9BAA7'\5>QXMIP_/[_8E;\@ED%\UQ7)T$H8F36[IF:V!7FQJZ8U/#9GJ"B
ME(Y"82D59>`X!0A"]HNX6LA;R<W&3E]L6,)V,IXHD&?":X(!!D!]5*^WOAE<
M#BS2)]0TX5^SA#Y*U,$E1U1U$5X5G<.*5/B&YO%"98FD`X$*_A@*7J3UN^((
M,6;#(DL^CH%%^]EQC#+4L8KQZHR;E($,N*U,D:,OB&/L6ESIEP,-$?41-?.N
M^2RG:RI0S?XGC$&H.\*#_PECA*^%))G[;Q'&>).23L+"YR&'=AAS!DV+A0I)
MF<]V<5#=6G'X(B:T*GUS#CUV[J;J]7CT4Y[]F`\_4,KPD=@[T/-DU-O4QV]X
MLJQ6VIO42QHJV3/=`=G[0,2/.L:;P<2T/F`1U7VKQ+MN!P7KSA:JR''T$W]%
M/5)>0]2+E.\"15\6<N!7VSPUJ(64:,IM,%[KI.79#64AZ[$QZRGM44Y)+\3(
MF"R(M$NM\PM^N!X3;R-&B=]<30M2\0,>'W#;GVYDJ5*TV2-7+EP78>RV;3,3
MY2%0KQ=V\EORB)#>*^X):^S8F>Z4)!0RR]9[K]Z</6WA.O"+!2)"%(3X%O.W
MB^[\W%`MAVYU5.OG;W]\JA4Z-1V>B!H/\8I#=D\76=I+9)S%!"X=RE7TJA;=
M-J;8A;IE.)'4PIE^`SU1F[4#/K=A%1H!F-Y?B/",@^G[SW;%%"%$KCA`'.&A
MB5>8/!JS%"[G$W$Q@X2)CTZWNQNI<*4<BL6X5V9Q1$7U_5L5NB;U"ZH;W/7^
M8DR>,+\&#G=IK]FG20^Z/Y,V389:?GXCA:R..`?&@>809BG5R!(EE8K*4X2,
M6$HMXP2V"GD0LG*5;@VX6,(F`>F?'U2#+__,1S"YZ(G1]<%?<\30.W[++/*>
M9B$`4BET$D7]QB9*P.X-=7GU(,QN67Z;M`?)T$\Z+[[AQ0((!SK0DNSF:7J<
MOBI68[2,:LZ`PR7/5<B!YN.<U>X.'^9Y?E"]JF&'+\QVGS^WA%JLCUK.9!MV
M/BG>;%$@1-(Y'$9,GS^JH\AX.L)YG>5`1\ZEJ=('R@&^:0^-[<-VB9(K]K/)
M;-^^/GYU^)KOP;T].CY^P:?A6N>26R\\5+N[CY6XOU.=MEK.Y>A2+]+?WHD\
M*P46'6TY$%;]G"M8-1D37W!OQ;1<^05)G%`[A:R&JSZ);9;`='/%H^?O*RM;
MM0ZYW`>UB3FT>CR9-VYWLT^Y119QH:L<Z]+=I(O?[&B7KE_5S-[DW&K(+057
MV2NEHKAB?#"><`_";1Y0PTOR$G:+ZO=O.1.ZL[??FNAO<_IK^:ZVSY[]AE>X
MKJLZ]0/_0R!GINJKUM+_L_?H*)0QG=O1^S-23U03$NQ:.K'_S'VQ%$=K%K_-
M#+Z5ODV1LR2].EL4T)*IL%+6>1`-NE@>I,,WI@0A:Q+HJIM+Z(C+I$XUE-!=
MNG&&:[PE+WV2CAP$BY=TD]<AIQ(P4E0Q`Z+1@"KDGE=U]X@@3F/('\,GF'63
MJ+XZ[X61:.%D+)F0`6X6@9#63CR!?]3<+O((-[W586I_S(<6,-.6IT>?*Q*;
M2D_C&EDW`!G5W[%C8AI/H%S+$V8"+IOA(X.[\.]Z"\1BTRRV(WJ&]09[4#\<
M>,'S.)!UQ\'V5LG:M<JRU1-C`\BP:1PA-G+&&_:AI,(W[,/M8I0BO)?%_%/!
MX0',F"[K7A)*C05C6.I9C`E##XKP!<(]2A[08]B9\73##*&D2OE[+J$T\QX[
M*(O%TP[%+P8W&ZH&@DF7FU"SL`I-&6F7S<U;`D('/56/PZ_<PRR.K=";K_)8
M>[8B+E,5!?ABR7+#?4['\J[#3\4E6$EU`EI6.3?]U2!O9;KB<_]4,CF$&Q*-
M]FGC*8S"SH5Y/#!;IOD%TVN!"QB)U+D*R\CW^Z)BFG,(=;@66`",[WWH^Z+(
M?SO1*K?%](#E!I&EL/U(1\!R=Y)541B.U4?86I,X?__=.7=`<CHI._YAV1FE
MU@L/(9P#3L`\V*FN);)[.>5?!UU?7@$:##DI$=!%+(27K@`R[M7AG^0Z`9^U
MG>>[G3V.4.,JK3[TE4[R13>;<D@0$6J$$;I[?(MR:S>>*N:7!P][`<MTAT2X
M+I!T7;!HE5.1IN@JC*XS);$Z,K[N-VC8FTM.LS*12GOC=/[F^C0@&4DE=!W\
M/^/*?(Y`\IE(*SDL#ZQ5FF(*)!3PKA_QA50`-]/D\;/O3G>_Z.:*&^:$[>;B
MM'0I1W>K]A5XMS-!:5(NY9>=$A$?TC>A<;^$BI$TCW15I>33$FNNEPV\VOMA
MK8']0SU*M>D2+G[T-YVS]3/NH^VA+5LW'2V[OC1;OU"J<\G+\1(K9OM.1ZX&
M/5D5AS&'V!/=//7U5_-OJQ=0K[Z)Z%'CG,_CA4,^3#A"WQJE,K5FDQ]7G']]
M=7QZ_`Y?Y^V[5X>G)_]VJ"N9[/CB=^_/3TZ/S\^S]1>Z\WC(IZ/7WY^_R-9:
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MAS4X_7>BJ&1K3>=FJ,Z6748%H62=@WI2<XL5HPZJ+-*<SNI6#/*1'=9%`_[9
MD6;3+_A>?"FLS4Y<!,+E&]F?WMBU3?_>?.L00&EW%0K&5NZZMOPUPNU(60H?
MOC+HS+*/X[?0(:\+1O:GU[H2U2Z[_ZW&Z'#64-<E-Y<0%-W*)1ZMONAV99N6
MGE]%O^66Y%2Z5P<V4:$/*=,CDK>&!5Q'W4=(X]'D*/;]6EODE9MAFT1Q=C8[
MWGSD](CW`]?5F\G&_^?LRG4:B('HK[BC05!P2#1(`18:(D`12)1<!0U"VD#%
MQ_/F\GK''B=01<J.C_6.Y_+,<]59KX6N;BT/>0:-"^K\=!Z@4FE7M]_CH(T<
M`$1"PC\B\+P);*O5<Y_B'F`V.7X-44K11.%RBKO[_E98:3@T7>CDD*,*1ME9
M*1@[;I<H%'C%<V9;;,%$@G-)9JWPB)^Z1PM,5X@[K],%B:'+?'&W;]4S8O["
MXHCJXB*C$PYE5FH6@<Z]#$;B9U`:"X?^8<EA)*'RQUM@]WU(V1:5*9=TMU('
MEA;P#5Z[4FLNO]650,19<.LJ_8$DRQ=S+<!)V>SVDX9C(\!/(:=,WW(4<WJ"
M@&ETIJ`ID7R:.K/\1;B;&_M=:O)=U&M_W^#(E642Y\?H!B/5X6=_@DMFR(ST
M_R^?<#J'$KMH]`#IQ'`'PW;,\R00[".*G^.'Y_T`@P:X;-A/"HSDB09#Q/O.
METQZD@N%]V=@/?\PM^?8!`X_!%$O)"-8/?]0(?;\W]4ZI)]D0O:2"\ZCA>WM
M]U)2>5=#O9.9G!H8YAP)O*+6A"1_FMW4]BSZK?R;\L8>%?!`1O`D)7+-E*:J
MR3P]8GP2TDH!Y2!B@).1^Y25Y-6F,/]:MF9%GG%<86QFR%5D$];L4+RJ?S'%
MWTD'P8ZSY\?!\T7&.<S@KJEIW9?K<O8$S+,:VO6_3&;^[(S+O.T7\=6,4ZPG
MOTIJ:R1;!:@LQCV(Z"#(18"A!>$C>+H`NF>S25AZP9760R4EE*E4>QQ50UJQ
M"CEGT$+O7/`^=A4=JDX99P"QI6>Z+;?A\,$T0:8T3F8Y[EI@^N@!K)_&`)..
MPM]`)<AETI8[YFEOM*Y<RU,BV70FY>8;J)`5@`.2%ZI`WT"YQ(GQ!RY"S"+)
MS\LRF:]M22U3R1-FS4]J7Q;<DS3S0HK<I^BE[S_+RDZ<_KQ52N`<=S#$+S%_
M"D5`'MO=%\+=^(U&;39Z!`.$+0A`Q7K;<I!&D_X0R!BU(?SRXJ4((<#J^1E`
M`(%R!#YQ+%QMRRIFO<6&_'H><0"`,=(`L(!U=S^M*N+`]V8%0+:2&&3^K<)^
ML,)>[DUM]\=Q??H+``#__P,`4$L#!!0`!@`(````(0#EP@M@T@L``-1I```-
M````>&PO<W1Y;&5S+GAM;.Q=^V_CQA'^O4#_!X+7%@E06Q)%69)C.3C)9GO`
MU0UR+EJ@*0I*HFS&?*@D=6<GZ/_>F>5K5N)C*5+:M.@9B2U*._/-?#.S3Y$W
MW[ZZCO+9"D+;]V;JX+*O*I:W\M>V]S13__)H7$Q4)8Q,;VTZOF?-U#<K5+^]
M_?6O;L+HS;$^/5M6I(`(+YRISU&TO>[UPM6SY9KAI;^U/'AGXP>N&<'+X*D7
M;@/+7(?8R'5Z6K]_U7--VU-C"=?N2D2(:P8ON^W%RG>W9F0O;<>.WI@L57%7
MUQ^>/#\PEPY`?1WHYBJ5S5X<B'?M5>"'_B:Z!'$]?[.Q5]8ARFEOV@-)MS?>
MSC7<*%16_LZ+9JJ675+B=SZL9^J5JL0F+_PU@/C=OW9^],UOXE_O?O_N7?^?
M7W_S]^^M]3]^^.KPO1^^5GNI&B(3.*B6>=FO%`MOQY)[B06W-QO?(X:,P$WH
MK>L7S__B&?@>!`.8AQ^[O0E_4CZ;#EP9(+R5[_B!$@'+8!^[XIFN%7]B83KV
M,K#Q8QO3M9VW^+*&%UA@))]S;:`)+_9B#>?5LT0TJ4T3A,'9-,0KU"873#+Q
M8K5-YH\%-G&Z1O6ZVOB/T\6LJ+:K,UV'<7'@PS:Z,JZ(GN!I.5,-`VK(H-]'
MMU+"3J1LNNB#OK,INQJ=S;*A,33&G5K&Q>(A;ZAP:'3IRAJ%QOOQW=G<V;VR
M,NN2,GRN#,"$Z]:+-J1N17Z/#?PY1YR<N4,[#6-,*E?T6>KEM?'1=JU0>;"^
M*-_[KNFA8VFGQC[-]<E<X)U&_(Z&P&E4<%'6O8HL@(GHI(/2V#\^@!N3<&+X
M*/YD)+!H"B',;,?)AL[#$0XNX<KM#8SB(ROP#'BA)'\_OFUA:.G!A`/]UHL_
M5_/II\!\&VAL@"76(/0=>XTHGA9L0)OPM;BZ-Q;W3"]!)HJB1*AA+,8G$'H_
MGRZZ1[J83KL6JAGPT['0]R/\Z5BH`?\6G?DTZ5+TKD!F\I3(Q@EH_W(\G4XG
M@ZO)9#+5AP-=9TY>)A%M>VOKU<(Y:6=N.D0P`@33X61ZI0&0OCYAJLZ*8`@`
MQJ/19#28:CK\Q_JPTR/HVJ<P!Y?,*D$@B56"0!*K;`[4ZZ#R)YD"RT&2624(
M)+%*$$AB==QQ!1Y+9Y4@D,0J02")5;9RUV&NPC*KY%PE""2Q2A!(8K6SP6=2
M@:?2624()+%*$)R;U71:M;B_-]@ZSN'(K+/Q<:(+!_'-=;%9(\Q3EWZPAOVP
M=)-G@+L\\;7;&\?:1#`C#>RG9_P=^5OX_]*/(M@]NKU9V^:3[YD._-E+6Z2_
M*UK"_AILI<W4Z-E>O8`R;ODF]DVLXE0:LJJGXVQ"'^O]L3[2KN()6T>J76MM
M[]Q#ZS+=A7$);D3?UAM.?.AE2I)PR)<0>\A"0I]@"T8U8UJP`<1$&A*"+;JP
M,5].%[61M!"SD300M)&T$+414J<HN5)/KOT=;.WN$VP8DWX_7KD4U5,MD``O
MB)AB$*3-H3]KFQ1XM+9-4UNAOASDQES#'S8Z+K"TIL6AG34-"JRL:2%J(Q\W
M*;N<\&SI`LMS`9(]?W,?/PX&*(H;IGCVBF!2GW!')=Y3$2YWO+D'>O9,::8G
MZ;J@)UQ9CO,)^Z:_;;+N$%:8;F]>-^1P`IP8P=U[//N`?\(R;O)GW/7%+P!B
M62.MM)%B;K?.V\/.75J!P8Z1,!7L*BX7YZ_FK,_.7[]W["?/M=@:F1J+^2[P
M(VL5L6,N;)6^#,^P!,\@$22"IXU^O40_^$G8'VWTPQI,(8G@%ZGZ(;B$]7<9
M#WB@)PEJH(`&=16>+A'`3#M%`"3(0(`'D!(?0'C*0``SF!0!!&B.`.!41$6;
M/!B0:@8QD*L$_:=2"34FM9)3>4(KR\HOZ*^PTN#*;RLWDWH+@9Z[&5Y4`&BE
MLJS$RBHQA';(M-P%\*+"!0;TNMUT>8.RFB_-(:3H`H;<(U`&JCS27522F@LZ
M<P#5'IEW.`XA08&E2#8$@",%`B$"EF+D8Y#4`]-HD-0%4PA<'WS&G*#1P/60
MDC``'BE9D8\3!ER/<48W$`BR*B2)!DU6B:089-7(G`I-5HDD$&152,J$K!))
M,<BJD80*62620`"/2*F0E`E9)9)BD%4C<RJ&LDHD@2"K0A(FAB<ND3VZ;!HO
MHI+UTZOI4>NGRNNF=B%U4#9I`M[3YO'L*9XY`A=L+D6FTOB5+S-=.U6>_<#^
M"2:9^-6O%2RF6H&*7Q6,[!6]\B4PMX_6*TQ%XRV8UTWY6F]SB/L+QVRJFBPW
MBTOCUVQ3PZ6Y`0A)EWGV<Y(GJI2:G`;8R5"5TW)0$R8ML+1W1*WEN+Q4NSVQ
MEQ_%X5)*1BT&&K3")G<-`A4W3ISSI@@6,-E<P5A!.@9"%<YKQ&J%(%6UP4J4
MX]Q2FG(XQRU/>>>6T[[TQUT8V9NW9F6[<W>T1B0<F:6%LT7/@1-=::'9WG+J
M_&1H!2.=7M78B2@=[D^Q^5&#P9;!TU%.J?>/K01UVJ&"XU@P&6K^]V&AW."A
M&($\+1YDU#BJN(,7)(^"9.=PFJ&D]>TXF,>P?`QHTAUUG@$M\31P(M\YGY!C
MXBX.WOZ"V%[%:,OF89XH^.VSN!+45;93`SVZT)W=:76>HAE0`TZL[G:9`36`
MVH:8:)4KRX":/K,MO%890'FMP=F<UT-D=6$V@,7*='`U/`&MC1*R%`ONBHN7
ML7FR-9\.3$J'130ENG3=&>`>DR*E[FWDW5-YDTQ`^6$*W(KJ%T(^&?MQ'1F7
MQX=P2T9_%67HJ`@^)B1D.KTE7@A:;K>IN#Y`_2L[_4M+GP1A-4NMM#8)3AM+
M#:JK1T>%FR`H\&S:OU0[N;2N-.E"_K^&5G`BO[)Z=N)V6@VK6>9G1Z7*:?3_
MCZRAE68G.*RX=C6H$,?Y2#@W3\H:Z54)('X,<."CDCY5;,C<I*)02#7CXXZ4
ME_BC6KD,?X!K"GO@JCZW\<9UA3!"31F4!BF4;GLW"0[Q;>DC,NB7"JAN2MDM
M+?&\K,7V`8%3-\$52V#:-S6?-1(XW05M'27GB-,Z#"<QO-%QB,X'AS02CNJ!
M.Q\3U!8OG`IL8.:9#!/%AN;%G4OIX*T(!#LJ!8>CR%=-^2^:9D>I%+R#)=QQ
MN_];Y4)YO\(JF"T`H+^6.]N!>[>@`7C,;04[K+X[CR\F!Y.J9,%F8CS:TG#6
M3F1!_]I4%DA(9.'11R(+IM5-98'Z6-80K"6RX%NXC67!<=1$%AY,S7'IT/LV
MQ05-$EF\[T>"OM>+>&1'N'-<:+((+BHKYQ$'1D06F-Q45LXC$$=E@<E-9>4\
M`D(B2P<E367E/`(+5!:$6U-9&8\Z$$=DC01]?U7((Q^K>-Y2!!>5E?/(Q^I0
M,%:IK)Q'/E;1Y*:X<AY!*O&7#F\TE97SR-<)7;!.4!MS'GG?CP1]OU]1^8C7
M!",^EI)S!W\1'^'<3<1'L92<-3[*AX)1'DO)^>+C6Q>,[UA*SA3((Q;I\(:X
M11E'0]Z[NJ!WY^8ZK;I\P&B"+H%G,ZQV#CPSP\<G;K#SQ+@L30S"0S4B!BV>
MK=6+LH#;0V2"^'S`;E1$T/WKUC$],_*#-P7/$&?B>-)'@N+^X/N9CW@)&KP4
M`?1'>#X)//I$`;_$'N)C&(?,3<1DN<"[9R#(6(H&6L=H^/C#!;8F:*!U+(8O
MJCA^$A'SP=ON,H;X6HI=MXB(C[;W8JWYR.$]K`%($4D/UBX*S"S^^)32!!WS
M@#<5R63P)2*^DW=Z!Y1D_/D`]Q!)G8B'>DGNX!A:!/B?=Q%Q([8B0O"0GXB0
M1SN"VR"E2<R)0%A"(GPXUY^)V*LH@C+^:@8>9@N7NGLQ6F)1_BT)&/VO7_,;
MS#"_1_@$'W;KF6P^`(Y:6QMSYT2/V9LS-?_[3^P&8Q!,R:>^LS_[$1,Q4_._
M/^*=VR"+85X*Y>9C"'<#@]_*+K!GZL_W\_'T[M[0+B;]^>1"'UJCB^EH?G<Q
MTA?SNSMCVM?ZBW^#R_!Q1]?PO)P6CQ-BCSV"7:B!?ATZ\-"A(#$V`?\IOS93
MR8L8/KM=$\"&`X.I$;TP>QS3[7\```#__P,`4$L#!!0`!@`(````(0"OZ9H$
MA`,``-P*```8````>&PO=V]R:W-H965T<R]S:&5E=#$N>&ULE)9=;Z,X%(;O
M5]K_@'R?@"$?310R:JBZ.]*.M-J/F6L'3&(5,&L[3?OOYQP,%)R=#KTA`1Z?
M\_H]]L&[3R]EX3USI86L8D+G`?%XE<I,5*>8_/O/X^R.>-JP*F.%K'A,7KDF
MG_:__K*[2O6DSYP;#R)4.B9G8^JM[^OTS$NFY[+F%;S)I2J9@5MU\G6M.,N:
M067AAT&P\DLF*F(C;-64&#+/1<H?9'HI>65L$,4+9D"_/HM:=]'*=$JXDJFG
M2SU+95E#B*,HA'EM@A*O3+>?3Y54[%C`O%_H@J5=[.;F)GPI4B6US,T<POE6
MZ.V<-_[&ATC[729@!FB[IW@>DWNZ36A$_/VN,>BKX%<]^._IL[S^ID3VAZ@X
MN`UU,NSX-R]X:G@&E2,>5N0HY1,._0R/`DBB&P"3Z/^Z-/<A9O'[-,/_7<K'
MIFQ_*B_C.;L4YB]Y_9V+T]E`IB78@&YLL]<'KE,H`^2:ATN,FLH"0L#5*P6N
M)["1O5AU(C/GF$2K^7(=1!1P[\BU>108DGCI11M9?K,0;4/9(&$;!'ZO]GVX
MF#PX:@?#;SN8!G.Z"%8_%^#;R30^/3##]CLEKQZL4I"K:X9KGFXA[O^;`2X@
M>X]P3#90KIAHJ,CS/MCYS^!YVA('2\"U)^B82#H"RP8:>B'@R'0A"*,0K!(J
M.]@'P[RAD]<24:-Z$=+H[?U(!G@P70;",8'J][.-QED/EECU0I/!@U%>6`73
M\R(<$[CV>1=.7DNL!L1R3"0=X=8!9C-=",)C(:MQFH,E5HWM=!$NP\`5TA&N
M$!`_70C"8R%K1X@E4$B^G\UH.(M@9>:XAF=T,V:3CG4EK3\B">&QI+MQFH,E
M(%E?1E=(1[A"\$,VV+78RB+HHN_O7APT%D3=[6N1P7*U#]9VURR#<+/:_&#C
M0%<82GI?"L*.%*=/'"PR-(>^96XV?=(AKCL4K)BNI:$=,>XV;AFKYMBXX5B7
M],B-&NQX@V*][PRU_7&XMZF[N5OFSE8E##8.D+1`4\=1EZ$?ZK(-[3CC[-Y#
MRXSJY/2`I&=NK/E0MX43Q<VJ<7=YR]A^$P;4D8NG$HPQ<,:>'>PWL>3JQ!->
M%-I+Y07/`A0\[I_VAYM[>^KH7\`QH68G_H6IDZBT5_`<A@;S-;0V90\:]L;(
MNOGB'J6!`T+S]PRG2`Y?L&`.<"ZEZ6[0J_Y<NO\.``#__P,`4$L#!!0`!@`(
M````(0"]-::]>P,``"P+```9````>&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM
M;)16VV[B,!!]7VG_(?)[R05(`!&J0M7=2KO2:K679Y,8L)K$D6U*^_<[$X=@
MAVT+$@(R.3YS9HXS\?SVI2R\9R85%U5*PD%`/%9E(N?5-B6_?SW<3(BG-*UR
M6HB*I>25*7*[^/QI?A#R2>T8TQXP5"HE.ZWKF>^K;,=*J@:B9A7<V0A94@V7
M<NNK6C*:-XO*PH^"(/9+RBMB&&;R$@ZQV?",W8ML7[)*&Q+)"JI!O]KQ6AW9
MRNP2NI+*IWU]DXFR!HHU+[A^;4B)5V:SQVTE)%T74/=+.*+9D;NY.*,O>2:%
M$AL]`#K?"#VO>>I/?6!:S',.%6#;/<DV*;D+9ZMP1/S%O&G0'\X.ROKOJ9TX
M?)$\_\8K!MT&G]"!M1!/"'W,,02+_;/5#XT#/Z27LPW=%_JG.'QE?+O38/<8
M*L+"9OGK/5,9=!1H!M$8F3)1@`#X]DJ.6P,Z0E^:WP//]2XEPW@P3H)A"'!O
MS91^X$A)O&ROM"C_&E#84AF2J"49@OKV?G0IB6\$-?7=4TT7<RD.'FP:2*EJ
MBELPG`'QL3`CHROUK4JA1"2Y0Y:43(D'12BPYWD1Q9.Y_PPMS5K,\AP3NHC5
M$8%.@+Q.(Q1N:_Q_TX]2$(Q2T`34MC0!X#YIZ^4]1XQ''<11`AVZ7`F"4S*R
M$\?3CM>(,YBX4[NR`DYFH+$SHT^C-S?@L1>X*"4`.Y6>!#T%!F,IL`*.`J"Y
M7@$NZO4@Z=F^-)BDV3;A-$@F2>)J7-F(>#A)QJ<B'(FQ*_']C8+@OK3(3;PT
M&*LY5L#)G+B9+[,'%WUDC\%8"JR`HP!?-;T'^>,-@HOZ/>C;8S"M/4$81TD4
MNVU:.9`H',?PZ2".2A@1MLKW'4)P7]VPXS4/D,%8_;$"3N80AKZ=^C*+FE4?
M>=2"+!%VQ%6!,^YJFT(S&>')M![DOD\MJ#5J,DJ"X/28-,U:.9`X'@/B!'%U
M7C5S0S-!77VG$6J<:D%VE\RR)N)F[\W9"[TRLQ.&A=6E4WVM"FO`MDVQ(JX*
MG(37>V7FI]N+,Z\,R'@U#I(P[.UK/,W@YK=Z8PXGYN5=,KEE*U84RLO$'@\>
M$8S/+MH=BNXB?+/TXDL\+&'<[V[`6:6F6_:=RBVOE%>P#5`&@P1Z*<UIQUQH
M43='AK70<$II_N[@5,K@/1L,`+P10A\O,$%WSEW\`P``__\#`%!+`P04``8`
M"````"$`87,[P4(-``!$/@``&0```'AL+W=O<FMS:&5E=',O<VAE970Q-RYX
M;6RLFUMSXK@6A=]/U?D/%.\3,'=<2:8(-A@P8`-]?:,)2:A)0@KHZ9E_/UNV
MMB7MQ<F$JM,/G>3STK*DK9LWYOKWOUZ>2W]N#\?=_O6F[%U5RZ7MZV9_OWM]
MO"E_6@U^ZY1+Q]/Z]7[]O'_=WI3_WA[+O]_^]S_7O_:'/XY/V^VI1`ZOQYOR
MT^GTYE<JQ\W3]F5]O-J_;5_IRL/^\+(^T9^'Q\KQ[;!=WV>%7IXKM6JU57E9
M[U[+N8-_^(C'_N%AM]D&^\W/E^WK*3<Y;)_7)ZK_\6GW=F2WE\U'[%[6AS]^
MOOVVV;^\D<6/W?/N]'=F6BZ];/S1X^O^L/[Q3.W^RVNL-^R=_0'V+[O-87_<
M/YRNR*Z25Q3;W*UT*^1T>WV_HQ:H;B\=M@\WY9[G]P:U5KER>YWUT.?=]M?1
M^KUT?-K_&AYV]_'N=4O=38%2(?BQW_^AI*-[A:AP!4H/LA`DA]+]]F']\_FT
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M/65S4Z:*T1P\TO+RYVVMT;RN_$DKPD9K[E#CN8H^*]3T5[:!!*$$`PF&$D02
MC"082S"1()9@*L%,@KD$B02I!`L)EA*L)/@DP6<)ODCP58)O$GR7H%>$EP/3
M*X)9$`A>#Z+7@_#U[/A5:$@6XY*&XO]C7"H;-2ZYFG<,K($J!B$KN$@@02C!
M0(*A!)$$(PG&$DPDB"682C"38"Y!(D$JP4*"I00K"3Y)\%F"+Q)\E>";!-\E
MZ/6`%,'D4/7ZH('H]2!\=/`QH\09A+1MP2"LTP9Z_M#":Z$J=5.FS:I8"[UV
MU1UD=[FFD9]TU%+7!Q(`"8$,@`R!1$!&0,9`)D!B(%,@,R!S(`F0%,@"R!+(
M"L@G()^!?`'R%<@W(-^!]'J(,*H]#&L/X]K#P/:<R#J#LB$&Y?N#4:EI;Z=C
M2S$::XV6.QJ#7-3,CO_9QAL"B8",@$QR4BM6VQ@D4R`S(',@"9`4R`+($L@*
MR"<@GX%\`?(5R+><F*;W>J#IW=G(B2DM%LY"\WY,E3J+*:][04[L``(9YL34
M,-(2>VC0@X0[-$:%B.\UECX3">*BC!ES7KOA&D\+$1O/I$^B)698IC9Q.I`.
M]1=TH%(['=C/B>F<(`=-MW/$B38L1-R&@?092A`59:S.:;;=SAD5(C8>2Y^)
M!'%1QC)NBQI/"Q$;SZ3/7(*D*&,;BW&2%B(V7E@^3JBH2R\(E5*[H<J)%:H<
MN*%JBQX-"Q'7;R!]AA)$11F[X1T1JD+$QF/I,Y$@+LK8QEW7>%J(V'@F?>82
M)$49R[@CSAYI(6+CA>7CA(H>4R\(E5*[H<J)%:H<N*'JB*?`L!!Q_0;29RA!
M5)2Q&UYS>W14B-AX+'TF$L1%&=NX[AI/"Q$;SZ3/7(*D*&,;BT4R+41LO+!\
MG%#1H_<%H5)J)U1W.3%+;5^"(`?6D34$,I"%AA)$4&8$9"P+322(H<P4R$P6
MFDN00)D4R,(JY/2WRJ-=T.&9W.UQC6ID5!S-O(Y8L/M&Q4,@0!1JU*QGJ1=R
M:7?D"CC`8D-$D4%6K5IRT3,JE>II7]7%'!X;`5=[@BA&-#7(NG]'[#8SHV+[
M.:+$(,M+MB75*MUWM4Z[46^+]BZ,$]W/'0<J66(GT-X_NJD<JIAY&C7I<&C&
M04MT:-^HN,4!HI!1,QL'S2K]<Y>J`2L:Q2%]B"A"-#(H#[E,[XV-@&LX010C
MFAID=4!';.`SHV+[.:($4<HH[Y-:O0Z=LF!)UBEN>%5JX(+PYID$>MSB2MYY
M.1+37`RPOE%QP0!1:)#54RVQS0V,BKV&B")$(T1C1!-$,:(IHAFB.:($48IH
MX2`W8NJY_(*(Y8_Q3L1RY$[(CCB>];U"Q;T<(`H->C=BX#4T!=D^0C1"-$8T
M010CFB*:(9HC2A"EB!8.<B.F'HLOB%C^%.U$+$?N'.N*I:_O%2KNT@!1J!%O
MI=WJN:T4G(;H%!EDQU[,_)%1Z755+'QC(^!J3Q#%B*8&*><.?:[J[@4S(V#G
M.:+$H'>:D6H5=UNUU6FWZJ(I"V-%-W3'@'JROV`,Y(D`9PSHW`"%QFRC7=A&
M"Q4W.5"?+]*63-.=4<@HWS(:U6;#@T462@VYE#&*#+(J)4\@(Z-2@:+/]!IB
MD(R-@NLX010CFB*:(9HC2@QZI^8IJW1'M:N=MB?JOF#-F<U5I0@N"'J>4:"@
MFRK5&F*,W:G/=]4)RWSFTT<4:-3L6$'/"[;J!1IHE86&B"*T'Z']&`M.$,6(
MINQE&C1#U1Q1@BA%M$"T1+1"]`G19T1?$'U%]`W1=T3T,22$B#Z(1,8!MZ)+
M'T:B+CS#W)B[:Y1*D_!P57O-OQSU\ZR*LT9I9$+95Z/9':Z!1E;M0XVL@3A`
M-$04,<I>SLE2^R.-FJ828U8Y:Z=,!4^,BA>A&-$4[6=&928N)(3G1L7V":*4
M[<W$7;#*3-PEHI6#W+BJG,H%<<U3,.3'];Q3[W.X0>QKU#(='VAD=7S(B`:!
MV;2:8I\>&!7?<8@H0C1B9(<ZKVK+#;581">Z(*GXCC$CTZ`IVL]8Y=C++/3<
MJ-@^092B_<*HK/YJB^S`TJC8?N4@-_HJPW-!]/.$D!-]C4PO]]4K.C0@G.CG
MR(F^1D[T,6]3J+@U0VU/>51&$:(1(U.O,=?+#8_8L2=&Q?8Q(SOZT*`9JUQ[
M\>0T-RJV3Q"E&EG]M3`J*_HRO;TT*K9?.<B)OEK&+XA^)G?3>(Q,+_<ULJ.O
MD=6:D)$3_:Z8B0.CXM8,$46(1HQ,O<8:N7._(TZV$Z/B.\:,K.BC_8Q53O0[
M(E<^-RJV3Q"E:+\P*COZ(F.^-"JV7SG(C;Z=O%.R]W?T&B;O-&KE[YEF+W)H
M9&W?`:*0"YHW0`:(AH@B]!HA&F/!":(8T12]9JB:(TH0I>BU0-42T<I!;L3L
M?-P'(H;YN-JY?%Q7K%%]H^)A%"`*-:J;D\>`53H3[U4[C49-;%!#+!=Q.3/%
M1HC&IJ`U!^3SY(0+ZHSG5;/:M?^)Y3XVIMS6*3N8VLQ0-6<5/0H7IQ=ZK][-
M,B18,.6"QGYA5,;+DRU;<L&\=YO=IM?N=D5[5L:*VN..'I5G^_A>7\O3<O9>
MKY&3&ZQ599;!J+A'`T2A1BWS^>A`(_6.6=&CGDSP#K%@A/8C1&,L.-&([LA5
MC5$U1:\9JN;HE:`J1:\%JI;HM7)4;EQIR[DDKDHN=O$<J17%='Q'C*Q^K5!Q
M9P6(0HV<54$7=&>*V'F'IJ!5B99X&HCPCB-$X_->HD$3+EBL%.[<C8T+-WC*
M1<R`F:%JSBJSO26H2EEEO!:H6K+*>*T<E3L45%[N@BF>I_&<*9XC,<7%,::O
MOC%"8\C*&@:(0HV<*9X7M";<$%41>HT0C;'@1*/W5Y`8"T[1?H:JN;'G`9&@
M*D6O!:J6Z+5R5&Y<5?K&CJOZHH)JY;\<V?*LCQ/?'#E3O585Y\@^?1=*Q9=4
MW-``4:B1,]5U07T`J-+RW<8#0"ZRRD7H/D(T-C>TEPB8UKH.Q;3^EP,`U&:*
MMYZ96W./S%E%0[I8-6M5L6`E6##E@J9W%T9EO,X<`)S>[;9;E)J7'Q6OC!75
M-!]%^??2\F^^O&P/C]O^]OGY6-KL?ZKOG-$LOKTNL/E&7+8S"WZGOBF7'??E
MA9KZ"IT:+O)"G2YD1T1QH=?P>Y0=QQ*4Z/1[U`J\0D^-OGK:PROT=.>K9S>\
M0@]FOGK&PBOT3.6KQR.\0L\GOGKZP"OT:.&K!P>\0@\*=)]S5^C83_<Y=X4R
M8+[*7*';F*ZH/!1>H223K_)%>(7R0[Y*]>"5T.O2?;)G81$$RHG0?<Y=H70&
MW>?<%<I$T'W.7:&4LJ\^(\`:T`<`ODKOXQ5*Y_M9'ALOJ;2U&F[GBE%2F&Z5
MI8"@26VZU;DKE(JE)IV[0EE4:M*Y*T''#\]U:=3QZ8TZK'/<\>F%..1)QT_/
M\:#KA^>Z,NKZ]&X8^L1=G][V0IYT_?0<#UH^O:B+^JCETWNVR..63Z_)(D]:
M?GJ.!VV?WBY%?=3V1^=XW/;IW4[4)VT_/<>#AA]F>5@1Y:CATROXZ!,W?'H_
M'3F]D4[#[-R5H.F'YY:AJ.G3^]_H%#=]>GT;>=+TTXQ7BJK25WC?UH_;Z?KP
MN'L]EIZW#[3<5J_4=V4/^9>`\S].^S<ZD--W(?<G^O)N]NL3?5M[2]^,J5Z1
M^&&_/_$?=.-*\?WOVW\```#__P,`4$L#!!0`!@`(````(0#H14`M<04``$H5
M```9````>&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;)Q86V_R.!!]7VG_0Y3W
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MNQG(&;RC:LZ!$1B@M'K<E)`!LUUKZ':I/Y%%1CS=6#WV!OU3TG,K?-;:?7U.
MFW+S6WFDX#:,$QN!Y[I^8=2?&P9!L*%$)_T(_-%H&[K-7P_=G_4YH^5NW\%P
MNY`12VRQ^8AH6X"C(#.S7*94U`?H`+QK5<E*`QS)W_OGN=QT^Z5N>S-W;MH$
MZ-HS;;ND9)*Z5KRV75W]RTEDD.(BUB`"ST&$6#/+=XGKW:%B#RKPG%3N[8HS
MB,!S$KF[*Y!Z[XHGJMS;E?D@`L^Q*][,L=RY?X^W,%'[KL!S5+G=6X./=E\\
M4=[EJ\>F/FLP(V$\VU/.YC=9@/)8-7R,+W7T61E!_3"1)Z:RU`-=@PIIH?;?
M5I;C/QIO4*_%P`FO<0*9LQXYK#R9<(2!>`2FEHBLD8R,42/E`+Q/G7--.2@;
M.6R&@3,7>Z"017NN3Z;1!49F+HPMAQP06R8X8Y5BN2BCZ!K'DA.(KW!D1J(R
M7$>FI"H%]S=3*99K7V0D[V#ZBMZQTK)A6?O:0Q:TU&':70:+F-Y%OR^*D'/Z
MM;0'UAB(,!!C(,%`BH%,`*2T8$&Y/RT6M-3A_9*6A=T/.4=("P/1"(@JKFQ.
M/'+&(DPPD&(@$P`I4Q@%,=.O!XZ1<89XX#AGWB\0Q#7Y2^[_FG,F%R(,Q#>H
M)#@HO2$H$X(D'V#QO]T'1L8^S.4<0\[A/GQB`Z<(-F`@_EXDP3'I]S&9$".9
M`)N7:,)MLYD%83/POL`YA/"JB!^FU81/;OZ[X`0&XF\4$AR0?A.0"0&2!^RL
MC#;+[U<T%H0]0+M`R#E3CFL,1!B(.4#,WC;7"GS31:J)1+$L-W`)7O&Q;"8`
M4NJPM]^?.@M"J7MHYPTY1T@=`Q$&8@[PZ6,[KN\Y.',<DF(@$P`I3S#T?R3:
M1^%,T38>#B3>;\<)S(`X:&58#YS)CDA!8DF'$&+YIN.@69/(I'G@V/X<-99*
MG.L=RB0.";RY100=V3IVB+I[>L#$5XL$G6["@31:YSNNZ:-LU@-'M(Y+3T@L
MZ8!UGN7Y'BX>12B5PASG6O.9&"7;PHY,@BU?;Z.$'[!@2YY."AX:W'`@38FM
M%212D'A`N(G$#)S`]TPE>=[^))TJ0IF(R*FR,Y.0ZFV;!.$G+3EEM%"%`VGJ
MUUI!(@6)!X2G',"-!+SDO3A1@E(IR+MV2,G$(-D!=I82'/AFL/G)2\X<'>A"
MPDE07^Q_E3N;(\)Z($S61`H2CR)\NT!;<*+PTY'_6:.9&"([P$Y1@@,WU@`_
M>\E.X.,CN\Z`_82/IFU=&\[UP!'-$(YU_8DBEG0\WS;GOJU8@J-2)4HMIDQL
M77:%':ON=X4?QF17T+H7PJ42<V7*>#T@L'3W_\1MNZ]AN>XC)2Q6D$1!4@5A
M=UJ7YGG*_(J*WS)4M-G1-3T<6JVH7]GUDPV=NJ"7J[$GB_UK1GA(%G`!H.(Q
M6<"_?,"-2P#<9)WR'?T];W;EL=4.=`M-F3!7=*WA=V'\2U>?^CN/Y[J#.ZS^
MXQ[N+"G<-9@S(&_KNAN_L`8NMZ"K_P```/__`P!02P,$%``&``@````A`.!<
M8R&8`P``@@P``!@```!X;"]W;W)K<VAE971S+W-H965T."YX;6R<5]MNVS`,
M?1^P?S#TWMAR;DT0IVA7=!NP`<.PR[-J*XE0VS(DI6G_?J1\B64[3;J7(&;(
M<WA(B696-R]9ZCUSI87,(T)'`?%X'LM$Y-N(_/[U<'5-/&U8GK!4YCPBKUR3
MF_7'#ZN#5$]ZQ[GQ`"'7$=D94RQ]7\<[GC$]D@7/X9>-5!DS\*BVOBX49XD-
MRE(_#(*9GS&1DQ)AJ2[!D)N-B/F]C/<9STT)HGC*#.2O=Z+0-5H67P*7,?6T
M+ZYBF14`\2A285XM*/&R>/EUFTO%'E/0_4(G+*ZQ[4,//A.QDEINS`C@_#+1
MON:%O_`!:;U*!"C`LGN*;R)R2Y=W84C\]<H6Z(_@!]WZ[NF=/'Q6(ODF<@[5
MACYA!QZE?$+7KPF:(-CO13_8#OQ07L(W;)^:G_+PA8OMSD"[IZ`(A2V3UWNN
M8Z@HP(S"*2+%,H4$X-/+!!X-J`A[B4@(Q"(QNXB,9Z/I/!A3</<>N38/`B&)
M%^^UD=G?THG:I$HLF]H],VR]4O+@0;_!6Q<,3P]=`G"=4XG09'DJ2<@.06X1
M)2(+X@&_ALH^KVDP7?G/4(VX\KDK?>#SZ--X^)!-DQ*DT4YIN#PU,SHC,Y8+
M4[DK#6V:<)AF[-*@\C'T]&TZ#(H(E/LH(I@U^&4&I<_,EKVM:](G#&?8ZC.<
M&`?MF3NDW>I63J"^E=F\R<PI,#!>7F!TMNQ-A2O+I"=PYN)B1</9]>BL0(QS
M*2H+1+;47`^K@;I<K@:=7:K*8B^<4R4<NYV;$4ZGH_E9.1CH<E065\YB6`Y<
MHC;MV\<1G5VJRM*70^%LMX%M=T#\VP0VRF6H3="C8W-H,*R&XJUO5?$,6S4C
MYL?K;`$@@?YIHYTY82_P`K(ZPU$-B#9'97+Z0^D)19VY<8:M'`9P>9OK0RO3
M0(LZ$^(,=#,7CM"5R6W-B?F'KYYWM`:].P>A,@T(P?O;ZCJVAH;7%\PZBI$=
MFLKD=F=\HCOOF@8X4[ML)^<!'1@(=#J^8"#8R(ZHH9%`)R=$O6LFT/Y0J$W]
M3H5#4R&87"#*1KJB:I/;J>.;RAFOX;LF@_7NL%7#8D#4_TT&V/VZIZ$VN8J.
M+_Q24;GQE6M5QM66?^)IJKU8[G&;"V$?:JS-IGEK%\VN?;*\!4JXSW[S"VR`
M!=OR[TQM1:Z]E&\`,[`-4N4.63X864!]8`^4!G8_^W4'NSZ'G2C`5_!&2E,_
M($'S[V']#P``__\#`%!+`P04``8`"````"$`WHZUI<,$``"R$0``&````'AL
M+W=O<FMS:&5E=',O<VAE970W+GAM;)Q876^C.!1]7VG_`^(]P3;?49)10]7=
MD7:DU6IWYID2)T$%'`%MVG^_UUP"MFDRR;RDQ3F^/O?<ZV.<Y9?WLK#>>-WD
MHEK9=$YLBU>9V.;5?F7_]^_3++*MIDVK;5J(BJ_L#][87]:__[8\B?JE.7#>
M6A"A:E;VH6V/"\=IL@,OTV8NCKR";W:B+M,6'NN]TQQKGFZ[267A,$("ITSS
MRL8(B_J6&&*WRS/^*++7DE<M!JEYD;;`OSGDQ^8<K<QN"5>F]<OK<9:)\@@A
MGO,B;S^ZH+959HNO^TK4Z7,!>;]3+\W.L;N'2?@RSVK1B%T[AW`.$IWF'#NQ
M`Y'6RVT.&4C9K9KO5O8#723,LYWULA/H>\Y/C?*_U1S$Z8\ZW_Z55QS4ACK)
M"CP+\2*A7[=R""8[D]E/707^KJTMWZ6O1?N/./W)\_VAA7+[D)%,;+']>.1-
M!HI"F#GS9:1,%$``/JTREZT!BJ3OW=]3OFT/*]L-YGY(7`IPZYDW[5,N0]I6
M]MJTHOR!(-J'PB"L#^("^_Y[=FL0!PEU^3VF;;I>UN)D0=/`DLTQE2U(%Q#X
MG!C2&%*]E"FD*(,\R"@K.[8M2**!\KRMHV#IO(&B60_93"%41R1GA"P$L!LH
M0MXJQ<\U/S.18,E$UD!2V^``Q!ZH,6/=*<+W!HC&!`2ZG8D$KVPH[[!P%`YA
MD1M"@H%LH@QH"WOW+"S!*QL^QX5=8V&$4-*5:N:S.")^K&,2'<.8'_OT@BZ0
MI*J+;"(7]MCU2LE)ACZ13F&#$$4?94#3)]`)7%]8@@U]C-PW"`D[>6CD>YX!
M2#1`X`?^P%SC%=[#2X)U7N$8%AL&(3TO0D.7&)(E*B(F-/#)Y\SDR63L^Y^7
M3$[2&4;&9MH@!!EZ/O$\(X5$!=`P)!?X@9>H_*Y75(+U5HK'L*@<0I164@:T
MDL&FN&/E#JU+PDQ)>@QJ,@M8..DF#>'%`1M%T[E)B[R[:A2-536$V/#>38]!
MCLR+8M_PJD1#S.+8=:-Q4^@L[S)LBO:KL9LHB)A>0=?SHV"JH89A+`C=8+0]
MG>!=/DZG1AZ/@;&[>HS27NJ(OKCT5:6&USN;H@MKZHPFW"^.F%Z=,&+4,_@E
M?9A!0'>LKD[.</*?D)M:>#QV;D].L>QN))'O3;!;.ZWTQ0T7O^T8H5,[CR?O
M'JI=,Y=X3+'%GI4*\25@=!"=I>'I-[*<FGL\UJ"72O7N('))&+FFO5/$?"+>
M+QDZG3IZ;"RYZ3'8.R$)*".1@4DTS%7U#%^_43TT:VT7C.;3JX<8I!D$;DB9
MV0<)53$S&C(0^4*9F7$,W$:TFZ4?!U19`9GV(&0*KQ8DII[1"XF&H7$0,C@K
M/S_)V2\="MTLDZEY*O0@9$HI91$<Z*:WZ*`P]MSH(E7C9+A15'1VL(WAA982
M\XA@"%(<6!W1=C"[R_X[M"F4H<&F!X&'#!1=@V%R':,SE(Y^\QD!%U_SM8P2
M\Y#H0=<98J`+&&2(5V2\0I:\WO.$%T5C9>)57G\9O#$/H\/5_(')&XXQOH$K
M>W>_=88OX,9\3/?\6UKO\ZJQ"KZ#D&0>0N5KO'/C0RN.W<7U6;1P5^[^/<!O
M(QRN>V0.X)T0[?E!7B:'7UO6_P,``/__`P!02P,$%``&``@````A`)#SK231
M!```WA$``!@```!X;"]W;W)K<VAE971S+W-H965T-BYX;6R46%V/JS80?:_4
M_X!X3\!\$R6YNGSV2JU45?>VSX0X"=J`(V`WN_^^8PP$#]%N\K(LXS,'G_&,
M/<[ZVWMY5MYHW12LVJADJ:L*K7*V+ZKC1OWU,UEXJM*T6;7/SJRB&_6#-NJW
M[>^_K:^L?FE.E+8*,%3-1CVU[66E:4U^HF76+-F%5C!R8'69M?!:'[7F4M-L
MWSF59\W0=4<KLZ)2!<.J?H2#'0Y%3B.6OY:T:@5)3<]9"_-O3L6E&=C*_!&Z
M,JM?7B^+G)47H-@5YZ+]Z$A5I<Q7/XX5J[/=&72_$RO+!^[N949?%GG-&G9H
MET"GB8G.-?N:KP'3=KTO0`$/NU+3PT;]3E8IL51MN^X"]&]!K\WD?Z4YL6M:
M%_L_BXI"M&&=^`KL&'OAT!][;@)G;>:=="OP=ZWLZ2%[/;?_L.L?M#B>6EAN
M&Q1Q8:O]1T2;'"(*-$O#YDPY.\,$X*]2%CPU("+9>_>\%OOVM%%-9VF[NDD`
MKNQHTR8%IU25_+5I6?F?`)&>2I`8/0D\>Q)B/$UB]B3P[$D,:^D2W3?=QV=B
M]23PO)$02W>>4`-?ZT("SY[#=!X.!2`[9W@.SC"7!^/H]L[P'&;O?^6LB07M
M\B/*VFR[KME5@:*#)6LN&2]AL@)"GA@FI-?]Q(",X#[?N5/G"N@&LOEMZSAK
M[0T2,.\AP1V(*T/".Q!/AD1W(+X,B><05Y<AR1T(D2'I'8@Q0C2(U1@PR-YI
MP#X/%`=O5%C:,5"N.=)VL0P$A.A=&"W+LVS=PY&2,"C2D30(28R<8VG<L&QB
MHRDD$H(8A#BZ16QYGJD$6KB.[1#/MT:0%",HSL=CQ,$H1C=:$2,!<;K=A"=@
M*`QN%S/;F4RCPT?381,V!IUX*+-B3)E@0SHQ2.)@-1\7Q\%('`IL("!""]&)
M:^IHKJ%`W.1'V!!C0_(E:3IQD>3!?C:5]]B&P)V03)2F@8`(F8:I6X:-RC04
MB(G,P<`W&!,%)1X&^6'%<R*9?8#<*KA#I!,723+LPL]+YDY(,JJ\0$!N@D)L
MB(1!!,4WB*NCF,38(\&&=&*01,%F_KPH[H1$H;@'`@)?';<T$\4Y'"!\W19H
M,)H.6F@P'@;'11T,'96%HI,.H[SUF>[1O&U]^E#C3D@[.FL"`9DLJ#"(]5M`
M3XLF&$W'"0S/$#&F3+`AG1@DD7#F/R^2.\DB/33G0$"$)L<S==?#M1<*R"T.
MT6`0E8K.EW@8'5=U]@G+1KMB.O&15,-!.9-M06%_?@YW7D@W:@&"'G-3%<XL
M46\9"O;>@LZ<DIDEG5ID=;P/>3ISB>A>8$<?:])#E17T&#%SZ#$L"T4\[!$W
M_=',$L\LR9>\Z=1'%LM;BHG8+Y90-""22)1H`1&8OAYMP_=T&]5PV&.F,H77
MS1+/,,G,DG[^+5DH;R4>%RH:#TDH;HB(P$`>\8HCT+$9CN?,I$HHQ!$A#@^W
MS;$,N-LYRA#BFX;INS[*K%1&+3SBV;X_Z4+E8/'&Y/%@<30J;/3Y`"[6''-;
MW["WB#PQY_VC-`X]N0O](SH'XQEK,K/P*_WX92%2W-#%#>R2'>E?67TLJD8Y
MTP/4KK[DE]A:W,_%2\LNW4UKQUJX5W?_GN!W%`H=C[X$\(&Q=GCAQ^#XR\SV
M?P```/__`P!02P,$%``&``@````A`')C4$6``@``Q`4``!@```!X;"]W;W)K
M<VAE971S+W-H965T-2YX;6R,E%UOVC`4AN\G[3]8OF^<!`(#$:I"U:W2*DW3
M/JZ-<Y)8C>/(-J7]]SN.(>-CJ[@)V'G]^#U?6=R^JH:\@+%2MSE-HI@2:(4N
M9%OE].>/AYM/E%C'VX(WNH6<OH&EM\N/'Q8[;9YM#>`($EJ;T]JY;LZ8%34H
M;B/=08MO2FT4=[@T%;.=`5[TAU3#TCB>,,5E2P-A;JYAZ+*4`NZUV"IH78`8
M:+A#_[:6G3W0E+@&I[AYWG8W0JL.$1O92/?60RE18OY8M=KP38-QOR9C+@[L
M?G&!5U(8;77I(L2Q8/0RYAF;,20M%X7$"'S:B8$RIW?)?#VF;+GH\_-+PLX>
M_2>VUKO/1A9?90N8;"R3+\!&ZV<O?2S\%AYF%Z<?^@)\,Z2`DF\;]UWOOH"L
M:H?5SC`@']>\>+L'*S"AB(G2S).$;M``/HF2OC,P(?RU_]W)PM4Y'4VB;!J/
M$I23#5CW(#V2$K&U3JO?093L40&2[B$C=+]_GUX+8<%0']\]=WRY,'I'L&?P
M2MMQWX')',&'P(*-(=3_18HA>LB=I^1T1@D&8;$Z+\O)>,%>,*-B+UE=2I)3
MQ?J@\(5`=X-%C/O8XK]S?G#BQ=Z)KX&WM@H;R!ZLI6?W7BJRO^9/G&""CIWX
M9(VPE]YWY`_E%,L\&,BR4P>K()D,IM='&R<&QJ<&WK_8BW.*S^'BR?G%09+$
M?<F2\60ZS4:GWG"J/&4OF26S418/BN`M3$WH*@6F@C4TC25";_U$I,@>=H=A
MO4M]L&?[*QSBON79\`*'J.,5/'%3R=:2!DI$QM$4TVG"&(:%TUW?RQOM<'SZ
MOS5^+0$[((Y07&KM#@O?7\/W=_D'``#__P,`4$L#!!0`!@`(````(0"DV_T3
MV`@``"4I```9````>&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;*R:VV[C.!*&
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M>-J51QH`_3LZ%2(U2)'L6_O[4>R;P^-X[DX<;[8DZ]%+7C=A(3R.1[OWNBE/
M_Y,V;4"]#[?S0;_*QW*R6,WFCG!RI>.\Z^CU'=W[_N)7^I'7=M#TVUW0G4WN
M%@MO>;>Z?L5EUY-^NY[7[5>=/?VJ*WUJA+2\VA'2K[K.YP9XWW6DWZZCXTS<
MNX6S:&?DBB@.Y8Z<2I%$<IZNRCF5J=!FEI\UV=-#57Z,:+G2;->73"Q^9RV\
MJIR2%^^S[$=)1MDEO#P+-X]C"H02J*:5\?7)\>8/TZ^4S;O.9C-@PRVVRD*D
MKG#KVR"P06B#R`:Q#1(;I`:8DBR]-I3C_P]MA!NAC8IJHX`6R[6$4!:JBV^#
MP`:A#2(;Q#9(;)`:@`E!:Y<),;SAJ%P0UH]C6FM&+G@\P(VT\>0N):9Z"\0'
M$@`)@41`8B`)D-0D+'3:KFX(75C32J(=Q(C=7@?2R*-MR3!:<(&VO5&?`D`"
M("&0"$@,)`&2FH3)0;-Z@QS"NI5#!;&1Q%OUBV$+Q`<2``F!1$!B(`F0U"0L
M4)J=&P(5UCQ023PZ$XQ)7EJ3W!LI?7P@`9`02`0D!I(`24W"8J?TO2%V8<UC
ME\2<9"`^D`!(""0"$@-)@*0F88&*PM@^_.9WHGCJ*IE/GW_"$Q=!$H\?B2LK
M`7JC/@&`!$!"(!&0&$@")#4)TX4&S72YOM\+:QZ[)&8"`/&!!$!"(!&0&$@"
M)#4)"U14/#=$VIKS4#MD+?0[:YZU53_1B`)$(:((48PH090RQ&40%9"Y$*Y/
MN",+)CKF5#2;#IE3CLA'%"`*$46(8D0)HI0A'K,H=LR81>7K+B:WKWU'EDU,
M#HFLU7]O9T5OI73T.U_44:$`48@H0A0C2A"E#'&%1%%D*O23K)`U%)/!+*O:
MBG[K`/(1!8A"1!&B&%&"*&6(QRPJGQMBEH42BUFB!>TL^N1?S.RI[ZW4//L.
MH`!1B"A"%"-*$*4,<1E$772##+*,8C)(9"3R5CRJH(/"0#ZB`%&(*$(4(TH0
MI0SQF$4]9,8L-H0%;76WW@K+NHJ)T95:=`X9.>'8.=%;Z9P`%#B`0D01HAA1
M@BAEB.LCRBA3GY]L![+J8C*8A5BW'0#RJ4>;)OIT"1"%B")$,:($4<H0CUF4
M2&;,(B=^K4)T9+5%UU*SN^D0/R46]K,`;:4Z^H@"1"&B"%&,*$&4,L0E$L65
M*=%/TD+68DP&B6BIJ0"W#B`?48`H1!0ABA$EB%*&6,SN;65C:\[+Q@Y1O63N
M"-:3@JVV4LKXB`)$(:((48PH090RQ&6XK6QTL6SLD%DV(O(1!8A"1!&B&%&"
M*&6(QVR7C=?3W<7:L$.>D>X*N?T*\!6B<LDX,JS':(&V4@D2*J1]18ABA;A[
MZ_E$HJV4^U2AUCU71E1VG]\(7%D(FAM!AY@RTLK3T?C*B@_=>GX6:"LU]%`A
M[2M"%"O$W5LW[HFV4NY3A0:4$97=#<K(0I`I(Q%3ID,Z&M_MT+Q/HP!1J)#N
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M5O./\O*CH]-8XZT;2T[AF3V4V796YG,:1`&B$%&$*$:4(!+?T>AQR<R2W\7(
MKQ=.>?66;_/CL1[MRG?QS0NE^--#C^4'.1MWMA;W+Y0#T$+?ZL@MRVZ9]U_Q
MV"V.MQ;/S`:\.0MJ:5</]%E2RW*PSXI:VH4#?>ZHI4U3:+FGEO:,L%NHRV`/
MZC!H[Y`R]$)@*!:*GQZ;#[6XU-(FIWUU9TXM;=EIM=#]`ND\I`Q]+/4\[(M<
M#5U=.!KB=.FA*S][ZV=*HH$P:!8')Y'F<&B@&YK!P0FD^1N:/KH#6XLR$J],
M-V)K44UB"]V/K<7=UE#+G%J&`J02G5J&(J'RE%J&KK.AZVP&6[;4LAULH5O1
MM;C1Q+'1K1BU#(V-;D6H96AL5(932SNV:9\K])':)7O+_YU5;\6Y'AWS5UK0
ML_;&H)*?N<D_FFZ7>RD;^CZMW?`.]#EB3M^/S,2+F]>R;-0?--QI_X'CT]\`
M``#__P,`4$L#!!0`!@`(````(0`TGVI]&@4``!\7```8````>&PO=V]R:W-H
M965T<R]S:&5E=#DN>&ULE)A;;^HX$,??5]KO$.7]D(M3*`@X:K?J[I%VI=5J
M+\]I,!`UB5$<2OOM=SQQ0GR#Y*4JPWAF_F/[9^/U]\^R\#YHS7-6;?QH%OH>
MK3*VRZO#QO_G[]=OC[['F[3:I06KZ,;_HMS_OOWYI_6%U>_\2&GC082*;_QC
MTYQ60<"S(RU3/F,G6L$W>U:7:0,?ZT/`3S5-=SBH+((X#.=!F>:5WT98U6-B
ML/T^S^@+R\XEK9HV2$V+M('Z^3$_\2Y:F8T)5Z;U^_GT+6/E"4*\Y47>?&%0
MWRNSU8]#Q>KTK0#=GU&29EUL_&"$+_.L9ISMFQF$"]I"3<W+8!E`I.UZEX,"
MT7:OION-_Q2MGI-'/]BNL4'_YO3"!_][_,@NO];Y[O>\HM!MF"<Q`V^,O0O7
M'SMA@L&!,?H59^#/VMO1?7HNFK_8Y3>:'XX-3/<#*!+"5KNO%\HSZ"B$F<4/
M(E+&"B@`_GIE+I8&="3]W/@Q),YWS7'CD_GL81&2"-R]-\J;UUR$]+WLS!M6
M_M<Z15A4&PM+>TF;=+NNV<6#^09O?DK%ZHE6$+BKJ8W05^DJ$JH309Y$E(V_
M]#W(SZ&S']LH6JR##^A&)GV>6Q_X>_7I/0*HIB\)RAB69&]/EUDXB\RB7:*4
MY]8P3!/;TQ`UC5!.8$YOIQ.#-CZT^RHB>NSCMQ6T/G-L^U!78B:,YV*J[^04
MXV!Z%DI2O;O2"=0/*EOVE2D-AHSC&RR<,7O?86E)#('S*7&%LQI76D#)54(<
MVB5`,\9+$,YJ*FDQ)0C6:MN!A//9XNXDB8%J#FF!D0,YD5T.[)QAVMMK4#BK
MJ:0%H:',=`0+>AA8+/(X3$;HP9%JELZD*G+LKDAL]T$G;TM";RV;Y`4"614U
M"1"1!,+BBHC.I*XT8I^:2./$'2'MYH?-VF\7#`#:B+%?(K%I!SU"^"Z6(Y"`
M([5^20*HLY,X1('7,/,=4<);RR9-EB6G40"7W!C,1281.I.JZ<&A26,"`AUV
MQAUM)AP$:85<->O<D=5"C%%4CTQB="8U\97TZBZ8Q(S(A$9G,J<PME!CGLR@
MK-N]Q''J.NE,JJ3KB:E(BB<Q`[VU;)(9%DF3F!&;S.A,L$@'.'<<L/$D9J"W
M)D1BQ"+$QHPEU'MG:B0=!ER*;<`@CO-6W%+&`P.]-44B`)@LBC1@W!%B4B*6
M)F5JB..DC35*W,EFT@$#V(584$`6X8A]8Z(@EB9EWQ#'61M/0@%Z:Y,CZ6!.
MCK@1#^<=CZ@Y_.RXM^!PH)JE,ZF:',<NF<0"]-:R21:8]W`RB07HK866>%`7
MG..H)9-8@-Y:-B<+B(4%XVYW.%)+8\6!XZPE8C</;BZW=Q%Z:]E$`#!95IS8
MS>-#R[T_X!J1)G5V',<WF80#]-:$])<%N/`IIQFQX0`VVIU>F2S`0-BKP=%#
M'-<",HD%Z*T)<K(@L;!@";;;@G"4FJ(SJ2!P7`J222!`;RV;\U*03`(!>FNA
MK2!P7`J222!`;RV;!(%)M,0"@E$G#P[4LM@XD#BN!<DD#J"WELW)@43C`/Z.
M>(Q&_#C"D5H:R01EQ26.*T(RB0GHK65S,@&>%Q6XX7$:QB-^C^-(+8WMCI#H
M=X3V.;)]\RMI?:"_T*+@7L;.XJDQAL>ZWMH_@S[%XK>J;D]63^WS:-!_`\^3
MI_1`_TCK0UYQKZ![B!FBG+I]X&P_-.P$M<,C)6O@81+_/<)#-(4'.[P?[1EK
MN@^"H_W3]O9_````__\#`%!+`P04``8`"````"$`Q30L].D$```B%@``&0``
M`'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6R<6%V/XC84?:_4_Q#E?4EB!Q@0
ML)KI:-J5NE)5M;O/F6`@FB1&<1AF_GVO;TR('1N2OHR&R_4]/O?CV'CU]:/(
MO7=6B8R7:S^:A+['RI1OLW*_]O_]Y^7+@^^).BFW2<Y+MO8_F?"_;G[]977F
MU9LX,%9[$*$4:_]0U\=E$(CTP(I$3/B1E?#-CE=%4L/':A^(8\62+2XJ\H"$
MX2PHDJSTFPC+:D@,OMME*7OFZ:E@9=T$J5B>U+!_<<B.XA*M2(>$*Y+J[73\
MDO+B""%>LSRK/S&H[Q7I\MN^Y%7RF@/OCRA.TDML_-`+7V1IQ07?U1,(%S0;
M[7->!(L`(FU6VPP8R+1[%=NM_<=H^13/_&"SP@3]R-A9=/[WQ(&??Z^R[9]9
MR2#;4"=9@5?.WZ3KMZTTP>*@M_H%*_!7Y6W9+CGE]=_\_`?+]H<:RCT%1I+8
M<OOYS$0*&84P$S*5D5*>PP;@KU=DLC4@(\G'VB<`G&WKP]JGL\ET'M((W+U7
M)NJ73(;TO?0D:E[\;)PBW%03"[?VG-3)9E7QLP?U!F]Q3&3W1$L(;-\+;$+Z
M/DKGM;_P/8`1D,#W#0GGJ^`=2*?*YZGQ@;^M3]1Z!`#:(@/:<&3I+)%E5N16
MGAI#%X;88:@.(Y-.H72WB<I%:Q^RVI(@X4,;O]E!XX/]HO&*=<#;0-(94C_7
MD,R4*B>@W-G.HMV.A@Y['IY5Z8SH;5J5A6+/=*LUT^/*-!+8]6UV<I$>7UF`
MT95*%-JI0/CA5*2S#J4L?2I23SLMCV,X@TFZQT:NTR&4!59VV#C:'::FBWH[
M<=)9AU(6U`6MX!$T<S<P-C@E4D+N5`=7ZB@7D\[(,5F1'/5.(F]30F\#36F%
MA90A#E@C\C"$E!*&^54J(F7225%[TT6&7MPAU8@`S&\[01@`>%I(C5*&J)6&
M:VAE@B'J]%OL(`)T1U1'>AO5428+$8L8Q.%B`N8[Z5+CWTV7,NG%F3HXC9($
MJ:HF)V6R<+*H`GV@0SJNKPN151AF#E*CE"'J2\/%U"=%+-H03>ED#MF^72E<
MJ??#Q:17ZGI6::I$1FD#>AMH3FT@AC;<(=+7`PP`:-!YG3&Z'N\ZD5%Z0/IZ
M<#%9JF/H`8K<`O9[AU%?&(@RZ:5QW!#DP3!<&-#;*(T,`"8+(SG,G1,!SZ+I
M?$B_]96!V)2!..X*\B[21;Z3PKXR8``[*8LRS.<#A('TA>%BT@I%'#<&,DH8
MT-LHE//2(&_`P].%WGKHBTF;(>*X*-!18H#>!II3#*@A!@-G")<9&$HH]-(X
M;@ETE"J@MX&FA*(_0]2B"C1:W+^>XD(#Q:8+Q'%AH*-T`;T--*<N4(LN##N'
M<*4!8].%R'$.T5&Z@-X&FO/&0`U=N"TYZ&V$5OH`1;J>0\1Q]:&CQ`"]#30E
M!OW?0[$A!CA#0WX0X4(=Y6+2I\AQ\XE'Z0)Z&VA.78C_GR[@,@/#J@N.=HM'
MZ0)Z&VA.78@-7;C=;NAMA%9BH$NVX]H3CQ(#]#;0G&(`3VS:V3.\W=3@=WX]
M8"P`UMO-O/@T+W+-LU?!JCW[C>6Y\%)^DJ]M!!ZR6FO[$OA(Y$\ZTQXO'YL7
MPJ#]!E[HCLF>?4^J?58*+V<[B!GBE:=JWOB:#S4_PD;AG8[7\#:'_Q[@+9;!
M8U8HQ7W'>7WY`,A!^[J[^0\``/__`P!02P,$%``&``@````A`-@-3'BP!0``
MA14``!D```!X;"]W;W)K<VAE971S+W-H965T,38N>&ULK)C;;N,V$(;O"_0=
M!-VO99UL1XBSB*VCT0)%L6VO%9FVA5BF(2G)[MOO4#R(!R6-T=[$\>>97^3/
M(372_=?OS=EZ16U7X\O:=F=SVT*7"N_KRW%M__4M_;*RK:XO+_ORC"]H;?]`
MG?WUX==?[M]P^]R=$.HM4+AT:_O4]]?(<;KJA)JRF^$KNL`O!]PV90]?VZ/3
M75M4[H>DYNQX\_G":<KZ8E.%J/V,!CX<Z@K%N'IIT*6G(BTZESV,OSO5UXZK
M-=5GY)JR?7ZY?JEP<P6)I_I<]S\&4=MJJJ@X7G!;/IUAWM_=H*RX]O#%D&_J
MJL4=/O0SD'/H0,TYWSEW#B@]W.]KF`&QW6K186T_NM'.#6SGX7XPZ.\:O772
M_U9WPF]96^]_JR\(W(9U(BOPA/$S"2WV!$&R8V2GPPK\T5I[="A?SOV?^"U'
M]?'4PW*',",RL6C_(T9=!8Z"S,P+B5*%SS``^&LU-2D-<*3\/GR^U?O^M+;]
MP+:>4->G-9&RK>JEZW'S#_W191(TV6/)\,F2O=4L\,+ERH6+?58%(H<AP"=3
M6<S"Y=R_16/!-."3:;@W:\"6&,8!GTS#G[G!?$&F\H$)=RP-/L7PWT]SJ/_#
M<L9E7S[<M_C-@CT"3G?7DNPX-W*A#/A"TBN+I7UO96%)B<HCD5G;,!98O`[*
M\?7!"_Q[YQ5*J&(Q&S/&52.V/(+4"Y&-=9#H(-5!IH-<!X4.=A)PP!;A#=37
M_^$-D2'>\%EM.)#,THS@$3PEUD&B@U0'F0YR'10ZV$E`,<+7C)C>Y;P62/3:
MANH5M>`&@3K!#8T)Z-%`EGIKD-@@B4%2@V0&R0U2&&0G$V7J<"HI-?#QU$DT
M[*2E-'?/F#L-"I:B(+8&B0V2&"0U2&:0W""%078R4>8.2WC#W$GT,'=>M!M*
M`GIX#XO,B">F'C,"_H_5$FK5DH@@+IT:0IE!<I$E2R_40BQ$$)?>R4**'7#(
MWV`'B5;MH$2V@Q')#D94.T)US(D(XF-.#:',(+G(DNU8JM*%".+2.UE(L0.*
M_`8[2+1J!R6R'8Q(=C#BBWI)#)(:69E!<I$ESWVES5T$B;G+0LK<21MKWC5G
M2ZB=_E17SQM,FYB)T\*'NR.]9Q(1U1)*9$L8D2QA9.CM!IW$(*F1E1DD%UFR
M)7>:)2)(6"(+*9;`O5^Q9&+JT-'PN9-H=>Z4>'`O'@^"Q5P=SU8$\?'$C(P&
M)8P$0Q<2+N^6"^TX28V<S-#-C9B"D<6@NYAYZM!V<H)B#.FJ;G!F"%>M8<B#
M<I2\,9HG<IVU[:W$9HEYXMA[)`SYJL_:9%(S,>-HE,\Y&N6+3\GOE$35+-*+
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M)C/2,((>Q,S(P@@Z$9/G802-^`1?1-"13O!E5`R[5YMROHJ**?U-&&VF^#:,
MME,\#B-XYC"O&R\B:+XG^#*"QG2"KR+HSH`[8J#P$NQ:'M'O97NL+YUU1@<H
M@_EP2K?T-1K]TK.]\81[>`TV;),3O.Y$\*@\GT&;><"XYU_(!<0+U(>?````
M__\#`%!+`P04``8`"````"$`/L\`EAX%```U%0``&0```'AL+W=O<FMS:&5E
M=',O<VAE970Q-2YX;6R46%N/JS80?J_4_X!X/P$;-C<E.<IVM>V16JFJ>GEF
MB9.@!1P!V>S^^\X8<QD#@;PD81C/S/=Y_-GQYOMG$EL?(LLCF6YM-G-M2Z2A
M/$3I:6O_\_?KMZ5MY460'H)8IF)K?XG<_K[[^:?-36;O^5F(PH((:;ZUST5Q
M63M.'IY%$N0S>1$IO#G*+`D*>,Q.3G[)1'!0@Y+8X:X[=Y(@2NTRPCJ;$D,>
MCU$H7F1X341:E$$R$0<%U)^?HTM>14O"*>&2('N_7KZ%,KE`B+<HCHHO%=2V
MDG#]XY3*+'B+`?<G\X.PBJT>.N&3*,QD+H_%#,(Y9:%=S"MGY4"DW>80`0*D
MW<K$<6OOV?K9=VUGMU$$_1N)6][Z;>5G>?LUBPZ_1ZD`MF&><`;>I'Q'UQ\'
M-,%@IS/Z5<W`GYEU$,?@&A=_R=MO(CJ="YCN)T"$P-:'KQ>1A\`HA)GQ)XP4
MRA@*@$\KB;`U@)'@<VMS2!P=BO/6]N:SIX7K,7"WWD1>O$88TK;":U[(Y+_2
MB:FBREBJM)>@"':;3-XLF&_PSB\!=@];0^"JIC)"7>50D5`=!MECE*V]LBW(
MGP.S'SON\XWS`6R$VN>Y]('/VH?5'@Y44Y<$9;1+ZJ>GRHS.F!GIPE*>2T,[
M35,(2>/1-(C<@SF]GPX';6V@NP'!EC6,LH+29ZYH;^/R:<+[B=`9YF31SL1=
M(Y-V@J^FG)83@0LU3V<5G57VFE9M\3NHYC1N2>-\MH`!]Q'B0)I#6V!D"\Y`
MDP`QT^&@,TVE+6J9$9I0;(WUP%U_`AP<2'-H"X4ST(RP=-II[S.'SBI5FR?/
MZ`WM1'NC<2*@&?3]]/3*FT*M3%ZG/1@N>X-0MEBAPHWTAQIII-$:0BGU:^04
MU$,ZPK1N+!HEJ4S=)F$]VL'G4S"5V@#+NEY8*A;`I)B>!C#ABC?8]&"F[_<+
MTSK1SJI--.M\("MXF5FGP<6!QA1J$TV\&$ALB,L(S*ZBL%I2@&_:'8:`H&[-
M_1F4-9*DJR4HTHB20FIV!9K7$)B1;+6JM)?ZJF:KW'"8]@*P+>%LO&@!#TD-
MJ[6F:5AMZBX+;LB(.DRL8&'=!ZF&T2ZI3(12K]G^"")N2,Q(-JTA,&D-65ZS
MR^A3A/8BE+:\:`$/*0WO*DUEZJ&T1VF\A3O>I[RK-)6)DCJP(7%#:49([2J,
M"J!6A;GT4/I-.6%S.,J.-@H.-!I%F^"K-9L#VQQ'-6BIYP@FK1VT49K-1C>*
M]J*-TGC11D&EF%Z`UI66;'-MZFD40U=P[4T[N/!:8^HE7IDHJP-[$G](4)2W
MFL/VA#4;CV95:PQEM?$BK.*I?3JKRILV467JLNH9TJ).MU#;_<Y1HXP46D\H
MHP/;GO>0GBAO(YN6F!Y`/7JR&O_7TQ433YLHH(%-SWM(3)1WIT6:[:QLD<J+
MMDCC15L$RGR@1=#;8%2;NO_J/!2`UII6+3)%H=5`(PO&`A,AU1_8]KR'Q$1Y
M&]D&Q<3K$Y,EFW#`52.--%I?**AFPZ43]9"8X-'7G"AMZK8^7.UT)HJY?,)?
M.S62@JI,%)2YEY970>5]2R*RD_A%Q'%NA?**USQ+N"BIK?H*BJ_6>UA:H,3F
M&\]?[\O;*?,-6^]YWP@8L.RS0XKR#T@GT!(BJ3LL\PW''(K2SILYO%%IG/H5
M7%I=@I/X(\A.49I;L3@"6E<1G9777N5#(2_`*EQ=R0*NJ]3/,UQ/"KC&42><
MHY1%]8"'B/K"<_<_````__\#`%!+`P04``8`"````"$`VZ;YQE06``!-@P``
M&0```'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6RLW5MSVSB6P/'WK=KOX/+[
MVI9D^59)IFA=>!5%ZBZ]N1TE<74<I6SW],RWWP.1$`C\L1ZK:N=AXO[Q`+R<
M0U`")>K3/_[U_//DG]N7UZ?=K\^GK;.+TY/MK\?=UZ=?WS^?SF?#_[DY/7E]
M>_CU]>'G[M?V\^F_MZ^G__CRW__UZ>_=RY^O/[;;MQ/IX=?KY],?;V^_[\[/
M7Q]_;)\?7L]VO[>_9,FWW<OSPYO\Y\OW\]??+]N'K_M&SS_/VQ<75^?/#T^_
M3JL>[EX^TL?NV[>GQVU_]_C7\_;76]7)R_;GPYML_^N/I]^ONK?GQX]T]_SP
M\N=?O__G<??\6[KXX^GGT]N_]YV>GCP_WL7??^U>'O[X*?O]K];EPZ/N>_\?
MZ/[YZ?%E][K[]G8FW9U7&\I]OCV_/9>>OGSZ^B1[H`[[R<OVV^?3H'47#+NM
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M5MK6M=3Y8%;/J[-]/WCT']X>OGQZV?U](D.R%-3K[P<UP+?N5&=ZV*A.UL-`
M\G^-(S*`J%X"U<WG4]D-&2)>9?3[YY?6U>VG\W_*@/58Q]Q[8NR(GHY0HY/J
MMN_"P(6A"Z$+D0NQ"XD+J0N9"R,7<A?&+A0NE"Y,7)BZ,'-A[L+"A:4+*Q?6
M+FQ<"`[IU8D)#LD\")(7('L!TA<T\W<N)7FH2RG%_X^Z5-VHNM2;>:_!%&K;
M*4(=H9OT71BX,'0A="%R(78A<2%U(7-AY$+NPMB%PH72A8D+4Q=F+LQ=6+BP
M=&'EPMJ%C0M!`#DD4Z<JZ"$&V0N0OJ"9/ZL(Y<*'(NS(T.M_3:7'0M7J\ZE<
MOLQ8>'UA%]E]%7-9O1!30UT/TH<,($-("(D@,22!I)`,,H+DD#&D@)20"60*
MF4'FD`5D"5E!UI`-)`A(S&K`M`;,:\#$!E9FK:*45U164;Y?C"I:KNWRJL94
M(Z[,55"S&B%]R``RA(20"!)#$D@*R2`C2`X90PI("9E`II`99`Y90):0%60-
MV4""@'1/ZI&8UX")#:S,6M4HP]P1U:BB]]6H1^S[2IJE!^E#!I`A)(1$D!B2
M0%)(!AE!<L@84D!*R`0RA<P@<\@"LH2L(&O(!A($)&8UZ#&*>0V86)DTV==,
M52%6Z<F;O"-*3T7;I5?)E?QCAL;KEGVA[AV"=,7V(0/($!)"(D@,22`I)(.,
M(#ED#"D@)60"F4)FD#ED`5E"5I`U9`,)`M(]B6D-F->`B0VLS%K5*%?8(ZI1
M1=O56$EW/\FW?_/;@_0A`\@0$D(B2`Q)("DD@XP@.60,*2`E9`*90F:0.60!
M64)6D#5D`PD"TCV):0V8UX")#:S,6J4G$T]'E)Z*MDNO$BF]YD#HOBT^!!T&
M0L@`,H2$D`@20Q)("LD@(T@.&4,*2`F90*:0&60.64"6D!5D#=E`@H!T3^J1
M^B0F-K`R:U6C3`(>48TJVJ[&2B[-G$T/TH<,($-("(D@,22!I)`,,H+DD#&D
M@)20"60*F4'FD`5D"5E!UI`-)`A(]R2F-6!>`R8VL#)KE9ZZLW)$[>W#[>*K
M2:JO.19VG!>%)NHP&)(&I"$I)$6DF)204E)&&I%RTIA4D$K2A#0ES4ASTH*T
M)*U(:]*&)//:JF`^GTJZ=2)E9IO6\UC?8YZ4RPQWLS^[7-5$>_/FR_M3.>KF
MGS-6UM38_AZI3QJ0AJ20%)%B4D)*21EI1,I)8U)!*DD3TI0T(\U)"]*2M"*M
M21N2U&:5[D9NI39IGH3+G1?&>5(NM=F,LVM3S:0?49O5Q+O,,^H3J=^JJ'MU
MH`$I(L6DM*;VH:N,02-23AJ3"E))FI"FI!EI3EJ0EJ05:5V3.1!2)SC.4B=-
ML_.JIJV/R&LURVWEM2(KKZ!0?6A`!BNSH5$M77E+9.9;NE?VI34V4;J0$G25
M0C+3K-'Y]:7=^<A$Z<YS=%7H(%.WI47VX50SJD<<SFH"MG$X>^JC$M:!ZM?B
M'*BNO2\#$Z7W98BN0DADFC4.5/?:[CPV4;KS!%VED,PT:W1^[6SYR$3ISG-T
M-884IEFS<Z=^2A.E.Y\TN[*3IZ86CTA>-1-I):\B4^5]]?D52:>=O&OG^`Y,
ME-[*84VFJQ`2F6;-0W#C)N^P";KS!%VED,S?N?,ACI&)TIWGZ&H,*4RSQI;?
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M2LI((T.-]=\XEZG<1.GNQZ3"4*,O=U_*.JH^=NV;Z\O.M;._$].3K,^N`S4S
M<T0=5!,Y5AU4U)47,J8.KIP#VE.?<51CZ^6A@/JD@:;NO@ZZ%_(_^^HVU!&F
MGY`4D6)#5<HOG4I-3(#.24K*2"-#C0-PXUSS<Q.ENQ^3"E*IJ3HF[4X'!V6B
M0_8'Q4JO.CN/2.\^W)X2J\DYS9T"ZYDHO7=]TL!0XTA=.=?`H8G2?86DB!23
M$E)*RD@C4DX:DPI229I89&=,O2?_^`G9KM["-T_(FNP3\L9Y)=<S4?HH]TD#
M0^]FK-J(QLD=FH:Z^X@4DQ)22LI((U).&I,*4DF:6&1G3+W;/B)CU9MS*V,5
MJ:(P0^BM,_3UVH<H?4C[I$%-^E)Z>^&YE+)92(H,-;;*O?S$)JH>5YV!+S$!
M>K-34D8:&5(]W\CW5NQK06X"=,]C4F'HG=THZRA]V"[DFR!7'6=7)J8K6:%=
M`VJ^XX@:J*9'K!JH)U&LR^BM>QEM'Z+T+O=)`TW5)>/RHGO9PB"+CD+=REQ:
M(T/O'+O81*E$M2[.+IW+0V(B]&:GI(PT(N6D,:DP],Z6ESJJ/E#7%S?7+6?;
M)SK&<W%5<S=')+V:ZK&27E%CDK?7!O5)`]*0%)(B4DQ*2"DI(XU(.6E,*D@E
M:4*:DF:D.6E!6I)6I#5I0Y+/JR.1P;W'/`D//!F7SZVS/SOG]H"D9H&:M:F^
MV=/NG@D?^=V>=C6?9)5M15*VC9/KUAEB>G7#1G'W20/2D!22(E),2D@I*2.-
M2#EI3"I()6E"FI)FI#EI05J25J0U:4.22CZD6X_>4LDT3\*EDAGG2;E\!Z,9
M9U?R<3-];<STW=?4*,0>J4\:D(:DD!218E)"2DD9:43*26-202I)$]*4-"/-
M20O2DK0BK4D;DM1FE>Y&;J4V:9Z$2VTRSI-RJ<UFG%V;QTUDMCF169,SE#HS
MMST3I<_`/FE`&I)"4D2*20DI)66D$2DGC4D%J21-2%/2C#0G+4A+THJT)FU(
M4JY5!=CE2O,D7,J5<9Z42[DVX^QR/6[2M\U)WYHNS3QPC]0G#4A#4DB*2#$I
M(:6DC#0BY:0QJ2"5I`EI2IJ1YJ0%:4E:D=:D#4EJLTIW([<RE-(\"9?:9)PG
MY5*;S3B[-M4$<?,%Z_N?AFI7\\G6J]**G*'4N4_5JQLVSL`^:4`:DD)21(I)
M"2DE9:01*2>-206I)$U(4]*,-"<M2$O2BK0F;4A2KH=TZVNBE"O-DW`I5\9Y
M4B[EVHRSRE5]#_B(<MV'VQ/K-34*L4?JDP:D(2DD1:28E)!24D8:D7+2F%20
M2M*$-"7-2'/2@K0DK4AKTH8D7PY6U>%\L-1CGH3+]X/9UI-R^89P,\ZNS>-N
M(71X"Z$F9RAUYE][)DJ?@7W2@#0DA:2(%),24DK*2"-23AJ3"E))FI"FI!EI
M3EJ0EJ05:4W:D*1<JPIH#$7!O<<\"9=R95M/RJ5<FW%VN1YW_T0]ID;.K>:5
MOZ;&]O=(?=*`-"2%I(@4DQ)22LI((U).&I,*4DF:D*:D&6E.6I"6I!5I3=J0
MI#:K=#=R*[5)\R1<:I-QGI1+;3;C[-I4MTD^_JJT4]U5L6JS(F<H=3X0TJL;
M-O:R3QJ0AJ20%)%B4D)*21EI1,I)8U)!*DD3TI0T(\U)"]*2M"*M21N2E.LA
MW?J:*.5*\R1<RI5QGI1+N3;C[')5]PB.*-?JEH)5KKC+T.N`^J0!:4@*21$I
M)B6DE)211J2<-"85I)(T(4U),]*<M"`M22O2FK0A26TBD5*;-$_"I389YTFY
MU&8SSJY--<-_1&U6-P2LVJSO$<@<0N-C$LY-^E[G$*7/P#YI0!J20E)$BDD)
M*25EI!$I)XU)!:DD34A3THPT)RU(2]**M"9M2%*N2*24*\V3<"E7QGE2+N7:
MC+/+54WZ'U&NU3T"JUSKVP:-N=(.J$\:D(:DD!218E)"2DD9:43*26-202I)
M$]*4-"/-20O2DK0BK4D;DM0F$BFU2>MYS)-Q>0(8V]HYMVM3S?`?49O5#0&K
M-@_W")I#J?/1EU[G$&6&4M"`44-22(I(,2DAI:2,-"+EI#&I()6D"6E*FI'F
MI`5I25J1UJ0-2<H569-RI7D2+D,IXSPIEZ&T&6>7JYKT/Z)<JWL$5KDV;QM4
MC\?I@/JD`6E("DD1*28EI)24D4:DG#0F%:22-"%-23/2G+0@+4DKTIJT(4EM
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M++*S+YMZ3/95N'-%K^BJ^N&=_:/C+RMJ7+[[I$%-5^:9\T-22(K85TQ*V#`E
M9:01^\H9-285I))]31@U)<TLLC.F)@B/.%^K^43K?*W(^7*?,T;UY"D%*M42
MI<NH3QK4)#>`=-101]5?G6]=W%Q>MIT+5,AVD6YG5AB3$M.P<0ZXWP%,=</Z
M*\IGW8O;YO^<::7,=*KW8J1[,%N3,VJLH^18'5Z]R`^-V5\++-BPU`U-]Q,3
M9?IJN7LVU0VKH]N][;:N;V^=_9F9KF1_[.I1TWI'5$\U"VA53T76EWG;%^[7
M`B\/4?J(]DF#FJ[,<TJ&-:G/$AV.:,O]1G;(AA&[CTD)&Z8UR1KUIF:,&K&O
MG%%C]E4PJF1?$T9-V=?,BK+SJN:ZCLAK-35FY;4B>U2X<2JK)Y_%Q:@`&M11
MUJA01]EGBG/E#4W#9O:==P,1-R(F)?Z^G!U*=</#2&&?NYGI15?'2#<Q!9,S
M:JRCS.6M8%2IHTQ?$T9-=93I:V9%V:6@IIN.*(5J=LHJA8J<4]QY&=.[/$3I
M(],G#6JR3O&J8>.$"QD5L:^8E+!A6M/[(TC&AB-VGS-J;+K7NUTPJF1?$T9-
MV=?,BK+SJJ9EFGE57Z!4>_G^Y]+5YWS<EVP56:=Z^\)Y'=FK&UHO``X-];X/
MZBCK5*^CZA<`%S)\7_,%0!74:!=QA3$I,2ML#A$XK>MM.)S6_^$%`+9FQ%7G
M9M5Z]\<ZRA[6G`&K8,-2-VR>^(>->&?/IKIA=71OKZ_DN_3NLUUFU@JM*E)/
M5;>JZ/WJV8?;+_AKDE7HH]`C]4D#TI`4DB)23$I(*2DCC4@Y:4PJ2"5I0IJ2
M9J0Y:4%:DE:D-6E#DI].4=7A?$S<8YZ$!YZ,R\^GL#\[YW9M'C<-*;]>ZXYL
M-:GR/[QZ;%\X;SYZ)DI7<)\T(*G?RW4.3TB*2#$I(:6DC#0BY:0QJ2"5I`EI
M2IJ1YJ0%:4E:D=:D#4G*%?D([CWF2;B4*]MZ4K[_C623\ZI<J]\\KGZV]'G[
M\GW;V_[\^7KRN/M+_9[Q]8T\*^S`U:\MWW<OU,\M[P=[+#*_Q.PNZG2D576)
MQ*)+M6C_"!`LZJI%^]>*6'2E%NT?4HA%UVK1?HH5BV[4HOW]!G=16[62[W?*
MB81%JI5\O<ZWZ%8MVE]`W%8==:"JEX98I`Z4?&K?TV&GK1;MWT:ZK=2JO&MJ
MJ37)P]`]W;74FN19U)Y%;77<Y<D7OD7JN,MC`WR+U'&7;VUSD?H=;N]V[S?!
MT^!>[:JWQ;Y8/"T"V62I=J[[7NV+=U?4GGAW1.V';S?N51UXRT!5@:\(9/;W
M3LW:<K-DEO9.S<%RB4RPWJFY4BZ1N=$[-<W))3+/>*=F$;E$I@COU`0@E\B$
MGZS'MT2F[V0]OB5R)TOVQW>8Y8Z3[(]OB=PLDO7XELA]'EF/;\G@LBWK\16`
MW-N0]?B6R&T)68]OB=Q1D/7XELBMX3MUKY]'1V[DWZG;]%PBM^7O`G4_FHO4
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M]7"D;[O=F_X/V<GSOW<O?^Y_-OW+_PH```#__P,`4$L#!!0`!@`(````(0!#
M-$38R@(``*<'```9````>&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;)1576^;
M,!1]G[3_8/F]&$@@"0JITE7=*JW2-.WCV3$&K`)&MM.T_W[7F#!HHC9]X>-R
M?,X]]]J7]?5S7:$GKK2038H#S\>(-TQFHBE2_/O7W=42(VUHD]%*-CS%+USC
MZ\WG3^N#5(^ZY-P@8&ATBDMCVH00S4I>4^W)EC?P)9>JI@9>54%TJSC-ND5U
M14+?CTE-18,=0Z(NX9!Y+AB_E6Q?\\8X$L4K:B!_78I6']EJ=@E=3=7COKUB
MLFZ!8B<J85XZ4HQJEMP7C51T5X'OYV!.V9&[>SFAKP534LO<>$!'7**GGE=D
M18!IL\X$.+!E1XKG*=X&R4W@8[)9=P7Z(_A!CYZ1+N7AJQ+9=]%PJ#;TR79@
M)^6CA=YG-@2+R<GJNZX#/Q3*>$[WE?DI#]^X*$H#[8[`D3669"^W7#.H*-!X
M8629F*P@`;BB6MBM`16AS]W](#)3ICA<><LHFL?+!=#LN#9WPG)BQ/;:R/JO
M0P4]EV,)>Q:X]RRSV(L6_BP`T7=(B,NH,WA+#=VLE3P@V#4@J5MJ]V"0`/%Y
M1V#%8K<6G.(51I"KAC8\;<)9O"9/4#K68VX<!JX#)A@0!$0'95"[7-F"K;*M
MK4WEQ@7&,N%YF=E'9"PXQ5#-(?EPMAAXG;+#Q-V&&?N9?T3(@J'DBXG2ZU+V
M(+`Z2F<YI#.I)N1\>34MN%,?RNDB\>+$5?P17@N>\O81<#*RL#IO`8IQN04+
MGDKUD=F)!3N%1UO<'MXH\.S!>WNWVW53B3X".^"_F[E_W@V<DK'JVU(6/)7J
M(]TTF30:YMR$N)M%0>2]:Z=;.!4YAF#MR-#K\^K&HIL:-5<%_\*K2B,F]W;D
MA3`'AN@PCK>A;</K^#S9NC%-AB\P)EM:\`>J"M%H5/$<./VN.\H-6O=B9`NY
MPYB3!N9C]UC"#Y'#+/"M]UQ*<WP!93+\8C?_````__\#`%!+`P04``8`"```
M`"$`)HW?&<4"``"O!P``&0```'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6R4
M55UOFS`4?9^T_V#YO9B/?"PHI$I7=9NT2=.TCV?'&+"*,;*=IOWWN\:$09.U
MZ4L(E^-S[KGW<EE?/\H:/7!MA&HR'`4A1KQA*A=-F>%?/^^N/F!D+&UR6JN&
M9_B)&WR]>?]N?5#ZWE2<6P0,C<EP96V;$F)8Q24U@6IY`T\*I26U<*M+8EK-
M:=X=DC6)PW!!)!4-]@RIOH1#%85@_%:QO>2-]22:U]1"_J82K3FR278)G:3Z
M?M]>,25;H-B)6MBGCA0CR=(O9:,TW=7@^S&:47;D[FY.Z*5@6AE5V`#HB$_T
MU/.*K`@P;=:Y``>N[$CS(L/;*+V)0DPVZZY`OP4_F-%_9"IU^*1%_E4T'*H-
M?7(=V"EU[Z!?<A>"P^3D]%W7@>\:Y;R@^]K^4(?/7)25A7;/P9$SEN9/M]PP
MJ"C0!/'<,3%50P+PBZ1PHP$5H8_=]2!R6V4X7@71+%P`&NVXL7?",6+$]L8J
M^<=CHI[)<\0]!UQ[CF01S)=A$KU.0GP^G;U;:NEFK=4!P<R`I&FIF\`H!>+S
M?L"(PVX=.,,KC"!7`TUXV,1)N"8/4#C68VX\!GX'3#0@"(@.RJ!VN;(#.V57
M69?*C0^,9>+S,LE;9!PXP]"2(?DX^9>^5_:813<N8S^SMP@Y,)1\.5%Z7DH/
MFH/543K_L0DY7UY-!^[4AW+VD6YT)UU:3'G=W$//W9"_,BONX%2CC\#)D9WD
M?->@,)?;<>"I5!\YM>/V\6C<N]=XN;K`CCLXU>@C4SNS\W;@E1G+OOR6.?!4
MJH^<VH&5-R%V?A)`ORS0G9HJ'$-3-_-G;OQZ]/M#<EWRC[RN#6)J[U9?#!MA
MB`YK>1N[-^5Y?)9N_;HFPQ-8ERTM^3>J2]$85/,".,-@"2EIOW#]C54MY`Y;
M4UG8E-W?"CZ,'+9"&`"X4,H>;T"9#)_:S5\```#__P,`4$L#!!0`!@`(````
M(0"2[;E/,@$``$`"```1``@!9&]C4')O<',O8V]R92YX;6P@H@0!**```0``
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````"<D4%/PR`8AN\F_H>&>TM9
MG1K2LD3-3BXQ<4;C#>';2BR4`-KNW\NZKL[HR2-Y7QZ>[Z-<]+I)/L%YU9H*
MD2Q'"1C12F6V%7I:+]-KE/C`C>1-:Z!"._!HP<[/2F&I:!T\N-:""PI\$DG&
M4V$K5(=@*<9>U*"YSV+#Q'#3.LU#/+HMMER\\RW@69Y?8@V!2QXXW@-3.Q'1
MB)1B0MH/UPP`*3`TH,$$CTE&\'<W@-/^SPM#<M+4*NQLG&G4/65+<0BG=N_5
M5.RZ+NN*02/Z$_RRNG\<1DV5V>]*`&+[_33<AU5<Y4:!O-FQ_LTUB?=UB7]G
MI12#'14.>`"9Q/?HP>Z8/!>W=^LE8K.<S--\GA*R)E>T*&AQ\5KB8VN\SR:@
M'@7^33P"V.#]\\_9%P```/__`P!02P,$%``&``@````A`+I7MONQ`@``V0<`
M`!``"`%D;V-0<F]P<R]A<'`N>&UL(*($`2B@``$`````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````G%51;]HP$'Z?M/^`\MZ&LJJ:JI`J#8%&@X3AT*I[
ML=SD*%:#'=DNHOOUNY#1PC!T[9OM^^[S=W?VG7>U6I2M)2C-I>@Z9Z=MIP4B
MEP47CUUGFO5/OCLM;9@H6"D%=)T7T,Z5__6+-U:R`F4XZ!92"-UUYL94EZZK
M\SDLF#Y%LT#+3*H%,[A5CZZ<S7@./9D_+T`8M]-N7[BP,B`**$ZJ5T*G8;Q<
MFL^2%C*O]>G;[*5"P;X75%7)<V8P2G_$<R6UG)E6M,JA]-QMHX?J".3/BIL7
MO^VYVUN/Y*R$$(G]&2LU>.[;@7<#K$[:F'&E?6]I+I>0&ZE:FO_&M'6<U@/3
M4,OI.DNF.!,&9=6P9K->EY4VRK^3ZDG/`8SV7`0TA^OE-G9[S<_]SL4:@:M=
M9,W0*$'#KL:,FQ)T.ALS96R2+[8UKU4TBAM!FRK20!0T$@;S16/15)O+;>6O
M,802"RTT%/2:E4SD0,E>F.^"*<H%\0X_,<Q`_<8TE3.:XD-EYA,N9Q_R(4;F
M3_,/N81,SVG?ZC*(DF@2#&DZ&01)_"O(XC2A0=*CUU,2)U87,AV-@LD]3?N4
MQ(,D[L=AD&0T",-TFF1VERP-?]RDPUXT(33Z.8VS^\,XFHYK%60MXRZ83)"=
M6.'#.(P2$JV!83H:Q=DH.HB-!ACF>)*&4=2+DX&=D4RO">I#%AK='N0ZG@%[
M.<E^"FC&'O!K6$-;PZV9J+VL+L=+>4#5T5IVK/?8(DF8PK?/ET#_VX5@`R^>
M2Z#V7WPD`7C9X5OL.</+/N%BS]F!5T=[8!C'/O_:6^J^VW2QO6?U%[Q3^YT>
M^D_7''+QI*=5)GO8<39C8??0(W-L604VS(W][<"[P8F@RIHDG#/Q",4&LV^H
MA]AM,ZG]L_/3]K<VSJ>M,\]]F\G^'P```/__`P!02P,$%``&``@````A`!R$
M&OZ5````J0```!````!X;"]C86QC0VAA:6XN>&UL/(Y!"@(Q$`3O@G\(<W=G
M];"()%E0\`7Z@)`=32"9+)D@^GOCQ4M#T5#=>G[GI%Y4)18VL!]&4,2^+)&?
M!NZWZ^X(2IKCQ:7"9.!#`K/=;K1WR5^"BZRZ@<5`:&T](8H/E)T,927NS:/4
M[%K'^D19*[E%`E'+"0_C.&'N`K#:JVK@/(&*_0.H]$NT&O\C]@L``/__`P!0
M2P$"+0`4``8`"````"$`<U]XW=$!``!I$@``$P``````````````````````
M6T-O;G1E;G1?5'EP97-=+GAM;%!+`0(M`!0`!@`(````(0"U53`C]0```$P"
M```+``````````````````H$``!?<F5L<R\N<F5L<U!+`0(M`!0`!@`(````
M(0":+9-<N`$``"H1```:`````````````````#`'``!X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+`0(M`!0`!@`(````(0"!8=IV'`,``.X(```/````
M`````````````"@*``!X;"]W;W)K8F]O:RYX;6Q02P$"+0`4``8`"````"$`
MRNZXIE<#```+"@``&`````````````````!Q#0``>&PO=V]R:W-H965T<R]S
M:&5E=#0N>&UL4$L!`BT`%``&``@````A`/U;3@\4!```PPX``!D`````````
M````````_A```'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"+0`4``8`
M"````"$`E86`8&8$``!_$```&0````````````````!)%0``>&PO=V]R:W-H
M965T<R]S:&5E=#(S+GAM;%!+`0(M`!0`!@`(````(0"0,A5%FP8``+L=```9
M`````````````````.89``!X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L!
M`BT`%``&``@````A`(.\@]\C`P```PH``!D`````````````````N"```'AL
M+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"+0`4``8`"````"$`FEC:[?\$
M```*$P``&0`````````````````2)```>&PO=V]R:W-H965T<R]S:&5E=#(P
M+GAM;%!+`0(M`!0`!@`(````(0`WTK.4_@<``%8H```9````````````````
M`$@I``!X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L!`BT`%``&``@````A
M`)GWP9$J!```#P\``!D`````````````````?3$``'AL+W=O<FMS:&5E=',O
M<VAE970R-BYX;6Q02P$"+0`4``8`"````"$`^V*E;90&``"G&P``$P``````
M``````````#>-0``>&PO=&AE;64O=&AE;64Q+GAM;%!+`0(M`!0`!@`(````
M(0`F;:&I:@0``"`0```8`````````````````*,\``!X;"]W;W)K<VAE971S
M+W-H965T,BYX;6Q02P$"+0`4``8`"````"$`G\3F6$`#``#3"@``&```````
M``````````!#00``>&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L!`BT`%``&
M``@````A`$:^'-8M/```W;P``!0`````````````````N40``'AL+W-H87)E
M9%-T<FEN9W,N>&UL4$L!`BT`%``&``@````A`.7""V#2"P``U&D```T`````
M````````````&($``'AL+W-T>6QE<RYX;6Q02P$"+0`4``8`"````"$`K^F:
M!(0#``#<"@``&``````````````````5C0``>&PO=V]R:W-H965T<R]S:&5E
M=#$N>&UL4$L!`BT`%``&``@````A`+TUIKU[`P``+`L``!D`````````````
M````SY```'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"+0`4``8`"```
M`"$`87,[P4(-``!$/@``&0````````````````"!E```>&PO=V]R:W-H965T
M<R]S:&5E=#$W+GAM;%!+`0(M`!0`!@`(````(0#H14`M<04``$H5```9````
M`````````````/JA``!X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L!`BT`
M%``&``@````A`.!<8R&8`P``@@P``!@`````````````````HJ<``'AL+W=O
M<FMS:&5E=',O<VAE970X+GAM;%!+`0(M`!0`!@`(````(0#>CK6EPP0``+(1
M```8`````````````````'"K``!X;"]W;W)K<VAE971S+W-H965T-RYX;6Q0
M2P$"+0`4``8`"````"$`D/.M)-$$``#>$0``&`````````````````!IL```
M>&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L!`BT`%``&``@````A`')C4$6`
M`@``Q`4``!@`````````````````<+4``'AL+W=O<FMS:&5E=',O<VAE970U
M+GAM;%!+`0(M`!0`!@`(````(0"DV_T3V`@``"4I```9````````````````
M`":X``!X;"]W;W)K<VAE971S+W-H965T,3`N>&UL4$L!`BT`%``&``@````A
M`#2?:GT:!0``'Q<``!@`````````````````-<$``'AL+W=O<FMS:&5E=',O
M<VAE970Y+GAM;%!+`0(M`!0`!@`(````(0#%-"STZ00``"(6```9````````
M`````````(7&``!X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L!`BT`%``&
M``@````A`-@-3'BP!0``A14``!D`````````````````I<L``'AL+W=O<FMS
M:&5E=',O<VAE970Q-BYX;6Q02P$"+0`4``8`"````"$`/L\`EAX%```U%0``
M&0````````````````",T0``>&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+
M`0(M`!0`!@`(````(0#;IOG&5!8``$V#```9`````````````````.'6``!X
M;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L!`BT`%``&``@````A`$,T1-C*
M`@``IP<``!D`````````````````;.T``'AL+W=O<FMS:&5E=',O<VAE970Q
M-"YX;6Q02P$"+0`4``8`"````"$`)HW?&<4"``"O!P``&0``````````````
M``!M\```>&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+`0(M`!0`!@`(````
M(0"2[;E/,@$``$`"```1`````````````````&GS``!D;V-0<F]P<R]C;W)E
M+GAM;%!+`0(M`!0`!@`(````(0"Z5[;[L0(``-D'```0````````````````
M`-+U``!D;V-0<F]P<R]A<'`N>&UL4$L!`BT`%``&``@````A`!R$&OZ5````
MJ0```!``````````````````N?D``'AL+V-A;&-#:&%I;BYX;6Q02P4&````
/`"0`)`"E"0``?/H`````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	word-wrap: break-word;
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0ED1CI">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>LICENSE AND COMMITMENTS (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2014</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>License And Commitments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
        <td class="nump"><a title="us-gaap_AccruedLiabilitiesCurrent" onclick="toggleNextSibling(this);">$ 717,847</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AccruedLiabilitiesCurrent</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_AccruedLiabilitiesCurrent" onclick="toggleNextSibling(this);">$ 327,847</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AccruedLiabilitiesCurrent</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
        <td class="nump"><a title="us-gaap_ResearchAndDevelopmentExpense" onclick="toggleNextSibling(this);">2,011,033</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ResearchAndDevelopmentExpense</span><span></span></td>
        <td class="nump"><a title="us-gaap_ResearchAndDevelopmentExpense" onclick="toggleNextSibling(this);">302,662</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ResearchAndDevelopmentExpense</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lbio_EstimatedBenchmarkPaymentsForProducts', window );">Estimated benchmark payments</a></td>
        <td class="nump"><a title="lbio_EstimatedBenchmarkPaymentsForProducts" onclick="toggleNextSibling(this);">36,300,000</a><span style="display:none;white-space:normal;text-align:left;">lbio_EstimatedBenchmarkPaymentsForProducts</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementScenarioAxis=lbio_OvarianCancerMember', window );">Ovarian Cancer [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>License And Commitments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lbio_EstimatedBenchmarkPaymentsForProducts', window );">Estimated benchmark payments</a></td>
        <td class="nump"><a title="lbio_EstimatedBenchmarkPaymentsForProducts[us-gaap_StatementScenarioAxis=lbio_OvarianCancerMember]" onclick="toggleNextSibling(this);">6,050,000</a><span style="display:none;white-space:normal;text-align:left;">lbio_EstimatedBenchmarkPaymentsForProducts<br>/ us-gaap_StatementScenarioAxis<br>= lbio_OvarianCancerMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementScenarioAxis=lbio_BreastCancerMember', window );">Breast Cancer [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>License And Commitments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lbio_EstimatedBenchmarkPaymentsForProducts', window );">Estimated benchmark payments</a></td>
        <td class="nump"><a title="lbio_EstimatedBenchmarkPaymentsForProducts[us-gaap_StatementScenarioAxis=lbio_BreastCancerMember]" onclick="toggleNextSibling(this);">12,100,000</a><span style="display:none;white-space:normal;text-align:left;">lbio_EstimatedBenchmarkPaymentsForProducts<br>/ us-gaap_StatementScenarioAxis<br>= lbio_BreastCancerMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementScenarioAxis=lbio_ColorectalCancerMember', window );">Colorectal Cancer [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>License And Commitments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lbio_EstimatedBenchmarkPaymentsForProducts', window );">Estimated benchmark payments</a></td>
        <td class="nump"><a title="lbio_EstimatedBenchmarkPaymentsForProducts[us-gaap_StatementScenarioAxis=lbio_ColorectalCancerMember]" onclick="toggleNextSibling(this);">12,100,000</a><span style="display:none;white-space:normal;text-align:left;">lbio_EstimatedBenchmarkPaymentsForProducts<br>/ us-gaap_StatementScenarioAxis<br>= lbio_ColorectalCancerMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementScenarioAxis=lbio_MelanomaMember', window );">Melanoma [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>License And Commitments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lbio_EstimatedBenchmarkPaymentsForProducts', window );">Estimated benchmark payments</a></td>
        <td class="nump"><a title="lbio_EstimatedBenchmarkPaymentsForProducts[us-gaap_StatementScenarioAxis=lbio_MelanomaMember]" onclick="toggleNextSibling(this);">6,050,000</a><span style="display:none;white-space:normal;text-align:left;">lbio_EstimatedBenchmarkPaymentsForProducts<br>/ us-gaap_StatementScenarioAxis<br>= lbio_MelanomaMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseArrangementTypeAxis=us-gaap_LicensingAgreementsMember', window );">Moffitt License Agreement</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>License And Commitments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Purchase commitment</a></td>
        <td class="nump"><a title="us-gaap_LongTermPurchaseCommitmentAmount[us-gaap_LeaseArrangementTypeAxis=us-gaap_LicensingAgreementsMember]" onclick="toggleNextSibling(this);">1,432,797</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LongTermPurchaseCommitmentAmount<br>/ us-gaap_LeaseArrangementTypeAxis<br>= us-gaap_LicensingAgreementsMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ResearchAndDevelopmentExpense[us-gaap_LeaseArrangementTypeAxis=us-gaap_LicensingAgreementsMember]" onclick="toggleNextSibling(this);">358,199</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ResearchAndDevelopmentExpense<br>/ us-gaap_LeaseArrangementTypeAxis<br>= us-gaap_LicensingAgreementsMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_ResearchAndDevelopmentExpense[us-gaap_LeaseArrangementTypeAxis=us-gaap_LicensingAgreementsMember]" onclick="toggleNextSibling(this);">25,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ResearchAndDevelopmentExpense<br>/ us-gaap_LeaseArrangementTypeAxis<br>= us-gaap_LicensingAgreementsMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseArrangementTypeAxis=lbio_ManufacturingServiceAgreementMember', window );">Manufacturing Service Agreement [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>License And Commitments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Purchase commitment</a></td>
        <td class="nump"><a title="us-gaap_LongTermPurchaseCommitmentAmount[us-gaap_LeaseArrangementTypeAxis=lbio_ManufacturingServiceAgreementMember]" onclick="toggleNextSibling(this);">738,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LongTermPurchaseCommitmentAmount<br>/ us-gaap_LeaseArrangementTypeAxis<br>= lbio_ManufacturingServiceAgreementMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
        <td class="nump"><a title="us-gaap_ResearchAndDevelopmentExpense[us-gaap_LeaseArrangementTypeAxis=lbio_ManufacturingServiceAgreementMember]" onclick="toggleNextSibling(this);">298,071</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ResearchAndDevelopmentExpense<br>/ us-gaap_LeaseArrangementTypeAxis<br>= lbio_ManufacturingServiceAgreementMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ResearchAndDevelopmentExpense[us-gaap_LeaseArrangementTypeAxis=lbio_ManufacturingServiceAgreementMember]" onclick="toggleNextSibling(this);">890,684</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ResearchAndDevelopmentExpense<br>/ us-gaap_LeaseArrangementTypeAxis<br>= lbio_ManufacturingServiceAgreementMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lbio_UpfrontLicenseFee', window );">Upfront license fee</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="lbio_UpfrontLicenseFee[us-gaap_LeaseArrangementTypeAxis=lbio_ManufacturingServiceAgreementMember]" onclick="toggleNextSibling(this);">100,000</a><span style="display:none;white-space:normal;text-align:left;">lbio_UpfrontLicenseFee<br>/ us-gaap_LeaseArrangementTypeAxis<br>= lbio_ManufacturingServiceAgreementMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_CradaMember', window );">Crada [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>License And Commitments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
        <td class="nump"><a title="us-gaap_AccruedLiabilitiesCurrent[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_CradaMember]" onclick="toggleNextSibling(this);">250,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AccruedLiabilitiesCurrent<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= lbio_CradaMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
        <td class="nump"><a title="us-gaap_ResearchAndDevelopmentExpense[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_CradaMember]" onclick="toggleNextSibling(this);">541,667</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ResearchAndDevelopmentExpense<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= lbio_CradaMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_ResearchAndDevelopmentExpense[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_CradaMember]" onclick="toggleNextSibling(this);">250,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ResearchAndDevelopmentExpense<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= lbio_CradaMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ResearchAndDevelopmentExpense[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_CradaMember]" onclick="toggleNextSibling(this);">500,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ResearchAndDevelopmentExpense<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= lbio_CradaMember</span><span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_CradaMember', window );">Crada [Member] | Per Quarter [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>License And Commitments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Purchase commitment</a></td>
        <td class="nump"><a title="us-gaap_LongTermPurchaseCommitmentAmount[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_CradaMember;us-gaap_StatementScenarioAxis=lbio_PerQuarterMember]" onclick="toggleNextSibling(this);">250,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LongTermPurchaseCommitmentAmount<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= lbio_CradaMember<br>/ us-gaap_StatementScenarioAxis<br>= lbio_PerQuarterMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_CradaMember', window );">Crada [Member] | Per Year [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>License And Commitments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Purchase commitment</a></td>
        <td class="nump"><a title="us-gaap_LongTermPurchaseCommitmentAmount[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_CradaMember;us-gaap_StatementScenarioAxis=lbio_PerYearMember]" onclick="toggleNextSibling(this);">1,000,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LongTermPurchaseCommitmentAmount<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= lbio_CradaMember<br>/ us-gaap_StatementScenarioAxis<br>= lbio_PerYearMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_NCIMember', window );">NCI [Member] | Per Quarter [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>License And Commitments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Purchase commitment</a></td>
        <td class="nump"><a title="us-gaap_LongTermPurchaseCommitmentAmount[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_NCIMember;us-gaap_StatementScenarioAxis=lbio_PerQuarterMember]" onclick="toggleNextSibling(this);">500,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LongTermPurchaseCommitmentAmount<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= lbio_NCIMember<br>/ us-gaap_StatementScenarioAxis<br>= lbio_PerQuarterMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_NCIMember', window );">NCI [Member] | Per Year [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>License And Commitments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Purchase commitment</a></td>
        <td class="nump"><a title="us-gaap_LongTermPurchaseCommitmentAmount[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_NCIMember;us-gaap_StatementScenarioAxis=lbio_PerYearMember]" onclick="toggleNextSibling(this);">2,000,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LongTermPurchaseCommitmentAmount<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= lbio_NCIMember<br>/ us-gaap_StatementScenarioAxis<br>= lbio_PerYearMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_LongTermPurchaseCommitmentAmount[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_NCIMember;us-gaap_StatementScenarioAxis=lbio_PerYearMember]" onclick="toggleNextSibling(this);">1,000,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LongTermPurchaseCommitmentAmount<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= lbio_NCIMember<br>/ us-gaap_StatementScenarioAxis<br>= lbio_PerYearMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_NIHMember', window );">NIH [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>License And Commitments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lbio_PercentageOfRoyaltyOnSales', window );">Percentage of royalty on sales</a></td>
        <td class="nump"><a title="lbio_PercentageOfRoyaltyOnSales[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_NIHMember]" onclick="toggleNextSibling(this);">6.00%</a><span style="display:none;white-space:normal;text-align:left;">lbio_PercentageOfRoyaltyOnSales<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= lbio_NIHMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
        <td class="nump"><a title="us-gaap_ResearchAndDevelopmentExpense[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_NIHMember]" onclick="toggleNextSibling(this);">40,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ResearchAndDevelopmentExpense<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= lbio_NIHMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lbio_UpfrontLicenseFee', window );">Upfront license fee</a></td>
        <td class="nump"><a title="lbio_UpfrontLicenseFee[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_NIHMember]" onclick="toggleNextSibling(this);">$ 350,000</a><span style="display:none;white-space:normal;text-align:left;">lbio_UpfrontLicenseFee<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= lbio_NIHMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lbio_EstimatedBenchmarkPaymentsForProducts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate amount of benchmark royalty payments to develop and manufacture certain proprietary autologous tumor infiltrating lymphocyte adoptive cell therapy products.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">lbio_EstimatedBenchmarkPaymentsForProducts</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>lbio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lbio_PercentageOfRoyaltyOnSales">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>It represents the percentage of royalty paid on net sales.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">lbio_PercentageOfRoyaltyOnSales</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>lbio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lbio_UpfrontLicenseFee">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Upfront License Fee</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">lbio_UpfrontLicenseFee</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>lbio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The minimum amount the entity agreed to spend under the long-term purchase commitment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentAmount</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 985<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 730<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseArrangementTypeAxis=lbio_ManufacturingServiceAgreementMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_LeaseArrangementTypeAxis=lbio_ManufacturingServiceAgreementMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseArrangementTypeAxis=us-gaap_LicensingAgreementsMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_LeaseArrangementTypeAxis=us-gaap_LicensingAgreementsMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_CradaMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_CradaMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_NCIMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_NCIMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_NIHMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=lbio_NIHMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=lbio_BreastCancerMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=lbio_BreastCancerMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=lbio_ColorectalCancerMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=lbio_ColorectalCancerMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=lbio_MelanomaMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=lbio_MelanomaMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=lbio_OvarianCancerMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=lbio_OvarianCancerMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001144204-15-029130-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001144204-15-029130-xbrl.zip
M4$L#!!0````(`/%KJT9X_MK!9U\``(-*!``1`!P`;&)I;RTR,#$U,#,S,2YX
M;6Q55`D``W7G4%5UYU!5=7@+``$$)0X```0Y`0``[%WK<]LXDO^^5?L_<'U7
MFYDJR^93))U)MAS'F75-8GMM9_?NOL$D)&.'(K5\V-;\]=<-DA(I0>+#>M%Q
M*G%D$D#_T-WH;C0>^N5OSR-/>J1AQ`+_PX%R)!](U'<"E_G##P=)U".1P]B!
M%,7$=XD7^/3#P81&!W_[^.<__?*77N\LI"2FKG0_D2YN+FX/I>O@B8:S!](9
M">\#O]?#\L_WH<=.\*<$5/WHA$6!KBKFAX.'.!Z?'!\_/3T=X>NC(!P>J[*L
M'6<E#K(*'O-_7U$:7]^3B.;%DSA<6MH^AK=Y07SALFG98KG^<?JR6)2M0NPC
MKYPIAN<%S$\:+ZW8MGW,WTZ+1DQ4$)I5CO_GV]=;YX&.2&^>@$OG@$?4.1H&
MC\?P`NHJ>D]6>IHRY4G4&Q(RGE89D.B>D\E>"*IX]RPH`<,'1TXPPK*&K$%)
M$*\D_8*=.8DXS!LZD'CG3N+)&)0F8J.QAYCYLX>0#CX<8#.]O(FCY\@]D([3
MAE)-<0(_IL^QQ-P/!V=]2[9M.24T+4']F,63[-GT*7/Q^8#14.)@:`E\SIZS
MB]\./LK`6UTU5-GXY7B^<D[J6$`KHS2F(0O<>?H@GS#^#./B(W8.>2DK>2NS
M=W.5J.\6JFC`_AEAMU`A?UH@G3_*^+6:A4KW6*@W9Z&^,18JLJIV@H6IG8A3
M;BAJ@1OYF_5P0^L:-[1-<D/O&C?FC,UZN6%TC1OZ)KEA[X`;,XM*AR,Z[<KT
MA0LPGL<><UC\C8[N@:C+H%P:#F8AP<EM#,83:Y__)P'$9\%H#)&@'T>GSRPZ
M^)@7NP:O3D.(_F[CP/D];>Z78R&5&;IC$;R]M7;:+B*0;<H0GH\"_Q4+<!?Q
MSS8$B,%T47IWP2=Z$44)=5^G''<1A&US()ZZ+HNA(O&N"7,O_#,R9C'Q7J<P
M=Q%#;E.8-S0FS*?N.0E]Y@^CURG%7<2^/TI\L[\Y!1#\+L+\'R(HVFNIFZ]<
MZGOA@?=:`ZQ7K@&[==M[+?JW7,96XK5-9N?TMUQ&QP7XELMX'7)\RV6\(F&^
MY3(Z+D53T52KLY.;&^(/:5EBWYC/1LGH+7J=2K>S$Q>1=,GSFW2+TMW)+J%M
M6N!_D3`$2_<F\53BNJ9T5N*G3R1T[R;CN3%]/AI[P812'OU>C3%V>H5N%@37
MV1G,O@INGX?IJYVO[M0P;VFHZIV-B/=UJ&YA618%U^]W57`=&74;%)ZM=W9I
M=5]'W<MWEI>DO3X':9E]I1N[A_>:A=W8<EQBH=93FK*05]'DS;!P%P[CQ2R4
M[<8LA"J;8:$I=S\)?.:1*+H:<#M=6)6Y!8;0Z"SP'VD8LWN/OFV*$JN`^C;9
M^:&\MV48G=T3\37PAW<T'%TGH?-`(HI+KRS&YCY-SH`_PR"<7`TN0"OR$FYQ
MH38D+JFG!JW4\-:A/@&)%$A>T_`?"4B;AF\&)U>_?F>3H%U4O_^EY$WW9KK7
M66?W,MV[/+OXT31OSYQNO[-[9]XTK^,VK[-SO.YIWENP-Z]\G3UKM;5@[X=0
M@\XN#W1;#?;H1AJN!IU=XNN<&FQCM1TEVMD=BB\,+B[^_F;=ITK0V83BJG#N
M&_6('XQ>Y[@U.YN$6R6RJT=X0/PSO'9PRT'XMN36V036*KE]"BF)XM<LMLYF
M?U:)[2SP@I`Z,?%>L^@ZNY^P8Q'.EN1I=78H?@4C24]Q,7O(1^1LTUH:KQ`_
M&1`G3D+F#V]I^,@<>CH,*2_[%JQ.Y=_==&@WY;]G"S%6=S.2G9'_-C8=6U9_
M)Z=R7CP:@!_[,1HL63:Z>SWA*;3I,B^)V2.]I0YH?<QH=/[L>(E+W2]A,,(-
M80F$KU#M:I"?`K^FX>T#">FGB;B!\MZQ_=C]O4<>E.M,9SWH5G1F]_L-]TU?
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M06?W8RS?`3DMP1RL!/.8?.?C+K\,;<_2SV9GMU%T3?#[9O@[FR.Y3>XC^I\$
MJI\_"N4^5V"W,M>;R]R`B=5F9-[9/,5F9/Y:`LJ]TK'.IECVVZZ4Y_/PM[^1
M^;RUB\3+&KAA;88;G<UN="TZTIM?@JVO[Q+LQ&>IU+_??IZ3^`@8F83T(XL"
M757,$RB1-Y2_*C:.+2UK.=\E-4?!98^@`_,=Q8J7R8B&)`X6/%9M6$56B%LL
MD/M,_6#$_-4$,_E@/Z(Z%!<;S=\6^EW)/<ZW:(EHJB!5MGZ=+`BEW/88/M9K
MN;2/]B'P7!I&Z5W4G-(=&2H'4J:!-W20??&FJAY(V`9_@CHHN=1A(^)%'P[`
M(.NZI1NR9?YRO+SY,OFOC-PS+]U[Y[O+P:@B,/I*,(JB&9II6/T9FBIJ[;!I
M+1C5-^2^I9MMH96W(UZ3\"KDEQVX_R1>0O/QFP/4:P"<COD"4`W<P)&,QJX9
MW558TP%RFL0/0<C^H&Z.T:C"F(VL`KR+RR\''PTY_;,,XSR]:FSIER#GN/I5
MBK<$E]:W]=684CK5>*Z2&",%%SQ@#LK<&*@"L5;(K+9B;(^L\!W650/!;CD0
M['0@R+*N]/L%>U*#]%*LRP:"(K=DH;(X%%:0J\!5'@2*T!?44#AP"*9B6=8*
M2*)AL%!(H&E*I4MHCZF.KBT'5ND/EHU.\%:RT@S8\F]Q3RM,057Z@&6@9$U1
M80Y016B13^D:!WJS,R`,B*GOL`(BH<5?<.G/$3OQF??A(`X3&)/'S>D(+?B"
M>ZZ@0Z(')`#_H3M^)!XG&9^1,)P`23[DIQ0KS;,H6%%42]9UK2#\.C1?`K/2
M5HL"/%NVE6+<T@(E6/<Q8>[Y\QCF=10J7\4/-#R-(AI'9PF8?3^>8A1:[`I6
MJC"XM9(SJ2+7&I]:::P7\?7[BJ:_`)X82*6%%NJ<+MN:6G!HC<D*C7"E#IF&
M:BGUJ#I.,DKXCL+/=!Q"._Q$#WSV*'X`?IV.@C!F?_#GUV$`$^EX@ALD8GB'
M*CD>%0$+C?-J/JF6W3?5`MPU8=IP3^M$_?,:(>NJJFVZITN+7=(9^GK>H2PG
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MF1N5]E8P]]`-B/57`:G%EC*..NGJE^"8QABNRW#^1KQKPMP+_XR,64R\Z=),
M"^.JV)JJV:9M%"(9,95F4%H86T55E#Y8MJ90;FA,F$_=_.Z0TF1X@/L-IJA:
MK$[V+,4R;-LH3!NJ";8&V&*)LF?VC;YB%1UU4X#+ETP-H<&M3%?UU;[5M^NO
M+M_01^HG,SMC+-I7V;;E9KG@A487C2<TJC1K-+V5!O?^X[TUU(]X0F5*8M$^
MBG#/V>>^:1;52TRB$8Q%PRCJ:0F&#9;`D)NAN!KCW@_0L+,@XHG]+#DZ8_FB
M9:SDAZ:"HRSF.I=2:0BFOV@>*[FBV$;?,M3&8&YH1$GH8,;],ZBA%_#<459V
M"FC12%9R1Y451=9*QF@%I3:@%FUD)9<TD%=?;85IRL\%:2V:PDKF&*IMR88M
MD%:%RBP07S1[E4Q05<,V%+TV\4L:7_A.,*)?@VA&N)[A*SN`A6Z7FJY#M9YE
M+%-=Z.\*J@O7>I&(.:@=>+%780^'T'PJU?,B%?#(1TIAEE]!L0SO7Y0-'^#I
MZ2-(;$@O$]R>>#7@%0LKN<M0"ZVM7",H-ONF51HX[8"LM3-"BZU4=T:53=M2
M57N]G:FI.*;0M,NU%4=OJ3C+-_X(XU^[:<:E8I?#\KC-%$:Z=MUD1U6\MKS?
MH@!6JS,6%B;H[?LNBEFUJB!,;K`9<@5M46)`JW`<V51P#=1%Z0&M\:SK!0!$
M^0',_C>;OU0!.'7_G43I;I*[8,D<\1L)83*-/V<K@Z8H88"IY95+K8JIR59Q
M3MJ,^)J@MXBDUP1]/D61IB>^CP/__)F&#HOHU2`[M125TT66*"&!BQM5UL!6
M%1/SA\U)-X=\.L)UFREDD>$N01:$OU8SI"G%%R,5F?@*958U65<5=2=P6\3S
M'*[14`^*<$L&):WTF7]US34_Q9&J3'I[;,3OGRW<)#N[;';:!:%CJ9'][*FE
M;/C+T-3J&4\>UN^8T&M5Y,74R@[5`[$120D=80W#H\RO7.R?K(0N=K6!TK<J
MJX;]:>&3>WJUA';7H7J>NB+-N$KM^,;#Z5;Y]CZVB:ISFO6Y58;8RJ?.1\2K
M*+4%UL*%]BU--G5C/ES>!+H6'I.CLS2K-;HZ(:(X-3QW#^QW`!G=4(C>(Q;3
M[*OB4MHWU`F&/BMFK&VA:UTM"=V0==UH%MVN$?I^\*U%OG"O^";,1]I"]VVM
M+PNZ-']A"[UKC;R-MIZ\C2WTAJOS-@TFSLO[+5K"UFOD;18/Z;3N.\1>52"J
M=E6TSUS`7%E$?%N9&T46N2*](G6SN';_$@2BU)U>D;M97!RO0E#<GSZW+7T&
M1;C\4J4(AJX71O\*.BT`"<ULQ=)AW^@;+?`4OC`)-Y_/+<\ILG"MIF$B2$RC
M&8XZ:S7S:\PR,&5^N"Z!P:?\7P@+TTAE@!=%4S>?Y/^*/ZG[)0@S-S,[1B97
M+L<L=XE-B;X4:N5BBT"6YBPSUAAISGCPBR'>Y_&9IO]?^-GIIL_9)D?A*:?9
M*=,ZRRWSD:EJ%H=G.P3K[85P^;UBU5.W^ZJQZ6ZD1<L;RM%F+.S,G_5%N&I?
MD5W3+=LP5_6E-HX-=$@X^:D0CFUKFK52R5KV"$))/#AY'09XPXC[:?(=(F%H
M+5_A/W5B]ICN=>='6Q-XEKT,_$*G6OBUGJ8;5E\OQ[4O`+.9CK7PCSU5[9M:
M7]M,QT"V^8S&@2@DI)7G\!3!`>1*Z9B6JA3/`M<G^W*X+1RPIFMF>[#IE=9A
MX%#J1OC5;9A6(+Y#,2,VS<UC5KZ8+,M]T@QX"P==7@EHC6&]_6CAO0WLQ9JZ
M,15C53.SFQC:^.V%C%(EO5HFY@OSH6)]$R,X.%T].N4^]+DX.7T9F,UTK,6&
MNUR--M$M\44!:1IGWJ'..M$F5]G73$6UB\=8&I!>!^@6N_QZBJG"B)`W!WK9
M+1#BD]:KY^<*'HB'&<,6+ZL0G[Y>G>Q73%O7K!?"O`":(<R",&\Y0U-O0_;J
MQ1AQR_7V6%>UC/G)._),HW+CZUA#6M:XX.AT<^3UG<["^6C3LOK*BE'6,W`3
M^/SJ5$.O(RY^'8(JQ13B&X>6@JF%@].F9?:5%5J+(%5-JP5RGFI52@X/+H01
M3<^FC3U6@#EO9CG,_L''OWKQ>Y<]8L%WY^Z0A+>GIV"4=<.T;(3X3HKBB4<_
M'`R@=F]`1LR;2"?2NSLV@DG7)7V2;H(1\=^]/_CK,'ZO]`9!V%-D&9L]AG;Q
MX:H4WP+B<A<_)1'S:11]II$3LG&6`L.=E1%RAT;`%.Z*[J!CG[R2]BR9,JVY
MQW_^$[8WSNN,2#AD_HDDC^/W4J$!J!_S^C[4#POUL?9]>)Q_/!X+&L5V3B0%
MVI3F0!RF#PZE6_`:@_=2@;PD%PCD'["EO%7D3`_T,DB=^0EH+,C%`WZG%2^O
M[LXEY4CZ]?SR_.;TJW1U\^OIY<7_G=Y=7%U*IY>?I4_?;R\NSV]O.6YL>=J)
M^RUUA_$/9#1^_U]*7TXILL8HCOT@A+'9",SX^;W$&4@\-H2'N!#&!I-,YA'[
M@_8(7QT[D?P`.)H]CT,:.P_X#"FF/?J*^>)/+(BI\^`'7C!D2!1L\)'T4_Q`
MI:Q_NOD>5]"(/SG,GUCO"R^?J/AY$A4>!V'A39"$LU<_2RR2B"\1R0$58`[Q
M`"T94@GF&^,'`G`=FL3X'$85AP%=<A*(%B6`CSC=V8$-:,C%8B/<8@4<RI+B
MP0`Z#H4D!\U;*+'1*/$#3*R0\40:AX&;.#!-<FD$/(6&XT`"RCC^.8%Q\`25
MH!$BC:%!H/,NDH(G/VV'2M$DBND(:T&#+D"-:4[)H9X7'4E722AYE+A(:QB2
M4=YG-QCCMX3S8E*.!WH+R'&I*TY&8-68/V!>G"84)&\R&C\$SB0&C?GI[N+K
MSX?2TP-S'B0\K'V7TH..@/V&?@Q@P.>0HW=I<R!B,)6\7Z`4A*^B8M]&-"81
MVC0'/L)L&C3Q2+J#4D"$-PXU`#&&Y7@JCW.:/H,\('J'#](C>PSX0UX.,',1
MW1.TC#ZPAC,RA8*<&N!.>WS(PA17SBHDF>F;]$2`SR$#[2<>V$(&X4$X1K,!
M+7.CP5OUR%.$/<#/V`.*OUS21^(25)%;.H[3.Z(5\U`")VT>2=]A2N%)W_#$
MCX3?MP=,I/`7>DD0.^\EG>K;[SX*&[!\"?D!`:CHD_1.:8`:CD&^?M:88AS.
M&G0>\.IIT%.0OD]&%/O]*P6U`NE_RK4['7&'G'7,Q\H*KXM*#"J4UG:RZR[N
M,[=TM/_69<XZ[C76JZ*6J'TN0HV+$*3&%1RE@P$U5SV4R&D((\6C7/$NIGJ)
MQB8.0)@0X@TE;F%`+?%PQF&F#25E6&Z!#R4Z&%`'#)J4N\_%,"=_"LAX,`-\
MQ4`DX@'83V!J>@")P%LT;YD=#`HKZ>EUT3^GCT.N<E"(-W(DG0[B;'R)6@?6
ML&RFR$>\Y/.S,GE39'8WP^Q%2@X_%2DA'TI=-.1#"(;P7[F3:?5#'"0DV_+!
M)30CA3A8%L,BF6*SJUOEI:?^Z1[,W^\@+^K\7G!AXS!;($EQ'TK_76R?7]E2
M;GI,0NF1SS3'>"L^$CJ2;K`1'-@1=@00`V,':=(#])\K&,]P9AK'3T"#KJ*Y
M!T:ES(R6<_,08/(%NRG)Q1+8\E-VTDDBZ5&G:C$5%0=HH`L)EJE'!.X3[.<]
M18_!QV#J5(&#'BKUTFKHF<#42^F5]1'R'"-MZAZ"O??0'_,Q]<2@(C+%?3.$
MZ\6Z$.3R*0\J0W'2@[]_]TD"HQ`$>Q:`B?31$'R9*O*%/\!FL?`N@F.&B.*3
M]$DC-O"(91@&$%[T'##)X0G&5S%]A9.`U5W%."R9RMB9REAHK++HZVP:H&<!
MYD-(J00V)'Z(I-21IF&2IG`?:W!;A-]C43`88UR.1C.+AMX!S^IR>_[$X@?^
M>\)OXD4;!##&Z(*'$%.%/$*$]^C'W<RV2KB_#W[CEPMQE*<P,X``G2-DF"1C
MHT*/V$QK.;)Q$J(WB6>FCB\ZI7W&)@`J;HI!7^]+7Z`NB+3W#U[WA@[Q_@IL
MZK;W&_A3WA4HZDT.L;&)Y`9HP]"/>HE+N=WC'FP.Q"`(XM0!9.0AJIZLEQ,8
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M`DW?\!%3'"Z_`6$/:O`!CG4*!Q20[OES%CGS&[DC7%><ST_<GI\5$PK!=#:6
MAO(&Y^ZR0`ODG'@NRBC$&3H`!]W]=^*G(7.&BL396*\3<#3++@DM>?/(86U$
M%US<5P9F!S1JTM+#=9H=_Z)\N&<3<!CHU!^2X4S!B\FG=."'9,P35M$LS9$F
M@_B$,C/ZW-VAJYPEJV9Y*-1Z7@!+3L`2I&8]S;I,>.3,;PGB`QZG6__?WK<V
MMVTDBWZ_5><_X'@W%;L*H@GP[6Q2)4MRHCVVI+7DI/(1(H<2-B#`Q4.R]M??
M[IX98/`@";Y!"EOGQ"()S/3T]/3TN_.FLMA0H/VA`B]FARO-AAL#325$VFC\
ML($AR7G2TXPH"8/?US&/"2R'H57/D2VT.)M(K&D-D`%C18V6'B]IT7*X>B&7
MH$V!*9:R>!PZH<4(>K0RJ$&*0#*$YQVGB/3(9`I"AKRVQ",H)1`#Q@V:+\,E
M6P0\/"(]UX(;+M0<3'.`S4VINQW='/3U9F>05GF7$_S(0I@:MJ6W.WV]VTX/
MF^P'*J56@#(($8HGXZRX79+?&8)<2X%!&(-!T]\*5&1@,PQ#-_M-O=UNI1<M
M@4)!"O]EB?L7KR*XO$!]#10/U(_T2/B2PRI.T36[>K^;P2OG"'!'>OY?M)6B
M=EUN@.9`;\/&=)OI`8[^])PG/(IVCWV?DJ$!.'#DDQG.!["T:*K2#8A[4NA\
MYN=*A%O0T>&YX')S)8N,,!K#S8S"#?SWT>@!S@N>`2)Q(0L%BJ4LF#)N02'9
MF9><HLU-^3!B6M:U1[@_`/BI]>)[,#N359]`+%-,<()K>F-&XA$_U^,QZ1EP
M[`.2XP(/8_FEH)4<'3)(`O[O`$&6KGT"1=`>P1\Q?&-KB"&FH+;0K"CI(V$_
M>*1\B(@\Q1Y_YHG!@9=\51>I5-;2XHZ+VMNSKZ?GI^]B]L,H=F'$O0:Q4'AE
M\1PO[8P[5BY=V/TP@KOJ[=79Y;N&1JE>TB4T!F@">8JM)\MV,&PV$0Q3)_V>
M.39`%E^%!$40C;'L(`(H#QL1D\O-O\D-.E)0&6\/"?DANGR"4#/;@@4=_2F,
MW2`MB5[5*@!ZX"AEDQWHYGR3+)H$4T9(-`FXG-2>044(T5P0W8,,`D^/&5<I
MPS1+[#>RXR>F4=PFO.*F(@@BQT^[_4:&V4^`"9!`8Y%]?,1MZ^K>"_5/`D3.
MH5A1,DVN*"W`3'>1L7H3F.DT>IV5,=,R&V8A9I9#S)7WQ!'349PNTAR!$DAJ
M4K,U8SM09$2W),J*(DY&>"*"1)F$\_L$RKH7(4?FW(.S%.YZHUZ<J**"T`3\
MQ^;&DR<&^/6!PY^S`-A`]F[@C";%.7S+#M!@C0_"R_;$X@:T(!0V=>IP(B24
MC/J`$-]=?CZYEWX5=`ASBSW^2C8$VDK'2:Q!/K<T>?Z+9DUAPT#VH,5.>#F>
M\-&#&T*(Y:B*C("]AWBZ)]8+JKU!=$_]@FTR'#V@4Y@XN>46+E:N,V:KI%W[
M#$B&T77JL!Q7Q76Q[\(>1/>I,'4$_%:]3S%<E=$FN@NJ`6A`<1!E::/-#'ZK
MQ[<V`0S#<@S&:@EL-E^3+:^-,/+IP=@BAC"HF\25$=2JT"KDDELC8.PO=/,%
MV8'Y+OM>]/`8D]Y81KC"J8_\(?=HH:!`MRG(VEBC@=2K($_#L9N8_-YP!^-&
M,7\2SQ)@G`![@&,/FVE+#.-]3T)01DOTBE1'KC'`9+GK*A]7M7R8U*K)'$EX
MU0KYXVLDI"CQ]W]PX3M3-]HH[CVQH.!P<P!B.DCI(JX^/?02A37@RJ:?%/PL
MC!_=2'6->.*"=.T;=$$F`)6I>3ZCTB%>WID\;1I\Y<C.;)0J12/.V2L,FL1\
M@K4B.Y?<P5S'B1R0,W:PNU0IH/([6*H/Q8P=1"%C\0[>@BQI`_O'))[8L7'C
M8>MU%N1#+`NZ46PCQ%+;0H2EMA$1?`,!EF9#N_WVY<OIUS^UZT_:[>6O5Y>?
M+L].K^ZTT[.SZV]7=Y=7OVHW7T_/[B[/+A:'6FYK74LY636Q__+;;<&#K=MX
MK+KV%DMUO-.`^C4B[A(`5@)+6]0"J?XL:0^VP)%#.$JT"YN4ERG5P[U_T4CR
M1O$G_P[\BJ+.G'`5J04)U4B)4I'&2.ZVTT$`E6)61&(]VF-BA<J/"\-DXJ!N
MBQX102O1_;^%E0G'(\'<9RD?V#WA(@?^'*"E@1UY"O<3X]B@?XCZP4Q4^RV!
M3HK+2E`*R@$P5#*$<`DWT1Z%87(M=$^=*,B$@BGB</H]KC"1WRUQ_*N#V6/2
M<4:X:+0C33T0ME%#R0R$]AUZV:9;3M>B(#;^HFDL`J6(+W'"0!$:-;2;&2,A
M(CF%J*Y4CE?N@WW&P%8>L2J"\RB*-[0EE*`6X",@1`_)]0^`C,2N*=L0[YM>
M3'ZE:4N.O01U65(+AS4\8&*FAJI@8W>\H<@LM>TY3\-942>Z.)]D@55VBEP>
MR?D2T<^@E.$IXD0N*`"P&9,F^M<DO2IF!W31IZDD!Y"^<!`9).)-N<(+9&'Q
M#.AT\*0^:/;T?J\WRVZ4C@1\E@G"LX9KZD;7U'MFM]QXF1!)?LQ!J$/]?L@K
M$$K#;AKJ?KLWS]J5CU],AW;V=,-HS7K9]=P3P>ZSIRR_%>V-;46WU==[G9)+
M6K@1IFYTNOC_Y5&TXF9T]6YGKNDQ=3TFIU@U$&SH1(N@M+^9]+]L:%^C8[L+
MF,H.1$$L:*/Q?-(O=-]P;^KNQ,`],%0U12-"RVYB5H7+DJQI(X9F*6ZLC..S
M>#`TDA#0'MGA>'D;I%9'J:B"GR<<F8$(D4:[LA(WAFP[:"CQIC-&\E$)HOC]
M4`5!&-!2X59<`L#<G0<13BZ$H<3>2#<RVH5><NXT'KA'JR>O-II?^0K$;9O,
M#DR'AZR'W$7V$-D\PG$JK%%RXF1UB4Z,`7SNR/)'@?;1@W^RD5"?3F\_JJ%0
M(S9&`QW?`\]QO&=*(L(E!<#=`#]H6I5QYB+,,;'X"BEDX9K18BL7J(;?I6*N
MBO?HP]$*'UE^9<8,ZS.1E"'@Z1@__2O"8'89NV^+/"LF3/C<OFWC.&2A%8BD
MZ)L8C[L1XA:MR4S6=$FDH<=9,,*=\)_Y2]7Y/46)"_<!\Y](7V$V#1(3+`5E
MRD_56'DK6?DW5P%=G)![U3V=1$7"5D83+DCL>QG5$<US8:5ZT1V"7B1*]\S$
MW.@R-CK`X`3<`RX/6;QBEA)#@<ZR[^2?$TQZ*&HU\%G2FV:C-H"AJ^1O<2WT
M%&U7_%F>CVU2WEDF0O1;0%MR(;R=.Y%^*L/F8Y&()R[$U]^,Z&N4O3&N&V_4
MS>8T"(=PH(3*<S?P7XDC6H02)EQ'L%NNS?*P=0QS1I%IP@\1VG%FRVDC.QB"
MNAS)1#-:"$4QS7B'SS(2:;KI$/U,^MLL<$18I$Q!YJ=9"?M+LC*XZ0^3+\*(
M$@]X2/Z0+$\C&R,1I*T'G>0QEAJ:XI%0D!?G:B1[AE=S8IW*HH?$*07;$VM$
MXB<R&/(!B^`-T$LC02&\?30.&XA*F#6;X6R&W%DG/-!++>K].MF-U,`XC:-@
M2-$;9$80*9N"Z"CA4[$PL,G4\5Z8(%&TCR3?`&WB%S+F#8-9Z%C!RX$U%.-Q
M>W/<PU6E53ACZ&QBHW0F?WPET[,*=!+B%%@I8<G:H+;TC($J]'@L1]`4S_BC
M'4B=+2DM(=@4MY7RE%PJ"X_ZH?<D`AZE@59RFV47GMN!;-K;'#2(%:RS>@Y5
M:D?M(-;@J8@#;D<T%4B9)'8.CB#@Z4)`M]XE:$,+/T_H0L10*A,"C.8CFU>=
ML)%:K.$CVNTQ%.5=ZG:(W^=N#)GQI8Z%1&/Y'"H14IUFI7$<3T.[4I#,ERRB
MK%(+'S[""4Q?OSXIQ%CZ>O:><_L$!M^@*?X$7:W21G'IQN:.H>T/HPD:XRDL
M1^Z&L#"[GHP_4I>82CD4I*[2BYXA)W(23"9LA(JZPYU'HGX!.46\D.[9N<OG
M&R,L)T+JD.L<%Y+`D7L0[G+:1UJ+2R?*I_8#4)D$`7+GE*5]="S`_^WPT:,H
M+_X":L3X\\0;,4?&I9-Y33&7Q8*$8K+Q[>"ODS%F.MBB[)OF\P`_'@4/3SUY
MZ(_B0=SQEXX]CM=2L`(1;"9HDIR*P-J!HE/]NYDLLJZ03(9?<*3ELA3+(`$!
MB"\#BPMQ.*-O8PD%SFE5K)#M35#LXO&%'(A[XW-[OY"#AT4K5$]$<E`Q(71?
M\EEUXB26`7)62L#KD^*^SLH`X2D;(H4::7;"DXQ1JT01`<NU<Q^^BPJ-)14F
M=/7"*97"F)21L.83IBK`R&,I]=$4(K*8KNY8D2+.0C*?L`8/>7L<BGKG);+T
M7,VM4%R'.=88UY@*A%,J&X;<T!:@@3OFISQSS0J2]+3X+E89&0]UDOEN<"$/
M>186%W1R]W-<5X2O]!%#EN.*6+:#P=\N"V0B#0_=YNJ]')WQK"R28#@FU;QM
MD18N0QXLH73B#'Q-I`2B"!0YQ$1!TF#<,@7;CC=K2IH$S==FSX%8C15&<3+`
MS&RB%!8L[3^1!>HT8$C()[5J22SGS(/[Q`U%//GK8T6?E!H8L0`MA1#5(Q['
MI2A4R3F1@C\Z'Y1#0<*)KK(R-'#12,*&^PI$1XFG"0AQ*,@%F10(3)`@AN3^
M-2LA-2-OIC,H&`4&8?02XZFZ,`5IL8X]0=X@Y^5^4.[YQ*F4,G8B6T.PJ;15
M3DF6X3]CM%A0!)*M%)%`6L'2,AJEOUIJ]1/T"V,=$(5$>'9(S8YB&6E(29*)
M+G_C>R[\/=Q=>,'6!,\M0G:)"8@OBL^HG`\=O>;OI.6U\,%O4[))O#V]_?9.
MN_(:-,5)<Z!KRIYQJS0I.&?QK4L&G#,`TIN`():@!T[Z[3<Y#$42DH#ALT>4
M"IY8;.7VE1Z*@0!(!%!B:E,03;&.V@AM)!;>ZQ;E"8M<JZ)!8ML13]F5M26_
M-6X;VJ^GIS?"SD6I=!K6^B,O1>*<$!H9"2D6Y@=[?BK>HV#.]&();F'8$&%)
M,N<HL:_%PZ2,@8D"C@9)$=_TX&%5'M4(R8/TX(X9PNJD0B@E(2Y2(4"6$WAI
M:)2(5<6S8=V#9,U-+^3WTX4W0L<H75+IL9J!*_1TGMBO.BF(.8X=[QFE66Y0
M)2H9"K)(A#0U&2Q07!#_CD8/B13-"^*0J3#]@W"Z*$9*/@\)TK'@G"3"`<[&
MD3-&#%@*?C*4R6,=D2;5:D@T'R_J(PLCW3,XI3Q!D9)`8T>N*(O:U>'N$+6D
MZ'3"N=,>+:SSYTT](BJ\"4^HQ-"(PM<LIZ%=<+H>"1T>(,(B&5,DN)!J`Y(C
MB%L@J;"2ST+?"Z8"Z/A%`![T?D`IA0(6/F('R;AIT=N.LP0I)Y9?M$P$O`C'
MDPV/\J!0%8,YI_],AU="<CN*!MB;6`2,^I\6T([_H@@X1`XEN+#@OYV3IJ&]
MO8WN0V]J#S73[)R8S7?:B4S-N)7(A:\NO@-IDP2"4R*NO[E1@+1["<\$,<G3
MF`SE)E=H;8S+MM.0%[@!UJJ.9&/A9SICR#E)>K.$FU&GIV$)Y.@%JG0]F;)Y
M']MU1?[H@\\><&7YP8/$8*;6*Y./J)4L:"3R0*/A5Q1#FP$RDCIG"8BIF`QU
M"G]&]FI]ERGNXAG!2&0O%C7[EM<"%<3+Y`LAMG'@1U.D+)S`*R<\I'J$A6G3
M"0F%@"K%Y]0=XC=?R#DW<3)^,)7Z;QGG='SI$0LCQ,:!1I$@!?1]$7_G9A%Q
M=XQQJR@%.4TE.<98E@MVBCA:ANLD/&N<G11Y7VS#I4KER,!B*V8<F9[E.JB#
M>0X978HK`!TYR^&=RGTN6:>"+E3)6O(?Z54$EJ3>R7AH+N#&?L`/(F_SS@+]
MY9/G#QEG8R(>PU5JE,`NGH%PP*^>&UZ707`XRY5VN+!D[;N9=>]&-I4*QO,H
M2Q0*O8[6DPX+R9*-O+NR9"/Y"(D*=#@6T$Y.<2MHQU$JW3/3KEQ)H4BP="$R
M=C`3]RS)U;D>7PB>(]-23WE,:YQ!FFU+TF\V.RUS<8ZM,6CV4GU_-@+75I>:
M[4="2VV56"H(;&;/[![26K/%`6BM)5*GC7Z[ETJ=KOY2LV4':*F=Q4OM-'N&
MT3JDE68K&M!*NR7RX5O]7N>@]C1;*H%6VBM!OJ;1Z<+_'=):LZ48:*W]$KO:
M[32W?52SS]#=])(O1-"9T9YRPX4(MIG`5.>RU[GL=2Y[G<M>Y[(?@A);Y[+7
MN>QU+OLN<]D3.7.!4)B6(#$OG-+"K\>Q#_(R":W@[R9RY(Q6X0<D1]:)\'4B
M?)T(7R?"UXGP=2)\G0A?)\*G9:=2XE!:@OH6P,-Q2GDB*NVF]N?.0^CJ'/HZ
MA[[.H=]U#GW"H=+LIJ`F,N6=J[EOU[+>^27%OL/=?8/%X;.J7=;3?"3\JD[&
MKY/QZV3\.AF_3L:OD_'K9/PZ&;_BR?B9'A3+"7-I:5#F*\/#2OKZ!8<L*_UE
M@^^.1/JKD_CK)/XZB;_:2?P)RRO!L=(L+I4._Q6NM#-*U<6_$M8VHQ'7H;.V
MNA1`70J@+@50U5(`"5.;PZ/*6.].T03#E_SQ)7GDAO<S/D4CQ`5IL8J;@E*(
M[AXM(2T&OY):<>GRMFI_B-BU4QZZ1C^>`_>/?1\)Z\RW#,SW,$P:JGT/[`^N
M[?S\!N"`C^]WM;S?25V5RTN@7[7#8,_L=HQ%@OCF`=\/NI:@AGR#Q'G4D&JO
MUVV8V0:)55A;MLOGLY+FE4JWX\+'S/#Z;([`D8@8=7F/NKQ'7=ZC+N]1E_>H
MRWL<I:I3E_>HRWO4Y3WJ\AYU>8^C+N^1:)[+JGB[TLEAW\;,+K)B=&>D;N>M
M&/LROPC845PH;TSHSL@DJIAIZ<H3:<M7/,$V!C\?W6LTS1(%/+)5+78&^LXQ
MM@0MY$,/,\C<OV&I_++V8]1-D%E41J=3HC9'KV]VFCO!91KR#>&+_O,[]PSS
M@8T$)T7E=@`GO]RT_MS`@@NF+EC4_>*1[Y=&Y>F#D-DO06FVW<`>$@W&U)J@
MH*@,3Z>?/F,J333?_-+N=XS.($L2>UE'IL*+`W<S"I#%6W8APXODVHL*\Z2.
M1'[MAMGI#OH=I7I+J3GW8\._PP"]`KY:5*8';=7S]KS3;+<[NS?5IY>0J7(C
MPA9ON5VM&*285&CV@,93?S_S@O#*"_]DL')IEDI&XB]E04PP650$J-N<B\F6
MT6Z#]*;D9>]K&1LB2C':=5+;(G,77GQG_M`.V`VF"L:XZV4%V)[1;AGEW$:]
M1KNW`5I<#O(,NC"Z4=1JX30-Z&?GL4J?]P;U=I,D_S__+Z6I*OKG3YHR`+P?
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MFS(#&3=4F-`Q`R2>&%V50%?<`(6)%(1%D7)<8E4SH/W$[GWN2.@*\^K!'=09
M/`GMBS)M*'5J*%B?E[4)A)$X4P#GR/G7>9*'&CYB+@7@)GR$D^)BR/^<@#AI
MWE7/O8$<JVP1H"11(HU_=4!SWF"X4OCK%$,$L"R1C>Z/FWCW;A5^QBU?RCQB
M%+$&/,!*WA<%_F),<N18/.PW"U<G"U6Z=AKZ,##!JQ2(&K"BT>9/VH*@D])2
MTWL7@[.=I2:??I]1"(*$N@`$_A-KA%]^P)PN)K\/?18.'_$[G'%VT+!"0\3"
M9$X:;N""@)[*+G.9L[]G6`7+2$*#)$>@U*\,2^CU33UW6M)BS(P:FI0ABHD'
MXK&%F:*T_4FA0OX\S[AX`,[&O2O$#P10$@ZD'YX=82GY?NHJB#6FUX"1%0&Y
MJ7G-(3$6"4,2$6IR;T8P%,4>F<BYE[:C@G2[#+"I(!ZXY4>B$L.0R;4K\DXL
M&H:9VHTB2B+A>39)2_<90:ZM]SN&WAFD]T_'B;CH\_<T^S<[77W0[Z0QA=PU
M3DB!O4/"$;Y9,D@A3Z0*"'$)IP(L*,7HA%EPM,3-):*,^):D5]AIZNUV!F*>
M.)Z*_DG6((-7D`0)S[PP0AQ^@D$%L4=_7F1Y4O(J+BR;2L!34ATQ$LT6,LR\
MNK,$=6I]+=UHMW5@+)D=%)(K^OWOE1R_]#+3Z7ZRAJ5R:LI<6ZMRJ^-FHKF2
MK_>+RA_K:4:SO9+!9:K1+@G<"C5G"\"S$M:JYJ&)7/54K=0YY9<E<[;NO2>>
M@:X4S1W'CN"LWANGJ\D!DW(T=(H<:\H/3?9JLF+Y),Y;4VL,P,B1S\-GMWF:
M-BZ.I<_:ML6LY2&]2U4?#.F6":()9H;^E\T6.BQ1>5`I$2ALGG/"UW>W*H[8
M!*Z*\EN.;B*WG]]@F!#SWZP,Z;,]"F'F0?.'G[1[O*;\DR%L+)ZW#YK\:UGX
MM2%SG&!J858\^CKH\Q2#EOEGOA:Q&E_"3CH<L$9YDNZ],/0FZM:$&#CT[%O3
MG]_P?XLP%8[FO2`G$]"<\$D`9;%9G+-1G-X9%6Y%N0E4GL`WJ6A\B7,.!J+>
M\^$GK#*0_4WL%`&:_H5F_*!1V!PBWT/<N^@@(6LYZ>?)&KRQHJ,*7EXEQ+V>
MG9%.)G4_A,-)_8K"(9*58C")^C,Z19-?R3VZ>VR_#WUEMD5'&N2IX5\//N92
M2L3^;3AD;#S.G'8QC$!PK_V#<``EY<.Y<*/'8=I""2C"0'HPXX<R))1[)W77
M.VP<KC!*,S.,CXA.1(#8#M8;Z+UN.^_1V@6,E<<.!G;M`C5K4S8H@R$KIFMY
M^!`0K-UJ),5;?^6"=,&B2B-TC;TH@?^3LLA?`8RC7^)VV>4<LN)!-=5%^=N>
MJ7<[QGJ(?U?=]2W#M0Z%5<6QZ7/6LCFA;A9R=B/"K4$+.P1P(SQ,V_B>U43P
M:HE@-Q>>!-)L=*;A3%4A[2Y8@EZ585<DSZ6WFD]9O-DC+[IWV'KDN#V`G/G-
MH-8BPF4WXH`V\N\5W+^UA)85-R]F&/(C&CV3G[=MO,\TU4!99T,V7/I+6+S%
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M<W=Y?76KG5Z=:W^<?OUZ>G5WF[_'RN;)[;_!R!Y`X^4PQ"';-W3[*,9R*C(4
M7Y*L=]FS,-/9/,QEE,NZU[*CQ:ST^!"S>RE'7J=JZ;PH==(^-I,S^:$2.$=N
M-72L`&Z>L\@///_&H^89;U*/*"(B>:TSCN"<HU@L9*$GF@NL0M;BWSU9OFVY
M8>9;J:6FOLP*:XEHQ['WDX8LY>2QZ-V9K)/ZI2"*@Y1GW6@V?Y!<>26/=Y[Q
M%_+]0L_X;#E]U\,IKL^*0WIT"Y_A^5T@"$B][0-I2?'@<'0\]Z&`-2@_%,`0
M8\%HY>!>Z)=?&DA58JD@,M;9WS+FBK5I<B.3+#?P<@;"FD,>$*/0EN$/^<5O
MGCTDH*@1.`L@W"-RJL"S]KQ!:ES4`6"KYO"5YO"OC]$I89ZOC<U5>%?VSM3J
MVV<NC%\9=HR7%=.KCZ8JP+"OHR3+=1X"FNJK<(^4\@U=!J^2Y59X4V2KE&HC
M9^^,8W\;)'N^1Y9S((BJ`@Q[VJRXW=DAH&E?E^$JJ6/'0#RIT*\/VM]X>C8&
M=O+P4>U_[0G6_K;<</&"N&?X$,BL(C`<PJ92O[(#P6<58#B$/?ULC^LM/:XM
M35)]*X[/#=SPV6=#;UJ0RZDM$@067_R'/5\VP_R8UUKC]GCFJW'[*G&[W:RP
MY2XX'J_W\QN,UZ/AE+Z^&-Q9OL#$"A?K&LF.VYU(S5HL.Y,V:_\HO?@$PSTI
M=A.ED7RRD:'W.SV]W^L1A"ME'"T';1%4<=*2SR-`._A@.@6ZLQ1.*PC2NGB;
MM<L9.(V9*UHEWVV'A-AKM%:O0U#3X$YH<.=`KD2&N>CRM>BRW\BTQJ.VAX>.
MY`J"5#/(^81HPBW=UEN]_A%PR6V63EDHH&<ES]FUG\H.60N5:5+MY%M@'R:=
M)D"N,<GF5-2#P-2^Q<A,*]M#1V=->`<J.!J9EM]'(3?6U'@8;-!LM8[D"MZE
MT;*$L"@CYVIQ<7/$ND:]M,J0:<TB]\`B#\(N41-=I3!5$UU-=#71'1HJ=V<P
M7-IQ??%]:OML]+Y,7>;*^*K7C8S;$M&O#M:!2*!++;#V!&V?G"O+_P]I216[
M+&KBKHF[)N[#P-LA44)-W)47\W<8H5JZKT'5A7ZST<>ZI+P<?;4$_Y*@K1L"
M.VCN-`1VZ<76U\EN2+R:,63[/!N]1KL^%D=[+"HIDE3<5-1OF#L+,*JM154[
M#8=T06S]*!A-O=OOZ=W6OJ^(G1^(2KLC*$"%-ZVOM92CD<3:S8[>-LQ:&#O6
MZZ?645:^AAKMG27%U.?B\*V,=5Q&38)U1B&(%'JOV==[QE%E%,J/Z0:F[U/-
ML=*?CJV'VOF,OF?4\BS7-0T?PQZ+EONB/?!,2,UR19\U+?2T:00O6`'35-(I
MR/`3#9^Q5=O0F\"<&N_8!D-81!,31FU,16,W,>>/@?;1L_P1?GUN^VP8>G[0
MT.ZH]9O:\.W1>F((&!,!^-H4R^;A:W_/&"PS^=K8%@[;9V)[M[$7^?!O$%J.
M0STC-2L0_=Z"#_%48\\G$..5PR0I@</4.S,63Q/!TK]8+QIB-]V9SI<%SN.I
M5/RJ0[`GYCHOF@?GF]YT8;/%;OXGLOR0222-+=O7GJBE*4<L@BL&?X;%C1@\
M.[%=V%68ZYZEL=7J#O+[&`62?#YB9^.3V^&CY^#&<I)`O.,#$V_$'%!M`QC:
MRW;.LX(@FG`P/FAO[7?:D^=8H>W8X8OF6V$.I6:F7_4/.KP%KXWL8`AZ<UCX
MDM'(6!XT_AJ\IS[V7^9[Z<?8]RG#3K\P_),]@G.AO=C,&?&->FL_O4N><.QQ
M;MYN>C1*[&KL\(!7GJL0'N&/=IJ]^-A)%)\>*CU=X4,0!KES;.A-HZ>WFOW\
M84X]-V@:>K>3IF`=9@IP_^PGYKS@)Z0]!-XC>/"$T2',-)5L:*<$2!&+M&3!
M^^2P1:(K;^J\I8#KZ]TN:.V]3@8\N`=A@F?;<:@]K>W"@/QT6A/0&^S_(@\.
M\FC"+Q$8.2'G-L0CX)`'&C;VQ86-X?I-42SP')9&I.R%Z:6>&P/&"HA;QXFM
MZ=0!40.NU<W3^O[(^MH5VVT.:+N;^L+;2;-&L`&,L_1?F<L"&QZSO2GP[XFE
M:Y?NL$%#(>CWA$5:$/W)6RMK:E=C[<:!>^TMCO8&7Z//;][AQ1!$<"'C)G&*
M(9Y,\&#/4O^)7]4):6;X5*M3^I+&*V\<A9'/N!"0[[BJ<P&52,8:PBI\O,]D
MSW3^;-$SD9M_"D\Q'QR("K!J<SSPEQNR_VU\#]L!XH%?]G!Q:WQ=<BDD&-PS
MYDKQA8_O>O(!^(]F/5FV0S91'!2E2YS"<N1JJ;$Q31;OP-%S="#]:R!HE,F0
M4\/"C3+$#SOF$>71&YH@:"!ZD*>`?2C4+%;5[OU$3^(/\JO^3^^X_)+,100!
MD@9L!(@M-NY@*&>3.\,'`<X9/H(T9P$!$I&A`,).D%5I4^I(SDG`&N)]`PP1
M+P'U(AI:+@Y.>P_BH(0\+7"F2()/+"^(<S;DLJRX(P![";D]LQR]J2>K<-Q7
M0&JW#'@F(<T82*3=+<-I/R.+`#8;LN&CZSG>@XV`2&;;+DV([6)"C'^A:SRF
M\GL0PB,_39Q6R$4"UXV`@TP82TD3\JE'D"A1Y[B"<6C=.$-V+M`&0AMXVHMF
M1>&CY]/5G^)YT92XZ1PV;^JM\NH8<%=7.P49WM'PKB-I+;E6K`D7YT(52%T+
MHOM_PXX@(,H2!9(L1\<?X!CY#-48DA`]T+`T-Y(*GX`E?`34P>%#20<7"#.E
M3H-`"N`\+0IVB]9'0DZ\]GB*M$#3QM]FX>9(CEULU[F7?U#3^#\LG^XVFF_;
M;>3WQUH6=HQ_%G@XZ);Q"_!;=X?/6!XKUAU>HS%_?L,+U\<'=L7Z$>N-OG;6
MKMR:!FW.0F`+@-M&.]2D[G*K1G<ET9U^JLBGL%)#IB(LK>UH<#;63B/&D]')
M(FJ;*$B$`O]]3:'+S;F'%EDUQ]H[/90XR\7'=X7(.6?95HC;8AR;W>MU>:>Z
M0^5POXUV?G^0I"GJ..QG6P[D2LL=I)W<:/F=TLIW]G[=/.X0[[R:">^)";=W
MVD3UEDQR]2YD=Z&@(][NKL+R?/7X3VE])Y>B\J\RQJD^RI62:D^E^V@1Q+4D
M4!/N7B6!;^@2K#>A4H*`+'M=2P*U)%"6S,_@(=\:AI'EU*>Y4K+`)6R,[0;V
M\$!D@;FFDMWPFZ5V^971\F;%@XTV;4\%P=2;MBMQ8J-[>(.)/I41/"K!"%ZC
M!+)&E9-2Q^BS/2Y#9:^,36Q53MDHF_@=\W)V(-"4Z]6^R,F^J6[S*SJ62DY_
M(&ZR32%S9>]9O:_UOB:@;.QBKA%;4^Q6_?C[K:"<2Z.:@]@5Q/;=]PS=D"2^
M^7(K!5`N4SFD"/J8+A'ZY0(6MPQM#!E!FR\79>C-?EMOF^DT_JI`OUM<UR=E
M'[LWKR10E8Z*V>@8QWE(:FJN'B_:,C&W&OU,9:!%';D/"]<U2;\^!MT9Z!VC
MIP\&I4NX51#9F]=AYE17IE-BNR,F\W"7]:;FE)I+2F0OC?*\LE>+8%4@NFH>
M\-*-*0\9Q?61.*S]VL^1J`)HM9!V&&BNZ;6FUT-"<TVO^U48YCH]-J\RR&CJ
M6FLX=,JKUA&6>L+;@6GHO4S1LZK`7@[3[^JC<5@;=B@F,[/1.>1S45/SOM%<
M!6*N`F@UO1X&FFMZ?47.B(OO4ZR'70M/!TYU]?&M?0XUX>^=\(_<#5=3\JNA
MY"J`5M/K8:"YIM>J>R/F)).LEY3ACF2#Q34;R-?R536)LUJG7$I41E,WNJ;>
M>QTY&?79J,1^'9#'HL["J*GY.#A]J]')M'2MLS!JDCYL!CWHZ=U.6S?ZO6-B
MT[$:(S^B1J#\G&HHEOYTF'WT-M/[.M?RFMG81S+5%]K46\VV;F8"$;"9W-`*
M'GEG0QPE[G7OC341TI.TLUO4I;XH!DAI"FF'0;HQ9!:?<DO_\3X*3AXL:_KA
MW`Z&CA=$/KL>JPV,OV)_;38ZPT;>5,;](S:%O[%>)@P`O0.L?G1@AE_^Y_]I
MVC_D8,F#ZE"GN+@'AB]^?,F-=0J+'XGNP(K:>L7[3-JCG]_<60]&'UO9P8)A
MWJ]L_/.;LY[1;K5[;[3(M?DWO-;\&VW$AO;$<H*?WUQ>?7KSB]'O]/J]7K+@
MC<.X-13(3ABB8+L,,*32:0EBC$6(^79[?L-\FE3%COGFEUZC96P%,?,@+T#7
M_>))[Y>>-*Y9KI0LO6/^Q$Q09^91-VAWWOQRT_^S^R6#F-W"N%F:^IU:VI^Z
MHXOO4X8]N^\\_$J!*RXD'E<1I<I;":I:):A,I:[FFU_,?J_=ZO4W1V`K+V.S
MV/R56/6E>T-=J7_UO2!(\-0NP)-A+&93'2R2MCE4%<"X)!*"I68HQZHZBY`S
MCU6U.TN@9W/0<[0Y][:W-A^8.^DL5I!@KUN,O5]NC.:?_WB_/P@W>[HD\F,H
M[K#M]"RVU"M!45FVU&IM]*B5`3B#(A3->(8Q%T+Y>YPST(^9H4?)@OME^<OW
MP/[@V@XHKWX$A^G]9G?ID^>/F1V"U!AP?FS[-$*,A`3B034@GBU:#HI$2Z-9
M0K0<-'<O6NY)5AH4B9G$??I_MFI9265*@P*Q,DU/>:9D-+O]7K>U05JJB+!T
MD3@>L\>N2*0L<^S:S4[;,#?.P!,0MX:!4E+2H%"$;):2DHQFH[U!@;LDZ#LY
M@`HL"P]@H9PY_P"V>\U^S]B^LK)X&;M35@99B;+?;':ZW5I9(>1D1<L<<BJK
MK.R$=K*"**&GC#W.[.R>=M802/@YEA-\LFR?3JF18"(KX!812H;;M+J#_`G:
M`I`;HH=XP%-06B;R;N!L[7?/@6$<.WSY"JQ,8L5L9H7J'%9NHMRY,1M&:P.D
M41[<+>+GJQW\]<EGR-P9G(,PC9VL-+T0.^TWOS0;36,C$F)9<'=`/>?VDSUB
M[BB-G:P`789V`#N;8"ME@=T0DYDW'2HW1H*4K+@LD/++3??/#3"2A8"D%WSJ
M.-X0_4/%B,8WW4#9T:Q,V^TW!X-%*I'1:S45B:S<G.O!F94<"<[Y]J1!T^AV
MFNN!>3&9.MX+8[?,?X)KO/C-*\]]XD(E;EA`9B;U=W3577GAGPP@'7H/KOW?
MQ'!D-K.R7K=O-,WVW)7UN]U.NZ=(,EL#<T?8$->CYXNO\#GEA.6-B2VSWX,3
M-OBR`QP4`E<-Q.2-CH"8/B"F\V<U$+,RN^<*__68"ZNG4?CH^>ES4RC=]1?+
MN:W.9G2D61#N"@%&H2`W6(P`L[4I-7%'*#@=C8BV+&<V,HKDMEX)]QY>$9M%
MQFQH=T8916):KY0!KWD8E+'(=6`:13;,,A84PVCVVVVS>ZQA*:919,4L:3[!
MV.C7&Y9B&CGS9;_7,]'5TOK3:'[IGM?>ED@AM"*W^`+S2V?0,7J#P:L*33&-
M(O%V4,2N%SAB5_9>FT:1(%D(0H9=#@#ZU(6Q-`P;-BCGG/[EF&+>%YY9_URF
MN,R-N=$%[.HZ-0N#/,N(5Z"#F[TCOD[-PBC/<J%3K_PZ-?/N>#IT>)UVOYB#
M^CI5KU.S,-!S@06LU^VTC7[U@A=N?&_(V"CXY'L3T30\YGO)BE>P39JM9MM4
M^?&\F39V?9I9P9`4+K."U^>J02&F623-[><&J%98B&D6A3KNY098/2ID#=8Z
M>])9K#6Q7YHSQ,XMW``K@)G!T_"1C2*'"9M&;IO4TWDZ#.TG.WRYP^GBC)QD
MV5EI4S"V7S`1:&0_X8,_7HP>+/_V]-0P6^U.KX]NZ>:/!1EMVLP4=Y$&1Z4E
MALQQ1&(:\DGZC'EK\K,85[0('WJ.8TT#]D&3?\FT.'P,4]U\(&'QW9/EVQ;F
M@*6^?68\_2WU91#Z+!P^9K\5N7:8:>?8+CMY+'IW9OZ>KH4\S2S@:694<0/'
M:_X@\;!.`_)%Q02R#=O7K$VPZ>'BUK9FU2$]NH5G'ENC8RB,!T?'<Q\*<C*5
M'PI@B+&`!M$9`*F)F+SM\;)5;N3L]_[[*B-CG?U=/JE[!9K<R"3+#;Q<^:2:
M0QX0H]"6X0_YQ6^>/22@2!&L!(1[1$X5>-:>-T@30O*!8*OF\)7F\*^/T7&C
MR*MD<Q7>E;TSM?KVF0MC;)(Y$#15`89]'25I[C\$--57X1XIY9L[8OZK9+D5
MWA3I&*@V<O;../:W08I3XD`05048]K19L<O[$-"TK\MPK@J\=ZQLCWB$;XWC
M\X/V-QYKK1G34`L\QQYI_VM/IIX?6FZX>$'<T7@(9%81&`YA4\D[?R#XK`(,
MA["GG^UQO:7'M:44SW8(^-S`#9]]-O2FZ<J]14U1UNBX<*#SJ71[[&NM<7L\
M\]6X?96XW6[/K.4NN/D=LD+MGY8;6?Z+MFQ+K%(7Z[)-@%9I`;;21"LULUBJ
MR8*4&&2Q>D/O=WIZOU>ZJ\*:>*EBGXV=@+0NWF;M<@9.8^:*%G;[V"\A8NW[
MF@:K38,[!W+]YCY+=Z')TF6_T4F1Y<)62@>!Y`J"5#/(^81HPBW=UEN]_A%P
MR;4E48)M1>]$5O*D)'T1E+K#SI)'+%1VFGHSTQ3I,.DT`7*-23:GHAX$IO8M
M1K8[->'5A+=_P='(=(4["KFQIL;#8(-FJW4D5_`NC98EA,6X`D,M+FZ,6$^.
M@$QK%KD'%GD0=HF:Z"J%J9KH:J*KB>[04+D[@^'2CFMJMLA&[T4+QB4DPSWZ
MJM>-C-L2T:\.UH%(H$LML/8$;9^<*\O_#VE)%;LL:N*NB;LF[L/`VR%10DW<
ME1?S=QBA^L7RAX]:ZX`"5&<0IMGH-X$V1UZ$)4,K)?B7!&W=$-A!<Z<AL$LO
MMKY.=D/BU8PAV^?9Z#7:];$XVF-129&DXJ:B?L/<68!1;2VJVFDXI`MBZT?!
M:.K=?D_OMO9]1>S\0%3:'1%W/*BUE"/24MK-CMXVS%H8.];KI]915KZ&&NV=
M)<74Y^+PK8QU7$9-@G5&(8@4>J_9UWO&4644RH\H`"L_C^PG_*1T%EN[L5>Z
M4=A7%C"4M4_=T3E[8HXWQ5YDV"_1#9*N<:UL1U5J&=B:WQV9KI@$\KDSK014
MKIEIO]_IMN<#U3:ZW=Y*0"F81QP_>@[<J,'%?R+`\)47,M&O,;CVOR))!/E.
M:JUL"]&ZD]KQ=%+3:,R?W_`B;V\6L*3MCKYVA*O<F@9MSD)@"X#;1NN0I$91
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M6N]K`LK&+N8:L37%;M6/O]]J0^=LR";WS)>IO.TYB-U!*N_Z_34V)(EO/C6I
M`,IELFR*H(_I$J%?+F!QR]#&D!&T^=1*0V_VVWK;[!+`)5*$CAC7]4G9Q^[-
M2Y^KTE$Q&YW2_4LKB.::FO>-YBH1<ZO17[+KZ6'ANB;IU\>@.P.]8_3TP:!T
MNG,%D;UY'69.)2(Z);8[8FXHTTO75&HN@R#:?>NL^H2_BDNK=!.'0T9Q?20.
M:[_V<R2J`%HMI!T&FFMZK>GUD-!<T^M^%8:Y3H_-JPQ[:[A;'^&C/L)23W@[
M,`V]5[Y5=@4Q_:X^&H>U88=B,C,;G4,^%S4U[QO-52#F*H!6T^MAH+FFUU?D
MC!"-FVOAZ<"IKCZ^M<^A)OR]$_Z1N^%J2GXUE%P%T&IZ/0PTU_1:=6_$G&22
M]9(RW)'&-M)LK9:OJDF<U3KE4J(RFKK1-?7>Z\C)J,]&)?;K@#P6=19&3<W'
MP>E;C4XZ5KW.PJA)^L`9]*"G=SMMW>B7[AE=063/5F/DQR6ZSRW7`RW=2NW,
MFTSL$#NM!:?N"(L(`NS,'=HL.+>#H>,%D9\TK$OZI[5VTC^-ZDY.Y2L3RW^P
M7=RFQ><\QK+:D6>:'Q.'X=X@+0."SK_0M5O>U$R976LJXZOTF>)+(S;T?.H$
M^$&+L,HJ=E;C+UY=WUUHG8;V^?+LXNKV0CN].M?.KK]\N;S[<G%U=YLG[/OM
MK2'-KK:*(IO63BBQ'.W2#4([C$(8T1MKOS'+"1]))PX?F18_=6:Y0^8G#Q.4
M]D$C)E6BXM\1+&S\PN>\&(\9=HIDVFGT`#]H'3($&#KA!)M+6NZ+%L"+;*19
M\(4W94AB\()LGT@85!HH:J<//F/TU]NSKZ?GI^^T9QL0G4+R:ENAO;TZNWS7
MT*B$,#T:,G]"0^"',8!U@O(&<(H$3E^%<Z3`:4DXTXM]MAU'>_;\OSC8YWY#
MNPWA-5<[;0"R`^;>,_]!U[XTSANZ=O-(_PP?;39&.`#`'P/M-O(?F/^B?02.
M.'R$\3TYLV:-O"G!A>T8-7LRB5P/I@=.#AP0`+$`,)_!XP+I]"J6O'K1)BRT
M@A!6-80_'<N%C>=-';4H(/,.7`6A#0L"",)HXOF:[8YM)T1$P,_.RV3ZZ`U?
M`.F-W5'8/JCZ3ME.V[5#VW*`Z=-^$T*GU@LGM+-+[>\I0X4.-P;^?UJ&!5HB
M.59[FWK:[,QX]C^1Y0-EON-<F%,7GH2&=NUJ_[1<^/E%,TUN<TM3'_O.AA'V
MO+%<S0+B'/&#A(\(3+9[/YW*'^17_9_>X;KBB?"#[0Z=:`2GPHM\NJAL=P0R
M!76';6BG`1^>C73X04,1`G_!%PO(3%>&!K$#I(L@GB"@W]2#!<?@[O*SQJGZ
M!0`09]5G5B@?$)0:\$-V[P``S-<U)W+A:(6^/778B8L%[?&HW,.;`1Q3/,&_
MW?Q^8@6!-[0M1-.06$2@\H08.WJ\R03OHQ6H-.![3S:@)WWT`98`<.IPO@1D
MPP]2`!P%9#)X\_XE/0>M#O8<_IG@(0O":(0'V0?,A7PF>T)SP8^(E8`YR'$!
MU;":]_`R?0FR'COQHA#!&D7Q[_AQR()`16]Z[Q`8RP6*<I"J2:Q*+<E&4$!&
M\SDL$^LO)BD%$?-H`7IA(Q'!\,08A)G,B4A3-T@_CB"3]%$H?(P8WST#R.P1
M4IDX%PZ>2J`PQ^'P`J93@W4*SF!#4P\U#<A9O@^75N&XI89%J#ZQ>Y^?2#B-
M@%VXBKSHX5$A>:(<NEXX&\!;1]>8C10.L/CA2_KTX?/XB21R^HDA=0!!*`]%
M4\!CMZF-K)?@1SA5<-[BK?&2D8^<59]'/IX,X@^/<#:U"4SQ&&A$WAGO!)T(
M+"259ID^B+T/+NA/H\Q^MPV]VTTK;33$0B:NH]`PY8*1\Z(C)?$]8[PY-"P3
M-#&`[!EX`LWO([2PZ[AE^/A,H4..@(2'BT!&RR2Y"J%%,FCX)E=#BP9,HT5?
MO*#\"CCH@H6/)#36<.A';)0\Y<7?<V3C7H$:-L)?@1E:#K)?+7AD+#QR0EU2
MK]B%UE`M!"6JQ/4P])!F"W4)*G-'%`>\SM)N@/R!^#\#\\/^[HKND!9Y<@^H
MHD\Y_4(GF0IM#2]28_@&PB'`<HN',-!NHGL'A!ZAC<#RGY`EX^#B>)PS/-_R
MM"I:RV\1($Z^$6AO$[BO+G]3(&W`''X066XH.7UN7;H&KV@/:$KA5[:*/`ON
M"?>$?8=3&R"F04UQ1L\HQO"K!F%QQ(BJS@%?`X#1&-LU^*AZ^*$%:P+I8NK;
M(.[!Y6=%H>=X#UZT0'?(*#!2R!-R2U`L[16*E![O(B]$.%U(>?%'!)H\YD!5
ML*/\:RX&Y*E%R#AIV4=(^J`ZP4;9G!0"^SN*:T,B,95MIEV3/[S#AUT6@CB(
MPN#;(+K_-P""8TKL";$++G9[$DW$-"^Q&/9.1X6,3P54QV\%4",C&([DK(#(
M#19"NAL:SQYH,0%?NQ--X+3"P/=`L8]P"O_*39&P9U`_G^)K1`(X=``TD"QI
M.)\]1""2>K#5()V!1NFYC.\6@]?E@<`M01)0=`5ZFPLD(QLW`W8%M@FNCL@7
M$C%2[#1#V+%VW=`NQVDBYM`&)%['B^.P%!)*-,5!$0Q^7TF!0=`<:+M<#(0[
M:H+!#;!BW#5YJ:4..6=&H8<D94V\B&,LB``%"9YC_)(M``38U`7;U9L%5RRG
MS((QY('@*.1"CH)>4+_&64R@`4!@"43\)8"@R;+G*BW/F[I1)`?CBP4'L/2[
M!2?U=(AR$6P6BE!V>1K`KTAI%9QLE$87)R[1[4S9PSG'A*PJ.1L/Z3Z*3H14
M7(CK5E=O%:DDQWV?7RN:T:#05)&ZR55SQ:R[3;FH,QR#B]/*Z'"HTU>=<JW%
MQJ]G"Q5S%[TE"ARY=X`#N?A<`!<EEZ_C0YD\2Q=H$%^\B>5F\;+2:"DP,\%B
M^<WMLS$,3+%7T10N`1@TN0+&C.5TUE:A=B*4#RM0=1_Z-%_KT$9+:%NZPG$3
M#4&*_&@=R2H+N7"RM-).1I@T=H9`<+"1OGI)WY,E`NT?F=M3N8TY`I2?[5BA
MFMBC$T0GH'AD/]A;N8=CQD(Z/*EQT1#M-./(P5MHZC"B,F^<(6E^3]T\PA(U
M,[F?T6CTHJ\Z4*MP(*`,9D_#Q#:.+WP"#=":HCD*'H8C`,>`P<G74'J"KZ0]
MRTI8K[AC\6%IBP(JBQR2"@E].'K\>,B&CR[*D;:\:HNO9B2?N9,4W]W20[#Z
MH$B(<M5#O#K\VL*BGGD44A@W#KB><N26EW\1\?Q=NGZ?O<@923E=0RV#LX`5
MSR;Q],1JG8):D2=0I$RD72E3%4$DP%88?U4$\".GS[QAY2*^E/-:_ZLSJZ#'
M*')>-%,8`.?+8'-0E[6H?/'&8SLL,+TH]@I=8[%5QR+]^9^1"U=77\(2"W2_
M-;3/P%ODH,)S>T;P$?G'[N+8-*/#G\.&:BP1;ZNF'7X<<^(AO]Z>N)\L%N)T
M;A`Y(8N((C"*<>'>%%*>S;TK*-`](QM"&]0)2#%<M53N,-6/`[KIHS?B1S;Q
MZ9"QY&26HY5?IT46$_18.7@I`58<F_F)CT!X=?"SY`IR+4`D`"3('6YH.UR`
M%6^+!QDF"%NJS."@2L=7J"ZF^-9^089I-GG0GF:-0\$*$RH8H=*5@2I1]8_[
M*&9M=S-/4/J,DK,*R+2<Q&]VMB#PXV$%A5S2@1W@.D"*1P!(Y279G#QU+UP[
MB6_!.8N,I=]XO)2P^:UQVY`SDOM4BB&Q+!&37>HVGZ=.Q3=G3'RP!"&'I^5E
M]-_88QM>36Y;?9'"D;RTBNKA>,]:6O6@?4G),%)RT''[0!2'7Q#A7+0ME*@(
M1`8$ZN+[,</E.)9R;VQ^C1<S1RSG2\C/(HT?0[A12.RV'BQTJ')C6[+BO!2$
M/.W9#A+Z(8R`C(6,)*T%IL@-W6RHE^,KTO2#UD5`3>+BCY<\]='^;G$:`7YK
M8ZS`!$`$$B/R$Q[S`$,H%!8H:%!@.S%J\N]SOOV9%)_EGRD3-ZY-!"/,4%XN
M(M^;<B#_:4TM5^C7PC#(E1'<!AXA(*74U%E`WY^`+CX71\YTCU-].>X]FR?2
MSW+XO4K)/C:P&LTR%E:V$(MI"^M&A&<Q6,6$Y[M9UYN85$(.X\,%X/$+`--?
M@7L.,?),C;02`6MT9&/CL@C\@DM!A&RAP(;Q6B<$R=2;HCI/EPEQ"!"Y?)3G
M$PW^T;ZW2=]'?$_AKR`6^A-A7PL\$$U\/251!X]X$_H,+S?$-Y>_%;&?I/K$
MU"7$>_(!DPIP]"&>ZUCT%Q^C+5KTV[5!OS;HUP;]VJ!?2\2U0?^`Z7.&H/\E
M#C/##98Q=#N5\O<ID\3QN@L#'PL1%60E^<^>^U]+^\-R_F)^\&0[3FPUIU_>
M%011\%?2R0Y*\)\.M#[\"\ZF#E*FS6,#1?X"QM$[-IP&*P@B/[:HR&\Q_=+W
M'`I4CGPUQ:.A3$H\'%Z-Y16>F92P]A-*=E!`(K.88.A2BDL-CC+'@P>GS@ZR
M48UPZD#VL@.0D!:,Z,`F,C%W7O0G_L%E#HO"ECCZ*<0-D/NKYXTR.W;CPY\\
MVG/XZY>;=T=QJ!>XH5RFR3#T9V[UI:Q`3"Y*Q;%3]MS;V^L_*"N)TX9B45Y`
M^7S#>8@>A1KB%@;R,9%1PK-W5*D>IL,=)&GHNST!<)R7M.C=:_4+PO;.$Q-Y
MN;R"_J"I=_OM7(!]+#:77ZIRR*42$,OG5B;X;D;VBM0ZN-DTSO5)X87+6>LE
M*W`7PM*RQT)LF@/8E)ZQ"6P>^1',7[:Q3_7,<QSK7B1_*^3U^HQJEQB&/PWI
M$HZ=U"Q[^<84/TPASLJ;T5;W:\-$__9@/@>O_@?2:4&VA&LUL$62PLQSAWJ/
M-'O--9&E8_`):&Y<(]M>:)_P4'Z,\\>*$BQ0DPI5/NO!)?K`D:!$/B;H`&Z1
M291MMTR]-TAG5U&F%&=CF2C&OFX,!NDS_DP<B"<&%C.7$V(N*)W8</TN9C$C
M&,SU0L'C-)Y.*[A(RG5C!PLI(,M+\O4PEBMDD2Z"`1S_X8[YDYL(0`"5/QGK
ME,<SQV4OVIFR%[U^O]-MOH%=LODWWV[/WP#Q#.'&<X*?WS3?_&(TZ7\)I(MF
M6Q6V3@%LG<%<V,S.;D#K%J'-F`W:27>'>.L5`6?.!\[<%7#](N!:<S>ULQ9H
MDH'"(5*J2%P(`V<,UZ`(KLY2Q#9WIC10I]P4^MFV[FU0?N!,GPE50`+4;A8!
MU%T*H)FS<&"<>]O[<!,;4Z['7[FUXMJ])3-,#(I1!$I?`05V@JFPF&]^:3::
MW7^\7S"%`L<%W&XH5(\^2N/)C;"9?/+\&QE^$(-D%H$TGS=TFP(]Y>=;';YL
M.2&$KS>?K^X4OB*^WYO#P)#OFT9S=P`6,?_>'":V<P"S5T"W;S3-]EP`6]W6
M.@!^XZJ8\"9]8@GW:A>Q_%YO/C`JM>6&7H6'MK.\O=]L=GKS44(L:R466A*F
M0K[>GPM3>V6V7OH:[!1Q]_Y\\NZU^EN_!CM%K+X__WKN#YK=?GLI?"T@YTX1
M=^_/)Z34T=\(.7>*>/B"/3('_6;/V#+M9'DW';/YHHH!ZA1H4ULFGBS/1L#Z
M\R\54-U`<UL)8;?1?<#^$^'/3\@T\T7].GD>71?U6[*H7Z^AW7[[>'OQKV\7
M5W?:Q>\[+^<70Y^V]NQB1FD'NWW$C.E+$84<'(&32=JR*(*`8<456>0(32QY
MT\<C#QWA45UIV\N@K7>,O-UX:`6/B;]?=`4@A^VS*.09NTZF@@?ACRDC4*>G
M]YL90WB`>T&I(G;(O4&>"]B`8W_DYMEK5_MBO6A=:9F2/N-`J9::B?O0E8(&
M\O$)F2[IR8^>Y8^H"A#57?!R[\OP"=O7K#$&1/.@B@`F2VU46^\5%0M(MBH=
MBZ)N&@^QX)SGV;?#D+F"(#'(QQN/>5@_5BW4IKX]S`<\84W;@AIY-'DZGDC:
M[P(T:E+=20Z@"!U))D-G!H:1"V,?H_0D-Z[J0O9--@H2\I:O+K;JS;RTTG?;
MC9CB$\P@"M_*KM^)"M+)2OTD""R0^@=M.*T)//,FRERWN%V7Y)/CAM0;LIL2
M;PSHQ^LIA1_$[<D30`L5`U4(YZ.HL%Y>?0*Q!9YJ*J+E\C`LL08XH?23@N"L
M\I!#\`RXV[V,):;<Q!E@K;@8\@U2/KS"+R()7C>K1!!X&2.(?"MCGJ%3H\`W
M8RX.T8C9'^**A)\<ZR$!(:LO2`EK#!.Q?[S/O9D,*$Q1GVSTF?\)0M\%B'P8
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M;#1/_I4>&M_+ZJY!D'BH7A+_5`)X;Q:GV*8NMB4G^7:4M9*>^:4UN&Y#^WSQ
MZ^EG[>;K]=G%Q?GEU:^+-3A>I7_'(O36)P49^A2D2$<S6T79[DG>"L:13CWF
M6HF,=\N&<'.3D_OB.^@K0.H:64V"`'EK)OO]]N(L53P9X[\HADE)NX//X[$4
M*N$%#"]"R3?BR2`6IF8\,0!?>,YC?719,A"*WA<K%`K>KQBZ;>%],`6&AS70
M**0`;QSMRFMHOUUK<`0[!>VT[)C>Z:^W6*WY+_B/BP$_R?+7AO!,J"O$E360
M4B<>"79IB!0,)]!QI47B6.XCA@.(B+)LT<,D4HE"Q3T?;ERZ;%3L<U4"=NG'
M(!F4DFK5VJ4.HP6,/-(=1$PNTYX?6?@H*W7'E9-UC#:VL1`5)CM36$1FRC\8
MKR(VCK#`N*PZK^:L(MD0%*1G77E/<7@H#TQYM$8R+R`)<1>!B2/!STD#$JFR
M<6*37".LVZ.L?%TB@(P!7#4"12;@Q<1?`$:?UFCQ\>-S(];;.';><J=2VZQZ
MD0\4<L/QJ&-Q.:`9GI^+CB#?!D%%%UG*6+D_3B>^9^$S8Y2-@,GI!7F[<<U-
M4.YE`C)#\<9.\E]DR79.99Y_0E$K-,'8QD8'(EB7#U"0(3WKQ7<<Z(2@<I4@
MB$R*8.-O6MB/QJ$X&I``X@J,<8D#C][')'RQ3$9]89(P&ZQ+2'@<VYBKC2D>
MS^P^L.,LD`0V7O@SA5ZUFCJ<V2=[%,%.P+'U:&H<G<ZA@&,!M-Y2X+V&@X'U
M)GFJA:@\+K(Y'<"?(^TI\$506*N/PFY%'73/3V+`T``H0L_H&:7V0PZI>4O,
M;)D59-M_O/]^#]?3!_PO?/S_4$L#!!0````(`/%KJT8V7=FX3PP``**I```5
M`!P`;&)I;RTR,#$U,#,S,5]C86PN>&UL550)``-UYU!5=>=0575X"P`!!"4.
M```$.0$``.U=67/;.!)^WZK]#UK-ZRJRXEQ.)3NER$E659Y(92<S\[8%D9"-
M'0K0`*0<[:]?@!0E7B`.4B*LS(L/$MUH-#YT-X`&^.[G[ZN@MX&4(8+?]T?/
M+OH]B#WB(WS_OA^Q`6`>0OT>"P'V04`P?-_?0M;_^5]__]N[?PP&$PI!"/W>
M8MN;WD[O_MF;DT=(#P]Z$T`7!`\&HGR`\!]OQ8\%8+#'*\8L_O=]_R$,UV^'
MP\?'QV??%S1X1NC]\/G%Q>4P+=W?%1=O_7!/D"W\<IB\S!9%-:P1%HWR#JR#
MFL*_WW!!#B6+0C]>QD5'5U=7P_CMOBCSJPIRGJ/A[[_<W'D/<`4.A9&Z\"`C
M-T-O6?SPAG@@C'M0J<F>M(3X;Y`6&XA'@]'SP>7H&6]$G_=?KY?T("4!O(7+
MGOC][7::JS-8(/+,(ZNA>#F<\O\&WH)Q46/*<+OF^&%HM0Y@^NR!PN7[OJ#C
M58Y>7EPF%?YTH!TVJ)L18E]Y3-RL=F_9I'I!G:W?`X$7!7%/"SSF.,/O(<0^
M]%/>0@R=KHG9IQ4$Q,LQ#02N",W+FQU[2\`6,8*XJ;@'8,V1-'HQA$'(TB>B
M92\&%Z,=D'[:/?[/F#$8LDE$*<1A6D$`%C"([8Z\3(A"T3))F6%7[9D`]C#&
MOOCU\<\(;4#`Y6'CD!M`NN76]%<01%#23B/:0OLU:?-ZR0!I3/,J`M1+:^)_
MEE"4-QF[$D,6K58QMP$*X2JE7U*R4G4F:::%R:$AO;>]RJIZ(>D95D&H#RGW
MAOW>(T3W#V'\9V?(ND%@@0(4(LBX['<A\?YX(`&7D(DVA%L)J'3)"GA2D[F@
MB'J[(2\H;ZS$@G0Q4K1[CA@TN7JDJ*K*#IZJ*MP:*==P31@*F006Q=<%,!Q>
M=P\!I;&4M,70'AZX[#KR^:$C!UWVY)S"-4#^Q^]KB!GDT)R%#Y#JQ`P&E(7^
MUZ)\`M`PUX`A:K0JV`'JT@W+H.TUM?VDVC,^%=>A;')SUU%5A5L`2=!;.P^I
MG8"XT/D%,8G>1*IN\&?[L'I\CRX<Z3_/(Q&/Y>=@"Q8!5,PK:PL7^U=2N/O^
MKHGYB&%CE4.\P@W(&#N&#.ZMEI"+EIBHNFEX3<ERJ%`NV3T@].R]NIG5:*@W
M\95<G8,"64,:;N<!P"%W6J(5ZQ4'[1<H#R?5)"5PU)%TCQ*YFS!HK*[7J&>9
MSCH<P0>W:#2"OO8Z@[)\V97(RG</"VUOHM5D2X<BX^T84"9DM2)8Z5!DQ8I+
MN*5BW:-!SY4H&FCC1\HL'>O[0MAS"P.Q`SH'5,M>:)/61Z$2TNYQ8Q63ZBBB
MA0A54DTZ$6V,K_)&GGB21?17\@%.&>-&KLIL:);>*419NGLPU!L1L^::V!(E
MY]:ZO"63XOM(-`P$<X#\*9Z`-0I!(+,B]:6+AD-6VG5XF#77QM5(.>_@\<(1
M>-S"$"`,_8^`8H3O&3=KT2J*;=DU7"(/R?R-/F$!-#J$3P4_QDJP@9).)3M4
MO70$5=)HF\_2OA#LV<U\*HEUIT$%XNX19K.<;J6:YDOLNM6F2S+Y=?>(<2'(
M.K&&'4^L4+B*LS*P/R$XY*,)8H\WIV:.I:"HF&Y)*9XFYO25T!QHM76E<S4-
M=+T;%E5\P_\_9K:;R.?K"MBS-:1`:&JW:RJ#L[1<`<05Y3H;M'M9)H3%H-!M
MHZR\K*WE\MT/5WF'$?,65X_.4A79X5C#VJWDG#A)@'LBD@H\Q7Q\PIVX,JAH
M$17QHB#J3`53'$(*65C?9DFI0B-+I1P8"GJ=172;*AD-M;5DAT:)>WE`=)KD
M),(RP!Y^@?0>TMWB5#R*)<!0EB]`I*:\`V#1L9NZ+;:PFS6LR[EPW28U4K3A
MS=C`*68AC>+(ZPL)KR%#]UB(/6;_AOY]/!+V!3[SZ>@-84R^L]D:WU(:96.^
M#J#3V)2UK<ZFQJ\%>=P:!^,5H2'Z7ZR1V?(:+L)KQ.+U_3F%*Q2M)#C7IBNN
M4JCIGB).3=71%(<:]94S`3MUR[>00=X'XJ#(-=S`@,3Y"O4QFQ9-:9&UEL8!
M<.FX:).66[AI!7NWDDBGJS5`5`@X6_+@$^![M`A@DA3S\;L71.)8[6="_$<4
MR'9WK'@4YP9F/)X(TIIHQ@)YAM6E>T9'VT1FX5<RQ7[D<2OK/7!QX%<*,`.>
M:%3U3K(627X[64'B`%2T/9Z%$FR=G5Y598ATZN?RGOD3P@![Z3J25BQ535(;
M1A5)GA*>+)30;O!4K"K=4'0$3WS.D#1$3"#&&X`"D73SE602,7:;"A\`0YX$
M8I9<BDL?IES<T)J.3G1:[,+`LNU(HM?NZJ%E6&EN02A?F6.IZ[.\K:@!2TU)
MV;Z*P\"IW4UI`H[*/113`'0:*VLJR6ZK2:&HTB93-CNW[(7<A)')WI(IHA2\
M'<MICL7-G^"Y1AOD0^R++<6Q_]^()5O^=?MT1@RJ]NPT&3B&+3O?9JVQUAV?
MB21:H_VD:W4;B"-IID'Q=6D%+GW=/:0TS;JD15;6_,"KVM<YD[;C+3O+V^'C
M2MP6-*=$C`C_P_8;@_X43_$&,J'9,9_;;Y)TNS@3*N+/=FHGN":>;X%I>0+0
MB&EWIS+!-K8N7\G8^S-"%$K/#$K4:<Z@>&+3@$'WEJ(E])`6%"CU10T$S)T>
M-1#,L>2.ZJO&YI`BPG7A40@8O(;);UEJJP4+K=OA9"RZQ[95D\F1+&LUNDU$
M+*PO-!+-K:VNP\C\%&'_AN#[$-+5#0&8/\H?M%-:;6T.4K.MP:%[;!_3;INJ
M\'2&6T,RQ^X>DVAAO_K>9LAGR%0OY--FVN5%'!Z$/OO$!P@7;<-=NMA<%=DA
M,FNAIBA?PR&G<-8:F`*"V*C(:/1K2E2X]$,N21JGC9P\@)0571P9%C=MSY:9
M510-?-;2U:!40G?N6-51URD1*Y$GW;U_2KC-K^KQJ#5Y`/E+<S#K,M-"N)K9
MCP-[0\5V,Q;40J;I".X/D$P`NM6,.60D-6`ODYP[I!5*.B5PRZ+LX/G*`)YG
MM`)B-]$XR0J(MFB5*98NVI>#U;R#7D3%'1!:1J:63LNMYNBZ!_.I/*A<7=TX
MRYP\.]B^=M,O2E2QWSIL<[7#D*G>:H<VT[]2_$XTO$V[N6G&7P,9-!(`7SDY
M;*_AFD(/)?V-_6RBL`1A&A3E#V+(*<X1??HJ.C86:R5)U\O=1.9?AZ"<P7/[
M)Z;:0[C=\:I+-S$?KX#,8CE$9D+]6='ZPE6?&:DH?(YPU5+,L7$I$R*=?+8-
M0,EYOT]\<,27E>96H;DK^`U0"L3=6\G=MM#_1.B8U9[>:H]A]JQ@0X;G!.#6
M%7PLD+<A:+K,>_J!\"MD7*A4RL_B9RSC':0;Y)4236S))2!7DY\SI`V5=RH`
MJ\5*EWW=#!S$K9TPADC^FHS=%1DLV6<1UV2P)`NG[A!&,V85E[3:,#NG0="J
M8H\=N-@*F2Y/OLJG7QW-H,_C>XD@#ZX\*$201BRU!;-&6E+PG)"HK9"C&EZ)
M`#L$O7'3Q&96Y0MQ3L9/S.@D`&@ELZQ6/(KK$68\S@F];:CQZ.L19K+M,'_E
M)N8/E[^E%[K-\.&9SIV`"CKIG7]2NG/$LZFZCK]JK)1G?]*O=7??XDI:\JV6
MZXCREB9I!7&XGSR63_@:\:A:=]/G<8[H;J+&DZS2Z<NVSSD^59";65A)Q$DO
MADK2H5D<FJ<.IBKXM6(@^3*4#H-S`G!C!1XUB#84+(5NZ[M]ILC5OG7.G%X+
MMX[>1W<JV-I>7G=LU-;==#=R=+ONA[YX_0A).XUN:6\Q@4=YI?NH]>V[UJ/>
MD3JH':EC5E=N8#I>2%I4P@DCSM$!3R\=G48=+NTYQ!+*#3,[XM+W)O6(SQ&>
M5HH[^KZ`IE#[?,<3!9J_4=XUL^5RMAS[&['REC\9OJT*+G5IL@&EFN:<H&BC
MIJ,&CFI9]L![[:1O+IYHF>(YA6N`Q(<]XP-QNQ2A,?;CF]22%#;91D(C9J5/
M0-DQ.R>\MZK8H^\Q6`JY'R%OW(PVRNU*Q,]_?EWD,9<^4JH]3HPY*@>+`<<?
M8\38JOCTP\9`TOW8N7HBWB6U!1.R$L8`5"RTV1$K!T0U\8^!?0W%G1[FU4*E
MB'ZM<5OG&9YDMCM$>)*3S-JB57Y9S5V3E)K;IKZ[J:?^P?VRJUY8ZG/?&%BH
M9BF%BMM[OJT)UMUY;<PLGYIHS<Q9;%N<WF]5L<<ZTM]4R#0-4N.<O_02[=T+
M\6/!QQA_\G]02P,$%`````@`\6NK1I\=LA)X'@``2S4"`!4`'`!L8FEO+3(P
M,34P,S,Q7V1E9BYX;6Q55`D``W7G4%5UYU!5=7@+``$$)0X```0Y`0``[5U;
M<^.VDG[?JOT/WLGK>FS/)<FDDCTERW*B&EMR),W,R5.*$F&9.Q3AD)0O^^L7
MI"2+).X@"(`RZU3E)%:ST8V^X-;X\.N_GE;AT0.(DP!&O[TY>WOZY@A$"^@'
MT?*W-^ODV$L60?#F*$F]R/="&('?WCR#Y,V__N<__^/7_SH^[L?`2X%_-'\^
M&DZ&T_\^NH&/(-[_X:COQ7,8'1]G]&$0??\E^\?<2\`1:CA*\O_\[<U=FM[_
M<G+R^/CX]FD>AV]AO#QY=WKZ_F1'_69+GOWJIR\?%(D_GFQ^+)(&#-9!E"FU
MV+,.&<3_OD*"["FK0C^^STG//GWZ=)+_^D*:^"1"Q//LY-_75]/%'5AY>^*`
M3WQ<D#L)?DGR/U[!A9?F%N3VY!&5(ONOXQW9<?:GX[-WQ^_/WB(EWB#['1UM
M+.C%BQB&8`)NC[;_^F4RQ$T21.F)'ZQ.MC0G7A@BD7,.Z?,]\J,D6-V'8/>W
MNQC<4L7?V3:3ZF,FSP\YMY/Z4MTA4>+%>@Z.T5]!E(6!1BF)W#5(_<+MV(<K
M+]`I,LY:K[S@UEN':3,"[WCKD#A7_G@%5G,0ZY2VS+<HZ4[,JHP9TW`>P+<+
MN#K)A1NB_T+:!GRYLN]0XV<?3]]O`OF'_;<UVDZ@]YC`['^^L@PE'FJR7`3)
M(H3).@;'T]FX_WE\,QN.1]/>Z.);;S+IC6;3+&?ZZQ#`VVGJI>LD^W^X^/[-
MBV,O2I,+D'I!F*CHH*_M&G98H.X#RA;8?EV[[Z^&_<%H.D"J]\?7U\/9]0!I
MKZ=KV:QK>7#BW==QWLWG>OSVC_'5Q6`R'?SY93C[:Y3Y1QH\`(W.R6F@9B:(
MZB6!2$L_?CG/U$/N,?BJS_VH7(ORHF$GB()L^I5-$DL-@J<41#YXZ9],:I&\
MGG/?\0_AHL0TS"9[,"8.0/G@DX#%VR5\.$&<T"!T]B'[ETS%#\>G9]OYW`_H
M3W]?P,4:C9WI,+J%\<K;:@"&*5B]=%SHS0&:&(N2IT&::<@G/[&FXLR;[WV`
MK5Z)E*W:EK2LUMXS>O%.P>T$0VJ^?!O#E80-H)1"%R]"'OURQ&OC*(4TFC+O
MW(Q(E3=',/9!C):6Z*=\+O1+%EP`+8O2>`WV?X11BJ)E$(*,+0I5L,S^I;:C
MW'K)/.]>M)9=>M[]QEM`F":[OU3=9OOGO[-!.Q>F'WI),MX,WKVGH!H:PO3;
M_A:@U^A%C/4-TZO*UH3R:HJX5=Y(YE+BS#&_>H?YU:T7)E@H&G2<HNP7I>59
MQ6/HA!57(1%J]!'::G+C(.*V@1*JE=R#VT311QBL,>=X?TC.\?>9=?<H+]ZU
M^@>FG1D/^="0AXA.4`814O=Y`I9!DF;+PI&W(DU.6&2%B0F93*<OD+9%U*8G
M`BHI34V8?#'[?W3"_GVD4^R%0[16>/H,GJD.0*'#/`"C<]D%V$K5\`$:8\P)
M?K3L!/UU'"-9+]'"TPO_`EX\B/P+E.@(?L`C+;@"G=1-;Q!43<DAN+PQG_C)
MB<1P&80@[B-!ES"FIP4B%984*E1N.@%?H1H)@<P6,_W/3IB^#U<K&.63F.F=
M%X-DO$[S8]@@6M('"(&/\-&"^9'+?B*A;IUQ1*05S(L^6?:BG7XSQ):QW57\
MF;#%M?G931]@J%!K4ZO$#]_(.K5LV!Z2T<_DO`P]4B8@_EXP;>5W-VW+4D+)
MN&2&N'7Q?4H[87L#X@#Z](D@DXX0R!4Z-ZTNHE2MT"8SQKV@J5U%62_83%@W
M4E^BO['.9:BT!&\@T+KM$3SE:GD%G3GN&4UM*:IY1K:4$?,+C)+J%07*-O@$
M33$-'H&SQOW!C0W$;R`,/T?P,9H"+X$1\(=)LM[W,[9.X-!C2P0JO9L>(J-D
MC84!KP'<6]S8;OP*PW64>O%F04S*'4PZS#LP.I>]@JU4#6^@,<:]P/9^XW99
MN]D3FX![&*=H*;NI4J-O+3#)\4T%"KG+KB&D8IV-!#9_W%'<V(2\6<_#8'$9
M0B^E>@>!!G.)$HW+?D!7IH;Q24QQBW/V'G\]J707:NQ[<[5HQ1I=:W4XV9;;
MN8?ZH@]7]R!*O(V;Q%ZTS(^"SY_W)#?><_:GWJ,7^YB1JP4[VAA7*WLT,+97
M]K2M6A[?<M5(:'J02NP:XU_M?'W\FRSF:\`)8?.=3*[)J*U"J01,N^CM+T7<
M*(5:890?$FDJL5&A,5EFV)QYH5@?D%U7ES1%#R9+(>"%MFO3E`-Y?)\1%H_%
M)C`,+V&<_:A[]!5J3->(S&G,S"2VX;'"A"%,#!S-ZM&"PF/U'+9/69%_$WI1
M5C/'K$YMLBG9V%5JRGCY-'E4D(G#^EU*C,*28%(!54>@%I1JUTTH/=_/^]H+
M]S?*DMX\JTI=5#=2C+:I>7#DM-F-D7)F:<%0*:;.(82XVR,F]49(F\9,UIT2
M*X.FV$T41X9-G<?/^%7H["_-9HLSRH!HH>6MM8VVW.;!T9Z)&APB;2AE[%*:
M^D`Y6-V'\!F`O`AZH^5UR=$JHQV7OC)@,>@="Y$ZV1O*=Y":JRL(61S"^,+9
M&(=ZRV4,EEX*AE$:!VCVL/CJA6O`&D`$/REF?NXGCOFC?,J6ZY2F<ZVH-,9N
M;CJQ?SY:,Y)K8^TTMVN^:Z<EP2.V)=S,)CK1)'JCD*E>0WOJ%;6,W;>T%\Z_
MYS!OPVA35_Y[#!/ME2C\EC2'-+&E+JA5S=+2L&8I9NPV;1UD)S2MS4NU_8LU
MFG,L-WIL[G86YKS)X`G$BR`!U#-L9488%I0\HX.-NKJ=:BNHU.4V=G?8WF"(
M.NP6!&F^$1+Y@Z?[(,XYO&21AH9&X78U#Y0"[1YL`!LV64L'47$US5U!MY<?
MMDDQJZ5K=.U+;4=S_!/:Z>)=S20MC6^Z6N:NFSNQE_4-!,N[%/B]!Q![2[";
M_MS$P8)Z2<!LZ\WM>[%;;U=&$*OZ:&933,**C:0+INX-[9@)Z6SN0KJ-*AOB
M?D,3^42_!-HJ<A0D>.UYI3%K.IY;&M#;'(2!PWL3%F8P6F0RO:?1925'+.YX
MGC+2$^9@-YS8-;&0HR1;;VZ'I<L[QJW8[@PCJ[,T3H>M7#+G]\E<>N4Y`9G7
MH[_W892;8NV%,Q"OWK'RBAU)2#G&M"1F\HV-0N5JUK%JXU(&,M@;6!ZRU`OX
MA62=IT*LNR`U%&:N0&DZ4Z^&V!($NREB7I"#3C+.6-AFCG&@$_`4HQ.TI*$4
M([MZ-)EU=,NF,Q'IDZW+39;\H/7I2GN_X!G,T:/V&IU&7\S2NN>LH85;#4DT
M+]R4)#GHO.6.C0]AX5:G%_"<U$)@#(Y%OH(DZY(\AX,%^M<9S/Y46.]2[OTU
MM%5=6Q[-F]<UY#&8I43O9FK<C=9E*#S)<)31N;U<7PD\1QS>L3NEEPJIU8D<
M(2Z/F1PA(L^KS!'2AG(Q1T@H@>>(P[M#NSN.>UD`SF":O>AK(!W(--W,T3:G
MZ<,.<H7NMQK/4O+N0W>=H'^#]YO5RQXI[R?S#S[LET['T]FX_WE\,QN.1]/>
MZ.);;S+IC6;3'5HVO-T\7)+]/UQ\_^;%^2[S!4B]($RZAR+HC+N'(LIZ=`]%
M=`]%*(.8=@]%$)`-T%B7R3#X9[UYN/H>1ED',!Z.$/H&PRM@?G-P#TO(])&Y
MAR;$I&H!<'U%?B:.+I.VBBI(IC6._2YF*"BG)-G/6"V5(/Z8+;0`NKFVSU#!
MDXUZ#0O]6(_;B,$9-^4X[MU&W"Y7F/"E1)J*FU1HS%:9LZT`Q30A.@*1<]$!
MR!Q?%SQC][R12S<GV"L<$X9HP9L-LL\;'=YEJ0Y>U96`[>!5FU:K@U?MX%4/
M/:@[>-4.7K6#5^W@53MXU4QI4X"JYB!4.]!4K69IZ6#8`:-VP*BO-J9?/3"J
MSONF;L1S]RIPZU_1LF&6%NPP*[X*W($?=^#'#F>`#ORX3>#'[M6IJ-=[=>#'
M2A*\]KS2@1]KT_M5@*MC%U=LI!@E(71G&4DAND33G$U;GFO45'\-6.L=8G&'
M6&S'BHZGE,81BW46]+&@^YKJ30S5"`/F,]8R!KMGH.66Y`3BAJD]$S6X;6I#
M*3RJ':WKF_.[9"Z]"=3AD'<XY,2YA%4;'P*<G58<\@-\&Z&#V.P@-CN(3;,Y
M22O$YIG.DD_*ZH<#-L1<O\A^6UR!B'_;^C6$8C<UO0J0%JO9MSO<V.GK(&!?
M`00L?QQTP&+2N'#T\<RJ-LT^Q^%TUNA`80\)%-9&UF@>'=9DUJ@%$\LIN#0'
M.3G,)M*+!,E@#S1RAWN#33II,&GX[)2"C7;E`DCC3A@FTB*1B*:62<Q#>I^3
MP-G$@0@QOD18-0XZX,^GA.L)S@,$PL7W.Q@B!9(-T@_K[BV1D'2WMD)H>)TI
MZ"4<A90\A<J3A"5I/PN\0EA(<C!KQ78L-:$'H-'N_+UX'L":5Y/H2//=,IV3
MV8&CCDIRH+)TRN`=]F;%%5S$WK3F'3W_?]=)FI<\SN#^#.#&"_QAU/?N@]0+
MK[WX^PQF_P2T"XRJ;"H^)<_&Q5Q3LS,44I%RBT[YX@WB!>(8^/FTBXG?R2*M
M^!29U%$T3P&]U$`]F8Q)H*[ZCLV05"L8%>!=OB`A=T6-X]LMW&C26\%U1#P[
M4V)0/$"39.!23JG=`1+9I$9;FCQ(3QXIJ,!,(E2Z2@8AT#F:/G@:J>4..E<2
M*+#QQ+&9A]=('&4&"HECQZ"MB8/8`0TECDI;QCQH!L_!1BYB3A`EIW@'3NY8
MAI#43RY1"#,G@1"[!F.8'Z[T8?0`XFSM.;[=_'L:S$,P!0M$F098NM'*4PS<
M4)2G2TFIB6Y2W=:MW;Q3SDQ;]+'F/T+?8"MTYC>.93T53=7F2&(MD%";7<M_
MFP%:<P*49"H#[WI8*5"MH_3E0-GVG?+H2?9`903\@1=GU<,),_NQB2L>2"-V
M--\)Z::6Z#BL2?#5KF6X?)P?IW=TJ$W1[R1F:MOO6I2*J.IJGG&5FVB#`VU/
M_N0]B/"AS%#7/A^B*ZQ[R.)XT2>+7C0"Z3!:P!6XHC]A0:2I^$:%QD4W8*FA
M8'$R.R+"9'O/U[MW"AL]9"<_P'[F^J$[N:YX`I(T#K(RX3P9?D'=ETP`ZHDD
M2-'T/'X(%F"3%2=@`9>;WJUQ9M^`%`I'_EJE<#%MVC5%0P4'30C,"^N?3]^]
MU&&:*W/?WY@]OAKV!Z/IH#>ZZ(^OKX>SZ\%H-KW(UDQA8JT&/I\;9?OSP<9D
MF"]6,@.7OA+##'IK.;8J$ZL^GDG+T=5@M3S?+%!.)V+@4ULIQC^;.Z&2_@..
M&>%X)?T5C);9I?.;=;RX0UELK^WY<Q_EQB6,G\>W6<_L*'Q&M75-;A4G5.9F
MHT*;[2M0=Q\).356R5VW;:=*?NG*4%1A+EIJ<A-V70XWXX7%=5U"R+-ENI#H
MV8I2BOF^F'1.%9%>`21AX?KE##7(RLL<\JKW4LG=SJQB6BJF3AYS334^S?D'
M._UQ/Q#P$7M)C&<<CI=()")*2SQ7X243FU455V@QBOHX0VZ(P088FGFFR*6O
MN@J=WNPVA8!AH+R:PGZ"'S/RFW#LH&B[6S)%8GMQ`$4N7I)H:1<NR[3V]-R*
M\25*[L$BN`TX<T<N?55?.KV]BV5$.T%Y)=G[;,562J=>7.[<O>Y3G36U-R#^
M<^W%*8CIA;0TFF+U+$YC>&>6VZ]03!NR66G<7^IEJ5S-FK,?>[['*(G&?RZ5
M0!=_-CQDU5RU0*Z&DNLM9K/[,FE"<UR+:[V/=>U%Z]L,5#$[0M_NN+^,LG1/
MD/BLZ"%"G[DXV5%46F'.(]T2UU_4ID+TA/\7\-C9'B>HI/HB@<-YGJJ'>I(G
ML.39[QV6X1W;3Q"9PJIM)K`Y<SO.S5U7XM56V<^$]U'M7&.5.IR2U%G]G$JX
M(:YG:1V"1_TA/9UB/Q93:>''=DZW:-HU,MG"&VO(SIKJ@F+@C6^OO,BGY`J<
MH%I-4R!P./ZI>JA'.H$E?B9G]8;68A&O@7\5>/,@S"]1]-=Q#*CC`I>^:GHZ
MO<N>(*AE#<?@MH#[B=HE%DJR'S^@>8P7];UHP=HS89`5!P`BF:LS:KY.BO-J
M%F->BG^O>SL,29MZ2S"^G<!G+TR?Q]'4"\F(!'SJRKJ)2NU@3,MI*!_1HOSQ
M\VBU90%M\C;\@S%YJ_Y8FKSM?VSIY(VB73.3-ZPQ;F1KG:2?HQE%DO+2-IVJ
M:'D2E:M)FZN18LYF\.49]H/>+6\8PA@L4B_D&9=-6<8"(5.Z:F0AS10-S>'-
M,_9'K<:^!J$7(?D8&]M$BM(>=H7"5:,R-5$T)H4GSX@_JAE1USWP!"#9[GJ1
M?P$>0`CO\PM%3]DE!%H-N-`WV*UPYC<.3M%4M%5?>HFU0J@6/U4#TZ:D@$&2
M!BLTY?#/0;2X6WGQ]^T[#,DEC&]BZ*\7*7&V+O5A,6$(?NB@@RCKK3B=EVN*
MY"I6M_SS<[W(GV0KDI"=8)BTQ!)"C-9!?Y'1KL8V/I,[R2O42I`%UOC#:)'-
M8\$PRH6:X!MX,I_05OO$3QPTOX*N&M;]K$9(KWAH/0[_<H_Z*;L6F14H@DM0
MC7<V4='@!")73<S31]&H=+8"%SVU6I6^6;%W/)*A9;XKVE[L.U?=04%K10^1
M:HGO-.]M%@EKO'I`Q8PP?_F`!1RAY_:!&'"$]OL'E-HJJ_<17+C81_<]MZ[V
M,1W3^MT^0:=VZ7:?@T@JVNXC4)W:^(T$(2`>Y2L)DB`\S5U*V-<X&GZ.,H&)
M=^];P^+H16G@!^$Z#1X*>)J#IT6X1HI<(G-G:"GK-`=+&=_N8!;1;"?'4\'F
M9-6J$<WLJT4FVMA;3!EWP%^':!E94QGFBYN--(*E)KV-F,`PT>Z?T%"G$_.D
M+FW*J;41+?`BIT]O6H;(4K,_SI_)#!A7-0VTJ#?!LEMTS'(C;\5>_XI^)M2'
MQ<^,WR4UX4A0N>.:R&TLD4OEF:*B-G0M4B-0\.9%=R9``)6.!`-<IC.[%RAL
MEBH&,$,Y"3?;-X0!`!,;<-HY:D82\_:05MYZQR([]Y":G&`VT=G&YI5ZA<<Q
MF&TB;&\?%V.F7B)-Q>,K-"YX+COELI2JG6[)S.4OKQI]^O'EL1*)UV0%O\*>
MA>1\Y;[[R"E>VZ%$FVOH!H>VXL(B@#'GC1D&+5Y,2*)UWXE$E*SM.NQ&Y.O'
MS5RH;V@O1]^41&*'@E(_K%-!C=,5(<7X]0*G[JT;:N^:4(^Z;.V;L$Z\'-LX
M$3L^:]O6B8VSN`)F_G0V[G_^8WQU,9A,!W]^&<[^&F4SSTPMV\CY_=!+DO%M
M/N;PCMZ8M-6Y(YG6@4.Q7*3SYUQ`L1,NZA?4XRK"%R;.GM@&(AXD\70CAC^Q
M'?(1#YT_7L=Z]NY]VTYL7NH(BETB`HU)HZ?!8^+T=J=[=+N24)0XVG)F7EA;
M1#PE:AM.(=<7I61.<NB$C$QK'TJ4:@4HH1J[9*?:1&D!3F>M"<2=4EX]!7&P
M>U96='=&_L-B@;7@AV:7UXS^AS44YHY"E3N=<FU@GF$5(NG1BWT.IC^1IKK6
M*=/8&R&)CV052I23\^<]S?9N7"[\7H/(OPF]B+LN;+*IZKC<2%/F3^V)C@2-
M=BEY@5D4K#3<-RF0TX>L![TMVZA9=6SE-B&@ONU?^Z4AM%>+1^`Q_XF^()+Y
M6.8MZ<+']N9`[%6XBNZ*"W*YIES%[Y5<?[+F2776G&2^W$,]FQ>K<DO?H`Q#
MW>[""$A3GBV!JP%%TT$Q:'!VI)OX-LUZ$\,%`'Z2;;EG,9S!$8UOLQM0,,H5
MHUA;^+N*$PA\YZAOR&JLYC+BK0C<_[9Y[VRS=D[RXYM<\,U0L1E"SBA>)?81
ML<J$_I&C_B2EJYHS"39!R$GO'72=[6Z,M/?@WXDY4/&[=OD056.M;D1HA>!)
M'ZQ>?N4MNFAKKL$_ZR!]'D9H3;7.%V<Y#L/LSHLVQ=7)[UG=7S*,-M-@U?TD
MS<W+[C%I:][1\+#4_S4FBR:%Y4\@/K8R=O-_?`5)^K)*I0T8332A*P:)31Q:
MG/'[T7`LL03BQ\N/UN-ESM=Y+IT_>LME#)9>"H91&@=1$BR^>N$:C++Q/TD!
M<_2S*A`I%BT)Y'+DNF"C&G%N5WQ^5OC)9E;HA3ESX)-3(AN04^[CZOFQX,>.
M1H:2[FI>+-D4W^,^61^'&IG'?LTC;S>/G<'4"R^](,X#T_@*3$088^LQMC".
M1I@3MG%MK28D.C<#G"FB^^K)`(/5?0B?`=B^T4KNK)>1-.^7)->T^'L?)ND(
MIG^!=`(6<!D%_U?,CYN/JIU'20+6Y:GD`8OR.)H*7+&06C:P+ST_(5C%(*Q1
MLTR]BF6N:ED(;E"M;%D2:[!VX;*+^)3M+N^DHV*VJ,"3>;W01H6GX"5")VL\
M+<)V>H^1/=A.Y3DQ-C/0M8;#IQR:UF-7;MU'5/9VP=N+>OC3[SK6Y6_B9J1&
M)R1?H]3:R6H5R%P5*#<T-8F.`R;]F`T#[;K.J=K'HW6VC-IV9M);IW<PSI8`
MNG,BKQU=*9+>CF/W`M3BMN'N-Q&_C:F`Q['%@-R>Y3+NPA$H*D%0HK"M"7.%
M0Z0A:V/MRABIOZ&8"L2P*/`K^C>9CU.^.0%A=NISX\7I\PS%7>(M\FV=\^?B
M+PS7E6>`7=T29V#YNH:F20;4T'N\FQ_U1"U?ZI(6T2FP@DFF,LN!J[]7_7/_
M^^&Y'T5W@]Z%2<"'.#B`CJ</^.:ZGB0#UODV[P45\PMSRD$G9(PUUB8?"@F5
M,F*(3U#$VZ2E?MXDQNH%LNTN*2/+DTBJU\)*)`>7<A@]8"[G$(7@[6;_9'OV
MP(8IP"E(,X@F(`G$T@TVPE8G`.(``B^\L"&<AT9C]7*_T,F<$&2*=;`38@`1
MHEQ\:"AR)(6J&7@1VIO>2(AQ1`Y`.D'IO>XR@=F=/SJ6!U=XIJTJ2%%D/D[C
M;70(44Z5$!Q``4&'$'40"%$'\4A(H^:K\[!($X+5?XS$JL-=HUY:K5=,AR/2
M5!RN0F/6X4AS<"@F/WVBOR$OFI?,!Y_LJYUH4.:`VWVJRR!.R&F!0U6<#9*H
MS%J*?"8$1;5@'3]59H4,7MR`M'DD=>T]\0.21%,-R#*-6P')D%\J((E\\("T
M>0!S$<1@@7@S#4HFJEBT2F38I/3=4"BH"'=O%A]1*?S:74_-J^OH^7ZP4<A4
M+1*_1=U52:P6'9NMVJE/$C9)&RJ5!)3AAC2V#WX`IQ)UT"WU'4NH86'B!FE#
MCB4"\OP>PT1[[3N_)5TYE=72J\ZEPB9P.8<**('/>-4>NF4<0\P>(?L8`B.H
M'D,4")P[AJ`)+WL,@?.1AV%V*8M2QQ"B4WX#P?(NNU_[`&)O"09/:(0-$CYD
ML5D)M&WR*TCP*K)Q8R9S(4LWH!PO17RPN1W5H1>9B"E]4$=ZPT$9%VGKNA]M
MNFYCH!`4;V^\/5,@)H<14Z;,82`,FU<%+V@]R,C=C,J7,-[^*:.C0=/:$<)4
MC%.$Z`*_IN':G`W8^F$IXB>;*:+X2L>V[&(WNZ86P0M\PG@K!?_D$()%HE,,
MN+:0-)@C?K+IB,QGN?(?MRO#G2+40SQE1C)/JE$8'8(KU^Y`$_L+ZC+RR\BL
MAD&FP9S?37/*ODD9=?,%<)/Y;D"#S>G"+><V=Q"!9\88IK;_FM2$7WIF/8A5
M.O-%TQY*;:M=!KL'V6.H7V&(V(1!^CSQ4NTHT?(MZSIUE6GY8*+<J(E<V._7
MJ!0W]M\=3.Q/@N3[90RRIQL`FMBDIB*?U6Z3<4]NMXMZ>?.T+>:9*O'+5`\F
MXG>Y[R)X"'P0^:;'>E*[)D;Z<KM=Q,N;IVT1SU2)&_%6#_.5ES>L?IB!>*5]
MF2[<H*Z%ND"#!Q/<)@SB\F)=7!=N.%LM<*B!$$4%S3>'$<6"O-<-$B6&9M\@
M3!3%?:SBB\E@^]#]I7ET'Z:C",+["#J`/,"/@U6]TC"U5.,:`:IEF5<&J5;,
MQ(I8M0Y>%%:`=:(:VOXC)W+(3F*VUHSMU-)2?2<0=KI'>HST:HM@=FP\TG,1
M)-DK%NL8'$^_G$\'?WX9C&:#K^@?TPN0>D&8V'N[9SU/P#]KU,&#!_0/;!%7
MC5$.>37*J.3V$EI9).9#.`Q2MJ(FGZ?A601**41>/U/:*`4UBS<O*#^BH&S9
M<R\5==F8>AQJCC-1</8,W4-GV97A6S*7RPE-L%Q+^L:XU0D4+CQ[%L2CYSN+
M-<0_GJ'8[B(.X$=IA^,S;<+CJXC/W"YATK*]Q1).']<V=$>1`-VCM<)PDS8A
MZ+W"2G2)J4[M^G*!*8]DU;B#/M3A`3NU6W$`>Q4='G"'!PRH-(X=97=XP,XX
M7'>=J=GY4$.7E$0VAIJ[>H2?C+BU)R(/L\?9"5%#S+-[@,0R_P@\YC]1]\VD
M/I8)X,+'+0U:FOK-!"K>&L_KWEOU.B_'JLPTRD&/D"JY'C0_XY!7/8M*[K`O
MB:FH[CT\_ERX*8?VV]1W:>D'SJ;W:5FGQCHV:L4.@8ULU785$EV%1%<A8:Y"
M8OOW[!]9D3/ZR_\#4$L#!!0````(`/%KJT90Q"D[AL```.GO#``5`!P`;&)I
M;RTR,#$U,#,S,5]L86(N>&UL550)``-UYU!5=>=0575X"P`!!"4.```$.0$`
M`.V]>W/C.)8O^/]&['?`]IV(KHYP=E4ZJWNF>N_5AM+IK/:=+-MCNZJV-^-&
M!RU!-F_)I(NDG.G^]`N`I,0''@?@`0G)GHCI<HHX#PF_WSD'(![__?_Y^K`F
M3S3+XS3Y'W]X^^?O_D!HLDB7<7+W/_ZPR=]$^2*._T#R(DJ6T3I-Z/_XPS/-
M__#_S/[/_^.__U]OWIQD-"KHDMP^D[.KL^LC<IE^H=GN`W(29;=I\N8-;[^.
MD]_^QO_G-LHI88:37/SS?_SAOB@>__;MMU^^?/GSU]ML_><TN_OV^+OOWGU;
MM_Y#U9P_C37MXX1[NMBU[^G_\DZT?OO##S]\*YYNF^:QK"%3^_;;__>G3]>+
M>_H0O6D8R.._Y>+#3^DB*L3O9_P>1-F"_^M-W>P-_^C-V^,W[][^^6N^_`/[
M]0@I?[\L7=,KNB+\OS]?G2EM_O`M;_%M0N]X!WV*;NF:^2Q4%,^/K!OS^.%Q
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M]U:])`A(_D8@HJ1(B8TA[U#]YUNK<-"*9K8@%;:&P92IF/$FY"8E92-2MR*-
M9H>*O%UO><<>-^4??<<@].E2JC4(CX>#\+@"(?M!RY`H#9<'"\+C\4!XW`/A
M@/+C8Q1GOT3K#;U8G:0/#VER7:2+W^;)\M<H8S:+?+Y8\/Q'EQ_3;)Y_C!-6
M<+*<QIW,9<4)BL)FZ3)0X7"^HGPCQ+)GJ#\&H@]3/[NBC^PG9=\B%V7/BFDC
M3UP=KZ`60B$;P#&-A`WBR)=*)XEJI6259B3*R:K66Y55C5(JHX]I5O!_A5-4
MX<`^Q0>>+!X-4MR)5OM-3]12;[@G/JG)RT2N@/Q2L['40:ZW;*S5D'F7C5M5
M1.AZ)9P.2D%3#J>&'>8"K,*M2%?0+*>&^G:X.UZ9=UPQ#R$/OC)/AZ>PF>>K
M</^%YLQB[<*/_'^%`]<T>XH7U%2F0\451;E9'#7<0+W%S><`J_`(8E36R=-E
M^UUVKB1$A*AEPHH+8$@IHX`E*%6,-ZE1\SLP6-L5JI8Y$V0<#]^\$N5M>%)C
M\&:_4Y'%"X[H_#YB_R)QGF\J?.<O%-_@:M(?PB65XJ#W7-M\>2:Z]R:]6*V8
MG<R0J:P$V^^\0((8$[H6'J*^_X+9-<[L0M3,3C:L7'T@IVOQLBL`/MH!HSN=
M:P^JSI0N0$%O8C<D0"*_Y8):Q`!C^<:K,7E1-N4_=]4XM-K(.U9-;\$\H17K
MC1C$%/JL`=PL"FB/MZ`MQ_WQ%K1I`[0!%3S^06MX:^8+M*@#<8G)\MW=29I4
M:]DN5G65!2QPS`H,A8Y.@1>^FCWV6_AH[=O35Z-N]HMT%F_'YNKU]V(KS-O6
M$WPAO*MR`YR1WV#0FEBN5F1F>T#`]UU@&2QC@EY5<.U6'.VD6`FVG:IZB6"W
MKL3\P-U;9:8Q:56A,?';U*5&,SB`BGMUS::-\B\2][;%G"?<CU/<@9=JV\N#
M2CMO*V/M_1VCL'-<WFVA[5#7>CO@#Q@$K%>!P_5``T``+!BGRG->.6ZESU#C
M!;NJ?%2,.]9WN"CW7-VY+TO'*>Z<UZA;Z3.4=L&N7Q\7[FYE'3+<1UCS+LRM
M:)8U)@WGR?)#G-%%0W.SNANDR+S&W:C(USH^X#?POJ;=[(?3LCV3VO!>=0X#
M&F2IG1UH58L1X`I!"^M")<`(J\8A'O@`OV&5>$.Z^;:5+V&M-;S2I0F0H`CC
M<^VWR?1(:[XA;GCAC7Z-=]'F3=K@S?*5-Q*4A,4;U/+SURPNF/G5Q6J^?.+'
M=^0WZ15=\VV\EU%6/,LJ3:A,LZ@TRPR/!5"_$$M%@$D#P8T:NIL8JVG!+USN
M#>,NIW=4B7)\9:4P>>32(4S[@>&2.O6FC)PFV0X/0P`G:AD',C80F+PX$VUX
MX<5!.&^`L&I(1,O#Q:"^M$)&(4[!9+2"7AN!+`X%XW$-1E-$/&`P:NL5;#"B
M5B&76;J@=)E_9#\2GW_C!B]6UW2Q8440>_@0YWF:/9^G!<W/:2$K2AQ5-&L4
M:Q7#V>CH-6(%8^^!@:JV"L.;X'*%4HK1M3+N6JKJ4#E\6*/6/BZV<2'-*Z-:
MA'!<D5J(9Z9*C.SDB!`D3/*E@E]?1XT*?YPJR]8H>M'EX@`R"XZ[+."CU[C!
MA+QBPN.."0D7?K$LT!9PX[(`M;S[0+/XB=4A3_13'-W&Z[AXOJ*+-%O2Y<^/
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M)4BVDN((ZI?,!>>!H!\V>!_2*<R..6[3N(!."N,(K)M'7C077`=+GK@PPD:U
M<K?<KW%Q+P9?E]%S=,NOX:O]XI]^B'-Q$+6L[L33:M["9J?5U]X$E^_F?7.;
MI5-.FQ:L;%A<W5+ME?W"%%=3/H^EZE:0BL0SLJP,[&&YBT@5R.Z(`1QLA;WA
MVD&[)O:/W"-LW+-VQSNQ#5OZSAI<+M_75-I:53A_0FJ-K\R$@6Q/N.ES6Z"5
M'R/M$;3VR3]%];L'G=+M*TEA6-L7DJ*.+*YI493K;2Y6U9TUM?F;^RS=W-TW
MW_9L'98-)P:J:HXAG%4-CUX#OP7B:,'=$T.8<E4\VPF*;3Z5Z#8&%:5PYYWP
M+GR%4,@/!6F*"199Q'%4V0DS^T<@U(I\B`]^R,-K[P9]+E;UU8J[*KL2WZVA
MNF@7Z*_LZ2(E./[@%-"NQCT<S#;$%4]$.AZ<AUZ)U`5,>$3R>W@O7\5T^I5F
MBSBGNQ.#K\6E8[+2UDF!]OA>O0(/)SI"//9Y@*_!ONV!CEIUL_/-PRW-Q#ZG
MUD5R8LDBK<0:YW2'4)FZ8<QPGJ,%3EODMU)D.L\Q**S[/:;7:!D3YZJ#>L5*
M_%JH>0L#*>5>(M@M#^OU!7=/Q_5J38YQ7J_1`53<*T[L547WG'P3)U4F^-.+
M!+_=T;W>P#]%43=_4"U_<%+@4-35"D;C?=OC\8NZK7T<TE?J7LB]#"`0.L4"
M*9!=(D&IR"T23$2&*:J^AF5,(MA7?:7<2P0[2M4W'.ZC5GV5R>FJOH8#J+BW
MK?I>).`Q*CT$P/NJ]&[2][0T_Q/E4SR&ND[57%'%]9NCLE;E#6Y*DEB!T[`G
MW$XU-REY3^N$\[EL\K_"XIFRRY6L,H!$Q:"NF)HO(\/*KM:Q#OU2<^X(ZY4S
M+P)CX,+$'662H@,[!HN%3.`0W&IMC,!5:T],:?GB9X3<-^9"DE)6<=4TP\(M
MK>L@L1F(W$9K\<HSOZ>T(,NHH(&-<E5X`%!'!B`S;\J?#D";$1#G:Q@J,^.,
M-GU$%DT."U(.P=@.5.CCOZY^OX,]F35W='6'<<T@=D3>???NZ.WQ7ZK9^@/#
M&71PYHPS_\,NT!H)57-CTO?R3ECEC>^T[["VH2?<7\F@JP&"3?705UD&X)CY
M8GI)-3+4_.=[IZ4%$G%-Q@]QT<!P:#DD?5MP>4S[+J_V(?ND3,8&8$R7]P-/
M]\X8LT_XUAA#3?F_T+R@RXOD(J'_H%$V3Y*858MYE#VKIUNA,LWD;Y89SANH
M7XAE`,"D@4!&#=V]^7&R2K,'X1=_JUU$<2)><J<D?10?\NWUA-^YS!JG"27/
M3"V)=GI#J!G`$$J=>EA&/I-LAX$A`!:UF``9&PA67E:4;3@`62O"FY%&NY#F
M=SV!4%]G(,,0I^(P6D$O.T`6AZ+QN(E&53A\"8C45B78B$2O3\Z2T]\WT?J_
M-E'&H+5^/DOR(EJO>7K.+YCM*_I0)L&;+REWZ6(UO\NH6!2F+V+0%'<K'03%
M.*1&^X;(-1.&7X#H,-R,6_45)X1RP^3WVC+[:&>:I$^<5O?\$(>'6L.7](T(
M3>FJO'BV=B24<@V/+/W@A4W$7GP;;$`2!`^'Y.AU)HY'8Q"\KE@Y984JLM5%
MFLH(UT:VZ@C35]:V_"K>6F5HI430E#67R4&2%J_@'NZ*EZH<QZU1N'N\XRY:
MNGWEL!,"]XO#N`<J\6G9VRBGRY/TX9$FN:@.YWQU[)TP^OYYU^0R>N8?S;]$
MV?)"5(QY.:`J7_M=K)I?1C9N\6^M=2R31VL(QV9X_RTP#W?RZ:SIY`U_MKL#
MI&3[^KH5@MFHJ3E""F%0,P*3TI'A*CW5PYO5[L$?+S16X)YCY=?-R>*$.`UK
M*TJ:ZDE#/[E])HUFE0DB;)#*"*GF='<+99J&7@.+'VP?:&A!.K_+GW_H8SS/
MODX78=AH\*(Q!RLO1%[#@Q]T'FIX0!TIUA9.F,W-NN"[)\^2(JW^R0:LVW&J
M=.CG(-X<RUF)#X^)#MXBCK;LK!N"EHTR]7AHL9-F(8DA>+&5WTT_!7'WA0O0
MTJ&=+XL@%FHZ(2%<L*,.%VSMX@&=%_2["ORDB^V=R.[U2`C)=U1HZZOG4<"-
M4]_:&$0O6&V-(V+\N(EQ6/Q^<1C7EH#C8!Q_.O]]HU(LBT2^W:HL*_-\\R`^
M^IAF*QH7FXQ>185T5_107;VI>"==2./;`=\#>QK=S17(T-1%<^_VM.UCDO'K
M2Z.M('L<%23.R8;/;L6)N/1%Q(^DGAWG9YKQ5Y9?ZO,+0R@(!^-8,B`=3HO^
M8--!IVPHN6<LPY^`=G7"$\.VD\?D?6M:N)KNV<J3G0*RTT"XBE<2]=$2((T0
MIV-=K/N9;'7UQ!>;^(UC[13URHX^!$)D!VJA.U\LLDU[RK2ZI^$L*;<:7JS$
M#D1^#]DZS9D3-_1K\9[9D-X&AJ&O6?`.TS<\BF!\'\3"=Z`[AF`R2'NW`&9_
MQ%EY'6'95"S_B$H3_#"#W;O?^@:7[7'=XN`#L5TXR--[44">HN-,%JR&Z.T$
MK'VF(FIU/-@1CS3D57(EWUY?<;GCV/668^6Q#SLUY#-71(2F$-:^!D8T?=4<
M"-5PJN=!'J!7T(.]\<DX5DG/3TZN?C[]0$XN?KH\/;^>WYQ=G)/+^3_F[S^=
MDK-S<OWW^=7I-;GX2*YO+D[^\Y59:LB$S*RI*^_Y;5YDT4)ZK06"NH%U]T[=
M).&G^VVF2?0-+_!CSE:Y;<`AGVO1/<WJ/:@.#CT*\`^-.[7:X6%'2:>!&^DO
MDIO[."N>KUD7B8TP-U_2F_MTDT?)\B.C94%IHM\Q;Z^ANS7>1@/./CM[GY$W
MNULY`-@X9Z&O.3)7;UVO1MY/V[,RMIK)N^^."`/3]R&,O1T!V-_WYHSB5HBP
MTR39QQ8R%="WA%N:1J7!=I,W@W8ITT`XW\E=BY%:+K1=H"/#WKPW>R3@X^VV
MMK#I95NUI7U<_!_O\-\/[2\=Z\8]S&-AW6V,6?WFXO?.Z>+/=^G3MTL:?\N[
MEO_!:\'OWWSW]DU5#;*/_GFRR3)6$WQD%6>TYEND3Y/EA_X:)DC3ZD?3-QU$
M88@7PY*4P8*:BUK!6?6$E(_*XT+80_)A\C>NH(Y-;3J@PQV=R(XD5J#Q.?:)
M5P.'/C(%5B.?MH(14I[,XS''/1W[0_-=2YWUJ(=_(LN-?]F+88\4?)8I40-@
MNWS85&2;#B<EP;@CGIYE3`)8C'=*L;TJ`;'A/G"P@P7XD88Z+9/CCW1ZYE%Q
MKQOG_.5E@WS8*`<-Y.B'P^I,7\=?A]5U4@4V=5U'@7]^2ST>L:[KVA]([[8Z
MM+KNK_M0U\G!9Q<#=`"VB@`M19818%H2C%K7]2UC$@!>UU5B^Y3RT.$^K*Y#
M`_PX=5W;Y.AU7=\\*NYU==U?7S;(!]5U>"`?/G>]BO);\8-O\C=W4?183F#3
M=9'7GW1GLJN/_SG/:'2Q^L1\ZO!'W:#ZL60-!G%5;7%8\I'J55-,TGS&_^8+
M?_F_IF6*IEM2\P_9P7F_X0['(W2O775A"+4*]3;]+!:!5SV]WM.>5B9NN[[&
MO0[],HN?HH)>KJ.%.'7@),WEIS1I&S;'CHJ&PVL%K0>(8T&5'4/JEXMU]Q`M
M4G&P]X*_'EJ299S11;%^)E_BXKZ\B"//-^+><P;T2)S_';-R.*=,@/T1POA.
M#X04WF6RS"X5Z&3P<0&&.LY26W`!%P^*U0.R?4+*G^SM(2!%/]1QQ@K.T$6N
M&GV(HC;C!)GC'60>MY#A02F$$WZ&`T8[;'`'#.KT[H<J#<V3Y6G"_'P^V\WY
MZ?9#V,@U$S),;C@A;/Q#B*5`<P:6@+3,ZE:$-2-E.])H&-9F!"N<I,Y=*&,8
M1+Y#."=T#CD'B^])*"\>_B!V8E^*3=C\D`+Z,<VN:<&^ECB\8'6>%C2O-C4P
M]ZH=#Y_BZ#9>QT5,I76R#_VM\[)0]2,<2N+A^V*>JX7KGNGL$DQKC3/ZNF<(
M5)>-5T<)E,<(B,,(^!`BWUKA`@FWLSV/@(\MZP,+UCM;(8PKO!`G]8Y5Z7DJ
MB':Z9ZP<,/UQ#_S"=FQ$ZHN#P0312X6DU$A*E>)@,,I/`B,[K>1B183>[;$(
MO%2ISTUHZ'YENCLL]YCK2">087ID-51^HMEM:CZ7#-N_,4G/AN8GZ<,#&TZT
MDOSFD7W"*,5OHQ8G::ZV&3Q."IKQ%X@\K3_2)%H7SZ_\=@?B/O,;][!@N6?E
MOFZ/HZ1A!@##)%<#WD+GL&_L?Z#D[)];Y'0T-RM+HI<X/AI(&5!81:$E)*JZ
M&8*%U0.A_AB#I`&>C4E[PS"I.A3NX,9)X3+>::04'N>]CI4<71IOL#3`P5')
MKQ@N\1-7@0E>-GPBWY3N_.F5_T-0NM_\1QU+G:Y6=%'$3_0L6:0/]";ZRL^\
MOJ*\]YE!49:??GUD;>B2/[E)BVC]5C9H&J:I.3IRU30\*@[[#HCC'6='#$'.
M46]WG5B^>>#!ZR-=TBQ:DVOV=38,<<^DB+Y6UZ_P_1"%.'B`?910$>Q65?M;
MFM!5',1]Y`-1FR+"1Q:5W#1VPL^^\0EU$#'`!2]<XL."K20I10F3%1>FD+8T
MJ<7+AZ6"5]*T,1(8;7#*<T?;=NO[N(RA"A_@AQ_V'`]CSRMYVC@)C3SCG<95
MK^QJ+.CZ%"?TK*`/W7<"T.:-4[GTS0>?S`7Q9OCI7`8K^A.ZM,*[)8NM=8J\
M`1$M)EZI".[QU+97)$=VZ<3:QW99H6K$K8#\5O<;9F7^->YR1]NFNR&PW09G
MTYC,+M*VP(YJP(ZQEL1,_)/P?Y//_).)0:_OJO[6,4V/UO"6MI5L']-V_(#9
MC1_90),-."^RNRB)_U6NVDV6[S<Y8TV>W_`Y%ME4AH58<]X")#:\-K3P#G%&
M`F;54/1!E,S."I+MIAON2A&2-F3$[,)M)17"+((-8%+7SI35:@#Q3F$6#DA1
MA_E0>\,!R@?P53/2;"=>U=4MR6?1-H0-%UZQJ1^&>T&GXPYCI#&"+&=`FNK'
M!ABT@WCA94Q@COU:0<58(`3^@#K6-`30Q7"=B+'TEX-F0+7T*8V2<QH7]S2[
MHH]1O#Q/LQ.QM),-TF5U$DB@62$9!(:G'9!'B%61R9XAW>C%.Y40?_'R5*\D
M6S-)DI2BO!&3)4F:54MQF70(91$,'ZE]#\J2C5:PDV:FQ2%JX6.V-`2#O-CA
M#4C5@I1-"&M#MHT.$6GZP@8-:[C'I?R:9K_%R=U)]!@7T5H6L>4MFB&ZVV(X
M%^0V$8-PSX`!\9WVW9?;VQC[I6Q'%F5#\N4^7MR3N&RUC%<KFE%^&,HM+;[P
M<_\6U=4#49Y3IHL/4NN/`ENMJX!!"N@W&1W:+3OX]PTHU&@J46T%)AXOJT](
M]=%^=K<^_EET.&Z$*]?4B?54)_P@HO6:+OG>_*^+>]9'M-R=(@M\5H+->`@4
M'(YJ*P\1HR?4KH$',#6=DG;17"*YJ,5$Y*2U8!F/0XB:=AA*W7M71CF0@@X3
MP\(N:J"&6\3`+0_KU7+><DG_MFEYYLH6JZ+U2X"J/C]X`^L$DW_E6EWU75W:
M=I)IOTX[M#D_J7V\";^N>MAL7UMJ-]57;8()YV(N?2]*Y_AT'2Z;X&NUE\_N
MZ;$Q9,LL7VK^/LK;5R+/LXQ3BUM^_[QK<AD]BS./^%O9BT?>,)\OES'_(UKO
M+DS.ZP.0WNK.!1O7<FN3[4B6$3;CC/H;8>S,&\MATYZ=<?R8"25$:"%-2Z1A
MBKQ_)LUVE3E2KO*H#)*=1=(P2;8VPSJL;63RIA.R0KHG:!0/NIN%7L-6RU.[
M80-P<^%XG@<1P<2T%(WO[OGT])S]1M$=7RW]4-W?<Y(FHMF&1:5/\2J$`<P+
MB#R&_<B'&WMPIP2%0[=FGV\5/O_(&A;Y65+6WC5+*I)L.=*@R`W-'I25[E2.
M]`K?\1U!2BA3_8*8I]5,]#T@N69TMW:))ZH23[9-/(M&XBE88W$*3OI8KO'D
MEG-R)XSRC?/E03E'_,\_7B;_2'Y*/MPD?V?_N?XC*1?%'`EY^C5Z>%S3(];J
M[3_^\M/;=Q_^V%U&P?Z9BE>U*QX#TQ5)$TJ>:90Q#7QCT0/SZSX_$A/1!;^,
MA[_>6T;/0;R\FS;.2#+EQ#&OGS;'=DB615_C+]!QW".#)OL&(<9><001U_KF
M5C]U<5M-753M6E,71_7<Q1'Y<1N++ZM8#!Q4<&=>(V<0@'B-G?*?95^CIX^C
MER;[(D$&T>,_S(1@$`L=7T.8_A2G%QO"4$^%FM_=9?0N*N@9,Q(G>;P0;]]U
M[_F`(LUY"J/(\)@,]`JA\C1;,@0WDX+9M@'9MJ@.VP_JG1$4"*E+1\DX;Q#M
ML'-ZT/EXH0$Q.0Q_XHY3%0(/%7;Z>AD5>+B3XG-F2^0:R9$,Z@;MX-QJ@,$*
MB464P-O6:X1YL_EL^\\@CF#0=$T7M^KNZV"TT;"'2%T7#WDEPR^$9;4-^TYQ
MGJ?9LSC4LGW_>NO-":!]ZP6'MCW"2`[@#\9DE=Z,:3"DDYY53\GN<76P].>R
M10A`!W5[:MTSTG&!1JY;OMN`:Q!)DI@?_2JL&0FB;]LFAZHM!C'T?J"00FG"
M2`B%Y*Q\0FI.!$@$0_=V20!"0X<`<ID>^('@&0!\H7:>+$]H5K"Q[`7?&7F6
M+.DM&^7R4Q[4-+"3;)("*CF<(G8^(A`&;-!`'Z">6<D>ONVA:DE$4])L&Q*Y
M+$&3#NA-&?%@&CHT=(3K\))-&&9/CXW%FJ*EI$SKM40KT!0^X)5F?0.PHJPK
M-VNG'OXD)(H8NE1:@NG[7U9\=23D99<)+#C7AJE&Q8HFBJN[L$;&"JNX-^C`
M1L==@?8--L$,D57]I+P]PC1,[C15W]_@/%1VV8)V*JX<_Y#R*?\.?%2/&QO.
MVH\'[S.361N^O:RC5;^KK-5X5OZ+?"[_'<!14=+^2$V_H63'6+-9>Z.8MD\Q
MY@NE8-,UD<X9HH!.9Q5SWA``/JE`<^XP"`QJNTDQ?ZC%HJRI:@X1'Y/USM^M
M"75-:FC:NEQ&U13AT'Z]%QB762@MF$[;5PC.Z@<DVH$YG,+4U*^IS>\O/>M>
M+M(]S!Z(F:'%Z27#UWV4T\:V=P#X+45[Q2Q$%*G(A7N)5?R"+$**8H"BJEBN
M6[:.AB#S$/EE"QU)?6T-O'[=;58AJ\<=8#ODX*%R)N:$#5%C)M.8G+E<1XOR
M+=H=WU^@YJFCBM9A1+8J$(YV<?,:XX@7:\NFHUXL%<[J"<ZM1&O:<RM$2JF0
MB.V*M12C[Z4GPMBIZIX-,Q#W2)?-*\=&RD:J2]_1QD=*R[BS1]`Q4E^D,X,4
MSD!)W6?J.TB-@Z5>8\U-H.@#IK/DB>:<'NH<I&C2A&FOR7"0*JPB0+2OV0#0
MKL!L^T%(X5O532GD9Y7ALM.T@TI3EV-@DH5L\1KK,LKX*:@`B&HEI(A52"`"
M6.L3)IY5AJ#PELLWT,XKF?+%;=4D2/SK,:"@`P0X<G9()55D@:%M`'=N[FF:
MT8<?LW3S^&F]4%-&V[#)%$7#X031>H#`"Y5^`QWD8K/J8R(^/R*?/IV$!'Y]
M;Z;PWUT&=:E`!^$PE*!-=MG.<-E.:_F>RQII`FO8K)5IJBK\V2F'*2G7>2B+
MR2=_,T[S9YI59VCS#)-05IY%>4&SCYMD^>E1S18KP=;K.Y@@PDL]&P\Q7O4!
M[9E>`(+4S'BS^O!W4C<D94O"F[*,\^?+D(AFAYC4O2^E[Q<A"KIO'9V0.H",
M[[.8U7SKLO;C?!>&BJ6:A3"))OU,$L-Y!_,)@7!&0P:F&>1GU7.R:U`3JUB&
M1"P@"%*'7I)122_9X9`EW(;<*\:W/YNK/$VSUAUBLF8(-S:IK6/<TB35;KJ9
M22(T^R3.;@FQ7-/U7PK]K:6W+?6;=^]8`F!B`(`O*8-.4D1W]&)UL2GR(DJ6
M<7+W2UJP_SW]?1,7SV<)RSZ,2-)EI2[R3<C;R0_G@HN_B,?G69HWL,A*6_<N
MJ,>ML#@E;B=.GH0\H4(!B6L-(1P0YP2W=#`"9-2UT=/A=,B@1SVSS-HP(N#Y
MKO[+%L8;$J04(:4,V0J]/(CKSP$8">2X)P386)ZO"GYY85YDFT6QR5B#H5E.
MK=$U[\DTCAL4U-]IHMPH=0@Q>$CT#\Z?).)*2=;4NF\Y50-N]Q!D9(QS2.IK
M'A"D0J3A9-E:X8I7"CIE="+TD):B5]+IL10X[7"KA6JRJ)ISU;Z,-C25S'CV
MFZ)-=:J\P)OCE%B`36[V!+>SFM63X%Y,FWI6.HUIP(%L_K(K(I^X-*(&J3B^
M2I^C=?%\D5Q':VJ<WI&W5A6UW=:XF5+NBZ=BM&?,(LMU9#N7Q/;KR*QL3\15
M]&E"$EJ0G(N&5BDJT*!.2%KX*%--6TJ31L;$F[>J2V+&&6N=:NEB1:KGY"(A
MHL5A(0I>OCAB"N<H;8W^8QM4L:+(>'2FP98[M(Z[A7@=MOB-UP<(K6/?T#I&
MW5V<%_%#5-#E>YHL[A^B[+?J*.;\8YI=9NF2%=)O9=G>2K"U\Q@FB+`/V<9#
MQ'(`:M>T5QFD9K9M1J*'=).(:WQN:PE6&I176#!P+>D37:>/XC*?ARC9\#M_
M-ADEBVH?UV.6/F8Q+:+LF40;5EFF=^F&P7+SD&8D3E;QNL@B,6Q>/S\\WJ>+
MYX*2:,FO*7KB6M9K7J)DT>,S5\6]"Z(.L<-IZHX@Z;YJB(+N+NN@^(%:OL`M
M8G#CGRUV;%O6U[KDA+4E56/R]B5`55_V>`,K3C$$,V55%\$.%8<;1D'M,0"U
M/[$PG?,\M&!_,I/I0_0B\*NMK?SA%[7BFB?))EKSJT-9.<>2K:RX4K5I+5/N
MM4%8D:RPBU@=24R8UAMW)6;S;:43B6>$WR'"!Q.\=F$E3W2[IKRCT]4J7O!5
MQU'./LZ$!'UX7*=E4;0]ZR6(0D79YRFHBZ1KBCMMN\N'1T`0:OT@56Z)'G&!
M0XD:_B$I/]W?_C?<S6"'`']K*R[3@OT9,V-ILC%.'\M;JZ:/NZUQ)U[DOGB:
M/NX9LYAWZ<AV9EVV3XEX'$+$`_2X>M9%"Q'EG$M;2C/G,B:FO$T12\PXXZG_
M0KV#J,,"%'R&V!%2N*'V)'UX2!.Q)^\F?4_+HS5D45;;L'7&DKPAPDE*.@\0
MPZK*CNET)*G8['PC7L$RV.?\TKJ<_[4034DN]I"R?K^E)"[/=XG$\UN64QE@
MF02E!5FR848(45>/@!3>5]+SC60"W5.,1D46:G!56W!!%0^IY0-2[D.^2=F`
MOSHCZ!"0H@^BSEC!#9V0*8!C62BU$K1]`]*?<O`T968U88;X!@1IONSX]0T(
MQK3<L8+6+ABWGI0[=IB4&X\?H[\!.<9Z`W)L]0;D^"5`=?@;$">PCO<&Y'BJ
M-R#'6&]`CD%O0"Z>HBR.$G+"*^SL14!WFC@[_G*3=Z[%UCO78NO=6.Q\-U&Q
M]0Z'FN]>BRV,,/!N0!CH8MPZ"+QS"`+C\6/T8NL=5K'USJK8>O<2H#J\V'("
MZWC%UKNIBJUW6,76.U"Q]3ZC45[L5ZTU#+F#:RTWY(Y>:WWO6FM][UIK?3\6
M.;^?J-;Z'H>9W[_66AAAX/L!8:"+<>L@\+U#$!B/'Z/76M]CU5K?6]5:W[\$
MJ`ZOM9S`.EZM]?U4M=;W6+76]Z!:ZX1%YXPN^*&I>U5O#4/OX'K+#;VCUUO2
ME6]6@K;U%LK:)2L/1ZZW`*OD8&IF\[N[C-Y%O/:1U%N[W=856U\++QA@[>.!
M=CD?2(%#-!B/**,77J"E?U!%X,(KA!6!WI$ZO.YRPNIX=9>'K>9PLRB0;55=
MO?'SRT#IX/K*#:6CK=+(_VGU:@UO=%`:1L'I.WUH?1$X'?QZRPVG_1=<0^ZK
MBAX>HT\TRJGFJBI%F]8M5;TV"!=4*>PB%"(2U:9KJ;H2,_$)$1^%=.*7LK=2
MT(\KO8"JT[9[]Y2I[P?@DP'_@68G]S%=G7ZEBPT?:UR4.R75@`4+-1$,$!H.
M:;!G"!B'V#*`WJQB5C8AH@W9-B)5JY"(`4=%ZM9G,NH8A3M<"@.%=H,^2!D-
M,SD4CGS$]Q._R*F(ULOT18!//Z9#AQ_R=H:'!YJ+.PM/TB3?K/GLDO:@4I!`
M:]91+X!0\$,\PI@Z,=@Q5?5:\9EX7-ZM278-0CO,%-;[J7W_2`MXG6"W<+="
MV;"MDX\TR<5,]&44+\^2DRB_ES%%W[*S>5+:$F6/F\8'W.V3<D/FG6XRN<:9
M'0OV[_+,4M;CY7$<E-8GWB\I'Y%QHJSHDF;16LRM\[-N*(F31?I`Q0>-4SR*
MZ"N3WB2L-<EIP;Y'^W"/$";,#<CI;:4SPZS%*[E$?RO=J)C$WGBI,N&$QVKK
MY?8)X8_(&=]/D-\?!F",FR]=(8.^<[UCXS_C1+5U7=-2'W[+ECZ@WO3!:_BM
M#%G#7<@UPF_.:M`L%E?=W[%2-'G)4;@%(!.I)&@S4(I+&"GE%YJ>H_#6A!,L
ME5&8/SP,P-A&83!D<*/P3]O%"XSTUS1[8L-3P%VE%F+-^`P2&\X("^\0R`&S
M9N`)1,FLU8A4K<*\#-4&(*EKY\F8!1#OT,P%E`,8=\V/D>'G%BZ;_)YG&4.'
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M+@;3W?*T%YQ[DMP:BH^=!!Z*6X>4&5"'CT%]J3W)"GR(+`R]$99(:[C<<(?<
M/I-FN\HE(GPZ(I571^1C)TN<MK/$994EMJFH<H]L_2,-!PGW\#6F[TM,U\]%
MA.)EH%$=9\5U,-_&PV:ZH+[;OH1WOCB=2]/EMY7.(([^#.7W"3VB:M?5A^)E
MJ!$5=??E.1N$5F^QU//5RD;-&29)H^&!7VD9H:Z6Z3;$O[[(K/%12#/(ZBY+
M83^PC)F]QAV*F"$P:(5>];)5MR9/VJ2]"J_3!&/=G=0JRDJ[KF;CVKJVP&S[
M04C85'53=[F<KC,["^1:37M+XO1=/@"3_&!M?MK`Q:IQXO;/CVG"8C:+XCD+
M[Q>K2Z:!9JQ4$4_5Z!VLK(GS`<J&,V+P-T'@SA`?#"QS5SVK1?E=T:TS[+DX
MV<GSYUL-59.`&#P<JBDN8&11P5EI)W[@46G0>B^QFC?2+2M0M6FO\>JVP5A"
M([>+LG2FI]JX9*8C,=M]$A*%E)W571ZC[=/.LIAVV]Z"&$/7#WDMOUV[=K&Z
MV!0YL[)D0Y>+VW5\5XYRU+"UE6V]U@;+(DQ"6?J),?4/-VF:N8%JFNU:\B34
M:$L:C4-BDC5^TD'=*IVR`.KH3BFXHG?(@)]^.34/^%6-6@/^?B.$`;_*,L:`
M7Z+;-.#OB<S81^0TQ!&_LL]2V"\L'?%W&W='_$8,#$HJ[#LOS6C5M6LG"UD[
MC,2@MH^2!*3JC0%?(C4K/PT2O]I>[(9L8X=WPG._?2\4`[`Q`,N?6#1_'Z<%
M7=PG_#RSF.9GB69[*:1]$]OZ]L,Q#O$'`>L&,P;,:Z5G_"GI/#XBK$%(+`#U
M>VK=-3)6Z.0Z[+!"UY!+WNNC!,^2(HN3/%[\$JTW='Z;BS<@;^L_9(RQE6U=
M"@^61;CJV])/!%99F#1="P[5U#@5<MN4B+9DVYA\KO\,@7G6^$D'=:OTVG&@
MCNYUY`&BUVX%'&REA)5M)""+>^]54'XYJ-6O@?*,6^R3/JK70?-D^2'F9T:G
M&>2=HKJY]/VBK#GBNT:U-YCO':56H.\@)<*-]Y%\%>7V<4@5&*3#%6\JC1"1
MO[7LBZG>8`)`A?*.0<,'92/Y6P9$["LMH[YG`..\+])XTQ`4HM5=IGK7`$!O
MK['R;8,'I)[^OHF+9S8$H0D_%^J2]1-K]%83Q2$"K3BN%T"(Y!"/,&*YP8XI
MFFO%9^5CLGU.>`/"6X1$`%COI_;](PWK.L%N8+="V9"!-5^("-B9KFO7&C!+
MVR$,+S3V,0;"<O6FL8),:B8^#7/[N+874_`/+BWU)>V[93T$&Q`L5[^#^`UR
MNOCS7?KT[9+&[+=X^SW_@^/\^S??O7U3(9U]],]31J3B^5>Z7O]GDGY)KFF4
MIPE=\C4</<2#VU<_!*#](`:`_1G&!(@9-2/,TK/R,>'/W_S&&Y"Z!2F;3$L1
M>+>GUCW3H8Q1;D<=>W`-.K>$#;B_BF,"V=B;9HEXVQRMM:\DP$+M,TN,0A@G
ME@`]0SFOQ&S+>%J)2<6L;%(=@]EJ%-P;"S@LNB>5V,&IE8:,PKU32FQAZ#=!
M_9*N-PF_W^ACO*99]WHK8[M>0NJU0TI$"OM8":BO'I)XNE)UPME^3LH'H:09
M52=*THN^O_MII=->EDY,T!B01JYH7F2;ZNR?>;*\HFM^9\1)FA>G7Q_IHOK[
MOS91QCBW?J[OD)!EEZ&ZFDG'7=?P7#3T>R`>)C/`%4,&<]8\NVJ?B?)[W6)[
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M]Y5YZVS4HJ:K%][1O/009VE<K,K[Z?:M7_7I'M2SHR=E,=`_807#79H]*W.Q
MM%4O!7=:(65>J6VLA-M5#LFS;9DZO8I/2?UQ*$E5WG&27*KKX7X*;;6694X]
M%`8DS$N:\1?@T1V]6)TEBXR3YBP1W+EBG\N2*%"DF5B-(L/C+]`KQ`1LMFB(
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MGCK?QWQ30[--QV_GG%A'5Q_M8S^#9I[,/3WZ[-,5O8OYOKVD.(\>NO`Q->NE
MT6XSI$PJMXZ53'O:(?FT(U2GU-W'A'\>2E95=)\DL6H[NI];V\UEZ=4`B0$9
M]M>(G^9<[,YF+@]FEN5:0]-FUE4V'1Z"#5X@9F*U)4-H5@EV5P)]*=LU[E\*
M:`&/J;=3FUZ1A7.%2">PCX\DU+2NL^&&(I[JJT>-*UFJZU@.!3?Z0F`0<L9?
M+T+Y6?;KLV1)O_XG5;^<4K3KKQ#IML-:&B*WC[8FI*<>M!BD([5=!5)^3L0#
MPIZ$4B2H>E&V[D/;X?TRH=->NM+#@(T!A<*/-.'7>U]D=U$2_ZN\"")9OM_D
M<4+S_!/[W[."/DC7.5N*-@L)L.CP=&#I)6*A`;=L2!E019UI@KM2C*0-.;'<
M^+:2#*$>L051.J1S95D'J**3A<(#,&I]8V,3![R\_JF:DF9;L<"W;DT^\_9$
M"(2P86P4\.J+)J_PQ3VNZ)H5:C0OCYHOXMLUA5XG82783#-`08QS4RT\1#E(
M%6;/>+(J1,VL;$;FI-$RY#L=[/#2/9#5'FLM0H(4](YL=<'I\.FA^CX(S7$S
M^I:2R:%>2[01O<('O.%\WP!L+-^5VP[DMP]"8H>A1Z4#>7WWRT;Q'0GY(-Z$
M%3R$'X,1?@Q&^+$WA!_[1OBQ(\*/50@_#ACAW1[5(ES>_3J$'T,0KL**YSFJ
MW2T_XD+'O'$U@WK""B#4G[W2"F%-90$\0YO7TML"37+I5&QGO!I79QV5%WCG
MS:M*@ID`@Z!"-AL&1Y-D:DPC+)TGLT'AD&7>ZV@ACH2:WU'M$9/:AJTEW?*&
M"*L5=1Y@+)!5Z#<M2)2*S;8?D_+SD+**OB]3^*\N76DH$^BN+P1A9`BLLW1!
MZ3+_R+[T[JJXRRQ^B@JZM7Y.Y?L8;(5;\(<+(U#"UE/,70X6MDT4`JN:U4T)
MAS.)ZYL;TQ5Y+)N3QRWQ$EJ$,"]L#Z=T6"=+60E5TF5JD'#&W1AA914+RF*S
M1`UFWGH[`"FO&2W!O,LB3.0E8=FPE\(WFG&GBS_0?)'%XL;YBV1[P/Y[FM!5
MO(BC]<67A&;Y??S87'>OO-=4EK+\6&CF-6P+PZ.%G^^,F"'1'33$'F1[LX8^
MPM^W;F_<N-VJ)&FML[,#<5$.!G,QH;[A]R@OMII#2,J>")..@%!90,2UU(F:
MATY]U&K"@VNCTI[7)1WB[Z[:V2DE6ZVDO=U.=X'Z*^^'P7//F8]=5#U&65'>
MT_MW&JV+^WFR_/OF(4JN:?84+ZAF,LM6MET(064QXIR=GRCQ"VS2&)>`FF:[
MECR"E&W%\B[1FM3-0YI"LT90-T(X`;##?)B.'J<=\3ODHM4T^5?T:[3^C06"
MIWB]IOIK5HVMFWS4M4:X8M7H"P+GM$9,UZNJ96?B&6D^#.Z@<D!?IY8=(N.*
M6JI[J2H<34.FIUD638IJ,R#@!AA(^]8DM+8]PD0=P!^,F3F]&=-4G$YZ5CZM
M]Z*&>64,J-M3ZYZ1SJAIY+J3:#;@&O0.I[ERK'P+>OJ5%9IQ3J7;_T`"[7<U
M6@&,"6V`1ZCO9/3VC)/7.O'9^4:@0;QKJ5=,EA,\>?FRG]9MR;(\TCC4L[]A
M2.E.7</1U9FLU@CV)JBG1"3R:Q63I2%H+%^?M-?M5DM.MFT.$6BF]R)(4,,=
MJC=F!,2U2<N;]"Q9;A;T].OBGB&`WF11DD<+'MQ*1V3AW5U+,^:[:,&X)M75
M=\3LX.2$\<)5:YV-/%+E#?Z78'`L5'"@QD()RRBE%E+LU(2>7`;@M'OUZT#`
MMV*#O;;>Y;'[P1S4+.9H'ITU/-^UIM9+.7*3DE*2U**D(5NEQ)=-"GW*G(`6
M.(<W.MBU.L_QB6:WJ?%$1T<O\/EQO.6'32KYII3^TPMGB/;HR"D8XG;`I*+\
M;%C^($J'\IR-7Z+UAMZD'^*,+I@J:<UI*=K:L0D51=BS:><E8DD)MVS:OPE4
M-!.?]"K&JB1\W!ZSLJPEQ!UD>?T&*:/)DK(Q3PAUHBVVTB%]+MW?"5/1W>$9
M'*Y1"SX;FSB8YJ5=JZ8K&U<')I$2\*S.VPJ\%.SJ"S>OZ,4IT:#&T,_9MC&,
M!&)U_;5\<;C5EE-^<3M&X536:&Z5DU(64#I)9+UQ5.FG_^))9MJ-I'U-YKFW
M`ZJDU%@#T=H$50BK>SI@M)X4Z6.44W*C2"@W%%35&'4_*BIL##O55%@H]EI5
M]:UYF.ZRLHT%9T!I1;[)@YG(&@O)+E46&I)1ZZS.J]ATO3Q+NIO21*4'6/5B
M%M:L@-$)HZ\],'OJ;V6,UK;=N@2-JMUD56_!#)/B%Q))-RUS@73%VO.DM4CS
M(HCC+>UQIEW6`,:I;H&#6HE^L4,@./>YWL9@%0OCTG4X'-QGB603LQ!Y25BV
M6JZ#CV:D:^+`YCQ47';&T6!]W(2U*69'!?FWXS]_]QT?-9?CZB-RGCZ5BV=9
MNG]W)`_K_)-_>WOTW0]OCXZ__^Y%\4)_69UW7HQ>OJF7M=E+VQ9P>(MQ['T=
MN82#+ENST"6=,GLA]9QVG8$S<*VY+EU5$"KR1R_JX,O.K+19E'7!K#(;$=/#
M*[N!J!ZOMO.W>LS2.AZ\)RCO0EIK-B9/!E=Z0WDRWBO1CVEV30OV+<O=U9?1
M<W2[ED[:#5`#?E&J4N-Y!E[O_5BO3Y5>#)F45R@%K4DK7Y[6PJ*&+,5#J`6'
MP-%B]AX$;/@TOER=S8Q^4!09[[VKQCX^/6!O8YDLV0F+(Q!+\9?.C@$O;'WQ
M8X37N`K#8[_1U;CA@2B*][S*S/'BJ>'^!M@;-4;;N#"XU@1H@6YG&#V-`GP?
M:9,#<IVITVF[=F\?*TX(*.%K<M'J38TVBW6Z(=%DM#T3Z+6F7JMY)\4>5IIC
ML,)]LX4G7OC?@H%19`[=C8%>8>JUVA68Y)LX(<$O+!R%'<Y;.GRQ`_<-=NOX
M5GY#]Z+81.N+VW5\URJ.6B^NH4*M]]5F(827&E#/,-].`VR:WE\85<RN=G=B
M\^-/NF>N;V5(NA4B<;+8B/<<@9^;`L=3ZM;;TA<0)N'N>X<@\(O[CAED;2AV
MQ1OE'5PO^$GA.[CNVATR$`WOC+&AB'N(E_SN%.5AWQ>KZMY(Q:*G@<K,5VZ!
ME/FZL\CBFWB_D@OFB].]1A#5W9RUB/)[EI-6Z_1+>8D7_S#.=Q=YZ:X.X<^_
M5)J;^2R@+#88V9`;D^R9TGGM[J@4=)]2Z,P;X?8PJ!>^6->Z76S5NEW,<$<'
M?UYK>:63##1!$@IK-9BK>?1)DV&N>./5L>X*2FCF>N65##EA\@IUGN5D'>7Y
M5OE%=A7?W1?;>W4N&3GOHYQ>9C'WKG:A:I:_E172.!I;!^0.U(APLB'*=\(\
M.'>H0Z;C#H?I[U;8NXOZ'BM1OJBU#%%?&OS8/MV]3FQ&L!"J:21XIQ[P)3TJ
M<9#F[K&)>TY$W'-XA[OBE83B?%ZNH5$_DS0CXG'C!KU:#[FL&;G-6'7KG+Q]
M99X>4(%S#^F`WV$^H%?D"/[XI2"KS>>*U/=**#U&0B>46Q5>]9GHKYPN_GR7
M/GV[I#'KM[??\S]XA?[]F^_>OJEJ=/;1/S]4)>''.%]$ZW_0*/O(/NE.8@-:
M5C^IMN6@(`'P85CBU1M0<UDG-ZL?D/()X8^(>#8M1R$]FEK\]!U&:21V3+'!
MRH!1Z#PIXD7\R'BW?+]9WE'VW].OCS19QL5&L4D=*-(<1QI%AF=(H%>((T&S
M14.*,RGHC>4>TDVY)N>V:DYHHWT(8S0H-E*7OI,E)H-H)_-,CT/4@1#$UC`,
M\J%,HPFIVY!FHT/%G7Z,@8H\G%&"R0CZ,`!B<"``C]L`E$:^@P6@MB;'!>!4
M576YNA%65TO:*BOK5EODVEKB!W9UW39A4U\W)7L5=K7Z/<@:6]:[FBI;#09U
MG=V0T57:.NP,J+5_H7EQD5S'7_]GE&RB[/GF2WISGV[R*%E^C%<%I8GZUF=;
MV6;U#9<=GH)L_42LQRU,&W(26%.W0H^359H]E`OT'FE61'$B5B6E)'T4'SXQ
MS83]MU),_GK$#PWY2PBENS7"TD$=+\MH4!V=U!8BOE'K?"NC2-CFE?\O%5I9
MZRUB67M2"Y!*(J1[TD>"L7YLX!G(.*,%L#7T88.592P\'^_PW(F^+Q&^VI&%
M;_CB;HQ?W-/E9DTO5J=Y$3_P`<[/.5UMUI]BEFUO^`:I&_JU>,]T_B:KK%SD
M6YOAK>01=C$Z^(NY`=[.O&GCHHVV&?OW9AUE9,FJ]'6:LW$KGPREM239"%&R
MYK)B)^-CEO(R[/F(G^#&3V]C.8O^OHD?^1<-H>AR`E\Z&`_2C8L6>KI;%@.F
M`.[F=EO#B/`7&]JK]GS+U%:"E")$R)#/0HIP,2+D0LAJ(\/<L']]'*`C[5FW
ML8B_6]W6.B;>CQMX3U5X?X'@UF\_'PG<J"7<3]'7^&'S\)XF=!4OXFA]\25A
MZ+R/'W?[&M\__SU=+^638R[RS1+.3GXXJ5W\12SA+,T;.&VE;79S3\E#*4%N
MMR(DK66:V]AOG\F]$`NA4G/"6#JXVV4<M]'3X7C(2$>MU*P-(Z*<5VI5>[(3
M(%L)TMC[_OZ9E$(O#^+Z*FTDD.-4:586T:LT:^N86#_>8=T0SU\@PK6EVE@(
MGZQ4:QY*\3&*LY^B[#>JOKP06;5K@:=5/6ZH`'S+B<I"O6>(\45G2!23[6./
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M[XI4_P/*\+5MU$&7GZY$#1IMK=!NY`%C7SM2'RJ,78E\XBW-_FL39:Q(5T<+
M59O.F>>=-BA'1$OMXIYHWC5A/@2Z+<&'`:3Z*"0\*GNM=Z"SKG-;V.RV[1_6
M[!T#V*>"]Y5;]G]UYO<!(<!X@K<-!M"C%3\M0ANJ^@TZ<:K9``6@?8NX$:JE
MWPS/1G.!3''Z2%BPE/11#Y/*?NS"<=>PCT6/?8T=B3J:;?JYCD%[W]/&T`/K
M:^21U-G?-2.I[L/62&KW$*'\[EK"'$DU=)M*\&W3&?LS)+3UNR+5_X#2\KMN
MU"V_O70E[DBJI17:C6(DM:<=:1A)F;H2-TQ</$59'"4G_-AE386B:=8,'=)F
MPY&GL8X83N16#(B4"<VJ#TGY:4@@U?5C"OW-9;"5-.\`>#QLH,8GE7Y[7/"8
M=:#(T(<T)VS@AKGW&8WRPA3EU*V:04[6:CB.U;810YS4B`')$IE9^5F`*-;T
M8`K\N64([K?N`'@L3*"&-H5Z:SSPP':(B-!'-0=,.,8TEV.]/M&[:'V:,,>?
MYU]CV6%>BA:-([QZ+08?W*6P.?RXKKYB_2%=W?8S\0$I/R&?^6<3@U?712G@
M-Y6<OM5IV3YSR]390U:(I.LTHXLB6IL2L+YE:]V(HB7".@.M#YBK252&3"L0
MY'*SW><!AF%#SZ8672!=JB"5Z*Y:&!DSN,M4U":<\"(6KQPX8@S+6]PQ,V(B
MK\]"O&%J)5E<]EAR"F?Y&.W@S:8UO+,V*ZVPXS5%X]V)FOR?TR=L:6](3\V4
M]%<S53>;R<_&E/;H@"3]\R/[&DGQ*5[0)*<?J713F+)1,S5+&@V/L$K+B`E9
M9L,06_LBL^HC4GU&V(<!1%-USZ6PWUD607N-.\%S'"2@IEFY=EL4\.1Z8#C0
MYU)K).!L#>FK1=_D(3=A#8CC'2#6%2!6>PX([08(>T#@;HRFK'O2!\V^!'F+
MUC;E3@N$G4Q2FYB;AKL&3-N*VNUG];]#&@<H.BH%_++2G3FMEMT--IZ[''<?
M:5^U57>+79V'T>&&/9+P+L=]Z_0I3>YN:/907Z+&;S6."\[CW>XL66RRD6M&
M+)C<<%#;^(<8W8!F#20`:9$<9L#/)MA>7;C8"G$XW;(G4;PDFS*IA7`T@16$
M4N?>E=$-(M\A84C`18W18(,(H.7QG+<CO.'N.MM=T\:._,-'J#XE>,(HSJ@&
M9`E]H`.VB@'5]C[T5@A](V+H"P"H=OSD"Z"HHZR?$]YG5TRU>IRE:M.:,>RU
M09@:4-C%G"_LFS#-"W0E9N4GA'\44@VN[+44]"-+9P0Z;;L3`B-@`'>F4*;<
MLO_%/.%!(<`P36B'`>S16)3,[S)*'[0!2].L/=:2-,/(_4KKJ",IF15C8N\+
MS?B'9/MI2`#6]6,W6YMZO).:>\U[F7@L;"`/5N3Z[7%1#D4.$AFF<84#-G##
M'+_W)T[N/L99KHERZE;=NPJ[K7"NNI+;1@QQ4B.`VZLZ,K/J,R(^#`G%FA[L
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M^3[(1&/7Y\9$`^MSMT33W/.QBO);\84W^9N[*'HL-W[0=9'7GW1W@%0?_W.^
M6*2;A(^Q+M-UO(AI/K_-BRQ:%!UXP06J'P,B,`CJ<(^&A3F0'34#`.*SZY]_
M^FE^]0]R\9%<G_UX?O;Q[&1^?D/F)R<7/Y_?G)W_2"ZOYB<W9R>GU^1S+38Q
M9RP`D=IW68=19L$=PQR`-SK?\LOHF=^T>477_`+.RR@KF'\GFRQC=96>>2!1
M.0<-HIAL!'F)RDN313!#]8IF=2M2-3LB54-2M3PB5=N@^`F#C8JI-J!3<%:K
M0LG>4"!K5S,_T>PVU=51UJ9QT,O+;=8NVS"T/I;M^"^?KE;Q@A5^)$J6_":M
M!U:P+&.^.S7-)KYZ>3P4*RMX_SA&V/6+EI&L<I!5UO%*VC$RRX!<HLD>(2<+
M6V(Y)00H=<;`SSAA?E!@;X?R$DQ5+#\D#-F&8TL4!1%RS]."YGS=1CY/EA_C
M)$H6;+1R11<T?N*^YN^?&Z?G7*Q.N!3-'EGR>.;;]"4',/DTH0CO."9028WY
MK7%3"9)G\*B!8K!]BE6Z(LU61^*,C"#.MO**?F7@\L`Q5;##,*4.D0?*9,])
M'<W%<4DMEE*^TMHOK<%53/C$GKIBRBA_W3Q_2-G(^5_BU?/%ZD.<EU^0?:W+
MC#[$FX?\+'FBN=B=I*F-!BCK5T%.RK"BY(!O@E;9N/D`"G<NJF=;.?)-4_)/
M/,1MA<5D5RU^1!H*@@EV0U`J"VO#42\)7PY*I8%JWU@$K"I^*'F4L/!:T"6H
MJG!UQA>AQ%1#0X#3:%F)$/9/!F96-!4QGTU.>*9Y)9`,)D%2:/*LOF&DB*/;
M>!TW)L29K^>L@TU3T1;"DJP-$4:++W!/\;(RR"8L:`!4;5\L-1J&$P@LD"(E
MOC729#0W*Y'3.C"DVHVG#2O*'$QC0;;Y-G21/CS2)"_S6_UJ-$Y(?A^Q7XYG
MO+Q(%[^])$"#,I<_2(>9F6R3D6W^\4WDD;+,,)9*<TEX;TH-/0ZGG2O/+*CE
M&U?CYH2A::`9^==[4ZXX(,L]AEM@:_"B=;,%JS7L-C/X&GM#\'6\PQ?]R@N+
M@P27:OT[*K@F7AW/O7J?)IL<6`+(V\K3?[<M)HGD?J"F_9X),&,ZDENN5)^'
MF>H5/:OBBQ8("J:T990L,>!F5'YL'C9B1>,'^IC112P&4.SO=3D5E2R;LU&7
M6?I(L^*9;W_AQ?[I[YOX\4%+*53U?18BJ<<B+NJW1>,ZEE>@\(!C;-;01)JJ
MCLA6F7@!U%1W1&J%1V)S6G$DFFRU!A.-<$DA"V`^:">)>2AFI&'R$(GM;QT+
MGGOC<5QL':X>"I[2^@FC;8/]RX:15P:[(FYO.8PY.,5Q"#:6=7AOC.?>B"P^
MYJO0\OQO9*[@K.!VU-#U2F)7P.TOB2>=!%@N8^Y=M+Z,XN59<A(]QD6T5HU9
M]*V[0Q!5:YR0I?<%:8"@-`*((@K9V>X!X4_XF[CJ62#L-_1RG\P@6/28*9>2
M$&T*'/FJ1S76G"$E9OQWH.+'0;]AH%H<(JC,5=M`6$W[:E;ND_1D+2L96&A&
M.9/)RB^O81IP.A=,0S=DO]F%[$`.^;$#`Y1LVH.^0+)@VHT'O7$C.^CL,*B.
M'@[/7A(.74._$Q(G3@/_>U.N8;U8_1IE&1LQY#_R_Z7+CVEV3;.G>$&5.T"L
MA'N)`2:,1%,;3[%2!=`FA*T@5;-=.[[4KFY)JJ;\3!)2-PZ%O%8(DK#8`8%]
M,D.4R%@='(+]K!^"F\:",L]`'Z,X(T_1>B.N=^0W.J9)N7R4%$P@7]$L8Z#>
M';PCIKCJ`W=>$KX!Z<HGP@-)8/E-JLJS4?;;3<K_ERK?D3NJ428UJ!KDX&#G
M/7:B`UNWB1-`I8WD)Y"LGOLZ(B*T_,)#2VAAPA)]FH#AA&-UX("ITX60H!GA
M.7%:.(%/C7XRY?O66.HLDVGZR.6#*PC'9H)%$AV+"^$DUBO*^RY>TW-:G"6L
M%J.?TIQ]?A+E]Y=9^A0OZ?+]\\\Y95_DXI%F$3\O=KXHXB>Q"-5T&+)'4[H$
MC68*/V0A_PH>$CV>AY81#\MPMV#8ZB5,,2DUDV^X[C_QQUP]J?63VV?R#3?!
MRHH_D:T5LC,3W@'3/DFFC[Y^**V-ST@F#3'\\`.(MREL3ZY.$TO*"?-6-,FV
MT21AT63-M/)/^=\+'D@V9>P@Z39T1%NM?WL-&-C@/;B0$4YIJ*AC+XI[S7MD
M2WF'699*?K3!9,O?\>95:K,XH\92F\U,BI`(,%Z!4.4T9I0!TV6H*/2XC1$G
MP?88E8#1/B+,><[^P*]YYN\,>-A-EOP4IEN:T%6\B!G8RP.9<KYX=D6C8I.)
MN9-'%DC+-P\A'64Q(O91)DJ&HC_X_'?-3SQY'[$\?M(X$^6*LO0=+PJZO.;@
M^3F)B_R*[[C(XX)6[U,N:1:G2UXGW"5"\X`LZL$+AUR,ZL5H4<_#;S=>78#K
M/$[8Q?3)ID81=M_<<L.D:9E?.53;)L(XX=9)FO4?S+]$V9(+5([5ZRA(Z1II
M^+8_&<%'='#**_["E$MN0O3&+<.]^'@YV=LX[.\07.#D5>\O3)#/.+%B-MO%
MN>J(MCC/-]52L3S0I6(O*Z"AE-N'%-*F+?W7Y?CCFMZ)+ZS?+Z%MW"VD%8UQ
MXK?6$Z2R5&4#$`3EHK-RE%A_&MK"<WWO]N,&!`T]<DN%)!R$H6=4HG#EC-E2
MYI^6QWFIB6,AW"<22!B+6!:>HA$-9A-$/(BJV;:=<C!%JK;!<-,&0#*NV@-0
MPEV`$BF70P.PGX(<;AH+R>)%K6C)#R9^Y'OFRX/X6>PDJ]T:N>(^*NI5<EE9
M>OR+_1GE]3F$+PGFY@K4*]#QCAZ!F?-T2";<.!K8C_\P:X;KYN'<+PJ_QI,[
M_.)WTE,W6K=8;.^L.DES];U.`)%NR:45P2$OP"ND\DIO"<!.G8+>%3#;YT0T
M"(28$`STZ0A'3H^"&E$)\:;%FZ\[BTPFAT%/;`/8@FUQR&`S5RQH<)MV-JI]
M1Q&]+>I[BJH[BD`A7B.GC?-2.0_DT_CG(^++S=ER3Z:E%_MYH^U5>N2;JMV?
M0J2E#B0&;IKQI:>G1-[$T0FA.4IR4-E%0.F^7E/G$:V6Z00'K],FEJ2(E_%Z
M4\1/])HN-IE8?'SZ=;'>+.GR(_OE^4!G4U3NGT99PA)B?DFS<BCT+%?0O#&X
MFY+\6^PF,Y\6<6*-_]\$*8%Z=100U#S:GS6?D=W#L*[T'H$]_;@Y&F5[\=:?
M94FD'C%.[$V$_Q0G]*R@#Y[">4\];NQNJ`\A4/>^;1!1N>F5]Q"\,Z:,M[4N
MPD,?:6CC%6JMCZ_'+-]1DL]<)Q%*#R-*]TF!'9)5M$..OULSZ,%63>RI(^MY
M]$`_I`]1K%S.#Q0#1<*FF,<(U_?.9^1J67.-2`TEJDAS1'@C\KEL%G3LD,`#
M&!.4P()Q?2<.Y;`&DE-S$QQ>V*!]H[YF"U,W;KU3ZPZAV&E_SR`JG:U+WLN<
MRA)6C7-$2H4AARA7`F#7-E)^(1<VI0WTJD9!WQ'#9IY3]7J!UL-NX*H>XD2>
MEB6DT%'K!'"_;#HK_QL(Y]H_?I\TLL[IH5XTDL`6O_,L%Q*F1;0&O!O9J8;V
M(G_+<<.UD_WK3?/K"&U_3OMB0;A07;EJ.A9.UU8:9WIM$9&K\`,S"O5-0.'<
ME:QBU/8&X/!.(]/VK0+X>BC(6="149%B1.3X.DA#:<L11#Q$UO`)+T@.@PXP
MA+J!)X``"XJLH)#JA1$^@ZA#].R&S4"C)13K5O'1A&VO_>]G6TG?A"T0Q!J8
MZ^O3F^M][G]@D(,B(("P5@5:2+T(J1-]9'F/=:%]*N_5@2'!N=M1^LQMDZ\-
M>=I'MWL<US8M6/;_;I0;?"$'A(%=X68`PJ01[?TFCQ.:Y_-%>=Y!G"::Y7&&
MUITHIVR-`GR#+SB13VW$S`&5[*Q^0!I/@EK'9>KF'CE@N.B21"'5IPL42-/2
MAO^94?WK=;`<@$H=.6^DDOKGCUY=<VY$:VN14NZ(U*T">\D.!PF(B#I\02C9
MDH>14P_-\6GZ@>:++!8WS,R3Y?LHC_.+U25C!$N_XFW7#?U:O&>._&;@K;TB
M!9%M%*$RV_X;X%+=RCZ<^Q9J=\&@(21N[1-B_!UW4Y!\YJ)$R`86(!S0J(P8
MSLA6A1"X0G5,V0.6>)D\<G3#!UWXX.W'T_/3J_DG<G'UX_S\[/^;WYQ=G)/Y
M^0?R_N?KL_/3ZT#FIZ:EA7%,.`TQ)AU=\NLDF'_\/Z>L)'B*UOQ4L,MT'2^>
M32G72K:398&R*"'#RD^<7`HU:8X',$TS<>L4SY#BCT;+(U*V)9^K_P:7*^U@
MU(L#+BCL$A^DH\_UX$#L)=7!+2.A6;Q05N'YY6#6F*Y\HC;$I"0.>#U+%AF-
M<OJ!EO^URTU:%;`4I5#AD^1:K[TF+)5E9Z;+%6K35WEP?BU#OJFE`CG^P@EI
MT(@`P2LP+$A5@:-#**CW\O[,V@%<^/-\5UTEVH4X^ZRDQ'S?4J%'_+LF1@\,
M"#!-SHN3*,N>X^1.7%QOE1\5LJ#$V)/U&!L4?OI,A7V3KD&@JTF7_**"U(V)
M:!TRYU7H`9)=#SX8QSLZH.2>$+MV">U11*'3!'`0%-PZ$I"UP[8C<LKOS5M5
MY=S+@;%CLL(!,MJ1R#!K5B<BEU"^+J*LP`(S[%!DJ"X=F-_3NSA)JLMQ7ARD
M3><D>X5T_Y1DGY!^9P-I\!X,N&TL.+]KP'G!_Z#[,8Y`1NZ[*9'[;LJQPGU,
M5Z=?Z4+L+;Y8K>(%S;27$@$DNN,"G00.9\T^(8T!M(8`I-3(S\1#LGU*JL>!
M75L$Z?\^"\&@Z3%/+2GAFP721N38.LKSBY6XHNR3X=PS;=LNK^1M<1BE\P.)
M2PH3`!9))6?B8UYXE5>NAG=^E[YS^Z0!8*%'%YF,A"@@Z(Q.D5]97HR2XB*[
MBN_N"T;D;!'G]#)C--X^S*NG^5L]A=QTR2EFJPN3@F[?`Y6BUBZ`*6RI>4?Q
MZIFX:YD_/"*U,!'2C3;YME$H%>T@@*K"Q""\*\*(G4YEF!E(GXG#T/F&UP\L
M6&X/WCF)UFNZ?/_<==TF(-EKA80F&ZW^@I3]=_,8KJR<<0Q<%C9T(:Q4(RJ8
MW9%>I29R^[Q?\<P!W[#(YDP<4(R#:P=&NP&,G&:$HMT%I6ZH&9N@[G-2>X`_
M*K'8R201ZXU'@MJJI.E)[4`$M!FI+Z`?@DR^W>@D?7B(RRO(^7Q=FO`+[FFR
M8'3EUVJLTWR34<.A*$XZNK2QTX'#*!>_D<AF:1K`0RN-LT]G)Z?GUZ=B2\3)
MQ4\_G=W\='I^<QW<`2YNV.H3>0!$>QRWT26A_R"D!Q$9[..`/>O]<WPT1@_E
M+TNHNX?E^]?FX^")ZD1+=Q):4<X_S#R=6F>R.`AQ8N5*!W.+P\><>6D*$NJF
M724)24#&K6Y.2ER*/O1]0TZ>CUCV66Z'LU.I*OR")[0.56[E'G@OG)4RQX)/
MC?)Q`T.:B''I991=9-<%OV%3+-6H#U371`.@I"0$&"71>`_T$8_L9H,PAIOT
MS,I&Y83+$6'M^%QIV;)<)[V[^R`<JD,A(^6W'=YDI#9HD#,Y&+!ZK"LAEE%P
M6]>9#+EYB=Q'AMPG@==OXH0LT_4ZRG+RR+";<X%0MKAY!B^H$/4!W\D+T\H_
M_4(\53MU;L%==*>RCYXW;!;8]:1:.2&TM73*+M31!;9NKMM>2P2_P/`?HQMV
M'##2B+^'AA*;$`K&22CA4;N14=%,'1Q1MW@IK*.'1HM-AUVA3K$L/CPB9WF^
MH:%L6E'UH0[WH$V"G>9:S/O$A?_(:+6=KR_6J4O_[;L_?\?^[_NW?_WK7W=%
MZO]-WO[ENR/V.?__LD+-2;0I[M,L_A=='I'OOS_ZCW]_>_0?__$?8@[UW;NC
M?V<";]D_J\:Q0)UXF&Z*O&!_Q,G=$6'/'NF"+^9>/^\[)FU",1"5H01B433G
M9>@PQV-9:W58;K?&9J',%_0@W3%B1<26;"=DE\^"C=G2?M;11`,,#5>:4EK*
MC(<D/^=M:6PY0ZH?XEL1^;`P91.!G5`55CR>;S,P-";W)4QQN2GAAU%]GSS%
MYY8A!T(UY*5QFNP:!$HK2?>;J:7$C)%<.TD`P<8$VCCANV-O$.*483PZ<,S9
MAW1'U(45VB]V@R1H;)>(F()[2\0/Z21>>0KO;4L.;&LJ4!3BC2:!TDV&`C/?
MU-@QTJTA"N#;N(@;)\YW#0Z#GC+2IX>//?M@[XR^J</]XX;!C9\9\LA7S)C>
M`^I:]X.\O#46VW2^H(5VA1$0M:2RL_H!V3X)[RV0MIME3`+@0D(AF924/2`@
MC4D;]B,F12:N4;B*\]].,KJ,"_Z7DCI&B1Y]-!)(%#+ZA$4CG2$(E=3RL]9#
MPC\[(N7SZA_!WSX`@(:$<E`\]6FGE)11;T(0>BJ:]/8&H;$LF1J/@UFWCPLQ
M0'F$`[*)BZ-$[`G;1.N+VW5\)_S[L*%GR3F+(3=?Z/J)_L3:W*OW9]DJZ.<`
ML`(L-EIZC)8AX'9!%(6JFS7:DEWC(\*:DS@A7("4$J04"8;2MMB2,=P-GQ*Z
M`Q5)V>^*\8E#@0WK;0CND\LCT-:=H2HR!LPX2W*Y\`A(F6G9\<2J+^9$=<K"
M#;-8_5D^*S1O!BUD^^R!R&*Q">XG&KM`)D%L`VB:[9IMSQ(Y(KSI[FB1;>M@
M.&F!'AE'K<$GX:Q9AY3##MB=D-/-U0?*`Q%!0B86=X3\T%?JF2?>=FTY$+:M
M0L[4ZN5_6&NT0(`P$U,')",C6\(`*NH!."$'WS__G,2_;VCS:M>OL6;X:25N
MXJ52W`]##=YZXJK:J@-K5<IFS60J6-R\9OPS;Q/.Y*0=ALQ4AJ'02&J%&@"]
MH3B>D.@-UZ#DEHB8"-T2\4-BB5>>B-NVY$#6I@)Y@FVT")2=,A"8&:F&CI&%
MS;AE9IX.<).7MMNJV[*Z[<O!"MRFG,\:M^^?US*W9<ZYTFUHT1:[H8]'E1"!
MEKQ*=`&KWIT\N/#5`'-"DIY'#U1_8JQ9PD3,IH0?2O9]\D3&EB$'&C;DY03D
M#4([:1:``#/OE+`Q,FXG">":!FMCLZR(;]?TDJFE64:7PCO#.C"0E)1M&BE$
MQAE]PV2=SAB4>6H=LT8#LFT1Z/$!,%PH.`@%E)R'2FD5%^%(')./><%/<,^>
MX@7-/['_27+*3S&K/U(R$BC7XZ11#HF50/^P>&DV!V&F2<N,-REO42@_.2)U
M,['#O/XX%'I"02(AJ!V^^A0UR,M(:@O-\6CZ@=X6C82>Q7=Q$JWYI_.'=),4
MJA$D6*Y#4X`<"DW!_N'0%&+.3%.SEAG_1V.V]8C4K0A_<D3*AF&P%(Z1'DMM
MX=5EJ5&^S])@D.GI?!.87020=G?;U`>5;![9)XO6`&S1*`B3M`@EO?@$KG'!
MJ0_H3KKXM.W==DKF+,F+;,,W04#>Q[LIT28?LQ(/?(=Z[B,M`6S;TM^HLI^P
M=BM)=C)!OO%WA)PA)%A"5Q\=3,I,H<*:`E-%#;OE`E:RVACA=Z&`E9\^(L*0
M)0(P35W^![L\P`XS!I*[+0P`Z3!1.KPE`=P_\(5@^L82KGJ[XDOO"1X;'2_M
M4HB6?-L]".Y6+D,'2XEE?<^67$A.G:!NSN(.[7+Q![K(:)33CTQ7_$03FNLR
M'DA.PB"#'!J90/[A\<ID#D8QO9:2;<TZMFYU1!KMPF$>#"-2$MK`2\9'K;R<
MFD$@T\O>79A5!(CRR9CF[YRNR))C]O:9+..,+E@<.R(%D^(#LB@75W5E\>VF
MJ&=HHL>XB-:'CV#0O`PVAL.>E[%Y`V`6MYV+\3GK:O9VI/D7][<#&F70.9=P
MWQ4`T&0_S>+RYD"MQF%J91I$C_(ZP6`>#]P6+Q>BQ2+CC^*$)66:%^(]]B--
MHG41R+GHXX'>\JV##]A/GNO@-U0:6FMG(;#OG#3XXF,>PNX6295L?R8BN/.*
M3/ULF(R`W@*ID#)-1XR$)&_C&Y4M9TC]\^U+`A4H9`^!U>0!>9<UC"OB3<VU
M@POTM?`F;WP,'BQ7P2N%^X.#`)>_&[O;4`B!%[ZKQ$QE3A!+WMO3"XVEP#L_
M+[-X074C>"MY[>2Q5M[#5!W`7Q^3R7JSMC-V.FW]R>5&ZZ/F.U4A$`YS[3!E
MF*J#PU(_8:?18YJX"PC9(TQ&FZPC0OR?[2V1CR\3QI8SSWZ`/'DQN//RK)JO
MN8H*6MXS?$DS?JQF=*>ZN-)>@3:5Z15X8#S$8Q_)S&#7ENI:=?UT5C<GO/U1
M?>7\3B3$4`#"EB$66.!3'PITBDRQP`KC8X:"<A/;3?1UGN>TR,^I>JF0NFF/
MWK*F2$16>X%%6:D%"#DE@K/Z4\(^)N7G;`Q(Q>8O?D%F>5+C?+U.OT1)./E8
MT]<2NAF1T2=67T1&H5%Q9%GMI46TAE1["D-N@.(U'/^MEC6LXF21/K#PP]`5
M\4:'`B!`F>8*H8F+K[Y#QD6:9A%`!$9?L&GVRE]$MER\J5&@CM#AK>4$X`!$
M+O"Z3K4HC&HC8L[;BW>#R6'P*U^R*&+YWPX5=T[!W0UY807[BT?*;ZM([CZE
M>7X29=GS*LV^1-E2O=+86H,I%>@T^&&IV6=/B4)KV(&X&GWR-+(5(%R"M$0"
M)3<`8&:N@U%J)+Y:$R`.A`3UL?*3P0-4U->CD70+\S6'^8*W(56CEPES^PSG
M">AAY;_MC,=VP@.:]]22IGPGD_1#?K6/GO*;U*`#PR5ZY/EL?V:L-'@Q\]H(
M-B.;^QH`+)X2J<#T]$.)U83>\3ELA_2DL(P"6IZ.=@B-7A9"[3,.$D:#R##\
MJE>:Y,*S3W%T&Z_CXOEDS8;1\2JFRW/6/QO6+C'-L5GK460?"SVH#+?V'S<S
MV9B'4QZN=9>UFC)D*W1$=F)'9"<85HBP!Z$R8+CB614\P/K4H21X:GA:]>/B
MA0>.\"0YK_;J+)HD>8R>(WXR6)R0O#P>*%V5NWY>V0%.KF/R8^+$^YCF<:&>
MMVP_[J7)^C$2Q=O6L)+:5BN$AU7C6?U7**SI=(2$#-*NZB.\;"8#KI?.]#8B
M::B']VOYHF8_>Q80O4Q].W6LR>@B+H<=R7+^D&9%_"_=5;H`B7Y$4DM@X=KD
M$UK<TA@"05XI/VL^Y.>O/*YI.=I.EJ394E37CUFZW"S"N?8(`@L9BX!8DM!*
M)2EEVG0`]/9R0F]Q$!:KB+Q]+"`8-1H<)N8@P1P%=<&$?$",!P1U#R3R%[:M
MN=&F0GC(AT'=`MEZ*$^*W"Q^8DX\T=WJ[_P\+3[0/+Y+>(TZS_].EW=Q<M=H
M\&,4)_S=G6[]-9+>'D<&ZT4B%M+WPV+C<'<@%!YJ9;93T=CMD;/JJR`[+?RL
ML4I/L]41X:K(-US9G\2BQU`B!Q;6)>$&ET;]&#50ORRP'0A#/4VL8G@U`E7%
M]LM[9D1,L:ZB."-/T7I#RT,"MR1>5U-^<3C7,X1+1D`Q'!X=)RZL^]Y?Q?EO
MVO/=S2*`HF(GXBT:=;WR5PHT++F%CJT">0(/[+!V``!`Y%;`!L+:6A1&2"78
MIF!:S?V+9/<9I-`WR"DYIY1#)I[!/VSVJ<W94%"EI<'#5EE,Q"T*NT<!%LDF
MG&BH"8.8FI\*>1U))T:GM]=*$+L(0-W_,A(?KA9E(!Y@`RGC3O@1XM&BN&$F
M#8>ZF464*44F@LQ7M5?8B41JR8::$@7-,JY^'-PQ;P``:,AGA(V:=7U1'>$`
M8)N":?EENHX7S^;C;$T"2I;U!9`YIO((FV$2.S;\ZHDWV)4?D?(I^5S]-\`S
M28T(T-#,@!HUR;J".HJ-CC3/<W]2<T,@5[Y=?K&@LZBHAL!NVAJJNI'E)_IP
M2S-5-)<VZD;P3B,<+DDM(T7JKFX`5=HBL_K?Y'/Y22@TD/=7'_JZ?NV!O=58
M`G!]_X\)Z?K<Z8M5<QWQ%5WS8>Q)FA>YN'+T?933Y67T+.:FC14-CM8>:09J
M16(9RG?#HN509R`\'F9CUC@./EVU]]E4.HA04MTR_.:6ZR&UHA"/D$>"MR3&
M8/*F'Y0&:9=%L0,@I)\Z$\$G[\SD%>OUS<7)?Y*+RYNSB_-K,C__0'Z=7UW-
MSV^N7ZD&0\V>D&WBPAGH^VW3=],I=RA*76L,A=)Q(YKVFXU<8:A\00QC<A.:
M&!;>B7PXF'6/9A`N.(<RJ?(!D0S&L1'#V(;>I!>K5;Q@5<!%=LVWNMZGZR7[
MUTFYPW*>`$X.<-/2#52V6G`BDYOO2*'(VC@@]ECJG#$!CNA:A*09:0H%$F8<
M(=:/*X.PV@LD=MHDD6,@Z$<.%55`NXPR_E;=-D3`I66A`2*-%Q+@OB*&`I!1
M8`@`Z*JI7\]95&T#8KP%8N1,MX:<E.%F+0IF.V!V/$:?1ED2)W?Y)<WJ85:\
M8,Y]B-<;YK2"R4"I#H.-4BC,!?J&PUBS,3-333IF=0-^24DYF7A$1".QU;-J
M%@9AH<#H$=4.45V"&J3[Q`P"BE[FZ"`V!V.R/O!4G.;[<E%IG"[#QN6DTUU=
MWV#+@(!2AE3A9YD&T#<_J<)E:9!)AS15A+YB`XH0(SOM%@P9I,W<G`23H^0,
MMT5$9BTB9YR5MSM4NPJV.#UL+%IGBJ%HG#93K%9T46Y$XGU]$WWE][WQY:QQ
MLF%.5\=TIXEJJYV]@F[^L%"`0UMKCY&RBHU=`(?AZF;;MC6E^0G9O#FYHIQJ
M\;H^'JFZXR\0BMMCJ\]V5WSV:`]6)(D`X6+<RQ5REN8QP<YSUP[N_&(B]B"4
ME#4JGLV);!1$!YC>VD&OW)IVEKA?_>#)"BA1#K#B,=(,_NX^4^X0YUQ#E;M-
MB^2]VV0IN0I#=A/&7N3[X3P"!E$LPL+BK+,U:#`^L,C@Z<!''UZ.'B2"OD9D
M7UGM6#^%R^O@*[%Y\9$N6=VXYO?-;Y@CSZW&`ZHOH&:'BLNH>;18"OR.XU56
M9H=P`J7)CD4%%16DTD6VRKI">U@T0>'O%%+MN.421`T6W`+GWA!WPL('XMDH
M'.8%3I^8^S"[$PX14>J9*:@8?-W"/KRF!?M-Q3IQ_B7H/%E^8DZM!]0L`*T.
M]8I6ZV@A#_#=QJM3],[@Q#>=#8OZA#_8Z3D2L9"*53Q"U1Z6)A"4.T5#.'U<
MXJ!&NUL,#)Z7$Y8A)J^\4U1L5!548R7'$4GX!>(KLJH*DEN:T%7\RCD@?/:$
M==-6'0^/Z_294K'!Y.*1NZH]\\78OELIJ-OCQ!J3/TC976,&$!24TK/Z4;FU
MBI0/`SLWQMSG?0X#8=+CIDI.PCHPLB9@$\V>X@7=;5)O;OX\3Y,GFO.ST+]$
MV3*_X2L=FL_YKM#SM/@'+7@(N4OB?]'E3E,I=%'<T^SF/DK*+ZY<,S6U/ZIH
M,+X_N-%FJM\3.9I-\#4LHN7HWC6B<6F[=4Q/4[VXPJ]T@)3*CMK'_?`[9IY9
M];:SWC[SIQ0BP@52,!^JT!_()KO)@:Y)*1/',F7*&MLO34I\#:]V_OM903_I
MMPDXSO)![L])MFW?OFM]P32^!L'0@J!Y5/T:!B=>@>KK6X\]MAA[[!!Z\MJ3
MVG_:G(-9NW/]D@+^P)/2!$EGJI0R8LH(/;CL5^4[=67[XBO7"8+$=)7GB&'B
M,"O'2YK%Z?)CFE4?\79OQRXGM4Z,56,JG`@[-VA_N<"K497O$R8/N4O^ZU:Q
M5H=9)JLT(PW;!YZJ]+P?+W]!XL]H*4WJS(AY[G#BX'X5SNJO$%I`-)?81^1Q
M%\^RUW@60CR;KD@/,J)-6\[_OHD?^3(S_4(N>:MN0=QMA1.IY;:12LJ><D"(
MZ\C,MA^$MA1+T6M]^FN[M\?.=FL)?0PX&!?=Q3-G99HP?[37^FK;2I`N:8N&
M=Z4?>*B7F8!AOR\Y*S\FV\\#N[!7W[52.IB0("-%3T9.#3-PQB/(QRC.^)9L
M>K'Z&"=1LHBC]5F2%]E&+#TNSX13$,9*MD,@H"P*H:S\Q"$8U*29<#!-,]Y,
M'*4B[I+;MB2-IN&?XVD'J!YM7?#8I3%(1Y_6P<'9RX`3;AD)UV)_[0[9/]&(
MWXXC&KP<Q!I'2SXQ.^G8Y.SAD?G(O;E8G24%`U1\NZ;E.2*G7Q?KS3).[GY,
MT^67>*W:TNJDHY.L+'6@L-S);YSD96O:3'8[C;-=<Y[,=@+UD6'?;&5(+?2G
M,.*!&]IZ<6$(:+O1P4I7/TH$CWTOF<[>`V02\,S7ID&\HT'$95XNX(T)<4S(
M3YL@Q192L3^4NVNX&-30NIOT5*UQ**[W!2F1*8T`V*J0G9VDR9(F_'7K]F'.
M^=DXEC:TVS5-'=^G(P@I/=K)I20$`T)K;"+=1%]W=W""R*25D!)*(8%(*JU/
MF,12&8*22RX_:QPVLGL<**?T_:_@%00T<FY))57\@B%M`HZ5QW'?T63Q_"E.
MZ!F+`JHMR2`9%<_D,KA,T_F%S#6%*0NV234T^=9H0#[S)D2T"8UR6C"H20?`
MD))V,ED-\4#0FY9Z-Q$K:BUHUVH/H%S5WAO=6O[XHUIMQHUFI;228N)QP.QJ
M]SF(63*80%@EY&",DB-KTF+1=(<=1,1<+F+?%`;QREO!:'=OG5:!JF0,[@47
M"`:0JA%Z19U.%%0WJB$W`=]H?AG%JAVFBE8J5M6M<(G4MHW,G:UR"[I4,@V&
MT)SPCP(C1*?3U!R0]JX2]F5K#=)]PL#/S+3$AC4>Q.QR`Q'[#0;S?+`E'*:>
MT\UHE-,/M/SO[@Z%YN)2=1"T$.['1I`P%E<L/$6+I#";($)!5,WJ=N2;NN6?
M6A<A-5L'PT(;",G(:0]!"6,!2J1$#@W"OK(`U#06EGG.F"\6V::[R^(Q>A9C
M-P;KG"^4%V]#6(L']BSGQRV^)%Q#<I%'9`>6N1A>T@U?2U1"Y(JNHX(N+Z.L
MB*EFRM=%BS&7&;1XB@@@WWUE-Y-QE]"@UZG*=[44J<2.2"5(*LE08P0,>X!@
M80-B<\S0:H,$CP#9X.DD=Q<OT(E1)<^2`W7"9-V4KE;Q@J5\<5?"*LT>:$:6
M<487+$2_<$XX9%*_K`@LMXKCY*J"[%,<W<;KV"JK&N2-^50I[REV&/SUE4/5
M9EV"A$J;*F^6)_[697=#(M388$(5("K`@&F.!@H]D#@0"+9'RX@Z^X@P;PXA
MXX0-=6E>B,S'QB_1NGA^>:!V2'+XL`XML94+*9.[D^@Q+J*U>2&>I0)S:E,J
M\,5_@\?>DIO:KA/M5>J4Z:T6()5$B,O\;-$%B08PA`*"@4(1*!J$@O+QTIS.
M`4S`\T17WH"=<YA'Y;8EGNG6N[#[MY>(<)>$YP'CH:6\*C$W!Y_S9(DPN@-K
M!(_W`!H]5\G@[^1[3`AQ9$CY;-9O'#>V9EU%!-K#P20<Q!:5N"TSX)6Y4;--
MK;X'=!M]F`KSR"OSI!.ZG%Y112_ZE;^4>^66"3*!LRNP0N'#AMZD%]5+`^:P
MN,[P/ETOV3_A2X(`2LQ+@[1*?*VO`'CN;:F0WK;3,@N=2N72H8UX<W31?'/4
M%`PUX(!0!UEU`4<O8.V%1AEH#49H+!AKM9')!6PZ\'Q;(;]^/_J2@>ZRS,@C
MU$/,DHZ+C32RL)PXTE(*C9]>,R#*(B*9)D.^VY/U0CKX0#D_<&V01`>8WP;P
M3DGJRXP^1O&R7O5X6HZO6"`J:WDQQ0IFN8TR(^UARCS%`9MOXBLP`'UPB10@
MU:K040F32DJ4RM7,F!`,-8A8H1,051S0;@XS$*60N!,\>X`E]0\E?Q)ZQR.H
M2U$-=L87D7B177.FGK\2I%G2QS2/7PDCAT60E)FX)"\7]U2>*=.RM%4OWW9:
M(84"J6VL#-E5#F%L6V96?U!GKU"X)^\S":ETG=OG2JNUC`0CH,!;I.];L09$
MN66W@@0]!$@``J@=*(((>=H3"OI-%,$.=5-ZWRINF+,XE:`AL$-S2,<12'I(
MB6/0002[IFK\>NIM3W/!'0-VW=X,8_O:Y^#`9>[UB4,6O[^*G\!YPTR=L&1V
MEV;QO\1&4NUM4'#!7G@S"R+1`.HA5B@$V(,PQ:AFMFN3!W;+C@4L)/RRA%2?
M<R8%,B9:PW%$=EY>Z$G8?=[EVNXY#J6Z]I"8TU`+(,BV]8S]&=AU:_T>Z<-<
MT6D]--?M)*!5]NN(V,SS3<1^CXN5>`LX3Y:_1ED6L9#T,<VJ2Q/SB^QD'<7J
MHUU=='0Q;J<#AP<N?B-QQ=(T@$]6&F=U<W["AQ`0LX.UB+ABM18B[.]2+!!R
M.L&M3^`!J.V1W$:7)!"$#GY?ZT*M?4#F@=C=T3C?AL1,FBX;^_D%$_)*[.7B
MWSQ0&I$!DPZU/J7)'1OU/7R@MZ+6G'^-57E1U[23_N1-48BN\P(GF2DLF+DJ
M%9SQ3]_PCPG__(CP)^0S?Q9(=:CMUQ[/`"CHDDDFTN<,"#/3$4-[0Z^^L8$<
MJ'?TZCWQ0Q"+6WH5H@J2!#6)8.AC(U%`E_7*A<QDF?RZWD_\!3#+<U<T*:*U
M_O6JMFV7+/*V.%S1^8%$%84)`%.DDK/=QG31(.?GE26!O8K5]V^?*``X]'@B
MDY'09&ST>'FSH;;D"",^3O@I38K[]3/).'R">FV+`1]C@3\$0-,6[,(C/IBX
MH_4$L;XV,0I(0ZY<`)$Y.H\P@Z_"#I0Z4O&9>$8:#\,L6<Q=KZ`3`"YR1LD$
M5;0"06Q:9NF&PX;F`%9A#HL-WOAC%'QXK!)6LRFD4;*INT%,@HR6%6(P%DT]
M:N8N\;U79P^/6?I47D*J?5L(D)`Q226!1R:]3XA\4AH"4DHA/]L^),VG@;V:
MA'2_G%D@S$C))9=4\`L(M#$I=A>M?XJ*HMSMN+M^+*:YZ;8O*]D>[4"R2`2T
M\!.+BC"3$%)"-,U$,U*U$Z\K6RT#O"3,#CT2UMJ#K\]?@`X9DUVP.S*G/U+E
M;N#><QDWR^=X_&O:0^18I1;((]&ZX@K_.R`FM/I#CG9)ETD1S=LI4"OMU9&1
M><KH4CSS\O)B=<)/IJ'98Y05SX9Y!["D#,TF23R<PWQ$9(#1()`;!CT5:\I6
MY8`J79%FP^"F*^"(D?/-"FY2)NHU*#@:"E8]K6N!6D:!+9^;?@6NJE]'ANZT
M,]V[P\Y.-AE_3Z'*-,J&W<0B:8C#3:4'2&E#IA]`M[[8K/'9$:D^#81%ZF[L
MD\;4Y3V&]`0DA!@/'I;O"=,B6@/BM-R,"TYX%+[A5FN(A'<JZS"XF$.J$V!"
M"9B=8[!.?]^P*&\.GUHQ=3!5B&%S1^L=>J!56;.BDUQ),PB+F9_R\^!XI8>#
MCF40(&D8)Q77\F]*"/H.YFJCP[&X"_1=3#;;_O&%(-0F*R!A-)2,424PPYTV
M9@%CR8U\FX?9(U\EN-6=-!IQ:4D>W'TS@)X'E%W`^V34@I`B;#2$^9IOT1L<
M`C:Q0VA_*OHA$'.H\%U`%DK\EB87>#0'B5N.`/SQ$.3M.","URR@5Z88(82<
M%6`(LB[)[#.&5HU]@381BOVL)+<QC@=G,:=_-G]_]NGLYNSTFLS//Y#KFXN3
M__S[Q:</IU?7;'CQ7S^?W?SCI6%Z\'!C.*HG3E\+<3[D74;+!8PT>S"L%C1+
M])*41@*)T4:?L%*1SA"$KFKY6?60;)\2\3BTY8*`_I?0$0J:/O^4DC+*P9$V
M.L=.TEQY"KFLB9Q%51-,VK2LHO*DU@PF1BFP98+X9U"P;_>0"N>R?E0`6S15
M(EG>VV-#-T[NMI2")`=->RFHI>T1$:[Q!Q/N<C-0[,ND9]M'NZ009C[0=;F"
M)6:4R"DCD5/Q9P)@>9N0TMD;@+%R(^IJ%1=\.JI3@!P>P@#U_G",37Z<#*][
M+AF&[R.>0AX>8G&0876(X?/%ZJR@V^=+X[$:`[1)SMUPTH9V,,>`[X)W<H>;
M$["C/5QT-\[^J!^1G>P1J:7Y&D`NOVVU#&T5X$"T2D\0&0[_7HQQTRH_@V3O
M^.0K0P[PQANUQ+3;*[E0R65.X1/3*]#T/W_@BXNM\WQ;#)S0:S'/D:;MG>\4
MO;4V)&!42DQQH6P6.O4[Z+#@N!17<"J7XC:<'161?MX=08P.AZ:XZJN&Y&+[
M\-"A.""ON((QT$SQ_EF1WPQ'DP[0!LXK!FV>R0WZ+KZSD,F)(1%`KWNF*U9#
M.BEF(!@M8H<-NN$!1:O5)LX$3)?1QX%F;[PQ1RSZ>^6.&SP"9<_$R3O/=V=H
M/'^(\\4ZS3>9^OP*HT`O!:L%D,*&R2.L1*JQ`V&\4GS6/BYF]RC$DV/,_2]A
M+A`S?6JJ!&7LFPQGG@9I6G-#`"=F$T]_G'\BEU<7)Z>G'\[.?[P^1'@!8C\&
MP(**X-%#=$=S?O'?+]%ZHSRX&R9EB.4]*2]$4_CF)ZKWC=DSK:MCQALTS@1[
M/B)5&W$OZ1$1S<(DH`H81A;J$64B8D?:S$83%"<CI&GCAKZUGH#8"]KUOG@A
MG-VF"X5L/YN%M[W"T,\F/D$W3\BEC/Q1(FDJWO#C_*+;-2Q_=1MK6;-K[($T
M74]\<*9APY8R6]%N2BJ/J>2/@N1+KX,-=%$`0L^66LA$%B6`IB[ZKM/-W7UA
M7_9)Y$"%7TO.8^DG\<]G\=<VYUK^-;5H"L"RV1Z4@#*0`(M`-;Y@96!#'EH(
M3@#-468!Y%81,,KG!&I,YN+CPP>C]?0`!AP#FBQ@B>Q3G%`^(PV;[I4)F&JM
MAH"?>JOGD:>:JVG'H>[:B4MK+_Y8O,X)Y_V-L>?-19@*+<9";"L(*,;4")MN
MT+]89)MH/2].HBQ[9A]:%&5Z6<.$@$+6R_2`UD\_DP4JD_93!W)-O4*-5`U#
MY*0)*<8I!0C03!,,4AWFZ8;)<3I&M::QC`187K553\1]X&MQW')."^9<2&OM
M_,/6MI9#!6Y8-=W[Y_.HV&3B&.B=X[HE=[8*3#6?1H&?&M#HL:>:4&?7H494
MJ^LGIK)E8$M^K(%D+B&A8#26E$I%@!(3#NC)2L[20<,F3*.$OKQL2_A(UC*?
MO)22'4/6^;@E+YG?J^D9V-8K,P!,Z5>#&D/*;4H:$ZT6:N.1[*?H:_RP>=`>
M5B%MTR%2IPT*=:1V<<C256VF1UMB5OTSL#,FY#W50[RN0[L8;[7MHUK?[R/B
M.$[,.):UZ>*XW08'QS*[2#CNJ`;@N"4QJ_X9&HZE/=7'L:9#>SANMI7@6-OO
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MME)J^,6#EZN4^A8L@<'#.X<&_WM_NQX24,&=+PEO&-U_;-/]X%W9?1NV`#@N
M`;#>;P`<8P+@V`L`WH$`\$,)@(3>105=V@+@G0,`WKV$Y+#[]3$`\BZ\&9^J
M3/,SX^.H'#;C8ZW<YRC1\9MZG?&Q]\EY<&AKRC3CL]5W.#,^KER`CB6'<0TX
MDK0T`AY)[C.7/9V;@^C<6+26S?G(F/S*4Q=T[253PYGSF3]%\9J7I3<I/U`H
M39HW0+V/\GBAKFU<M.CFC2!:\$<2<-\]S#V!C%L.00`Z94.46HICOI1KW>Q\
M1(1H,$'*"7SZ48TUBK6C'K,VP[@H5#KXGWH#^H#.B^;T76_,+N'$RR:#W33A
M"'28.JL.*`R\3"!XF3@(8I`1TD3!"",)S(F!8&(6!K"11Q=>QQ388XD@B.BK
M%ACJDF]&UI6"X*2@X5ERL(-Z7W3S/(C')ER(Y05PK8F7%:E>5J(&L6HMI)6G
M(RQ.PUQI&G2\LP4V\H(UK\O4L)>G!4'$,<L+&Y=\,[)57FPY^?[Y8->*^J*<
MY[6AV*0+L<0X2YYHCCV#8:D45F*`E?J,;);?S&N)`??%.:!!39A*C*V>/2\Q
M;($-C7=NA`%&.Z!R<+3;)R*.66+8N.2;D=(9#!D+7^F&7UY,1+@]+B_<5EHZ
M*D<M-\99G>7X34,H/S!66MJ:0BQ']F6EI2L7D$/FL)66ED:P`VB07!YWI:6+
M<V/16K;2\E!+FK%XZKG$\<W4$$L>R?NFP>L_!J_U&/UU\E1K.)#?#CNMS0@Z
M`.G0->`-,-J[WB'O=2<-!E_FBP6_3YUYQ%Q-V)\+<8QN?IFNX\5S^;_\2DYQ
M(Z<R)+BIZ04&6S5(X<'->ZP@86T=$BHLE;*`\87L1$A;YHB4[<GGZK_!W='J
MC$!)\!B$Y7X(L5,G"R1[P0I/I^DX.(%/#U[#7]$%>Z[FR$OG`:`F'YL)T];9
MK+-8_O^)9G<TNZ)KOM?_),T+95EM:M]-ENKV./PW^8.4_C1F`$162L^J1Z1\
M1JJ'1#P-A*O&'N^3$@B2'O=4<A*2384K/PE$:VT`P,2T#ON#I"ORB0WN"1O9
M)SD;W/._WY"L@MMCE!7/AP<W<[!'`!S>*3U*"YY.[-':&P*Z8PXZL>4KYQN-
M2)SG&X8R?@]*%X0'"#KC"4`8H.N?##1JS9#6\P/E)K/3KX\TR:GI32-4KE]#
MF.2P"`CS#ZVF,)H#L="@9=9LLMVZ7+7Z4WCOX,`HD7'2"F`29NKEI0P-`YN^
MZA*`5020\CKEHKAG%7!<X9-6^#Q\4$*J%'188E8M!DO>JA>`70QH'K>A^0(`
M":A@\`$Y;453T/PR>F[>3-\K7OI->G5*LPD2N_I6L:J/EF8(41H",_$O4OTS
M%$I(>DB"?F4_]F&^:RI#M*:W1X;NF1A@O=5!M]-$!MUM$SSH=JPB0G>G&0C=
M6J"";OG/@)#;[2`Y<N7=*$5NU52!7'^=[:D2[1BPZW5>7WZ@6?S$$M`3)>LX
MNHW7<?%,,KI(,[[P8/.8)F*B(F+=Q:?+6+^Q8J2(.?D3`9DH69(O499%X;Q'
ML08.H-B$0F?2]Q87JU6\H*>_;^)'_F9%>WV6MFTG$"K:HI!$ZP=.:%29,+-%
M+CDK/R;;SP.[;TO?M3TF0)#0)814IL\,&'!&)$A=;7^B44[SCQM^:V-U61BK
M6L3KR`\;RO=7/M%_T"A3O?%S5]2EEH,B'-XY?P,D4KK8!S#67NULMZ*N%#HB
MI1BIK].K!8\($V4C7L*%B9`.A/'N<.R'@Z'0[L4*:X620+(_-/%2Z3FZX8,O
MO&IDX?6'5^1GYG>ITV`?;1[3P;2?B4U'1[S@__@5__W>#@O_4TZ;;MVMYG)-
M6TV-[5458[\]+N=5_B#7?Q(S%K3M23>JN?I9<&]SS5VNYJ8!)4H"=N4T/!L;
M6)XV'.KM#<!8O7ZLG/RJWLF&-A)`@!:\NAD`KFDGS+I>06,T-#;[HH[G6.S&
M#UGL#905%FRPY0``^[Y0X>7L&;D5!WCPL'G#;9+%O@1/"YC8!TL`4,((CL:Z
MFT$59[*TJ\AYLG2G:.1Q</<;C#U9VK"/.?C=JG69+&7"^SE9VH/C@"&S`MKN
M`^9:X9`!\^0TF7BRM.6&#[Y4DZ7_\8I\U,E23.Q/,%FZ-3WU9&G+$2_X/W[%
M?[^WP\)_$).E)G=OF%6<-_)]3:Y59E/3N!&D_QU&KC-;#B`&CH9>ATI32.]E
MJ2D!I7O$42+<.>#L-`Z(."'09=IZL^.'%]Y4%>>_OQ(`M^9$IL#X56?#]L1E
M9\<3/S0X?J6!K,=#H\%^%)]?4IS2LZ/'N?#<ZADYA'3\'[OHW)G'C!FU5I>"
M\TNZG^5F%X@#@HP<T^X!IM(W)+Q,3(^)B\RF%QYX4A68?WV%/&)QB0?Z"0K+
MVO+49673#Q_`/WX%?K>G0P)^$*7D[GYY4['8;ZDJ!YLM<:G=]P&YI&L9L.!D
M0ZY1EM7']/#/`SD#1=>=:J(I^UY)I)V$ABIC`,7O&J..'2?$\`)%_%"\ITA:
M-@CFGK>A@($7'9:0"6.MD5A7.T^6T`69JO:J6-IOCTL4E3_(<55BQH(K/>E&
MC-TM;`YT":>RQ]7L,8!$R:"NG(9'8^/*]YIYJ;T!$!-GF6U!5B_[)-_$R6*]
M6?+/_NT[@;I_>WOTW;]_=_3OW_T[/V\B29,WXBC@_#[*Z)O;B-^"P2(6%Q=1
MO5Q+&EHQ@(!1>)P?@-(P8KZ^PC_99!G[<]C<:T>)V\3K5LF8X^N.YZ-.N>YL
MHPVG:Y7PR58^UWI$SOFM%3=?Z/J)M4B3XCZTM&2'/]<QN!S'CL/O2IGSV'M*
M/DPYQ]IT`9L8U>SJ7UXRNK'F59'P/?:,:FUVTNG4IA/H&#]^Q3C6%"H6QH.8
M/-6[.JP"'%;ZC1L!)BGV,(EN6=[M52`8'`%PB._,^'&A['>Z&&`;#=/;[:LO
M"ZU8Q9@S7J>=H\CNHB3^EYAJ.DF3/%W'2_&/>;*\9#QA/HI_7JP^QDF4+.)H
M?<T^*2\V,QW\@JF[F]9P=.-$"LSOB902D5P"!!<42[,?3\]/K^:?R,75C_/S
ML_]O?G-V<4[FYQ_(^Y^OS\Y/KZ_#.^,&%=W]Z.6!/+W(AF%#$O>\<'/$F,CO
M?>!76<6%<.E&<T&`MFTW9LG;XL0@G1](,45A`A`CI)+5_1J-S\EG\204@FN[
MMD]8`!)Z!)3)2`@U-G!\O7Q3VG+$D%@)$2_XJQ["@LMA8\E<J`Y`T[1%:,>C
M3W%"SU@^4"Z.,+4W!-Y&>R\<ZOGC)P`WS=@3:"<M"\3\*1&/`V50O\^-+%+!
MQ,2CK9R92Z,A:Z0(W;8W`&3:2'W08+,.VRYPFSY\*Z_ZTL5PHY`LD&N$\#AG
M]`PQI.ML`2FG5E$%=^UMH`&1SHP(.?.@2)*23RFL8."T"/0SXVPV.12*N^,1
MTX#O_/2#0E@20,/A].G@4QHEAKL5E>UD0;_=#H]E,ON(H;VC'DBAEE05P,5G
M85V]J.Y`.3LT?2VE0[.]@@%:6(P,^4NFD&8975X7Z>*W#_%3O*3)DJ]&G2__
M]R8O*S8=%ZP4R$@"5(#''BN/$6D%M0OD&TQ=1<1M8R):DVUSL;J[(1`02>V0
M)6>O"SJEM`8I4O`]3(0#*[(?2HPG]"XJZ!)8D\$=P`1[>7,F?6`H7U8M2$;7
MW&_>,[<TH:N8O[BI+LS,^4Z%%8W$"IC.-9J/6\+DW.)+I`6L_/-.C$G+PGK%
MPTWZ<9,L/Z7)74&S!Y'`;]*K$EN7$<.,<D^<@X9.EK32@!)$''S&R9-VALVQ
MPT;?;+OVC8&5-R>\_1LN4-6Q[/-*AE1"880%%XCUXH([3KMAP4)3/RX$#79/
M*=/6`U3<\Z0Y7S[QJZ1%=]0)\Y$]?GZ9^#8FOK$0'D3J^YAFGQB2U]>T8#^&
M;CP(D%"D-JD$*KLU/N&F+KDA.&5E\KO4M$HS(AZ3QO.P6*KK?24KS9!1<5`B
MJ>8<!&=3%)?SQ>^;.*.7&9\9+9XO&58*OB&XOJ+;6%M"%2A+2[,"Y&0+]1B[
ML`38M<FO1G6MLK)J3>KF1T0(')4G.]0R8?'9`ER:I&L)4'7&-2G2)=S@0.Z]
MH`0Y@(EW7DY>LE_HGF\>X),JCU7+\F*QEPQQB[+2)\B#*"HO5F+*YRS/-WSD
M(4[`,"0YG8@BK<E%4#FN\PHW=2DLP<DK5;!+3XRKY;N!ND%YZ%!83-6"0,E-
M`'147)2)JMDW$>"\'+M@-#@,>>+HH=6*9GQMS^*0D0:.^\.Q%DALKW;(5"<;
M&>.ZO+DRIG>;(]-+[@UV+.]9L6%31[@5P[?/P@S?BK[6$$J+#C65VF(Z&AGP
M-,5\P.G#XSI]IH"72KV6RA%^HR7R**?G`_:8O6G`9K"RDVN-PK<?AT4.66=J
MAANJGE>/*K82NN&#&B8C$H'U\'GT0#^D#U&<J#@@;=2%?Z<1#O*EEI%`W]4-
MP'M;9,;_3?@'Y'/Y42#[$Q0=UH>XKF-[Z&XUE@!;#X#Q,3W_&BNCNJ2)`L]E
M$U0T-ZWB8KG2#$>R$&CBF'\0&(I;G:3$L*0K50CF3=7XE7;XB.AMK=2YC+*+
M3.Q^7_X2K3?TDF;7_"18%:ZMA+N(!PKC<,'*4R260&T"^`-3->NL!CWBRUE(
MFI&R,1&M"6M.1/M`>&<'HCXC74#8XRI(B83%X8'8TUY,"^-8>!:O'-K+-8_X
M\A7R)'#\#2L+ENEZS>\S>628%F=6![)O9QQ0FR>@O,)ZVDFIEHO"+U"6:K74
MIJ2JI0?JMGSPD6QJ`[9,+.7Z:41\?B1>(-!EB`QK]ZJ!3C((Z)E3)DX#33SC
M992XOK/D!!UIQ/ZW[_[\W7=O=X'[_R9_^>[HN^_$_Y=!.R?1IKA/L_A?='E$
MWAW]]8?OMP^2)?E+\X-88%!\GFZ*O&!_Q,G=$6'/'NFBB)_H.I35C0,1:AG=
MX1@-*&Z+/)*7<044OF4"VBC>%O!`3IE'/F)ZQXXM/UOB_0A?/@XXPDL[WD`C
M#5CT7&H*FB@U*L#\O!#6FQN"-&E":$7R0\2:9>1V15MP<7R^S>(6L;PO!(CG
M32%OE.M[YB^NMVRY,:ZA0AG?=VW"Y9T$$"#N*8$$8=].&,;`D0$X6MSOF!R*
M1%W\CUX$%IUR@3L:@\L)%[M!FD52D$@!LD)+RALK);[YRPMM8VYT;.I09H9&
MHW#I*(,%B(]J/$'HV)"&\7%T((Z6'[HV!R-2ER'2EX))IR0Q!)4!I8F?Z,,M
MS4"YH=U4FQ#JIA[(U_;"1^C?6K!E5R78#?+D<_D@E)46NDXU4$<*`3U;2A$3
M1;P#9I3Y^X8I-^RTP_%AHL<RVMK@9^JX^AC%]6W#\V0ISN*9YSDM<OVUOA:2
M_:AKEL3B%-1'M)@,,`BBF5'/K&I4WP(OWF^5)[R5#8](U308$H(!(^.D)=HD
M!#5ID/(U'*CZRP8@RRBHK7*%P.WVBGD.W"5]3/,XF#TJGK$*22=>T#IQLHF?
MHH)>KJ.%.&_#4,;K&O=2BKPQ$C5UGF`E#H4-".NDHK/J<[)]$%Q1INU@":T`
M@.CS2"8DHPX(0&-R)5U0NLP_LM_LURC+HJ0X_4JS19RK-X(!1'J\T8D@L<?L
M%1:'M)8@3-(HF-5/"8<QJ9Z3;8-02`7`@(1:8.3T":86E=%L4KQYFO(T&!P&
MO+)B:D+O2P4]>NC0`U1)6."3U$4>X'=L`S^+`MY@<B``C[L`9%6E6(DC#@81
M9R4_/*1).1%/-H_LSQJ:_&D%U\-%Z?%X*#T.I"(YV9V._8'>JJ>(C!*:>J0G
M@<Y/A4_XU4C?D!TEN_(=/C8>$_X\/*:I>E]+-#UD="SK2.I)-CK.O%<A,GN#
M`->O0?HI8`?!)"UH?D02>J!`M"I+AD!QXLF:G5_UN4(7V76TIA<K?GY<\0R(
M^GI!3?!7":)S4^\A?BI0VK,CJ$)-AZ7;T]OX?E[6CC.U;!D>,PU0T1(4!#,=
M2^4*]&0%0G0:QC;.#G\&5F@J$0U+^R+H_%1YA<],B24[3O84=-C8O"_B.=!"
M30D"+?\,T-$QKRNJY]P$@/->K4D-#D.>N/RHW-FWC#.Z8`'G4*%F58P-`UMX
MY=CJFBXV&5T"([Q6#E*,M>7\U6(R_SR68AUSCI582XNR$%N1JEF@"4"/$5@5
MIH$7J`AKR@-KL"F0Z3TSJ*TB0-0\IL\KH#ZRA^SS-'L.>FB/C5RKS(*%W0!S
M3'O-XCQ9EA]0]E!\8I5XH,I`V<BLS&,@@'X3GWD+X(-KI#"JUF2X[F)@OKYK
M)UY^&'+\`(,4&%0L00^+,R:ET.`3-(F\+7ET=L87G\SI^+&[XRGP+#PVBQSS
M]5@\"C*SMQ>]669RN3`P<W>%O089N:=^,W//IGODZ*C29M[.FL^P`X0"0>"`
MH$4@E/YM)7"Z&Q`\-;E/Q*(<^PI=(@>B=$O.(YLE_ODD<MN<*X>;6C3T+9N%
M7R#+,`(DK1I>,+XVY*%4G0"9(TX-=:TB0!2RW&.WXB_X0A0'K8[EY3"\3ETT
MKN+B4YIK-AQT&O0SQ;8!%O$Z%M%B_TXOB$%U\]DY+<A9P@A!R3?\DS\=\7^N
M-^*,A<LT*V)&E'E19/'MIHCX^B@&@W.&Y30IF'=KWNPL82&`YN&PJ-NM,KK(
MNU["BJJA%/Z^X.%OXJ!IP`8I/*ARK*S9W_O8SY#X!^CIJ2.:_![4RW0=+YYO
MZ-?B_5I;,%N)]Z,A4!R+#%;>HD52J%40>V#*9I?M2[3;=VBS#T5[\KGZ+Q<D
M0C*8O9"6R)(1U06;$A*#U$@I'B*Z?57B<.-X,*_J\MT5VJ'=$C\:BB')R#..
MPTQD/^=TM5E_BE?JFRW`DM#TU93TR^V^CYZ35LO@`"(W])A25=F4\+:!LUJ"
M&#BAE7`#,WFGP8+$&JP&P-X?,^U@&R`$Y6PEY)>N+<\\,[6V-8"DI0H3/T6K
MP)G9A@2<E#(H@?DHA"VH*(=@`"QDHW1;#C9$H`P4(G[YU_`*PKXE7<5)S.>K
M?MS$2SX7Z4;%TNP`(G(%[4*7[O@7TF2S&0QP[O4A!&8>GU:"\VX<X-F-NP8$
M_MK6,+PUAU:*P']^N,!S'TY90P_SH`VU$6\';>A-#L3@L3;J\?=NT6*Q>=B4
MV\B6]#&CBS@2+QC8LW\[_H\?CO[Z[\="]-_>?O?]T?'QNX-%+.#0#2S$3GSH
MAMRQT[R('S@.ZA'-D^Y<,'L=T#)&KL,OPW5^>\XV"M,#B"_5:,I%6Z'==,%3
M0.=`.<`-SGX`:L'!0*;+(CJ`P!]`L)C?YD46+:R'-5TY:%#8R?D-!%W_/)._
M86X`X;=:]"0GG^N&H;^CZJ$$SF4%P,#\K>4M.*O$9@`\=7X![?SJ>;37<F._
M;D9ZT0Q]Q4P^WXBU/?OS9GG(V[C!;Y-=WK^IH1H"<YGE#^E#%"?6U.U)@KG;
MD/1,WIZ/OMG;-#B$OCL]II*:-R6?R\;!<[>/&0ORJ@`'9^]6@PU]U6@-@+_O
MG[E_\Z^Q]2"Z+PGE;U/2+W_[/GKF;\O@`/XV],#XRYN&SEX)8N#L5<(-S-Z=
M!@OV:K`:`'L_Q/EBG>:;C#I7T!H54#Y+5?@EML9KSPR76QY`=9E"0\V]$V'E
M]]X4WCJDP>.`&:_@@"!191$9(*@/($1\BA-Z5M`'Z_S>$X2&@X:@WR#0\]`S
M]9OV!A!^I\8TM.8MB6@:.K?[8($S6@4T,(^W"BS8JP;I>)R]8@#2E=Z]YQT&
M-IZC$*UG#X=/3;5FVNQ:S\2?096V_1[IP5S5:5TT;]OU0:ONUY&QJ;VG3-)"
MAD_4&\DD-A$Q:G'W6+-]C=.@IE!DO2/'*N@ZL49+!5XGOSBL>6KI318E>;3@
M*T1R^!C)04,7\38:<!AA[S,28ZP,`QAEH6]V=?II?G/Z@5S.KV[^06ZNYN?7
M\Y.;LXOSZT#8YX"D/CN=X=AC+UR3A-T#,#TY^TVC'Z@8C.?8(Q^H=UX9;3?J
M,2J9M4^#;[0)<+P#A@>4O-"QCDD<3-,@QCF*"/+^N?E$-Q"R5@#,RS(%7M.R
MVF._65EJUSTI2]1U>!W4J,T>/N!D;(0@-!?W%<%3<0`P]G3NB*4#F(CF.R->
M,=WMW4E1/>G6\]:M&+H5+^J&FJR$NIY%[0%^EK%8K2(1ZS(LK#D4=4=JN01:
M9-(7T#/#,T!&B-\-0RY8D<3C`T*+582%XR68B-D,[(95^5`Q8(V/O"8?ZIW?
M>MYJ1;Y1B68^+;C5^&!T@,L=X%I\DSB\L`E@)?X5S2G[T>_GR?(#?:+KM-PB
MP&_=OA/'.NM?_=A)]X@*E$;BJY6O6+2%&H6P%Z9K5C<4JP@:34FC+?E<M@Z&
MS'9`DG#:!8E]:H.TR!@>()2]E7)PZVBH+HN^5UP;NWHB9$]<7QI\/.%'#;-$
M>Y->TFR59@\?T^RBN*=9;ESVCJK;-@'"=(\34VR^YTC)$^@20A`"60(%J"-2
MZ^)<J[01]C^DU!?@.GY<"MB'.`>&68<_B`V'X.A$X*D#Y^G71YKDJO,S03*@
M0+>5\1C`.G[Y#$P[4ZX!I]:@#B15BY#C0A<)0+[+`03C<24+Y>>(N/-R^++9
MXD``]HKM90."]-`AZ%A+NX$0[30PO14_QX&9;0X%XK$:B`<,0-/17J@`G/)P
M+ZUGY7'C+E5(6]*F%JDE_5.R[>,(=<G6X$!.5GJ,-4KX=T[88,B.P5(`6K&X
M^LWLN#PV>L>O;AIV46"LFU9\&2`=5NT,@.F^SA@:#[I!U8TW8XA^6`[J]YQ\
MQM#RP!T<2Z@SAH$M@L$D`>:<(?CT'Q0;J'.&09P@-,#_#S1?9/$C7_O`I&]H
MIMF.X\,(7C"5&IDZJFJ^^>3A5>Z;US@K,XD4<!NJA2*A?.\#KXXYF!'8S%#$
M4"PQAAJ3(9%@+X+S29H7^5FRV&097>KN8?)B`R\TRVQ,'9G5WWORP"QUS6M<
MEEA$"LM",ZE5!W53E1_28$9E(S<1@W+?%FI,!H2`44-RD<6+@B[%A?:F];3J
MMOT0*6N+%>K4?J"%+*D)4.B12,YV'Q/Q>7@K`35=*R.R$0D20O9EI,0:%SB^
MIHD5EAP15$T%UQA:I`\/K+K/#Q1*D&E?9S!-/;5;9)M%L<GBY(XECVKS!<\)
M?/YY4?U]1?D\"FOR5A>+7?3(XK2='CPJNOB/&-\MS0.9:Z5UUA(1]66]>9"W
M/"*UG/@GV4H&1'4G$,K#P``\2P.$C3Y%\!A$C<G#RGQ1Q$]Q$5/S9D9+>5@8
MD<G[#!]J?[V&#:E9YW`AT:8)$[O6`>Z!M`45-"P8<0D,!WT]X#``@'9`]+<Y
M7=!=E6U0\'G>H/NW&"E4N)]`Z*`8%D""/K!]$##M`XO+\87V*AW"36@'&C;<
MY>60<#FGV1/]9#S4$"ZJBRQ*4?Q(8O#20^106[2,%"I%G<@@AAEE>!`-@SSM
MT`(W>N+#4*<END*%@=A0S(Y)Y((-8^CR-,KX8":?[ZZR_D!7\2)6#QV@@CT2
MFP61*`SU$(O``'L0^AK5S.HVI&Y$OFDT(U6[/X5"7#!2)+2U1%F?M"8%,LH&
M@U!OIR6`#&.`E<]@-[&Y+#]^"=`$3&?[`.?$$]UM]PQO%G6-#7D#^161SA,_
M^<'J[:)45)('0GLII.U@(Z>`;QAE0F;FC`"@D<*WY7M&A?!,4D(<))ZLX[(=
MHB:.OT\TV5#UX+O]N!=CZ\=(I&A;PXJC6ZT0M%>-9_5?H2"YTQ$2[$J[JH_5
MLID,G5XZTUM,:ZB']VNY0&(_>Q80ATQ].VFLN;Z/,GH;Y?R%Z`/?1!>)!<>[
MQ7#OGW=-+J-GL53N2Y0M+\3*Y/P7FK-4<Y9<TBQ.EQ^C./LE6F^H:NV#;W.=
M6.C/'`H=??\:.+':HY?F&.'-^$R(O1%RI*F[=>C?[3-IMJL,$&'AB%0VCDAI
MA<0)*>T<$6Z)"%-A1#3OQ.M%R)&HWHVWOLSVX_<+#2Y>%EUZ=7:Z*,,K&Q$)
MGO@_2;HB:2GP&A1\@?)@P\)^EHE;_^=YOGDHOV&]!(_O:4,O%,$&L4I%@,%I
MXSGX%YFX7(3XZ3&4F\UCE(R[NI`T[#06"W-3>YX=X!3$RP^VM$?+#T;#B!EB
M_T--6,4CS-TI8PXO(+>A81VO]GTT&61H\%<\!A4<]K.`//U]$Q?/9PE?@<4_
MS,5.W)O[**GJY?G=74;OHH*>)446)WF\$+]"649C5Y<XWF"5GD.]F399X/R6
M$Q>M@[^$Q^PRT#>,<K=T@31\*,]4(`7S8C=_NG6$;#TIB^1Z:G7/TQY2V,#+
MB:AQ#"U=#O,*,9<B!]8#3K/G:?(45*;M.31ULFTXM)_YMO>+[FG*;7Z/`+/N
MSKTP$N_6GQ>:>_N!9/KTJPINDV?@K6,!).'#";AAS9;A?)V0(R^?;=O^XXBL
MMF]N7T-@>"'0WZS=007!_9SU:[T+/]_P)=D7*]%4M2K:IRDOJPJ[I@):]"/_
M%4):3=CS<*PU/AW#LVKJX9LX(;GX*)`-FU[IX&E9CY9\?A;TM$WZ6LQCH/H>
MQ./3KX]Q)AJ7RY+09WL4^M$F;WKZ)QX:*+[OU%,K?;=\UNM=:R@3'UNEU5KL
M/8_'2F8@EN)Z\N'5U1T[F&6RB=][$&,OZG?V-%O$>72[IK_2^.Z>GR#T1+/H
MCFZ/*ZP/J-Y$:R]K*(=[@EPQ.WD21$$]X#<,H]YV^P+^RW$7OU#W_#0<."*U
M"Z3R@6R=(`TO#F%Q)T)L0!\^#`]4V*,+!X_P!Q\O*FK:S94_BBKA-%GZWYKD
M^EV"#*'E>M2M&*')DL>XVXBYNMCW:?(#"6W>]T+M:W"33(7O3W@[M@EO(^VZ
M=/T>88:VX]?0%GQH.WX-;<H?9F]#VSLOA]%,]4W"#&[O7H-;\,'MW6MP4_XP
M>SN=>[$I\B(2=`-^W^-.@`[`$^3I7"=/@DAO`W[#,*9SW;Z`_YSFXA?J=&[#
M@1<XG3LD-J#GSN&!"CMS.GB$GSE?5-1TF<Z]+J*L\#\P</TV0091/J';$'N-
M9B%$,^\SN/L:SX*9P77Q/<097-?O$68L.WZ-9>'%LM?:3/W#[&TL"W/*UO6;
MA!G-WKU&L_"BF>\YVKV-9I/.T49K>K&Z+M+%;Y=9O*"7-!/?3S61:FC>G>U4
M-L<)WP9OD.8-U58`T4\E/.-/^+'&XMD1$4_YNOMRRBV0F&7J[GY@@0&DQWV%
MF(2@TT#*SWYRG3%W;/&)B1).CPQ.^2'"R3S,'PRH:7?_[IPZCQ[8GS<L`>4L
M:;`<\R'EB<0<H`V"ZE"M%,1FF,%#]/"MMF=%-I6:=D@GG\N/`[D[S`(8.A;"
M0*5AHT*!EI=00([(SP5-HBQ.?T[R1[J(5S%=ZFEI:M]EH[H]#@E-_B!Q3V,&
M0#FE]*Q^=$0:#T-CG+'/^T0#PJ3'+Y6<A%9@9(W)IGNZW'"ZSY,B7L;K31$_
MT6NZV&1Q$=/\].MBO5G2Y4?V^_)AV:80H[*+57WS8)VS;_C:&"4%?1CI\1;7
M"!+9?7QSK`B![!LDK*":G-7Z>.9O:B0[E:3627B((`VM7&A[>^UV]$<^"]W!
M!#(OS)%$/X\,[8=,3&.R..LU$DP1G(4[[[MS8Z)"JT]48M794UP\"Y]OZ-?B
M/7/L-V-`'JI8&83=%2,'WJ'?$#O8#O#')L`ZFVD%U6M&C4V^&UA5HJ$%Q\$H
MU@1$)(:H@Z"K`5W@0V/?M,&N.<O?=)X?%E>^'=C=&N$<^(8;`03!(4:\!<3A
MW]Q?<!SDFUN@'&"R'335"W=;4?2(;#4WK]6J*E#"M1.A/KAB%)4\H-B+1E)(
M''8W!HO)!Q8,_+R@P7=Q[*C`7P8UX\*J=:<JC1;WU<6J).+*"<V+^"'B"_C9
M1\4])4M^Q#EK>I=%+(1L<KZ2GW_^?ATM?GO#5+/?,Z]U/&;Q@C=X2)=T_1HP
M,.!\$"%CVI=IVZ]RNEI17G+2LV21/K"A]=<KANXKRF$4KV/Q'2Q+.'>5RH+-
M125R1';_5MC%F),G-D'6P4`KH&[E2:F`,`V$JR!M'7M040W`LB8<#F:(.O39
MJ]8%.@3>31'4/M`5S3*Z9/ZR^$N+?)XL/\71+7.93S1:QC,G;<I09JD-.8HY
M?1?L`&;KA$WLLM/="ENUJ`A7I3")DB5IB.]!Q')#JR98#8&_.DY9:=6%J&%\
MFB(Z;6]3N&+_RT8'["]1.OZ<Q(7K^X(!.I61RDDG<KP:\+VPHY:;*S:QR\5"
M*X+M[@S9::CFMH0.4BO9@S@V!-&::#:<*.J8YJ!;%]GVE'^>IYU</?),Q.ZD
M4H^`M=@KS\S`V0.F!3)]\W%3;#+Z4YS$#YN'*YH4T;J:DLH_IMG%(^7GV"=W
MGVB46X][$'0K:XM!NI%C',+WQ*XUAKED$^J&6&H%O%(1J3214E7]GBTGJS0C
M6VVD5+<'50@&!S11$H]BZE@YP(8N9AX(@SU7*T,]&XG*W>JE9K%HNR7Q*SGM
M4;6']`RDM)'O.^Y4:/,$<Q;%GTG]4B1DDS[6(GCY5;PL4\+VU'IY`JX#RB5,
M30M'_?$FG[G>_UD@CXPT+5?P&0<,2Q=031L7,OB-/E.DCBNZYNMU+J.,N;?;
M(YF_?VX]`6V-<M"E#/96NI"CN,/WP`[/=B[8Q%T;S9UI.O&8B.>D*7K$SWIM
M/PYT"Y(+0C7!SQWPZJAFH5,7KH;P9YHXQ&]:7[!*G)7:(HP*+T_2O,BAT0>H
M01-SC!K0(PW09_SX8C9L%U5,^OI3_G7SJOXJPX>0"#=\0"&F#1IV.-6%"H,F
M?8"P!?L48>$R2]GXNWB^9$@LF)>GOV_B1SXTA\4$F+@R()C$D:,!S%OL4&"T
M:A,'#,IF]?,C(EH(ZF_;A$I[((HTG+?"H9KP>C4ZMELB>9))+#Y<>O]\LHYR
M8,972JBGD/H2V#-`*I_0)W`DAJSF7WKRG6VS?#S,ZGK1(%1FJA&@F[(PP$8S
MX]"5U$X8&+$VS51QFA7\Y,@/]!:81-4BFJG:O@CZ5*O**_RI4HDENZG.GH+.
M5"5[_J9@#0AO$2S9U#C03A`:T*.;X.N*ZB?HC)@+Y]R+QIFP>74H;&^3%)2=
M*/HM3\&PT#_*81C6WW><,S%LW!I^-`;<&NA-2?,VIUQ[G5.X$0N'&]9G:[C2
MS_"RP]V._4D;[@R?;/!PGZZ7-,OYV*9X/D\+^FO$OT217V17_#3MW.+UMIL^
M_<##1I^/88G]]_$R:+%RPWI(8Z%=>TY0+19<3'-$IFE`Y`QVPW`)KM<XF!K`
MGQ%C$LUBFL\OLVJSE?#\)_IP2S-5U#%+=..*3@(G<IA]0HH-6D,`]FOD9^5#
M,B?;Q_7IRF6+4`H6``#Z]`6CID=0M:2$@E-"S<^*4X.]09@3JT-KU)WPO1)9
M$?/ZZV4AT+RH$PF#TR[`-!7.JKJYS&!G"7\#)PKLB^*>9C?W45*=B;+;99.N
MUQ_3C`NILL<D3L@NIA[1";S[NT;_Y1"OHQ[3=^!57>.YA'$)=6F9-$P389L4
MS/CNC+NM??;G1H2H>M8D)Y^Y3Z1R*I1H/DU(D-\3-E5HZF6<49U1W`WV&B)U
M3OLI]\;_"J'%2EZ4=@/7:Z0*`>>OL:KZ.0ZPAO]13$V=)9=L])*.7[W+S8]6
MMW?-!YZ.Y+]6Z+5ZS^LI,T_'F1'K\](RB1-2VC[TW*:@]HA931M<QLMF;3?&
MS&-['=[VK,Z6.!].G..UM?B$OH:=R6#\8@//BRB=.U>ABX<?HH)^C.*,'QZN
M7",7FG\3%=\`__8J?8%_[_TJWR%?*YR\9_9VP@'`$:G=(Y5_91/"/23<17%O
M32@7FP?399.G=-M0.E7&-_HY74GPXJ+]7H]F8-]NC\+^BQT/'4)T#69$M<_Q
M->PQF7(M/^3+GGZEV2+.Z646][+#A![8CJLP/1@GE^+_9B.-C5`=1TB#B/Z`
MQC?Z?5-'5D.8VCP1]O<DNWI@NWW^]!9RK/,CGB<.&?`EQSV[4<)CFL?\+B^$
M@0+R5P@J!C:*_2-"Z_#T^!J>ID?Y"P]0DB(\_!!U/,5$!K+_8<6GXS_,SO)\
MLS=S$8<6CHY?P]'VA]B[</3.)APQ!;=I:`'I77`!Z=V^S8X>6D1Z]QJ1MC]$
MN+.4P]>7E_L=IMLSV;8__G;)VG[@[_H4OU?H*S?Z;@>QYZ?R9LJMD7N2UM`)
M/L66(FF,F6`O4;6W;(IM1/L9YBPG(T4R/TV606QV;'R#@&*>V.*8)F^J.YUS
MKI2%IY]8S+@G[]X>$5:)_.4U-DT']!<<G<:;BT3SV&HFLHQ/UT64%2%%**39
M2$1_9!'J?T;))LJ>R6N(FASK+SE$]><G]V`V8+OD:I[GFX?RBYU^?:3\\K5?
MTC53LV:_PE54T)^BK_QR3^SI`&<'L.8#'!R8-A,Y_V(3SPBX^.TQ^=B[@S$G
ML-LX01IVCTAMF>Q,$VZ;U]_"^IYG-7>:XZ6UH:$&+:M9.X*8UH:'N\/*:N65
MU1-FM;8#$V2UVH&]R6KM7VQ_LMK6[S"R6N7.1%FMM/YRLEJ'YI-D-6FHF2*K
ME8Y,D]44X6[JK&:5@:RRA=?(/D84'A`QU=$MY,AC&R6<&`UE7W!,`82#<D;F
M8C5?+F,N$JU%NWR^*>[3+/X713]+#FX1J\*#6)RVI(/_)A/7<"!'/19M`/L8
M5=KN_-*=H?H,YIVID`,C+A'Q:C!K]J,576;+B%76(82<L(XZ`/H[:>QI'WT<
M[4)'^?Z-1*^A8R3$'GCP"'O7O_-[PE_$2\+)#C&6FQ]M-6W7?."K..2_5NAK
M:7M>3[EHH^/,B"MI2\LOYQ!C!;5'7`BB#2[CK0)INS'F(I"]#F]AU<(NSH<3
MYWB57,6?;U@`*FOC/[U&H*D0_6)CT!XLE>TX#%LI^T,9A1)Z%S'A@.+0U(MD
M>^Y4<>@U]DR%XY<;>_9R#6RUT*F>H"BG)=@7.GUX7*?/%/UL=*@]K#&ZV=ZT
M^0+Z>TP\"@>XZ3$-&*UCC+/KY8:]*SJ9(5);VO.\`F8?7B*Q)#Q:WC#914P4
MUC%F#_*";%'159S_]C&C]"QAPV&6^T;>&0$P[W,%J=9\>.M'`;]6@*M']5Z/
MO'94YXS/E:/<+N&&26WYX+=#0+CM=]DH/+IX732J<</SDE&;^+8'"4S\#Q^A
MQ<E=.4![BYVD-":P$I'4Q+3)1O.M)TXH<L\\)@V908S$(/Y#*L6'\3Y/QQ6\
MP&YF)%KPEIA"#-#[P?NPWJ&I'!PW`-3OPCAS'U^9BX*NO>?N@:[NVIX"8;S4
MYBI=KS^F&=<Z^B*P05Z.?_*BG9>!O^T<]-N'OO+,]<L%<:J0E<_3G`@)NX23
M?)[?,I71HOA?>YYI/4>R*<Y(&A!RQWN#[.3M)*<MO>:&L(8<'K_CWB4)/O!Y
MO3;Y\,-T"&=R'E2@WL_!H?3&@!^S-,^Q!WAF2UB#-)VE:9.I^3>8>+"D==!C
M+M/8Q1BT:.[7%$;V/)4!J(67CL`\1DLH:HN(26$?@T985;3!STFB!Z]F]^KJ
MM\`I[J]JG)CDTV\YT?AF=0X[WA5LCIY.0_3C?;M2+72F>]L*,C73]W*#QZ<X
MH6<%?4`?EO448XW"&HJG#:R];SCQ&*OIC\=8N3,S?`1%/G-M1*C;]]<S?<#C
MA5,5F=!BY]8`8J@,CZAAC6O:;HW!6#YJF2\6&1NVD$63KX_1<W2[IF2[.Y_O
M;\J+=/';*T.=,;97'-W/66;$&?>`UQT%O-AHZM#NX5<^G&5%>_.:..@%1'N>
M]'S$H2#?0>_!:^<PWS4?4`S?YYMO85]N/P+ZZWVY!Q18]V)%3YBA=?JW/YA?
M9J^O[85]O3T)KZ^7_1Y2?`W@BN!]C:^3OW.[S.)>Z%8WD,W@5`WPTD3+(N)L
M1JT7&"/+YN7(GHA_!!20VKTB#PNRGI-24S14$,1/[_I[D;%3;]/-_ZP/-B"/
M^]K1L"K7V-4'.H_^,<U6-"XV#*?AS:2[.#?:7+J=<X$/%EQ^Z=#GTRV_TY0C
M!"M71YQ3;_CU.JL^(":-.#P9$#/'&Y[8.#GF`.7%QO2P%M#@?[5]">Z\WJ[:
M[_VZY!<52B><2S^$8'K8HZL);\)3>C#V.&F/+HQ2_F9[,N()YE:\OC_CCUU>
MTMUX:K*/GS4#N"&OY\D$V6^?P]Y^#@H"NBU/YM&+*^\#BT;3%^J!Q*/]++G!
M)]C'R:3WD[3-CWX_26U^3^XG:?]:^W(_R=;K$.XGJ9R9YGZ2TOB>)S17;D]P
M/XDTNJ`E,DLWIKB?1!'?`DI@N>&@@=.O-%O$.=V>-="9(ZN?&]<AC>Z$;3)#
M=F*<E.;EEQLIL6'[CI#><%T");D<>L3;UG;SE+?>R^ZZ57`KWL;GOWW"\QF'
MK-,>JC,.R>\U'DXSL83_%4(+C'QZJ?Y@7Z:7#C)$#9]D.J@@-=YN*5RW)SI&
M#_]+!!>HCE\#51B!:O`6I<,*5)-O.W*9-6E_4W[>DX^Y!%SKR$>W@ZT'<62K
MY6\5QA'O<*?]G^<*]07U*/B&T4.9'T#F-/HQLVY!!6TBW,X+_,-H#S*JA7>4
MBX/_P82XQI!?'/1(DR6_@?8V8NZ]AJ&ID/U"`]'A+"DY_?I(%^Q;?HB?XB7C
M%'_I.,9:$IU=GXM(Y';#6SVB^WT"7#:B<'?D]2)2+WPN%*D-DMJB6">RY\G(
MFJY^UX4`(H77!2$R^YY7@NQSD`IK+;65UP%$J[+*K8+*L@XJSS%=[\OL\1Y'
M%7]E;<!Q93]+6>,J\%_$\5OU5/A-6D3KZ8YW@3@SVC9%O3.!;]V!_)*A;UXT
M?(<I]_%H71MQ2V/I1W.9VLLY=P44+$;<6&01O,;;8:1S:LS-1@<;3,,JXX=_
ME5"CJKC0Z.XNHW>\_%OQ*/?T&N7"BG(3[J3<ASBW!T>$:]T/[`[9X5\FV%AW
M_(?9+]7--:^1+LA(-]U!WGL1Z?9[U=QCG`F9[0I!;RODE);05\-)+`6R1D3Y
M&X2RRDWFX!C+/?IVD5>O;0T<S(%(`&)Y6`MB8C'^JH^>11\K//8H9`!'X3^4
M02,1@\A1%I#)/9TD>E2OS.)L;S98!,[R$59W3</S%_&J*[S+#1S]F^B%V/X?
MA^WX>^_7:[/0+SJP]7;2EVNO%QX,B5.3S=V$>^V!I9_3S>^\N&B_U^_UPK\"
MP=[?:D;\-;CN6W`-YJW@/H?7_1R2]3<+G6\>;FF&/;0RV?&WM[RV$\C$F.+[
MAS*3WG=OU&V3E55_>\!+`WN>HHQD\KF;4LI;C[LF2WM>]T>&'2+V8?-UP],)
MXL4+VU`].MG'W"0]&MWWNEZ;+Y<Q_R-:?XCSQ3K-^8U=\UM6RT:+PE/M!K*)
M7,<9;`81L$&_2QCUG<E5_[%;[P%JW;<S11JVR.?:VO\ZC,0`HR5ZDK")!MCI
M0FL;/W7L?1`*:Z84[/'$T8A7E2_BR+`0(XCWDC.D&#+]M@.0EX'M+@#[/'4<
M.7Z-(]/%$6_;`$*,(WNYJ+\<CE^LQ--\_A3%:SY*_YAFXB4+]F@6:`YK(&LT
M-VW@!_X:$P]?S5YZC/$FXQB#UFK6*UV5C7*R-4-6:58N8MKS)`'E'5Y^L&,Z
M6F(PF$7,";:Q90^2@>H$>+%[[2PILCC)XX67U;\.IOV\M3:8#F*D8/,KA3'W
M"?1XM-=7>D=\O`%OWY:V-7@02V)=R.OKQ9E-Z/#T)DWK@K>7:X<2N(*<+P4[
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M>0)`J/`Z1R"S[WF&8)^C5%CUII77`80K7H_R%>#IAD6?[#66C`K8%Q1-]K."
MK58.?$RS%8T+L44B64J.T85<38^\O!3%)^1UIP-]"F)=%\KO&L9*U:%?Q?\"
ML&$>HJYM;;A"HF0IOS-!<B[L(6[`PXDMZ&O7,$,>]I*V0;[AKW5[\9$XK%$!
MVC<*/"0W+I[XME*T]W/:!QP3O2_T/:2H>-@CF*E&*5.-1/8EQ^W9B"*,%#7!
MR."%)+D)$]G4J6J"=+0O02K0.]E@?@<0KUYRV3QA1)F^_)T@INQU&7NQ*?(B
M$J<R3S#E;FD=N:0%6P\B9UC^5F&4MW"G_2<-J"^HI6[#Z`N9ZK;E-'J6<@LJ
MV)D*Z`5^OCK(J!;L30LV_@<3XGAUW&AZD+<R[$L8\EXRAQZ(@CEB%^JOU6&[
M92BZ+J*L""<8C7/T+MR;5C"ZI7=QDKS&H\GA_5+CT5X>U=NZ&;&<IQ`[E&]2
M_E'CBIWYW5TFI@M'.;)QL#_(0_X!_@21HP;_GF%,"PSY&OX3E[MWJ%,'U17J
MU0NR\BP+%A3YQYVK$[?N'.;1D<.#"'HRQ8IKV,G5V2_\=/MB0VVP<Q7#OE'`
M<?<EW#)Y2$'0^YS'(83!8.9%W+^!U4S)2"N&AWV;D(/@<3L(OG^-?H%&/]\S
M+`<1_<*;A2F_$OLN9PSN21$_T4O&L/PR7<>+9ZOY$Y`FT,R'09/'_`'Z#CYG
M&TP.N(9JO5[E"+\>N(OQ^E:4"%E2"I//U7]OZ->"O&<`_BWHFVYA,`4&5AO,
MPP*B5B,TE`5*H!$W6YG]\,(D/F:[+A@%WKSO<>F5%&T,!$:+0UGP6)X-YG]I
M8]N.OT6,M9T@1HW*[Q_&&PB9>Z.^$J^L^EML6!H(.91BD,GG:W(I;SV^#J].
ML?3YXCOL$!'LS+G<TPGBQ0M;N3<ZV<=<C3<:W8.92>Y[MA=KZ1J^3D'Y%[<^
M;GS6C[CF;3S6AS>#ZO1MKM+U^F.:\8?^AVH28_[&:RUCH05HR2\1W,BM[>.H
ML;EIVM<8CGSF5DAE)NBI8C2R^0SV:G)[C/<-HUZ#_KX$DR"/$=.X.E54$?/C
M7"PG/R=+5C&4K5^#@`\H'F08"''8UW3/:NSW1+/;=,)0,/K@KVV\'0I^C;C&
M(G\-!C[@>)C!(.C18*[Z3N)_;IA_\V3)WT">1P_T0_H0Q8GK6'"`*=N1H).I
M<2+V@%]AI%&@FX<((=K%\.ST]PV_Q%HT(9_+3_=EP#:$$?;!>3C_K`.S@TF'
ML(S!]H!"LMO"SD;R"6*C*=R?<3::0OP)HF8?_'N&,5DXY&M,MM8?X-UX&TU;
M:TI>YD93BR`RUBX#Z[@VTAX#LU^C[3$X_%`;['*98=\HX+C[$I;?'%(0G&JC
MZ5Z%P6#FB=V_0;C+B(9]IY!#X<M8EG10T7"BC:?[%0TGGRAOSN#K9DMD[62S
M&.UV>)%>9A]QU-]1#PR%+:GJK5EK$!M06))VH#Q<:/I:2N)F>P6YQH"%WQ%*
MSY(#1GA%7YV40+Z)$Y*+!G_:?Y3`2E]+G."6BBW-GDNXGBT7K!P?*E9`A8$M
M5J9-I&E6W-#LX0.]+3[%"3TKZ$.NS*:ZQKV4*F^,1`N=)UC)56$#P@BIZ$Q\
M_J9@#PA_0C[S9T0\#.8EJ+:+)10!0*+/$IF0C"H@"(W(EO@NB5?Q(F(U]&*1
M;I*"\5?L]8YIS@^K$&=5J-AC)=QE$U`8AUU6GB*Q#6H3P#Z8JEFC'=DU)'5+
M\CF\XT?L(-1GJPL$>^P%*9&P.3P(^UEC#3>-A66Q!OKGGWZ:7_V#7'PDUV<_
MGI]]/#N9G]^0^<G)Q<_G-V?G/Y++J_G)S=G)Z?5+`K.YO/<*YVF/`"FB0LP!
M72]H$K&1P/QKK*SM=&V[R4C>%H>X.C^04HW"!("-4LE9_2_RF?\[E%RA[=`^
MFP#]WZ..3$;"%!!<)J#%#3]7S\2'5B,5$:I&N`QH64:&?JW;`O.ER&S[;U8?
M\4]"@WN[O]0XE_6K$N"BL0;9\OZ?`-+&(;RRH0K:Z$-WI0?($+<<LO?%FE`/
M;Z"N[D@UYL$#])Z`!OM!#,QK9RY6XJR\^W2]9-5ZN=I\?IL76;0H3)2`R*I8
MHI?%)0[$3V0N&4Q:T$NK:7:2)DN:\#686X&<I"O2E/DCJ381?*[E0J,D"$AJ
MEEK@4$E<G0X-EZU@/`F]3Z+\_N,Z_9+#6:T449-9(H+-8:57Z-256;)B;%^!
MDJB\*1%M0Z:G&A$Z5IIPI"%C3U3+03/Z)J!>&0SX(I,TX;T-F4O0R:C()Y?!
M99_.+V3Z*4Q9\$^JH=Y(M_LXS,D'+0+49`,`1\DVF:R&;B"\39+J/L9)E"SB
M:'V9YK%8U05.>491=>K3B&*G0*.7Z*E09]$J):H5-5)CO0;B^I[2(NB$:,:+
M+C%"T:9)D$H5VD0)Q^H$!#Y91WE>%=209*EJKZ)JOSTN/U7^()-28L:"B3WI
MF?AD.V8,,RLJNUK-,@,ZE-3JRFGX9`34F"1B/ISE^88N/VPR_F*M7,@FUDZ5
MGW],LVN:/<4+JF:6BY(>W>R4(''0Q7,L8EK:AK#52F5YW04I'Y!2@I0B1Z1>
MJ5P]7:49J05#(;D3ZB3,'X#>?CBP42:+$<&SP,]:#GL7L.G`UW:PT<E#FI!<
M\"(ND<_ZB*$QWZP+?L*5($)>]]\W8:VXG801YH4?HW(";T6XG5E/A\?9.X'.
MBV,Y+]I$"&[U^31<,*Y;'Y<+DZYXU[DZ7_R^B<NAI%-5*9.W*2C;\O[CA<S?
M$<K(CMF!H:&E#50\-B7V("Y(4647$C3`M(H%33V686!*;-L5ASAIL&<?$>:J
MHI`GOT_\=*,BBY(\6HB3CO:H&D1&^K`:$`GK$R\!UG@I'EX_KN/"*=E)Q&UR
M74O<?SB0>#M"IFM;'1@!FLI`>:YL4TKL`?ME@+(COQJ25LQOJ+$D_G2@!J:X
M'TI8)^)$!\@&<AOS>/C>WGK[BG!`CT^&\7!SVTU&HWR3/8M&5[2LCURRG%:1
M3;Y3*/(?)+3?8(0<J+(_,%K(U8*B1BU:A8]:>`\"B!Z-=J$$@FRKD")5:!E<
MPF+)^"\5U&[XH`M/LY?L=[N/<LK?F2\:8\I7-E#`S3>3\"'$M"L.!=M.]?(E
MK';95BT/2[(R>9]10^VOUY0J->L<&B3:9A_H$UVGCV+?TW41W5%RFC`/XUVY
M70H<E2=:MU[%<PU!QPT-RJ#AP@A48(SHZP&'ANFQ/NZ$JL(^(NQU$ZH+WC4;
M<:%4<4\)^R&+;+,HA+XCDM""9\YTM:*BUERD>;D5XM_>?O?#T0\_?/?R^.":
M-5$9$6*.[+P//6?=QCP]29,\9N@2)W<.6LNF4^BTKDVN<,1U#+IO-.9Z-X4?
M6(L:I.HM,K%D55REDK1T!AV+;,#LN"`"0!"WI1$RQ:[+)((DW11O4,T.^>0?
M+PD^1G%&GL3)RYW1<;M`8)!?K\M.Y[5`X_S'+]45E.2;Z[UY"SLZ!9'6ZODF
M88@EA2A\W)<M*<4M!MWC+>Q0>NM_R(VU9*FO3#MC70VQ]V;!DAI/5L.)X<N5
M>FKLAA(38GJ"H37>4B69.O!*I9>&[$'C9!QL!YO26.)ET,Z9CQ>K\N\BOEW3
M:[I@+?D0R"'/@75:)#^`3N_1`_R]_*=)B"O#@HO9`B2A[K2(4TMV>LA.4?CA
M"`YHJQAERQ.;L&74;1?+]H)^$V1TF$^>F:C*_9M']LFBQ<!'EE9HEK&'Y6+E
M5^Z9P;0'[`NVO-B.\]WVD.MUN+RP'F?OK-[O$5]<8^P?5VB$I/_&//E>[!XW
MX,WM5=VPO>-R78XO[*9$_Y2OLG%VCBMU&C?(OES0X[RC1H*][\WA"JNPO>%(
M.P8T/F`#'[`S_`4#WW$ON!_@![L3_**XIYE=42@1M%ET40GZ?\_;\G"$112U
MO8$O:TLUH/7]HFG0%)=AQ>Z%J@QG5J]-A0++UZ/C8G2*-0<[PQAP[=5@>;I>
MDC@ACUG\Q-(I>5Q'"W'XFFHAX7Z=8#(8T,-6`CA#.I1YBK?FC-/]@>1-L!EJ
MQ42K?&%-M<[.T.!8\1:$?PN<O]4BVD=G^][V]-8^P+[5#6?CI*#K-5T4FVC-
M0FOZ2+/B>5^!81,"#=#P,:Y\ZW_8^-9^5/A6->ACO\\RSA@TTBR\01\4$19#
M-A,B)A]P73SRA0>7K&M/OS[R<[)U*4_96);\)(WQP*_T!#$ARFP`6=`7K9(D
MBXX_)W%!R@:$MR!5DX#HH.YG.3%,N)`2I">DH,JX./*7:^6F7`'57P[]1/."
MO[`M<?88VN+$P9B")6)G5.$FY[YZCR=_RHTY(^OXQ2$+E-#=D35YDE<-MAO^
MYJ=?:;:(<[=36;2*K$\AZRL:Z>@FU3<8ZV0RB7V,,YQZ:F?BX9O;B%^+PN_:
M83`MMV?,^?:8N_*6S=MGTFQW&3V+C^=?HFQY5%4P^1&IU>9\(JVT'5!P<$.L
MPR%0!O1;39Q)%;H<"Q4,D\8_N47MA@]*[?G)+=[9@'`XF@\^C',,O-ST!$?!
MJQWQP@E62&[_\4J"9I>'18)^?3H:"=Z-N>;%Y(@7$KQ[)8&BR\,BP;OP!FGM
M13JR+="#UDEK%;HLFE8H'&\IG?8;C;B<6N4'TLHZN?I!)X7MW_$D-EAV6Z('
MX0<P>`$4.R[="Y-S4R[B5CODDWZXQY.\,D^'J:"Y%\K:I7[=<TZ_B$=.MTOT
MA&UF=1O"_@<:/4]'F+UMVAPXBMBI`JVM9<W+%F''#!6([`84*A!:#2&V2BR'
M#=.`>/R)T[9I+#2+&R3$1W4N7):`?MR7-P9HX!TV%SH8OB$F*)%7'?9X].4L
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M@@HU`9K-W_MS4&UA;1>Q/)V$"E1N&=?V@X935`B>3T.%&W$]#G7/C@&9C([#
MBHK1"1EB\2'FTQS?W,ME+=Z0C/3*4^ZG_S<E*&_M.YH@;TSVY)V]`CY6T\\#
MW]BW==A-0JO!.S*I[],U&Y+FY13J%>4QB(H'UX_KN-!1&B8I([1)$H_.,!\1
MR6PT"*2R0<^LV>B/I&QV1*J&U42;:!H0B8&`D5/8"FU2`NLU*.AK"=4IR3N_
MS8LL6L`YVQ4P4G4GX(FA78]\$;-AQX6/6W$I#<F\*++X=E-$?&C,8'7)ZKND
M()]KL9#>3.D!`:"B`D1F!M:"$.*-!CR?`TZUP2$8_.=;.0H/$6.P$=M@E$T_
MTFJY!8[GX#CNC4:^X[8C5ZSB=*C$L2&,-4T@]/"&&KN@6R[)/4V@.VW[IEP@
MQ,/L^VC-=\<<`D`<(BD$(K@G%K156YU(4(+DNHBRP@DF%J<.=`4/"B:@,P'L
M88*ZI[^M&K9GOUXMFA;1V@D@%CORNX*S&VZ5[%/19H49T!9Z>\Q,O@6^Y<YY
M6E#K`;=,R%BLM84\T4;FF:\BKF/+A44M%;/KFXN3__S[Q:</IU?7C$G_]?/9
MS3_V8+0M10.`8!H4F:G6%(;03HN^J0GX(<X7ZS3?9/2&?BW>,_N_67%1(P^B
MI53>(T,U_OHDJ]RL*V]EVJ04#IFW.N0`*6P&'XS-$CU08D/P.R+'-[<Y_7W#
MAN"G3^Q_<B.G3>V['%:WQ^&LR1\DCFK,`#BIE)Y=__S^FC'O]/R&G/["_O<Z
M$`(:N[E/."`R>@13R4D(!0;3=`0RU:>&Y@;Z8->D!F_\D,>N#E4)]ZD37OEI
MZFPCB:`EIT+,3*$0RLRV2S=\9AC&GE93/7.JICY8T_+""V-J"]9L*05GNT^)
M^)A\%@_"9$F[4TT,D4'`P(Z;^M4#1'$HK/@4)_2LH`_*]7Z&YGIV-)K[8$C/
M&R\L:5JQ9LI.6,(6_I"(IV%2IM_;)MJH\&&@SE;,2!\UHB:CD'[7MZZMGCRX
MN[]U?GBAC<TN<*FDA#!A;0;7=JV)*;!-X3(9(T>FWQS>27G,WH?T(8H38/G5
M:V^HP1KMO11B/7_\5&--,_8EV4ZZ3QS^D'PN'X?)'DF?&TLT%4Q,==I6SERL
MJ9$U*9OF7V-@P=9M;692V=H7CYJ^>&-19<2)0T)6Q2#^,%S^M/H9PAX),`#<
MX5(@YDB1-"YOXF4<9<_7T9I>K,2TN8$YVO82[BC:H[%'ZP\>?U1F8`R22\_X
M!WQ+8[E_(33NZ'M:RAX(.&3\D<K)&03#TY@<>GQ<BQ/-HC4_-.'C.OUR6GY@
MGI&&B_:8!1%%(AG<2RR^@2Q"J`=0-&NV$D?R$-Z.U`T#G-NV@(V$IM:@ZS/6
MK$)&WJ`@ZVOK`]0T#GK%=H@F?G?ON,5Q.CLXGR6K-'L0QZ+_[:7@V+SLUQN2
M)]U4<1-]/<GH,BY.HBQ[9OW.;XF</Z2;1)6*`!*=#*250&$QP"><?*,W9":J
M3G[&'I+R*6D^/B)E@S"H".G^'@/AF.G23B/99YL-T$:D&/]F%ZNS9!D_Q<M-
MM-8,F[1MN[22M\4AE,X/)"HI3`!())6<B8]Y)ML]"&J@I._;/F<`4.BQ128C
MX0D(.1,RY->XN+^BY5T[^7W\>).>\J,RG[43WXY:3*PR:?'#-YCOGIAH-.[`
M48/.6?,91VSY-+!Y=E>(F<EMA54C[?7:``'!$O3CA8J?<^;G:5[$;'RB/%=)
MWJA#]&XC%![++>/0M*?;S,*.R.SG\I;K[2='Y#)=QPM&L^J_?+$F$:LU`V&<
MHBM[A-)V>9<O[<9].HP`#2]W-TA,V&*$SQ)T4;+/2#".Z^VP,.E8_1?*W$CN
M-,,'28M.U&NU0,&UQ"9.O&LK-@.YV7Y6_2.H`8"L=WKP57=A%[F-EGW8ZOIY
M=,1JRW9I&SEJ44MNJ5U4Y%J4RVV)'7J#JG[E/:5",*AR;;55HGCRJO.7>$$O
M&:KBI6F)HJ9E%].RECC(5ON`A&^I`0#*)7*S_QD]L+S[XY_)>RJN``AK7:*N
M/_O(-W9^#_]]"0D+`$@9CPN_EG<=:UD@;=/!?Z<-"O*E=G$PWU5M1GM;8E;]
M,S!\RWNJAVQ=AW8QW6K;1[/W?O<RM.I;L`0`'U@=#@2,PRH;$$PZJ/J5QG?W
M!5W.GV@6W='S#??H8B6.'K_87?'^/LKCQ3Q9?HC7&]9:%?<&*>L&2$=E.(P:
M]$V00JZK#P!JNJF>U7*D$B2EI%B95UXQT)`^(D*>L'^12D,@C!\&TWYHP(!]
M+X(X*96$FOVCD:<%1P.<\<4HD14KR3<UIZK;/5X)Y0R;("FU2_/-3OO$_F(?
MUA^Q_[F-<LH^^?\!4$L#!!0````(`/%KJT;7VV/^NCD``(!4!``5`!P`;&)I
M;RTR,#$U,#,S,5]P<F4N>&UL550)``-UYU!5=>=0575X"P`!!"4.```$.0$`
M`.U]6W/;.+;N^ZDZ_R$G^_6D$R?=LSM3TV>7XDM&-8[EL9W.GJ<IFH)E[J8(
M#TDY\?SZ`Y"BQ`LN"R!(`)1JJKI[+&#=\*T%$)>U_O)?/];QJV>49A%.?GM]
M\M.[UZ]0$N)EE*Q^>[W)W@19&$6O7V5YD"R#&"?HM]<O*'O]7__O?_^OO_R?
M-V].4Q3D:/GJ_N75_&9^^W]?7>/O*-W_X=5ID-[CY,T;VCZ.DC_^3/]Q'V3H
M%6&<9,7__>WU8YX__?GMV^_?O__TXSZ-?\+IZNW[=^\^O*U:O]XVI[\N\UV'
M>N-?WI8_UIM&`M)10I4*]Z1C0>/_OB2"[%NVA?[^H6AZ\O'CQ[?%K[NFV9+5
MD-`\>?O?7RYOPT>T#O:-(WGC-S6YL^C/6?''2QP&>3&"4DN^XK:@_^]-U>P-
M_=.;D_=O/IS\1)1X3<;OU:MR!%,<HQOT\(K^^^O-O,$SOH_P3R%>OZ4_OIV3
M__=FB0A^"J/\.7]Y(OC)HO53C*J_/:;HX;?7M!]A>?++NP\EP__8]WVKQ?LL
MRL(89YL4O;F]6YS^[:^+R[/SF]OSOW^=W_WC*DA38K!G=(;R((HS'0$5&>AI
M45@AP\'W9*EMQ*I[3PDR3/_73XP=C?YC^O43-?7YU=WY[^0?MX8&DD?5#`87
MUW?SQ=7M[.KLV^SF9D884)]>;F*$'V[S(-]D]-\X_.,;A4^29P;AJ<^[%VZR
MX.FI!V3*[GTEZ`/:LGM?"?H)T(M_F.'P09O_MG<?_O=:^-WW[>U[E_/3\ZO;
M<P+]T\67+_.[+]2U>_H4A^8PLIH)`V+2/6>'7M-";^YY+_9Y7__*4!__HKW[
M\<=]V&-=[G360&N4Y&].<;)$28:6NS^1R63QA-)B49I=!RGYTR/*HS"(=435
MY=3?&\\_SRZO;Q:GY^=G\ZO/O8-&AUR/<5_AX%Y_8MOV[LF_%_M!5O;[1<T-
MRO(T"G.*%;*LF85D.1[E+T.M^.&,!_&V@M4CCI?D4_[\7QO";VBODW+LMV;0
M7S*5G0?`UEUP'R/SR*G(]ID#]2>@GK-/ADYZL#Z!\Z[O57PL!4C0BFX^70;W
M"`!P%JTX31NDZ*['1[KK<?*G0LPFA[JH3RG*"-B+:8?N#378HQ\Y(AZSB\Z4
M!62;I*!?<8AQV"`:TST>G,HL2__RSS,<;JB;SI+E>9(3UYPG#SA=%]+.[DEX
M"L+=DBFFRI64E/J1GZE6"OW>JNM7W^?+4/C3"C^_)98B(#CYF?X'U?WG-^].
MMMM4_T'^M!.F)D/A8BV%(4VW.HJ;-M6J`V.6-E4,TK"B3/ZS@XKF=MRVQ=NG
M(JJ^"1^C>`>HAQ2O=88,*ZE]75/EU9]?@=F]RO$K,1N<DEGCM]<G-C%!O!;-
MR6R6P7#1:2[&1JWY2"K.B`1+*L5%'*P8.C%_KRG1^MT:JL'VQW*]6@B6D:Z`
MVR)9H74\N)YN4FJ>"[)L".)_H"`]3Y9G9"9B#*NL:6V$^4V]&6R@MIKCSJ>^
MA<!_CAZPKE$:X25_^(7M&"&JU<Z;@8?HJ3GJ'-*5U[\?;<S+"?4;BN._)?A[
M<HN"#"=H.<^R#4H98P]J7\.`I+TW6%#16Q,3$A85-GX9&1N_XWA#E$E?+J*8
M?'9S,<%IU\%"IYUG&!#KV6OL.Z2K,?_3R&.^G91NT!-.\RA9E8=UW*$7-^\@
M@-?<,R"`M.Z%!QZ'"A;C+0U*>0I8GI*9:H73%RX:F*TZ(&BU\FSL13KV&O(6
MX>U(_SKR0%]O[N,HO(AQT-ZR$;;I#'*CC6=#S->OUP`WR%:.//;XWJ!51/=-
MDOPJ6+.6^*)FG5%N-_-LH(5:]AKK-N7M<(^]@CLEPJ9!/$^6Z,??$#]P<]IU
MY^]V.\\&7*QGOQF[37H[Y*,OX/!ZC9/BN.SVD9@O6VSRXCXM647PQQ_0J0L&
M82??D`&W0#^8"/EL,?-Q](V?_2;4!?F+:).:TY*Q^=-IZ0TD8+KVW`#J$*^6
M!#];&OUR1PHV_HRV7`0TVGJ*`;Z^1E#0(%_AX,/H.+@C9`5#7_^9,=KES]X-
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M/MC`PJ.:F!-T&J(UYIU!1-ID1!3\1$G1^\E/9(6?1OG+;Z_?-=:&9(P>4)IN
MKWT*QJ`8@+A^-]3R)-A9'0KF0=Y*4M+6FIZSN"".EFQLG/^@_]G^5M+KW(ZZ
MP,[6/5T\O+BG.3@^S&1:]V4H,X!W_OKNXP=5_WQ&Z3W.T*5M-\7)-LO"UE;E
M7F-QH61YPO-74*>VXTHZ^0-3)?5UX2ECLH/>!V7H69\:V*J5?\Z58=?M!T->
MO9_WX.,:P3#^ZGQV$/S9.PB>KY]B_(+0+4J?HQ"QIX`KJFM&="T6;]D=SH.X
M_OLISO(KG/\#Y3<HQ*LD^G=],BD[+?)'E-X]!LFBF$%X*R#K\K1<QJ(\_KBB
M*X.FZ^(6Y8<LJDY.E,-*3B*6]275=8I#A);9!4$5G:YI4J3%0^TXEQ,#P/U:
MO@KHYX]/J1I!%_L`/J"%_WL_,5IXZ+U@(V.[CW'?WL<H7U3/DRQ/BUWZCF_/
M5JNT>)TZ3_(T2K(H_#V(-V@71D3[:58%8NVZ61+('W=U9MATXX!-!4`!YC\]
M#C"BG5+>1JG4KI^++&#SI+P)H;L];YB]ZI:],?:>A8KQAZ178!A%7%`8^.7`
MPD#QC]])H(R256DHWJ[0$"Q,N3.3Q0&XK-RTH[LE4R20Z_W)8]>[3J.0=_C4
M;<""_;:!9Z!EJ=4+<EN".U"\^Y._H!AD5ON]6-16LUJQ37011&FQYAU]D081
M9K0EFU@8SQS+]G"YMYP3"P_:Z'SGZ^EQ8>_R2/)LD^YFUO*HZ`I]+W[BWXM5
MZ=RY)`OK[)%[Z9A#VQV`S`#P?:]\-<F)F=#&)=T^J?-NR0#MCE^C^YBL2+8V
M+QA^0>O[3C(6]8[UY'G`CDYY6&N`<`\;`%RKY$;]2H7+_@F#7V?F52;9K?*?
M7@I3L%(8*O1HAW51#^M(@^A3O\XFN#K-N^[.Y]"XN]:D#(C2'Y2_5YAP<]_H
MD+ND_8S/X5"YM1E#']\SN0@NS6=-B@`#O6[R"V.MW./,U0JH;0M;G+;V<37D
MVP6L9BL>&`<0L8YBCFCC/78X/HGC/HGS*WAT,_I?X1QQ\H6K=6+M*@@Z.0`P
MD%989PW.A9N(96/>$K':I];N`;YQ'W'6J]0=GV@>GV@>GV@J'PD<GV@Z/*_N
M'ZD7-U]WQKI!,7T71V]V9YW+;YEDWC5#M.5??8FZL&>FC4O@#IL9^OS]N+[T
MK4<S0\ADKZV,6I\3\_HIP%FI]17<R+K.QBL-R!("-/F+I^T^9SZ4\B)!_+,=
M9H/Z&4ZK@74?Y.]H2/7A.$5W`X)%:9#YN^<YIF#0[[YC\:!W&K0'O=;`AT'G
MZ:,^Z#5*TSV\KO07?!2RFG`"ER-[\4R),3`82X#2_DHXB/7]#9W#!1#I_-[>
M7-__;E<'\7%!MP5+#V>B8=?J&*(,!^`[:HVM]SH5;^'[)?@1K3=KX>`SV[2&
MO]7&#0"T),8PE40@*#O48="B5"L<Y1D0HD0.!%:;-A":;9P'@D`E12`T*=7J
M!OH%A.V'[G60YB]WY`LU(Y^U]`KNIY?Z+Z(93YE`Y[P93L`),PD_;_D-!6H[
MLSNM,9A807>>BX&Y-@_#N]SV91_\\L*S*$4AH2V,Q^Q&G6W=9B.G(,6_="'4
M#0";[EV)-D7(YXB98WR[=ZX,[9H:NW/93YY^-S1II;;C@'*_^BV/9U,,P'`>
M1Y/[?6MY*&LR&+T1-;FQTETLCSJ8"D+Z>GE6^^WBI23OLCG"IA[37O(R.D_-
MN8R;?DRG,R%\Y8QFYLD1O7&;0T*PR\!HT?*/1HMI`YUOC#$1VY#"UP_O8ZKY
M_N\NX&%UH+ST_27426)?5955WO)U)-'`8*EJ.=XR.+^Q\BU/UB?'&J%1W'A`
M9:K)3MGSG;CH,IAAJCJ:Z?9/M!TOPYP=(<:*$!PACF'#_%CZ'4LX&E;[G7X&
MF'H>\&^T+E^2G_]`:1AEW+Q%D"Z"%.W=+A-U-04[C>(88GFJ@NI^PGA_[5\Q
MC34SB=DN?YDPY^J`[$SE8I>RFZCKC30^H[CM<+I`#F75+TGY'0]V]IEEV69=
M6I#N(M`\#G<H71N/"&"&IF("@.$Q*O0;([?C`D`;2&10WTMS)S)H;:HST]=_
M0]'JD7Y'/*,T6*%J027-.SVN!,:>ZVM(,.5@8F44QXLN8ZD'"#<_*T>;)YQ%
MM,B\\P&'9\BK#;T,N7B8+9=1:9JB73;;Y(_$/OS-^Q$XFKKO`.%XJ`'$V"BY
M$3#ZJ#/(]5$_EB-*8?9SBC/CEYWDG$Q%`Q&G8Q30'!6WO5^D1N79'ST]M-<V
MBN@+[2QZCI8H6=X$N?&Z(JI\3?D]G.\Q"A@9,;=C`EPIR+I`_<O![X6!R'J_
MXYB0B8F)Q@X?;,YC!)`VYV,(,31J_@:1MEJ0,/+^P,)(]5DVUI[#6#L-Q_T%
M0R/BMOOSE=!-V.>W.[/"X4V4_7&1(EJ@&Q$CY6.M"41\AUP1L/D>W=_(B+D=
M#N!*@5(/>!H\1$7OBA\7U3JI/)[A3O;:A%2J&'((3=5?^]IT'`?4D!*46]!/
MC]I>HQ1F@F&V:?E!JXW[$#=4OD=D&TME>UHB33(QYO8UJ#`W%K,-^QFO,QFQ
M6&]MNT]Q5;)=U2@RGM.V,EF-F$^.DSMY*]=%E&;LH"1I5<^BS&KER@AS,BE+
M%1./<BN;,HL:Z,JLCR5^,DS_=ZSS8_^:X;'.S['.C[4Z/^.7R..5^^YYH6!_
MFVA?-617"N2$4\/'`N=&P?&1.!L>)9T[Z)!+HC>(8I+,P*<X*23?!#&]G\X=
M-%N"=,9P?$&LA5`;+H,=&O16V![1'+MUJB4S5`FLQD^I,E`PNL#I`XKRPMC)
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M8@E$GF,LT1P[-V,)1`WMPC1N[18=X\D&_5.X]WV,*&Y'E,[H^1]3?K&R@V.J
M[&^U1;9XJ!MP6V>/9HS/.GM?&6<_R"S13EGA?D3M!6[3A;C:@=AXH:]66#5'
MW_J=6$/(Q,-;GW-SMI\"C<!I3G"C+T6F5BI/=+_?8NWJ\5_W',NFZA.>MHL8
M-[VO95.]#:#F!A#;.14?X;7YJ&KI/GD17>V;!K#4SJN'1X14GBI7N,^W-(="
M_$![4R">AG>?)#PGYHHV1LKM9#XPA717"A,)!K5MN1L<QQ<XI3\.%`7$S`R[
M/X_9T>_UQ\8+A^=I,NV,?L=Z1,=Z1!H3^21+%4$L8*V*T:XPVH&N./AO4XQ$
M(;/<A[G7*^=^C#[C#*SSD<>4UE74^?5@K^NH/O,=(QH9D<EPC.HITS%RV02!
M[_&LIRVJ*'>8CR7XK^;&B&6*W(?;[3G&I\%VA@XH$H&UUBXL.9F5E1=Q9[!+
MSL?(8SORR&Y`3S_V*!]E.W1ANJ^QCJ5M?8D?DB,FK\O="E4<JP2N\N;.]+:4
MRX)>PV\>-_D,MTU<\3DZO[%1\M;U&8KMRDX>[,>'=,?(UM:MK>W98ZP8<!2]
MC1T`1=7K%'TL8TE2W+;U/I+4!F'05027SW`;$\=5A/%1\C82,!33+DDTF56$
M-=\?8UORZ/T#C-,$_5_S!,.-7<1CT5K//-2U0K9P!]20?.MA'SW=H#M?/\7X
M!:&:=L)BMM+V+5\1M'??)0P5N87:S%+!6X%XNN\I+1:TW!_@O;G]^NGV_.]?
MSZ_NSG\G_[@]0WD0Q=FQQ*7UERMR_SF6N#0<[-C`.L02EY.LZ/TMH%8Y%J+7
MG:-%MCD6HA]N"MG<9^A?&V*8\V<DSY8G:]X.Y=SFKB@L3%8G:"I6U)44<M+A
MPDK:\OR0PZ4QDS"IC^=2]HUO-.D:@[0@?QJD"(+OD>M2EC)-TESLT)<NI3<#
MX@JHL2;$^-0!:/O@.]HD'Y&2UI+)@_-AZ0_4S`8S+O%)+LBN4QPBM,PNR$!L
M%Z"[2C<<M$&ZM"`G[N(:[KJA"VMI#P/@)2MSBIC+($ATX^%<4*2@I#N3Q<7X
M:Y06GU2\P"=IWHY\W.9>01"H=0_X\3D`H/>SI]`[GCN.#N2A3@XA$-?@/<B'
MC?O@OT+?BY^XRT^ESBH@KW6>#K!Y%AD*S#5^@WPKN0'@[JI=?,`D:R__:&(?
M]=C367@6(&PKUM6=LP'IF/&_$94V^GE\!)^)X^_:NS$`W--%H'_!AZ!S6,CG
M,/P@V+OC<+<X_=OB^FZ^N+J=79U]F]W<S*[N;JOT_9@LVH-\D^%R\;[]=,ST
M;T)PBF$/^@"[DX*^7E-[7,[UTMQC<;9[O^->KN"]_%4;L-;["6^VLB<)ZW;(
MV)+8+9DWLH>UKZ18'796Q;UQ[-&Y!S.V':H/6(^S*O<P&3]1!\]D[P>*73TD
M,1R[M"0YQBY;PSZ-V*5E!UN;;YS5L:1NC7!]J]JWOD*%]W7W#K$$D)R:M+49
MSXE2S7!YQBG4#)''Z4+-\MCKP"!JU&OFQU`[^O0LW#R!!\23*08_;H3QOA2\
MC0BC/(B.1QB5TO":F0Z/$<:="#-8RH-CC+$ZC!.*,LI57AW*A-"OH#TG6)@A
MVO+WOD3MA7+3M;O;H=EX;?!6H#5'W_KILB%DXN&MSSFT[J=`(W":$WQ?*]%>
MSHE_;:+\A<J/$R*=\%Z.L&T[UP2[[?%-KF''%(])OT>U3-J"5['[#!7^+?\O
M96_&C!$VM1R_=.D=FO%@;F+MS3,][UZ3*26,++-KPF_]ZA>K=Y#)+$EE:\6$
M3/3R#=*G<^-8V&?B0%<PV*@8%LNUK^UN?WC,A0IL\T[;H!7`1U6K6N(:S<DV
M#61IGB8/CPVX8)7K*R?&=R3CWJ!>,-".,*P^E-D]7PG/B7FGC9$:U*M'4JB*
M]<K[NN[<4NQA''%2UN$R7+,RP`Z6Y+K![.CV^F/CA;_S--DZNG+]7U]F?>ZG
M$;,ZV!#5.,U+8"RSIH8$_@:*P6IR#C;`SE?E-*EYM>)0OA'GQXI#9JI=VAF;
MH4A+"-/12%&(8T`:=9B]CTF*RE=A27F!Y$=8@A=0M%"H7)'[<#5%CQ'([&>5
MWL`Z'WI,:5W%'.7JQ).YN@NNYS[TCHR%N`/F?HP[XPRL[W$'K'45=S3+FAWC
MSCC<QZB`>(P\5B+/6$43W8T]FL^5G'A(T-=8S>VRSRG.C%]AE',R'%.8G+R/
M'^/5596/E+=U59FJ;>.`\J?/1+9;&%7F!]I:X7(ROHW"X'0,``9'RML`P%1-
M/7'DQS("),4]-^\_06J[1(,65N?R&6X;]5A6W?@H>>S['<4JSU>^@3K%[8=!
M?9_+9[@-A:/O&Q\E;WV?H5CE^\I9,8^^WY?/&-N)1^\?8)PFZ/^:)P]N[/X=
M"QMYYJ%#E44:W@$U)-]Z&/SQ'N"SV@8\0`]K:Z,,R73!&T@1K_IX<'A4I7[L
M5+.8TZ2Y&<Z"IR>-@A1F8N(L#/$FR2E"<1R%D?1%G;Q#*\:).EB;"DZ#['&6
M+.F_*#2>@YBBIA#PY8X,XR?"^P^.!93ZMHP![&O=B0&CC/M9A./1?,9U=P8R
MW.=R\/"HXA0G(:+YO:F%;J+LCU,B?I33_^(!4]ZC#4=1#]]`"-:^'_1$;*JS
M,:*GEY@[#U*:5SZKRIS"`B*P5SMIE:R79_A3LT(O#$I9[7.=>0C"BR!*BQP(
MBX>+*`F2,`KB>4*LL%GOHSP'BDI]6X`$]O4,ECH6Z05.(,-](AL/(7J%OM>,
MD>*$_&>(:OK!`J<NF19PU<EXAN&>=NH%9W7>^T6`\E4Y)\!-E'Q":?YR'0=)
M3G,.DQ7V$U48!FK5[BTPP[M[!F)-N_0"+YSG'K1^+AINB)7(R-&OPC/TC&)<
MJ$G392<9$BX9%'JVH`KJZ1E*U:W1"Z`@=GML^KE:8&\WEQO`1/%Y\4$9/2/J
MI>+E;0]*H*-#"27/L-S?6KVPK<5^G];70Z!_S<BB_SS+HW60(][->':C%CS;
MC3Q#GE#'7J!J4]Z?8/3%BZVSC^7Q[&/DZ6B7MG9&1%M&\89&H5L4;M(H)R*>
M_PCC#1G)"^(`-')MRA$GL&MM.\'J/9ADPBWZ8(:)9U%F4!OWF_H,2^9`[8:>
MBGQZ81,0I/0>@6,[7`W)T;&1NPK62%B``]H-9,-Z-_M19@1@86U#\@+/<$+7
M(Y=<V$U&A,3%*CZ(Z;(KPJ31RV^OWS6>QC@&=["A+B6U.4R3-QN"+GEU.OP9
M@-F:3K##6+])VZSI*]J^A[<N0J6QK)_]APEXEZP<M8;$K]49L'D]YAFE>436
MA]?5EV]QL5)8=0K8JWM-1MS+4<PSYEBL:PLEE.X9MZ[.B!D"IM8/-J?6&T0^
M=2):?U..-&';[D$"JZV7J(+H;0!+'#8`!/UL$T&UJ]]"]'#;L1X0--MYB1J9
MO@80PV#A^E)^JG44=1"B45)1!1TM\@!DO.\@PVJ)-*-;@.96O`J[4-(J:R94
M-+@:%JL&0-"O[]X=,=1CS\`WP%QVJDS^^FX_O]@Z?SL>OXV\!(Q62?00A?1&
M5D<^V>4ZM<[MQ2*PL_6(I'@,IF.3?L=;0([FKN%;"`YAAL,'>\%A^3^;+"^N
MV=[A&Q3B)(QB=(7R>4+$1)<X(W^G[[^N4_P<$=4^O7S-T'*>+)X0?9N3K&8A
M"=/EA"P)*P.R:@>D05AIA#(ZWM3TO[S[L#5\48RR=G>?S&1KG!0?3;-DN5T>
M9UNXD\D.I[-L>[\_69WB+&\?&)@CN#6B"8+V0]N08,,#6)T7*`?08U<3M:?\
MEN[0R7WJ=Y01F2LEBNR:A0JW*'V.PLZ-.=WN''^1=S\X[U"TJ&5?D$MKZ<$S
M!_DUWRU38=SAQ0-9-J%4@GFECG6T`SL>!LYUK&@#X4`Y[;U0@<-[GBPW(2K/
MN;)B#Z#R5B#,Y00D<!<1.%C8@ZWJ"/Q%\FKGX>M=#U;5#<Y_A(\TH=(=D3PC
M&A-%E+Q`T!_D!,S^!^X#<ILZY0),<;6ST`[E`>S/E4+F4KK=A$:?N44I"FN4
MY5_+0$+RKV0IH<-P#A-6=N>K6"JWO=>3''?YED8YT>%A\3!;/I,/=U38*J8Y
M[*Z#-&^_?53J4W<">9_#P+NB[6Q`6RZBK2JO'`Q?I]$SD>XZ#LI<$-P-4&'#
M.EHY#0\#HA`KV<`E1R[=7+A./-*=A6&*"@"M<9I'_]X>5M,R8W1/-2.3!S'U
M.MJLLSGY`-G:EG\DVX-8][A6B]CD?<2HM4?VH[ZR;WT-'O?=*C:S-^O^(UZZ
M\:_7F7O6*.Y\.-ZC8TU;W@*4M5H6^9GB]`P1H<,HV&;$J$<&CD<`>K3<0-CC
M8+`/MYLEP`L%U+U'TWO#QQ3,BV5D](P^!U%"3;5(]G\C-N2"'=BO`WEIOP,"
MOIH-K<%?*J9RW4VW%D+S]5,0I>6,-B<&3E;T'=@LRU"^O4%+C/09X^7W*(XY
M#J%%H^4<BC0.QE'ZV-:2TRB*['7&67HN0C?&%@_MNU"U]>`B/8V#B/MT7XM&
MVWW4:!R.^_2PK2WW41-9N3R-6XNP*V(^8JLO*%VA=+NWS-JU!;=O)V'FMS\8
M)X#:S!+@!>)57QC*>?0<03>GWE1Q7%C^6;[;I$4#5M",1^-@/*./;2UYBZ+(
MWE<%WZM[(G<0;D7.1I-#A#>P!N:(Z#W9@Q/^),!!<):Y"VBVX&U^;!%,N8WY
M"20:C0\+NC)KV00Q0S9S27]M?,DF88J"#)VA\M\U:YP&3U$>Q)+W>NH$VM^P
M"@0<,M/9=JCKV<3!)A)UEIJ'W=EZB-```NYI(TX@@$O2^``'2N!U3OBNDMO'
M>]EU\$(3+-3N>47<;Q--*E)D2ZA,#N(J5AL8ZQ)1>CSW<>2;G&&H_!&E]"(,
M695>1L%]%$=*F)?TET]SO/Z3PSG,4@,CG"N$[OK->6#7'9J>XO>'.I@B&/P`
MBI-U!U5KCN0@`+%T#^^<=1EBVJ<@6E8KONVW'=&^-$IQB`GV%A5B4D>!$9N<
MCVC8<&#W@$FD?#G*K:VM*Y2S=DAV.3WV.R2GF.99VI"_;<V)$UEJ'[/$.V57
MS1`W^2H%AP@M,YJ)KG:Z2S/5D94U^6.493A]N<(YRKK7SOJ0:+YD421A/908
MA@DV8DM.<#$C:^V%BZ*,RM?0!GZ'Q1*_]CSRZQ-.H/D8>A.3>P&(V&'Y@[I]
M;7H&2-J)[<^?;=#N:3%]IU-H_XACHB1\B0HA(M^(%A*9H-\8L>?@_J(KI>]%
MI_M9<)`UZR!KU4F[EE%[C^9J?:76?L*,R>>K;;^K3\VUHC)GZ)[W(0CHT?(8
M88\)NP/<4J-A72B2N1S+EH%<SW<!1#*OBP#*W2X'@F6)K:R`N2N3\FMW5]'<
MV4L`0EK83X!K3K\#`3?$:E80SA',ZZ=8;/V:%>W*;!;D#XC\6/Q%"?M08B"'
MD!,[."]1M*]EUY%+JYOWV9'34>E6FY+S,/J!_*31[^!<@F\UR^AO".;U54B.
MQ1B7P<T==6H2AVT?*1-WU:MTK<3,+C18%1DU1U34B9U]R*0NNEM.HDEJ4A#2
M?M@P&C!4)-1.3>7(HJ0!=W[0[;;IQLYZFPGC5V2-T2#:$D)W0\4=$/:PSR!+
MA4&6"%/W"W/V'M.1>DFMG['9A2,FCO9E:M*!UNJ:Q&&.J$S<4],/8O)!3.UN
MS-,%HCSFZ=E;+>8I2@^(>6"IM2]^N1#RKH.7[2??Q2997N)DE:-T?8F#I)F-
MG_^,1X-">V=.A<*$W4??DJ/YBI*(R@<^;CU2V.LZ"_^UB5)$[$B,D[_0M`SY
M+%F>D[\^T292SX`2X#J&G,!!^(6B'2VXA5Q"SY_NW!)SHC+])C7B18R_RU:^
MD"Z=##6B+M:4I[*0T:3_HB/Z',1TU,L<6>UM,HXQ=$BTC*-&PGI@``T_-F(A
MCL.+)*B[L1IG[6,I%]9];%5G)#"FZ0N)=T7&-R4(<_J"L-OI.Q'0BFTR"%H[
M+'4W0Y\*V)\GUF><P:'Z3UYBOX,&:\<JH\)5^0"IA"L1)LU=.314'99!'B[W
M'#53,IE_'>?O@/:[GC',@"K+-$1Y%G^'M-\N_C!#JBR3Y^E6;C=/3W%AKR"N
M['5>_D'ZA:K0M?VE"NKJ'<XU+-(3Q3".0]PGZI.+8%^OI\I<]$+O3A$IE_2I
M>/U&X^X-4Y%7@:8\RO,@?$1+47J"(>C7,Q:8I6\?YBJPQ</;F.<3`#%W.0G,
MBJ=;T6.85!X"W689JQ"OHH^(B0`=@4=D<F@'66M@2/-DL/1ZB(/;BR!*BP_6
MQE7U,O7\MRA_+/QOE^2TTHS^M:I]RP*R.:IU9)N@ZB?4C=O3!/9-"&7IQ2C'
M&6Y1GL?;)5XKL>/=8XHWJT?(^QX3I.JPUR;E)];-6,X$P+4EL;:V-U7Q]3ZO
MI89*HU64!#']ZVQ-C<"K,`/NUZGX*NWG'91U;=(3MPIL/7]U2769)T3S#35"
M=9AY06B1Q5B"N(\>P/T8()7T\QJD*C8Q"%()6Z]?3#:=</M12S<T*Y55PJF\
MNS"JBKI[C5L-"PT28T7<=;...A)JRQ=)=\$/NIR/EARX<EIULR(V6WD+/K&^
MAC#68;+)"'%<%-4*8HJG"*=1_O+;ZW?[G86QM\1,H8R(@;)<"+%NDPZ^ZDT\
M!A=74V/(JG,`P.K$3U@5NQ#BRIBL)IWZR/4FWL)*H*DA6#4Y>)W>3K&F*O?R
ME6-5576Q(]35$'J8=4\-7+7YR]N.M2_)'\K?F#\U1@+]R%&R1#N#=L:";A?]
M1&;JDO^<[BZ&]]EK6\@MBVN<;E**!<F-`6';%I(Y;:UY:$,>B'X0O1QP4?&8
M8)AR')=DTFZD3VG2/%X.G_#E<##0#-X*EP)0[7ZMK_45S]`3SB)NE:SVSYW-
MG>IG?S#$44D7)GMROC_/+`ME,0MDB><VA9Z='(*`GOY`2]T0NJ@#<?*\0F:I
M#6C="%HP.K-2%*HB5,$99Y"O!E6`SE__#9(!QV&KB3^`-(W8(>IY/B_N8_!N
M.3Z5+MW\MH(N'B!*06=E8(EI^YZUL%8T%[9[(>_0`I>H@[W9251,7K*]H="U
M/;.!NEKW-\`0XU[VX/@@GV\CT(/X57[IZXVPEI9*D%0"X41@-SS0.M!2WJ!S
M!UJM<NE2=(G;=P'&:^\?QD":]X49C\GT%A?@105X,>$=J(9%DP!&O[Y[]\[+
M,X6:3JV2H'0MGK_`5ZR@[GS(2;J[%]&)P%<X"?7".[,S--:W.KODHS`00*8!
MD87D7BR4`S1#M/A/]TH1?>L1E04FZ#E5D8I@A9*0GUH4T*-]@BCJX35^X;8P
M"%HATVJ[WM=M.9E!-&<BS1G(<W@J6L4@1N6<J[L8!NL>^SLZ6COV/<>%MZ%_
MXNM1G_+R57G!"E^B>@9%L"4,0E'$LYK%?-UCK*77V29E"^)K>L.#P@&<EU?:
ME9^?5]#5.E"5-.P<;FKG.>+RZIYU]D^HYFJ&/"6#:W[>&QH*.'>WLI#47L_?
MX4^HO`'.NIP);%U/GR!J[0#,(%..FM9<+(EF&"F+"C"^)M6;+9=1N1=!7SS-
MDVW%/]XVE+AU>]^)U]H3?*EIK84O*8L*7[ZNI&N^([Q5SFG&V/YI-O,,2A(]
M>V&H2[L"CZ^7P:\;-=)%^!&T[%[Q[;;T#$5R;7L!B4F^PI+RZ90C6+I!>1`E
M:'D>I$F4K+)9&&[6F^):RAEZB,*(]Q4%[]A"&J2C9\!3MD4O'$*X5;#T]9X'
M>%L:O!'MY-9SWSTDD[`2;"&_5[[$T=U"'O=1+<T9&.-LDZ(WE_/3\ZO;\]G5
MV>GBRY?YW9?SJ[M;:X]M!4=+>YDE&UA:-.`GABP:+IZ>[N6\(^CX%'=S*_8C
MHF.Q&A'KP44/)K"S5[G9.+%(22C@F2Q3F/V^HHOQYXS.X;&]-__',*1FK^+=
M7DW8.WJKEF,78=N6_IRV_L<.B!%,AP@.3\^??E_2-(<SFL=^56SNWQ&&9WA-
M/@%X-S6D'=IW-`0=S.W:?PF2S0,9L4U*AO,6I<]1B&:K%!4LOZ#U/4I;"JEV
MJ^_C@[I9=S/`4&%M._!.DKD\=SO[(%Z0&WO*.0QCV\Y&-$TR6CRH4C=C0A/<
MOG,=BMO>$S"J:JZ%0@`3S[-DLO2?_8AX5T)ES0$1O6SN),H:FF"-F4P!9)17
M`V("'KH/L*U',9RL[E"ZOMZDX2-1;[\F.@URM,+IR^)AGJ/=[TOQ>J(?M38T
M=:D9O#^0!LN`O^)@_-RX(5#_V;X[]1P<+%6:YUMZC/>W!^H,(6L)Y:UL?2_D
MX.;J=,Y'3>?'.F9J/TX&,3R%!\)+C1TDJ[$#:)G_58"6]H\-M.Q_G`Y:.`H/
MA98].P!:/HR(EJ%G^$\O'`N)5I?]J(%G>`DUA\$.LP,VO6A2]@ZAG(UEKZY\
M0V0KLS#4XOU)R3<(`_R<D6*RD7U^E.1U*^XP0Y/3%C82?;0'0)>[YV6CVX:Y
MC!)$M>3-$=+VDI.-6GM_H`E56A=\`OI5G/457[O'"+<A2@*RZ!*L/X1M>4]P
MFFW]P11$65T\<6A#/IB4<69["3Q+4;!XN`P27OV7;H/V1?Q:`^?PTPTU&*`:
M$#@[XHW+]C6B%2H<*;5ZC=*0JK5"BX<;_!+$^<LBN0WB3@H%8.OZU[:HM1^H
M4%-:!R)2#MJSU3!X.<_R:$TOQ'Y"2?BX#M(_KH.70JT+G%ZG>+D)._E]U3O6
M403LZ!&@=$RAC2T@LWTV*$>`5O>)>5*6I)PGQ4?=#6)7.P=VX84H9A>/8*6F
MOI%@Q62S@Y+Z)85AH/3UB9@TR<LC;W2!F(]9N8WJ<&$T\@@@,A6U(<$@#%@8
M__KNO2,`X>]4[,'.PHQ*OSJ,8/T\0I:&(;3!!N,%PM^'L?%W3-4Z[L=<OTRM
ML&\[::+6]^IIHEQ`6;E_GBSII![$VT(KPDM4G+;,&U2=MGXA"Z)P'U1QZ.]7
MZ0:*,3IUN%K6Z%8^16UV`Q^75MT\`YV:&7KA3\IJD*LB3H#TAIB-C""M?7>&
MGE&,B[H>X@`(ZM-YKBWLXQ<V50S0!Y@2/OL`Z6FMX^WIPM<D>T)A]!!);I!*
MV[?/>/CMC6[=_'T3I,2@_&M:O#:MS9E6&^L^(;<WABG(>U#.HU_??FG1A5SQ
M5$ZB8?S2'I'['\1SA8CH-FC!H=[`+RQP5>L#A#I1R'QL'P6+9Z)4D)P&22B*
M#H)F=40PFWF$"[F:VNA@DH9<V+2/D4]T2SF7083?JHX05BN/`")54AL?+,H`
M>/QL'QZG.,8I"LEGL0PBXI;-W)3LEAY!!:2L-EQXU`&0^<4^9+Z@.$B(0H*W
MT,P6C6?/K18>04.HG#8DVE0!4/B3&2C83$/,O%J&U3_(9(F&ZWP:]]#X](?_
M#A@WT\N<.G.&@^_6<KGLDV(L'D[QFNXQ%)IMJTN>XBS/;A\)>.[IY>7J7H4D
MN8L9HJWO^KY$K6UX@`7_5!=<EI;*$%5=(_.H6@]CAK"'A[(T)RKV$[L>/GN+
M:RZIOJ5@FA^CZ72CZ6WXB):;F(B]!W%=@2(3Y:)8(F2S,(^>R?J@N.HN"ZCF
M"'<VI/L3GF!8-6[OP2.K"8EU@ZOM!Q,UW3NI7J]PCKX%]!EBGBW2FVCU*%^^
M]*;'=S)5>M/VK5[6'=.E5`75?4ML^W,OS'"&K*U02M/20<,)44MX\BILV_(_
M3MN!Z_:(-D:ES:65>YS9!Q,/A+!JC\J&&).-N&)/*Z&:KV5-.:5BA-G[0'U@
MU7O\`9J.\JIH`_+80L[7&H0U=Q+"C-N.7\;'/SC)E-2%$(.N;F8,1V#3K",C
M1(ZHJ;"`CW_X`:BJ"R$VZ>JLV%,4M:O`"'$D;BPIT.,?ED#JZJ*)1]SSA+2[
M,SU1:GMV(UZ&#F8R>QLJ74IRV_`;\E2[="B;#6=06"E'>/K)SGGYB48N.QEK
M/GJW+U;ITG+]#)*Q1M2'!QYV'Y]P!-!:'U)LXKKIM@:XV;5;D)8?T%^)G.<_
M4!I&&5H\5-M=Q>89,\>$%@'.3@>$@#O`ZH8?QL:'LDUD2+OL/,Y5Y&;M>Z,?
M`IF/U?0):"#0F0=LYA"H\H:M/P(K;IY_J\R6_[/)MBG+,&]/*$C_N,/TGXC[
M0ER33&<'3Y6,X_@U9!\E%.OSU#WT<>+E&T1=]LGR#<KR-`KS[2[$UR3*LQM$
MECI9E*-MC9UKE$9X>8-"O$H*RCT<80`I-/S(J!03<L/A1F<P+S8J,N06\-@I
MOLQ$B"N4SY,0K]$ESGA?C\PV+>]JM?$$^R+-M)#9(KA_.>UKP?7RHV*QR;,\
M2)91LN+M,/#:M7<5NNT\P8I,0RV\,(CN,[TI7]EZ*B+7>;+T%C7_/)D^;CHZ
M&D:.\D14PH:P2W/KP-E_8IX5Y1S+R?CW(-Z@4YR0H)@1(]$[8/2_\^@^)K-V
M2%K2'%'<S4\#-#N;H[UH^@)=@Y;3`WD_`3R_(\31?NOY-+&+&N(9'6&P;G3T
M&[M\&Y@$:(.+[D&3VR@L?%`#A-U^"J%U$A#D6L!XB&P"T,^\G$(/,[PD4"2J
M$CPGORC0LYWYH`M?%OAZC[/[;D&$<F9#%G);#7U"HTA'?82UJ/;(@N?.=[D^
M=/A?YE,"CZ%O<SY\-+'CR,?Y5FG6VRG)DV*EOKR;2.*^[H`.I"/KHA+KGJ(,
M@2)FS`M+6R9&WX7:M+;P=E?-RI#'93)CLWC5C<SAX?'+06SMX6!YD+(SO23`
M2%JW0@JWM;7@6MW/)FO9ZN@R"FE"WBC>Y/M1:S^8A/5J/YV4];+NW++1Q+HF
MX#@XAU_#M65\=#\KG/C,GNHYL`*0-`Z#`;!AGPBK)W''>1`[!9+9<Q#%1:X)
M7+L>N%V&%,X!@1&<B@AH$"K>0E'91(;`"N&K>\+B!IQQ@LGG%;%3LBK5WJ:\
MERPUP/W:D)7W\PJDBF;H`4LY)Z^O:2XJY;9JR?)S2=NWBYOSV_L$.*C:^D`3
M<-"]7.'(IO&BZ3^"59Z@)0]6OJ[XY*H:@!)C]??^)^7'.4Y,F,5Y8O-Y^EGT
M'"U1LLS(EU#M6BX/6\H$VI!3(.`5$G4-TP.@"BR5GY1]+%&;H!5-SV4;MS?H
M&24;[FEP^^=.@H'J9Y\0Q5%*'R][@KH[QXY,A=\03>R&EC,B3[!"5QN:$&&;
M8;%VGQ*V`=>/6`MINL1\PJ41@^FC6)>]M709W$>U67Z'Y\ER$Y*/H?`Q2%;H
M+@V2C.C;?8FETJ7Y<%;2Q3KRX!^A6,L,'*1)V=:>SDK85=$4OB7HUN0Z6^,T
MC_Y=6&CQ<!$E01(2JQ0I.3E!$]*E_7I/V,4O&&J8H0\,8>QV,/P)/J^[#,0S
M=)_3K+'T13JQWCK:K$%H%/030I+9;PJXE!O$/#B9/"N$?O@)O@GC%D+/4!H]
M$Q6?T3PA)M@47U=7.#]#6;1*J(2S[*]HN2H,MFOP.8@2NGUPQ<TT8(QN.V5_
M?[I^>H!I@YKP$`,R[3W(ST*^\X2(@3))V6A.J\X-D%8K/Y$J5M8$[CH<=BCR
M-`H7&U]<$XAV+J6=6+N5@DY^0D[)%"80*&-8`=+/3?7Y^BF(TO(F)_$U\GU(
MWRO,L@SE&?E@C#=T/^(SQLOO41SS0IX.C79`5*-A';ORTT!LQD`<"'/Y-X*G
M&M_JJ:#""M>E^9GX:!ADCU]0ND)IO30'_R*%N'WW`@6OO5]PA"K>!WH"'KHO
M4IT`64=YZ"4)Z.4(W\`D4[0/B!BTM:N>.C';[A0J7&&6+*$HXK7GH:G;WE-4
M210W@JXN#\_?:-X0HY"!>:1'2.@9Q?BI>#TB_,0`]>F<30O[^`4Y%0/T@9V$
MSVX19N2`>]Q7.[NSSS>GF'0C^BQW?\KPP]8\.,FNBZ%[1'D4!O'QB<\HVK)3
M$G*4%3=F9<=B-+;N_PH7`T`*ZQ_\\\A/K<#[OE+BF\OSS[/+ZYO%Z?GYV?SJ
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M#B&.(ZAU%E;6YG>>K@-HF6\L\$.%TTT4Y!;P@:MI6"<AT`]I3:UD+CO`YJZL
M^^5`M`)H'"*TS"[(V-*DT\06:/%P75S&1]=Q$!8FX0);I7,'X+#.4P:ZAOG&
M`SQ,./7[\DXCO_;YK`1Z1C\0WAO]#@WJ?*/917E#+NT*B+8!7DQ2Q&%#WD*\
MVX!U\6+;8+K8Y)IA+!#6!:C09B9QM2N53*[0]^(GK8HEG<XJE4EJG2>,8!WS
MC89NH'##7U5RHB0%33249JC\C'B*(WY)`7!/:<D*1L^).X.2X4;U!)ED1@L7
M^%%\!8SCPX*M,RC5SP]EN\(#O2EVO"CFS44Q,W;_M,FB!&79&<K"-'K:2DYS
MGF5T`V.OP!V!U*>8_Z6O3ZAE41U"TXUTO<TZ5B34$51W^K9]L;9VL?[V;G'Z
MM[\N+L_.;V[/__YU?O>/V_`1+3<QP@\WB)@I"O/M/OCV+//E#.5!%&?60BW[
M^<,L36D^.CJ^GU[V3:Z#E^(9Q?<@79837"VC3)&-X>XQ2!;%>&=7M,AB1O2]
MP7%\@5/:2>E-R]!"@-[*#">$8\^-3"CZF9#(LWE2?J>./MAL]J,-<YN]]7G(
MDEM)WVX-/M:<:6Y<>\@?F0UA!\!>T'L#;U<F%;9VHU=F_;4W237YCS\_5?R/
MD<O::!]0Z.H8`A"[?E&.7>[46#Z4^,6O"'V,8%.,8.#:V,<8IGD6YU*M[\%,
M^7MA1VL?CVSVHT6P-OMC`+,UU@<4O=IV``2O#_#@Y=8KI.&L2(;L`44V8Q=7
M@M'"%T."8P2S..('%,08I@#$L9^/FV"<`6Q5PBHV&,](!+\(HK1XB^3$>8Z.
ME.-_CJI).4%4-;>GI>:P?&0$EL_2F1)`OD.8=;5\W\*IE"J<[$W:*A:U<:X%
ML.3QX&O(\7=XHG=X=C^&8[OA6!M$QTBL9\3C"=X!!V*;YW['4#R94.S0<>+D
M@_'Q*%*TI4BS0;L7D'6$&_L<`"C<,23;#,D]@'0,R;IF/!Y-]#VF=B\B:\IG
MZ6[),2X['I?[P>D8FGM8TNP%&*>B<^=M^A7..^6<I0D'6)VDR0>:G>P'%YA6
MXWX6\X^K>0XMU&+DK]&&]".5SSDBR-B-"!\@IJ;>2*>!3A5Q[`Z7&\4<=S(N
M&")*9R"%OIV)"-377AK-T@^RK7A5$D51871(EW;R3&$7!T*IR@!C+5-PPQN`
M=2/EI9#EA"\@!#':ZESD6I1DJ9<U;[LIM[F_X`2:P!0P^>RF6\HPO,^>7)C2
M=AEQKG$6%=@$SVC2KOP)3=#57)G!6C+?._P)E9DH"V"UYR=H\WH!0F%SEUQ?
M/DQ8V0)RS^=RW146%'(;X$-K1/^:A>%FO8GINZ$S1.0G=J`F(/\=H\(6R7*V
MQFF^S5EUG>(GE)+U;DP^"LAO-%(6M=LY/FB:?,M/S9'WS@T&MG!/MS$OG6[2
M,O(1>X_M^UDMA"B6(E+HR:]WZ'`1(EW@J]O%$*9!C'6K9KD'UW*>*^<\.419
MK65E.*O64X"B0'_S\&LRTTV`Z\0ZY%C_U1CX5.M0]08@H\:4<OUA-T&XV.19
M'B3+*%E!4<CH(H-AH\MT<,BWQ%!`;'#4K?[N!!*A-0K9>]<'4;Q2%Z=:UC&$
M6"AOW1K8CJP>684(A0M(>0=`Y4GOEY%@*PR"1N9B4KGXJ8/1$[B>A'7RK0*J
M22P.O;"4\=2M7^HL)N7+2V`O`"JGL<A4L\>`N&0M-7_Q[7A/6%#A+KB/D<5R
M"8Y>HQS3!-N2%HN'_?4_U*AM\36)\JPJ<%$,F*Q>C!&:;0/VH^E`,%*^9&C0
MBOVO!/839KH7%S)TC%ZNW8/?3SG22*7:'V089G\?(Y"F=?I'&SCC_9&MQ1!P
M8B\&;.XS]*\-T>?\&<G+Y<F:M^'-;6[/XULB23U<UEZBLE,>+!L]K*XWSU<Y
MK!I>RF<!]\KM+_0?]T&&R%_^/U!+`P04````"`#Q:ZM&Y[NO:#T1``!.MP``
M$0`<`&QB:6\M,C`Q-3`S,S$N>'-D550)``-UYU!5=>=0575X"P`!!"4.```$
M.0$``.T=:W/;N/%[9_H?6'_I=::*+#O)73+Q=6193M3*HBK)EUZ_="`2DC"A
M`!U`VM;]^BY`4N(#?,E.`K6:F\F9P"ZP#V"QNWCHP]^>UI[U@+D@C%Z==5Z=
MGUF8.LPE='EU%H@6$@XA9Y;P$761QRB^.MMB<?:WG__XAP]_:K5Z'",?N]9\
M:PTF@^E?K3%[Q'Q?8/40GS/::DGX)^&^%\X*KY$%O5+Q_LDC],O5V<KW-^_;
M[<?'QU>/EZ\87[8[[]Z]:ZO:LQA4N#K`B_/S3OM?=\.I:G8/3*J!6X1*KAP<
M8^6(>9IS+T:\;,OJ.1([<%GK^CN$)/";=E@9@W*\*&SX;1MJ8T#**`W6>EC7
MYVU_N\%M`&H!%.;$V>%5(V40\%+JK9"J=VW./,`*P9(LDQ(1927ZY)4`_VN8
M4*\W)RP%*PM>.6P-L)TWYY>7G1C2Q20M<X&=5TOVT(8*"?RZ==YI[<%A""\1
MVNQ0%DC,%0U110H%^3XG\\#'MXRO;_`"!1XH.*"_!<@C"R(%@3V\QM1/`22J
M?<27V!^A-18;Y.`*EF!26)::%HA2YB,?)J$JBTLW&T(7+"J"0CD&W\<#<8(7
MEIHC[Z6&K\X$66\\*7M5ME*#3O;9BOO[SX;C5R"6&$2JN$1!:@0`B@!^%6G#
M?<=Q$X@[N59R<Q@:81O,?8)%8A:U7XPM!WE-V0(4)_",YLK%BZ9<`0JAQ&2F
M/#1ORA2@8._K\B/;F0$'EOSC?C+03UM%S4"R`Z;FS")@/7=?NP;C)O>J^!E6
M':MEW3`GD)8C^6>7NE:?^L2'Q1+F.5^K`?FAG6TAVW@@L&O3G]7?V0D:84<@
M99B9.5`?,3W,]'A1:2S99PK<F8N$P.57N<`O0,I3D`F.)-YCU,44*+2ND2=7
M*&NZPM@7)U'K1+U)RWI3(>S+FL*V?A@C#B`K[!,0R%].PL\+7S"6%+[\+!?^
MZT+A[TJ%Q1:6#590B>`TYK5BE\M"4N[P72[XMS4%/_69\V7%/!=BK#];_=\"
ML/8G%>A4X"S2*H#O<A7\5%,%/216UJW''D]C/R_X)4/SA-S59YG8.Z$W0X3C
M,1%P#!\?^Z/^I#NT[,G'[FCP[^YL8(^L[NC&NKZ?#D;]Z?0D]IS8P<*@Y#H;
M?I<+_B(K^.G]W5UW\JMEWUK3P<?1X';0ZXYF5K?7L^]'L\'HHS6>='NS0:]_
M4H%&!4F37V'O.SDO9SJS>__X9`]O^I,IV/5_W@]FOYZ$K!GGZ#$US.&S7-"O
M<Z-<2MJRQ]*L3)5=^=R=3&"@GP9U2MY[H;6&,.5'TS[(JF??W0UF=WV05JB&
M2JAR[;S):B=J1.DET<Q)-1I[TTD9G$Z%J'_,F_OK*1@:$*_5_^4DY.)U-;>P
MEJ^L%\]:62&L91YQ"!:GB%9O__W,`N"7:N.RR0I@_3!#<^\D^B+/WLVX]FZI
MZ%^?'^+=6S_<8!\1[Z2$(GOD9NU1E1HN\FIH9)%."JEPD)+>>^B[CQ"7";('
M',DNYRW50"E7ZJ5&J9H@POIAU^Y?3IJL6%JHFUE;:-74>EV@A8+EY:2+VKH`
MRP;_9142EU9I)>^"E6A%GN!P`P^'"5;D!_M4JV5O5)K[I*^:5C"2,`@XEF\L
M7;8(92O_#Y+]+*<"]46I@3RXM:KQ<?E2XR/N^#1`#LPC%.F_%+A<O6_R1KD@
MKW!2FEYIN]1D:[<+LM\$B:9<M`L5[D&E]F)#73ZSC?+-FA^?L5]VVCFN.U_[
M'[O#\<3N]?LW$!)H4GY9@/(4U-O<K)3X5J*!DRH:S,+])GSSV5>$6S[KWC0^
M'G"::P>'D&$JJD;@&`&69\'T#D\N6#SEOYJJ:>^03K#P.7%\.=-@U>DZ$.C!
M<E,_`U"[J:K,@#[Z"?OZ\W2G[*1?N^\Q<FSC/D^.;8U1L=M*"7=2"E5>`%>N
MSY]TZ;O,WLW_A9(^M+/'V*.2]'%W==B=K#>,^Q;5GITONHH17B<9,D<U5H(B
MOUHQ7DL6M3H7K<O.*^@Z/A!<3H;^@D=-`F($V?.;^GT67!:IV:F"ECV^;9U?
MM"Y^/+!?_<63.C0D,4<AHB3GG11]Y^VSR3F,E)>B0W-+I@XA'N<IK!<A)'GU
MIMF4B/$.FA*%EWKJT^`=/A>++OX4=*[%D7^T]LCU*2B]1U1&@1:QC3U?Q"5E
M]$37CQ1!5V<])OP9&U`W<'#_R5DANL0SCJA`CNPX7,WD&OB?2LCP`H>ZX/5^
MS2@L37P[@`!!&G-@*)@+G_B!A/W(6;")00F`G%F4>)YT0Z_.?!X`.`)H#BU?
MG2V0IV[,*>!Y>!S\ZLS%<^+'I1!Y$.;.5/]N$$8A)3S?(L)_05Z`[46/K8'4
MT-^B;IS7ZSH."RC,K%O&N^*64.B3T*64@$A(Y)GM'*.\?@&/$>_X^RC_5=Q-
M,7\@#BZ03C76T<@BH>B!$`%V9\Q>+(`)KI="3?AOP?_S.0TG?X_1Z+:OO8AU
M6LYQ&=XQ:[Z>V6R"=C32T-L^Q<L"<YX8YV`/;PC'CL]XI>VLQ#\:^7SFT"=P
M8"^Z[H-L3LS8!'O271LC[F\3HJ@&/1JNQYPY&+OBEK.U'.VR17LQQ0Y$L"Y4
MKHD0C&]'S,=BA/V$$!IC'HU,;@#\0>W_#PF:$X_XVPEV&'>Q>[]A=,]L:!]]
M`G0I-F'@=WT?R7R-QLR^;+,&KC\E#';%6-7AL0<.M<21+E4]X13A'LUXTEO.
M<&WY3/R54O(8;24]>Z9EJ<PF27^TT@PW:^QH)#?%OA\6@*D-7?.8M]D*2%NN
MDK-F)XV$N`YNX9O*R`&3^7)NCK0F_2?,'2+PWG&;KA`O=W3+\9("$:K,-'=7
M3W]WG9E!#?&.<B#,V#4.F;O#ZSGF>O;S4"&SX8LT[UVV1H2^`*_A]\OQI.Q?
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M&N_H^)Z2IX/XSN`9Q[<N4R1224MM_=$D1.)7Y+K4#=^02SPAI[%B]<!-,U>)
MT/PFD.2,%;X*Z-0>W#ZED\QVR31I:+7C%"))A4XOVZPA<>7AX@Q7L9>7YZ'M
M&I=?ZB\66)ZNA!7?86L\0T_2%90Y5>H`U0J]_[3!\C2FK)DQB!DZ"0$=VH!I
MON9'3#%'GLV7B)+?0^-!W>M`$(J%4&>1$US7@C[`Y+C^^]56"B28X\'7,SY#
MAN@(//^5#+8WB+@CQJ,-&>PFV*R`.Q[S\)GQ+_*("]H0/[Z6$.YR9BK,6"0;
M)=)ZLC'/PZY<`*/=^[+L81G\\6AT'^66YT*N"W(A7==5!W^1MP]N1.PN=#1N
MQK?JT#A'Y9E))W6N2@QHN'!^QF2Y`N/1!1N"EGB7Z@.KHD@-D#?#?/V"2:\#
M^T^J(9;2]P[ZETNNCM8.J!P7@CAJUNH"^RI(TP;9+BG7?2(BQ4BJ_+`5U270
M@HCT][5FB?9(2"[T+`<S+M*<8DJDCZN(+N*H",0X;N)S)CUP7X`86[HU`PJ+
M,-@#Z;;E>*N+8!RG275<G'<NBL9A#L`\3O;Q5\8TY&K,-0X[*W:C)*JS;W&-
M<0J(/<3B+;U"".-X44-F''"@5^"$]UO,6VT,XWB-;%9/^=B,)\S8+B_87<I=
ML/S9B::8QO&>3-ID9YRFSCCZ!Q!A"RGZG&YR->;2#L-&+9CRL##1.`Y5@,9Q
M-EMAQO%:=3?TG!Q#!?7&\9&V:35-G_'VKKO%/,KBR(%$,<P1)'S,;P/J#C<Y
M]FK"&\?G-2<P:[QP]LAR1:^?/P)7!6@<9T,9UA<.1VVM<3R,PUPV6F)[80>^
M^G%!<$1_8?+D2?CD#X3DF./,CETC---2YTVH[RY\F4N&;@/'5QLJ!XI!UY!I
M@HFF8&1F=&M&(831(WO"MLCSMS:=(@\7C>,LD&G*Z4.7:WF;Z1I39[5&_$N4
M/)3;>F/.7!A7J8VN>O"&9-"K=Q"Z,+20)[/5H"`@,KDVYJK,V!9I.$S'S(<_
M"7#":%`T3+-`I@U3[5GHJK/2&394?OS[GI*N,WLN&LZVBR.:;77XN6S(_^7_
M&/^O&_+_^G^,?]&0?W,.Z%3S/T/K#1IB6%+R<7.NRCCG1_XH,H2+*X(7_2?L
M!/*\2W0//,=.#5CC^.NOUUBHSO;GY'7N:@6<<7RE3S83=T#E+^:E5T\MP-'X
M.WD&_D&H6\IA"'`T'-XA&BQ0%.-%3Y,4IPEJ01LW3I][QF%_D4.H38H-B=X\
M_7['+EZ.)`-/8HQ@PJPW'MOB_'*FJ3-NO/4C`O-9^5R-<;1KK[++V\W)AWS&
M'(?OM:C:_-[#X6T8)X_]13?-+>ALE7'4)\]/)U)^]MPCR]!>:,XNU$4QCML1
M?NP7VHU\G7'T3^6Q;K>0!7VU<5S(K81KPGSLK"CSV))@6)3RSFXYF'%<59SY
MTQUIK8]RP-F:;[.`)9[A*EG,=%#&*3!Q8[G$DIM+?[Q!(Y.F$/..P?>_..]T
M\EHIAS..+^75%D<<^FKCN+A#,&V?5&]J#XVB\#"ZSO+5@#6.O]16(,SWZ*DZ
M>?<QOGXD_]X].A&GTQ)L'][$T033,J*R%RK9ELS`)4L-#+>2^S4P!KDD=$`5
MO1.<>O:H$M*T[9U(],21OUV25TE<;J!2HB>D]I%]&-8G[U8501C(3?F%OB'\
M*PE,6HO:&*;Y3E,`QR+Q_F)%L%P3WK@5(1I^<:R?=T2*`$SG)'^<OPC`.$ZJ
MSAX?RPEC_;NPV8<7ZKPEJ\4Y&G_B!@N'$Y7QM>DNG+P&T[@@#@'K^"@/5J[(
M)KDP%^;<4D^EOFS#7\4(/^\=V0VXD6$6ZQ-&GK^"U>-3L$8T?GX]-SGJHQ@W
M7X:,_HX^(^\+Z.,!.L#:A$L)D'$<C9$\-Q0Y:,7183F8>5REEO;PE8OXU5`W
M9<M*X5*SS81G+IH\=U_]AFP-9.,D4/8PS(SMLF,UGY))81AR".6YK\0TDH(&
MQ3B59R8I\]P!S;H;V7<B&N`<C]KK,)6;]4V0C%-]DV>+HA>+#GST:(=]/,.A
MP1M9M653BFS<\$@[S;OS%OLMU(*46@&L:4DU?:15LM6O^2&+9[1Q--%;ST-"
M["BW^42>R-D%6_'=/S!Z3N+)^`A,).]&/+>AX[$=7>I#_+E1)W,#=XGA_W)O
M@+KA4:?4)8H*R*,9)N%[F5/R]'=$`R"R]M.B=5","X'B7R*V%[LSV/<"+P)O
M2!YP^+2;[I'A9F@IKDUY5/@./9%UL"Y-LEQO/X$GE-DM;(+V3=>*ZG/I38A/
MKH3R%VKN$/^"<Q[TB[5HF*1Z'+DH?S`A66K<7![U!OES5OLRX^B%\1#M+N<3
M2;DJ$ZF7/]>@(SU9;AS=H\&G_"C9EQE'K_V`.$%4O>.8E[:VUC@>KN76O%_`
M@J[2.`YZS&,R]X.\`BZ*`(SCY'ZSX&R7I+[%R=5,4V>&WUIC:<?0!H@W?[PI
M4V&<0H:,+N4!D#APDE$G41L_>X<AO6]2`]PP=^*>RO>$)[H]DWR5@1I"96^5
MZ&J-XT'&:(0N;PD7^M]IRE8:QX$\.FK3_#GT3+F1=$-$K*4[4?X]Z?[0EF0+
M"&K7"#[_"U!+`0(>`Q0````(`/%KJT9X_MK!9U\``(-*!``1`!@```````$`
M``"D@0````!L8FEO+3(P,34P,S,Q+GAM;%54!0`#=>=0575X"P`!!"4.```$
M.0$``%!+`0(>`Q0````(`/%KJT8V7=FX3PP``**I```5`!@```````$```"D
M@;)?``!L8FEO+3(P,34P,S,Q7V-A;"YX;6Q55`4``W7G4%5U>`L``00E#@``
M!#D!``!02P$"'@,4````"`#Q:ZM&GQVR$G@>``!+-0(`%0`8```````!````
MI(%0;```;&)I;RTR,#$U,#,S,5]D968N>&UL550%``-UYU!5=7@+``$$)0X`
M``0Y`0``4$L!`AX#%`````@`\6NK1E#$*3N&P```Z>\,`!4`&````````0``
M`*2!%XL``&QB:6\M,C`Q-3`S,S%?;&%B+GAM;%54!0`#=>=0575X"P`!!"4.
M```$.0$``%!+`0(>`Q0````(`/%KJT;7VV/^NCD``(!4!``5`!@```````$`
M``"D@>Q+`0!L8FEO+3(P,34P,S,Q7W!R92YX;6Q55`4``W7G4%5U>`L``00E
M#@``!#D!``!02P$"'@,4````"`#Q:ZM&Y[NO:#T1``!.MP``$0`8```````!
M````I('UA0$`;&)I;RTR,#$U,#,S,2YX<V155`4``W7G4%5U>`L``00E#@``
;!#D!``!02P4&``````8`!@`:`@``?9<!````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="margin: 0pt; font-family: 'times new roman';"><br/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b><font style="text-decoration: underline;">NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES</font></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b><i>&#160;</i></b></p> <div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b><i>Net Income (Loss) Per Share</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period, excluding unvested shares of restricted common stock. Shares of restricted stock subject to vesting are included in basic weighted average common shares outstanding from the time they vest. Diluted earnings per share is computed by dividing the net income applicable to common stock holders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation when their effect is antidilutive. When calculating diluted net income per share, shares of restricted stock subject to vesting are included in diluted weighted average common shares outstanding as of their grant date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">At March 31, 2015 and 2014, basic and diluted net loss per share are the same as the effect of potentially dilutive securities was antidilutive. At March 31, 2015, potentially dilutive securities include options to acquire <font>1,907,877</font> shares of common stock, warrants to acquire <font>10,162,726</font> shares of common stock, preferred stock that can be converted into <font>1,847,000</font> shares of common stock, and <font>507,113</font> shares of non-vested restricted stock. At March 31, 2014, potentially dilutive securities include options to acquire <font>638,750</font> shares of common stock, warrants to acquire <font>12,156,156</font> shares of common stock, and preferred stock that can be converted into <font>6,650,000</font> shares of common stock.</p></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #222222; text-indent: 0.5in;">&#160;</p> <div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b><i>Fair Value Measurements</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The Company uses various inputs in determining the fair value of certain assets and liabilities and measures these on a recurring basis. Financial assets and liabilities recorded at fair value in the balance sheets are categorized by the level of objectivity associated with the inputs used to measure their fair value. Authoritative guidance provided by the Financial Accounting Standards Board (the &#147;FASB&#148;) defines the following levels directly related to the amount of subjectivity associated with the inputs to fair valuation of these financial assets and liabilities:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;">Level 1&#151;Quoted prices in active markets for identical assets or liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;">Level 2&#151;Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;">Level 3&#151;Unobservable inputs based on the Company's assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">At March 31, 2015 and December 31, 2014, the fair value of cash and cash equivalents, accounts payable, and accrued expenses approximate their carrying values based on their short term nature.</p></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><i>Use of Estimates</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include accounting for potential liabilities and the assumptions made in valuing stock instruments issued for services.</p></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><i>Stock-Based Compensation</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The Company periodically grants stock options and warrants to employees and non-employees in non-capital raising transactions as compensation for services rendered. The Company accounts for stock option grants to employees based on the authoritative guidance provided by the Financial Accounting Standards Board where the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option grants to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board where the value of the stock compensation is determined based upon the measurement date at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The fair value of the Company's common stock option grants is estimated using a Black-Scholes option pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the common stock options, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes option pricing model, and based on actual experience. The assumptions used in the Black-Scholes option pricing model could materially affect compensation expense recorded in future periods.</p></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><i>&#160;</i></b></p> <div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><i>Research and Development</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Research and development costs consist primarily of fees paid to consultants and outside service providers, patent fees and costs, and other expenses relating to the acquisition, design, development and testing of the Company's treatments and product candidates. Research and development costs are expensed as incurred over the life of the underlying contracts on the straight-line basis, unless the achievement of milestones, the completion of contracted work, or other information indicates that a different expensing schedule is more appropriate. The Company reviews the status of its research and development contracts on a quarterly basis.</p></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><i>Concentrations</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The Company maintains cash balances at one bank. As of March 31, 2015, the Company's cash balances were in excess of insured limits maintained at the bank. Management believes that the financial institution that holds the Company's cash is financially sound and, accordingly, minimal credit risk exists.</p></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><i>Recent Accounting Pronouncements</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, <i>Revenue from Contracts with Customers</i>. ASU 2014-09 is a comprehensive revenue recognition standard that will supersede nearly all existing revenue recognition guidance under current U.S. GAAP and replace it with a principle based approach for determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. ASU 2014-09 is effective for interim and annual periods beginning after December 15, 2016, however, the FASB has proposed a one-year deferral. Early adoption is not permitted, and either full retrospective adoption or modified retrospective adoption is permitted. The Company is in the process of evaluating the impact of ASU 2014-09 on the Company's financial statements and disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">In January 2015, the FASB issued Accounting Standards Update No. 2015-01 (Subtopic 225-20) - Income Statement - Extraordinary and Unusual Items. ASU 2015-01 eliminates the concept of an extraordinary item from GAAP. As a result, an entity will no longer be required to segregate extraordinary items from the results of ordinary operations, to separately present an extraordinary item on its income statement, net of tax, after income from continuing operations or to disclose income taxes and earnings-per-share data applicable to an extraordinary item. However, ASU 2015-01 will still retain the presentation and disclosure guidance for items that are unusual in nature and occur infrequently. ASU 2015-01 is effective for periods beginning after December 15, 2015. Early adoption is permitted. The adoption of ASU 2015-01 is not expected to have a material effect on the Company's consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission (&#147;SEC&#148;) did not or are not believed by management to have a material impact on the Company's present or future financial statements.</p></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for all significant accounting policies of the reporting entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18861-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18743-107790<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18854-107790<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>17
<FILENAME>Financial_Report.xls
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y
M/2(M+2TM/5].97AT4&%R=%]B.3%F-#(Q8U]F9&,T7S0W.61?.#`W.%]C-#5C
M8S4T,#5B-6$B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7
M96(@4&%G92P@86QS;R!K;F]W;B!A<R!A(%=E8B!!<F-H:79E(&9I;&4N("!)
M9B!Y;W4@87)E('-E96EN9R!T:&ES(&UE<W-A9V4L('EO=7(@8G)O=W-E<B!O
M<B!E9&ET;W(@9&]E<VXG="!S=7!P;W)T(%=E8B!!<F-H:79E(&9I;&5S+B`@
M4&QE87-E(&1O=VYL;V%D(&$@8G)O=W-E<B!T:&%T('-U<'!O<G1S(%=E8B!!
M<F-H:79E+"!S=6-H(&%S($UI8W)O<V]F="!);G1E<FYE="!%>'!L;W)E<BX-
M"@T*+2TM+2TM/5].97AT4&%R=%]B.3%F-#(Q8U]F9&,T7S0W.61?.#`W.%]C
M-#5C8S4T,#5B-6$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8CDQ
M9C0R,6-?9F1C-%\T-SED7S@P-SA?8S0U8V,U-#`U8C5A+U=O<FMB;V]K+FAT
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M;V9T+6-O;3IO9F9I8V4Z97AC96PB('AM;&YS/3-$(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+U)%0RUH=&UL-#`B/@T*/&AE860^#0H\;65T82!N86UE/3-$(D5X
M8V5L(%=O<FMB;V]K($9R86UE<V5T(CX-"@T*/&UE=&$@;F%M93TS1%!R;V=)
M9"!C;VYT96YT/3-$17AC96PN4VAE970^#0H\;&EN:R!R96P],T1&:6QE+4QI
M<W0@:')E9CTS1")7;W)K<VAE971S+V9I;&5L:7-T+GAM;"(^#0H-"CPA+2U;
M:68@9W1E(&US;R`Y73X\>&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX
M.D5X8V5L5V]R:W-H965T<SX-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^1&]C=6UE;G1?06YD7T5N=&ET>5]);F9O<FUA=&EO/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N9&5N<V5D7T)A
M;&%N8V5?4VAE971S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E
M($A2968],T0B5V]R:W-H965T<R]3:&5E=#`R+FAT;6PB+SX-"B`@(#PO>#I%
M>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX
M.DYA;64^0V]N9&5N<V5D7T)A;&%N8V5?4VAE971S7U!A<F5N/"]X.DYA;64^
M#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3
M:&5E=#`S+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX
M.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N9&5N<V5D7U-T871E
M;65N='-?;V9?3W!E<F%T/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`T+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^0V]N9&5N<V5D7U-T871E;65N='-?;V9?3W!E<F%T,3PO>#I.
M86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E
M=',O4VAE970P-2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@
M("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D-O;F1E;G-E9%]3
M=&%T96UE;G1S7V]F7U-T;V-K:#PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970P-BYH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/D-O;F1E;G-E9%]3=&%T96UE;G1S7V]F7T-A<VA?1CPO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970P-RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D=%3D5204Q?
M3U)'04Y)6D%424].7T%.1%]"55-)3CPO>#I.86UE/@T*("`@(#QX.E=O<FMS
M:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970P."YH=&UL(B\^
M#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@("`\>#I.86UE/E-534U!4EE?3T9?4TE'3DE&24-!3E1?04-#3U5.
M5#PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O
M<FMS:&5E=',O4VAE970P.2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE
M970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E-43T-+
M2$],1$524U]%455)5%D\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R
M8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,3`N:'1M;"(O/@T*("`@/"]X
M.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@
M/'@Z3F%M93Y35$]#2U]/4%1)3TY37T%.1%]705)204Y44SPO>#I.86UE/@T*
M("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE
M970Q,2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%
M>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DQ)0T5.4T5?04Y$7T-/34U)
M5$U%3E13/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968]
M,T0B5V]R:W-H965T<R]3:&5E=#$R+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^
M3$5'04Q?4%)/0T5%1$E.1U,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713
M;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,3,N:'1M;"(O/@T*("`@
M/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@
M("`@/'@Z3F%M93Y354)315%514Y47T5614Y44SPO>#I.86UE/@T*("`@(#QX
M.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q-"YH
M=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@("`\>#I.86UE/E-534U!4EE?3T9?4TE'3DE&24-!3E1?
M04-#3U5.5#$\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E
M9CTS1")7;W)K<VAE971S+U-H965T,34N:'1M;"(O/@T*("`@/"]X.D5X8V5L
M5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M
M93Y35$]#2TA/3$1%4E-?15%525197U1A8FQE<SPO>#I.86UE/@T*("`@(#QX
M.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q-BYH
M=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@("`\>#I.86UE/E-43T-+7T]05$E/3E-?04Y$7U=!4E)!
M3E137U1A8CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F
M/3-$(E=O<FMS:&5E=',O4VAE970Q-RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7
M;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE
M/D=%3D5204Q?3U)'04Y)6D%424].7T%.1%]"55-)3C$\+W@Z3F%M93X-"B`@
M("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T
M,3@N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC
M96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y354U-05)97T]&7U-)1TY)1DE#
M04Y47T%#0T]53E0R/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E
M($A2968],T0B5V]R:W-H965T<R]3:&5E=#$Y+FAT;6PB+SX-"B`@(#PO>#I%
M>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX
M.DYA;64^4U1/0TM(3TQ$15)37T5154E465].87)R871I=F5?/"]X.DYA;64^
M#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3
M:&5E=#(P+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX
M.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4U1/0TM(3TQ$15)37T51
M54E465]38VAE9'5L95]O/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#(Q+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^4U1/0TM?3U!424].4U]!3D1?5T%24D%.5%-?3F%R/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#(R+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4U1/0TM?3U!424].
M4U]!3D1?5T%24D%.5%-?4V-H/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#(S+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^4U1/0TM?3U!424].4U]!3D1?5T%24D%.5%-?4V-H,3PO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970R-"YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DQ)0T5.4T5?
M04Y$7T-/34U)5$U%3E137T1E=&%I;#PO>#I.86UE/@T*("`@(#QX.E=O<FMS
M:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R-2YH=&UL(B\^
M#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@("`\>#I.86UE/E-50E-%455%3E1?159%3E137T1E=&%I;',\+W@Z
M3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE
M971S+U-H965T,C8N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*
M("`\+W@Z17AC96Q7;W)K<VAE971S/@T*("`\>#I3='EL97-H965T($A2968]
M,T0B5V]R:W-H965T<R]R97!O<G0N8W-S(B\^#0H@(#QX.D%C=&EV95-H965T
M/C`\+W@Z06-T:79E4VAE970^#0H@(#QX.E!R;W1E8W13=')U8W1U<F4^1F%L
M<V4\+W@Z4')O=&5C=%-T<G5C='5R93X-"B`@/'@Z4')O=&5C=%=I;F1O=W,^
M1F%L<V4\+W@Z4')O=&5C=%=I;F1O=W,^#0H@/"]X.D5X8V5L5V]R:V)O;VL^
M#0H\+WAM;#X\(5ME;F1I9ETM+3X-"CPO:&5A9#X-"B`@/&)O9'D^#0H@("`\
M<#Y4:&ES('!A9V4@<VAO=6QD(&)E(&]P96YE9"!W:71H($UI8W)O<V]F="!%
M>&-E;"!84"!O<B!N97=E<BX\+W`^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*
M+2TM+2TM/5].97AT4&%R=%]B.3%F-#(Q8U]F9&,T7S0W.61?.#`W.%]C-#5C
M8S4T,#5B-6$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8CDQ9C0R
M,6-?9F1C-%\T-SED7S@P-SA?8S0U8V,U-#`U8C5A+U=O<FMS:&5E=',O4VAE
M970P,2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M
M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB
M=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P
M+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C
M:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@
M<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J
M+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S
M/3-$<F5P;W)T(&ED/3-$240P15%!044^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O
M;F<^1&]C=6UE;G0@06YD($5N=&ET>2!);F9O<FUA=&EO;CQB<CX\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0Q/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$U/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/DUA>2`P."P@,C`Q-3QB<CX\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY$;V-U;65N="!)
M;F9O<FUA=&EO;B!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^16YT:71Y(%)E9VES=')A;G0@3F%M93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^3&EO;B!":6]T96-H;F]L
M;V=I97,L($EN8RX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D5N=&ET>2!#96YT<F%L($EN9&5X($ME>3PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^,#`P,30R-3(P-3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0W5R<F5N="!&
M:7-C86P@665A<B!%;F0@1&%T93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^+2TQ,BTS,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^16YT:71Y($9I;&5R($-A=&5G;W)Y/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#Y!8V-E;&5R871E9"!&:6QE<CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YT
M:71Y($-O;6UO;B!3=&]C:RP@4VAA<F5S($]U='-T86YD:6YG/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-2PP,CDL-CDR/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$;V-U;65N="!4
M>7!E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XQ,"U1/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;65N
M9&UE;G0@1FQA9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^9F%L
M<V4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D1O8W5M96YT(%!E<FEO9"!%;F0@1&%T93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^36%R(#,Q+`T*"0DR,#$U/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$;V-U;65N="!&:7-C
M86P@4&5R:6]D($9O8W5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#Y1,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^1&]C=6UE;G0@1FES8V%L(%EE87(@1F]C=7,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/C(P,34\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*
M#0HM+2TM+2T]7TYE>'1087)T7V(Y,68T,C%C7V9D8S1?-#<Y9%\X,#<X7V,T
M-6-C-30P-6(U80T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]B.3%F
M-#(Q8U]F9&,T7S0W.61?.#`W.%]C-#5C8S4T,#5B-6$O5V]R:W-H965T<R]3
M:&5E=#`R+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E
M9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T
M/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT
M='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[
M(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP
M="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT
M("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA
M<W,],T1R97!O<G0@:60],T1)1#!%4%5!13X-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T
M<F]N9SY#;VYD96YS960@0F%L86YC92!3:&5E=',@*%531"`D*3QB<CX\+W-T
M<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R
M,#$U/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L
M(#(P,30\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^0W5R<F5N="!!<W-E=',\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^0V%S:"!A;F0@8V%S:"!E<75I=F%L96YT<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q,3$L,C@P+#0T,SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M-#0L.3`Y+#$T-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4')E<&%I9"!E>'!E;G-E<R!A;F0@9&5P;W-I=',\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R."PX.#,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV-BPQ,S0\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4
M;W1A;"!#=7)R96YT($%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,3$Q+#0P.2PS,C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XT-"PY-S4L,C@Q/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]P97)T>2!A;F0@97%U
M:7!M96YT+"!N970@;V8@86-C=6UU;&%T960@9&5P<F5C:6%T:6]N(&]F("0R
M.#DL-C<R(&%N9"`D,3`T+#(R,SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,BPQ,C@L,C8P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,2PU,S$L-38V/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@07-S971S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,3,L-3,W+#4X-CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0V+#4P-BPX
M-#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^0W5R<F5N="!,:6%B:6QI=&EE<SPO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-O=6YT<R!P87EA8FQE
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#$P-RPS-S`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#(T
M."PT,3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D%C8W)U960@97AP96YS97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C<Q-RPX-#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XS,C<L.#0W/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-R=65D('!A>6%B;&4@=&\@
M;V9F:6-E<G,@86YD(&9O<FUE<B!D:7)E8W1O<G,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C@U+#4P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C@U+#4P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L($-U<G)E;G0@
M3&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L
M.3$P+#<Q-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$L-C8Q+#<V,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^0V]M;6ET;65N=',@86YD(&-O;G1I;F=E;F-I
M97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P
M.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=&]C:VAO;&1E<G,G($5Q=6ET>3PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F5F
M97)R960@<W1O8VLL("0P+C`P,2!P87(@=F%L=64[(#4P+#`P,"PP,#`@<VAA
M<F5S(&%U=&AO<FEZ960L(#,L-CDT('-H87)E<R!A;F0@-2PV.30@<VAA<F5S
M(&ES<W5E9"!A;F0@;W5T<W1A;F1I;F<L(')E<W!E8W1I=F5L>3PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:RP@)#`N
M,#`P,#0Q-C8V('!A<B!V86QU93L@,34P+#`P,"PP,#`@<VAA<F5S(&%U=&AO
M<FEZ960L(#0T+#@W,2PX.#@@86YD(#,S+#<U,"PQ.#@@<VAA<F5S(&ES<W5E
M9"!A;F0@;W5T<W1A;F1I;F<L(')E<W!E8W1I=F5L>3PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,2PX-S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0P-SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K('1O
M(&)E(&ES<W5E9"P@,S`S+#$R-2!S:&%R97,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(T-2PQ-3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR-#4L,34S/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!9&1I=&EO;F%L('!A:60M
M:6X@8V%P:71A;#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3DS
M+#(S.2PW.34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ,C$L,38P+#0Q-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^06-C=6UU;&%T960@9&5F:6-I=#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH.#$L.#4Y+#DU,RD\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@W-BPU-C$L
M.#DT*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E1O=&%L(%-T;V-K:&]L9&5R<R<@17%U:71Y/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ,3$L-C(V+#@V.3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0T+#@T-2PP.#<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4
M;W1A;"!,:6%B:6QI=&EE<R!A;F0@4W1O8VMH;VQD97)S)R!%<75I='D\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,3$S+#4S-RPU.#8\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0V
M+#4P-BPX-#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'10
M87)T7V(Y,68T,C%C7V9D8S1?-#<Y9%\X,#<X7V,T-6-C-30P-6(U80T*0V]N
M=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]B.3%F-#(Q8U]F9&,T7S0W.61?
M.#`W.%]C-#5C8S4T,#5B-6$O5V]R:W-H965T<R]3:&5E=#`S+FAT;6P-"D-O
M;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O
M;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*
M/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT
M96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G
M/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS
M/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H
M96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60]
M,T1)1#!%54-!13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY#;VYD96YS960@
M0F%L86YC92!3:&5E=',@*%!A<F5N=&AE=&EC86PI("A54T0@)"D\8G(^/"]S
M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@
M,C`Q-3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q
M+"`R,#$T/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/D-O;F1E;G-E9"!"86QA;F-E(%-H965T<R!;06)S=')A8W1=/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;W!E
M<G1Y(&%N9"!E<75I<&UE;G0L(&%C8W5M=6QA=&5D(&1E<')E8VEA=&EO;CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R.#DL-C<R/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q,#0L
M,C(S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y0<F5F97)R960@<W1O8VLL('!A<B!V86QU92`H:6X@9&]L;&%R<R!P
M97(@<VAA<F4I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N
M,#`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`P+C`P,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4')E9F5R<F5D('-T;V-K+"!S:&%R97,@875T:&]R:7IE
M9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3`L,#`P+#`P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4P
M+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E!R969E<G)E9"!S=&]C:RP@<VAA<F5S(&ES<W5E9#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPV.30\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#8Y-#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')E9F5R
M<F5D('-T;V-K+"!S:&%R97,@;W5T<W1A;F1I;F<\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C,L-CDT/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-2PV.30\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:RP@<&%R
M('9A;'5E("AI;B!D;VQL87)S('!E<B!S:&%R92D\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,"XP,#`P-#$V-C8\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#`P,#0Q-C8V/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#
M;VUM;VX@<W1O8VLL('-H87)E<R!A=71H;W)I>F5D/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ-3`L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U,"PP,#`L,#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM
M;VX@<W1O8VLL('-H87)E<R!I<W-U960\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C0T+#@W,2PX.#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XS,RPW-3`L,3@X/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VLL
M('-H87)E<R!O=71S=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-#0L.#<Q+#@X.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C,S+#<U,"PQ.#@\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:R!T;R!B
M92!I<W-U960@<VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XS,#,L,3(U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,S`S+#$R-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM
M+3U?3F5X=%!A<G1?8CDQ9C0R,6-?9F1C-%\T-SED7S@P-SA?8S0U8V,U-#`U
M8C5A#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V(Y,68T,C%C7V9D
M8S1?-#<Y9%\X,#<X7V,T-6-C-30P-6(U82]7;W)K<VAE971S+U-H965T,#0N
M:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT
M86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S
M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I
M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E
M=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS
M1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C
M<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E
M<&]R="!I9#TS1$E$,$5:3T%#/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D-O
M;F1E;G-E9"!3=&%T96UE;G1S(&]F($]P97)A=&EO;G,@*%531"`D*3QB<CX\
M+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,CXS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$U/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\
M8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M0V]N9&5N<V5D(%-T871E;65N=',@;V8@3W!E<F%T:6]N<R!;06)S=')A8W1=
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E
M=F5N=65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF
M;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0V]S=',@86YD(&5X<&5N<V5S
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P
M97)A=&EN9R!E>'!E;G-E<R`H:6YC;'5D:6YG("0P(&%N9"`D,2PP-S`L-S`W
M(&]F(&YO;BUC87-H('-H87)E+6)A<V5D(&-O;7!E;G-A=&EO;B!C;W-T<RD\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L,C@W+#`R-CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.34V
M+#@U,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4F5S96%R8V@@86YD(&1E=F5L;W!M96YT/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR+#`Q,2PP,S,\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,#(L-C8R/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@8V]S
M=',@86YD(&5X<&5N<V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XU+#(Y."PP-3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR+#(U.2PU,30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@3&]S<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XD("@U+#(Y."PP-3DI/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@R+#(U.2PU,30I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.
M970@3&]S<R!097(@4VAA<F4L($)A<VEC(&%N9"!$:6QU=&5D/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#`N,30I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@P+C$Q*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V5I9VAT
M960M079E<F%G92!#;VUM;VX@4VAA<F5S($]U='-T86YD:6YG+"!"87-I8R!A
M;F0@1&EL=71E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S<L
M-C<X+#8V,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(P+#<Y."PR,CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM
M+2T]7TYE>'1087)T7V(Y,68T,C%C7V9D8S1?-#<Y9%\X,#<X7V,T-6-C-30P
M-6(U80T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]B.3%F-#(Q8U]F
M9&,T7S0W.61?.#`W.%]C-#5C8S4T,#5B-6$O5V]R:W-H965T<R]3:&5E=#`U
M+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN
M=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA
M<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U
M:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S
M970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,]
M,T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S
M8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R
M97!O<G0@:60],T1)1#!%1T@^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^0V]N
M9&5N<V5D(%-T871E;65N=',@;V8@3W!E<F%T:6]N<R`H4&%R96YT:&5T:6-A
M;"D@*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$,CXS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-
M87(N(#,Q+"`R,#$U/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/DUA<BX@,S$L(#(P,30\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/CQS=')O;F<^0V]N9&5N<V5D(%-T871E;65N=',@;V8@3W!E<F%T
M:6]N<R!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E-H87)E+6)A<V5D($-O;7!E;G-A=&EO;CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q+#0V-RPW-3,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#DQ.2PS-3`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-
M"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V(Y,68T
M,C%C7V9D8S1?-#<Y9%\X,#<X7V,T-6-C-30P-6(U80T*0V]N=&5N="U,;V-A
M=&EO;CH@9FEL93HO+R]#.B]B.3%F-#(Q8U]F9&,T7S0W.61?.#`W.%]C-#5C
M8S4T,#5B-6$O5V]R:W-H965T<R]3:&5E=#`V+FAT;6P-"D-O;G1E;G0M5')A
M;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP
M93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@
M(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@
M8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@
M='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO
M="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\
M8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%2D1"
M1SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A
M;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY#;VYD96YS960@4W1A=&5M96YT
M<R!O9B!3=&]C:VAO;&1E<G,G($5Q=6ET>2`H55-$("0I/&)R/CPO<W1R;VYG
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E1O=&%L/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E!R969E<G)E9"!3=&]C:R!;365M
M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y#;VUM;VX@
M4W1O8VL@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^0V]M;6]N(%-T;V-K(%1O($)E($ES<W5E9"!;365M8F5R73QB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y!9&1I=&EO;F%L(%!A:60M26X@
M0V%P:71A;"!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y!8V-U;75L871E9"!$969I8VET(%M-96UB97)=/&)R/CPO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"86QA;F-E(&%T($1E8RX@,S$L
M(#(P,30\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-#0L.#0U
M+#`X-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,2PT,#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#(T-2PQ-3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$R,2PQ-C`L-#$U/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@W-BPU-C$L
M.#DT*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')C/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0F%L86YC92`H:6X@<VAA<F5S*2!A="!$96,N(#,Q+"`R,#$T/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#8Y-#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,S+#<U,"PQ.#@\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D9A:7(@=F%L=64@;V8@=F5S=&5D('-T;V-K(&]P=&EO;G,\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,#$W+#,P.#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,#$W+#,P.#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M
M;6]N('-T;V-K(&ES<W5E9"!U<&]N(&5X97)C:7-E(&]F('=A<G)A;G1S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#,P-"PR-3`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS.#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L,S`T
M+#(Q,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0V]M;6]N('-T;V-K(&ES<W5E9"!U<&]N(&5X97)C:7-E(&]F('=A
M<G)A;G1S("AI;B!S:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XY,C$L-S`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VL@:7-S=65D('5P;VX@8V]N=F5R
M<VEO;B!O9B!P<F5F97)R960@<VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@R*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0R/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-#`I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VL@
M:7-S=65D('5P;VX@8V]N=F5R<VEO;B!O9B!P<F5F97)R960@<VAA<F5S("AI
M;B!S:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R+#`P
M,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:R!S;VQD(&EN('!R:79A=&4@<&QA
M8V5M96YT+"!N970@;V8@;V9F97)I;F<@8V]S=',\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C8X+#,P-RPX,S@\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS.#,\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV."PS,#<L-#4U/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM
M;VX@<W1O8VL@<V]L9"!I;B!P<FEV871E('!L86-E;65N="P@;F5T(&]F(&]F
M9F5R:6YG(&-O<W1S("AI;B!S:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XY+#(P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E9E<W1I;F<@;V8@<F5S=')I8W1E9"!S
M:&%R97,@:7-S=65D(&9O<B!S97)V:6-E<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-#4P+#0T-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C0U,"PT-#4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@U+#(Y."PP-3DI/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-2PR.3@L,#4Y*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')C/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M0F%L86YC92!A="!-87(N(#,Q+"`R,#$U/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#$Q,2PV,C8L.#8Y/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`T/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q+#@W,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C0U+#$U,SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M,3DS+#(S.2PW.34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B0@*#@Q+#@U.2PY-3,I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"86QA;F-E("AI;B!S:&%R97,I
M(&%T($UA<BX@,S$L(#(P,34\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C,L-CDT/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-#0L.#<Q+#@X.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM
M+2TM+3U?3F5X=%!A<G1?8CDQ9C0R,6-?9F1C-%\T-SED7S@P-SA?8S0U8V,U
M-#`U8C5A#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V(Y,68T,C%C
M7V9D8S1?-#<Y9%\X,#<X7V,T-6-C-30P-6(U82]7;W)K<VAE971S+U-H965T
M,#<N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R
M:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S
M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE
M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA
M<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R
M8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\
M+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS
M1')E<&]R="!I9#TS1$E$,$5264%%/@T*("`@("`@/'1R/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG
M/D-O;F1E;G-E9"!3=&%T96UE;G1S(&]F($-A<V@@1FQO=W,@*%531"`D*3QB
M<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS
M<&%N/3-$,CXS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$U
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P
M,30\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^0V%S:"!&;&]W<R!&<F]M($]P97)A=&EN9R!!8W1I=FET:65S/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#4L,CDX+#`U.2D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@
M*#(L,C4Y+#4Q-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/CQS=')O;F<^061J=7-T;65N=',@=&\@<F5C;VYC:6QE
M(&YE="!L;W-S('1O(&YE="!C87-H('5S960@:6X@;W!E<F%T:6YG(&%C=&EV
M:71I97,Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D1E<')E8VEA=&EO;B!A;F0@86UO<G1I>F%T:6]N/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ.#4L-#0Y/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,38L-38U/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&86ER('9A;'5E
M(&]F('9E<W1E9"!S=&]C:R!O<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+#`Q-RPS,#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XY,#$L-C4P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y697-T:6YG(&]F(')E<W1R
M:6-T960@<VAA<F5S(&ES<W5E9"!F;W(@<V5R=FEC97,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C0U,"PT-#4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-RPW,#`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0VAA
M;F=E<R!I;B!A<W-E=',@86YD(&QI86)I;&ET:65S.CPO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F5P86ED(&5X<&5N<V5S
M(&%N9"!D97!O<VET<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M-C(L-S0Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C0Y+#8R-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^06-C;W5N=',@<&%Y86)L92!A;F0@86-C<G5E9"!E
M>'!E;G-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C0X+#DU
M-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#DY,RPS.#DI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3F5T($-A<V@@57-E9"!);B!/<&5R871I;F<@06-T:79I
M=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,RPT-3@L-C0Y
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#(L,C8W+#,V,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/CQS=')O;F<^0V%S:"!&;&]W<R!&<F]M($EN=F5S=&EN
M9R!!8W1I=FET:65S/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E!U<F-H87-E<R!O9B!P<F]P97)T>2!A;F0@97%U:7!M96YT
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@W.#(L,30S*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,L-#,W
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY#87-H($9L;W=S($9R;VT@1FEN86YC:6YG($%C=&EV:71I
M97,\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4')O8V5E9',@9G)O;2!I<W-U86YC92!O9B!C;VUM;VX@<W1O8VL@=7!O;B!C
M;VYV97)S:6]N(&]F('=A<G)A;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR+#,P-"PR-3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XU-#(L-3`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]C965D<R!F<F]M('1H92!I
M<W-U86YC92!O9B!C;VUM;VX@<W1O8VLL(&YE=#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-C@L,S`W+#@S.#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!#87-H(%!R;W9I9&5D
M($)Y($9I;F%N8VEN9R!!8W1I=FET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XW,"PV,3(L,#@X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-30R+#4P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!);F-R96%S92`H
M1&5C<F5A<V4I($EN($-A<V@@06YD($-A<V@@17%U:79A;&5N=',\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8V+#,W,2PR.38\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#<R."PS,#`I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y#87-H(&%N9"!#87-H($5Q=6EV86QE;G1S+"!"96=I;FYI;F<@;V8@4&5R
M:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-"PY,#DL,30W
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3DL-C<R+#$W-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0V%S:"!A;F0@0V%S:"!%<75I=F%L96YT<RP@16YD(&]F
M(%!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$Q+#(X
M,"PT-#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ-RPY-#,L.#<W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-U<'!L96UE;G1A;"!$:7-C;&]S
M=7)E<R!O9B!#87-H($9L;W<@26YF;W)M871I;VXZ/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN=&5R97-T/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S
M<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DEN8V]M92!487AE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M
M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B.3%F-#(Q8U]F9&,T7S0W.61?.#`W
M.%]C-#5C8S4T,#5B-6$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO
M8CDQ9C0R,6-?9F1C-%\T-SED7S@P-SA?8S0U8V,U-#`U8C5A+U=O<FMS:&5E
M=',O4VAE970P."YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q
M=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA
M<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\3454
M02!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H
M=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S
M8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M
M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE
M(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\
M<W1R;VYG/D=%3D5204P@3U)'04Y)6D%424].($%.1"!"55-)3D534SQB<CX\
M+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,3XS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$U/&)R
M/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D=%
M3D5204P@3U)'04Y)6D%424].($%.1"!"55-)3D534R!;06)S=')A8W1=/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=%3D52
M04P@3U)'04Y)6D%424].($%.1"!"55-)3D534SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/&1I=B!I9#TS1$5D9V%R4T%!,3(S-#4W.#DP,#`P
M('-T>6QE/3-$)V9O;G0M9F%M:6QY(#H@)U1I;65S($YE=R!2;VUA;B<[)SX-
M"CQP('-T>6QE/3-$)VUA<F=I;CH@,'!T.R!F;VYT+69A;6EL>3H@)W1I;65S
M(&YE=R!R;VUA;B<[)SX\8G(O/CPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T
M(#`[)SX\8CX\9F]N="!S='EL93TS1"=T97AT+61E8V]R871I;VXZ('5N9&5R
M;&EN93LG/DY/5$4@,2X@1T5.15)!3"!/4D=!3DE:051)3TX@04Y$($)54TE.
M15-3/"]F;VYT/CPO8CX\+W`^#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R<^
M/&(^/&D^)B,Q-C`[/"]I/CPO8CX\+W`^#0H\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T+VYO<FUA;"!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN.B`P<'0@,'!X.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!F;VYT+7-I>F4M
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M<R!O9B!T:&4@<W1A=&4@;V8@3F5V861A(&]N(%-E<'1E;6)E<B`Q-RP@,C`P
M-RX@56YT:6P@36%R8V@@,C`Q,"P@=V4@=V5R92!A;B!I;F%C=&EV92!C;VUP
M86YY(&MN;W=N(&%S($9R96EG:'0@36%N86=E;65N="!#;W)P+B!/;B!-87)C
M:"`Q-2P@,C`Q,"P@=V4@8VAA;F=E9"!O=7(@;F%M92!T;R!'96YE<VES($)I
M;W!H87)M82P@26YC+BP@86YD(&EN(#(P,3$@=V4@8V]M;65N8V5D(&]U<B!C
M=7)R96YT(&)U<VEN97-S+CPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0O
M;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ
M(#!P="`P<'@[('1E>'0M86QI9VXZ(&IU<W1I9GD[(&9O;G0M<VEZ92UA9&IU
M<W0Z(&YO;F4[(&9O;G0M<W1R971C:#H@;F]R;6%L.R<^)B,Q-C`[/"]P/@T*
M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="]N;W)M86P@5&EM97,@3F5W(%)O;6%N
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M,3`P/"]F;VYT/B!R979E<G-E('-T;V-K('-P;&ET("AP<F\M<F%T82!R961U
M8W1I;VX@;V8@;W5T<W1A;F1I;F<@<VAA<F5S*2!O9B!O=7(@8V]M;6]N('-T
M;V-K+B!!9G1E<B!T:&4@<F5V97)S92!S=&]C:R!S<&QI="!W92!I;F-R96%S
M960@=&AE(&YU;6)E<B!O9B!O=7(@875T:&]R:7IE9"!N=6UB97(@;V8@<VAA
M<F5S(&]F(&-O;6UO;B!S=&]C:R!T;R`\9F]N=#XQ-3`L,#`P+#`P,#PO9F]N
M=#X@<VAA<F5S+"!I;B!A9&1I=&EO;B!W92!A=71H;W)I>F5D('1H92!I<W-U
M86YC92!O9B`\9F]N=#XU,"PP,#`L,#`P/"]F;VYT/B!S:&%R97,@;V8@)B,Q
M-#<[8FQA;FL@8VAE8VLF(S$T.#L@<')E9F5R<F5D('-T;V-K+"`D/&9O;G0^
M,"XP,#$\+V9O;G0^('!A<B!V86QU92!P97(@<VAA<F4N(%)E9F5R96YC97,@
M:6X@=&AE<V4@9FEN86YC:6%L('-T871E;65N=',@86YD(')E;&%T960@;F]T
M97,@=&\@;G5M8F5R<R!O9B!S:&%R97,@;V8@8V]M;6]N('-T;V-K+"!P<FEC
M97,@<&5R('-H87)E(&]F(&-O;6UO;B!S=&]C:RP@86YD('=E:6=H=&5D(&%V
M97)A9V4@;G5M8F5R(&]F('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@;W5T<W1A
M;F1I;F<@<')I;W(@=&\@=&AE(')E=F5R<V4@<W1O8VL@<W!L:71S(&AA=F4@
M8F5E;B!A9&IU<W1E9"!T;R!R969L96-T('1H92!R979E<G-E('-T;V-K('-P
M;&ET<R!F;W(@86QL('!E<FEO9',@<')E<V5N=&5D+"!U;FQE<W,@;W1H97)W
M:7-E(&YO=&5D+CPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0O;F]R;6%L
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P
M<'@[('1E>'0M86QI9VXZ(&IU<W1I9GD[(&9O;G0M<VEZ92UA9&IU<W0Z(&YO
M;F4[(&9O;G0M<W1R971C:#H@;F]R;6%L.R<^)B,Q-C`[/"]P/@T*/'`@<W1Y
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M;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P<'@[('1E>'0M:6YD96YT
M.B`P<'@[(&9O;G0M<VEZ92UA9&IU<W0Z(&YO;F4[(&9O;G0M<W1R971C:#H@
M;F]R;6%L.R!B86-K9W)O=6YD+6-O;&]R.B!W:&ET93LG/CQB/CQI/B8C,38P
M.SPO:3X\+V(^/"]P/@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="]N;W)M86P@
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M;2`Q,"U1(&%N9"!296=U;&%T:6]N(%,M2RX@06-C;W)D:6YG;'DL('1H97D@
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M965T(&EN9F]R;6%T:6]N(&%S(&]F($1E8V5M8F5R(#,Q+"`R,#$T('=A<R!D
M97)I=F5D(&9R;VT@=&AE(&%U9&ET960@9FEN86YC:6%L('-T871E;65N=',@
M:6YC;'5D960@:6X@=&AE($-O;7!A;GDG<R!F:6YA;F-I86P@<W1A=&5M96YT
M<R!A<R!O9B!A;F0@9F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+"`R
M,#$T(&EN8VQU9&5D(&EN('1H92!#;VUP86YY)W,@06YN=6%L(%)E<&]R="!O
M;B!&;W)M(#$P+4L@9FEL960@=VET:"!T:&4@4V5C=7)I=&EE<R!A;F0@17AC
M:&%N9V4@0V]M;6ES<VEO;B`H=&AE("8C,30W.U-%0R8C,30X.RD@;VX@36%R
M8V@@,38L(#(P,34N(%1H97-E(&9I;F%N8VEA;"!S=&%T96UE;G1S('-H;W5L
M9"!B92!R96%D(&EN(&-O;FIU;F-T:6]N('=I=&@@=&AA="!R97!O<G0N/"]P
M/@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF
M>3LG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M
M86QI9VXZ(&IU<W1I9GD[)SX\8CX\:3Y,:7%U:61I='D\+VD^/"]B/CPO<#X-
M"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[
M)SXF(S$V,#L\+W`^#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R!T97AT+6%L
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M=65S(&1U<FEN9R`R,#$U(&9R;VT@=&AE('-A;&4@;W(@;&EC96YS:6YG(&]F
M(&%N>2!P<F]D=6-T<RX@26X@861D:71I;VXL('=E(&AA=F4@;F]T(&=E;F5R
M871E9"!A;GD@<F5V96YU97,@9G)O;2!O=7(@<')I;W(@8G5S:6YE<W,@<&QA
M;G,N/"]P/@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@
M:G5S=&EF>3LG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[
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M=&AS(&5N9&5D($UA<F-H(#,Q+"`R,#$U(&%N9"!U<V5D("0\9F]N=#XS+#0U
M."PV-#D\+V9O;G0^)B,Q-C`[;V8@8V%S:"!I;B!O=7(@;W!E<F%T:6YG(&%C
M=&EV:71I97,@9'5R:6YG('1H92!T:')E92!M;VYT:',@96YD960@36%R8V@@
M,S$L(#(P,34N($%S(&]F($UA<F-H(#,Q+"`R,#$U+"!W92!H860@)#QF;VYT
M/C$Q,2PR.#`L-#0S/"]F;VYT/B!O9B!C87-H(&]R(&-A<V@@97%U:79A;&5N
M=',@;VX@:&%N9"P@<W1O8VMH;VQD97)S)R!E<75I='D@;V8@)#QF;VYT/C$Q
M,2PV,C8L.#8Y/"]F;VYT/B!A;F0@:&%D('=O<FMI;F<@8V%P:71A;"!O9B`D
M/&9O;G0^,3`Y+#0Y."PV,#D\+V9O;G0^+CPO<#X-"CQP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SXF(S$V,#L\+W`^#0H\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#!P="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R<^
M1'5R:6YG(#(P,34L('=E(&5X<&5C="!T;R!F=7)T:&5R(')A;7`@=7`@;W5R
M(&]P97)A=&EO;G,L('=H:6-H('=I;&P@:6YC<F5A<V4@=&AE(&%M;W5N="!O
M9B!C87-H('=E('=I;&P@=7-E(&EN(&]U<B!O<&5R871I;VYS+B!/=7(@8G5D
M9V5T(&9O<B`R,#$U(&EN8VQU9&5S(&EN8W)E87-E9"!S<&5N9&EN9R!O;B!R
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M=F4@4F5S96%R8V@@86YD($1E=F5L;W!M96YT($%G<F5E;65N="`H0U)!1$$I
M('=E(&AA=F4@96YT97)E9"!I;G1O('=I=&@@=&AE($YA=&EO;F%L($-A;F-E
M<B!);G-T:71U=&4@*$Y#22DN($)A<V5D(&]N('1H92!F=6YD<R!W92!H860@
M879A:6QA8FQE(&]N($UA<F-H(#,Q+"`R,#$U+"!W92!B96QI979E('1H870@
M=V4@:&%V92!S=69F:6-I96YT(&-A<&ET86P@=&\@9G5N9"!O=7(@86YT:6-I
M<&%T960@;W!E<F%T:6YG(&5X<&5N<V5S(&9O<B!A="!L96%S="`R-"!M;VYT
M:',N/"]P/@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@
M:G5S=&EF>3LG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[
M('1E>'0M86QI9VXZ(&IU<W1I9GD[)SY/;B!-87)C:"`S+"`R,#$U+"!T:&4@
M0V]M<&%N>2!S;VQD(#QF;VYT/CDL,C`P+#`P,#PO9F]N=#X@<VAA<F5S(&]F
M(&ET<R!C;VUM;VX@<W1O8VL@:6X@86X@=6YD97)W<FET=&5N('!U8FQI8R!O
M9F9E<FEN9R!A="`D/&9O;G0^."XP,#PO9F]N=#X@<&5R('-H87)E(&9O<B!N
M970@<')O8V5E9',@;V8@)#QF;VYT/C8X+C,\+V9O;G0^(&UI;&QI;VXL(&%F
M=&5R(&1E9'5C=&EN9R!E>'!E;G-E<R!O9B!T:&4@;V9F97)I;F<N($]N($1E
M8V5M8F5R(#(R+"`R,#$T+"!T:&4@0V]M<&%N>2!S;VQD(#QF;VYT/C8L,#`P
M+#`P,#PO9F]N=#X@<VAA<F5S(&]F(&ET<R!C;VUM;VX@<W1O8VL@:6X@86X@
M=6YD97)W<FET=&5N('!U8FQI8R!O9F9E<FEN9R!A="`D/&9O;G0^-2XW-3PO
M9F]N=#X@<&5R('-H87)E(&9O<B!N970@<')O8V5E9',@;V8@)#QF;VYT/C,R
M+C(\+V9O;G0^(&UI;&QI;VX@869T97(@9&5D=6-T:6YG(&5X<&5N<V5S(&]F
M('1H92!O9F9E<FEN9RX@3VX@3F]V96UB97(@-2P@,C`Q,RP@=V4@8V]M<&QE
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M;VYS(&9O<B!A="!L96%S="`R-"!M;VYT:',L('=E('=I;&P@:&%V92!T;R!O
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M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*
M("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?8CDQ9C0R
M,6-?9F1C-%\T-SED7S@P-SA?8S0U8V,U-#`U8C5A#0I#;VYT96YT+4QO8V%T
M:6]N.B!F:6QE.B\O+T,Z+V(Y,68T,C%C7V9D8S1?-#<Y9%\X,#<X7V,T-6-C
M-30P-6(U82]7;W)K<VAE971S+U-H965T,#DN:'1M;`T*0V]N=&5N="U4<F%N
M<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E
M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@
M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C
M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T
M>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T
M(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB
M;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5-13X-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS
M1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY354U-05)9($]&(%-)1TY)1DE#04Y4
M($%#0T]53E1)3D<@4%)!0U1)0T53/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C,@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/DUA<BX@,S$L(#(P,34\8G(^/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4U5-34%262!/1B!324=.249)0T%.
M5"!!0T-/54Y424Y'(%!204-424-%4R!;06)S=')A8W1=/"]S=')O;F<^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-534U!4ED@3T8@4TE'
M3DE&24-!3E0@04-#3U5.5$E.1R!04D%#5$E#15,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQD:78@:60],T1%9&=A<E-!03$R,S0U-S@Y,#`P
M,"!S='EL93TS1"=F;VYT+69A;6EL>2`Z("=4:6UE<R!.97<@4F]M86XG.R<^
M(#QP('-T>6QE/3-$)VUA<F=I;CH@,'!T.R!F;VYT+69A;6EL>3H@)W1I;65S
M(&YE=R!R;VUA;B<[)SX\8G(O/CPO<#X@/'`@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@
M,#LG/CQB/CQF;VYT('-T>6QE/3-$)W1E>'0M9&5C;W)A=&EO;CH@=6YD97)L
M:6YE.R<^3D]412`R+B!354U-05)9($]&(%-)1TY)1DE#04Y4($%#0T]53E1)
M3D<@4%)!0U1)0T53/"]F;VYT/CPO8CX\+W`^(#QP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,'!T(#`[)SX\8CX\:3XF(S$V,#L\+VD^/"]B/CPO<#X@/&1I=CX\<"!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!M87)G:6XZ(#!P="`P.R<^/&(^/&D^3F5T($EN8V]M92`H3&]S<RD@4&5R
M(%-H87)E/"]I/CPO8CX\+W`^(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[)SX\
M8CX\:3XF(S$V,#L\+VD^/"]B/CPO<#X@/'`@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@
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M;F<@87,@;V8@=&AE:7(@9W)A;G0@9&%T92X\+W`^(#QP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SXF(S$V,#L\+W`^(#QP
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SY!
M="!-87)C:"`S,2P@,C`Q-2!A;F0@,C`Q-"P@8F%S:6,@86YD(&1I;'5T960@
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M;B!B92!C;VYV97)T960@:6YT;R`\9F]N=#XQ+#@T-RPP,#`\+V9O;G0^('-H
M87)E<R!O9B!C;VUM;VX@<W1O8VLL(&%N9"`\9F]N=#XU,#<L,3$S/"]F;VYT
M/B!S:&%R97,@;V8@;F]N+79E<W1E9"!R97-T<FEC=&5D('-T;V-K+B!!="!-
M87)C:"`S,2P@,C`Q-"P@<&]T96YT:6%L;'D@9&EL=71I=F4@<V5C=7)I=&EE
M<R!I;F-L=61E(&]P=&EO;G,@=&\@86-Q=6ER92`\9F]N=#XV,S@L-S4P/"]F
M;VYT/B!S:&%R97,@;V8@8V]M;6]N('-T;V-K+"!W87)R86YT<R!T;R!A8W%U
M:7)E(#QF;VYT/C$R+#$U-BPQ-38\+V9O;G0^('-H87)E<R!O9B!C;VUM;VX@
M<W1O8VLL(&%N9"!P<F5F97)R960@<W1O8VL@=&AA="!C86X@8F4@8V]N=F5R
M=&5D(&EN=&\@/&9O;G0^-BPV-3`L,#`P/"]F;VYT/B!S:&%R97,@;V8@8V]M
M;6]N('-T;V-K+CPO<#X\+V1I=CX@/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@
M8V]L;W(Z(",R,C(R,C([('1E>'0M:6YD96YT.B`P+C5I;CLG/B8C,38P.SPO
M<#X@/&1I=CX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R<^/&(^/&D^1F%I<B!6
M86QU92!-96%S=7)E;65N=',\+VD^/"]B/CPO<#X@/'`@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN
M.B`P<'0@,#LG/B8C,38P.SPO<#X@/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@
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M=',@86YD(&QI86)I;&ET:65S.CPO<#X@/'`@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@
M,#L@=&5X="UA;&EG;CH@:G5S=&EF>3LG/B8C,38P.SPO<#X@/'`@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@=&5X="UI;F1E
M;G0Z(#`N,C5I;CLG/DQE=F5L(#$F(S$U,3M1=6]T960@<')I8V5S(&EN(&%C
M=&EV92!M87)K971S(&9O<B!I9&5N=&EC86P@87-S971S(&]R(&QI86)I;&ET
M:65S+CPO<#X@/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@
M:G5S=&EF>3L@=&5X="UI;F1E;G0Z(#`N,C5I;CLG/DQE=F5L(#(F(S$U,3M)
M;G!U=',L(&]T:&5R('1H86X@=&AE('%U;W1E9"!P<FEC97,@:6X@86-T:79E
M(&UA<FME=',L('1H870@87)E(&]B<V5R=F%B;&4@96ET:&5R(&1I<F5C=&QY
M(&]R(&EN9&ER96-T;'DN/"]P/B`\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R!T
M97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,"XR-6EN.R<^3&5V
M96P@,R8C,34Q.U5N;V)S97)V86)L92!I;G!U=',@8F%S960@;VX@=&AE($-O
M;7!A;GDG<R!A<W-U;7!T:6]N<RX\+W`^(#QP('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T
M(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[('1E>'0M:6YD96YT.B`P+C(U:6X[
M)SXF(S$V,#L\+W`^(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI
M9VXZ(&IU<W1I9GD[)SY!="!-87)C:"`S,2P@,C`Q-2!A;F0@1&5C96UB97(@
M,S$L(#(P,30L('1H92!F86ER('9A;'5E(&]F(&-A<V@@86YD(&-A<V@@97%U
M:79A;&5N=',L(&%C8V]U;G1S('!A>6%B;&4L(&%N9"!A8V-R=65D(&5X<&5N
M<V5S(&%P<')O>&EM871E('1H96ER(&-A<G)Y:6YG('9A;'5E<R!B87-E9"!O
M;B!T:&5I<B!S:&]R="!T97)M(&YA='5R92X\+W`^/"]D:78^(#QP('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SXF(S$V,#L\
M+W`^(#QD:78^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@
M:G5S=&EF>3LG/CQB/CQI/E5S92!O9B!%<W1I;6%T97,\+VD^/"]B/CPO<#X@
M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3LG
M/B8C,38P.SPO<#X@/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG
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M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3LG
M/B8C,38P.SPO<#X@/&1I=CX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R!T97AT
M+6%L:6=N.B!J=7-T:69Y.R<^/&(^/&D^4W1O8VLM0F%S960@0V]M<&5N<V%T
M:6]N/"]I/CPO8CX\+W`^(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M
M86QI9VXZ(&IU<W1I9GD[)SXF(S$V,#L\+W`^(#QP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SY4:&4@0V]M<&%N>2!P97)I
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M:6]D(&]F('1H92!M96%S=7)E;65N="!D871E+CPO<#X@/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3LG/B8C,38P.SPO<#X@
M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3LG
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M:6]D<RX\+W`^/"]D:78^(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M
M86QI9VXZ(&IU<W1I9GD[)SX\8CX\:3XF(S$V,#L\+VD^/"]B/CPO<#X@/&1I
M=CX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y
M.R<^/&(^/&D^4F5S96%R8V@@86YD($1E=F5L;W!M96YT/"]I/CPO8CX\+W`^
M(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[
M)SXF(S$V,#L\+W`^(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI
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M=')A8W1S(&]N(&$@<75A<G1E<FQY(&)A<VES+CPO<#X\+V1I=CX@/'`@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3LG/B8C,38P
M.SPO<#X@/&1I=CX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R!T97AT+6%L:6=N
M.B!J=7-T:69Y.R<^/&(^/&D^0V]N8V5N=')A=&EO;G,\+VD^/"]B/CPO<#X@
M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3LG
M/B8C,38P.SPO<#X@/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG
M;CH@:G5S=&EF>3LG/D9I;F%N8VEA;"!I;G-T<G5M96YT<RP@=VAI8V@@<&]T
M96YT:6%L;'D@<W5B:F5C="!T:&4@0V]M<&%N>2!T;R!C;VYC96YT<F%T:6]N
M<R!O9B!C<F5D:70@<FES:RP@8V]N<VES="!P<FEN8VEP86QL>2!O9B!C87-H
M+CPO<#X@/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S
M=&EF>3LG/B8C,38P.SPO<#X@/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X
M="UA;&EG;CH@:G5S=&EF>3LG/E1H92!#;VUP86YY(&UA:6YT86EN<R!C87-H
M(&)A;&%N8V5S(&%T(&]N92!B86YK+B!!<R!O9B!-87)C:"`S,2P@,C`Q-2P@
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M97AI<W1S+CPO<#X\+V1I=CX@/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X
M="UA;&EG;CH@:G5S=&EF>3LG/B8C,38P.SPO<#X@/&1I=CX\<"!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M
M87)G:6XZ(#!P="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R<^/&(^/&D^4F5C
M96YT($%C8V]U;G1I;F<@4')O;F]U;F-E;65N=',\+VD^/"]B/CPO<#X@/'`@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3LG/CQB
M/CQI/B8C,38P.SPO:3X\+V(^/"]P/B`\<"!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P
M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R<^26X@36%Y(#(P,30L('1H92!&:6YA
M;F-I86P@06-C;W5N=&EN9R!3=&%N9&%R9',@0F]A<F0@*$9!4T(I(&ES<W5E
M9"!!8V-O=6YT:6YG(%-T86YD87)D<R!5<&1A=&4@*$%352D@3F\N(#(P,30M
M,#DL(#QI/E)E=F5N=64@9G)O;2!#;VYT<F%C=',@=VET:"!#=7-T;VUE<G,\
M+VD^+B!!4U4@,C`Q-"TP.2!I<R!A(&-O;7!R96AE;G-I=F4@<F5V96YU92!R
M96-O9VYI=&EO;B!S=&%N9&%R9"!T:&%T('=I;&P@<W5P97)S961E(&YE87)L
M>2!A;&P@97AI<W1I;F<@<F5V96YU92!R96-O9VYI=&EO;B!G=6ED86YC92!U
M;F1E<B!C=7)R96YT(%4N4RX@1T%!4"!A;F0@<F5P;&%C92!I="!W:71H(&$@
M<')I;F-I<&QE(&)A<V5D(&%P<')O86-H(&9O<B!D971E<FUI;FEN9R!R979E
M;G5E(')E8V]G;FET:6]N+B!!4U4@,C`Q-"TP.2!W:6QL(')E<75I<F4@=&AA
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M,C`Q-"TP.2!I<R!E9F9E8W1I=F4@9F]R(&EN=&5R:6T@86YD(&%N;G5A;"!P
M97)I;V1S(&)E9VEN;FEN9R!A9G1E<B!$96-E;6)E<B`Q-2P@,C`Q-BP@:&]W
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M=&5M96YT<R!A;F0@9&ES8VQO<W5R97,N/"]P/B`\<"!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ
M(#!P="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R<^)B,Q-C`[/"]P/B`\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#!P="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R<^26X@
M2F%N=6%R>2`R,#$U+"!T:&4@1D%30B!I<W-U960@06-C;W5N=&EN9R!3=&%N
M9&%R9',@57!D871E($YO+B`R,#$U+3`Q("A3=6)T;W!I8R`R,C4M,C`I("T@
M26YC;VUE(%-T871E;65N="`M($5X=')A;W)D:6YA<GD@86YD(%5N=7-U86P@
M271E;7,N($%352`R,#$U+3`Q(&5L:6UI;F%T97,@=&AE(&-O;F-E<'0@;V8@
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M;F%R>2!I=&5M+B!(;W=E=F5R+"!!4U4@,C`Q-2TP,2!W:6QL('-T:6QL(')E
M=&%I;B!T:&4@<')E<V5N=&%T:6]N(&%N9"!D:7-C;&]S=7)E(&=U:61A;F-E
M(&9O<B!I=&5M<R!T:&%T(&%R92!U;G5S=6%L(&EN(&YA='5R92!A;F0@;V-C
M=7(@:6YF<F5Q=65N=&QY+B!!4U4@,C`Q-2TP,2!I<R!E9F9E8W1I=F4@9F]R
M('!E<FEO9',@8F5G:6YN:6YG(&%F=&5R($1E8V5M8F5R(#$U+"`R,#$U+B!%
M87)L>2!A9&]P=&EO;B!I<R!P97)M:71T960N(%1H92!A9&]P=&EO;B!O9B!!
M4U4@,C`Q-2TP,2!I<R!N;W0@97AP96-T960@=&\@:&%V92!A(&UA=&5R:6%L
M(&5F9F5C="!O;B!T:&4@0V]M<&%N>2=S(&-O;G-O;&ED871E9"!F:6YA;F-I
M86P@<W1A=&5M96YT<RX\+W`^(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E
M>'0M86QI9VXZ(&IU<W1I9GD[)SXF(S$V,#L\+W`^(#QP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SY/=&AE<B!R96-E;G0@
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M86P@<W1A=&5M96YT<RX\+W`^/"]D:78^(#PO9&EV/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\
M+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?8CDQ9C0R,6-?9F1C-%\T-SED
M7S@P-SA?8S0U8V,U-#`U8C5A#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O
M+T,Z+V(Y,68T,C%C7V9D8S1?-#<Y9%\X,#<X7V,T-6-C-30P-6(U82]7;W)K
M<VAE971S+U-H965T,3`N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN
M9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[
M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@
M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E
M>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J
M879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES
M($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT
M86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5,13X-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS
M1#(^/'-T<F]N9SY35$]#2TA/3$1%4E,G($5154E463QB<CX\+W-T<F]N9SX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$U/&)R/CPO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-43T-+2$],1$52
M4R<@15%52519(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4U1/0TM(3TQ$15)3)R!%455)5%D\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78@:60],T1%9&=A<E-!03$R
M,S0U-S@Y,#`P,"!S='EL93TS1"=F;VYT+69A;6EL>2`Z("=4:6UE<R!.97<@
M4F]M86XG.R<^#0H\<"!S='EL93TS1"=M87)G:6XZ(#!P=#L@9F]N="UF86UI
M;'DZ("=T:6UE<R!N97<@<F]M86XG.R<^/&)R+SX\+W`^#0H\<"!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M
M87)G:6XZ(#!P="`P.R<^/&(^/&9O;G0@<W1Y;&4],T0G=&5X="UD96-O<F%T
M:6]N.B!U;F1E<FQI;F4[)SY.3U1%(#,N(%-43T-+2$],1$524R<@15%52519
M/"]F;VYT/CPO8CX\+W`^#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R<^)B,Q
M-C`[/"]P/@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#LG/CQB/CQI/E!U8FQI
M8R!O9F9E<FEN9SPO:3X\+V(^/"]P/@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@
M,#LG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M
M86QI9VXZ(&IU<W1I9GD[)SY/;B!-87)C:"`S+"`R,#$U+"!T:&4@0V]M<&%N
M>2!C;VUP;&5T960@86X@=6YD97)W<FET=&5N('!U8FQI8R!O9F9E<FEN9R!O
M9B`\9F]N=#XY+#(P,"PP,#`\+V9O;G0^('-H87)E<R!O9B!I=',@8V]M;6]N
M('-T;V-K(&%T(&$@<')I8V4@;V8@)#QF;VYT/C@N,#`\+V9O;G0^('!E<B!S
M:&%R92!O9B!C;VUM;VX@<W1O8VLN(%1H92!N970@<')O8V5E9',@=&\@=&AE
M($-O;7!A;GD@9G)O;2!T:&4@;V9F97)I;F<@=V5R92`D/&9O;G0^-C@N,SPO
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M:"!W87,@9FEL960@=VET:"!T:&4@4T5#(&]N($YO=F5M8F5R(#(P+"`R,#$T
M(&%N9"!D96-L87)E9"!E9F9E8W1I=F4@;VX@1&5C96UB97(@,3`L(#(P,30L
M(&$@<')E;&EM:6YA<GD@<')O<W!E8W1U<R!S=7!P;&5M96YT('1H97)E=6YD
M97(L(&%N9"!A(')E9VES=')A=&EO;B!S=&%T96UE;G0@;VX@1F]R;2!3+3,@
M9FEL960@=VET:"!T:&4@4T5#(&]N($9E8G)U87)Y(#(V+"`R,#$U+CPO<#X-
M"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[)SXF(S$V,#L\+W`^#0H\<"!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!M87)G:6XZ(#!P="`P.R<^/&(^/&D^27-S=6%N8V4@;V8@8V]M;6]N('-T
M;V-K('5P;VX@8V]N=F5R<VEO;B!O9B!P<F5F97)R960@<W1O8VL\+VD^/"]B
M/CPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[)SXF(S$V,#L\+W`^#0H\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#!P="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R<^
M1'5R:6YG('1H92!T:')E92!M;VYT:',@96YD960@36%R8V@@,S$L(#(P,34L
M('1H92!#;VUP86YY(&ES<W5E9"`\9F]N=#XQ+#`P,"PP,#`\+V9O;G0^('-H
M87)E<R!O9B!C;VUM;VX@<W1O8VL@=7!O;B!T:&4@8V]N=F5R<VEO;B!O9B`\
M9F]N=#XR+#`P,#PO9F]N=#X@<VAA<F5S(&]F(%-E<FEE<R!!($-O;G9E<G1I
M8FQE(%!R969E<G)E9"!3=&]C:RX@5&AE(&YU;6)E<B!C;VYV97)S:6]N('-H
M87)E<R!I<W-U960@=V%S(&1E=&5R;6EN960@;VX@82!F;W)M=6QA(&)A<VES
M(&]F(#QF;VYT/C4P,#PO9F]N=#X@8V]M;6]N('-H87)E<R!F;W(@96%C:"!3
M97)I97,@02!#;VYV97)T:6)L92!0<F5F97)R960@4W1O8VL@:&5L9"X\+W`^
M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y
M.R<^/&)R+SX\+W`^#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYO<FUA;"!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,'!X
M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!F;VYT+7-I>F4M861J=7-T.B!N;VYE
M.R!F;VYT+7-T<F5T8V@Z(&YO<FUA;#LG/CQB/CQI/D-O;6UO;B!S=&]C:R!W
M:71H('9E<W1I;F<@=&5R;7,\+VD^/"]B/CPO<#X-"CQP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!M87)G:6XZ(#!P="`P<'@[('1E>'0M86QI9VXZ(&IU<W1I9GD[(&9O;G0M
M<VEZ92UA9&IU<W0Z(&YO;F4[(&9O;G0M<W1R971C:#H@;F]R;6%L.R<^)B,Q
M-C`[/"]P/@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="]N;W)M86P@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#!P>#L@=&5X
M="UA;&EG;CH@:G5S=&EF>3L@9F]N="US:7IE+6%D:G5S=#H@;F]N93L@9F]N
M="US=')E=&-H.B!N;W)M86P[)SY$=7)I;F<@,C`Q-"P@=&AE($-O;7!A;GD@
M9W)A;G1E9"`\9F]N=#XW.#(L-3`P/"]F;VYT/B!S:&%R97,@;V8@:71S(')E
M<W1R:6-T960@8V]M;6]N('-T;V-K('1O(&YI;F4@;V8@:71S(&5M<&QO>65E
M<R!I;B!A8V-O<F1A;F-E('=I=&@@=&AE('1E<FUS(&]F('1H96ER(&5M<&QO
M>6UE;G0@86=R965M96YT<RX@5&AE(#<X,BPU,#`@<VAA<F5S('9E<W0@;W9E
M<B!A('!E<FEO9"!O9B`\9F]N=#YT:')E93PO9F]N=#X@>65A<G,N($%S('1H
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M;G-E9"!I;B`R,#$T+B!4:&4@86QL;V-A8FQE('!O<G1I;VX@;V8@=&AE(&9A
M:7(@=F%L=64@;V8@=&AE('-T;V-K('1H870@=F5S=&5D(&1U<FEN9R!T:&4@
M=&AR964@;6]N=&AS(&5N9&5D($UA<F-H(#,Q+"`R,#$U(&%M;W5N=&5D('1O
M("0\9F]N=#XT-3`L-#0U/"]F;VYT/B!A;F0@=V%S(')E8V]G;FEZ960@87,@
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M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="]N;W)M86P@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#!P>#L@9F]N="US:7IE+6%D
M:G5S=#H@;F]N93L@9F]N="US=')E=&-H.B!N;W)M86P[)SXF(S$V,#L\+W`^
M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYO<FUA;"!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,'!X.R!T97AT+6%L:6=N
M.B!J=7-T:69Y.R!F;VYT+7-I>F4M861J=7-T.B!N;VYE.R!F;VYT+7-T<F5T
M8V@Z(&YO<FUA;#LG/E=H96X@8V%L8W5L871I;F<@8F%S:6,@;F5T(&EN8V]M
M92`H;&]S<RD@<&5R('-H87)E+"!T:&5S92!S:&%R97,@87)E(&EN8VQU9&5D
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M0F]A<F0N/"]P/@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="]N;W)M86P@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#!P>#L@
M=&5X="UA;&EG;CH@:G5S=&EF>3L@9F]N="US:7IE+6%D:G5S=#H@;F]N93L@
M9F]N="US=')E=&-H.B!N;W)M86P[)SX\8CXF(S$V,#L\+V(^/"]P/@T*/'`@
M<W1Y;&4],T0G9F]N=#H@,3!P="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#!P>#L@9F]N="US:7IE+6%D:G5S
M=#H@;F]N93L@9F]N="US=')E=&-H.B!N;W)M86P[)SY4:&4@9F]L;&]W:6YG
M('1A8FQE('-U;6UA<FEZ97,@<F5S=')I8W1E9"!C;VUM;VX@<W1O8VL@86-T
M:79I='DZ/"]P/CQD:78^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="]N;W)M86P@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#!P
M>#L@9F]N="US:7IE+6%D:G5S=#H@;F]N93L@9F]N="US=')E=&-H.B!N;W)M
M86P[)SX-"CPO<#X\<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYO<FUA;"!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,'!X.R!F
M;VYT+7-I>F4M861J=7-T.B!N;VYE.R!F;VYT+7-T<F5T8V@Z(&YO<FUA;#LG
M/B8C,38P.SPO<#X-"CQT86)L92!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=F
M;VYT.B`Q,'!T+VYO<FUA;"!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@=VED=&@Z(#DP)3L@8F]R9&5R+6-O;&QA<'-E.B!C;VQL87!S93L@9F]N
M="US:7IE+6%D:G5S=#H@;F]N93L@9F]N="US=')E=&-H.B!N;W)M86P[)R!C
M96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P/@T*#0H\='(@<W1Y;&4]
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M;VTM8V]L;W(Z(&)L86-K.R!B;W)D97(M8F]T=&]M+7=I9'1H.B`Q<'0[(&)O
M<F1E<BUB;W1T;VTM<W1Y;&4Z('-O;&ED.R<@8V]L<W!A;CTS1#(^3G5M8F5R
M)B,Q-C`[;V8\8G(O/B!3:&%R97,\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A
M<"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T.R!F;VYT+7=E:6=H=#H@
M8F]L9#LG/B8C,38P.SPO=&0^#0H\=&0@;F]W<F%P/3-$;F]W<F%P('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`Q<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^
M)B,Q-C`[/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@8V5N=&5R.R!F;VYT+7=E:6=H=#H@8F]L9#L@8F]R9&5R+6)O
M='1O;2UC;VQO<CH@8FQA8VL[(&)O<F1E<BUB;W1T;VTM=VED=&@Z(#%P=#L@
M8F]R9&5R+6)O='1O;2US='EL93H@<V]L:60[)R!C;VQS<&%N/3-$,CY796EG
M:'1E9#QB<B\^($%V97)A9V4\8G(O/B!'<F%N="8C,38P.T1A=&4\8G(O/B!&
M86ER)B,Q-C`[5F%L=64\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL
M93TS1"=P861D:6YG+6)O='1O;3H@,7!T.R!F;VYT+7=E:6=H=#H@8F]L9#LG
M/B8C,38P.SPO=&0^#0H\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L
M:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z("-C8V5E9F8[)SX-"CQT
M9"!S='EL93TS1"=W:61T:#H@-S0E.R<^3F]N+79E<W1E9"!S:&%R97,L($IA
M;G5A<GD@,2P@,C`Q-3PO=&0^#0H\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R<^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI
M9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`Q
M,"4[('1E>'0M86QI9VXZ(')I9VAT.R<^/&9O;G0^-3<Y+#<V-#PO9F]N=#X\
M+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F
M=#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R<^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ
M(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`Q,"4[
M('1E>'0M86QI9VXZ(')I9VAT.R<^/&9O;G0^-BXR,#PO9F]N=#X\+W1D/@T*
M/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@;&5F=#LG/B8C
M,38P.SPO=&0^#0H\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z('=H:71E.R<^#0H\=&0@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.B`P+C$R-6EN.R<^1W)A;G1E9#PO=&0^#0H\
M=&0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T
M.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H
M=#LG/CQF;VYT/BT\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X-"CQT9#XF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R<^/&9O;G0^+3PO9F]N=#X\
M+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\
M+W1D/@T*/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T
M=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^#0H\=&0@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.B`P+C$R-6EN.R<^5F5S=&5D/"]T9#X-"CQT9#XF
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M.B`R+C5P=#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG
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M+W1D/@T*/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R+C5P=#LG/B8C
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M9RUB;W1T;VTZ(#(N-7!T.R<^)B,Q-C`[/"]T9#X-"CPO='(^#0H-"CPO=&%B
M;&4^#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T+VYO<FUA;"!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,'!X.R!T97AT+6%L
M:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,"XU:6X[(&9O;G0M<VEZ92UA
M9&IU<W0Z(&YO;F4[(&9O;G0M<W1R971C:#H@;F]R;6%L.R<^)B,Q-C`[/"]P
M/CPO9&EV/@T*/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM
M/5].97AT4&%R=%]B.3%F-#(Q8U]F9&,T7S0W.61?.#`W.%]C-#5C8S4T,#5B
M-6$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8CDQ9C0R,6-?9F1C
M-%\T-SED7S@P-SA?8S0U8V,U-#`U8C5A+U=O<FMS:&5E=',O4VAE970Q,2YH
M=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A
M8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C
M:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV
M/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T
M/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$
M4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R
M:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P
M;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-43T-+
M($]05$E/3E,@04Y$(%=!4E)!3E13/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C,@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/DUA<BX@,S$L(#(P,34\8G(^/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4U1/0TL@3U!424].4R!!3D0@5T%2
M4D%.5%,@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y35$]#2R!/4%1)3TY3($%.1"!705)204Y44SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!I9#TS1$5D9V%R4T%!
M,3(S-#4W.#DP,#`P('-T>6QE/3-$)V9O;G0M9F%M:6QY(#H@)U1I;65S($YE
M=R!2;VUA;B<[)SX-"CQP('-T>6QE/3-$)VUA<F=I;CH@,'!T.R!F;VYT+69A
M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[)SXF(S$V,#L\8G(O/CPO<#X-"CQP
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SX\
M8CX\9F]N="!S='EL93TS1"=T97AT+61E8V]R871I;VXZ('5N9&5R;&EN93LG
M/DY/5$4@-"X@4U1/0TL@3U!424].4R!!3D0@5T%24D%.5%,\+V9O;G0^/"]B
M/CPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU
M<W1I9GD[)SX\8CX\:3XF(S$V,#L\+VD^/"]B/CPO<#X-"CQP('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA
M<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SX\8CX\:3Y3=&]C
M:R!/<'1I;VYS/"]I/CPO8CX\+W`^#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P
M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R<^)B,Q-C`[/"]P/@T*/'`@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3LG/D$@<W5M;6%R
M>2!O9B!T:&4@<W1A='5S(&]F('-T;V-K(&]P=&EO;G,@870@36%R8V@@,S$L
M(#(P,34L(&%N9"!T:&4@8VAA;F=E<R!D=7)I;F<@=&AE('1H<F5E(&UO;G1H
M<R!T:&5N(&5N9&5D+"!I<R!P<F5S96YT960@:6X@=&AE(&9O;&QO=VEN9R!T
M86)L93H\+W`^#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R!T97AT+6%L:6=N
M.B!J=7-T:69Y.R<^)B,Q-C`[/"]P/@T*/&1I=B!C;&%S<STS1$-U<G-O<E!O
M:6YT97(^#0H\9&EV/@T*/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL<W!A
M8VEN9STS1#`@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.B!C;VQL87!S93L@
M9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A<FEA;G0Z(&YO<FUA;#L@9F]N
M="UW96EG:'0Z(&YO<FUA;#L@9F]N="US=')E=&-H.B!N;W)M86P[(&9O;G0M
M<VEZ93H@,3!P=#L@;&EN92UH96EG:'0Z(&YO<FUA;#L@9F]N="UF86UI;'DZ
M("=T:6UE<R!N97<@<F]M86XG+"!T:6UE<RP@<V5R:68[('=I9'1H.B`Q,#`E
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M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<^
M/'-T<F]N9SXF(S$V,#L\+W-T<F]N9SX\+W1D/@T*/'1D(&-O;'-P86X],T0Q
M,R!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R
M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P
M>#LG/CQB<B\^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G
M9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[
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M)R!N;W=R87`],T1N;W=R87`^/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A
M;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)R!N;W=R87`],T1N;W=R87`^/"]T
M9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA
M;B<[)R!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^/"]T9#X-"CQT9"!S
M='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)R!N;W=R
M87`],T1N;W=R87`^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4]
M,T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P
M<'@[)SX\<W1R;VYG/B`\+W-T<F]N9SX\+W1D/@T*/'1D(&-O;'-P86X],T0R
M(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([
M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X
M.R<^/'-T<F]N9SY796EG:'1E9#PO<W1R;VYG/CPO=&0^#0H\=&0@;F]W<F%P
M/3-$;F]W<F%P('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O
M;6%N)SL@<&%D9&EN9SH@,'!X.R<^/'-T<F]N9SX@/"]S=')O;F<^/"]T9#X-
M"CQT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T
M:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/B8C,38P
M.SPO<W1R;VYG/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#(@;F]W<F%P/3-$;F]W
M<F%P('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@9F]N="UF86UI;'DZ
M("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/E=E
M:6=H=&5D($%V97)A9V4\+W-T<F]N9SX\+W1D/@T*/'1D(&YO=W)A<#TS1&YO
M=W)A<"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[
M('!A9&1I;F<Z(#!P>#LG/CQS=')O;F<^)B,Q-C`[/"]S=')O;F<^/"]T9#X-
M"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[
M)R!N;W=R87`],T1N;W=R87`^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F
M;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)R!C;VQS<&%N/3-$,B!N
M;W=R87`],T1N;W=R87`^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT
M+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)R!N;W=R87`],T1N;W=R87`^
M)B,Q-C`[/"]T9#X-"CPO='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI
M9VXZ(&)O='1O;3LG/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM
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M<F]M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/E-H87)E<SPO<W1R;VYG
M/CPO=&0^#0H\=&0@;F]W<F%P/3-$;F]W<F%P('-T>6QE/3-$)V9O;G0M9F%M
M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<^/'-T<F]N
M9SX@/"]S=')O;F<^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4]
M,T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P
M<'@[)SX\<W1R;VYG/B`\+W-T<F]N9SX\+W1D/@T*/'1D(&-O;'-P86X],T0R
M(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([
M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X
M.R<^/'-T<F]N9SY!=F5R86=E/"]S=')O;F<^/"]T9#X-"CQT9"!N;W=R87`]
M,T1N;W=R87`@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M
M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/B`\+W-T<F]N9SX\+W1D/@T*
M/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I
M;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#LG/CQS=')O;F<^)B,Q-C`[
M/"]S=')O;F<^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R
M87`@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>3H@
M)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#LG/CQS=')O;F<^4F5M
M86EN:6YG/"]S=')O;F<^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@<W1Y
M;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG
M.B`P<'@[)SX\<W1R;VYG/B8C,38P.SPO<W1R;VYG/CPO=&0^#0H\=&0@;F]W
M<F%P/3-$;F]W<F%P('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W
M(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<^/'-T<F]N9SXF(S$V,#L\+W-T<F]N
M9SX\+W1D/@T*/'1D(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<"!S='EL
M93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B`G=&EM97,@
M;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<^/'-T<F]N9SY!9V=R96=A=&4\
M+W-T<F]N9SX\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=F
M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#LG
M/CQS=')O;F<^)B,Q-C`[/"]S=')O;F<^/"]T9#X-"CPO='(^#0H\='(@<W1Y
M;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/@T*/'1D('-T>6QE/3-$
M)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SLG(&YO=W)A<#TS1&YO
M=W)A<#X\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=F;VYT
M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#LG/CQS
M=')O;F<^(#PO<W1R;VYG/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#(@;F]W<F%P
M/3-$;F]W<F%P('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@9F]N="UF
M86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R
M;VYG/E5N9&5R/"]S=')O;F<^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@
M<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D
M:6YG.B`P<'@[)SX\<W1R;VYG/B`\+W-T<F]N9SX\+W1D/@T*/'1D(&YO=W)A
M<#TS1&YO=W)A<"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R
M;VUA;B<[('!A9&1I;F<Z(#!P>#LG/CQS=')O;F<^(#PO<W1R;VYG/CPO=&0^
M#0H\=&0@8V]L<W!A;CTS1#(@;F]W<F%P/3-$;F]W<F%P('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&-E;G1E<CL@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M
M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/D5X97)C:7-E/"]S=')O;F<^
M/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G9F]N="UF86UI
M;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG
M/B`\+W-T<F]N9SX\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS
M1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P
M>#LG/CQS=')O;F<^)B,Q-C`[/"]S=')O;F<^/"]T9#X-"CQT9"!C;VQS<&%N
M/3-$,B!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N
M=&5R.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z
M(#!P>#LG/CQS=')O;F<^0V]N=')A8W1U86P\+W-T<F]N9SX\+W1D/@T*/'1D
M(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S
M(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#LG/CQS=')O;F<^)B,Q-C`[/"]S
M=')O;F<^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G9F]N
M="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[)SX\
M<W1R;VYG/B8C,38P.SPO<W1R;VYG/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#(@
M;F]W<F%P/3-$;F]W<F%P('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@
M9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[
M)SX\<W1R;VYG/DEN=')I;G-I8SPO<W1R;VYG/CPO=&0^#0H\=&0@;F]W<F%P
M/3-$;F]W<F%P('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O
M;6%N)SL@<&%D9&EN9SH@,'!X.R<^/'-T<F]N9SXF(S$V,#L\+W-T<F]N9SX\
M+W1D/@T*/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T
M=&]M.R<^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=4:6UE<R!.97<@
M4F]M86XG.R<@;F]W<F%P/3-$;F]W<F%P/B8C,38P.SPO=&0^#0H\=&0@;F]W
M<F%P/3-$;F]W<F%P('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W
M(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<^/'-T<F]N9SXF(S$V,#L\+W-T<F]N
M9SX\+W1D/@T*/'1D(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<"!S='EL
M93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B`G=&EM97,@
M;F5W(')O;6%N)SL@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`Q<'0@<V]L:60@
M(6EM<&]R=&%N=#L@<&%D9&EN9SH@,'!X.R<^/'-T<F]N9SY/<'1I;VX\+W-T
M<F]N9SX\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=F;VYT
M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#LG/CQS
M=')O;F<^)B,Q-C`[/"]S=')O;F<^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R
M87`@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P
M861D:6YG.B`P<'@[)SX\<W1R;VYG/B8C,38P.SPO<W1R;VYG/CPO=&0^#0H\
M=&0@8V]L<W!A;CTS1#(@;F]W<F%P/3-$;F]W<F%P('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&-E;G1E<CL@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG
M.R!B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#%P="!S;VQI9"`A:6UP;W)T86YT
M.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/E!R:6-E/"]S=')O;F<^/"]T9#X-
M"CQT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T
M:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/B8C,38P
M.SPO<W1R;VYG/CPO=&0^#0H\=&0@;F]W<F%P/3-$;F]W<F%P('-T>6QE/3-$
M)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X
M.R<^/'-T<F]N9SXF(S$V,#L\+W-T<F]N9SX\+W1D/@T*/'1D(&-O;'-P86X]
M,T0R(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT
M97([(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@8F]R9&5R+6)O
M='1O;3H@(S`P,#`P,"`Q<'0@<V]L:60@(6EM<&]R=&%N=#L@<&%D9&EN9SH@
M,'!X.R<^/'-T<F]N9SY,:69E/"]S=')O;F<^/"]T9#X-"CQT9"!N;W=R87`]
M,T1N;W=R87`@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M
M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/B8C,38P.SPO<W1R;VYG/CPO
M=&0^#0H\=&0@;F]W<F%P/3-$;F]W<F%P('-T>6QE/3-$)V9O;G0M9F%M:6QY
M.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<^/'-T<F]N9SXF
M(S$V,#L\+W-T<F]N9SX\+W1D/@T*/'1D(&-O;'-P86X],T0R(&YO=W)A<#TS
M1&YO=W)A<"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M
M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@8F]R9&5R+6)O='1O;3H@(S`P,#`P
M,"`Q<'0@<V]L:60@(6EM<&]R=&%N=#L@<&%D9&EN9SH@,'!X.R<^/'-T<F]N
M9SY686QU93PO<W1R;VYG/CPO=&0^#0H\=&0@;F]W<F%P/3-$;F]W<F%P('-T
M>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN
M9SH@,'!X.R<^/'-T<F]N9SXF(S$V,#L\+W-T<F]N9SX\+W1D/@T*/"]T<CX-
M"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^#0H\=&0@
M<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ('1O<#L@=&5X="UA;&EG;CH@;&5F
M=#L@9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R<^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L
M:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)SXF
M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!T;W`[
M('1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O
M;6%N)SLG(&-O;'-P86X],T0R/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M=F5R=&EC86PM86QI9VXZ('1O<#L@=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF
M86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R<^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!L969T
M.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)SXF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!T;W`[('1E>'0M86QI
M9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SLG(&-O
M;'-P86X],T0R/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G=F5R=&EC86PM
M86QI9VXZ('1O<#L@=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF86UI;'DZ("=4
M:6UE<R!.97<@4F]M86XG.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=V
M97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!L969T.R!F;VYT+69A
M;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)SXF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!T;W`[('1E>'0M86QI9VXZ(&QE9G0[
M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SLG(&-O;'-P86X],T0R
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ('1O
M<#L@=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF86UI;'DZ("=4:6UE<R!.97<@
M4F]M86XG.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=V97)T:6-A;"UA
M;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)U1I
M;65S($YE=R!2;VUA;B<[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W9E
M<G1I8V%L+6%L:6=N.B!T;W`[('1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M
M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SLG(&-O;'-P86X],T0R/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ('1O<#L@=&5X="UA
M;&EG;CH@;&5F=#L@9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R<^
M)B,Q-C`[/"]T9#X-"CPO='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI
M9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@(V-C965F9CLG/@T*/'1D
M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D
M9&EN9SH@,'!X.R<@=VED=&@],T0Q,#`E/D]U='-T86YD:6YG(&%T($IA;G5A
M<GD@,2P@,C`Q-3PO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T
M:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[)SXF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G
M=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ
M("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[('9E<G1I8V%L+6%L
M:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R87`[)SX\9F]N=#XQ+#@U
M-RPX-S<\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z
M(#!P>#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X
M.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P
M<'@[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@
M<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O
M;6%N)SL@<&%D9&EN9SH@,'!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!P
M861D:6YG+7)I9VAT.B`Q,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R<^)#PO
M=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0[(&9O;G0M9F%M
M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!V97)T:6-A
M;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R<^/&9O;G0^
M-RXS,3PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
M9G0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@
M,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[
M('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P
M>#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R!P
M861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M
M86XG.R!P861D:6YG.B`P<'@[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I
M;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL
M>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE
M.B`Q,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@
M;F]W<F%P.R<^/&9O;G0^."XU/"]F;VYT/B!Y96%R<SPO=&0^#0H\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N
M97<@<F]M86XG.R!P861D:6YG.B`P<'@[('=H:71E+7-P86-E.B!N;W=R87`[
M('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V
M,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W
M(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P
M861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[
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M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G=&EM
M97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W
M<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^
M)B,Q-C`[/"]T9#X-"CPO='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI
M9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@=VAI=&4[)SX-"CQT9"!S
M='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)R!W:61T
M:#TS1#$P,"4^1W)A;G1E9#PO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI
M;'DZ("=4:6UE<R!.97<@4F]M86XG.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE
M=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@<FEG:'0[(&9O;G0M9F%M:6QY.B`G=&EM97,@
M;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!V97)T:6-A;"UA;&EG;CH@8F]T
M=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R<^/&9O;G0^-3`L,#`P/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF
M86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[('=H:71E
M+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL
M969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W=H:71E+7-P
M86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T
M.B`U<'@[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SLG/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF
M86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[('=H:71E
M+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL
M969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A
M9&1I;F<Z(#!P>#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M<W!A
M8V4Z(&YO=W)A<#LG/CQF;VYT/C<N-#4\+V9O;G0^/"]T9#X-"CQT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE
M=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@
M<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D
M9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#L@9F]N="UF86UI
M;'DZ("=4:6UE<R!.97<@4F]M86XG.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE
M=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@
M<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0[(&9O;G0M
M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT
M+7-I>F4Z(#$P<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P
M86-E.B!N;W=R87`[)SX\9F]N=#XQ,#PO9F]N=#X@>65A<G,\+W1D/@T*/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G=&EM
M97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W
M<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=W:&ET92US<&%C93H@;F]W<F%P
M.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R!F;VYT
M+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)SXF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G=&EM
M97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W
M<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@
M9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[
M('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R87`[
M)SX\9F]N=#XR,S,L,#`P/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@;&5F=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG
M.R!P861D:6YG.B`P<'@[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M
M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*
M/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B
M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^#0H\=&0@<W1Y;&4],T0G9F]N
M="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R<@=VED=&@],T0Q,#`E/D5X
M97)C:7-E9#PO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=4:6UE
M<R!.97<@4F]M86XG.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[
M('!A9&1I;F<Z(#!P>#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@<FEG:'0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N
M)SL@<&%D9&EN9SH@,'!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET
M92US<&%C93H@;F]W<F%P.R<^/&9O;G0^+3PO9F]N=#X\+W1D/@T*/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G=&EM97,@
M;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P
M.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=W:&ET92US<&%C93H@;F]W<F%P.R!P
M861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R!F;VYT+69A
M;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)SXF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G=&EM97,@
M;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P
M.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@9F]N
M="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[('=H
M:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN
M9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@
M<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I
M9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT
M.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R!F;VYT+69A;6EL>3H@)U1I;65S
M($YE=R!2;VUA;B<[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@
M<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I
M9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ("=T
M:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[('=H:71E+7-P86-E.B!N
M;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[
M)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[
M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X
M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A
M9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=W
M:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I
M;F<M;&5F=#H@-7!X.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[
M)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[
M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X
M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A
M9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M
M86XG.R!P861D:6YG.B`P<'@[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I
M;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY
M.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C
M93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@
M-7!X.R<^)B,Q-C`[/"]T9#X-"CPO='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC
M86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@=VAI=&4[)SX-
M"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[
M('!A9&1I;F<Z(#!P>#LG('=I9'1H/3-$,3`P)3Y%>'!I<F5D+T9O<F9E:71E
M9#PO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@
M<F]M86XG.R!P861D:6YG.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W
M(')O;6%N)SL@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`Q<'0@<V]L:60@(6EM
M<&]R=&%N=#L@<&%D9&EN9SH@,'!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N
M97<@<F]M86XG.R!B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#%P="!S;VQI9"`A
M:6UP;W)T86YT.R!P861D:6YG.B`P<'@[('9E<G1I8V%L+6%L:6=N.B!B;W1T
M;VT[('=H:71E+7-P86-E.B!N;W=R87`[)SX\9F]N=#XM/"]F;VYT/CPO=&0^
M#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF86UI;'DZ
M("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&)O<F1E<BUB;W1T
M;VTZ(",P,#`P,#`@,7!T('-O;&ED("%I;7!O<G1A;G0[('=H:71E+7-P86-E
M.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U
M<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G
M=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@
M;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X
M.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T
M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&)O<F1E<BUB;W1T
M;VTZ(",P,#`P,#`@,7!T('-O;&ED("%I;7!O<G1A;G0[('!A9&1I;F<Z(#!P
M>#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R!P
M861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@<FEG:'0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O
M;6%N)SL@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`Q<'0@<V]L:60@(6EM<&]R
M=&%N=#L@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D
M:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL
M>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@=VAI=&4M<W!A
M8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z
M(#5P>#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ
M("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[('=H:71E+7-P86-E
M.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U
M<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
M9G0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@8F]R9&5R+6)O
M='1O;3H@(S`P,#`P,"`Q<'0@<V]L:60@(6EM<&]R=&%N=#L@<&%D9&EN9SH@
M,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[
M('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@
M<F]M86XG.R!B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#%P="!S;VQI9"`A:6UP
M;W)T86YT.R!P861D:6YG.B`P<'@[('=H:71E+7-P86-E.B!N;W=R87`[('!A
M9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\
M+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M
M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US
M<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F
M=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL
M>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@=VAI=&4M<W!A
M8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z
M(#5P>#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M;&5F=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!B;W)D97(M
M8F]T=&]M.B`C,#`P,#`P(#%P="!S;VQI9"`A:6UP;W)T86YT.R!P861D:6YG
M.B`P<'@[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P
M>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE
M=R!R;VUA;B<[(&)O<F1E<BUB;W1T;VTZ(",P,#`P,#`@,7!T('-O;&ED("%I
M;7!O<G1A;G0[('!A9&1I;F<Z(#!P>#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@
M<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF
M86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[('=H:71E
M+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL
M969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/"]T<CX-"CQT<B!S='EL93TS1"=V
M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E
M969F.R<^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@
M<F]M86XG.R!P861D:6YG.B`P<'@[)R!W:61T:#TS1#$P,"4^3W5T<W1A;F1I
M;F<@870@36%R8V@@,S$L(#(P,34\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M
M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT
M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&)O<F1E<BUB;W1T;VTZ(",P
M,#`P,#`@,BXX,'!T(&1O=6)L92`A:6UP;W)T86YT.R!P861D:6YG.B`P<'@[
M)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&)O<F1E<BUB;W1T
M;VTZ(",P,#`P,#`@,BXX,'!T(&1O=6)L92`A:6UP;W)T86YT.R!P861D:6YG
M.B`P<'@[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N
M;W=R87`[)SX\9F]N=#XQ+#DP-RPX-S<\+V9O;G0^/"]T9#X-"CQT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE
M=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@8F]R9&5R+6)O='1O;3H@(S`P,#`P
M,"`R+C@P<'0@9&]U8FQE("%I;7!O<G1A;G0[('=H:71E+7-P86-E.B!N;W=R
M87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF
M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@
M;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P
M.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT
M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&)O<F1E<BUB;W1T;VTZ(",P
M,#`P,#`@,BXX,'!T(&1O=6)L92`A:6UP;W)T86YT.R!P861D:6YG.B`P<'@[
M('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('!A9&1I;F<M<FEG:'0Z(#$P<'@[
M('=H:71E+7-P86-E.B!N;W=R87`[)SXD/"]T9#X-"CQT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M
M86XG.R!B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#(N.#!P="!D;W5B;&4@(6EM
M<&]R=&%N=#L@<&%D9&EN9SH@,'!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M
M.R!W:&ET92US<&%C93H@;F]W<F%P.R<^/&9O;G0^-RXT-SPO9F]N=#X\+W1D
M/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY
M.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!B;W)D97(M8F]T
M=&]M.B`C,#`P,#`P(#(N.#!P="!D;W5B;&4@(6EM<&]R=&%N=#L@=VAI=&4M
M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE
M9G0Z(#5P>#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI
M;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[('=H:71E+7-P
M86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T
M.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&QE9G0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@8F]R9&5R
M+6)O='1O;3H@(S`P,#`P,"`Q<'0@<V]L:60@(6EM<&]R=&%N=#L@<&%D9&EN
M9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U
M<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N
M97<@<F]M86XG.R!B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#%P="!S;VQI9"`A
M:6UP;W)T86YT.R!P861D:6YG.B`P<'@[('9E<G1I8V%L+6%L:6=N.B!B;W1T
M;VT[('=H:71E+7-P86-E.B!N;W=R87`[)SX\9F]N=#XX+C(U/"]F;VYT/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF86UI
M;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&)O<F1E<BUB
M;W1T;VTZ(",P,#`P,#`@,7!T('-O;&ED("%I;7!O<G1A;G0[('=H:71E+7-P
M86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T
M.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY
M.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C
M93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@
M-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&)O<F1E<BUB
M;W1T;VTZ(",P,#`P,#`@,7!T('-O;&ED("%I;7!O<G1A;G0[('!A9&1I;F<Z
M(#!P>#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUR:6=H=#H@
M,3!P>#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#LG/B0\+W1D/@T*/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE
M=R!R;VUA;B<[(&)O<F1E<BUB;W1T;VTZ(",P,#`P,#`@,7!T('-O;&ED("%I
M;7!O<G1A;G0[('!A9&1I;F<Z(#!P>#L@=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#LG/CQF;VYT/C$P+#8X-RPV,S<\+V9O
M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT
M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@8F]R
M9&5R+6)O='1O;3H@(S`P,#`P,"`Q<'0@<V]L:60@(6EM<&]R=&%N=#L@=VAI
M=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG
M+6QE9G0Z(#5P>#LG/B8C,38P.SPO=&0^#0H\+W1R/@T*/'1R('-T>6QE/3-$
M)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z('=H
M:71E.R<^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@
M<F]M86XG.R!P861D:6YG.B`P<'@[)R!W:61T:#TS1#$P,"4^17AE<F-I<V%B
M;&4@870@36%R8V@@,S$L(#(P,34\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M
M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT
M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&)O<F1E<BUB;W1T;VTZ(",P
M,#`P,#`@,BXX,'!T(&1O=6)L92`A:6UP;W)T86YT.R!P861D:6YG.B`P<'@[
M)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&)O<F1E<BUB;W1T
M;VTZ(",P,#`P,#`@,BXX,'!T(&1O=6)L92`A:6UP;W)T86YT.R!P861D:6YG
M.B`P<'@[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N
M;W=R87`[)SX\9F]N=#XT,#4L-#$R/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@
M<F]M86XG.R!P861D:6YG.B`P<'@[(&)O<F1E<BUB;W1T;VTZ(",P,#`P,#`@
M,BXX,'!T(&1O=6)L92`A:6UP;W)T86YT.R!W:&ET92US<&%C93H@;F]W<F%P
M.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE
M=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@
M<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF
M86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!B;W)D97(M8F]T=&]M.B`C,#`P
M,#`P(#(N.#!P="!D;W5B;&4@(6EM<&]R=&%N=#L@<&%D9&EN9SH@,'!X.R!V
M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!P861D:6YG+7)I9VAT.B`Q,'!X.R!W
M:&ET92US<&%C93H@;F]W<F%P.R<^)#PO=&0^#0H\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@<FEG:'0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N
M)SL@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`R+C@P<'0@9&]U8FQE("%I;7!O
M<G1A;G0[('!A9&1I;F<Z(#!P>#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@
M=VAI=&4M<W!A8V4Z(&YO=W)A<#LG/CQF;VYT/C$P+C0X/"]F;VYT/CPO=&0^
M#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF86UI;'DZ
M("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&)O<F1E<BUB;W1T
M;VTZ(",P,#`P,#`@,BXX,'!T(&1O=6)L92`A:6UP;W)T86YT.R!W:&ET92US
M<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F
M=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL
M>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@=VAI=&4M<W!A
M8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z
M(#5P>#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M;&5F=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG
M.B`P<'@[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P
M>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE
M=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@
M<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF
M86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[('=H:71E
M+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL
M969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M
M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US
M<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F
M=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N
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M='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#LG/CQF;VYT/C0L-S`X+#<Q.#PO
M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O
M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W
M:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I
M;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CPO='(^#0H-"CPO=&%B;&4^
M#0H\+V1I=CX-"CPO9&EV/@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X
M="UA;&EG;CH@:G5S=&EF>3LG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SY$=7)I;F<@=&AE('1H
M<F5E(&UO;G1H<R!E;F1E9"!-87)C:"`S,2P@,C`Q-2P@=&AE($-O;7!A;GD@
M9W)A;G1E9"!A;B!O<'1I;VX@=&\@<'5R8VAA<V4@/&9O;G0^-3`L,#`P/"]F
M;VYT/B!S:&%R97,@;V8@8V]M;6]N('-T;V-K('1O(&$@;F5W(&UE;6)E<B!O
M9B!T:&4@0V]M<&%N>2=S($)O87)D(&]F($1I<F5C=&]R<RX@5&AE('-T;V-K
M(&]P=&EO;G,@:&%V92!A;B!E>&5R8VES92!P<FEC92!O9B`D/&9O;G0^-RXT
M-3PO9F]N=#X@86YD('9E<W0@:6X@9F]U<B!I;G-T86QL;65N=',@87,@9F]L
M;&]W<SH@;W!T:6]N<R!F;W(@=&AE('!U<F-H87-E(&]F(#QF;VYT/C$R+#4P
M,#PO9F]N=#X@<VAA<F5S('9E<W0@;VX@36%Y(#$U+"`R,#$U+"!A;F0@=&AE
M(')E;6%I;FEN9R!O<'1I;VYS('1O('!U<F-H87-E('-H87)E<R!V97-T(&5V
M96YL>2!O=F5R('1H92!N97AT('1H<F5E('%U87)T97)S+B!4:&4@9F%I<B!V
M86QU92!O9B!T:&5S92!O<'1I;VYS('=A<R!D971E<FUI;F5D('1O(&)E("0\
M9F]N=#XS-CDL,#`P/"]F;VYT/B!U<VEN9R!T:&4@0FQA8VLM4V-H;VQE<R!O
M<'1I;VX@<')I8VEN9R!M;V1E;"!B87-E9"!O;B!T:&4@9F]L;&]W:6YG(&%S
M<W5M<'1I;VYS.B`H:2D@=F]L871I;&ET>2!R871E(&]F(#QF;VYT/C(Q,SPO
M9F]N=#XE+"`H:6DI(&1I<V-O=6YT(')A=&4@;V8@/&9O;G0^,2XS-SPO9F]N
M=#X@)2P@*&EI:2D@/&9O;G0^>F5R;SPO9F]N=#X@97AP96-T960@9&EV:61E
M;F0@>6EE;&0L(&%N9"`H:78I(&5X<&5C=&5D(&QI9F4@;V8@/&9O;G0^-CPO
M9F]N=#X@>65A<G,N/"]P/@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X
M="UA;&EG;CH@:G5S=&EF>3LG/B8C,38P.SPO<#X-"CQP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SY$=7)I;F<@=&AE('1H
M<F5E(&UO;G1H<R!E;F1E9"!-87)C:"`S,2P@,C`Q-2!A;F0@,C`Q-"P@=&AE
M($-O;7!A;GD@<F5C;W)D960@8V]M<&5N<V%T:6]N(&-O<W1S(&]F("0\9F]N
M=#XQ+#`Q-RPS,#@\+V9O;G0^(&%N9"`D/&9O;G0^.3`Q+#8U,#PO9F]N=#XL
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M+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[)SXF(S$V,#L\+W`^#0H\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#!P="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R<^
M3VX@36%R8V@@,CDL(#(P,3`L('1H92!#;VUP86YY)W,@0F]A<F0@;V8@1&ER
M96-T;W)S(&%D;W!T960@=&AE($=E;F5S:7,@0FEO<&AA<FUA+"!);F,N(#(P
M,3`\8CX@/"]B/D5Q=6ET>2!#;VUP96YS871I;VX@4&QA;B`H=&AE("(R,#$P
M(%!L86XB*2!P=7)S=6%N="!T;R!W:&EC:"!T:&4@0F]A<F0@<F5S97)V960@
M86X@86=G<F5G871E(&]F(#QF;VYT/C,U+#`P,#PO9F]N=#X@<VAA<F5S(&]F
M(&-O;6UO;B!S=&]C:R!F;W(@9G5T=7)E(&=R86YT<R!O9B!S=&]C:R!O<'1I
M;VYS+"!R:6=H=',@=&\@86-Q=6ER92!R97-T<FEC=&5D('-T;V-K+"!R:6=H
M=',@=&\@86-Q=6ER92!U;G)E<W1R:6-T960@<W1O8VLL(&%N9"!S=&]C:R!A
M<'!R96-I871I;VX@<FEG:'1S+B!/<'1I;VYS(&9O<B!T:&4@:7-S=6%N8V4@
M;V8@86QL(#,U+#`P,"!S:&%R97,@:&%V92!B965N(&=R86YT960L(&%N9"!N
M;R!S:&%R97,@87)E(&%V86EL86)L92!F;W(@861D:71I;VYA;"!G<F%N=',@
M=6YD97(@=&AE(#(P,3`@4&QA;BX\+W`^#0H\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P
M="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R<^)B,Q-C`[/"]P/@T*/'`@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3LG/D]N($]C
M=&]B97(@,30L(#(P,3$L('1H92!#;VUP86YY)W,@0F]A<F0@;V8@1&ER96-T
M;W)S(&%P<')O=F5D(&$@,C`Q,2!%<75I='D@26YC96YT:79E(%!L86X@*'1H
M92`F(S$T-SLR,#$Q(%!L86XF(S$T.#LI+B!4:&4@0V]M<&%N>2=S('-T;V-K
M:&]L9&5R<R!D:60@;F]T(&%P<')O=F4@=&AE(#(P,3$@4&QA;B!W:71H:6X@
M82!R97%U:7)E9"!O;F4M>65A<B!P97)I;V0L(&%N9"!A8V-O<F1I;F=L>2P@
M=&AE($-O;7!A;GD@8V%N;F]T(&=R86YT(&EN8V5N=&EV92!S=&]C:R!O<'1I
M;VYS('5N9&5R('1H92`R,#$Q(%!L86XN($%S(&]F($1E8V5M8F5R(#,Q+"`R
M,#$T+"!N;R!S:&%R97,@=V5R92!A=F%I;&%B;&4@9F]R(&9U='5R92!G<F%N
M="!U;F1E<B!T:&4@,C`Q,2!0;&%N+CPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SXF(S$V,#L\+W`^#0H\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#!P="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R<^3VX@
M4V5P=&5M8F5R(#$Y+"`R,#$T+"!4:&4@0V]M<&%N>2=S($)O87)D(&]F($1I
M<F5C=&]R<R!A9&]P=&5D('1H92!,:6]N($)I;W1E8VAN;VQO9VEE<RP@26YC
M+B`R,#$T($5Q=6ET>2!);F-E;G1I=F4@4&QA;B`H=&AE("8C,30W.S(P,30@
M4&QA;B8C,30X.RDN(%1H92`R,#$T(%!L86X@=V%S(&%P<')O=F5D(&)Y(&]U
M<B!S=&]C:VAO;&1E<G,@870@=&AE(&%N;G5A;"!M965T:6YG(&]F('-T;V-K
M:&]L9&5R<R!H96QD(&EN($YO=F5M8F5R(#(P,30N(%1H92`R,#$T(%!L86X@
M:6YI=&EA;&QY(&%U=&AO<FEZ960@=&AE(&ES<W5A;F-E('5P('1O(&%N(&%G
M9W)E9V%T92!O9B`\9F]N=#XR+#,U,"PP,#`\+V9O;G0^('-H87)E<R!O9B!C
M;VUM;VX@<W1O8VLN($]N($%P<FEL(#$P+"`R,#$U('1H92!";V%R9"!A;65N
M9&5D('1H92`R,#$T(%!L86XL('-U8FIE8W0@=&\@<W1O8VMH;VQD97(@87!P
M<F]V86PL('1O(&EN8W)E87-E('1H92!T;W1A;"!N=6UB97(@;V8@<VAA<F5S
M('1H870@8V%N(&)E(&ES<W5E9"!U;F1E<B!T:&4@,C`Q-"!0;&%N(&)Y(#QF
M;VYT/C$L-C4P+#`P,#PO9F]N=#X@9G)O;2`R+#,U,"PP,#`@<VAA<F5S('1O
M(#QF;VYT/C0L,#`P+#`P,#PO9F]N=#X@<VAA<F5S+CPO<#X-"CQP('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SXF(S$V,#L\
M+W`^#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R<^/&(^/&D^5V%R<F%N=',\
M+VD^/"]B/CPO<#X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[)SXF(S$V,#L\
M+W`^#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R!T97AT+6%L:6=N.B!J=7-T
M:69Y.R<^02!S=6UM87)Y(&]F('1H92!S=&%T=7,@;V8@<W1O8VL@=V%R<F%N
M=',@870@36%R8V@@,S$L(#(P,34L(&%N9"!T:&4@8VAA;F=E<R!D=7)I;F<@
M=&AE('1H<F5E(&UO;G1H<R!T:&5N(&5N9&5D+"!I<R!P<F5S96YT960@:6X@
M=&AE(&9O;&QO=VEN9R!T86)L93H\+W`^#0H\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P
M="`P.R<^)B,Q-C`[/"]P/@T*/&1I=B!C;&%S<STS1$-U<G-O<E!O:6YT97(^
M#0H\9&EV/@T*/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS
M1#`@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.B!C;VQL87!S93L@9F]N="US
M='EL93H@;F]R;6%L.R!F;VYT+79A<FEA;G0Z(&YO<FUA;#L@9F]N="UW96EG
M:'0Z(&YO<FUA;#L@9F]N="US=')E=&-H.B!N;W)M86P[(&9O;G0M<VEZ93H@
M,3!P=#L@;&EN92UH96EG:'0Z(&YO<FUA;#L@9F]N="UF86UI;'DZ("=T:6UE
M<R!N97<@<F]M86XG+"!T:6UE<RP@<V5R:68[('=I9'1H.B`Q,#`E.R<^#0H-
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M+6QE9G0Z(#5P>#L@9F]N="US:7IE.B`Q,"XP<'0[(&9O;G0M9F%M:6QY.B`G
M5&EM97,@3F5W(%)O;6%N)SLG(&%L:6=N/3-$8V5N=&5R/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG
M.R<@;F]W<F%P/3-$;F]W<F%P(&-O;'-P86X],T0S(&%L:6=N/3-$8V5N=&5R
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=4:6UE<R!.97<@
M4F]M86XG.R<@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R/CPO=&0^
M#0H\=&0@<W1Y;&4],T0G=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR
M:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#L@9F]N="US:7IE.B`Q,"XP
M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SLG(&%L:6=N/3-$
M8V5N=&5R/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ
M("=4:6UE<R!.97<@4F]M86XG.R<@;F]W<F%P/3-$;F]W<F%P(&-O;'-P86X]
M,T0S(&%L:6=N/3-$8V5N=&5R/CPO=&0^#0H\=&0@86QI9VX],T1C96YT97(@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>3H@)W1I
M;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP
M<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@
M<&%D9&EN9RUL969T.B`U<'@[)SX\<W1R;VYG/B8C,38P.SPO<W1R;VYG/CPO
M=&0^#0H\=&0@;F]W<F%P/3-$;F]W<F%P(&-O;'-P86X],T0Q-2!A;&EG;CTS
M1&-E;G1E<B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M
M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I
M>F4Z(#$P+C!P=#LG/CQB<B\^/"]T9#X-"CQT9"!S='EL93TS1"=W:&ET92US
M<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F
M=#H@-7!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@9F]N="UF86UI;'DZ("=4:6UE
M<R!.97<@4F]M86XG.R<@86QI9VX],T1C96YT97(^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)R!N
M;W=R87`],T1N;W=R87`@8V]L<W!A;CTS1#,@86QI9VX],T1C96YT97(^)B,Q
M-C`[/"]T9#X-"CPO='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ
M(&)O='1O;3LG/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@
M3F5W(%)O;6%N)SLG(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<CX\
M+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O
M;6%N)SLG(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<CX\+W1D/@T*
M/'1D('-T>6QE/3-$)W=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG
M:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[(&9O;G0M<VEZ93H@,3`N,'!T
M.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)R!A;&EG;CTS1&-E
M;G1E<CXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G
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M-7!X.R!P861D:6YG+6QE9G0Z(#5P>#L@9F]N="US:7IE.B`Q,"XP<'0[)SX\
M<W1R;VYG/B8C,38P.SPO<W1R;VYG/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#,@
M;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&-E;G1E<CL@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG
M.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/E=E:6=H=&5D/"]S=')O;F<^/"]T
M9#X-"CQT9"!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=T97AT+6%L:6=N.B!C
M96YT97([(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN
M9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=VAI=&4M<W!A8V4Z(&YO=W)A
M<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/CQS
M=')O;F<^)B,Q-C`[/"]S=')O;F<^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R
M87`@8V]L<W!A;CTS1#,@86QI9VX],T1C96YT97(@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[
M('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[)SX\<W1R;VYG/E=E
M:6=H=&5D($%V97)A9V4\+W-T<F]N9SX\+W1D/@T*/'1D('-T>6QE/3-$)W=H
M:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN
M9RUL969T.B`U<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!F;VYT+69A;6EL>3H@
M)U1I;65S($YE=R!2;VUA;B<[)R!A;&EG;CTS1&-E;G1E<CXF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N
M)SLG(&YO=W)A<#TS1&YO=W)A<"!C;VQS<&%N/3-$,R!A;&EG;CTS1&-E;G1E
M<CXF(S$V,#L\+W1D/@T*/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA
M;&EG;CH@8F]T=&]M.R<^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=4
M:6UE<R!.97<@4F]M86XG.R<@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N
M=&5R/CPO=&0^#0H\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R
M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D
M9&EN9SH@,'!X.R<^/'-T<F]N9SX@/"]S=')O;F<^/"]T9#X-"CQT9"!A;&EG
M;CTS1&-E;G1E<B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M
M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET
M92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M
M;&5F=#H@-7!X.R!F;VYT+7-I>F4Z(#$P+C!P=#LG/CQS=')O;F<^)B,Q-C`[
M/"]S=')O;F<^/"]T9#X-"CQT9"!C;VQS<&%N/3-$-"!N;W=R87`],T1N;W=R
M87`@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>3H@
M)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#LG/CQS=')O;F<^4VAA
M<F5S/"]S=')O;F<^/"]T9#X-"CQT9"!A;&EG;CTS1&-E;G1E<B!S='EL93TS
M1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W
M(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P
M861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R!F;VYT+7-I
M>F4Z(#$P+C!P=#LG/CQS=')O;F<^)B,Q-C`[/"]S=')O;F<^/"]T9#X-"CQT
M9"!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>3H@)W1I
M;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#LG/CQS=')O;F<^079E<F%G
M93PO<W1R;VYG/CPO=&0^#0H\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$
M8V5N=&5R('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N
M)SL@<&%D9&EN9SH@,'!X.R<^/'-T<F]N9SX@/"]S=')O;F<^/"]T9#X-"CQT
M9"!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([
M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X
M.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D
M9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/CQS=')O;F<^
M)B,Q-C`[/"]S=')O;F<^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@8V]L
M<W!A;CTS1#,@86QI9VX],T1C96YT97(@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M8V5N=&5R.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I
M;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[)SX\<W1R;VYG/E)E;6%I;FEN
M9SPO<W1R;VYG/CPO=&0^#0H\=&0@86QI9VX],T1C96YT97(@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R
M;VUA;B<[('!A9&1I;F<Z(#!P>#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D
M9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#L@9F]N="US:7IE
M.B`Q,"XP<'0[)SX\<W1R;VYG/B8C,38P.SPO<W1R;VYG/CPO=&0^#0H\=&0@
M8V]L<W!A;CTS1#,@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@9F]N="UF86UI;'DZ("=T:6UE
M<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/D%G9W)E9V%T
M93PO<W1R;VYG/CPO=&0^#0H\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L
M+6%L:6=N.B!B;W1T;VT[)SX-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@
M)U1I;65S($YE=R!2;VUA;B<[)R!N;W=R87`],T1N;W=R87`@86QI9VX],T1C
M96YT97(^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT
M97(@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P
M861D:6YG.B`P<'@[)SX\<W1R;VYG/B`\+W-T<F]N9SX\+W1D/@T*/'1D(&%L
M:6=N/3-$8V5N=&5R('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@9F]N
M="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[('=H
M:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN
M9RUL969T.B`U<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R<^/'-T<F]N9SXF(S$V
M,#L\+W-T<F]N9SX\+W1D/@T*/'1D(&-O;'-P86X],T0T(&YO=W)A<#TS1&YO
M=W)A<"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY
M.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<^/'-T<F]N9SY5
M;F1E<CPO<W1R;VYG/CPO=&0^#0H\=&0@86QI9VX],T1C96YT97(@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE
M=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@
M<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#L@9F]N="US
M:7IE.B`Q,"XP<'0[)SX\<W1R;VYG/B8C,38P.SPO<W1R;VYG/CPO=&0^#0H\
M=&0@8V]L<W!A;CTS1#(@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@9F]N="UF86UI;'DZ("=T
M:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/D5X97)C
M:7-E/"]S=')O;F<^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@86QI9VX]
M,T1C96YT97(@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M
M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/B`\+W-T<F]N9SX\+W1D/@T*
M/'1D(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E
M<CL@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P
M<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!W:&ET92US<&%C93H@;F]W<F%P.R!P
M861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^/'-T<F]N
M9SXF(S$V,#L\+W-T<F]N9SX\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!C
M;VQS<&%N/3-$,R!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=T97AT+6%L:6=N
M.B!C96YT97([(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D
M9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#LG/CQS=')O;F<^0V]N=')A
M8W1U86P\+W-T<F]N9SX\+W1D/@T*/'1D(&%L:6=N/3-$8V5N=&5R('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@9F]N="UF86UI;'DZ("=T:6UE<R!N
M97<@<F]M86XG.R!P861D:6YG.B`P<'@[('=H:71E+7-P86-E.B!N;W=R87`[
M('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[(&9O;G0M
M<VEZ93H@,3`N,'!T.R<^/'-T<F]N9SXF(S$V,#L\+W-T<F]N9SX\+W1D/@T*
M/'1D(&-O;'-P86X],T0S(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E
M<B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B`G
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M:6=N/3-$8V5N=&5R('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W
M(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<^/'-T<F]N9SXF(S$V,#L\+W-T<F]N
M9SX\+W1D/@T*/'1D(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&-E;G1E<CL@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P
M861D:6YG.B`P<'@[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG
M:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[(&9O;G0M<VEZ93H@,3`N,'!T
M.R<^/'-T<F]N9SXF(S$V,#L\+W-T<F]N9SX\+W1D/@T*/'1D(&-O;'-P86X]
M,T0T(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT
M97([(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@8F]R9&5R+6)O
M='1O;3H@(S`P,#`P,"`Q<'0@<V]L:60@(6EM<&]R=&%N=#L@<&%D9&EN9SH@
M,'!X.R<^/'-T<F]N9SY787)R86YT<SPO<W1R;VYG/CPO=&0^#0H\=&0@86QI
M9VX],T1C96YT97(@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT
M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@=VAI
M=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG
M+6QE9G0Z(#5P>#L@9F]N="US:7IE.B`Q,"XP<'0[)SX\<W1R;VYG/B8C,38P
M.SPO<W1R;VYG/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#(@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E
M<CL@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!B;W)D97(M8F]T
M=&]M.B`C,#`P,#`P(#%P="!S;VQI9"`A:6UP;W)T86YT.R!P861D:6YG.B`P
M<'@[)SX\<W1R;VYG/E!R:6-E/"]S=')O;F<^/"]T9#X-"CQT9"!N;W=R87`]
M,T1N;W=R87`@86QI9VX],T1C96YT97(@<W1Y;&4],T0G9F]N="UF86UI;'DZ
M("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/B8C
M,38P.SPO<W1R;VYG/CPO=&0^#0H\=&0@86QI9VX],T1C96YT97(@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE
M=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[('=H
M:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN
M9RUL969T.B`U<'@[)SX\<W1R;VYG/B8C,38P.SPO<W1R;VYG/CPO=&0^#0H\
M=&0@;F]W<F%P/3-$;F]W<F%P(&-O;'-P86X],T0S(&%L:6=N/3-$8V5N=&5R
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@9F]N="UF86UI;'DZ("=T
M:6UE<R!N97<@<F]M86XG.R!B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#%P="!S
M;VQI9"`A:6UP;W)T86YT.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N
M,'!T.R<^/'-T<F]N9SY,:69E/"]S=')O;F<^/"]T9#X-"CQT9"!A;&EG;CTS
M1&-E;G1E<B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M
M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US
M<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F
M=#H@-7!X.R!F;VYT+7-I>F4Z(#$P+C!P=#LG/CQS=')O;F<^)B,Q-C`[/"]S
M=')O;F<^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,R!N;W=R87`],T1N;W=R87`@
M86QI9VX],T1C96YT97(@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!F
M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&)O<F1E<BUB;W1T;VTZ
M(",P,#`P,#`@,7!T('-O;&ED("%I;7!O<G1A;G0[('!A9&1I;F<Z(#!P>#LG
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M9VX],T1C96YT97(^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=V97)T:6-A
M;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!L969T.R!W:&ET92US<&%C93H@
M;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X
M.R!F;VYT+7-I>F4Z(#$P+C!P=#L@9F]N="UF86UI;'DZ("=4:6UE<R!.97<@
M4F]M86XG.R<@86QI9VX],T1C96YT97(^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!L969T.R!F
M;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)R!C;VQS<&%N/3-$,R!A
M;&EG;CTS1&-E;G1E<CXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W9E<G1I
M8V%L+6%L:6=N.B!T;W`[('1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY
M.B`G5&EM97,@3F5W(%)O;6%N)SLG(&%L:6=N/3-$8V5N=&5R/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ('1O<#L@=&5X="UA
M;&EG;CH@;&5F=#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H
M=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#L@9F]N="US:7IE.B`Q,"XP<'0[
M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SLG(&%L:6=N/3-$8V5N
M=&5R/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ
M('1O<#L@=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF86UI;'DZ("=4:6UE<R!.
M97<@4F]M86XG.R<@8V]L<W!A;CTS1#,@86QI9VX],T1C96YT97(^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT
M+6%L:6=N.B!L969T.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=VAI=&4M<W!A8V4Z
M(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P
M>#L@9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R<@86QI9VX],T1C
M96YT97(^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG
M;CH@=&]P.R!T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)U1I;65S
M($YE=R!2;VUA;B<[)R!C;VQS<&%N/3-$,R!A;&EG;CTS1&-E;G1E<CXF(S$V
M,#L\+W1D/@T*/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!T;W`[('1E
M>'0M86QI9VXZ(&QE9G0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M
M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[(&9O;G0M<VEZ93H@,3`N
M,'!T.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)R!A;&EG;CTS
M1&-E;G1E<CXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L
M:6=N.B!T;W`[('1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G5&EM
M97,@3F5W(%)O;6%N)SLG(&-O;'-P86X],T0S(&%L:6=N/3-$8V5N=&5R/B8C
M,38P.SPO=&0^#0H\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z("-C8V5E9F8[)SX-"CQT9"!S
M='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I
M;F<Z(#!P>#LG('=I9'1H/3-$,3`P)3Y/=71S=&%N9&EN9R!A="!$96-E;6)E
M<B`S,2P@,C`Q-#PO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T
M:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[)SXF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@
M)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q
M,"XP<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P
M>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@
M,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R<@
M86QI9VX],T1L969T/CPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ
M("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@
M,3`N,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@
M;F]W<F%P.R<@86QI9VX],T1R:6=H=#X\9F]N=#XQ,2PP.#0L-#(V/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@
M<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!V97)T
M:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D
M:6YG+7)I9VAT.B`U<'@[)R!A;&EG;CTS1&QE9G0^/"]T9#X-"CQT9"!S='EL
M93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z
M(#!P>#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M<FEG:'0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN
M9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=VAI=&4M<W!A8V4Z(&YO=W)A
M<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N
M97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!V
M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P
M861D:6YG+7)I9VAT.B`U<'@[)R!A;&EG;CTS1&QE9G0^)#PO=&0^#0H\=&0@
M<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D
M:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R<@86QI9VX],T1R:6=H=#X\
M9F]N=#XR+C4Q/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI
M;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ
M93H@,3`N,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C
M93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[)R!A;&EG;CTS1&QE9G0^
M/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@9F]N="UF
M86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M
M<VEZ93H@,3`N,'!T.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I
M9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A
M9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[('9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z
M(#5P>#LG(&%L:6=N/3-$;&5F=#X\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M
M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT
M+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M
M<W!A8V4Z(&YO=W)A<#LG(&%L:6=N/3-$<FEG:'0^/&9O;G0^,RXX-3PO9F]N
M=#X@>65A<G,\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM
M97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P
M=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A
M<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R<@86QI9VX],T1L969T/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0[(&9O;G0M9F%M:6QY.B`G
M=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P
M+C!P=#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X
M.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P
M<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M
M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[)R!A
M;&EG;CTS1&QE9G0^)#PO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ
M("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@
M,3`N,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@
M;F]W<F%P.R<@86QI9VX],T1R:6=H=#X\9F]N=#XU.2PU,3<L.3DX/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@
M<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!V97)T
M:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D
M:6YG+7)I9VAT.B`U<'@[)R!A;&EG;CTS1&QE9G0^/"]T9#X-"CPO='(^#0H\
M='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N
M9"UC;VQO<CH@=VAI=&4[)SX-"CQT9"!S='EL93TS1"=T97AT+6EN9&5N=#H@
M,3!P=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG
M.B`P<'@[)R!W:61T:#TS1#$P,"4^27-S=65D/"]T9#X-"CQT9"!S='EL93TS
M1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)SXF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL
M>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE
M.B`Q,"XP<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z
M(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN
M9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O
M='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X
M.R<@86QI9VX],T1L969T/CPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI
M;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ
M93H@,3`N,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C
M93H@;F]W<F%P.R<@86QI9VX],T1R:6=H=#X\9F]N=#XM/"]F;VYT/CPO=&0^
M#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG
M.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!V97)T:6-A;"UA
M;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I
M9VAT.B`U<'@[)R!A;&EG;CTS1&QE9G0^/"]T9#X-"CQT9"!S='EL93TS1"=F
M;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)SXF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@
M)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q
M,"XP<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P
M>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@
M,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R<@
M86QI9VX],T1L969T/CPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ
M("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@
M,3`N,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@
M;F]W<F%P.R<@86QI9VX],T1R:6=H=#X\+W1D/@T*/'1D('-T>6QE/3-$)V9O
M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F
M;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI
M=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R<@86QI9VX]
M,T1L969T/CPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0[
M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X
M.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D
M9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M
M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!V97)T:6-A
M;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG
M+7)I9VAT.B`U<'@[)R!A;&EG;CTS1&QE9G0^/"]T9#X-"CQT9"!S='EL93TS
M1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P
M>#L@9F]N="US:7IE.B`Q,"XP<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M('=H:71E+7-P86-E.B!N;W=R87`[)R!A;&EG;CTS1')I9VAT/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P
M861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!V97)T:6-A;"UA;&EG
M;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT
M.B`U<'@[)R!A;&EG;CTS1&QE9G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG
M.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!W:&ET92US<&%C
M93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@
M-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@
M)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q
M,"XP<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N
M;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#LG(&%L:6=N/3-$;&5F=#X\+W1D
M/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N
M)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM
M86QI9VXZ(&)O='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#LG(&%L:6=N/3-$
M<FEG:'0^/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S
M(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[
M('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R87`[
M('!A9&1I;F<M<FEG:'0Z(#5P>#LG(&%L:6=N/3-$;&5F=#X\+W1D/@T*/"]T
M<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K
M9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^#0H\=&0@<W1Y;&4],T0G=&5X="UI
M;F1E;G0Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@
M<&%D9&EN9SH@,'!X.R<@=VED=&@],T0Q,#`E/D5X97)C:7-E9#PO=&0^#0H\
M=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R<^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@
M9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[
M(&9O;G0M<VEZ93H@,3`N,'!T.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D
M:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA
M;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[('9E<G1I8V%L
M+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M
M<FEG:'0Z(#5P>#LG(&%L:6=N/3-$;&5F=#X\+W1D/@T*/'1D('-T>6QE/3-$
M)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X
M.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@
M=VAI=&4M<W!A8V4Z(&YO=W)A<#LG(&%L:6=N/3-$<FEG:'0^/&9O;G0^*#DR
M,2PW,#`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@
M)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q
M,"XP<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N
M;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#LG(&%L:6=N/3-$;&5F=#XI/"]T
M9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA
M;B<[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I
M9VAT.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z
M(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[('=H:71E+7-P86-E.B!N;W=R87`[
M('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V
M,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W
M(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R
M=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D
M9&EN9RUR:6=H=#H@-7!X.R<@86QI9VX],T1L969T/B0\+W1D/@T*/'1D('-T
M>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN
M9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O
M='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#LG(&%L:6=N/3-$<FEG:'0^/&9O
M;G0^,BXU,#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY
M.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z
M(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M<W!A8V4Z
M(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R<@86QI9VX],T1L969T/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0[(&9O;G0M9F%M
M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I
M>F4Z(#$P+C!P=#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H
M=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P.SPO=&0^#0H\=&0@
M<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D
M:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U
M<'@[)R!A;&EG;CTS1&QE9G0^/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A
M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US
M:7IE.B`Q,"XP<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P
M86-E.B!N;W=R87`[)R!A;&EG;CTS1')I9VAT/CPO=&0^#0H\=&0@<W1Y;&4]
M,T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P
M<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M
M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[)R!A
M;&EG;CTS1&QE9G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R
M:6=H=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG
M.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!W:&ET92US<&%C93H@;F]W<F%P
M.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q
M-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE
M=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[('9E
M<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R87`[('!A
M9&1I;F<M<FEG:'0Z(#5P>#LG(&%L:6=N/3-$;&5F=#X\+W1D/@T*/'1D('-T
M>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN
M9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O
M='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#LG(&%L:6=N/3-$<FEG:'0^/"]T
M9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA
M;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[('9E<G1I8V%L
M+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M
M<FEG:'0Z(#5P>#LG(&%L:6=N/3-$;&5F=#X\+W1D/@T*/"]T<CX-"CQT<B!S
M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O
M;&]R.B!W:&ET93LG/@T*/'1D('-T>6QE/3-$)W1E>'0M:6YD96YT.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P
M>#LG('=I9'1H/3-$,3`P)3Y%>'!I<F5D/"]T9#X-"CQT9"!S='EL93TS1"=F
M;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)SXF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@
M)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q
M,"XP<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P
M>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@
M,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R<@
M86QI9VX],T1L969T/CPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ
M("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@
M,3`N,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@
M;F]W<F%P.R<@86QI9VX],T1R:6=H=#X\+W1D/@T*/'1D('-T>6QE/3-$)V9O
M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F
M;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI
M=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R<@86QI9VX]
M,T1L969T/CPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=4:6UE
M<R!.97<@4F]M86XG.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG
M.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!W:&ET92US<&%C
M93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@
M-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@
M)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q
M,"XP<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N
M;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#LG(&%L:6=N/3-$;&5F=#X\+W1D
M/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N
M)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM
M86QI9VXZ(&)O='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#LG(&%L:6=N/3-$
M<FEG:'0^/&9O;G0^+3PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M
M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT
M+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M
M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R<@86QI9VX],T1L
M969T/CPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0[(&9O
M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F
M;VYT+7-I>F4Z(#$P+C!P=#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN
M9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG
M.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!V97)T:6-A;"UA
M;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I
M9VAT.B`U<'@[)R!A;&EG;CTS1&QE9G0^/"]T9#X-"CQT9"!S='EL93TS1"=F
M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@
M9F]N="US:7IE.B`Q,"XP<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H
M:71E+7-P86-E.B!N;W=R87`[)R!A;&EG;CTS1')I9VAT/CPO=&0^#0H\=&0@
M<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D
M:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U
M<'@[)R!A;&EG;CTS1&QE9G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P
M861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!W:&ET92US<&%C93H@
M;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X
M.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I
M;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP
M<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R
M87`[('!A9&1I;F<M<FEG:'0Z(#5P>#LG(&%L:6=N/3-$;&5F=#X\+W1D/@T*
M/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@
M<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI
M9VXZ(&)O='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#LG(&%L:6=N/3-$<FEG
M:'0^/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE
M=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[('9E
M<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R87`[('!A
M9&1I;F<M<FEG:'0Z(#5P>#LG(&%L:6=N/3-$;&5F=#X\+W1D/@T*/"]T<CX-
M"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O
M=6YD+6-O;&]R.B`C8V-E969F.R<^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@;&5F=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D
M:6YG.B`P<'@[)R!W:61T:#TS1#$P,"4^3W5T<W1A;F1I;F<@86YD(&5X97)C
M:7-A8FQE(&%T($UA<F-H(#,Q+"`R,#$U/"]T9#X-"CQT9"!S='EL93TS1"=F
M;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)SXF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@
M)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q
M,"XP<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P
M>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@
M,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R<@
M86QI9VX],T1L969T/CPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ
M("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@
M,3`N,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@
M;F]W<F%P.R<@86QI9VX],T1R:6=H=#X\9F]N=#XQ,"PQ-C(L-S(V/"]F;VYT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@
M<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!V97)T
M:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D
M:6YG+7)I9VAT.B`U<'@[)R!A;&EG;CTS1&QE9G0^/"]T9#X-"CQT9"!S='EL
M93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)SXF(S$V,#L\
M+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A
M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US
M:7IE.B`Q,"XP<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG
M:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D
M9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ
M(&)O='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@
M-7!X.R<@86QI9VX],T1L969T/B0\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M
M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT
M+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M
M<W!A8V4Z(&YO=W)A<#LG(&%L:6=N/3-$<FEG:'0^/&9O;G0^,BXU,3PO9F]N
M=#X\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W
M(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R
M=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D
M9&EN9RUR:6=H=#H@-7!X.R<@86QI9VX],T1L969T/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@<FEG:'0[(&9O;G0M9F%M:6QY.B`G=&EM97,@
M;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@
M=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D
M:6YG+6QE9G0Z(#5P>#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N
M="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O
M;G0M<VEZ93H@,3`N,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET
M92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[)R!A;&EG;CTS
M1&QE9G0^/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S
M(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[
M('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R87`[
M)R!A;&EG;CTS1')I9VAT/CQF;VYT/C,N-3@\+V9O;G0^('EE87)S/"]T9#X-
M"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[
M('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[('9E<G1I8V%L+6%L
M:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG
M:'0Z(#5P>#LG(&%L:6=N/3-$;&5F=#X\+W1D/@T*/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA
M;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[('=H:71E+7-P
M86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T
M.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY
M.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z
M(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M<W!A8V4Z
M(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R<@86QI9VX],T1L969T/B0\
M+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O
M;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC
M86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#LG(&%L:6=N
M/3-$<FEG:'0^/&9O;G0^.3<L-C4T+#$X-SPO9F]N=#X\+W1D/@T*/'1D('-T
M>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN
M9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O
M='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X
M.R<@86QI9VX],T1L969T/CPO=&0^#0H\+W1R/@T*#0H\+W1A8FQE/@T*/"]D
M:78^#0H\+V1I=CX-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI
M9VXZ(&IU<W1I9GD[)SXF(S$V,#L\+W`^#0H\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P
M="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R<^1'5R:6YG('1H92!T:')E92!M
M;VYT:',@96YD960@36%R8V@@,S$L(#(P,34L('1H92!#;VUP86YY(')E8V5I
M=F5D("0\9F]N=#XR+#,P-"PR-3`\+V9O;G0^(&EN(&-A<V@@9G)O;2!T:&4@
M97AE<F-I<V4@;V8@.3(Q+#<P,"!W87)R86YT<R!F;W(@=&AE('!U<F-H87-E
M(&]F(#QF;VYT/CDR,2PW,#`\+V9O;G0^('-H87)E<R!O9B!I=',@8V]M;6]N
M('-T;V-K+CPO<#X-"CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM
M+2TM+3U?3F5X=%!A<G1?8CDQ9C0R,6-?9F1C-%\T-SED7S@P-SA?8S0U8V,U
M-#`U8C5A#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V(Y,68T,C%C
M7V9D8S1?-#<Y9%\X,#<X7V,T-6-C-30P-6(U82]7;W)K<VAE971S+U-H965T
M,3(N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R
M:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S
M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE
M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA
M<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R
M8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\
M+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS
M1')E<&]R="!I9#TS1$E$,$5,13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY,
M24-%3E-%($%.1"!#3TU-251-14Y44SQB<CX\+W-T<F]N9SX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$U/&)R/CPO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DQ)0T5.4T4@04Y$($-/34U)5$U%
M3E13(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3$E#14Y312!!3D0@0T]-34E4345.5%,\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78@:60],T1%9&=A<E-!03$R,S0U
M-S@Y,#`P,"!S='EL93TS1"=F;VYT+69A;6EL>2`Z("=4:6UE<R!.97<@4F]M
M86XG.R<^(#QP('-T>6QE/3-$)VUA<F=I;CH@,'!T.R!F;VYT+69A;6EL>3H@
M)W1I;65S(&YE=R!R;VUA;B<[)SX\8G(O/CPO<#X@/'`@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN
M.B`P<'0@,#LG/CQB/CQF;VYT('-T>6QE/3-$)W1E>'0M9&5C;W)A=&EO;CH@
M=6YD97)L:6YE.R<^3D]412`U+B!,24-%3E-%($%.1"!#3TU-251-14Y44SPO
M9F]N=#X\+V(^/"]P/B`\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R<^)B,Q-C`[
M/"]P/B`\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R<^/&(^/&D^3F%T:6]N86P@
M26YS=&ET=71E<R!O9B!(96%L=&@@86YD('1H92!.871I;VYA;"!#86YC97(@
M26YS=&ET=71E/"]I/CPO8CX\+W`^(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[
M)SXF(S$V,#L\+W`^(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI
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M9V5R>2!"<F%N8V@L('1O(&1E=F5L;W`@861O<'1I=F4@8V5L;"!I;6UU;F]T
M:&5R87!I97,@=&AA="!A<F4@9&5S:6=N960@=&\@9&5S=')O>2!M971A<W1A
M=&EC(&UE;&%N;VUA(&-E;&QS('5S:6YG(&$@<&%T:65N="=S('1U;6]R(&EN
M9FEL=')A=&EN9R!L>6UP:&]C>71E<RX\+W`^(#QP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SXF(S$V,#L\+W`^(#QP('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SY4:&4@
M0V]M<&%N>2!I;FET:6%L;'D@86=R965D('1O('!A>2!T:&4@3D-)("0\9F]N
M=#XQ+#`P,"PP,#`\+V9O;G0^('!E<B!Y96%R("@D/&9O;G0^,C4P+#`P,#PO
M9F]N=#X@<&5R('%U87)T97(I('5N9&5R('1H92!#4D%$02X@3VX@2F%N=6%R
M>2`R,BP@,C`Q-2P@=&AE($-O;7!A;GD@97AE8W5T960@86X@86UE;F1M96YT
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M('1H92!.0TD@:&%V92!I;F-R96%S960@9G)O;2`D/&9O;G0^,3PO9F]N=#X@
M;6EL;&EO;B!T;R`D/&9O;G0^,CPO9F]N=#X@;6EL;&EO;BP@=&\@8F4@<&%I
M9"!I;B!Q=6%R=&5R;'D@:6YS=&%L;&UE;G1S(&]F("0\9F]N=#XU,#`L,#`P
M/"]F;VYT/BX@5&AE($-O;7!A;GD@<&%I9"!T:&4@9FER<W0@<75A<G1E<FQY
M(&EN<W1A;&QM96YT(&]F("0\9F]N=#XU,#`L,#`P/"]F;VYT/B!I;B!&96)R
M=6%R>2`R,#$U+B!!;'1H;W5G:"!T:&4@0U)!1$$@:&%S(&$@9FEV92!Y96%R
M('1E<FTL(&5I=&AE<B!P87)T>2!T;R!T:&4@0U)!1$$@:&%S('1H92!R:6=H
M="!T;R!T97)M:6YA=&4@=&AE($-2041!('5P;VX@-C`@9&%Y<R<@;F]T:6-E
M('1O('1H92!O=&AE<B!P87)T>2X\+W`^(#QP('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T
M(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SXF(S$V,#L\+W`^(#QP('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SY$=7)I;F<@
M=&AE('1H<F5E(&UO;G1H<R!E;F1E9"!-87)C:"`S,2P@,C`Q-2!A;F0@,C`Q
M-"P@=&AE($-O;7!A;GD@<F5C;V=N:7IE9"`D/&9O;G0^-30Q+#8V-SPO9F]N
M=#X@86YD("0\9F]N=#XR-3`L,#`P/"]F;VYT/BP@<F5S<&5C=&EV96QY+"!O
M9B!#4D%$02!E>'!E;G-E<RP@=VAI8V@@=V5R92!R96-O<F1E9"!A<R!P87)T
M(&]F(')E<V5A<F-H(&%N9"!D979E;&]P;65N="!E>'!E;G-E<R!I;B!T:&4@
M<W1A=&5M96YT(&]F(&]P97)A=&EO;G,N($%S(&]F($1E8V5M8F5R(#,Q+"`R
M,#$T(&%N9"!-87)C:"`S,2P@,C`Q-2P@)#QF;VYT/C(U,"PP,#`\+V9O;G0^
M(&]F($-2041!(&5X<&5N<V5S('=E<F4@:6YC;'5D960@:6X@=&AE(&%C8W)U
M960@97AP96YS97,@;VX@=&AE(&%C8V]M<&%N>6EN9R!C;VYD96YS960@8F%L
M86YC92!S:&5E="X\+W`^(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M
M86QI9VXZ(&IU<W1I9GD[)SXF(S$V,#L\+W`^(#QP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SX\8CX\:3Y.871I;VYA;"!)
M;G-T:71U=&5S(&]F($AE86QT:#PO:3X\+V(^/"]P/B`\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#!P="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R<^)B,Q-C`[/"]P/B`\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#!P="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R<^
M169F96-T:79E($]C=&]B97(@-2P@,C`Q,2P@=&AE($-O;7!A;GD@96YT97)E
M9"!I;G1O(&$@4&%T96YT($QI8V5N<V4@06=R965M96YT("AT:&4@)B,Q-#<[
M3&EC96YS92!!9W)E96UE;G0F(S$T.#LI('=I=&@@=&AE($YA=&EO;F%L($EN
M<W1I='5T97,@;V8@2&5A;'1H+"!A;B!A9V5N8WD@;V8@=&AE(%5N:71E9"!3
M=&%T97,@4'5B;&EC($AE86QT:"!397)V:6-E('=I=&AI;B!T:&4@1&5P87)T
M;65N="!O9B!(96%L=&@@86YD($AU;6%N(%-E<G9I8V5S("@F(S$T-SM.24@F
M(S$T.#LI+B!0=7)S=6%N="!T;R!T:&4@3&EC96YS92!!9W)E96UE;G0L($Y)
M2"!G<F%N=&5D('1O('1H92!#;VUP86YY(&$@;F]N+65X8VQU<VEV92!W;W)L
M9'=I9&4@<FEG:'0@86YD(&QI8V5N<V4@=&\@9&5V96QO<"!A;F0@;6%N=69A
M8W1U<F4@8V5R=&%I;B!P<F]P<FEE=&%R>2!A=71O;&]G;W5S('1U;6]R(&EN
M9FEL=')A=&EN9R!L>6UP:&]C>71E(&%D;W!T:79E(&-E;&P@=&AE<F%P>2!P
M<F]D=6-T<R!F;W(@=&AE('1R96%T;65N="!O9B!M971A<W1A=&EC(&UE;&%N
M;VUA+"!O=F%R:6%N(&-A;F-E<BP@8G)E87-T(&-A;F-E<BP@86YD(&-O;&]R
M96-T86P@8V%N8V5R+B!4:&4@3&EC96YS92!!9W)E96UE;G0@<F5Q=6ER97,@
M=&AE($-O;7!A;GD@=&\@<&%Y(')O>6%L=&EE<R!O9B!S:7@@<&5R8V5N="`H
M/&9O;G0^-CPO9F]N=#XE*2!O9B!N970@<V%L97,@*'-U8FIE8W0@=&\@8V5R
M=&%I;B!A;FYU86P@;6EN:6UU;2!R;WEA;'1Y('!A>6UE;G1S*2P@82!P97)C
M96YT86=E(&]F(')E=F5N=65S(&9R;VT@<W5B;&EC96YS:6YG(&%R<F%N9V5M
M96YT<RP@86YD(&QU;7`@<W5M(&)E;F-H;6%R:R!R;WEA;'1Y('!A>6UE;G1S
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M;F]M82P@=7`@=&\@86YD(&EN8VQU9&EN9R!T:&4@<')O9'5C="=S(&9I<G-T
M(&-O;6UE<F-I86P@<V%L92!I;B!T:&4@56YI=&5D(%-T871E<RP@=&AE('1O
M=&%L(&%M;W5N="!O9B!S=6-H(&)E;F-H;6%R:R!P87EM96YT<R!W:6QL(&)E
M("0\9F]N=#XV+#`U,"PP,#`\+V9O;G0^+B!4:&4@8F5N8VAM87)K('!A>6UE
M;G1S(&9O<B!T:&4@;W1H97(@=&AR964@:6YD:6-A=&EO;G,L(&EF(&%L;"!B
M96YC:&UA<FMS(&%R92!A8VAI979E9"P@=VEL;"!B92`D/&9O;G0^-BPP-3`L
M,#`P/"]F;VYT/B!F;W(@;W9A<FEA;B!C86YC97(L("0\9F]N=#XQ,BPQ,#`L
M,#`P/"]F;VYT/B!F;W(@8G)E87-T(&-A;F-E<BP@86YD("0\9F]N=#XQ,BPQ
M,#`L,#`P/"]F;VYT/B!F;W(@8V]L;W)E8W1A;"!C86YC97(N($%C8V]R9&EN
M9VQY+"!I9B!T:&4@0V]M<&%N>2!A8VAI979E<R!A;&P@8F5N8VAM87)K<R!F
M;W(@86QL(&9O=7(@;&EC96YS960@:6YD:6-A=&EO;G,L('1H92!A9V=R96=A
M=&4@86UO=6YT(&]F(&)E;F-H;6%R:R!R;WEA;'1Y('!A>6UE;G1S('1H870@
M=&AE($-O;7!A;GD@=VEL;"!H879E('1O(&UA:V4@=&\@3DE(('=I;&P@8F4@
M)#QF;VYT/C,V+#,P,"PP,#`\+V9O;G0^+CPO<#X@/'`@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN
M.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3LG/B8C,38P.SPO<#X@/'`@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3LG/D]N
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M96YS:6YG(&9E92!O9B`D/&9O;G0^,S4P+#`P,#PO9F]N=#XL('=H:6-H('=A
M<R!R96-O9VYI>F5D(&%S(')E<V5A<F-H(&%N9"!D979E;&]P;65N="!E>'!E
M;G-E(&1U<FEN9R!T:&4@=&AR964@;6]N=&AS(&5N9&5D($UA<F-H(#,Q+"`R
M,#$U+"!A;F0@:6YC;'5D960@:6X@=&AE(&)A;&%N8V4@;V8@86-C<G5E9"!E
M>'!E;G-E<R!A="!-87)C:"`S,2P@,C`Q-2X@5&AE($-O;7!A;GD@86QS;R!A
M9W)E960@=&\@<&%Y(&-U<W1O;6%R>2!R;WEA;'1I97,@8F%S960@;VX@82!P
M97)C96YT86=E(&]F(&YE="!S86QE<R`H=VAI8V@@<&5R8V5N=&%G92!I<R!I
M;B!T:&4@;6ED+7-I;F=L92!D:6=I=',I+"!A('!E<F-E;G1A9V4@;V8@<F5V
M96YU97,@9G)O;2!S=6)L:6-E;G-I;F<@87)R86YG96UE;G1S+"!A;F0@;'5M
M<"!S=6T@8F5N8VAM87)K('!A>6UE;G1S('5P;VX@=&AE('-U8V-E<W-F=6P@
M8V]M<&QE=&EO;B!O9B!T:&4@0V]M<&%N>2=S(&9I<G-T(%!H87-E(#(@8VQI
M;FEC86P@<W1U9'DL('1H92!S=6-C97-S9G5L(&-O;7!L971I;VX@;V8@=&AE
M($-O;7!A;GDG<R!F:7)S="!0:&%S92`S(&-L:6YI8V%L('-T=61Y+"!T:&4@
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M;V-E<W,@:6X@86YY(&9O<F5I9VX@8V]U;G1R>2X\+W`^(#QP('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA
M<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SXF(S$V,#L\+W`^
M(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[
M)SY$=7)I;F<@=&AE('1H<F5E(&UO;G1H<R!E;F1E9"!-87)C:"`S,2P@,C`Q
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M<RX\+W`^(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU
M<W1I9GD[)SXF(S$V,#L\+W`^(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E
M>'0M86QI9VXZ(&IU<W1I9GD[)SX\8CX\:3Y%>&-L=7-I=F4@3&EC96YS92!!
M9W)E96UE;G0\+VD^/"]B/CPO<#X@/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@
M=&5X="UA;&EG;CH@:G5S=&EF>3LG/B8C,38P.SPO<#X@/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3LG/D]N($IU;'D@,C$L
M(#(P,30L('1H92!#;VUP86YY(&5N=&5R960@:6YT;R!A;B!%>&-L=7-I=F4@
M3&EC96YS92!!9W)E96UE;G0@*'1H92`F(S$T-SM-;V9F:71T($QI8V5N<V4@
M06=R965M96YT)B,Q-#@[*2P@969F96-T:79E(&%S(&]F($IU;F4@,C@L(#(P
M,30L('=I=&@@=&AE($@N($QE92!-;V9F:71T($-A;F-E<B!#96YT97(@86YD
M(%)E<V5A<F-H($EN<W1I='5T92P@26YC+B`H)B,Q-#<[36]F9FET="8C,30X
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M=&5C:&YO;&]G>2!O<B`R,"!Y96%R<R!A9G1E<B!T:&4@969F96-T:79E(&1A
M=&4@;V8@=&AE(&QI8V5N<V4@86=R965M96YT+CPO<#X@/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3LG/B8C,38P.SPO<#X@
M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3LG
M/E!U<G-U86YT('1O('1H92!-;V9F:71T($QI8V5N<V4@06=R965M96YT+"!T
M:&4@0V]M<&%N>2!P86ED(&%N('5P9G)O;G0@;&EC96YS:6YG(&9E92!O9B`D
M/&9O;G0^,C4L,#`P/"]F;VYT/BP@=VAI8V@@=V%S(')E8V]G;FEZ960@87,@
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M=&AA="!T:&4@0V]M<&%N>2!A;F0@36]F9FET="!A9W)E960@=&\N/"]P/B`\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#!P="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R<^
M)B,Q-C`[/"]P/B`\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R!T97AT+6%L:6=N
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M<SPO<#X@/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S
M=&EF>3LG/B8C,38P.SPO<#X@/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X
M="UA;&EG;CH@:G5S=&EF>3LG/CQB/CQI/D5X8VQU<VEV92!0871E;G0@3&EC
M96YS92!!9W)E96UE;G0\+VD^/"]B/CPO<#X@/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P
M<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3LG/B8C,38P.SPO<#X@/'`@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3LG/D]N($9E
M8G)U87)Y(#$P+"`R,#$U+"!T:&4@0V]M<&%N>2!E;G1E<F5D(&EN=&\@86X@
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M;G0@<FEG:'0@97AP:7)E<RX\+W`^(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[
M('1E>'0M86QI9VXZ(&IU<W1I9GD[)SXF(S$V,#L\+W`^(#QP('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA
M<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SY);B!C;VYS:61E
M<F%T:6]N(&9O<B!T:&4@97AC;'5S:79E(')I9VAT<R!G<F%N=&5D('5N9&5R
M('1H92!E>&-L=7-I=F4@4&%T96YT($QI8V5N<V4@06=R965M96YT+"!T:&4@
M0V]M<&%N>2!A9W)E960@=&\@<&%Y('1H92!.24@@82!N;VXM<F5F=6YD86)L
M92!U<&9R;VYT(&QI8V5N<VEN9R!F964@;V8@)#QF;VYT/C0P+#`P,#PO9F]N
M=#XL('=H:6-H('=A<R!R96-O9VYI>F5D(&%S(')E<V5A<F-H(&%N9"!D979E
M;&]P;65N="!E>'!E;G-E(&1U<FEN9R!T:&4@=&AR964@;6]N=&AS(&5N9&5D
M($UA<F-H(#,Q+"`R,#$U+"!A;F0@:6YC;'5D960@:6X@=&AE(&)A;&%N8V4@
M;V8@86-C<G5E9"!E>'!E;G-E<R!A="!-87)C:"`S,2P@,C`Q-2X@5&AE($-O
M;7!A;GD@86QS;R!A9W)E960@=&\@<&%Y(&-U<W1O;6%R>2!R;WEA;'1I97,@
M8F%S960@;VX@82!P97)C96YT86=E(&]F(&YE="!S86QE<R`H=VAI8V@@<&5R
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M971I;VX@;V8@=&AE($-O;7!A;GDG<R!F:7)S="!0:&%S92`S(&-L:6YI8V%L
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M<F]D=6-T(&]R('!R;V-E<W,@:6X@86YY(&9O<F5I9VX@8V]U;G1R>2X\+W`^
M(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[
M)SXF(S$V,#L\+W`^(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI
M9VXZ(&IU<W1I9GD[)SY$=7)I;F<@=&AE('1H<F5E(&UO;G1H<R!E;F1E9"!-
M87)C:"`S,2P@,C`Q-2P@=&AE<F4@=V5R92!N;R!N970@<V%L97,@<W5B:F5C
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M<R!I;F1I8V%T:6]N<RX\+W`^(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E
M>'0M86QI9VXZ(&IU<W1I9GD[)SXF(S$V,#L\+W`^(#QP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,'!T(#`[)SX\8CX\:3Y-86YU9F%C='5R:6YG(%-E<G9I8V4@06=R965M
M96YT/"]I/CPO8CX\+W`^(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[)SXF(S$V
M,#L\+W`^(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU
M<W1I9GD[)SY);B!$96-E;6)E<B`R,#$Q+"!T:&4@0V]M<&%N>2!E;G1E<F5D
M(&EN=&\@82!-86YU9F%C='5R:6YG(%-E<G9I8V5S($%G<F5E;65N="!W:71H
M($QO;GIA(%=A;&ME<G-V:6QL92P@26YC+B`H3&]N>F$I('!U<G-U86YT('1O
M('=H:6-H($QO;GIA(&AA<R!A9W)E960@=&\@;6%N=69A8W1U<F4L('!A8VMA
M9V4L('-H:7`@86YD('!E<F9O<FT@<75A;&ET>2!A<W-U<F%N8V4@86YD('%U
M86QI='D@8V]N=')O;"!O9B!O=7(@5$E,('1H97)A<'DN($QO;GIA(&AA<R!C
M;VUM96YC960@9&5V96QO<&EN9R!A(&-O;6UE<F-I86PM<V-A;&4@;6%N=69A
M8W1U<FEN9R!P<F]C97-S(&9O<B!T:&4@5$E,('1H97)A<'DN(%1H92!G;V%L
M(&ES('1O(&1E=F5L;W`@86YD(&5S=&%B;&ES:"!A(&UA;G5F86-T=7)I;F<@
M<')O8V5S<R!F;W(@=&AE(&QA<F=E+7-C86QE('!R;V1U8W1I;VX@;V8@5$E,
M('1H870@:7,@:6X@86-C;W)D('=I=&@@8W5R<F5N="!';V]D($UA;G5F86-T
M=7)I;F<@4')A8W1I8V5S("AC1TU0*2X\+W`^(#QP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SXF(S$V,#L\+W`^(#QP('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SY/;B!*
M=6YE(#$L(#(P,30@=V4@:7-S=65D(&$@;F5W('-T871E;65N="!O9B!W;W)K
M("A33U<I('1O($QO;GIA('5N9&5R('1H92!-86YU9F%C='5R:6YG(%-E<G9I
M8V5S($%G<F5E;65N="X@5&AE('1O=&%L(&-O<W0@9F]R('-E<G9I8V5S('1O
M(&)E('!R;W9I9&5D('5N9&5R('1H92!33U<@:7,@87!P<F]X:6UA=&5L>2`D
M/&9O;G0^-S,X+#`P,#PO9F]N=#XN($1U<FEN9R`R,#$T+"!T:&4@0V]M<&%N
M>2!R96-O9VYI>F5D("0\9F]N=#XX.3`L-C@T/"]F;VYT/B!O9B!E>'!E;G-E
M<R!U;F1E<B!T:&4@36%N=69A8W1U<FEN9R!397)V:6-E<R!!9W)E96UE;G0@
M=VET:"!,;VYZ82P@=VAI8V@@:6YC;'5D960@82`D/&9O;G0^,3`P+#`P,#PO
M9F]N=#X@:6X@=7!F<F]N="!C;W-T<R!R97%U:7)E9"!U;F1E<B!T:&4@4T]7
M+"!A;F0@=V5R92!R96-O<F1E9"!A<R!P87)T(&]F(')E<V5A<F-H(&%N9"!D
M979E;&]P;65N="!E>'!E;G-E<R!I;B`R,#$T+B!$=7)I;F<@=&AE('1H<F5E
M(&UO;G1H<R!E;F1E9"!-87)C:"`S,2P@,C`Q-2P@=&AE($-O;7!A;GD@<F5C
M;V=N:7IE9"`D/&9O;G0^,CDX+#`W,3PO9F]N=#X@;V8@97AP96YS97,@=6YD
M97(@=&AE($UA;G5F86-T=7)I;F<@4V5R=FEC97,@06=R965M96YT+CPO<#X@
M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3LG
M/B8C,38P.SPO<#X@/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG
M;CH@:G5S=&EF>3LG/CQB/CQI/E)E<V5A<F-H($-O;&QA8F]R871I;VX@06=R
M965M96YT(#PO:3X\+V(^/"]P/B`\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R!T
M97AT+6%L:6=N.B!J=7-T:69Y.R<^)B,Q-C`[/"]P/B`\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#!P="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R<^26X@4V5P=&5M8F5R
M+"`R,#$T+"!W92!E;G1E<F5D(&EN=&\@82!R97-E87)C:"!C;VQL86)O<F%T
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M9B!W:&EC:"`D/&9O;G0^,S4X+#$Y.3PO9F]N=#X@=V%S('!A:60@:6X@,C`Q
M-"X@1'5R:6YG('1H92!T:')E92UM;VYT:"!P97)I;V0@96YD960@36%R8V@@
M,S$L(#(P,34L('1H92!#;VUP86YY(&1I9"!N;W0@<F5C;W)D(&%N>2!E>'!E
M;G-E<R!R96QA=&5D('1O('1H:7,@<F5S96%R8V@@8V]L;&%B;W)A=&EO;B!A
M9W)E96UE;G0N/"]P/B`\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM
M+2TM+2T]7TYE>'1087)T7V(Y,68T,C%C7V9D8S1?-#<Y9%\X,#<X7V,T-6-C
M-30P-6(U80T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]B.3%F-#(Q
M8U]F9&,T7S0W.61?.#`W.%]C-#5C8S4T,#5B-6$O5V]R:W-H965T<R]3:&5E
M=#$S+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP
M<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U
M<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M
M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H
M87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S
M<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO
M/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,]
M,T1R97!O<G0@:60],T1)1#!%344^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^
M3$5'04P@4%)/0T5%1$E.1U,\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^36%R+B`S,2P@,C`Q-3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY,14=!3"!04D]#145$24Y'4R!;06)S=')A
M8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/DQ%1T%,(%!23T-%141)3D=3/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\9&EV(&ED/3-$161G87)304$Q,C,T-3<X.3`P,#`@<W1Y;&4],T0G
M9F]N="UF86UI;'D@.B`G5&EM97,@3F5W(%)O;6%N)SLG/B`\<"!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M
M87)G:6XZ(#!P="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R<^/&)R+SX\+W`^
M(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[
M)SX\8CX\9F]N="!S='EL93TS1"=T97AT+61E8V]R871I;VXZ('5N9&5R;&EN
M93LG/DY/5$4@-BX@3$5'04P@4%)/0T5%1$E.1U,\+V9O;G0^/"]B/CPO<#X-
M"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[
M)SXF(S$V,#L\+W`^#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R!T97AT+6%L
M:6=N.B!J=7-T:69Y.R<^3VX@07!R:6P@,C,L(#(P,30L('1H92!#;VUP86YY
M(')E8V5I=F5D(&$@<W5B<&]E;F$@9G)O;2!T:&4@4V5C=7)I=&EE<R!%>&-H
M86YG92!#;VUM:7-S:6]N("AT:&4@)B,Q-#<[4T5#)B,Q-#@[*2!T:&%T('-T
M871E9"!T:&%T('1H92!S=&%F9B!O9B!T:&4@4T5#(&ES(&-O;F1U8W1I;F<@
M86X@:6YV97-T:6=A=&EO;B`\:3X\9F]N="!S='EL93TS1"=T97AT+61E8V]R
M871I;VXZ('5N9&5R;&EN93LG/DEN('1H92!-871T97(@;V8@1V%L96YA($)I
M;W!H87)M82P@26YC+B!&:6QE($YO+B!(3R`Q,C,U-CPO9F]N=#X\+VD^(#QI
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M4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SXF
M(S$V,#L\+W`^#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R!T97AT+6%L:6=N
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M:71Y(')E<V5A<F-H(&]R(&]T:&5R(&9I;F%N8VEA;"!W96)S:71E<RX\+W`^
M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y
M.R<^)B,Q-C`[/"]P/@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA
M;&EG;CH@:G5S=&EF>3LG/E1H97)E(&%R92!N;R!O=&AE<B!P96YD:6YG(&QE
M9V%L('!R;V-E961I;F=S('1O('=H:6-H('1H92!#;VUP86YY(&ES(&$@<&%R
M='D@;W(@;V8@=VAI8V@@:71S('!R;W!E<G1Y(&ES('1H92!S=6)J96-T+CPO
M<#X-"CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X
M=%!A<G1?8CDQ9C0R,6-?9F1C-%\T-SED7S@P-SA?8S0U8V,U-#`U8C5A#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V(Y,68T,C%C7V9D8S1?-#<Y
M9%\X,#<X7V,T-6-C-30P-6(U82]7;W)K<VAE971S+U-H965T,30N:'1M;`T*
M0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*
M0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*
M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O
M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M
M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N
M:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\
M+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I
M9#TS1$E$,$5,13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY354)315%514Y4
M($5614Y44SQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,3XS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N
M(#,Q+"`R,#$U/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#X\<W1R;VYG/E-50E-%455%3E0@159%3E13(%M!8G-T<F%C=%T\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4U5"4T51545.
M5"!%5D5.5%,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78@
M:60],T1%9&=A<E-!03$R,S0U-S@Y,#`P,"!S='EL93TS1"=F;VYT+69A;6EL
M>2`Z("=4:6UE<R!.97<@4F]M86XG.R<^(#QP('-T>6QE/3-$)VUA<F=I;CH@
M,'!T.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[)SX\8G(O/CPO
M<#X@/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#LG/CQB/CQF;VYT('-T>6QE/3-$
M)W1E>'0M9&5C;W)A=&EO;CH@=6YD97)L:6YE.R<^3D]412`W+B!354)315%5
M14Y4($5614Y44SPO9F]N=#X\+V(^/"]P/B`\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P
M="`P.R<^/&(^)B,Q-C`[/"]B/CPO<#X@/'`@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@
M,#LG/CQB/CQI/E-H87)E($ES<W5A;F-E<SPO:3X\+V(^/"]P/B`\<"!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!M87)G:6XZ(#!P="`P.R<^)B,Q-C`[/"]P/B`\<"!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ
M(#!P="`P.R<^26X@=&AE('-E8V]N9"!Q=6%R=&5R(&]F(#(P,34L('1H92!#
M;VUP86YY(&AA<R!R96-E:79E9"`D/&9O;G0^,SDT+#4Q,#PO9F]N=#X@:6X@
M8V%S:"!F<F]M('1H92!E>&5R8VES92!O9B!W87)R86YT<R!F;W(@=&AE('!U
M<F-H87-E(&]F(#QF;VYT/C$U-RPX,#0\+V9O;G0^('-H87)E<R!O9B!I=',@
M8V]M;6]N('-T;V-K+CPO<#X@/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X
M="UA;&EG;CH@:G5S=&EF>3LG/B8C,38P.SPO<#X@/'`@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN
M.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3LG/D]N($UA>2`V+"`R,#$U
M+"!C97)T86EN('-T;V-K:&]L9&5R<R!O9B!T:&4@0V]M<&%N>2P@:6YC;'5D
M:6YG(&-E<G1A:6X@;65M8F5R<R!O9B!";V%R9"!O9B!$:7)E8W1O<G,@;V8@
M=&AE($-O;7!A;GD@86YD('1H96ER(&%F9FEL:6%T97,L('-O;&0@/&9O;G0^
M-"PW-3`L,#`P/"]F;VYT/B!S:&%R97,@;V8@=&AE($-O;7!A;GDG<R!C;VUM
M;VX@<W1O8VL@:6X@86X@=6YD97)W<FET=&5N('-E8V]N9&%R>2!O9F9E<FEN
M9R!A="!A('!R:6-E(&]F("0\9F]N=#XQ,"XP,#PO9F]N=#X@<&5R('-H87)E
M+B!4:&4@0V]M<&%N>2!D:60@;F]T('-E;&P@86YY('-H87)E<R!I;B!T:&4@
M;V9F97)I;F<@86YD('=I;&P@;F]T(')E8V5I=F4@86YY(&]F('1H92!P<F]C
M965D<R!F<F]M('1H92!O9F9E<FEN9RX\+W`^(#PO9&EV/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^
M#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?8CDQ9C0R,6-?9F1C-%\T
M-SED7S@P-SA?8S0U8V,U-#`U8C5A#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE
M.B\O+T,Z+V(Y,68T,C%C7V9D8S1?-#<Y9%\X,#<X7V,T-6-C-30P-6(U82]7
M;W)K<VAE971S+U-H965T,34N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O
M9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT
M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@
M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$
M)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X
M="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4
M:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@
M(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5(1D%#/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S
M<&%N/3-$,CX\<W1R;VYG/E-534U!4ED@3T8@4TE'3DE&24-!3E0@04-#3U5.
M5$E.1R!04D%#5$E#15,@*%!O;&EC:65S*3QB<CX\+W-T<F]N9SX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO;G1H<R!%
M;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$U/&)R/CPO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-534U!4ED@3T8@4TE'3DE&
M24-!3E0@04-#3U5.5$E.1R!04D%#5$E#15,@6T%B<W1R86-T73PO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@26YC;VUE
M("A,;W-S*2!097(@4VAA<F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQD:78@:60],T1%9&=A<E-!03$R,S0U-S@Y,#`P,"!S='EL93TS1"=F
M;VYT+69A;6EL>2`Z("=4:6UE<R!.97<@4F]M86XG.R<^/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN.B`P<'0@,#LG/CQB/CQI/DYE="!);F-O;64@*$QO<W,I(%!E<B!3:&%R
M93PO:3X\+V(^/"]P/B`\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R<^/&(^/&D^
M)B,Q-C`[/"]I/CPO8CX\+W`^(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E
M>'0M86QI9VXZ(&IU<W1I9GD[)SY"87-I8R!N970@:6YC;VUE("AL;W-S*2!P
M97(@<VAA<F4@:7,@8V]M<'5T960@8GD@9&EV:61I;F<@;F5T(&EN8V]M92`H
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M(&]F('1H96ER(&=R86YT(&1A=&4N/"]P/B`\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P
M="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R<^)B,Q-C`[/"]P/B`\<"!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!M87)G:6XZ(#!P="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R<^070@36%R
M8V@@,S$L(#(P,34@86YD(#(P,30L(&)A<VEC(&%N9"!D:6QU=&5D(&YE="!L
M;W-S('!E<B!S:&%R92!A<F4@=&AE('-A;64@87,@=&AE(&5F9F5C="!O9B!P
M;W1E;G1I86QL>2!D:6QU=&EV92!S96-U<FET:65S('=A<R!A;G1I9&EL=71I
M=F4N($%T($UA<F-H(#,Q+"`R,#$U+"!P;W1E;G1I86QL>2!D:6QU=&EV92!S
M96-U<FET:65S(&EN8VQU9&4@;W!T:6]N<R!T;R!A8W%U:7)E(#QF;VYT/C$L
M.3`W+#@W-SPO9F]N=#X@<VAA<F5S(&]F(&-O;6UO;B!S=&]C:RP@=V%R<F%N
M=',@=&\@86-Q=6ER92`\9F]N=#XQ,"PQ-C(L-S(V/"]F;VYT/B!S:&%R97,@
M;V8@8V]M;6]N('-T;V-K+"!P<F5F97)R960@<W1O8VL@=&AA="!C86X@8F4@
M8V]N=F5R=&5D(&EN=&\@/&9O;G0^,2PX-#<L,#`P/"]F;VYT/B!S:&%R97,@
M;V8@8V]M;6]N('-T;V-K+"!A;F0@/&9O;G0^-3`W+#$Q,SPO9F]N=#X@<VAA
M<F5S(&]F(&YO;BUV97-T960@<F5S=')I8W1E9"!S=&]C:RX@070@36%R8V@@
M,S$L(#(P,30L('!O=&5N=&EA;&QY(&1I;'5T:79E('-E8W5R:71I97,@:6YC
M;'5D92!O<'1I;VYS('1O(&%C<75I<F4@/&9O;G0^-C,X+#<U,#PO9F]N=#X@
M<VAA<F5S(&]F(&-O;6UO;B!S=&]C:RP@=V%R<F%N=',@=&\@86-Q=6ER92`\
M9F]N=#XQ,BPQ-38L,34V/"]F;VYT/B!S:&%R97,@;V8@8V]M;6]N('-T;V-K
M+"!A;F0@<')E9F5R<F5D('-T;V-K('1H870@8V%N(&)E(&-O;G9E<G1E9"!I
M;G1O(#QF;VYT/C8L-C4P+#`P,#PO9F]N=#X@<VAA<F5S(&]F(&-O;6UO;B!S
M=&]C:RX\+W`^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y&86ER(%9A;'5E($UE87-U<F5M96YT<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!I9#TS1$5D9V%R4T%!
M,3(S-#4W.#DP,#`P('-T>6QE/3-$)V9O;G0M9F%M:6QY(#H@)U1I;65S($YE
M=R!2;VUA;B<[)SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R<^/&(^/&D^1F%I
M<B!686QU92!-96%S=7)E;65N=',\+VD^/"]B/CPO<#X@/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN.B`P<'0@,#LG/B8C,38P.SPO<#X@/'`@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@
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M<W-E=',@86YD(&QI86)I;&ET:65S.CPO<#X@/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P
M<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3LG/B8C,38P.SPO<#X@/'`@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@=&5X="UI
M;F1E;G0Z(#`N,C5I;CLG/DQE=F5L(#$F(S$U,3M1=6]T960@<')I8V5S(&EN
M(&%C=&EV92!M87)K971S(&9O<B!I9&5N=&EC86P@87-S971S(&]R(&QI86)I
M;&ET:65S+CPO<#X@/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG
M;CH@:G5S=&EF>3L@=&5X="UI;F1E;G0Z(#`N,C5I;CLG/DQE=F5L(#(F(S$U
M,3M);G!U=',L(&]T:&5R('1H86X@=&AE('%U;W1E9"!P<FEC97,@:6X@86-T
M:79E(&UA<FME=',L('1H870@87)E(&]B<V5R=F%B;&4@96ET:&5R(&1I<F5C
M=&QY(&]R(&EN9&ER96-T;'DN/"]P/B`\<"!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P
M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,"XR-6EN.R<^
M3&5V96P@,R8C,34Q.U5N;V)S97)V86)L92!I;G!U=',@8F%S960@;VX@=&AE
M($-O;7!A;GDG<R!A<W-U;7!T:6]N<RX\+W`^(#QP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[('1E>'0M:6YD96YT.B`P+C(U
M:6X[)SXF(S$V,#L\+W`^(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M
M86QI9VXZ(&IU<W1I9GD[)SY!="!-87)C:"`S,2P@,C`Q-2!A;F0@1&5C96UB
M97(@,S$L(#(P,30L('1H92!F86ER('9A;'5E(&]F(&-A<V@@86YD(&-A<V@@
M97%U:79A;&5N=',L(&%C8V]U;G1S('!A>6%B;&4L(&%N9"!A8V-R=65D(&5X
M<&5N<V5S(&%P<')O>&EM871E('1H96ER(&-A<G)Y:6YG('9A;'5E<R!B87-E
M9"!O;B!T:&5I<B!S:&]R="!T97)M(&YA='5R92X\+W`^/"]D:78^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y5<V4@
M;V8@17-T:6UA=&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M9&EV(&ED/3-$161G87)304$Q,C,T-3<X.3`P,#`@<W1Y;&4],T0G9F]N="UF
M86UI;'D@.B`G5&EM97,@3F5W(%)O;6%N)SLG/CQP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SX\8CX\:3Y5<V4@;V8@17-T
M:6UA=&5S/"]I/CPO8CX\+W`^(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E
M>'0M86QI9VXZ(&IU<W1I9GD[)SXF(S$V,#L\+W`^(#QP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SY4:&4@<')E<&%R871I
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M97)V:6-E<RX\+W`^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C:RU"87-E9"!#;VUP96YS871I;VX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78@:60],T1%9&=A
M<E-!03$R,S0U-S@Y,#`P,"!S='EL93TS1"=F;VYT+69A;6EL>2`Z("=4:6UE
M<R!.97<@4F]M86XG.R<^/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA
M;&EG;CH@:G5S=&EF>3LG/CQB/CQI/E-T;V-K+4)A<V5D($-O;7!E;G-A=&EO
M;CPO:3X\+V(^/"]P/B`\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R!T97AT+6%L
M:6=N.B!J=7-T:69Y.R<^)B,Q-C`[/"]P/B`\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P
M="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R<^5&AE($-O;7!A;GD@<&5R:6]D
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M9"!O9B!T:&4@;65A<W5R96UE;G0@9&%T92X\+W`^(#QP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SXF(S$V,#L\+W`^(#QP
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SY4
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M9',N/"]P/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4F5S96%R8V@@86YD($1E=F5L;W!M96YT/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV(&ED/3-$161G87)304$Q
M,C,T-3<X.3`P,#`@<W1Y;&4],T0G9F]N="UF86UI;'D@.B`G5&EM97,@3F5W
M(%)O;6%N)SLG/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ
M(&IU<W1I9GD[)SX\8CX\:3Y297-E87)C:"!A;F0@1&5V96QO<&UE;G0\+VD^
M/"]B/CPO<#X@/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@
M:G5S=&EF>3LG/B8C,38P.SPO<#X@/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@
M=&5X="UA;&EG;CH@:G5S=&EF>3LG/E)E<V5A<F-H(&%N9"!D979E;&]P;65N
M="!C;W-T<R!C;VYS:7-T('!R:6UA<FEL>2!O9B!F965S('!A:60@=&\@8V]N
M<W5L=&%N=',@86YD(&]U='-I9&4@<V5R=FEC92!P<F]V:61E<G,L('!A=&5N
M="!F965S(&%N9"!C;W-T<RP@86YD(&]T:&5R(&5X<&5N<V5S(')E;&%T:6YG
M('1O('1H92!A8W%U:7-I=&EO;BP@9&5S:6=N+"!D979E;&]P;65N="!A;F0@
M=&5S=&EN9R!O9B!T:&4@0V]M<&%N>2=S('1R96%T;65N=',@86YD('!R;V1U
M8W0@8V%N9&ED871E<RX@4F5S96%R8V@@86YD(&1E=F5L;W!M96YT(&-O<W1S
M(&%R92!E>'!E;G-E9"!A<R!I;F-U<G)E9"!O=F5R('1H92!L:69E(&]F('1H
M92!U;F1E<FQY:6YG(&-O;G1R86-T<R!O;B!T:&4@<W1R86EG:'0M;&EN92!B
M87-I<RP@=6YL97-S('1H92!A8VAI979E;65N="!O9B!M:6QE<W1O;F5S+"!T
M:&4@8V]M<&QE=&EO;B!O9B!C;VYT<F%C=&5D('=O<FLL(&]R(&]T:&5R(&EN
M9F]R;6%T:6]N(&EN9&EC871E<R!T:&%T(&$@9&EF9F5R96YT(&5X<&5N<VEN
M9R!S8VAE9'5L92!I<R!M;W)E(&%P<')O<')I871E+B!4:&4@0V]M<&%N>2!R
M979I97=S('1H92!S=&%T=7,@;V8@:71S(')E<V5A<F-H(&%N9"!D979E;&]P
M;65N="!C;VYT<F%C=',@;VX@82!Q=6%R=&5R;'D@8F%S:7,N/"]P/CPO9&EV
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0V]N8V5N=')A=&EO;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQD:78@:60],T1%9&=A<E-!03$R,S0U-S@Y,#`P,"!S='EL93TS1"=F
M;VYT+69A;6EL>2`Z("=4:6UE<R!.97<@4F]M86XG.R<^/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3LG/CQB/CQI/D-O;F-E
M;G1R871I;VYS/"]I/CPO8CX\+W`^(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,'!T(#`[
M('1E>'0M86QI9VXZ(&IU<W1I9GD[)SXF(S$V,#L\+W`^(#QP('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA
M<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SY&:6YA;F-I86P@
M:6YS=')U;65N=',L('=H:6-H('!O=&5N=&EA;&QY('-U8FIE8W0@=&AE($-O
M;7!A;GD@=&\@8V]N8V5N=')A=&EO;G,@;V8@8W)E9&ET(')I<VLL(&-O;G-I
M<W0@<')I;F-I<&%L;'D@;V8@8V%S:"X\+W`^(#QP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SXF(S$V,#L\+W`^(#QP('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SY4:&4@
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M+"!M:6YI;6%L(&-R961I="!R:7-K(&5X:7-T<RX\+W`^/"]D:78^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y296-E
M;G0@06-C;W5N=&EN9R!0<F]N;W5N8V5M96YT<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/&1I=B!I9#TS1$5D9V%R4T%!,3(S-#4W.#DP,#`P
M('-T>6QE/3-$)V9O;G0M9F%M:6QY(#H@)U1I;65S($YE=R!2;VUA;B<[)SX\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#!P="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R<^
M/&(^/&D^4F5C96YT($%C8V]U;G1I;F<@4')O;F]U;F-E;65N=',\+VD^/"]B
M/CPO<#X@/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@;6%R9VEN.B`P<'0@,#L@=&5X="UA;&EG;CH@:G5S
M=&EF>3LG/CQB/CQI/B8C,38P.SPO:3X\+V(^/"]P/B`\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#!P="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R<^26X@36%Y(#(P,30L
M('1H92!&:6YA;F-I86P@06-C;W5N=&EN9R!3=&%N9&%R9',@0F]A<F0@*$9!
M4T(I(&ES<W5E9"!!8V-O=6YT:6YG(%-T86YD87)D<R!5<&1A=&4@*$%352D@
M3F\N(#(P,30M,#DL(#QI/E)E=F5N=64@9G)O;2!#;VYT<F%C=',@=VET:"!#
M=7-T;VUE<G,\+VD^+B!!4U4@,C`Q-"TP.2!I<R!A(&-O;7!R96AE;G-I=F4@
M<F5V96YU92!R96-O9VYI=&EO;B!S=&%N9&%R9"!T:&%T('=I;&P@<W5P97)S
M961E(&YE87)L>2!A;&P@97AI<W1I;F<@<F5V96YU92!R96-O9VYI=&EO;B!G
M=6ED86YC92!U;F1E<B!C=7)R96YT(%4N4RX@1T%!4"!A;F0@<F5P;&%C92!I
M="!W:71H(&$@<')I;F-I<&QE(&)A<V5D(&%P<')O86-H(&9O<B!D971E<FUI
M;FEN9R!R979E;G5E(')E8V]G;FET:6]N+B!!4U4@,C`Q-"TP.2!W:6QL(')E
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M86-T+B!!4U4@,C`Q-"TP.2!I<R!E9F9E8W1I=F4@9F]R(&EN=&5R:6T@86YD
M(&%N;G5A;"!P97)I;V1S(&)E9VEN;FEN9R!A9G1E<B!$96-E;6)E<B`Q-2P@
M,C`Q-BP@:&]W979E<BP@=&AE($9!4T(@:&%S('!R;W!O<V5D(&$@;VYE+7EE
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M;F-I86P@<W1A=&5M96YT<R!A;F0@9&ES8VQO<W5R97,N/"]P/B`\<"!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!M87)G:6XZ(#!P="`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R<^)B,Q-C`[
M/"]P/B`\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!M87)G:6XZ(#!P="`P.R!T97AT+6%L:6=N.B!J=7-T
M:69Y.R<^26X@2F%N=6%R>2`R,#$U+"!T:&4@1D%30B!I<W-U960@06-C;W5N
M=&EN9R!3=&%N9&%R9',@57!D871E($YO+B`R,#$U+3`Q("A3=6)T;W!I8R`R
M,C4M,C`I("T@26YC;VUE(%-T871E;65N="`M($5X=')A;W)D:6YA<GD@86YD
M(%5N=7-U86P@271E;7,N($%352`R,#$U+3`Q(&5L:6UI;F%T97,@=&AE(&-O
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M97AT<F%O<F1I;F%R>2!I=&5M+B!(;W=E=F5R+"!!4U4@,C`Q-2TP,2!W:6QL
M('-T:6QL(')E=&%I;B!T:&4@<')E<V5N=&%T:6]N(&%N9"!D:7-C;&]S=7)E
M(&=U:61A;F-E(&9O<B!I=&5M<R!T:&%T(&%R92!U;G5S=6%L(&EN(&YA='5R
M92!A;F0@;V-C=7(@:6YF<F5Q=65N=&QY+B!!4U4@,C`Q-2TP,2!I<R!E9F9E
M8W1I=F4@9F]R('!E<FEO9',@8F5G:6YN:6YG(&%F=&5R($1E8V5M8F5R(#$U
M+"`R,#$U+B!%87)L>2!A9&]P=&EO;B!I<R!P97)M:71T960N(%1H92!A9&]P
M=&EO;B!O9B!!4U4@,C`Q-2TP,2!I<R!N;W0@97AP96-T960@=&\@:&%V92!A
M(&UA=&5R:6%L(&5F9F5C="!O;B!T:&4@0V]M<&%N>2=S(&-O;G-O;&ED871E
M9"!F:6YA;F-I86P@<W1A=&5M96YT<RX\+W`^(#QP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SXF(S$V,#L\+W`^(#QP('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68[(&UA<F=I;CH@,'!T(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[)SY/=&AE
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M92!F:6YA;F-I86P@<W1A=&5M96YT<RX\+W`^/"]D:78^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B.3%F-#(Q8U]F9&,T7S0W
M.61?.#`W.%]C-#5C8S4T,#5B-6$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z
M+R\O0SHO8CDQ9C0R,6-?9F1C-%\T-SED7S@P-SA?8S0U8V,U-#`U8C5A+U=O
M<FMS:&5E=',O4VAE970Q-BYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D
M:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M
M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N
M/3-$,CX\<W1R;VYG/E-43T-+2$],1$524R<@15%52519("A486)L97,I/&)R
M/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0Q/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,34\
M8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M4U1/0TM(3TQ$15)3)R!%455)5%D@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y38VAE9'5L92!O9B!297-T
M<FEC=&5D(%-T;V-K($%C=&EV:71Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\9&EV(&ED/3-$161G87)304$Q,C,T-3<X.3`P,#`@<W1Y;&4]
M,T0G9F]N="UF86UI;'D@.B`G5&EM97,@3F5W(%)O;6%N)SLG/CQP('-T>6QE
M/3-$)V9O;G0Z(#$P<'0O;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#!P="`P<'@[(&9O;G0M<VEZ92UA9&IU<W0Z(&YO
M;F4[(&9O;G0M<W1R971C:#H@;F]R;6%L.R<^#0H\+W`^/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68[(&UA<F=I;CH@,'!T(#!P>#L@9F]N="US:7IE+6%D:G5S=#H@;F]N93L@
M9F]N="US=')E=&-H.B!N;W)M86P[)SXF(S$V,#L\+W`^#0H\=&%B;&4@86QI
M9VX],T1C96YT97(@<W1Y;&4],T0G9F]N=#H@,3!P="]N;W)M86P@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[('=I9'1H.B`Y,"4[(&)O<F1E<BUC
M;VQL87!S93H@8V]L;&%P<V4[(&9O;G0M<VEZ92UA9&IU<W0Z(&YO;F4[(&9O
M;G0M<W1R971C:#H@;F]R;6%L.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D
M:6YG/3-$,#X-"@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T
M;VT[)SX-"CQT9"!N;W=R87`],T1N;W=R87`^)B,Q-C`[/"]T9#X-"CQT9"!N
M;W=R87`],T1N;W=R87`@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#%P=#L@
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M9#X-"CQT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G<&%D9&EN9RUB;W1T
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M97(M8F]T=&]M+7=I9'1H.B`Q<'0[(&)O<F1E<BUB;W1T;VTM<W1Y;&4Z('-O
M;&ED.R<@8V]L<W!A;CTS1#(^5V5I9VAT960\8G(O/B!!=F5R86=E/&)R+SX@
M1W)A;G0F(S$V,#M$871E/&)R+SX@1F%I<B8C,38P.U9A;'5E/"]T9#X-"CQT
M9"!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#%P
M=#L@9F]N="UW96EG:'0Z(&)O;&0[)SXF(S$V,#L\+W1D/@T*/"]T<CX-"CQT
M<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD
M+6-O;&]R.B`C8V-E969F.R<^#0H\=&0@<W1Y;&4],T0G=VED=&@Z(#<T)3LG
M/DYO;BUV97-T960@<VAA<F5S+"!*86YU87)Y(#$L(#(P,34\+W1D/@T*/'1D
M('-T>6QE/3-$)W=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=W:61T:#H@,3`E.R!T97AT+6%L:6=N.B!R:6=H=#LG
M/CQF;VYT/C4W.2PW-C0\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=W:61T
M:#H@,24[('1E>'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)W=I9'1H.B`Q)3LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=W:61T:#H@,3`E.R!T97AT+6%L:6=N.B!R:6=H=#LG/CQF
M;VYT/C8N,C`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=W:61T:#H@,24[
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M#0H\=&0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R
M:6=H=#LG/CQF;VYT/BT\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X-"CPO='(^#0H\='(@<W1Y;&4]
M,T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@
M(V-C965F9CLG/@T*/'1D('-T>6QE/3-$)W!A9&1I;F<M;&5F=#H@,"XQ,C5I
M;CLG/E9E<W1E9#PO=&0^#0H\=&0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!R:6=H=#LG/CQF;VYT/B@W,BPV-3$\+V9O;G0^/"]T
M9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^*3PO=&0^#0H\
M=&0^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T
M.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H
M=#LG/CQF;VYT/C8N,C`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!L969T.R<^)B,Q-C`[/"]T9#X-"CPO='(^#0H\='(@<W1Y;&4]
M,T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@
M=VAI=&4[)SX-"CQT9"!S='EL93TS1"=P861D:6YG+6QE9G0Z(#`N,3(U:6X[
M)SY&;W)F96ET960\+W1D/@T*/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M
M.B`Q<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[/"]T9#X-"CQT9"!S
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M=&]M.B`Q<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[/"]T9#X-"CQT
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M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E
M969F.R<^#0H\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#(N-7!T.R<^
M3F]N+79E<W1E9"!S:&%R97,L($UA<F-H(#,Q+"`R,#$U/"]T9#X-"CQT9"!S
M='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0[)SXF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)O<F1E<BUB;W1T;VTM
M8V]L;W(Z(&)L86-K.R!B;W)D97(M8F]T=&]M+7=I9'1H.B`R+C5P=#L@8F]R
M9&5R+6)O='1O;2US='EL93H@9&]U8FQE.R<^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@8F]R9&5R+6)O='1O;2UC;VQO
M<CH@8FQA8VL[(&)O<F1E<BUB;W1T;VTM=VED=&@Z(#(N-7!T.R!B;W)D97(M
M8F]T=&]M+7-T>6QE.B!D;W5B;&4[)SX\9F]N=#XU,#<L,3$S/"]F;VYT/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@<&%D9&EN9RUB
M;W1T;VTZ(#(N-7!T.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@,BXU<'0[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&QE9G0[(&)O<F1E<BUB;W1T;VTM8V]L;W(Z(&)L86-K
M.R!B;W)D97(M8F]T=&]M+7=I9'1H.B`R+C5P=#L@8F]R9&5R+6)O='1O;2US
M='EL93H@9&]U8FQE.R<^)#PO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@<FEG:'0[(&)O<F1E<BUB;W1T;VTM8V]L;W(Z(&)L86-K.R!B;W)D97(M
M8F]T=&]M+7=I9'1H.B`R+C5P=#L@8F]R9&5R+6)O='1O;2US='EL93H@9&]U
M8FQE.R<^/&9O;G0^-BXR,#PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&QE9G0[('!A9&1I;F<M8F]T=&]M.B`R+C5P=#LG/B8C,38P
M.SPO=&0^#0H\+W1R/@T*#0H\+W1A8FQE/@T*/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA
M<F=I;CH@,'!T(#!P>#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@=&5X="UI;F1E
M;G0Z(#`N-6EN.R!F;VYT+7-I>F4M861J=7-T.B!N;VYE.R!F;VYT+7-T<F5T
M8V@Z(&YO<FUA;#LG/B8C,38P.SPO<#X\+V1I=CX\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H
M=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V(Y,68T,C%C7V9D8S1?-#<Y9%\X
M,#<X7V,T-6-C-30P-6(U80T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#
M.B]B.3%F-#(Q8U]F9&,T7S0W.61?.#`W.%]C-#5C8S4T,#5B-6$O5V]R:W-H
M965T<R]3:&5E=#$W+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z
M('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C
M:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-
M151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT
M+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V
M87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#
M;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B
M;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%,D8^#0H@("`@("`\='(^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R
M/CQS=')O;F<^4U1/0TL@3U!424].4R!!3D0@5T%24D%.5%,@*%1A8FQE<RD\
M8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L
M<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q
M-3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY35$]#2R!/4%1)3TY3($%.1"!705)204Y44R!;06)S=')A8W1=/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-C:&5D=6QE
M(&]F(%-T871U<R!O9B!3=&]C:R!/<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\9&EV(&ED/3-$161G87)304$Q,C,T-3<X.3`P,#`@
M<W1Y;&4],T0G9F]N="UF86UI;'D@.B`G5&EM97,@3F5W(%)O;6%N)SLG/@T*
M/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`@<W1Y;&4]
M,T0G8F]R9&5R+6-O;&QA<'-E.B!C;VQL87!S93L@9F]N="US='EL93H@;F]R
M;6%L.R!F;VYT+79A<FEA;G0Z(&YO<FUA;#L@9F]N="UW96EG:'0Z(&YO<FUA
M;#L@9F]N="US=')E=&-H.B!N;W)M86P[(&9O;G0M<VEZ93H@,3!P=#L@;&EN
M92UH96EG:'0Z(&YO<FUA;#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M
M86XG+"!T:6UE<RP@<V5R:68[('=I9'1H.B`Q,#`E.R<^#0H-"CQT<B!S='EL
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M=&0@;F]W<F%P/3-$;F]W<F%P('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM
M97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<^/'-T<F]N9SXF(S$V,#L\
M+W-T<F]N9SX\+W1D/@T*/'1D(&-O;'-P86X],T0Q,R!N;W=R87`],T1N;W=R
M87`@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>3H@
M)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#LG/CQB<B\^/"]T9#X-
M"CQT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T
M:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/B8C,38P
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M;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)R!N;W=R87`],T1N;W=R
M87`^/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE
M=R!2;VUA;B<[)R!N;W=R87`],T1N;W=R87`^/"]T9#X-"CQT9"!S='EL93TS
M1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)R!C;VQS<&%N/3-$
M,B!N;W=R87`],T1N;W=R87`^/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A
M;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)R!N;W=R87`],T1N;W=R87`^/"]T
M9#X-"CQT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G9F]N="UF86UI;'DZ
M("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/B`\
M+W-T<F]N9SX\+W1D/@T*/'1D(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A
M<"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B`G
M=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<^/'-T<F]N9SY796EG
M:'1E9#PO<W1R;VYG/CPO=&0^#0H\=&0@;F]W<F%P/3-$;F]W<F%P('-T>6QE
M/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@
M,'!X.R<^/'-T<F]N9SX@/"]S=')O;F<^/"]T9#X-"CQT9"!N;W=R87`],T1N
M;W=R87`@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG
M.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/B8C,38P.SPO<W1R;VYG/CPO=&0^
M#0H\=&0@8V]L<W!A;CTS1#(@;F]W<F%P/3-$;F]W<F%P('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&-E;G1E<CL@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M
M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/E=E:6=H=&5D($%V97)A9V4\
M+W-T<F]N9SX\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=F
M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#LG
M/CQS=')O;F<^)B,Q-C`[/"]S=')O;F<^/"]T9#X-"CQT9"!S='EL93TS1"=F
M;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)R!N;W=R87`],T1N;W=R
M87`^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I
M;65S($YE=R!2;VUA;B<[)R!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S
M($YE=R!2;VUA;B<[)R!N;W=R87`],T1N;W=R87`^)B,Q-C`[/"]T9#X-"CPO
M='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/@T*
M/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SLG
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M.B`P<'@[)SX\<W1R;VYG/E-H87)E<SPO<W1R;VYG/CPO=&0^#0H\=&0@;F]W
M<F%P/3-$;F]W<F%P('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W
M(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<^/'-T<F]N9SX@/"]S=')O;F<^/"]T
M9#X-"CQT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G9F]N="UF86UI;'DZ
M("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/B`\
M+W-T<F]N9SX\+W1D/@T*/'1D(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A
M<"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B`G
M=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<^/'-T<F]N9SY!=F5R
M86=E/"]S=')O;F<^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4]
M,T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P
M<'@[)SX\<W1R;VYG/B`\+W-T<F]N9SX\+W1D/@T*/'1D(&YO=W)A<#TS1&YO
M=W)A<"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[
M('!A9&1I;F<Z(#!P>#LG/CQS=')O;F<^)B,Q-C`[/"]S=')O;F<^/"]T9#X-
M"CQT9"!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA
M;B<[('!A9&1I;F<Z(#!P>#LG/CQS=')O;F<^4F5M86EN:6YG/"]S=')O;F<^
M/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G9F]N="UF86UI
M;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG
M/B8C,38P.SPO<W1R;VYG/CPO=&0^#0H\=&0@;F]W<F%P/3-$;F]W<F%P('-T
M>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN
M9SH@,'!X.R<^/'-T<F]N9SXF(S$V,#L\+W-T<F]N9SX\+W1D/@T*/'1D(&-O
M;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=T97AT+6%L:6=N
M.B!C96YT97([(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D
M9&EN9SH@,'!X.R<^/'-T<F]N9SY!9V=R96=A=&4\+W-T<F]N9SX\+W1D/@T*
M/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I
M;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#LG/CQS=')O;F<^)B,Q-C`[
M/"]S=')O;F<^/"]T9#X-"CPO='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM
M86QI9VXZ(&)O='1O;3LG/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G
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M97<@<F]M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/E5N9&5R/"]S=')O
M;F<^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G9F]N="UF
M86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R
M;VYG/B`\+W-T<F]N9SX\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL
M93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z
M(#!P>#LG/CQS=')O;F<^(#PO<W1R;VYG/CPO=&0^#0H\=&0@8V]L<W!A;CTS
M1#(@;F]W<F%P/3-$;F]W<F%P('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E
M<CL@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P
M<'@[)SX\<W1R;VYG/D5X97)C:7-E/"]S=')O;F<^/"]T9#X-"CQT9"!N;W=R
M87`],T1N;W=R87`@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@
M<F]M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/B`\+W-T<F]N9SX\+W1D
M/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=F;VYT+69A;6EL>3H@
M)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#LG/CQS=')O;F<^)B,Q
M-C`[/"]S=')O;F<^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!N;W=R87`],T1N
M;W=R87`@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL
M>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#LG/CQS=')O;F<^
M0V]N=')A8W1U86P\+W-T<F]N9SX\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A
M<"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A
M9&1I;F<Z(#!P>#LG/CQS=')O;F<^)B,Q-C`[/"]S=')O;F<^/"]T9#X-"CQT
M9"!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE
M<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/B8C,38P.SPO
M<W1R;VYG/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#(@;F]W<F%P/3-$;F]W<F%P
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@9F]N="UF86UI;'DZ("=T
M:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/DEN=')I
M;G-I8SPO<W1R;VYG/CPO=&0^#0H\=&0@;F]W<F%P/3-$;F]W<F%P('-T>6QE
M/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@
M,'!X.R<^/'-T<F]N9SXF(S$V,#L\+W-T<F]N9SX\+W1D/@T*/"]T<CX-"CQT
M<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^#0H\=&0@<W1Y
M;&4],T0G9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R<@;F]W<F%P
M/3-$;F]W<F%P/B8C,38P.SPO=&0^#0H\=&0@;F]W<F%P/3-$;F]W<F%P('-T
M>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN
M9SH@,'!X.R<^/'-T<F]N9SXF(S$V,#L\+W-T<F]N9SX\+W1D/@T*/'1D(&-O
M;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=T97AT+6%L:6=N
M.B!C96YT97([(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@8F]R
M9&5R+6)O='1O;3H@(S`P,#`P,"`Q<'0@<V]L:60@(6EM<&]R=&%N=#L@<&%D
M9&EN9SH@,'!X.R<^/'-T<F]N9SY/<'1I;VX\+W-T<F]N9SX\+W1D/@T*/'1D
M(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S
M(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#LG/CQS=')O;F<^)B,Q-C`[/"]S
M=')O;F<^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G9F]N
M="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[)SX\
M<W1R;VYG/B8C,38P.SPO<W1R;VYG/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#(@
M;F]W<F%P/3-$;F]W<F%P('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@
M9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!B;W)D97(M8F]T=&]M
M.B`C,#`P,#`P(#%P="!S;VQI9"`A:6UP;W)T86YT.R!P861D:6YG.B`P<'@[
M)SX\<W1R;VYG/E!R:6-E/"]S=')O;F<^/"]T9#X-"CQT9"!N;W=R87`],T1N
M;W=R87`@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG
M.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/B8C,38P.SPO<W1R;VYG/CPO=&0^
M#0H\=&0@;F]W<F%P/3-$;F]W<F%P('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G
M=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<^/'-T<F]N9SXF(S$V
M,#L\+W-T<F]N9SX\+W1D/@T*/'1D(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO
M=W)A<"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY
M.B`G=&EM97,@;F5W(')O;6%N)SL@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`Q
M<'0@<V]L:60@(6EM<&]R=&%N=#L@<&%D9&EN9SH@,'!X.R<^/'-T<F]N9SY,
M:69E/"]S=')O;F<^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4]
M,T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P
M<'@[)SX\<W1R;VYG/B8C,38P.SPO<W1R;VYG/CPO=&0^#0H\=&0@;F]W<F%P
M/3-$;F]W<F%P('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O
M;6%N)SL@<&%D9&EN9SH@,'!X.R<^/'-T<F]N9SXF(S$V,#L\+W-T<F]N9SX\
M+W1D/@T*/'1D(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS
M1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W
M(')O;6%N)SL@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`Q<'0@<V]L:60@(6EM
M<&]R=&%N=#L@<&%D9&EN9SH@,'!X.R<^/'-T<F]N9SY686QU93PO<W1R;VYG
M/CPO=&0^#0H\=&0@;F]W<F%P/3-$;F]W<F%P('-T>6QE/3-$)V9O;G0M9F%M
M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<^/'-T<F]N
M9SXF(S$V,#L\+W-T<F]N9SX\+W1D/@T*/"]T<CX-"CQT<B!S='EL93TS1"=V
M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^#0H\=&0@<W1Y;&4],T0G=F5R=&EC
M86PM86QI9VXZ('1O<#L@=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF86UI;'DZ
M("=4:6UE<R!.97<@4F]M86XG.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!L969T.R!F;VYT
M+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)SXF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!T;W`[('1E>'0M86QI9VXZ(&QE
M9G0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SLG(&-O;'-P86X]
M,T0R/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ
M('1O<#L@=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF86UI;'DZ("=4:6UE<R!.
M97<@4F]M86XG.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=V97)T:6-A
M;"UA;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@
M)U1I;65S($YE=R!2;VUA;B<[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)W9E<G1I8V%L+6%L:6=N.B!T;W`[('1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M
M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SLG(&-O;'-P86X],T0R/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ('1O<#L@=&5X
M="UA;&EG;CH@;&5F=#L@9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG
M.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@
M=&]P.R!T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)U1I;65S($YE
M=R!2;VUA;B<[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W9E<G1I8V%L
M+6%L:6=N.B!T;W`[('1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G
M5&EM97,@3F5W(%)O;6%N)SLG(&-O;'-P86X],T0R/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ('1O<#L@=&5X="UA;&EG;CH@
M;&5F=#L@9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R<^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT
M+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[
M)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!T
M;W`[('1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W
M(%)O;6%N)SLG(&-O;'-P86X],T0R/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4]
M,T0G=F5R=&EC86PM86QI9VXZ('1O<#L@=&5X="UA;&EG;CH@;&5F=#L@9F]N
M="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R<^)B,Q-C`[/"]T9#X-"CPO
M='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C
M:V=R;W5N9"UC;VQO<CH@(V-C965F9CLG/@T*/'1D('-T>6QE/3-$)V9O;G0M
M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<@=VED
M=&@],T0Q,#`E/D]U='-T86YD:6YG(&%T($IA;G5A<GD@,2P@,C`Q-3PO=&0^
M#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG
M.R!P861D:6YG.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N
M)SL@<&%D9&EN9SH@,'!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M
M86XG.R!P861D:6YG.B`P<'@[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H
M:71E+7-P86-E.B!N;W=R87`[)SX\9F]N=#XQ+#@U-RPX-S<\+V9O;G0^/"]T
M9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL
M>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@=VAI=&4M<W!A
M8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z
M(#5P>#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ
M("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[('=H:71E+7-P86-E
M.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U
M<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
M9G0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@
M,'!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!P861D:6YG+7)I9VAT.B`Q
M,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R<^)#PO=&0^#0H\=&0@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@<FEG:'0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W
M(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M
M.R!W:&ET92US<&%C93H@;F]W<F%P.R<^/&9O;G0^-RXS,3PO9F]N=#X\+W1D
M/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY
M.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C
M93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@
M-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@
M)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@=VAI=&4M<W!A8V4Z
M(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P
M>#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F
M=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P
M<'@[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@
M<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R
M;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,'!T.R!V97)T:6-A
M;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R<^/&9O;G0^
M."XU/"]F;VYT/B!Y96%R<SPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@;&5F=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D
M:6YG.B`P<'@[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z
M(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T
M>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN
M9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U
M<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
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M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@
M<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I
M9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CPO
M='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C
M:V=R;W5N9"UC;VQO<CH@=VAI=&4[)SX-"CQT9"!S='EL93TS1"=F;VYT+69A
M;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)R!W:61T:#TS1#$P,"4^1W)A;G1E
M9#PO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=4:6UE<R!.97<@
M4F]M86XG.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I
M;F<Z(#!P>#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@<FEG:'0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D
M9&EN9SH@,'!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C
M93H@;F]W<F%P.R<^/&9O;G0^-3`L,#`P/"]F;VYT/CPO=&0^#0H\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N
M97<@<F]M86XG.R!P861D:6YG.B`P<'@[('=H:71E+7-P86-E.B!N;W=R87`[
M('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V
M,#L\+W1D/@T*/'1D('-T>6QE/3-$)W=H:71E+7-P86-E.B!N;W=R87`[('!A
M9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[(&9O;G0M9F%M
M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N
M97<@<F]M86XG.R!P861D:6YG.B`P<'@[('=H:71E+7-P86-E.B!N;W=R87`[
M('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V
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M4F]M86XG.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I
M;F<Z(#!P>#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@
M-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@<FEG:'0[(&9O;G0M9F%M:6QY.B`G=&EM97,@
M;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P<'0[('9E
M<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R87`[)SX\
M9F]N=#XQ,#PO9F]N=#X@>65A<G,\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@
M<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I
M9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT
M.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R!F;VYT+69A;6EL>3H@)U1I;65S
M($YE=R!2;VUA;B<[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@
M<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I
M9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ("=T
M:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[('9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R87`[)SX\9F]N=#XR,S,L,#`P
M/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@
M9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[
M('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D
M9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/"]T<CX-"CQT<B!S='EL
M93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R
M.B`C8V-E969F.R<^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=4:6UE
M<R!.97<@4F]M86XG.R<@=VED=&@],T0Q,#`E/D5X97)C:7-E9#PO=&0^#0H\
M=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R<^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F
M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#LG
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0[
M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X
M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P
M.R<^/&9O;G0^+3PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D
M9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT
M.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U
M<'@[('!A9&1I;F<M;&5F=#H@-7!X.R!F;VYT+69A;6EL>3H@)U1I;65S($YE
M=R!2;VUA;B<[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D
M9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT
M.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ("=T:6UE
M<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[('=H:71E+7-P86-E.B!N;W=R
M87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF
M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O
M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W
M:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I
M;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=W:&ET
M92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M
M;&5F=#H@-7!X.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)SXF
M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O
M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W
M:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I
M;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG
M.R!P861D:6YG.B`P<'@[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M
M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G
M=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@
M;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X
M.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=W:&ET92US<&%C93H@;F]W
M<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R!F
M;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)SXF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G
M=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@
M;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X
M.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H
M=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P
M<'@[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@
M<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O
M;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D
M:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T
M9#X-"CPO='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@8F%C:V=R;W5N9"UC;VQO<CH@=VAI=&4[)SX-"CQT9"!S='EL93TS1"=F
M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#LG
M('=I9'1H/3-$,3`P)3Y%>'!I<F5D+T9O<F9E:71E9#PO=&0^#0H\=&0@<W1Y
M;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG
M.B`P<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&QE9G0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@8F]R9&5R
M+6)O='1O;3H@(S`P,#`P,"`Q<'0@<V]L:60@(6EM<&]R=&%N=#L@<&%D9&EN
M9SH@,'!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!R:6=H=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!B;W)D
M97(M8F]T=&]M.B`C,#`P,#`P(#%P="!S;VQI9"`A:6UP;W)T86YT.R!P861D
M:6YG.B`P<'@[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E
M.B!N;W=R87`[)SX\9F]N=#XM/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M
M86XG.R!P861D:6YG.B`P<'@[(&)O<F1E<BUB;W1T;VTZ(",P,#`P,#`@,7!T
M('-O;&ED("%I;7!O<G1A;G0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I
M;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N
M)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG
M+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@
M)W1I;65S(&YE=R!R;VUA;B<[(&)O<F1E<BUB;W1T;VTZ(",P,#`P,#`@,7!T
M('-O;&ED("%I;7!O<G1A;G0[('!A9&1I;F<Z(#!P>#L@=VAI=&4M<W!A8V4Z
M(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P
M>#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG
M:'0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@8F]R9&5R+6)O
M='1O;3H@(S`P,#`P,"`Q<'0@<V]L:60@(6EM<&]R=&%N=#L@<&%D9&EN9SH@
M,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[
M('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R
M;VUA;B<[('!A9&1I;F<Z(#!P>#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D
M9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M
M86XG.R!P861D:6YG.B`P<'@[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I
M;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D
M/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY
M.B`G=&EM97,@;F5W(')O;6%N)SL@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`Q
M<'0@<V]L:60@(6EM<&]R=&%N=#L@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C
M93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@
M-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R
M:6=H=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!B;W)D97(M
M8F]T=&]M.B`C,#`P,#`P(#%P="!S;VQI9"`A:6UP;W)T86YT.R!P861D:6YG
M.B`P<'@[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P
M>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W
M(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P
M861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R
M;VUA;B<[('!A9&1I;F<Z(#!P>#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D
M9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF86UI
M;'DZ("=T:6UE<R!N97<@<F]M86XG.R!B;W)D97(M8F]T=&]M.B`C,#`P,#`P
M(#%P="!S;VQI9"`A:6UP;W)T86YT.R!P861D:6YG.B`P<'@[('=H:71E+7-P
M86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T
M.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(')I9VAT.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&)O<F1E
M<BUB;W1T;VTZ(",P,#`P,#`@,7!T('-O;&ED("%I;7!O<G1A;G0[('!A9&1I
M;F<Z(#!P>#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@
M-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N
M97<@<F]M86XG.R!P861D:6YG.B`P<'@[('=H:71E+7-P86-E.B!N;W=R87`[
M('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V
M,#L\+W1D/@T*/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^#0H\=&0@<W1Y
M;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG
M.B`P<'@[)R!W:61T:#TS1#$P,"4^3W5T<W1A;F1I;F<@870@36%R8V@@,S$L
M(#(P,34\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@
M;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)W1I;65S
M(&YE=R!R;VUA;B<[(&)O<F1E<BUB;W1T;VTZ(",P,#`P,#`@,BXX,'!T(&1O
M=6)L92`A:6UP;W)T86YT.R!P861D:6YG.B`P<'@[)SXF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@
M)W1I;65S(&YE=R!R;VUA;B<[(&)O<F1E<BUB;W1T;VTZ(",P,#`P,#`@,BXX
M,'!T(&1O=6)L92`A:6UP;W)T86YT.R!P861D:6YG.B`P<'@[('9E<G1I8V%L
M+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R87`[)SX\9F]N=#XQ
M+#DP-RPX-S<\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I
M;F<Z(#!P>#L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`R+C@P<'0@9&]U8FQE
M("%I;7!O<G1A;G0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG
M:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D
M9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT
M.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)W1I;65S
M(&YE=R!R;VUA;B<[(&)O<F1E<BUB;W1T;VTZ(",P,#`P,#`@,BXX,'!T(&1O
M=6)L92`A:6UP;W)T86YT.R!P861D:6YG.B`P<'@[('9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VT[('!A9&1I;F<M<FEG:'0Z(#$P<'@[('=H:71E+7-P86-E.B!N
M;W=R87`[)SXD/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H
M=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!B;W)D97(M8F]T
M=&]M.B`C,#`P,#`P(#(N.#!P="!D;W5B;&4@(6EM<&]R=&%N=#L@<&%D9&EN
M9SH@,'!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@
M;F]W<F%P.R<^/&9O;G0^-RXT-SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O
M;6%N)SL@<&%D9&EN9SH@,'!X.R!B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#(N
M.#!P="!D;W5B;&4@(6EM<&]R=&%N=#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@
M<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@
M<F]M86XG.R!P861D:6YG.B`P<'@[('=H:71E+7-P86-E.B!N;W=R87`[('!A
M9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\
M+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M
M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@8F]R9&5R+6)O='1O;3H@(S`P,#`P
M,"`Q<'0@<V]L:60@(6EM<&]R=&%N=#L@<&%D9&EN9SH@,'!X.R!W:&ET92US
M<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F
M=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!R:6=H=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!B;W)D
M97(M8F]T=&]M.B`C,#`P,#`P(#%P="!S;VQI9"`A:6UP;W)T86YT.R!P861D
M:6YG.B`P<'@[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E
M.B!N;W=R87`[)SX\9F]N=#XX+C(U/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@
M<F]M86XG.R!P861D:6YG.B`P<'@[(&)O<F1E<BUB;W1T;VTZ(",P,#`P,#`@
M,7!T('-O;&ED("%I;7!O<G1A;G0[('=H:71E+7-P86-E.B!N;W=R87`[('!A
M9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\
M+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O
M;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D
M:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL
M>3H@)W1I;65S(&YE=R!R;VUA;B<[(&)O<F1E<BUB;W1T;VTZ(",P,#`P,#`@
M,7!T('-O;&ED("%I;7!O<G1A;G0[('!A9&1I;F<Z(#!P>#L@=F5R=&EC86PM
M86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUR:6=H=#H@,3!P>#L@=VAI=&4M<W!A
M8V4Z(&YO=W)A<#LG/B0\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(')I9VAT.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&)O<F1E
M<BUB;W1T;VTZ(",P,#`P,#`@,7!T('-O;&ED("%I;7!O<G1A;G0[('!A9&1I
M;F<Z(#!P>#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M<W!A8V4Z
M(&YO=W)A<#LG/CQF;VYT/C$P+#8X-RPV,S<\+V9O;G0^/"]T9#X-"CQT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)W1I;65S
M(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@8F]R9&5R+6)O='1O;3H@(S`P
M,#`P,"`Q<'0@<V]L:60@(6EM<&]R=&%N=#L@=VAI=&4M<W!A8V4Z(&YO=W)A
M<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C
M,38P.SPO=&0^#0H\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z('=H:71E.R<^#0H\=&0@<W1Y
M;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG
M.B`P<'@[)R!W:61T:#TS1#$P,"4^17AE<F-I<V%B;&4@870@36%R8V@@,S$L
M(#(P,34\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@
M;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)W1I;65S
M(&YE=R!R;VUA;B<[(&)O<F1E<BUB;W1T;VTZ(",P,#`P,#`@,BXX,'!T(&1O
M=6)L92`A:6UP;W)T86YT.R!P861D:6YG.B`P<'@[)SXF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@
M)W1I;65S(&YE=R!R;VUA;B<[(&)O<F1E<BUB;W1T;VTZ(",P,#`P,#`@,BXX
M,'!T(&1O=6)L92`A:6UP;W)T86YT.R!P861D:6YG.B`P<'@[('9E<G1I8V%L
M+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R87`[)SX\9F]N=#XT
M,#4L-#$R/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M;&5F=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG
M.B`P<'@[(&)O<F1E<BUB;W1T;VTZ(",P,#`P,#`@,BXX,'!T(&1O=6)L92`A
M:6UP;W)T86YT.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT
M.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I
M;F<Z(#!P>#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@
M-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N
M97<@<F]M86XG.R!B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#(N.#!P="!D;W5B
M;&4@(6EM<&]R=&%N=#L@<&%D9&EN9SH@,'!X.R!V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M.R!P861D:6YG+7)I9VAT.B`Q,'!X.R!W:&ET92US<&%C93H@;F]W
M<F%P.R<^)#PO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0[
M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@8F]R9&5R+6)O='1O
M;3H@(S`P,#`P,"`R+C@P<'0@9&]U8FQE("%I;7!O<G1A;G0[('!A9&1I;F<Z
M(#!P>#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M<W!A8V4Z(&YO
M=W)A<#LG/CQF;VYT/C$P+C0X/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M
M86XG.R!P861D:6YG.B`P<'@[(&)O<F1E<BUB;W1T;VTZ(",P,#`P,#`@,BXX
M,'!T(&1O=6)L92`A:6UP;W)T86YT.R!W:&ET92US<&%C93H@;F]W<F%P.R!P
M861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[
M/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R
M;VUA;B<[('!A9&1I;F<Z(#!P>#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D
M9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF86UI
M;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[('=H:71E+7-P
M86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T
M.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(')I9VAT.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I
M;F<Z(#!P>#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@
M-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N
M97<@<F]M86XG.R!P861D:6YG.B`P<'@[('=H:71E+7-P86-E.B!N;W=R87`[
M('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V
M,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W
M(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P
M861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[
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M8V4Z(&YO=W)A<#LG/CQF;VYT/C0L-S`X+#<Q.#PO9F]N=#X\+W1D/@T*/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G=&EM
M97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W
M<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^
M)B,Q-C`[/"]T9#X-"CPO='(^#0H-"CPO=&%B;&4^#0H\+V1I=CX\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-C:&5D
M=6QE(&]F(%-T871U<R!O9B!3=&]C:R!787)R86YT<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!I9#TS1$5D9V%R4T%!,3(S-#4W.#DP
M,#`P('-T>6QE/3-$)V9O;G0M9F%M:6QY(#H@)U1I;65S($YE=R!2;VUA;B<[
M)SX-"CQT86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T
M>6QE/3-$)V)O<F1E<BUC;VQL87!S93H@8V]L;&%P<V4[(&9O;G0M<W1Y;&4Z
M(&YO<FUA;#L@9F]N="UV87)I86YT.B!N;W)M86P[(&9O;G0M=V5I9VAT.B!N
M;W)M86P[(&9O;G0M<W1R971C:#H@;F]R;6%L.R!F;VYT+7-I>F4Z(#$P<'0[
M(&QI;F4M:&5I9VAT.B!N;W)M86P[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W
M(')O;6%N)RP@=&EM97,L('-E<FEF.R!W:61T:#H@,3`P)3LG/@T*#0H\='(@
M<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/@T*/'1D('-T>6QE
M/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SLG(&YO=W)A<#TS
M1&YO=W)A<"!A;&EG;CTS1&-E;G1E<CX\+W1D/@T*/'1D('-T>6QE/3-$)V9O
M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SLG(&YO=W)A<#TS1&YO=W)A
M<"!A;&EG;CTS1&-E;G1E<CX\+W1D/@T*/'1D('-T>6QE/3-$)W=H:71E+7-P
M86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T
M.B`U<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!F;VYT+69A;6EL>3H@)U1I;65S
M($YE=R!2;VUA;B<[)R!A;&EG;CTS1&-E;G1E<CXF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SLG(&YO
M=W)A<#TS1&YO=W)A<"!C;VQS<&%N/3-$,R!A;&EG;CTS1&-E;G1E<CX\+W1D
M/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N
M)SLG(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<CX\+W1D/@T*/'1D
M('-T>6QE/3-$)W=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z
M(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!F
M;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)R!A;&EG;CTS1&-E;G1E
M<CXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM
M97,@3F5W(%)O;6%N)SLG(&YO=W)A<#TS1&YO=W)A<"!C;VQS<&%N/3-$,R!A
M;&EG;CTS1&-E;G1E<CX\+W1D/@T*/'1D(&%L:6=N/3-$8V5N=&5R('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@9F]N="UF86UI;'DZ("=T:6UE<R!N
M97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!W
M:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I
M;F<M;&5F=#H@-7!X.R<^/'-T<F]N9SXF(S$V,#L\+W-T<F]N9SX\+W1D/@T*
M/'1D(&YO=W)A<#TS1&YO=W)A<"!C;VQS<&%N/3-$,34@86QI9VX],T1C96YT
M97(@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>3H@
M)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q
M,"XP<'0[)SX\8G(O/CPO=&0^#0H\=&0@<W1Y;&4],T0G=VAI=&4M<W!A8V4Z
M(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P
M>#L@9F]N="US:7IE.B`Q,"XP<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W
M(%)O;6%N)SLG(&%L:6=N/3-$8V5N=&5R/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R<@;F]W<F%P
M/3-$;F]W<F%P(&-O;'-P86X],T0S(&%L:6=N/3-$8V5N=&5R/B8C,38P.SPO
M=&0^#0H\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T
M;VT[)SX-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2
M;VUA;B<[)R!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(^/"]T9#X-
M"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[
M)R!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(^/"]T9#X-"CQT9"!S
M='EL93TS1"=W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U
M<'@[('!A9&1I;F<M;&5F=#H@-7!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@9F]N
M="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R<@86QI9VX],T1C96YT97(^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S
M($YE=R!2;VUA;B<[)R!N;W=R87`],T1N;W=R87`@8V]L<W!A;CTS1#,@86QI
M9VX],T1C96YT97(^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@86QI9VX]
M,T1C96YT97(@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M
M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/B`\+W-T<F]N9SX\+W1D/@T*
M/'1D(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E
M<CL@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P
M<'@[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@
M<&%D9&EN9RUL969T.B`U<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R<^/'-T<F]N
M9SXF(S$V,#L\+W-T<F]N9SX\+W1D/@T*/'1D(&-O;'-P86X],T0S(&YO=W)A
M<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=T97AT+6%L:6=N
M.B!C96YT97([(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D
M9&EN9SH@,'!X.R<^/'-T<F]N9SY796EG:'1E9#PO<W1R;VYG/CPO=&0^#0H\
M=&0@86QI9VX],T1C96YT97(@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R
M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P
M>#L@9F]N="US:7IE.B`Q,"XP<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A
M9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SX\<W1R;VYG
M/B8C,38P.SPO<W1R;VYG/CPO=&0^#0H\=&0@;F]W<F%P/3-$;F]W<F%P(&-O
M;'-P86X],T0S(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&-E;G1E<CL@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D
M:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R<^/'-T<F]N9SY796EG:'1E
M9"!!=F5R86=E/"]S=')O;F<^/"]T9#X-"CQT9"!S='EL93TS1"=W:&ET92US
M<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F
M=#H@-7!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@9F]N="UF86UI;'DZ("=4:6UE
M<R!.97<@4F]M86XG.R<@86QI9VX],T1C96YT97(^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)R!N
M;W=R87`],T1N;W=R87`@8V]L<W!A;CTS1#,@86QI9VX],T1C96YT97(^)B,Q
M-C`[/"]T9#X-"CPO='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ
M(&)O='1O;3LG/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@
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M(#5P>#L@9F]N="US:7IE.B`Q,"XP<'0[)SX\<W1R;VYG/B8C,38P.SPO<W1R
M;VYG/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#0@;F]W<F%P/3-$;F]W<F%P('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@9F]N="UF86UI;'DZ("=T:6UE
M<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/E-H87)E<SPO
M<W1R;VYG/CPO=&0^#0H\=&0@86QI9VX],T1C96YT97(@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA
M;B<[('!A9&1I;F<Z(#!P>#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN
M9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#L@9F]N="US:7IE.B`Q
M,"XP<'0[)SX\<W1R;VYG/B8C,38P.SPO<W1R;VYG/CPO=&0^#0H\=&0@8V]L
M<W!A;CTS1#(@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N=&5R('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@9F]N="UF86UI;'DZ("=T:6UE<R!N
M97<@<F]M86XG.R!P861D:6YG.B`P<'@[)SX\<W1R;VYG/D%V97)A9V4\+W-T
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M="US:7IE.B`Q,"XP<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M
M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SX\<W1R;VYG/B8C,38P
M.SPO<W1R;VYG/CPO=&0^#0H\=&0@;F]W<F%P/3-$;F]W<F%P(&-O;'-P86X]
M,T0S(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E
M<CL@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P
M<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R<^/'-T<F]N9SY296UA:6YI;F<\+W-T
M<F]N9SX\+W1D/@T*/'1D(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&-E;G1E<CL@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG
M.R!P861D:6YG.B`P<'@[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M
M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[(&9O;G0M<VEZ93H@,3`N
M,'!T.R<^/'-T<F]N9SXF(S$V,#L\+W-T<F]N9SX\+W1D/@T*/'1D(&-O;'-P
M86X],T0S(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!S='EL93TS
M1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W
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M>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN
M9SH@,'!X.R<^/'-T<F]N9SX@/"]S=')O;F<^/"]T9#X-"CQT9"!A;&EG;CTS
M1&-E;G1E<B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M
M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US
M<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F
M=#H@-7!X.R!F;VYT+7-I>F4Z(#$P+C!P=#LG/CQS=')O;F<^)B,Q-C`[/"]S
M=')O;F<^/"]T9#X-"CQT9"!C;VQS<&%N/3-$-"!N;W=R87`],T1N;W=R87`@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>3H@)W1I
M;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#LG/CQS=')O;F<^56YD97(\
M+W-T<F]N9SX\+W1D/@T*/'1D(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&-E;G1E<CL@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M
M86XG.R!P861D:6YG.B`P<'@[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I
M;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[(&9O;G0M<VEZ93H@
M,3`N,'!T.R<^/'-T<F]N9SXF(S$V,#L\+W-T<F]N9SX\+W1D/@T*/'1D(&-O
M;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E;G1E<B!S='EL
M93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B`G=&EM97,@
M;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<^/'-T<F]N9SY%>&5R8VES93PO
M<W1R;VYG/CPO=&0^#0H\=&0@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$8V5N
M=&5R('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@
M<&%D9&EN9SH@,'!X.R<^/'-T<F]N9SX@/"]S=')O;F<^/"]T9#X-"CQT9"!A
M;&EG;CTS1&-E;G1E<B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O
M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F
M;VYT+7-I>F4Z(#$P+C!P=#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN
M9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/CQS=')O;F<^)B,Q
M-C`[/"]S=')O;F<^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@8V]L<W!A
M;CTS1#,@86QI9VX],T1C96YT97(@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N
M=&5R.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z
M(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[)SX\<W1R;VYG/D-O;G1R86-T=6%L
M/"]S=')O;F<^/"]T9#X-"CQT9"!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=T
M97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O
M;6%N)SL@<&%D9&EN9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D
M:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R!F;VYT+7-I>F4Z
M(#$P+C!P=#LG/CQS=')O;F<^)B,Q-C`[/"]S=')O;F<^/"]T9#X-"CQT9"!C
M;VQS<&%N/3-$,R!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>3H@)W1I;65S
M(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#LG/CQS=')O;F<^26YT<FEN<VEC
M/"]S=')O;F<^/"]T9#X-"CPO='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM
M86QI9VXZ(&)O='1O;3LG/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G
M5&EM97,@3F5W(%)O;6%N)SLG(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E
M;G1E<CXF(S$V,#L\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS
M1&-E;G1E<B!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA
M;B<[('!A9&1I;F<Z(#!P>#LG/CQS=')O;F<^)B,Q-C`[/"]S=')O;F<^/"]T
M9#X-"CQT9"!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=T97AT+6%L:6=N.B!C
M96YT97([(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN
M9SH@,'!X.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U
M<'@[('!A9&1I;F<M;&5F=#H@-7!X.R!F;VYT+7-I>F4Z(#$P+C!P=#LG/CQS
M=')O;F<^)B,Q-C`[/"]S=')O;F<^/"]T9#X-"CQT9"!C;VQS<&%N/3-$-"!N
M;W=R87`],T1N;W=R87`@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!F
M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[(&)O<F1E<BUB;W1T;VTZ
M(",P,#`P,#`@,7!T('-O;&ED("%I;7!O<G1A;G0[('!A9&1I;F<Z(#!P>#LG
M/CQS=')O;F<^5V%R<F%N=',\+W-T<F]N9SX\+W1D/@T*/'1D(&%L:6=N/3-$
M8V5N=&5R('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@9F]N="UF86UI
M;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[('=H:71E+7-P
M86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T
M.B`U<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R<^/'-T<F]N9SXF(S$V,#L\+W-T
M<F]N9SX\+W1D/@T*/'1D(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<"!A
M;&EG;CTS1&-E;G1E<B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O
M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@8F]R9&5R+6)O='1O;3H@
M(S`P,#`P,"`Q<'0@<V]L:60@(6EM<&]R=&%N=#L@<&%D9&EN9SH@,'!X.R<^
M/'-T<F]N9SY0<FEC93PO<W1R;VYG/CPO=&0^#0H\=&0@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM
M97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<^/'-T<F]N9SXF(S$V,#L\
M+W-T<F]N9SX\+W1D/@T*/'1D(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&-E;G1E<CL@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M
M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!W:&ET92US
M<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F
M=#H@-7!X.R<^/'-T<F]N9SXF(S$V,#L\+W-T<F]N9SX\+W1D/@T*/'1D(&YO
M=W)A<#TS1&YO=W)A<"!C;VQS<&%N/3-$,R!A;&EG;CTS1&-E;G1E<B!S='EL
M93TS1"=T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B`G=&EM97,@
M;F5W(')O;6%N)SL@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`Q<'0@<V]L:60@
M(6EM<&]R=&%N=#L@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#LG
M/CQS=')O;F<^3&EF93PO<W1R;VYG/CPO=&0^#0H\=&0@86QI9VX],T1C96YT
M97(@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>3H@
M)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@=VAI=&4M<W!A8V4Z
M(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P
M>#L@9F]N="US:7IE.B`Q,"XP<'0[)SX\<W1R;VYG/B8C,38P.SPO<W1R;VYG
M/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#,@;F]W<F%P/3-$;F]W<F%P(&%L:6=N
M/3-$8V5N=&5R('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@9F]N="UF
M86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!B;W)D97(M8F]T=&]M.B`C,#`P
M,#`P(#%P="!S;VQI9"`A:6UP;W)T86YT.R!P861D:6YG.B`P<'@[)SX\<W1R
M;VYG/E9A;'5E/"]S=')O;F<^/"]T9#X-"CPO='(^#0H\='(@<W1Y;&4],T0G
M=F5R=&EC86PM86QI9VXZ(&)O='1O;3LG/@T*/'1D('-T>6QE/3-$)W9E<G1I
M8V%L+6%L:6=N.B!T;W`[('1E>'0M86QI9VXZ(&QE9G0[)SX\+W1D/@T*/'1D
M('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!T;W`[('1E>'0M86QI9VXZ(&QE
M9G0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SLG(&%L:6=N/3-$
M8V5N=&5R/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI
M9VXZ('1O<#L@=&5X="UA;&EG;CH@;&5F=#L@=VAI=&4M<W!A8V4Z(&YO=W)A
M<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#L@9F]N
M="US:7IE.B`Q,"XP<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N
M)SLG(&%L:6=N/3-$8V5N=&5R/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G
M=F5R=&EC86PM86QI9VXZ('1O<#L@=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF
M86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R<@8V]L<W!A;CTS1#,@86QI9VX]
M,T1C96YT97(^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=V97)T:6-A;"UA
M;&EG;CH@=&]P.R!T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)U1I
M;65S($YE=R!2;VUA;B<[)R!A;&EG;CTS1&-E;G1E<CXF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!T;W`[('1E>'0M86QI9VXZ
M(&QE9G0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P
M>#L@<&%D9&EN9RUL969T.B`U<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!F;VYT
M+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[)R!A;&EG;CTS1&-E;G1E<CXF
M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!T;W`[
M('1E>'0M86QI9VXZ(&QE9G0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O
M;6%N)SLG(&-O;'-P86X],T0S(&%L:6=N/3-$8V5N=&5R/B8C,38P.SPO=&0^
M#0H\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ('1O<#L@=&5X="UA;&EG
M;CH@;&5F=#L@9F]N="US:7IE.B`Q,"XP<'0[('=H:71E+7-P86-E.B!N;W=R
M87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[(&9O
M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SLG(&%L:6=N/3-$8V5N=&5R
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ('1O
M<#L@=&5X="UA;&EG;CH@;&5F=#L@9F]N="UF86UI;'DZ("=4:6UE<R!.97<@
M4F]M86XG.R<@8V]L<W!A;CTS1#,@86QI9VX],T1C96YT97(^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!T97AT+6%L
M:6=N.B!L969T.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT
M.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@
M9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R<@86QI9VX],T1C96YT
M97(^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@
M=&]P.R!T97AT+6%L:6=N.B!L969T.R!F;VYT+69A;6EL>3H@)U1I;65S($YE
M=R!2;VUA;B<[)R!C;VQS<&%N/3-$,R!A;&EG;CTS1&-E;G1E<CXF(S$V,#L\
M+W1D/@T*/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T
M=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^#0H\=&0@<W1Y;&4]
M,T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P
M<'@[)R!W:61T:#TS1#$P,"4^3W5T<W1A;F1I;F<@870@1&5C96UB97(@,S$L
M(#(P,30\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@
M;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ("=T:6UE
M<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T
M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A
M9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F
M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@
M9F]N="US:7IE.B`Q,"XP<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H
M:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#LG(&%L:6=N
M/3-$;&5F=#X\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM
M97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P
M=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A
M<#LG(&%L:6=N/3-$<FEG:'0^/&9O;G0^,3$L,#@T+#0R-CPO9F]N=#X\+W1D
M/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N
M)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM
M86QI9VXZ(&)O='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR
M:6=H=#H@-7!X.R<@86QI9VX],T1L969T/CPO=&0^#0H\=&0@<W1Y;&4],T0G
M9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[
M)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P
M>#L@9F]N="US:7IE.B`Q,"XP<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A
M9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\
M+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O
M;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC
M86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN
M9RUR:6=H=#H@-7!X.R<@86QI9VX],T1L969T/B0\+W1D/@T*/'1D('-T>6QE
M/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@
M,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#LG(&%L:6=N/3-$<FEG:'0^/&9O;G0^
M,BXU,3PO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G
M=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P
M+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M<W!A8V4Z(&YO
M=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R<@86QI9VX],T1L969T/CPO=&0^
M#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0[(&9O;G0M9F%M:6QY
M.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z
M(#$P+C!P=#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@
M-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P.SPO=&0^#0H\=&0@<W1Y
M;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG
M.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T
M=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[
M)R!A;&EG;CTS1&QE9G0^/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL
M>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE
M.B`Q,"XP<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E
M.B!N;W=R87`[)R!A;&EG;CTS1')I9VAT/CQF;VYT/C,N.#4\+V9O;G0^('EE
M87)S/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE
M=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[('9E
M<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R87`[('!A
M9&1I;F<M<FEG:'0Z(#5P>#LG(&%L:6=N/3-$;&5F=#X\+W1D/@T*/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@)W1I;65S
M(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[
M('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D
M9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O
M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F
M;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI
M=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R<@86QI9VX]
M,T1L969T/B0\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM
M97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P
M=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A
M<#LG(&%L:6=N/3-$<FEG:'0^/&9O;G0^-3DL-3$W+#DY.#PO9F]N=#X\+W1D
M/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N
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M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X
M.R<@=VED=&@],T0Q,#`E/DES<W5E9#PO=&0^#0H\=&0@<W1Y;&4],T0G9F]N
M="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R<^)B,Q-C`[/"]T9#X-"CQT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ("=T
M:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N
M,'!T.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[
M('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS
M1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P
M>#L@9F]N="US:7IE.B`Q,"XP<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#LG(&%L
M:6=N/3-$;&5F=#X\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G
M=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P
M+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M<W!A8V4Z(&YO
M=W)A<#LG(&%L:6=N/3-$<FEG:'0^/&9O;G0^+3PO9F]N=#X\+W1D/@T*/'1D
M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D
M9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ
M(&)O='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@
M-7!X.R<@86QI9VX],T1L969T/CPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF
M86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R<^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ("=T:6UE
M<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T
M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A
M9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F
M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@
M9F]N="US:7IE.B`Q,"XP<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H
M:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#LG(&%L:6=N
M/3-$;&5F=#X\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM
M97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P
M=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A
M<#LG(&%L:6=N/3-$<FEG:'0^/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A
M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US
M:7IE.B`Q,"XP<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P
M86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#LG(&%L:6=N/3-$;&5F
M=#X\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT
M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N
M="US:7IE.B`Q,"XP<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M
M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*
M/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@
M<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI
M9VXZ(&)O='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H
M=#H@-7!X.R<@86QI9VX],T1L969T/CPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N
M="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O
M;G0M<VEZ93H@,3`N,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET
M92US<&%C93H@;F]W<F%P.R<@86QI9VX],T1R:6=H=#X\+W1D/@T*/'1D('-T
M>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN
M9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O
M='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X
M.R<@86QI9VX],T1L969T/CPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@<FEG:'0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D
M9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=VAI=&4M<W!A8V4Z(&YO
M=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE
M<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T
M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P
M.R!P861D:6YG+7)I9VAT.B`U<'@[)R!A;&EG;CTS1&QE9G0^/"]T9#X-"CQT
M9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A
M9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[('9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R87`[)R!A;&EG;CTS1')I9VAT
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@
M<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!V97)T
M:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D
M:6YG+7)I9VAT.B`U<'@[)R!A;&EG;CTS1&QE9G0^/"]T9#X-"CPO='(^#0H\
M='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N
M9"UC;VQO<CH@(V-C965F9CLG/@T*/'1D('-T>6QE/3-$)W1E>'0M:6YD96YT
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I
M;F<Z(#!P>#LG('=I9'1H/3-$,3`P)3Y%>&5R8VES960\+W1D/@T*/'1D('-T
M>6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SLG/B8C,38P
M.SPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0[(&9O;G0M
M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT
M+7-I>F4Z(#$P+C!P=#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR
M:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P.SPO=&0^#0H\
M=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P
M861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!V97)T:6-A;"UA;&EG
M;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT
M.B`U<'@[)R!A;&EG;CTS1&QE9G0^/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT
M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N
M="US:7IE.B`Q,"XP<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E
M+7-P86-E.B!N;W=R87`[)R!A;&EG;CTS1')I9VAT/CQF;VYT/B@Y,C$L-S`P
M/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE
M<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T
M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P
M.R!P861D:6YG+7)I9VAT.B`U<'@[)R!A;&EG;CTS1&QE9G0^*3PO=&0^#0H\
M=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R<^
M)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@
M9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[
M(&9O;G0M<VEZ93H@,3`N,'!T.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D
M:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T
M9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA
M;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[('9E<G1I8V%L
M+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M
M<FEG:'0Z(#5P>#LG(&%L:6=N/3-$;&5F=#XD/"]T9#X-"CQT9"!S='EL93TS
M1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P
M>#L@9F]N="US:7IE.B`Q,"XP<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M('=H:71E+7-P86-E.B!N;W=R87`[)R!A;&EG;CTS1')I9VAT/CQF;VYT/C(N
M-3`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I
M;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP
M<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R
M87`[('!A9&1I;F<M<FEG:'0Z(#5P>#LG(&%L:6=N/3-$;&5F=#X\+W1D/@T*
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@
M)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q
M,"XP<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P
M>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE
M/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@
M,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R<@
M86QI9VX],T1L969T/CPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ
M("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@
M,3`N,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@
M;F]W<F%P.R<@86QI9VX],T1R:6=H=#X\+W1D/@T*/'1D('-T>6QE/3-$)V9O
M;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F
M;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI
M=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R<@86QI9VX]
M,T1L969T/CPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0[
M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X
M.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D
M9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C,38P.SPO
M=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M
M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!V97)T:6-A
M;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG
M+7)I9VAT.B`U<'@[)R!A;&EG;CTS1&QE9G0^/"]T9#X-"CQT9"!S='EL93TS
M1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P
M>#L@9F]N="US:7IE.B`Q,"XP<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M('=H:71E+7-P86-E.B!N;W=R87`[)R!A;&EG;CTS1')I9VAT/CPO=&0^#0H\
M=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P
M861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!V97)T:6-A;"UA;&EG
M;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT
M.B`U<'@[)R!A;&EG;CTS1&QE9G0^/"]T9#X-"CPO='(^#0H\='(@<W1Y;&4]
M,T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@
M=VAI=&4[)SX-"CQT9"!S='EL93TS1"=T97AT+6EN9&5N=#H@,3!P=#L@9F]N
M="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[)R!W
M:61T:#TS1#$P,"4^17AP:7)E9#PO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF
M86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R<^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ("=T:6UE
M<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T
M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A
M9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F
M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@
M9F]N="US:7IE.B`Q,"XP<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H
M:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#LG(&%L:6=N
M/3-$;&5F=#X\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM
M97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P
M=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A
M<#LG(&%L:6=N/3-$<FEG:'0^/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A
M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US
M:7IE.B`Q,"XP<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P
M86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#LG(&%L:6=N/3-$;&5F
M=#X\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W
M(%)O;6%N)SLG/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@<FEG:'0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D
M9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=VAI=&4M<W!A8V4Z(&YO
M=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG
M/B8C,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE
M<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T
M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P
M.R!P861D:6YG+7)I9VAT.B`U<'@[)R!A;&EG;CTS1&QE9G0^/"]T9#X-"CQT
M9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A
M9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[('9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R87`[)R!A;&EG;CTS1')I9VAT
M/CQF;VYT/BT\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL
M>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE
M.B`Q,"XP<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E
M.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#LG(&%L:6=N/3-$;&5F=#X\
M+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A
M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US
M:7IE.B`Q,"XP<'0[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG
M:'0Z(#5P>#L@<&%D9&EN9RUL969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D
M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D
M9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ
M(&)O='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@
M-7!X.R<@86QI9VX],T1L969T/CPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF
M86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M
M<VEZ93H@,3`N,'!T.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US
M<&%C93H@;F]W<F%P.R<@86QI9VX],T1R:6=H=#X\+W1D/@T*/'1D('-T>6QE
M/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@
M,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R<@
M86QI9VX],T1L969T/CPO=&0^#0H\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M<FEG:'0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN
M9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=VAI=&4M<W!A8V4Z(&YO=W)A
M<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R!P861D:6YG+6QE9G0Z(#5P>#LG/B8C
M,38P.SPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N
M97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!V
M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P
M861D:6YG+7)I9VAT.B`U<'@[)R!A;&EG;CTS1&QE9G0^/"]T9#X-"CQT9"!S
M='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I
M;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[('9E<G1I8V%L+6%L:6=N.B!B
M;W1T;VT[('=H:71E+7-P86-E.B!N;W=R87`[)R!A;&EG;CTS1')I9VAT/CPO
M=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M
M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!V97)T:6-A
M;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG
M+7)I9VAT.B`U<'@[)R!A;&EG;CTS1&QE9G0^/"]T9#X-"CPO='(^#0H\='(@
M<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC
M;VQO<CH@(V-C965F9CLG/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
M9G0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@
M,'!X.R<@=VED=&@],T0Q,#`E/D]U='-T86YD:6YG(&%N9"!E>&5R8VES86)L
M92!A="!-87)C:"`S,2P@,C`Q-3PO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF
M86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R<^)B,Q-C`[/"]T9#X-"CQT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ("=T:6UE
M<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T
M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A
M9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F
M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@
M9F]N="US:7IE.B`Q,"XP<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H
M:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#LG(&%L:6=N
M/3-$;&5F=#X\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM
M97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P
M=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A
M<#LG(&%L:6=N/3-$<FEG:'0^/&9O;G0^,3`L,38R+#<R-CPO9F]N=#X\+W1D
M/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N
M)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I>F4Z(#$P+C!P=#L@=F5R=&EC86PM
M86QI9VXZ(&)O='1O;3L@=VAI=&4M<W!A8V4Z(&YO=W)A<#L@<&%D9&EN9RUR
M:6=H=#H@-7!X.R<@86QI9VX],T1L969T/CPO=&0^#0H\=&0@<W1Y;&4],T0G
M9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R<^)B,Q-C`[/"]T9#X-
M"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ
M("=T:6UE<R!N97<@<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@
M,3`N,'!T.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U
M<'@[('!A9&1I;F<M;&5F=#H@-7!X.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL
M93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z
M(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T
M;VT[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#LG
M(&%L:6=N/3-$;&5F=#XD/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL
M>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE
M.B`Q,"XP<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E
M.B!N;W=R87`[)R!A;&EG;CTS1')I9VAT/CQF;VYT/C(N-3$\+V9O;G0^/"]T
M9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA
M;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[('9E<G1I8V%L
M+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M
M<FEG:'0Z(#5P>#LG(&%L:6=N/3-$;&5F=#X\+W1D/@T*/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R
M;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[('=H:71E
M+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#L@<&%D9&EN9RUL
M969T.B`U<'@[)SXF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V9O;G0M9F%M
M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@<&%D9&EN9SH@,'!X.R!F;VYT+7-I
M>F4Z(#$P+C!P=#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VAI=&4M<W!A
M8V4Z(&YO=W)A<#L@<&%D9&EN9RUR:6=H=#H@-7!X.R<@86QI9VX],T1L969T
M/CPO=&0^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@
M<F]M86XG.R!P861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!V97)T
M:6-A;"UA;&EG;CH@8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R<@86QI
M9VX],T1R:6=H=#X\9F]N=#XS+C4X/"]F;VYT/B!Y96%R<SPO=&0^#0H\=&0@
M<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P861D
M:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M.R!W:&ET92US<&%C93H@;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U
M<'@[)R!A;&EG;CTS1&QE9G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!P
M861D:6YG.B`P<'@[(&9O;G0M<VEZ93H@,3`N,'!T.R!W:&ET92US<&%C93H@
M;F]W<F%P.R!P861D:6YG+7)I9VAT.B`U<'@[('!A9&1I;F<M;&5F=#H@-7!X
M.R<^)B,Q-C`[/"]T9#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I
M;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP
M<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R
M87`[('!A9&1I;F<M<FEG:'0Z(#5P>#LG(&%L:6=N/3-$;&5F=#XD/"]T9#X-
M"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[
M('!A9&1I;F<Z(#!P>#L@9F]N="US:7IE.B`Q,"XP<'0[('9E<G1I8V%L+6%L
M:6=N.B!B;W1T;VT[('=H:71E+7-P86-E.B!N;W=R87`[)R!A;&EG;CTS1')I
M9VAT/CQF;VYT/CDW+#8U-"PQ.#<\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS
M1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('!A9&1I;F<Z(#!P
M>#L@9F]N="US:7IE.B`Q,"XP<'0[('9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M('=H:71E+7-P86-E.B!N;W=R87`[('!A9&1I;F<M<FEG:'0Z(#5P>#LG(&%L
M:6=N/3-$;&5F=#X\+W1D/@T*/"]T<CX-"@T*/"]T86)L93X-"CPO9&EV/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*
M("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?8CDQ9C0R
M,6-?9F1C-%\T-SED7S@P-SA?8S0U8V,U-#`U8C5A#0I#;VYT96YT+4QO8V%T
M:6]N.B!F:6QE.B\O+T,Z+V(Y,68T,C%C7V9D8S1?-#<Y9%\X,#<X7V,T-6-C
M-30P-6(U82]7;W)K<VAE971S+U-H965T,3@N:'1M;`T*0V]N=&5N="U4<F%N
M<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E
M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@
M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C
M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T
M>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T
M(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB
M;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$565D%'
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N
M/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D=%3D5204P@3U)'04Y)6D%424].
M($%.1"!"55-)3D534R`H1&5T86EL<RD@*%531"`D*3QB<CX\+W-T<F]N9SX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,SXQ($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0R/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@
M,S$L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^3F]V
M+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y3
M97`N(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/DUA<BX@,S$L(#(P,34\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/CQS=')O;F<^1T5.15)!3"!/4D=!3DE:051)3TX@04Y$
M($)54TE.15-3(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4W1O8VMH;VQD97)S)R!%<75I='DL(%)E=F5R
M<V4@4W1O8VL@4W!L:70\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQD:78@:60],T1%9&=A<E-!03$R,S0U-S@Y,#`P,"!S='EL93TS1"=F;VYT
M+69A;6EL>2`Z("=4:6UE<R!.97<@4F]M86XG.R<^,2UF;W(M,3`P/"]D:78^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y#;VUM;VX@4W1O8VLL(%-H87)E<R!!=71H;W)I>F5D/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ-3`L,#`P+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U,"PP,#`L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,34P
M+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E!R969E<G)E9"!3=&]C:RP@4VAA<F5S($%U=&AO<FEZ960\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4P+#`P,"PP,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,"PP
M,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-3`L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4')E9F5R<F5D(%-T;V-K+"!087(@;W(@4W1A
M=&5D(%9A;'5E(%!E<B!3:&%R93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`P+C`P,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,"XP,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#`Q/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@26YC;VUE("A,;W-S
M*2!!='1R:6)U=&%B;&4@=&\@4&%R96YT/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#4L,CDX+#`U.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,BPR-3DL-3$T/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@0V%S:"!0
M<F]V:61E9"!B>2`H57-E9"!I;BD@3W!E<F%T:6YG($%C=&EV:71I97,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L-#4X+#8T.3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V%S:"!A
M;F0@0V%S:"!%<75I=F%L96YT<RP@870@0V%R<GEI;F<@5F%L=64\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0T+#DP.2PQ-#<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,3$L,C@P+#0T
M,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$W+#DT,RPX-S<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XT-"PY,#DL,30W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3DL-C<R+#$W-SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1O8VMH;VQD97)S
M)R!%<75I='D@071T<FEB=71A8FQE('1O(%!A<F5N=#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-#0L.#0U+#`X-SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$Q,2PV,C8L.#8Y/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#0L.#0U
M+#`X-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^5V]R:VEN9R!#87!I=&%L/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ,#DL-#DX+#8P.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4W1O8VL@27-S=65D($1U<FEN9R!097)I
M;V0L(%-H87)E<RP@3F5W($ES<W5E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^.2PR,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-BPP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R92!0<FEC93PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U+C<U/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`X/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U+C<U/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0
M<F]C965D<R!F<F]M($ES<W5A;F-E(&]F($-O;6UO;B!3=&]C:SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S(L,C`P+#`P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8X+#,P-RPX,S@\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV
M."PS,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y0<F]C965D<R!F<F]M($ES<W5A;F-E(&]F(%!R:79A=&4@
M4&QA8V5M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(S
M+#,P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'10
M87)T7V(Y,68T,C%C7V9D8S1?-#<Y9%\X,#<X7V,T-6-C-30P-6(U80T*0V]N
M=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]B.3%F-#(Q8U]F9&,T7S0W.61?
M.#`W.%]C-#5C8S4T,#5B-6$O5V]R:W-H965T<R]3:&5E=#$Y+FAT;6P-"D-O
M;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O
M;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*
M/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT
M96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G
M/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS
M/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H
M96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60]
M,T1)1#!%5D]!13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY354U-05)9($]&
M(%-)1TY)1DE#04Y4($%#0T]53E1)3D<@4%)!0U1)0T53("A$971A:6QS*3QB
M<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS
M<&%N/3-$,CXS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$U
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P
M,30\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5Q=6ET
M>2!/<'1I;VX@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY!;G1I9&EL=71I=F4@4V5C=7)I=&EE<R!%>&-L=61E
M9"!F<F]M($-O;7!U=&%T:6]N(&]F($5A<FYI;F=S(%!E<B!3:&%R92!;3&EN
M92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^06YT:61I;'5T:79E(%-E8W5R:71I97,@17AC;'5D960@9G)O;2!#
M;VUP=71A=&EO;B!O9B!%87)N:6YG<R!097(@4VAA<F4L($%M;W5N=#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PY,#<L.#<W/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C,X+#<U,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M5V%R<F%N="!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#X\<W1R;VYG/D%N=&ED:6QU=&EV92!396-U<FET:65S($5X8VQU9&5D
M(&9R;VT@0V]M<'5T871I;VX@;V8@16%R;FEN9W,@4&5R(%-H87)E(%M,:6YE
M($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y!;G1I9&EL=71I=F4@4V5C=7)I=&EE<R!%>&-L=61E9"!F<F]M($-O
M;7!U=&%T:6]N(&]F($5A<FYI;F=S(%!E<B!3:&%R92P@06UO=6YT/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PQ-C(L-S(V/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3(L,34V+#$U
M-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0V]N=F5R=&EB;&4@4')E9F5R<F5D(%-T;V-K(%M-96UB97)=/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^06YT:61I;'5T
M:79E(%-E8W5R:71I97,@17AC;'5D960@9G)O;2!#;VUP=71A=&EO;B!O9B!%
M87)N:6YG<R!097(@4VAA<F4@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%N=&ED:6QU=&EV92!396-U
M<FET:65S($5X8VQU9&5D(&9R;VT@0V]M<'5T871I;VX@;V8@16%R;FEN9W,@
M4&5R(%-H87)E+"!!;6]U;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$L.#0W+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C8L-C4P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5S=')I8W1E9"!3=&]C:R!;365M
M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/D%N=&ED:6QU=&EV92!396-U<FET:65S($5X8VQU9&5D(&9R;VT@0V]M<'5T
M871I;VX@;V8@16%R;FEN9W,@4&5R(%-H87)E(%M,:6YE($ET96US73PO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;G1I9&EL
M=71I=F4@4V5C=7)I=&EE<R!%>&-L=61E9"!F<F]M($-O;7!U=&%T:6]N(&]F
M($5A<FYI;F=S(%!E<B!3:&%R92P@06UO=6YT/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XU,#<L,3$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*
M+2TM+2TM/5].97AT4&%R=%]B.3%F-#(Q8U]F9&,T7S0W.61?.#`W.%]C-#5C
M8S4T,#5B-6$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8CDQ9C0R
M,6-?9F1C-%\T-SED7S@P-SA?8S0U8V,U-#`U8C5A+U=O<FMS:&5E=',O4VAE
M970R,"YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M
M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB
M=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P
M+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C
M:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@
M<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J
M+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S
M/3-$<F5P;W)T(&ED/3-$240P139604<^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O
M;F<^4U1/0TM(3TQ$15)3)R!%455)5%D@*$YA<G)A=&EV92D@*$1E=&%I;',I
M("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#$^,2!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXS($UO;G1H<R!%;F1E9#PO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$T/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,34\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$T/&)R/CPO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-L87-S
M(&]F(%-T;V-K(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R97,@:7-S=65D(&1U<FEN9R!P97)I
M;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDL,C`P+#`P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8L
M,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4VAA<F4@<')I8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@-2XW-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@-2XW-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O8V5E9',@9G)O;2!T:&4@:7-S
M=6%N8V4@;V8@8V]M;6]N('-T;V-K+"!N970\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,S(L,C`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-C@L,S`W+#@S.#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-C@L,S`P
M+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0V]N=F5R<VEO;B!O9B!3=&]C:RP@4VAA<F5S($ES<W5E9#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PP,#`L,#`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYV97)S
M:6]N(&]F(%-T;V-K+"!3:&%R97,@0V]N=F5R=&5D/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1W)A;G1E9#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R92UB87-E9"!C
M;VUP96YS871I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L
M,#$W+#,P.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/CDP,2PV-3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E)E<W1R:6-T960@4W1O8VL@6TUE;6)E<ET\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#;&%S<R!O
M9B!3=&]C:R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^1W)A;G1E9#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-S@R+#4P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5F5S=&EN9R!P97)I;V0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/C,@>65A<G,\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYO;G9E<W1E9"P@9F%I
M<B!V86QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PX-3$L
M-3DP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-"PX-3$L-3DP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y3:&%R92UB87-E9"!C;VUP96YS871I;VX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,C4V+#DX-3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5F5S=&5D+"!F
M86ER('9A;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-3`L
M-#0U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y5;G)E8V]G;FEZ960@8V]M<&5N<V%T:6]N(&-O<W0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,RPQ-#0L,38P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y397)I97,@02!#
M;VYV97)T:6)L92!0<F5F97)R960@4W1O8VL@6TUE;6)E<ET\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#;&%S<R!O9B!3=&]C
M:R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0V]N=F5R<VEO;B!O9B!3=&]C:RP@4VAA<F5S($-O;G9E
M<G1E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO
M8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B.3%F-#(Q8U]F
M9&,T7S0W.61?.#`W.%]C-#5C8S4T,#5B-6$-"D-O;G1E;G0M3&]C871I;VXZ
M(&9I;&4Z+R\O0SHO8CDQ9C0R,6-?9F1C-%\T-SED7S@P-SA?8S0U8V,U-#`U
M8C5A+U=O<FMS:&5E=',O4VAE970R,2YH=&UL#0I#;VYT96YT+51R86YS9F5R
M+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E
M>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A
M9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E
M;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4]
M,T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M
M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^
M#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P13-,04,^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q
M(')O=W-P86X],T0R/CQS=')O;F<^4U1/0TM(3TQ$15(G4R!%455)5%D@*%-C
M:&5D=6QE(&]F(%)E<W1R:6-T960@4W1O8VL@06-T:79I='DI("A$971A:6QS
M*2`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H(&-O;'-P86X],T0Q/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA
M<BX@,S$L(#(P,34\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^3G5M8F5R(&]F(%-H87)E<SPO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.;VXM=F5S=&5D('-H87)E<RP@
M2F%N=6%R>2`Q+"`R,#$U/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XU-SDL-S8T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y'<F%N=&5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E9E<W1E9#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH-S(L-C4Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1F]R9F5I=&5D/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYO;BUV97-T960@<VAA
M<F5S+"!-87)C:"`S,2P@,C`Q-3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-3`W+#$Q,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY796EG:'1E9"!!=F5R86=E($=R86YT
M($1A=&4@1F%I<B!686QU93PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y.;VXM=F5S=&5D('-H87)E<RP@2F%N=6%R>2`Q+"`R
M,#$U/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#8N,CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1W)A
M;G1E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB
M<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y697-T960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M-BXR/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y&;W)F96ET960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^3F]N+79E<W1E9"!S:&%R97,L($UA<F-H(#,Q+"`R
M,#$U/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#8N,CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\
M+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?8CDQ9C0R,6-?
M9F1C-%\T-SED7S@P-SA?8S0U8V,U-#`U8C5A#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T,Z+V(Y,68T,C%C7V9D8S1?-#<Y9%\X,#<X7V,T-6-C-30P
M-6(U82]7;W)K<VAE971S+U-H965T,C(N:'1M;`T*0V]N=&5N="U4<F%N<V9E
M<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T
M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE
M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT
M96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E
M/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E
M;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y
M/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5+6D%)/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$
M,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-43T-+($]05$E/3E,@04Y$(%=!4E)!
M3E13("A.87)R871I=F4I("A$971A:6QS*2`H55-$("0I/&)R/CPO<W1R;VYG
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C,@
M36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L
M<W!A;CTS1#$^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#$^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#$^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,34\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y-87(N(#(Y+"`R,#$P/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D%P<BX@,3`L(#(P,34\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^3F]V+B`S,"P@,C`Q-#QB<CX\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3:&%R92UB87-E
M9"!#;VUP96YS871I;VX@07)R86YG96UE;G0@8GD@4VAA<F4M8F%S960@4&%Y
M;65N="!!=V%R9"!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4VAA<F4M8F%S960@8V]M<&5N<V%T:6]N
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L,#$W+#,P.#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M.3`Q+#8U,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^56YR96-O9VYI>F5D(&-O;7!E;G-A=&EO;B!C;W-T/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX+#8V-2PT-S4\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;V-E961S
M(&9R;VT@=V%R<F%N="!E>&5R8VES97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C(L,S`T+#(U,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5V%R<F%N="!;365M8F5R73PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-H87)E+6)A<V5D
M($-O;7!E;G-A=&EO;B!!<G)A;F=E;65N="!B>2!3:&%R92UB87-E9"!087EM
M96YT($%W87)D(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y0=7)C:&%S92!O9B!C;VUM;VX@<W1O8VL\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDR,2PW,#`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/C(P,3`@
M4&QA;B!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#X\<W1R;VYG/E-H87)E+6)A<V5D($-O;7!E;G-A=&EO;B!!<G)A;F=E;65N
M="!B>2!3:&%R92UB87-E9"!087EM96YT($%W87)D(%M,:6YE($ET96US73PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.=6UB
M97(@;V8@<VAA<F5S(&%U=&AO<FEZ960\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C,U+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^,C`Q-"!0;&%N(%M-96UB97)=/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4VAA<F4M8F%S960@
M0V]M<&5N<V%T:6]N($%R<F%N9V5M96YT(&)Y(%-H87)E+6)A<V5D(%!A>6UE
M;G0@07=A<F0@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DYU;6)E<B!O9B!S:&%R97,@875T:&]R:7IE
M9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PP,#`L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPS
M-3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y.=6UB97(@;V8@861D:71I;VYA;"!S:&%R97,@875T:&]R:7IE
M9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PV-3`L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-
M:6YI;75M(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^4VAA<F4M8F%S960@0V]M<&5N<V%T:6]N($%R<F%N9V5M
M96YT(&)Y(%-H87)E+6)A<V5D(%!A>6UE;G0@07=A<F0@6TQI;F4@271E;7-=
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E5N
M<F5C;V=N:7IE9"!C;VUP96YS871I;VX@8V]S="P@<&5R:6]D(&9O<B!R96-O
M9VYI=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^.2!M;VYT
M:',\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DUA>&EM=6T@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY3:&%R92UB87-E9"!#;VUP96YS871I;VX@07)R
M86YG96UE;G0@8GD@4VAA<F4M8F%S960@4&%Y;65N="!!=V%R9"!;3&EN92!)
M=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^56YR96-O9VYI>F5D(&-O;7!E;G-A=&EO;B!C;W-T+"!P97)I;V0@9F]R
M(')E8V]G;FET:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XU
M('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y$:7)E8W1O<B!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-H87)E+6)A<V5D($-O;7!E;G-A=&EO
M;B!!<G)A;F=E;65N="!B>2!3:&%R92UB87-E9"!087EM96YT($%W87)D(%M,
M:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y'<F%N=&5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XU,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D=R86YT960L(&5X97)C:7-E('!R:6-E/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#<N-#4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9A:7(@=F%L=64@;V8@;W!T
M:6]N<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`S-CDL,#`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y%>'!E8W1E9"!V;VQA=&EL:71Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR,3,N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y$:7-C;W5N="!R871E/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ+C,W)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AP96-T960@9&EV:61E;F0@>6EE
M;&0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`N,#`E/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>'!E
M8W1E9"!L:69E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XV('EE
M87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y$:7)E8W1O<B!;365M8F5R72!\(%9E<W1I;F<@1FER<W0@6TUE;6)E
M<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3
M:&%R92UB87-E9"!#;VUP96YS871I;VX@07)R86YG96UE;G0@8GD@4VAA<F4M
M8F%S960@4&%Y;65N="!!=V%R9"!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1W)A;G1E9#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3(L-3`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO
M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B.3%F-#(Q8U]F9&,T7S0W.61?
M.#`W.%]C-#5C8S4T,#5B-6$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O
M0SHO8CDQ9C0R,6-?9F1C-%\T-SED7S@P-SA?8S0U8V,U-#`U8C5A+U=O<FMS
M:&5E=',O4VAE970R,RYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG
M.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@
M8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\
M345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X
M="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA
M=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@
M0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A
M8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P158V044^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X]
M,T0R/CQS=')O;F<^4U1/0TL@3U!424].4R!!3D0@5T%24D%.5%,@*%-C:&5D
M=6QE(&]F(%-T871U<R!O9B!3=&]C:R!/<'1I;VYS*2`H1&5T86EL<RD@*$5M
M<&QO>65E(%-T;V-K($]P=&EO;B!;365M8F5R72P@55-$("0I/&)R/CPO<W1R
M;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L
M(#(P,34\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
M,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M16UP;&]Y964@4W1O8VL@3W!T:6]N(%M-96UB97)=/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4VAA<F5S(%5N9&5R($]P=&EO
M;CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/
M=71S=&%N9&EN9R!B96=I;FYI;F<@8F%L86YC93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,2PX-3<L.#<W/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'<F%N=&5D/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XU,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X97)C:7-E9#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>'!I<F5D
M+T9O<F9E:71E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB
M<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y/=71S=&%N9&EN9R!E;F1I;F<@8F%L86YC93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PY,#<L.#<W/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PX-3<L.#<W/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%
M>&5R8VES86)L92!E;F1I;F<@8F%L86YC93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-#`U+#0Q,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY796EG:'1E9"!!=F5R86=E
M($5X97)C:7-E(%!R:6-E/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D]U='-T86YD:6YG(&)E9VEN;FEN9R!B86QA;F-E/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#<N,S$\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=R86YT960\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-RXT-3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W5T<W1A
M;F1I;F<@96YD:6YG(&)A;&%N8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@-RXT-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@-RXS,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^17AE<F-I<V%B;&4@96YD:6YG(&)A;&%N
M8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,3`N-#@\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^5V5I9VAT960@079E<F%G92!296UA:6YI;F<@0V]N=')A8W1U86P@
M3&EF93PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y/=71S=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M."!Y96%R<R`S(&UO;G1H<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/C@@>65A<G,@-B!M;VYT:',\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=R86YT960\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C$P('EE87)S/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/D%G9W)E9V%T92!);G1R:6YS:6,@5F%L=64\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W5T<W1A;F1I;F<@8F5G:6YN:6YG
M(&)A;&%N8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,BPX
M-S0L,S<X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y'<F%N=&5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XR,S,L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y/=71S=&%N9&EN9R!E;F1I;F<@8F%L86YC93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`L-C@W+#8S-SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L.#<T+#,W.#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M17AE<F-I<V%B;&4@0F%L86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`T+#<P."PW,3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM
M+2T]7TYE>'1087)T7V(Y,68T,C%C7V9D8S1?-#<Y9%\X,#<X7V,T-6-C-30P
M-6(U80T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]B.3%F-#(Q8U]F
M9&,T7S0W.61?.#`W.%]C-#5C8S4T,#5B-6$O5V]R:W-H965T<R]3:&5E=#(T
M+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN
M=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA
M<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U
M:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S
M970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,]
M,T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S
M8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R
M97!O<G0@:60],T1)1#!%5EI!13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY3
M5$]#2R!/4%1)3TY3($%.1"!705)204Y44R`H4V-H961U;&4@;V8@4W1A='5S
M(&]F(%-T;V-K(%=A<G)A;G1S*2`H1&5T86EL<RD@*%=A<G)A;G0@6TUE;6)E
M<ETL(%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$U/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,30\8G(^/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G0@6TUE;6)E<ET\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3:&%R97,@56YD97(@
M5V%R<F%N=',\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^3W5T<W1A;F1I;F<@8F5G:6YN:6YG(&)A;&%N8V4\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$Q+#`X-"PT,C8\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5E9#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>&5R
M8VES960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#DR,2PW,#`I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y/=71S=&%N9&EN9R!E;F1I;F<@8F%L86YC93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3`L,38R+#<R-CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$Q+#`X-"PT,C8\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X97)C:7-A
M8FQE(&5N9&EN9R!B86QA;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ,"PQ-C(L-S(V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E=E:6=H=&5D($%V97)A9V4@17AE
M<F-I<V4@4')I8V4\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^3W5T<W1A;F1I;F<@8F5G:6YN:6YG(&)A;&%N8V4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,BXU,3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AE<F-I<V5D/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(N-3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W5T<W1A;F1I
M;F<@96YD:6YG(&)A;&%N8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,BXU,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,BXU,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^17AE<F-I<V%B;&4@96YD:6YG(&)A;&%N8V4\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,BXU,3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY796EG:'1E9"!!=F5R86=E(%)E;6%I;FEN9R!#;VYT<F%C='5A;"!,:69E
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]U
M='-T86YD:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XS('EE
M87)S(#8@;6]N=&AS(#(Y(&1A>7,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XS('EE87)S(#$P(&UO;G1H<R`V(&1A>7,\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D5X97)C:7-A8FQE(&5N9&EN9R!B86QA;F-E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XS('EE87)S(#8@;6]N=&AS(#(Y(&1A>7,\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^06=G<F5G871E($EN=')I;G-I8R!686QU93PO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=71S=&%N9&EN9R!B96=I;FYI
M;F<@8F%L86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U
M.2PU,3<L.3DX/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y/=71S=&%N9&EN9R!E;F1I;F<@8F%L86YC93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Y-RPV-30L,3@W/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U.2PU,3<L
M.3DX/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B
M;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B
M.3%F-#(Q8U]F9&,T7S0W.61?.#`W.%]C-#5C8S4T,#5B-6$-"D-O;G1E;G0M
M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8CDQ9C0R,6-?9F1C-%\T-SED7S@P-SA?
M8S0U8V,U-#`U8C5A+U=O<FMS:&5E=',O4VAE970R-2YH=&UL#0I#;VYT96YT
M+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT
M+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL
M/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4
M>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R
M:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$
M;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-
M"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P
M140Q0TD^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O
M;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^3$E#14Y312!!3D0@0T]-
M34E4345.5%,@*$1E=&%I;',I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,R!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,3XQ($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$@36]N=&AS($5N9&5D/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/DUA<BX@,S$L(#(P,34\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y397`N(#,P+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/D1E8RX@,S$L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^1F5B+B`R."P@,C`Q-3QB<CX\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY,:6-E;G-E($%N9"!#;VUM:71M
M96YT<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^06-C<G5E9"!L:6%B:6QI=&EE<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`W,3<L.#0W/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`S,C<L.#0W/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y297-E
M87)C:"!A;F0@9&5V96QO<&UE;G0@97AP96YS93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,BPP,3$L,#,S/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S`R+#8V,CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17-T:6UA=&5D(&)E
M;F-H;6%R:R!P87EM96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,S8L,S`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^3W9A<FEA;B!#86YC97(@6TUE;6)E<ET\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY,:6-E;G-E($%N
M9"!#;VUM:71M96YT<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17-T:6UA=&5D(&)E;F-H;6%R:R!P
M87EM96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPP-3`L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y"<F5A<W0@0V%N8V5R(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3&EC96YS92!!;F0@0V]M;6ET;65N
M=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D5S=&EM871E9"!B96YC:&UA<FL@<&%Y;65N=',\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R+#$P,"PP,#`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;&]R
M96-T86P@0V%N8V5R(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^3&EC96YS92!!;F0@0V]M;6ET;65N=',@6TQI
M;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D5S=&EM871E9"!B96YC:&UA<FL@<&%Y;65N=',\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$R+#$P,"PP,#`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUE;&%N;VUA(%M-
M96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^3&EC96YS92!!;F0@0V]M;6ET;65N=',@6TQI;F4@271E;7-=/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5S=&EM871E
M9"!B96YC:&UA<FL@<&%Y;65N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C8L,#4P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^36]F9FET="!,:6-E;G-E($%G<F5E;65N=#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DQI8V5N
M<V4@06YD($-O;6UI=&UE;G1S(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0=7)C:&%S92!C;VUM:71M
M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0S,BPW.3<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E)E<V5A<F-H(&%N9"!D979E;&]P;65N="!E>'!E;G-E/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XS-3@L,3DY/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C4L,#`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-86YU9F%C='5R
M:6YG(%-E<G9I8V4@06=R965M96YT(%M-96UB97)=/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3&EC96YS92!!;F0@0V]M;6ET
M;65N=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E!U<F-H87-E(&-O;6UI=&UE;G0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C<S."PP,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E<V5A<F-H(&%N9"!D
M979E;&]P;65N="!E>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR.3@L,#<Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^.#DP+#8X-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^57!F<F]N="!L:6-E;G-E(&9E93PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`P+#`P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0W)A9&$@6TUE
M;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY,:6-E;G-E($%N9"!#;VUM:71M96YT<R!;3&EN92!)=&5M<UT\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06-C<G5E9"!L
M:6%B:6QI=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C4P
M+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4F5S96%R8V@@86YD(&1E=F5L;W!M96YT(&5X<&5N<V4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4T,2PV-C<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-3`L,#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3`P+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0W)A9&$@6TUE;6)E<ET@?"!097(@475A<G1E<B!;365M8F5R73PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DQI8V5N<V4@
M06YD($-O;6UI=&UE;G1S(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0=7)C:&%S92!C;VUM:71M96YT
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-3`L,#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#<F%D
M82!;365M8F5R72!\(%!E<B!996%R(%M-96UB97)=/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3&EC96YS92!!;F0@0V]M;6ET
M;65N=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E!U<F-H87-E(&-O;6UI=&UE;G0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,#`P+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3D-)(%M-96UB97)=
M('P@4&5R(%%U87)T97(@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY,:6-E;G-E($%N9"!#;VUM:71M96YT<R!;
M3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4'5R8VAA<V4@8V]M;6ET;65N=#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-3`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3D-)(%M-96UB97)=('P@4&5R(%EE
M87(@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY,:6-E;G-E($%N9"!#;VUM:71M96YT<R!;3&EN92!)=&5M<UT\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4'5R
M8VAA<V4@8V]M;6ET;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,BPP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,2PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.24@@6TUE;6)E<ET\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY,:6-E;G-E($%N9"!#
M;VUM:71M96YT<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4&5R8V5N=&%G92!O9B!R;WEA;'1Y(&]N
M('-A;&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV+C`P)3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4F5S96%R8V@@86YD(&1E=F5L;W!M96YT(&5X<&5N<V4\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C0P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^57!F<F]N="!L:6-E;G-E(&9E
M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`S-3`L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@
M(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B.3%F-#(Q
M8U]F9&,T7S0W.61?.#`W.%]C-#5C8S4T,#5B-6$-"D-O;G1E;G0M3&]C871I
M;VXZ(&9I;&4Z+R\O0SHO8CDQ9C0R,6-?9F1C-%\T-SED7S@P-SA?8S0U8V,U
M-#`U8C5A+U=O<FMS:&5E=',O4VAE970R-BYH=&UL#0I#;VYT96YT+51R86YS
M9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z
M('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\
M:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O
M;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y
M<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@
M4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O
M9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U(04<^
M#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X]
M,T0Q(')O=W-P86X],T0R/CQS=')O;F<^4U5"4T51545.5"!%5D5.5%,@*$1E
M=&%I;',I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,3XQ($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$U/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,30\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%Y(#$Q+"`R,#$U/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA>2`P-BP@,C`Q-3QB<CX\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=6)S
M97%U96YT($5V96YT(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]C965D<R!F<F]M('=A<G)A;G0@
M97AE<F-I<V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(L
M,S`T+#(U,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4VAA<F5S(&ES<W5E9"!D=7)I;F<@<&5R:6]D/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XY+#(P,"PP,#`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV+#`P,"PP,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=A
M<G)A;G0@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY3=6)S97%U96YT($5V96YT(%M,:6YE($ET96US73PO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0=7)C:&%S
M92!O9B!C;VUM;VX@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/CDR,2PW,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E-U8G-E<75E;G0@179E;G0@6TUE;6)E<ET\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=6)S97%U96YT
M($5V96YT(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y0<F]C965D<R!F<F]M('=A<G)A;G0@97AE<F-I
M<V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,Y-"PU,3`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E-H87)E<R!I<W-U960@9'5R:6YG('!E<FEO9#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-"PW-3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<FEC92!P97(@<VAA<F4\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,3`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-U8G-E<75E;G0@
M179E;G0@6TUE;6)E<ET@?"!787)R86YT(%M-96UB97)=/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W5B<V5Q=65N="!%=F5N
M="!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4'5R8VAA<V4@;V8@8V]M;6]N('-T;V-K/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-3<L.#`T/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO
M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B.3%F-#(Q8U]F9&,T7S0W.61?
M.#`W.%]C-#5C8S4T,#5B-6$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O
M0SHO8CDQ9C0R,6-?9F1C-%\T-SED7S@P-SA?8S0U8V,U-#`U8C5A+U=O<FMS
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M9CTS1")3:&5E=#`Q+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P
M,BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#,N:'1M;"(O/@T*
M(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`T+FAT;6PB+SX-"B`\;SI&:6QE($A2
M968],T0B4VAE970P-2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
M,#8N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`W+FAT;6PB+SX-
M"B`\;SI&:6QE($A2968],T0B4VAE970P."YH=&UL(B\^#0H@/&\Z1FEL92!(
M4F5F/3-$(E-H965T,#DN:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E
M=#$P+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q,2YH=&UL(B\^
M#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3(N:'1M;"(O/@T*(#QO.D9I;&4@
M2%)E9CTS1")3:&5E=#$S+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE
M970Q-"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,34N:'1M;"(O
M/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$V+FAT;6PB+SX-"B`\;SI&:6QE
M($A2968],T0B4VAE970Q-RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T,3@N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$Y+FAT;6PB
M+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R,"YH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T,C$N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3
M:&5E=#(R+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R,RYH=&UL
M(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,C0N:'1M;"(O/@T*(#QO.D9I
M;&4@2%)E9CTS1")3:&5E=#(U+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B
M4VAE970R-BYH=&UL(B\^#0H\+WAM;#X-"BTM+2TM+3U?3F5X=%!A<G1?8CDQ
E9C0R,6-?9F1C-%\T-SED7S@P-SA?8S0U8V,U-#`U8C5A+2T-"@``
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>GENERAL ORGANIZATION AND BUSINESS<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>GENERAL ORGANIZATION AND BUSINESS [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">GENERAL ORGANIZATION AND BUSINESS</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">
<p style="margin: 0pt; font-family: 'times new roman';"><br/></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b><font style="text-decoration: underline;">NOTE 1. GENERAL ORGANIZATION AND BUSINESS</font></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b><i>&#160;</i></b></p>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;">Lion Biotechnologies, Inc. (the &#147;Company,&#148; &#147;we,&#148; &#147;us&#148; or &#147;our&#148;) is an a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells. Our lead program is an adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors, for the treatment of metastatic melanoma. The TIL are then activated and expanded ex vivo and then infused back into the patient to fight their tumor cells. The Company was originally incorporated under the laws of the state of Nevada on September 17, 2007. Until March 2010, we were an inactive company known as Freight Management Corp. On March 15, 2010, we changed our name to Genesis Biopharma, Inc., and in 2011 we commenced our current business.</p>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;">&#160;</p>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;">On September 26, 2013, we amended and restated our Articles of Incorporation to, among other things, change our name to Lion Biotechnologies, Inc., effect a <font>1-for-100</font> reverse stock split (pro-rata reduction of outstanding shares) of our common stock. After the reverse stock split we increased the number of our authorized number of shares of common stock to <font>150,000,000</font> shares, in addition we authorized the issuance of <font>50,000,000</font> shares of &#147;blank check&#148; preferred stock, $<font>0.001</font> par value per share. References in these financial statements and related notes to numbers of shares of common stock, prices per share of common stock, and weighted average number of shares of common stock outstanding prior to the reverse stock splits have been adjusted to reflect the reverse stock splits for all periods presented, unless otherwise noted.</p>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;">&#160;</p>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"><b><i>Basis of Presentation of Unaudited Condensed Financial Information</i></b></p>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-indent: 0px; font-size-adjust: none; font-stretch: normal; background-color: white;"><b><i>&#160;</i></b></p>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal; background-color: white;">The unaudited condensed financial statements of the Company for the three months ended March 31, 2015 and 2014 have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Regulation S-K. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. However, such information reflects all adjustments (consisting solely of normal recurring adjustments), which are, in the opinion of management, necessary for the fair presentation of the financial position and the results of operations. Results shown for interim periods are not necessarily indicative of the results to be obtained for a full fiscal year. The balance sheet information as of December 31, 2014 was derived from the audited financial statements included in the Company's financial statements as of and for the year ended December 31, 2014 included in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission (the &#147;SEC&#148;) on March 16, 2015. These financial statements should be read in conjunction with that report.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><i>Liquidity</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">We are currently engaged in the development of therapeutics to fight cancer, we do not have any commercial products and have not yet generated any revenues from our biopharmaceutical business. We currently do not anticipate that we will generate any revenues during 2015 from the sale or licensing of any products. In addition, we have not generated any revenues from our prior business plans.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">We have not had any revenues and are still in the development stage. As shown in the accompanying condensed financial statements, we have incurred a net loss of $<font>5,298,059</font> for the three months ended March 31, 2015 and used $<font>3,458,649</font>&#160;of cash in our operating activities during the three months ended March 31, 2015. As of March 31, 2015, we had $<font>111,280,443</font> of cash or cash equivalents on hand, stockholders' equity of $<font>111,626,869</font> and had working capital of $<font>109,498,609</font>.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">During 2015, we expect to further ramp up our operations, which will increase the amount of cash we will use in our operations. Our budget for 2015 includes increased spending on research and development activities, higher payroll expenses as we increase our professional staff, the costs associated with operating our new Tampa, Florida, research facility, as well as ongoing payments under the Cooperative Research and Development Agreement (CRADA) we have entered into with the National Cancer Institute (NCI). Based on the funds we had available on March 31, 2015, we believe that we have sufficient capital to fund our anticipated operating expenses for at least 24 months.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">On March 3, 2015, the Company sold <font>9,200,000</font> shares of its common stock in an underwritten public offering at $<font>8.00</font> per share for net proceeds of $<font>68.3</font> million, after deducting expenses of the offering. On December 22, 2014, the Company sold <font>6,000,000</font> shares of its common stock in an underwritten public offering at $<font>5.75</font> per share for net proceeds of $<font>32.2</font> million after deducting expenses of the offering. On November 5, 2013, we completed a $<font>23.3</font> million private placement of our securities to various institutional and individual accredited investors. Despite the amount of funds that we have raised, the estimated cost of completing the development of our TIL-based therapy, and of obtaining all required regulatory approvals to market those product candidates, may be substantially greater than the amount of funds we have available. Therefore, while we believe that our existing cash balances will be sufficient to fund our currently planned level of operations for at least 24 months, we will have to obtain additional funds in the future to complete our development plans. We intend to seek this additional funding through various financing sources, including possible sales of our securities, and in the longer term through strategic alliances with other pharmaceutical or biopharmaceutical companies.</p>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EPUAE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Condensed Balance Sheets (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
        <td class="nump"><a title="us-gaap_CashAndCashEquivalentsAtCarryingValue" onclick="toggleNextSibling(this);">$ 111,280,443</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CashAndCashEquivalentsAtCarryingValue</span><span></span></td>
        <td class="nump"><a title="us-gaap_CashAndCashEquivalentsAtCarryingValue" onclick="toggleNextSibling(this);">$ 44,909,147</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CashAndCashEquivalentsAtCarryingValue</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and deposits</a></td>
        <td class="nump"><a title="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" onclick="toggleNextSibling(this);">128,883</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</span><span></span></td>
        <td class="nump"><a title="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" onclick="toggleNextSibling(this);">66,134</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</span><span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
        <td class="nump"><a title="us-gaap_AssetsCurrent" onclick="toggleNextSibling(this);">111,409,326</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AssetsCurrent</span><span></span></td>
        <td class="nump"><a title="us-gaap_AssetsCurrent" onclick="toggleNextSibling(this);">44,975,281</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AssetsCurrent</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation of $289,672 and $104,223</a></td>
        <td class="nump"><a title="us-gaap_PropertyPlantAndEquipmentNet" onclick="toggleNextSibling(this);">2,128,260</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PropertyPlantAndEquipmentNet</span><span></span></td>
        <td class="nump"><a title="us-gaap_PropertyPlantAndEquipmentNet" onclick="toggleNextSibling(this);">1,531,566</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PropertyPlantAndEquipmentNet</span><span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
        <td class="nump"><a title="us-gaap_Assets" onclick="toggleNextSibling(this);">113,537,586</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_Assets</span><span></span></td>
        <td class="nump"><a title="us-gaap_Assets" onclick="toggleNextSibling(this);">46,506,847</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_Assets</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
        <td class="nump"><a title="us-gaap_AccountsPayableCurrent" onclick="toggleNextSibling(this);">1,107,370</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AccountsPayableCurrent</span><span></span></td>
        <td class="nump"><a title="us-gaap_AccountsPayableCurrent" onclick="toggleNextSibling(this);">1,248,413</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AccountsPayableCurrent</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
        <td class="nump"><a title="us-gaap_AccruedLiabilitiesCurrent" onclick="toggleNextSibling(this);">717,847</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AccruedLiabilitiesCurrent</span><span></span></td>
        <td class="nump"><a title="us-gaap_AccruedLiabilitiesCurrent" onclick="toggleNextSibling(this);">327,847</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AccruedLiabilitiesCurrent</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Accrued payable to officers and former directors</a></td>
        <td class="nump"><a title="us-gaap_AccountsPayableRelatedPartiesCurrent" onclick="toggleNextSibling(this);">85,500</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AccountsPayableRelatedPartiesCurrent</span><span></span></td>
        <td class="nump"><a title="us-gaap_AccountsPayableRelatedPartiesCurrent" onclick="toggleNextSibling(this);">85,500</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AccountsPayableRelatedPartiesCurrent</span><span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
        <td class="nump"><a title="us-gaap_LiabilitiesCurrent" onclick="toggleNextSibling(this);">1,910,717</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LiabilitiesCurrent</span><span></span></td>
        <td class="nump"><a title="us-gaap_LiabilitiesCurrent" onclick="toggleNextSibling(this);">1,661,760</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LiabilitiesCurrent</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 50,000,000 shares authorized, 3,694 shares and 5,694 shares issued and outstanding, respectively</a></td>
        <td class="nump"><a title="us-gaap_PreferredStockValue" onclick="toggleNextSibling(this);">4</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PreferredStockValue</span><span></span></td>
        <td class="nump"><a title="us-gaap_PreferredStockValue" onclick="toggleNextSibling(this);">6</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PreferredStockValue</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.000041666 par value; 150,000,000 shares authorized, 44,871,888 and 33,750,188 shares issued and outstanding, respectively</a></td>
        <td class="nump"><a title="us-gaap_CommonStockValue" onclick="toggleNextSibling(this);">1,870</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockValue</span><span></span></td>
        <td class="nump"><a title="us-gaap_CommonStockValue" onclick="toggleNextSibling(this);">1,407</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockValue</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lbio_CommonStockToBeIssuedValue', window );">Common stock to be issued, 303,125 shares</a></td>
        <td class="nump"><a title="lbio_CommonStockToBeIssuedValue" onclick="toggleNextSibling(this);">245,153</a><span style="display:none;white-space:normal;text-align:left;">lbio_CommonStockToBeIssuedValue</span><span></span></td>
        <td class="nump"><a title="lbio_CommonStockToBeIssuedValue" onclick="toggleNextSibling(this);">245,153</a><span style="display:none;white-space:normal;text-align:left;">lbio_CommonStockToBeIssuedValue</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
        <td class="nump"><a title="us-gaap_AdditionalPaidInCapital" onclick="toggleNextSibling(this);">193,239,795</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AdditionalPaidInCapital</span><span></span></td>
        <td class="nump"><a title="us-gaap_AdditionalPaidInCapital" onclick="toggleNextSibling(this);">121,160,415</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AdditionalPaidInCapital</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
        <td class="num"><a title="us-gaap_RetainedEarningsAccumulatedDeficit" onclick="toggleNextSibling(this);">(81,859,953)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_RetainedEarningsAccumulatedDeficit</span><span></span></td>
        <td class="num"><a title="us-gaap_RetainedEarningsAccumulatedDeficit" onclick="toggleNextSibling(this);">(76,561,894)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_RetainedEarningsAccumulatedDeficit</span><span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' Equity</a></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity" onclick="toggleNextSibling(this);">111,626,869</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity</span><span></span></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity" onclick="toggleNextSibling(this);">44,845,087</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity</span><span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Equity</a></td>
        <td class="nump"><a title="us-gaap_LiabilitiesAndStockholdersEquity" onclick="toggleNextSibling(this);">$ 113,537,586</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LiabilitiesAndStockholdersEquity</span><span></span></td>
        <td class="nump"><a title="us-gaap_LiabilitiesAndStockholdersEquity" onclick="toggleNextSibling(this);">$ 46,506,847</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LiabilitiesAndStockholdersEquity</span><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lbio_CommonStockToBeIssuedValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of common stock to be issued as of balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">lbio_CommonStockToBeIssuedValue</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>lbio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(k)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 08<br><br><br><br> -Paragraph k<br><br><br><br> -Subparagraph 1<br><br><br><br> -Article 4<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 12<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 18<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_Assets</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 450<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.25)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-03.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-03.(a),19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.32)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 32<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 21<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.31(a)(3))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30, 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EJDBG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Condensed Statements of Stockholders' Equity (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Total</div>
        </th>
        <th class="th">
          <div>Preferred Stock [Member]</div>
        </th>
        <th class="th">
          <div>Common Stock [Member]</div>
        </th>
        <th class="th">
          <div>Common Stock To Be Issued [Member]</div>
        </th>
        <th class="th">
          <div>Additional Paid-In Capital [Member]</div>
        </th>
        <th class="th">
          <div>Accumulated Deficit [Member]</div>
        </th>
      </tr>
      <tr class="rc">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2014</a></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity" onclick="toggleNextSibling(this);">$ 44,845,087</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity</span><span></span></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity[us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember]" onclick="toggleNextSibling(this);">$ 6</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_PreferredStockMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity[us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember]" onclick="toggleNextSibling(this);">$ 1,407</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_CommonStockMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity[us-gaap_StatementEquityComponentsAxis=lbio_CommonStockToBeIssuedMember]" onclick="toggleNextSibling(this);">$ 245,153</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity<br>/ us-gaap_StatementEquityComponentsAxis<br>= lbio_CommonStockToBeIssuedMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity[us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember]" onclick="toggleNextSibling(this);">$ 121,160,415</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_AdditionalPaidInCapitalMember</span><span></span></td>
        <td class="num"><a title="us-gaap_StockholdersEquity[us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember]" onclick="toggleNextSibling(this);">$ (76,561,894)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_RetainedEarningsMember</span><span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2014</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_SharesOutstanding[us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember]" onclick="toggleNextSibling(this);">5,694</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharesOutstanding<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_PreferredStockMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_SharesOutstanding[us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember]" onclick="toggleNextSibling(this);">33,750,188</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharesOutstanding<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_CommonStockMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket', window );">Fair value of vested stock options</a></td>
        <td class="nump"><a title="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" onclick="toggleNextSibling(this);">1,017,308</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket[us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember]" onclick="toggleNextSibling(this);">1,017,308</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_AdditionalPaidInCapitalMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lbio_CommonStockIssuedUponExerciseOfWarrantsAmount', window );">Common stock issued upon exercise of warrants</a></td>
        <td class="nump"><a title="lbio_CommonStockIssuedUponExerciseOfWarrantsAmount" onclick="toggleNextSibling(this);">2,304,250</a><span style="display:none;white-space:normal;text-align:left;">lbio_CommonStockIssuedUponExerciseOfWarrantsAmount</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="lbio_CommonStockIssuedUponExerciseOfWarrantsAmount[us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember]" onclick="toggleNextSibling(this);">38</a><span style="display:none;white-space:normal;text-align:left;">lbio_CommonStockIssuedUponExerciseOfWarrantsAmount<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_CommonStockMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="lbio_CommonStockIssuedUponExerciseOfWarrantsAmount[us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember]" onclick="toggleNextSibling(this);">2,304,212</a><span style="display:none;white-space:normal;text-align:left;">lbio_CommonStockIssuedUponExerciseOfWarrantsAmount<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_AdditionalPaidInCapitalMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lbio_CommonStockIssuedUponExerciseOfWarrantsShares', window );">Common stock issued upon exercise of warrants (in shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="lbio_CommonStockIssuedUponExerciseOfWarrantsShares[us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember]" onclick="toggleNextSibling(this);">921,700</a><span style="display:none;white-space:normal;text-align:left;">lbio_CommonStockIssuedUponExerciseOfWarrantsShares<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_CommonStockMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Common stock issued upon conversion of preferred shares</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num"><a title="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities[us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember]" onclick="toggleNextSibling(this);">(2)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_PreferredStockMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities[us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember]" onclick="toggleNextSibling(this);">42</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_CommonStockMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num"><a title="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities[us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember]" onclick="toggleNextSibling(this);">(40)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_AdditionalPaidInCapitalMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Common stock issued upon conversion of preferred shares (in shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num"><a title="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities[us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember]" onclick="toggleNextSibling(this);">(2,000)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_PreferredStockMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities[us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember]" onclick="toggleNextSibling(this);">1,000,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_CommonStockMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Common stock sold in private placement, net of offering costs</a></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodValueOther" onclick="toggleNextSibling(this);">68,307,838</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodValueOther</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodValueOther[us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember]" onclick="toggleNextSibling(this);">383</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodValueOther<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_CommonStockMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodValueOther[us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember]" onclick="toggleNextSibling(this);">68,307,455</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodValueOther<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_AdditionalPaidInCapitalMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Common stock sold in private placement, net of offering costs (in shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodSharesOther[us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember]" onclick="toggleNextSibling(this);">9,200,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodSharesOther<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_CommonStockMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Vesting of restricted shares issued for services</a></td>
        <td class="nump"><a title="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" onclick="toggleNextSibling(this);">450,445</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition[us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember]" onclick="toggleNextSibling(this);">450,445</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_AdditionalPaidInCapitalMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num"><a title="us-gaap_NetIncomeLoss" onclick="toggleNextSibling(this);">(5,298,059)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetIncomeLoss</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num"><a title="us-gaap_NetIncomeLoss[us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember]" onclick="toggleNextSibling(this);">(5,298,059)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetIncomeLoss<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_RetainedEarningsMember</span><span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2015</a></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity" onclick="toggleNextSibling(this);">$ 111,626,869</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity</span><span></span></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity[us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember]" onclick="toggleNextSibling(this);">$ 4</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_PreferredStockMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity[us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember]" onclick="toggleNextSibling(this);">$ 1,870</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_CommonStockMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity[us-gaap_StatementEquityComponentsAxis=lbio_CommonStockToBeIssuedMember]" onclick="toggleNextSibling(this);">$ 245,153</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity<br>/ us-gaap_StatementEquityComponentsAxis<br>= lbio_CommonStockToBeIssuedMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity[us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember]" onclick="toggleNextSibling(this);">$ 193,239,795</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_AdditionalPaidInCapitalMember</span><span></span></td>
        <td class="num"><a title="us-gaap_StockholdersEquity[us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember]" onclick="toggleNextSibling(this);">$ (81,859,953)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_RetainedEarningsMember</span><span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Mar. 31, 2015</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_SharesOutstanding[us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember]" onclick="toggleNextSibling(this);">3,694</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharesOutstanding<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_PreferredStockMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_SharesOutstanding[us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember]" onclick="toggleNextSibling(this);">44,871,888</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharesOutstanding<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_CommonStockMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lbio_CommonStockIssuedUponExerciseOfWarrantsAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of exchange transaction inducement costs capitalized during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">lbio_CommonStockIssuedUponExerciseOfWarrantsAmount</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>lbio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lbio_CommonStockIssuedUponExerciseOfWarrantsShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued upon exercise of warrant.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">lbio_CommonStockIssuedUponExerciseOfWarrantsShares</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>lbio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase (decrease) to additional paid in capital (APIC) resulting from changes in fair value of common and preferred stock issued to employee benefit trust but unearned.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 31<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of equity-based compensation, related to restricted stock units or restricted stock awards, recognized as expense or an asset, if compensation is capitalized.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued which are neither cancelled nor held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued during the period as a result of the conversion of convertible securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-30)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The gross value of stock issued during the period upon the conversion of convertible securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EKZAI">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCK OPTIONS AND WARRANTS (Narrative) (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 29, 2010</div>
        </th>
        <th class="th">
          <div>Apr. 10, 2015</div>
        </th>
        <th class="th">
          <div>Nov. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
        <td class="nump"><a title="us-gaap_AllocatedShareBasedCompensationExpense" onclick="toggleNextSibling(this);">$ 1,017,308</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AllocatedShareBasedCompensationExpense</span><span></span></td>
        <td class="nump"><a title="us-gaap_AllocatedShareBasedCompensationExpense" onclick="toggleNextSibling(this);">$ 901,650</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AllocatedShareBasedCompensationExpense</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
        <td class="nump"><a title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" onclick="toggleNextSibling(this);">8,665,475</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from warrant exercises</a></td>
        <td class="nump"><a title="us-gaap_ProceedsFromWarrantExercises" onclick="toggleNextSibling(this);">2,304,250</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProceedsFromWarrantExercises</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Purchase of common stock</a></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised[us-gaap_AwardTypeAxis=us-gaap_WarrantMember]" onclick="toggleNextSibling(this);">921,700</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_WarrantMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lbio_PlanOneMember', window );">2010 Plan [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized[us-gaap_PlanNameAxis=lbio_PlanOneMember]" onclick="toggleNextSibling(this);">35,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized<br>/ us-gaap_PlanNameAxis<br>= lbio_PlanOneMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lbio_PlanTwoMember', window );">2014 Plan [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized[us-gaap_PlanNameAxis=lbio_PlanTwoMember]" onclick="toggleNextSibling(this);">4,000,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized<br>/ us-gaap_PlanNameAxis<br>= lbio_PlanTwoMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized[us-gaap_PlanNameAxis=lbio_PlanTwoMember]" onclick="toggleNextSibling(this);">2,350,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized<br>/ us-gaap_PlanNameAxis<br>= lbio_PlanTwoMember</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of additional shares authorized</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized[us-gaap_PlanNameAxis=lbio_PlanTwoMember]" onclick="toggleNextSibling(this);">1,650,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized<br>/ us-gaap_PlanNameAxis<br>= lbio_PlanTwoMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, period for recognition</a></td>
        <td class="text">9 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, period for recognition</a></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_DirectorMember', window );">Director [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross[us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_DirectorMember]" onclick="toggleNextSibling(this);">50,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross<br>/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis<br>= us-gaap_DirectorMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted, exercise price</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice[us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_DirectorMember]" onclick="toggleNextSibling(this);">$ 7.45</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice<br>/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis<br>= us-gaap_DirectorMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair value of options</a></td>
        <td class="nump"><a title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1[us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_DirectorMember]" onclick="toggleNextSibling(this);">$ 369,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1<br>/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis<br>= us-gaap_DirectorMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate[us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_DirectorMember]" onclick="toggleNextSibling(this);">213.00%</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate<br>/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis<br>= us-gaap_DirectorMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Discount rate</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate[us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_DirectorMember]" onclick="toggleNextSibling(this);">1.37%</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate<br>/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis<br>= us-gaap_DirectorMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate[us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_DirectorMember]" onclick="toggleNextSibling(this);">0.00%</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate<br>/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis<br>= us-gaap_DirectorMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
        <td class="text">6 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_DirectorMember', window );">Director [Member] | Vesting First [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross[us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_DirectorMember;us-gaap_VestingAxis=lbio_VestingFirstMember]" onclick="toggleNextSibling(this);">12,500</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross<br>/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis<br>= us-gaap_DirectorMember<br>/ us-gaap_VestingAxis<br>= lbio_VestingFirstMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.F)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section F<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Unrecognized cost of unvested share-based compensation awards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.D.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section D<br><br> -Subsection 2<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(iv)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of additional shares authorized for issuance under an established share-based compensation plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross number of share options (or share units) granted during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of share options (or share units) exercised during the current period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_WarrantMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lbio_PlanOneMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_PlanNameAxis=lbio_PlanOneMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lbio_PlanTwoMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_PlanNameAxis=lbio_PlanTwoMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_DirectorMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_DirectorMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EVZAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCK OPTIONS AND WARRANTS (Schedule of Status of Stock Warrants) (Details) (Warrant [Member], USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2014</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top">
          <div class="a">Warrant [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares Under Warrants</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding beginning balance</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber[us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember]" onclick="toggleNextSibling(this);">11,084,426</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_WarrantMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Issued</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
        <td class="num"><a title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised[us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember]" onclick="toggleNextSibling(this);">(921,700)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_WarrantMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding ending balance</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber[us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember]" onclick="toggleNextSibling(this);">10,162,726</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_WarrantMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber[us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember]" onclick="toggleNextSibling(this);">11,084,426</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_WarrantMember</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable ending balance</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber[us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember]" onclick="toggleNextSibling(this);">10,162,726</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_WarrantMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Exercise Price</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding beginning balance</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice[us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember]" onclick="toggleNextSibling(this);">$ 2.51</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_WarrantMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice[us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember]" onclick="toggleNextSibling(this);">$ 2.50</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_WarrantMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding ending balance</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice[us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember]" onclick="toggleNextSibling(this);">$ 2.51</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_WarrantMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice[us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember]" onclick="toggleNextSibling(this);">$ 2.51</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_WarrantMember</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable ending balance</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice[us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember]" onclick="toggleNextSibling(this);">$ 2.51</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_WarrantMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract', window );"><strong>Weighted Average Remaining Contractual Life</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding</a></td>
        <td class="text">3 years 6 months 29 days<span></span></td>
        <td class="text">3 years 10 months 6 days<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable ending balance</a></td>
        <td class="text">3 years 6 months 29 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lbio_AggregateIntrinsicValueAbstract1Abstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Outstanding beginning balance</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue[us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember]" onclick="toggleNextSibling(this);">$ 59,517,998</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_WarrantMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Outstanding ending balance</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue[us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember]" onclick="toggleNextSibling(this);">$ 97,654,187</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_WarrantMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue[us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember]" onclick="toggleNextSibling(this);">$ 59,517,998</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_WarrantMember</span><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lbio_AggregateIntrinsicValueAbstract1Abstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">lbio_AggregateIntrinsicValueAbstract1Abstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>lbio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>lbio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross number of share options (or share units) granted during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of options outstanding, including both vested and non-vested options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount by which the current fair value of the underlying stock exceeds the exercise price of fully vested and expected to vest options outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of share options (or share units) exercised during the current period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0ERYAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Condensed Statements of Cash Flows (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash Flows From Operating Activities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num"><a title="us-gaap_NetIncomeLoss" onclick="toggleNextSibling(this);">$ (5,298,059)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetIncomeLoss</span><span></span></td>
        <td class="num"><a title="us-gaap_NetIncomeLoss" onclick="toggleNextSibling(this);">$ (2,259,514)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetIncomeLoss</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
        <td class="nump"><a title="us-gaap_DepreciationAndAmortization" onclick="toggleNextSibling(this);">185,449</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_DepreciationAndAmortization</span><span></span></td>
        <td class="nump"><a title="us-gaap_DepreciationAndAmortization" onclick="toggleNextSibling(this);">16,565</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_DepreciationAndAmortization</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Fair value of vested stock options</a></td>
        <td class="nump"><a title="us-gaap_StockOptionPlanExpense" onclick="toggleNextSibling(this);">1,017,308</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockOptionPlanExpense</span><span></span></td>
        <td class="nump"><a title="us-gaap_StockOptionPlanExpense" onclick="toggleNextSibling(this);">901,650</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockOptionPlanExpense</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lbio_FairValueOfVestedWarrantsGrantedForServices', window );">Vesting of restricted shares issued for services</a></td>
        <td class="nump"><a title="lbio_FairValueOfVestedWarrantsGrantedForServices" onclick="toggleNextSibling(this);">450,445</a><span style="display:none;white-space:normal;text-align:left;">lbio_FairValueOfVestedWarrantsGrantedForServices</span><span></span></td>
        <td class="nump"><a title="lbio_FairValueOfVestedWarrantsGrantedForServices" onclick="toggleNextSibling(this);">17,700</a><span style="display:none;white-space:normal;text-align:left;">lbio_FairValueOfVestedWarrantsGrantedForServices</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and deposits</a></td>
        <td class="num"><a title="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" onclick="toggleNextSibling(this);">(62,749)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</span><span></span></td>
        <td class="nump"><a title="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" onclick="toggleNextSibling(this);">49,625</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
        <td class="nump"><a title="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" onclick="toggleNextSibling(this);">248,957</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</span><span></span></td>
        <td class="num"><a title="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" onclick="toggleNextSibling(this);">(993,389)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</span><span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net Cash Used In Operating Activities</a></td>
        <td class="num"><a title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" onclick="toggleNextSibling(this);">(3,458,649)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</span><span></span></td>
        <td class="num"><a title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" onclick="toggleNextSibling(this);">(2,267,363)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash Flows From Investing Activities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
        <td class="num"><a title="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" onclick="toggleNextSibling(this);">(782,143)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</span><span></span></td>
        <td class="num"><a title="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" onclick="toggleNextSibling(this);">(3,437)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash Flows From Financing Activities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants', window );">Proceeds from issuance of common stock upon conversion of warrants</a></td>
        <td class="nump"><a title="lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" onclick="toggleNextSibling(this);">2,304,250</a><span style="display:none;white-space:normal;text-align:left;">lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants</span><span></span></td>
        <td class="nump"><a title="lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants" onclick="toggleNextSibling(this);">542,500</a><span style="display:none;white-space:normal;text-align:left;">lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from the issuance of common stock, net</a></td>
        <td class="nump"><a title="us-gaap_ProceedsFromIssuanceOfCommonStock" onclick="toggleNextSibling(this);">68,307,838</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProceedsFromIssuanceOfCommonStock</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations', window );">Net Cash Provided By Financing Activities</a></td>
        <td class="nump"><a title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" onclick="toggleNextSibling(this);">70,612,088</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations</span><span></span></td>
        <td class="nump"><a title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" onclick="toggleNextSibling(this);">542,500</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations</span><span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net Increase (Decrease) In Cash And Cash Equivalents</a></td>
        <td class="nump"><a title="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" onclick="toggleNextSibling(this);">66,371,296</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</span><span></span></td>
        <td class="num"><a title="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" onclick="toggleNextSibling(this);">(1,728,300)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents, Beginning of Period</a></td>
        <td class="nump"><a title="us-gaap_CashAndCashEquivalentsAtCarryingValue" onclick="toggleNextSibling(this);">44,909,147</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CashAndCashEquivalentsAtCarryingValue</span><span></span></td>
        <td class="nump"><a title="us-gaap_CashAndCashEquivalentsAtCarryingValue" onclick="toggleNextSibling(this);">19,672,177</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CashAndCashEquivalentsAtCarryingValue</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents, End of Period</a></td>
        <td class="nump"><a title="us-gaap_CashAndCashEquivalentsAtCarryingValue" onclick="toggleNextSibling(this);">111,280,443</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CashAndCashEquivalentsAtCarryingValue</span><span></span></td>
        <td class="nump"><a title="us-gaap_CashAndCashEquivalentsAtCarryingValue" onclick="toggleNextSibling(this);">17,943,877</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CashAndCashEquivalentsAtCarryingValue</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Disclosures of Cash Flow Information:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income Taxes</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lbio_FairValueOfVestedWarrantsGrantedForServices">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>No authoritative reference available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">lbio_FairValueOfVestedWarrantsGrantedForServices</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>lbio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the cash inflow from the issuance of common stock upon conversion of warrants during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">lbio_ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>lbio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 830<br><br><br><br> -SubTopic 230<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450594&amp;loc=d3e33268-110906<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 25<br><br><br><br> -Subparagraph (f)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of cash paid for interest during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 25<br><br><br><br> -Subparagraph (e)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_InterestPaid</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 26<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3574-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 25<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Investing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3213-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Financing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The noncash expense that accounts for the value of stock or unit options distributed to employees as compensation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EUCAE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Condensed Balance Sheets (Parenthetical) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Condensed Balance Sheets [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property and equipment, accumulated depreciation</a></td>
        <td class="nump"><a title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" onclick="toggleNextSibling(this);">$ 289,672</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</span><span></span></td>
        <td class="nump"><a title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" onclick="toggleNextSibling(this);">$ 104,223</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
        <td class="nump"><a title="us-gaap_PreferredStockParOrStatedValuePerShare" onclick="toggleNextSibling(this);">$ 0.001</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PreferredStockParOrStatedValuePerShare</span><span></span></td>
        <td class="nump"><a title="us-gaap_PreferredStockParOrStatedValuePerShare" onclick="toggleNextSibling(this);">$ 0.001</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PreferredStockParOrStatedValuePerShare</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
        <td class="nump"><a title="us-gaap_PreferredStockSharesAuthorized" onclick="toggleNextSibling(this);">50,000,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PreferredStockSharesAuthorized</span><span></span></td>
        <td class="nump"><a title="us-gaap_PreferredStockSharesAuthorized" onclick="toggleNextSibling(this);">50,000,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PreferredStockSharesAuthorized</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
        <td class="nump"><a title="us-gaap_PreferredStockSharesIssued" onclick="toggleNextSibling(this);">3,694</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PreferredStockSharesIssued</span><span></span></td>
        <td class="nump"><a title="us-gaap_PreferredStockSharesIssued" onclick="toggleNextSibling(this);">5,694</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PreferredStockSharesIssued</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
        <td class="nump"><a title="us-gaap_PreferredStockSharesOutstanding" onclick="toggleNextSibling(this);">3,694</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PreferredStockSharesOutstanding</span><span></span></td>
        <td class="nump"><a title="us-gaap_PreferredStockSharesOutstanding" onclick="toggleNextSibling(this);">5,694</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PreferredStockSharesOutstanding</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
        <td class="nump"><a title="us-gaap_CommonStockParOrStatedValuePerShare" onclick="toggleNextSibling(this);">$ 0.000041666</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockParOrStatedValuePerShare</span><span></span></td>
        <td class="nump"><a title="us-gaap_CommonStockParOrStatedValuePerShare" onclick="toggleNextSibling(this);">$ 0.000041666</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockParOrStatedValuePerShare</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
        <td class="nump"><a title="us-gaap_CommonStockSharesAuthorized" onclick="toggleNextSibling(this);">150,000,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockSharesAuthorized</span><span></span></td>
        <td class="nump"><a title="us-gaap_CommonStockSharesAuthorized" onclick="toggleNextSibling(this);">150,000,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockSharesAuthorized</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
        <td class="nump"><a title="us-gaap_CommonStockSharesIssued" onclick="toggleNextSibling(this);">44,871,888</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockSharesIssued</span><span></span></td>
        <td class="nump"><a title="us-gaap_CommonStockSharesIssued" onclick="toggleNextSibling(this);">33,750,188</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockSharesIssued</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
        <td class="nump"><a title="us-gaap_CommonStockSharesOutstanding" onclick="toggleNextSibling(this);">44,871,888</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockSharesOutstanding</span><span></span></td>
        <td class="nump"><a title="us-gaap_CommonStockSharesOutstanding" onclick="toggleNextSibling(this);">33,750,188</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockSharesOutstanding</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lbio_CommonStockToBeIssuedShares', window );">Common stock to be issued shares</a></td>
        <td class="nump"><a title="lbio_CommonStockToBeIssuedShares" onclick="toggleNextSibling(this);">303,125</a><span style="display:none;white-space:normal;text-align:left;">lbio_CommonStockToBeIssuedShares</span><span></span></td>
        <td class="nump"><a title="lbio_CommonStockToBeIssuedShares" onclick="toggleNextSibling(this);">303,125</a><span style="display:none;white-space:normal;text-align:left;">lbio_CommonStockToBeIssuedShares</span><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lbio_CommonStockToBeIssuedShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of common stock to be issued.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">lbio_CommonStockToBeIssuedShares</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>lbio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.14)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 14<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0E2F">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCK OPTIONS AND WARRANTS (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>STOCK OPTIONS AND WARRANTS [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Status of Stock Options</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 100%;">

<tr style="vertical-align: bottom;">
<td style="font-family: 'Times New Roman';" nowrap="nowrap"></td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap"></td>
<td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"></td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap"></td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap"></td>
<td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"></td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap"></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td colspan="13" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><br/></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td>
<td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap">&#160;</td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td>
</tr>
<tr style="vertical-align: bottom;">
<td style="font-family: 'Times New Roman';" nowrap="nowrap"></td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap"></td>
<td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"></td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap"></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Weighted</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Weighted Average</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td>
<td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap">&#160;</td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td>
</tr>
<tr style="vertical-align: bottom;">
<td style="font-family: 'Times New Roman';" nowrap="nowrap"></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Shares</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Average</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Remaining</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Aggregate</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="font-family: 'Times New Roman';" nowrap="nowrap"></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Under</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Exercise</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Contractual</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Intrinsic</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><strong>Option</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><strong>Price</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><strong>Life</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><strong>Value</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="2">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="2">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="2">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="2">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: #cceeff;">
<td style="font-family: 'times new roman'; padding: 0px;" width="100%">Outstanding at January 1, 2015</td>
<td style="font-family: 'times new roman'; padding: 0px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>1,857,877</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>7.31</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap;"><font>8.5</font> years</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>2,874,378</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="font-family: 'Times New Roman';" width="100%">Granted</td>
<td style="font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>50,000</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>7.45</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap;"><font>10</font> years</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>233,000</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: #cceeff;">
<td style="font-family: 'Times New Roman';" width="100%">Exercised</td>
<td style="font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>-</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="font-family: 'times new roman'; padding: 0px;" width="100%">Expired/Forfeited</td>
<td style="font-family: 'times new roman'; padding: 0px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>-</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 1pt solid !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: #cceeff;">
<td style="font-family: 'times new roman'; padding: 0px;" width="100%">Outstanding at March 31, 2015</td>
<td style="font-family: 'times new roman'; padding: 0px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>1,907,877</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 2.80pt double !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td>
<td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>7.47</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 2.80pt double !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>8.25</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 1pt solid !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td>
<td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>10,687,637</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 1pt solid !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="font-family: 'times new roman'; padding: 0px;" width="100%">Exercisable at March 31, 2015</td>
<td style="font-family: 'times new roman'; padding: 0px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>405,412</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 2.80pt double !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td>
<td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>10.48</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 2.80pt double !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>4,708,718</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
</tr>

</table>
</div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Status of Stock Warrants</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 100%;">

<tr style="vertical-align: bottom;">
<td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"></td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"></td>
<td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center">&#160;</td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap" colspan="3" align="center"></td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"></td>
<td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center">&#160;</td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap" colspan="3" align="center"></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><strong>&#160;</strong></td>
<td nowrap="nowrap" colspan="15" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt;"><br/></td>
<td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center">&#160;</td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap" colspan="3" align="center">&#160;</td>
</tr>
<tr style="vertical-align: bottom;">
<td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"></td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"></td>
<td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center">&#160;</td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap" colspan="3" align="center"></td>
<td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"><strong>&#160;</strong></td>
<td colspan="3" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Weighted</strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><strong>&#160;</strong></td>
<td nowrap="nowrap" colspan="3" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt;"><strong>Weighted Average</strong></td>
<td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center">&#160;</td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap" colspan="3" align="center">&#160;</td>
</tr>
<tr style="vertical-align: bottom;">
<td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"></td>
<td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"><strong>&#160;</strong></td>
<td colspan="4" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Shares</strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Average</strong></td>
<td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><strong>&#160;</strong></td>
<td nowrap="nowrap" colspan="3" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt;"><strong>Remaining</strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"><strong>&#160;</strong></td>
<td colspan="3" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Aggregate</strong></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"></td>
<td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"><strong>&#160;</strong></td>
<td colspan="4" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Under</strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Exercise</strong></td>
<td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><strong>&#160;</strong></td>
<td nowrap="nowrap" colspan="3" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt;"><strong>Contractual</strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"><strong>&#160;</strong></td>
<td colspan="3" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Intrinsic</strong></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center">&#160;</td>
<td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"><strong>&#160;</strong></td>
<td colspan="4" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><strong>Warrants</strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><strong>Price</strong></td>
<td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><strong>&#160;</strong></td>
<td nowrap="nowrap" colspan="3" align="center" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; font-size: 10.0pt;"><strong>Life</strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"><strong>&#160;</strong></td>
<td colspan="3" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><strong>Value</strong></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="vertical-align: top; text-align: left;"></td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" align="center">&#160;</td>
<td style="vertical-align: top; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="3" align="center">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" align="center">&#160;</td>
<td style="vertical-align: top; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="3" align="center">&#160;</td>
<td style="vertical-align: top; text-align: left; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';" align="center">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="3" align="center">&#160;</td>
<td style="vertical-align: top; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="3" align="center">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: #cceeff;">
<td style="font-family: 'times new roman'; padding: 0px;" width="100%">Outstanding at December 31, 2014</td>
<td style="font-family: 'times new roman'; padding: 0px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>11,084,426</font></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left">$</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>2.51</font></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>3.85</font> years</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left">$</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>59,517,998</font></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-indent: 10pt; font-family: 'times new roman'; padding: 0px;" width="100%">Issued</td>
<td style="font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>-</font></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
</tr>
<tr style="vertical-align: bottom; background-color: #cceeff;">
<td style="text-indent: 10pt; font-family: 'times new roman'; padding: 0px;" width="100%">Exercised</td>
<td style="font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>(921,700</font></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left">)</td>
<td style="font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left">$</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>2.50</font></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-indent: 10pt; font-family: 'times new roman'; padding: 0px;" width="100%">Expired</td>
<td style="font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>-</font></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
</tr>
<tr style="vertical-align: bottom; background-color: #cceeff;">
<td style="text-align: left; font-family: 'times new roman'; padding: 0px;" width="100%">Outstanding and exercisable at March 31, 2015</td>
<td style="font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>10,162,726</font></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left">$</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>2.51</font></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>3.58</font> years</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left">$</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>97,654,187</font></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
</tr>

</table>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Article 4<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section S99<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 28<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EQAAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Document And Entity Information<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
        <th class="th">
          <div>May 08, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
        <td class="text">Lion Biotechnologies, Inc.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
        <td class="text">0001425205<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
        <td class="text">--12-31<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
        <td class="text">Accelerated Filer<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="dei_EntityCommonStockSharesOutstanding" onclick="toggleNextSibling(this);">45,029,692</a><span style="display:none;white-space:normal;text-align:left;">dei_EntityCommonStockSharesOutstanding</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
        <td class="text">10-Q<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
        <td class="text">false<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
        <td class="text">Mar. 31,  2015<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
        <td class="text">Q1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
        <td class="text">2015<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">dei_AmendmentFlag</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:booleanItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>End date of current fiscal year in the format --MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gMonthDayItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:fiscalPeriodItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">dei_DocumentType</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:submissionTypeItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:centralIndexKeyItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">dei_EntityFilerCategory</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:filerCategoryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">dei_EntityRegistrantName</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EVVAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>GENERAL ORGANIZATION AND BUSINESS (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="3">1 Months Ended</th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2014</div>
        </th>
        <th class="th">
          <div>Nov. 30, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>GENERAL ORGANIZATION AND BUSINESS [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Stockholders' Equity, Reverse Stock Split</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">1-for-100</div><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
        <td class="nump"><a title="us-gaap_CommonStockSharesAuthorized" onclick="toggleNextSibling(this);">150,000,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockSharesAuthorized</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_CommonStockSharesAuthorized" onclick="toggleNextSibling(this);">150,000,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockSharesAuthorized</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_CommonStockSharesAuthorized" onclick="toggleNextSibling(this);">150,000,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockSharesAuthorized</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
        <td class="nump"><a title="us-gaap_PreferredStockSharesAuthorized" onclick="toggleNextSibling(this);">50,000,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PreferredStockSharesAuthorized</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_PreferredStockSharesAuthorized" onclick="toggleNextSibling(this);">50,000,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PreferredStockSharesAuthorized</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_PreferredStockSharesAuthorized" onclick="toggleNextSibling(this);">50,000,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PreferredStockSharesAuthorized</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
        <td class="nump"><a title="us-gaap_PreferredStockParOrStatedValuePerShare" onclick="toggleNextSibling(this);">$ 0.001</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PreferredStockParOrStatedValuePerShare</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_PreferredStockParOrStatedValuePerShare" onclick="toggleNextSibling(this);">$ 0.001</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PreferredStockParOrStatedValuePerShare</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_PreferredStockParOrStatedValuePerShare" onclick="toggleNextSibling(this);">$ 0.001</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PreferredStockParOrStatedValuePerShare</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_NetIncomeLoss" onclick="toggleNextSibling(this);">$ 5,298,059</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetIncomeLoss</span><span></span></td>
        <td class="nump"><a title="us-gaap_NetIncomeLoss" onclick="toggleNextSibling(this);">$ 2,259,514</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetIncomeLoss</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Provided by (Used in) Operating Activities</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_NetCashProvidedByUsedInOperatingActivities" onclick="toggleNextSibling(this);">3,458,649</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetCashProvidedByUsedInOperatingActivities</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents, at Carrying Value</a></td>
        <td class="nump"><a title="us-gaap_CashAndCashEquivalentsAtCarryingValue" onclick="toggleNextSibling(this);">44,909,147</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CashAndCashEquivalentsAtCarryingValue</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_CashAndCashEquivalentsAtCarryingValue" onclick="toggleNextSibling(this);">111,280,443</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CashAndCashEquivalentsAtCarryingValue</span><span></span></td>
        <td class="nump"><a title="us-gaap_CashAndCashEquivalentsAtCarryingValue" onclick="toggleNextSibling(this);">17,943,877</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CashAndCashEquivalentsAtCarryingValue</span><span></span></td>
        <td class="nump"><a title="us-gaap_CashAndCashEquivalentsAtCarryingValue" onclick="toggleNextSibling(this);">44,909,147</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CashAndCashEquivalentsAtCarryingValue</span><span></span></td>
        <td class="nump"><a title="us-gaap_CashAndCashEquivalentsAtCarryingValue" onclick="toggleNextSibling(this);">19,672,177</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CashAndCashEquivalentsAtCarryingValue</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity" onclick="toggleNextSibling(this);">44,845,087</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity" onclick="toggleNextSibling(this);">111,626,869</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity" onclick="toggleNextSibling(this);">44,845,087</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lbio_WorkingCapital', window );">Working Capital</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="lbio_WorkingCapital" onclick="toggleNextSibling(this);">109,498,609</a><span style="display:none;white-space:normal;text-align:left;">lbio_WorkingCapital</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodSharesNewIssues" onclick="toggleNextSibling(this);">9,200,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodSharesNewIssues" onclick="toggleNextSibling(this);">6,000,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
        <td class="nump"><a title="us-gaap_SharePrice" onclick="toggleNextSibling(this);">$ 5.75</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharePrice</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_SharePrice" onclick="toggleNextSibling(this);">$ 8.00</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharePrice</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_SharePrice" onclick="toggleNextSibling(this);">$ 5.75</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharePrice</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from Issuance of Common Stock</a></td>
        <td class="nump"><a title="us-gaap_ProceedsFromIssuanceOfCommonStock" onclick="toggleNextSibling(this);">32,200,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProceedsFromIssuanceOfCommonStock</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ProceedsFromIssuanceOfCommonStock" onclick="toggleNextSibling(this);">68,307,838</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProceedsFromIssuanceOfCommonStock</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ProceedsFromIssuanceOfCommonStock" onclick="toggleNextSibling(this);">68,300,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProceedsFromIssuanceOfCommonStock</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from Issuance of Private Placement</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" onclick="toggleNextSibling(this);">$ 23,300,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lbio_WorkingCapital">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the value of working capital which is the difference between current assets and current liabilities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">lbio_WorkingCapital</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>lbio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Price of a single share of a number of saleable stocks of a company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SharePrice</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -Subparagraph (SAB TOPIC 4.C)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section C<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EZOAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Condensed Statements of Operations (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Condensed Statements of Operations [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Costs and expenses</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Operating expenses (including $0 and $1,070,707 of non-cash share-based compensation costs)</a></td>
        <td class="nump"><a title="us-gaap_OperatingCostsAndExpenses" onclick="toggleNextSibling(this);">3,287,026</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OperatingCostsAndExpenses</span><span></span></td>
        <td class="nump"><a title="us-gaap_OperatingCostsAndExpenses" onclick="toggleNextSibling(this);">1,956,852</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OperatingCostsAndExpenses</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
        <td class="nump"><a title="us-gaap_ResearchAndDevelopmentExpense" onclick="toggleNextSibling(this);">2,011,033</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ResearchAndDevelopmentExpense</span><span></span></td>
        <td class="nump"><a title="us-gaap_ResearchAndDevelopmentExpense" onclick="toggleNextSibling(this);">302,662</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ResearchAndDevelopmentExpense</span><span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total costs and expenses</a></td>
        <td class="nump"><a title="us-gaap_OperatingExpenses" onclick="toggleNextSibling(this);">5,298,059</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OperatingExpenses</span><span></span></td>
        <td class="nump"><a title="us-gaap_OperatingExpenses" onclick="toggleNextSibling(this);">2,259,514</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OperatingExpenses</span><span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
        <td class="num"><a title="us-gaap_NetIncomeLoss" onclick="toggleNextSibling(this);">$ (5,298,059)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetIncomeLoss</span><span></span></td>
        <td class="num"><a title="us-gaap_NetIncomeLoss" onclick="toggleNextSibling(this);">$ (2,259,514)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetIncomeLoss</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net Loss Per Share, Basic and Diluted</a></td>
        <td class="num"><a title="us-gaap_EarningsPerShareBasicAndDiluted" onclick="toggleNextSibling(this);">$ (0.14)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_EarningsPerShareBasicAndDiluted</span><span></span></td>
        <td class="num"><a title="us-gaap_EarningsPerShareBasicAndDiluted" onclick="toggleNextSibling(this);">$ (0.11)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_EarningsPerShareBasicAndDiluted</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-Average Common Shares Outstanding, Basic and Diluted</a></td>
        <td class="nump"><a title="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" onclick="toggleNextSibling(this);">37,678,662</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</span><span></span></td>
        <td class="nump"><a title="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" onclick="toggleNextSibling(this);">20,798,229</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</span><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 985<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 730<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_Revenues</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0ELE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>LICENSE AND COMMITMENTS<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>LICENSE AND COMMITMENTS [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">LICENSE AND COMMITMENTS</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="margin: 0pt; font-family: 'times new roman';"><br/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b><font style="text-decoration: underline;">NOTE 5. LICENSE AND COMMITMENTS</font></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b><i>National Institutes of Health and the National Cancer Institute</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Effective August 5, 2011, the Company signed a Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health and the National Cancer Institute (NCI). Under the terms of the five-year cooperative research and development agreement, the Company will work with Dr. Steven A. Rosenberg, M.D., Ph.D., chief of NCI's Surgery Branch, to develop adoptive cell immunotherapies that are designed to destroy metastatic melanoma cells using a patient's tumor infiltrating lymphocytes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The Company initially agreed to pay the NCI $<font>1,000,000</font> per year ($<font>250,000</font> per quarter) under the CRADA. On January 22, 2015, the Company executed an amendment (the &#147;Amendment&#148;) to the CRADA to include four new indications. As amended, in addition to metastatic melanoma, the CRADA now also includes the development of TIL therapy for the treatment of patients with bladder, lung, triple-negative breast, and HPV-associated cancers. Under the Amendment, the NCI also has agreed to provide the Company with samples of all tumors covered by the Amendment for performing studies related to improving TIL selection and/or TIL scale-out production and process development. As amended, the annual payments the Company is required to make to the NCI have increased from $<font>1</font> million to $<font>2</font> million, to be paid in quarterly installments of $<font>500,000</font>. The Company paid the first quarterly installment of $<font>500,000</font> in February 2015. Although the CRADA has a five year term, either party to the CRADA has the right to terminate the CRADA upon 60 days' notice to the other party.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">During the three months ended March 31, 2015 and 2014, the Company recognized $<font>541,667</font> and $<font>250,000</font>, respectively, of CRADA expenses, which were recorded as part of research and development expenses in the statement of operations. As of December 31, 2014 and March 31, 2015, $<font>250,000</font> of CRADA expenses were included in the accrued expenses on the accompanying condensed balance sheet.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><i>National Institutes of Health</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Effective October 5, 2011, the Company entered into a Patent License Agreement (the &#147;License Agreement&#148;) with the National Institutes of Health, an agency of the United States Public Health Service within the Department of Health and Human Services (&#147;NIH&#148;). Pursuant to the License Agreement, NIH granted to the Company a non-exclusive worldwide right and license to develop and manufacture certain proprietary autologous tumor infiltrating lymphocyte adoptive cell therapy products for the treatment of metastatic melanoma, ovarian cancer, breast cancer, and colorectal cancer. The License Agreement requires the Company to pay royalties of six percent (<font>6</font>%) of net sales (subject to certain annual minimum royalty payments), a percentage of revenues from sublicensing arrangements, and lump sum benchmark royalty payments on the achievement of certain clinical and regulatory milestones for each of the various indications and other direct cost incurred by NIH pursuant to the agreement. If the Company achieves all benchmarks for metastatic melanoma, up to and including the product's first commercial sale in the United States, the total amount of such benchmark payments will be $<font>6,050,000</font>. The benchmark payments for the other three indications, if all benchmarks are achieved, will be $<font>6,050,000</font> for ovarian cancer, $<font>12,100,000</font> for breast cancer, and $<font>12,100,000</font> for colorectal cancer. Accordingly, if the Company achieves all benchmarks for all four licensed indications, the aggregate amount of benchmark royalty payments that the Company will have to make to NIH will be $<font>36,300,000</font>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">On February 9, 2015, the Company entered into an amendment to the License Agreement with the NIH pursuant to which the Company's non-exclusive license to melanoma was converted into an exclusive license. In consideration for the exclusive rights granted under the amendment to the License Agreement, the Company agreed to pay the NIH a non-refundable upfront licensing fee of $<font>350,000</font>, which was recognized as research and development expense during the three months ended March 31, 2015, and included in the balance of accrued expenses at March 31, 2015. The Company also agreed to pay customary royalties based on a percentage of net sales (which percentage is in the mid-single digits), a percentage of revenues from sublicensing arrangements, and lump sum benchmark payments upon the successful completion of the Company's first Phase 2 clinical study, the successful completion of the Company's first Phase 3 clinical study, the receipt of the first FDA approval or foreign equivalent for a licensed product or process resulting from the licensed technologies, the first commercial sale of a licensed product or process in the United States, and the first commercial sale of a licensed product or process in any foreign country.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">During the three months ended March 31, 2015, there were no net sales subject to certain annual minimum royalty payments or sales that would require us to pay a percentage of revenues from sublicensing arrangements. In addition there were no benchmarks or milestones achieved that would require payment under the lump sum benchmark royalty payments on the achievement of certain clinical and regulatory milestones for each of the various indications.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><i>Exclusive License Agreement</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">On July 21, 2014, the Company entered into an Exclusive License Agreement (the &#147;Moffitt License Agreement&#148;), effective as of June 28, 2014, with the H. Lee Moffitt Cancer Center and Research Institute, Inc. (&#147;Moffitt&#148;) under which the Company received an exclusive, world-wide license to Moffitt's rights in and to two patent-pending technologies related to methods for improving tumor-infiltrating lymphocytes for adoptive cell therapy. Unless earlier terminated, the term of the license extends until the earlier of the expiration of the last patent related to the licensed technology or 20 years after the effective date of the license agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Pursuant to the Moffitt License Agreement, the Company paid an upfront licensing fee of $<font>25,000</font>, which was recognized as research and development expense during 2014. A patent issuance fee will also be payable under the Moffitt License Agreement, upon the issuance of the first U.S. patent covering the subject technology. In addition, the Company agreed to pay milestone license fees upon completion of specified milestones, customary royalties based on a specified percentage of net sales (which percentage is in the low single digits) and sublicensing payments, as applicable, and annual minimum royalties beginning with the first sale of products based on the licensed technologies, which minimum royalties will be credited against the percentage royalty payments otherwise payable in that year. The Company will also be responsible for all costs associated with the preparation, filing, maintenance and prosecution of the patent applications and patents covered by the Moffitt License Agreement related to the treatment of any cancers in the United States, Europe and Japan and in other countries selected that the Company and Moffitt agreed to.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">During the three months ended March 31, 2015, there were no net sales subject to certain annual minimum royalty payments or sales that would require us to pay a percentage of revenues from sublicensing arrangements</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><i>Exclusive Patent License Agreement</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">On February 10, 2015, the Company entered into an exclusive Patent License Agreement with the NIH under which the Company received an exclusive, world-wide license to the NIH's rights in and to two patent-pending technologies related to methods for improving tumor-infiltrating lymphocytes for adoptive cell therapy. The licensed technologies relate to the more potent and efficient production of TIL from melanoma tumors by selecting for T-cell populations that express various inhibitory receptors. Unless terminated sooner, the license shall remain in effect until the last licensed patent right expires.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">In consideration for the exclusive rights granted under the exclusive Patent License Agreement, the Company agreed to pay the NIH a non-refundable upfront licensing fee of $<font>40,000</font>, which was recognized as research and development expense during the three months ended March 31, 2015, and included in the balance of accrued expenses at March 31, 2015. The Company also agreed to pay customary royalties based on a percentage of net sales (which percentage is in the mid-single digits), a percentage of revenues from sublicensing arrangements, and lump sum benchmark payments upon the successful completion of the Company's first Phase 2 clinical study, the successful completion of the Company's first Phase 3 clinical study, the receipt of the first FDA approval or foreign equivalent for a licensed product or process resulting from the licensed technologies, the first commercial sale of a licensed product or process in the United States, and the first commercial sale of a licensed product or process in any foreign country.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">During the three months ended March 31, 2015, there were no net sales subject to certain annual minimum royalty payments or sales that would require us to pay a percentage of revenues from sublicensing arrangements. In addition there were no benchmarks or milestones achieved that would require payment under the lump sum benchmark royalty payments on the achievement of certain clinical and regulatory milestones for each of the various indications.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b><i>Manufacturing Service Agreement</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">In December 2011, the Company entered into a Manufacturing Services Agreement with Lonza Walkersville, Inc. (Lonza) pursuant to which Lonza has agreed to manufacture, package, ship and perform quality assurance and quality control of our TIL therapy. Lonza has commenced developing a commercial-scale manufacturing process for the TIL therapy. The goal is to develop and establish a manufacturing process for the large-scale production of TIL that is in accord with current Good Manufacturing Practices (cGMP).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">On June 1, 2014 we issued a new statement of work (SOW) to Lonza under the Manufacturing Services Agreement. The total cost for services to be provided under the SOW is approximately $<font>738,000</font>. During 2014, the Company recognized $<font>890,684</font> of expenses under the Manufacturing Services Agreement with Lonza, which included a $<font>100,000</font> in upfront costs required under the SOW, and were recorded as part of research and development expenses in 2014. During the three months ended March 31, 2015, the Company recognized $<font>298,071</font> of expenses under the Manufacturing Services Agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><i>Research Collaboration Agreement </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">In September, 2014, we entered into a research collaboration agreement with the H. Lee Moffitt Cancer Center and Research Institute, Inc. to jointly engage in transitional research and development of adoptive tumor-infiltrating lymphocyte cell therapy with improved anti-tumor properties and process. The total obligation under the agreement was $<font>1,432,797</font>, of which $<font>358,199</font> was paid in 2014. During the three-month period ended March 31, 2015, the Company did not record any expenses related to this research collaboration agreement.</p> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for commitments and contingencies.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.25)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 460<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6398077&amp;loc=d3e12565-110249<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 450<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 440<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394976&amp;loc=d3e25287-109308<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCK OPTIONS AND WARRANTS<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>STOCK OPTIONS AND WARRANTS [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK OPTIONS AND WARRANTS</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">
<p style="margin: 0pt; font-family: 'times new roman';">&#160;<br/></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><font style="text-decoration: underline;">NOTE 4. STOCK OPTIONS AND WARRANTS</font></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><i>&#160;</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><i>Stock Options</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">A summary of the status of stock options at March 31, 2015, and the changes during the three months then ended, is presented in the following table:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p>
<div class="CursorPointer">
<div>
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 100%;">

<tr style="vertical-align: bottom;">
<td style="font-family: 'Times New Roman';" nowrap="nowrap"></td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap"></td>
<td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"></td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap"></td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap"></td>
<td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"></td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap"></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td colspan="13" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><br/></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td>
<td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap">&#160;</td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td>
</tr>
<tr style="vertical-align: bottom;">
<td style="font-family: 'Times New Roman';" nowrap="nowrap"></td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap"></td>
<td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap"></td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap"></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Weighted</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Weighted Average</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td>
<td style="font-family: 'Times New Roman';" colspan="2" nowrap="nowrap">&#160;</td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td>
</tr>
<tr style="vertical-align: bottom;">
<td style="font-family: 'Times New Roman';" nowrap="nowrap"></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Shares</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Average</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Remaining</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Aggregate</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="font-family: 'Times New Roman';" nowrap="nowrap"></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Under</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Exercise</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Contractual</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Intrinsic</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="font-family: 'Times New Roman';" nowrap="nowrap">&#160;</td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><strong>Option</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><strong>Price</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><strong>Life</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><strong>Value</strong></td>
<td nowrap="nowrap" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="2">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="2">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="2">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="2">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: #cceeff;">
<td style="font-family: 'times new roman'; padding: 0px;" width="100%">Outstanding at January 1, 2015</td>
<td style="font-family: 'times new roman'; padding: 0px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>1,857,877</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>7.31</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap;"><font>8.5</font> years</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>2,874,378</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="font-family: 'Times New Roman';" width="100%">Granted</td>
<td style="font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>50,000</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>7.45</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10pt; vertical-align: bottom; white-space: nowrap;"><font>10</font> years</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>233,000</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: #cceeff;">
<td style="font-family: 'Times New Roman';" width="100%">Exercised</td>
<td style="font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>-</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="font-family: 'times new roman'; padding: 0px;" width="100%">Expired/Forfeited</td>
<td style="font-family: 'times new roman'; padding: 0px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>-</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 1pt solid !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: #cceeff;">
<td style="font-family: 'times new roman'; padding: 0px;" width="100%">Outstanding at March 31, 2015</td>
<td style="font-family: 'times new roman'; padding: 0px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>1,907,877</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 2.80pt double !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td>
<td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>7.47</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 2.80pt double !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>8.25</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 1pt solid !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td>
<td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>10,687,637</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 1pt solid !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="font-family: 'times new roman'; padding: 0px;" width="100%">Exercisable at March 31, 2015</td>
<td style="font-family: 'times new roman'; padding: 0px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>405,412</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 2.80pt double !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td>
<td style="text-align: right; font-family: 'times new roman'; border-bottom: #000000 2.80pt double !important; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>10.48</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; border-bottom: #000000 2.80pt double !important; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; padding-right: 10px; white-space: nowrap;">$</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; vertical-align: bottom; white-space: nowrap;"><font>4,708,718</font></td>
<td style="text-align: left; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
</tr>

</table>
</div>
</div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">During the three months ended March 31, 2015, the Company granted an option to purchase <font>50,000</font> shares of common stock to a new member of the Company's Board of Directors. The stock options have an exercise price of $<font>7.45</font> and vest in four installments as follows: options for the purchase of <font>12,500</font> shares vest on May 15, 2015, and the remaining options to purchase shares vest evenly over the next three quarters. The fair value of these options was determined to be $<font>369,000</font> using the Black-Scholes option pricing model based on the following assumptions: (i) volatility rate of <font>213</font>%, (ii) discount rate of <font>1.37</font> %, (iii) <font>zero</font> expected dividend yield, and (iv) expected life of <font>6</font> years.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">During the three months ended March 31, 2015 and 2014, the Company recorded compensation costs of $<font>1,017,308</font> and $<font>901,650</font>, respectively, relating to the vesting of stock options. As of March 31, 2015, the aggregate value of unvested options was $<font>8,665,475</font>, which will continue to be amortized as compensation cost as the options vest over terms ranging from <font>nine</font> months to <font>five</font> years, as applicable.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">On March 29, 2010, the Company's Board of Directors adopted the Genesis Biopharma, Inc. 2010<b> </b>Equity Compensation Plan (the "2010 Plan") pursuant to which the Board reserved an aggregate of <font>35,000</font> shares of common stock for future grants of stock options, rights to acquire restricted stock, rights to acquire unrestricted stock, and stock appreciation rights. Options for the issuance of all 35,000 shares have been granted, and no shares are available for additional grants under the 2010 Plan.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">On October 14, 2011, the Company's Board of Directors approved a 2011 Equity Incentive Plan (the &#147;2011 Plan&#148;). The Company's stockholders did not approve the 2011 Plan within a required one-year period, and accordingly, the Company cannot grant incentive stock options under the 2011 Plan. As of December 31, 2014, no shares were available for future grant under the 2011 Plan.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">On September 19, 2014, The Company's Board of Directors adopted the Lion Biotechnologies, Inc. 2014 Equity Incentive Plan (the &#147;2014 Plan&#148;). The 2014 Plan was approved by our stockholders at the annual meeting of stockholders held in November 2014. The 2014 Plan initially authorized the issuance up to an aggregate of <font>2,350,000</font> shares of common stock. On April 10, 2015 the Board amended the 2014 Plan, subject to stockholder approval, to increase the total number of shares that can be issued under the 2014 Plan by <font>1,650,000</font> from 2,350,000 shares to <font>4,000,000</font> shares.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b><i>Warrants</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">A summary of the status of stock warrants at March 31, 2015, and the changes during the three months then ended, is presented in the following table:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p>
<div class="CursorPointer">
<div>
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; width: 100%;">

<tr style="vertical-align: bottom;">
<td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"></td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"></td>
<td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center">&#160;</td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap" colspan="3" align="center"></td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"></td>
<td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center">&#160;</td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap" colspan="3" align="center"></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><strong>&#160;</strong></td>
<td nowrap="nowrap" colspan="15" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt;"><br/></td>
<td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center">&#160;</td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap" colspan="3" align="center">&#160;</td>
</tr>
<tr style="vertical-align: bottom;">
<td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"></td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"></td>
<td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center">&#160;</td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap" colspan="3" align="center"></td>
<td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"><strong>&#160;</strong></td>
<td colspan="3" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Weighted</strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><strong>&#160;</strong></td>
<td nowrap="nowrap" colspan="3" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt;"><strong>Weighted Average</strong></td>
<td style="white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center">&#160;</td>
<td style="font-family: 'Times New Roman';" nowrap="nowrap" colspan="3" align="center">&#160;</td>
</tr>
<tr style="vertical-align: bottom;">
<td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"></td>
<td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"><strong>&#160;</strong></td>
<td colspan="4" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Shares</strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Average</strong></td>
<td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><strong>&#160;</strong></td>
<td nowrap="nowrap" colspan="3" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt;"><strong>Remaining</strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"><strong>&#160;</strong></td>
<td colspan="3" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Aggregate</strong></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center"></td>
<td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"><strong>&#160;</strong></td>
<td colspan="4" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Under</strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Exercise</strong></td>
<td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><strong> </strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><strong>&#160;</strong></td>
<td nowrap="nowrap" colspan="3" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt;"><strong>Contractual</strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"><strong>&#160;</strong></td>
<td colspan="3" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px;"><strong>Intrinsic</strong></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="font-family: 'Times New Roman';" nowrap="nowrap" align="center">&#160;</td>
<td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"><strong>&#160;</strong></td>
<td colspan="4" nowrap="nowrap" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><strong>Warrants</strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"><strong>&#160;</strong></td>
<td colspan="2" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><strong>Price</strong></td>
<td nowrap="nowrap" align="center" style="font-family: 'times new roman'; padding: 0px;"><strong>&#160;</strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;"><strong>&#160;</strong></td>
<td nowrap="nowrap" colspan="3" align="center" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px; font-size: 10.0pt;"><strong>Life</strong></td>
<td align="center" style="text-align: center; font-family: 'times new roman'; padding: 0px; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt;"><strong>&#160;</strong></td>
<td colspan="3" nowrap="nowrap" align="center" style="text-align: center; font-family: 'times new roman'; border-bottom: #000000 1pt solid !important; padding: 0px;"><strong>Value</strong></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="vertical-align: top; text-align: left;"></td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" align="center">&#160;</td>
<td style="vertical-align: top; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="3" align="center">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" align="center">&#160;</td>
<td style="vertical-align: top; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="3" align="center">&#160;</td>
<td style="vertical-align: top; text-align: left; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-family: 'Times New Roman';" align="center">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="3" align="center">&#160;</td>
<td style="vertical-align: top; text-align: left; white-space: nowrap; padding-right: 5px; padding-left: 5px; font-size: 10.0pt; font-family: 'Times New Roman';" align="center">&#160;</td>
<td style="vertical-align: top; text-align: left; font-family: 'Times New Roman';" colspan="3" align="center">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: #cceeff;">
<td style="font-family: 'times new roman'; padding: 0px;" width="100%">Outstanding at December 31, 2014</td>
<td style="font-family: 'times new roman'; padding: 0px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>11,084,426</font></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px;">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left">$</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>2.51</font></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>3.85</font> years</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left">$</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>59,517,998</font></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-indent: 10pt; font-family: 'times new roman'; padding: 0px;" width="100%">Issued</td>
<td style="font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>-</font></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
</tr>
<tr style="vertical-align: bottom; background-color: #cceeff;">
<td style="text-indent: 10pt; font-family: 'times new roman'; padding: 0px;" width="100%">Exercised</td>
<td style="font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>(921,700</font></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left">)</td>
<td style="font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left">$</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>2.50</font></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="text-indent: 10pt; font-family: 'times new roman'; padding: 0px;" width="100%">Expired</td>
<td style="font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>-</font></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
</tr>
<tr style="vertical-align: bottom; background-color: #cceeff;">
<td style="text-align: left; font-family: 'times new roman'; padding: 0px;" width="100%">Outstanding and exercisable at March 31, 2015</td>
<td style="font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>10,162,726</font></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'Times New Roman';">&#160;</td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left">$</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>2.51</font></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>3.58</font> years</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
<td style="text-align: right; font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; white-space: nowrap; padding-right: 5px; padding-left: 5px;">&#160;</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left">$</td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap;" align="right"><font>97,654,187</font></td>
<td style="font-family: 'times new roman'; padding: 0px; font-size: 10.0pt; vertical-align: bottom; white-space: nowrap; padding-right: 5px;" align="left"></td>
</tr>

</table>
</div>
</div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">During the three months ended March 31, 2015, the Company received $<font>2,304,250</font> in cash from the exercise of 921,700 warrants for the purchase of <font>921,700</font> shares of its common stock.</p>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 40<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6418621&amp;loc=d3e17540-113929<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5444-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EV6AE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCK OPTIONS AND WARRANTS (Schedule of Status of Stock Options) (Details) (Employee Stock Option [Member], USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2014</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top">
          <div class="a">Employee Stock Option [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares Under Option</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding beginning balance</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber[us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember]" onclick="toggleNextSibling(this);">1,857,877</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_EmployeeStockOptionMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross[us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember]" onclick="toggleNextSibling(this);">50,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_EmployeeStockOptionMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Expired/Forfeited</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding ending balance</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber[us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember]" onclick="toggleNextSibling(this);">1,907,877</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_EmployeeStockOptionMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber[us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember]" onclick="toggleNextSibling(this);">1,857,877</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_EmployeeStockOptionMember</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable ending balance</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber[us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember]" onclick="toggleNextSibling(this);">405,412</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_EmployeeStockOptionMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Exercise Price</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding beginning balance</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice[us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember]" onclick="toggleNextSibling(this);">$ 7.31</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_EmployeeStockOptionMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice[us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember]" onclick="toggleNextSibling(this);">$ 7.45</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_EmployeeStockOptionMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding ending balance</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice[us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember]" onclick="toggleNextSibling(this);">$ 7.47</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_EmployeeStockOptionMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice[us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember]" onclick="toggleNextSibling(this);">$ 7.31</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_EmployeeStockOptionMember</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable ending balance</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice[us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember]" onclick="toggleNextSibling(this);">$ 10.48</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_EmployeeStockOptionMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract', window );"><strong>Weighted Average Remaining Contractual Life</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding</a></td>
        <td class="text">8 years 3 months<span></span></td>
        <td class="text">8 years 6 months<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm', window );">Granted</a></td>
        <td class="text">10 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lbio_AggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Outstanding beginning balance</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue[us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember]" onclick="toggleNextSibling(this);">$ 2,874,378</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_EmployeeStockOptionMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Granted</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue[us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember]" onclick="toggleNextSibling(this);">233,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_EmployeeStockOptionMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Outstanding ending balance</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue[us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember]" onclick="toggleNextSibling(this);">10,687,637</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_EmployeeStockOptionMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue[us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember]" onclick="toggleNextSibling(this);">2,874,378</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_EmployeeStockOptionMember</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Exercisable Balance</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue[us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember]" onclick="toggleNextSibling(this);">$ 4,708,718</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_EmployeeStockOptionMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lbio_AggregateIntrinsicValueAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">lbio_AggregateIntrinsicValueAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>lbio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">lbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract1Abstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>lbio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for option awards grants in period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">lbio_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>lbio_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (d)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(3)-(4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross number of share options (or share units) granted during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of options outstanding, including both vested and non-vested options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of fully vested and expected to vest options that are exercisable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount by which the current fair value of the underlying stock exceeds the exercise price of fully vested and expected to vest options outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of share options (or share units) exercised during the current period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EVOAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES (Details)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember', window );">Equity Option [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
        <td class="nump"><a title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount[us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember]" onclick="toggleNextSibling(this);">1,907,877</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount<br>/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis<br>= us-gaap_StockOptionMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount[us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember]" onclick="toggleNextSibling(this);">638,750</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount<br>/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis<br>= us-gaap_StockOptionMember</span><span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
        <td class="nump"><a title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount[us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember]" onclick="toggleNextSibling(this);">10,162,726</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount<br>/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis<br>= us-gaap_WarrantMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount[us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember]" onclick="toggleNextSibling(this);">12,156,156</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount<br>/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis<br>= us-gaap_WarrantMember</span><span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
        <td class="nump"><a title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount[us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember]" onclick="toggleNextSibling(this);">1,847,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount<br>/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis<br>= us-gaap_ConvertiblePreferredStockMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount[us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember]" onclick="toggleNextSibling(this);">6,650,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount<br>/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis<br>= us-gaap_ConvertiblePreferredStockMember</span><span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
        <td class="nump"><a title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount[us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember]" onclick="toggleNextSibling(this);">507,113</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount<br>/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis<br>= us-gaap_RestrictedStockMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Antidilution<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Diluted Earnings Per Share<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Contingent Stock Agreement<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EHFAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES (Policies)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income (Loss) Per Share</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b><i>Net Income (Loss) Per Share</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period, excluding unvested shares of restricted common stock. Shares of restricted stock subject to vesting are included in basic weighted average common shares outstanding from the time they vest. Diluted earnings per share is computed by dividing the net income applicable to common stock holders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation when their effect is antidilutive. When calculating diluted net income per share, shares of restricted stock subject to vesting are included in diluted weighted average common shares outstanding as of their grant date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">At March 31, 2015 and 2014, basic and diluted net loss per share are the same as the effect of potentially dilutive securities was antidilutive. At March 31, 2015, potentially dilutive securities include options to acquire <font>1,907,877</font> shares of common stock, warrants to acquire <font>10,162,726</font> shares of common stock, preferred stock that can be converted into <font>1,847,000</font> shares of common stock, and <font>507,113</font> shares of non-vested restricted stock. At March 31, 2014, potentially dilutive securities include options to acquire <font>638,750</font> shares of common stock, warrants to acquire <font>12,156,156</font> shares of common stock, and preferred stock that can be converted into <font>6,650,000</font> shares of common stock.</p></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value Measurements</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b><i>Fair Value Measurements</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The Company uses various inputs in determining the fair value of certain assets and liabilities and measures these on a recurring basis. Financial assets and liabilities recorded at fair value in the balance sheets are categorized by the level of objectivity associated with the inputs used to measure their fair value. Authoritative guidance provided by the Financial Accounting Standards Board (the &#147;FASB&#148;) defines the following levels directly related to the amount of subjectivity associated with the inputs to fair valuation of these financial assets and liabilities:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;">Level 1&#151;Quoted prices in active markets for identical assets or liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;">Level 2&#151;Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;">Level 3&#151;Unobservable inputs based on the Company's assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">At March 31, 2015 and December 31, 2014, the fair value of cash and cash equivalents, accounts payable, and accrued expenses approximate their carrying values based on their short term nature.</p></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><i>Use of Estimates</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include accounting for potential liabilities and the assumptions made in valuing stock instruments issued for services.</p></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><i>Stock-Based Compensation</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The Company periodically grants stock options and warrants to employees and non-employees in non-capital raising transactions as compensation for services rendered. The Company accounts for stock option grants to employees based on the authoritative guidance provided by the Financial Accounting Standards Board where the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option grants to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board where the value of the stock compensation is determined based upon the measurement date at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The fair value of the Company's common stock option grants is estimated using a Black-Scholes option pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the common stock options, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes option pricing model, and based on actual experience. The assumptions used in the Black-Scholes option pricing model could materially affect compensation expense recorded in future periods.</p></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><i>Research and Development</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Research and development costs consist primarily of fees paid to consultants and outside service providers, patent fees and costs, and other expenses relating to the acquisition, design, development and testing of the Company's treatments and product candidates. Research and development costs are expensed as incurred over the life of the underlying contracts on the straight-line basis, unless the achievement of milestones, the completion of contracted work, or other information indicates that a different expensing schedule is more appropriate. The Company reviews the status of its research and development contracts on a quarterly basis.</p></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><i>Concentrations</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The Company maintains cash balances at one bank. As of March 31, 2015, the Company's cash balances were in excess of insured limits maintained at the bank. Management believes that the financial institution that holds the Company's cash is financially sound and, accordingly, minimal credit risk exists.</p></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><i>Recent Accounting Pronouncements</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, <i>Revenue from Contracts with Customers</i>. ASU 2014-09 is a comprehensive revenue recognition standard that will supersede nearly all existing revenue recognition guidance under current U.S. GAAP and replace it with a principle based approach for determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. ASU 2014-09 is effective for interim and annual periods beginning after December 15, 2016, however, the FASB has proposed a one-year deferral. Early adoption is not permitted, and either full retrospective adoption or modified retrospective adoption is permitted. The Company is in the process of evaluating the impact of ASU 2014-09 on the Company's financial statements and disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">In January 2015, the FASB issued Accounting Standards Update No. 2015-01 (Subtopic 225-20) - Income Statement - Extraordinary and Unusual Items. ASU 2015-01 eliminates the concept of an extraordinary item from GAAP. As a result, an entity will no longer be required to segregate extraordinary items from the results of ordinary operations, to separately present an extraordinary item on its income statement, net of tax, after income from continuing operations or to disclose income taxes and earnings-per-share data applicable to an extraordinary item. However, ASU 2015-01 will still retain the presentation and disclosure guidance for items that are unusual in nature and occur infrequently. ASU 2015-01 is effective for periods beginning after December 15, 2015. Early adoption is permitted. The adoption of ASU 2015-01 is not expected to have a material effect on the Company's consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission (&#147;SEC&#148;) did not or are not believed by management to have a material impact on the Company's present or future financial statements.</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for credit risk.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 825<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28088331&amp;loc=SL29635902-196195<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35750535&amp;loc=d3e13531-108611<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 21<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35750535&amp;loc=d3e13537-108611<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6875567&amp;loc=d3e14489-108613<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 825<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6480020&amp;loc=d3e61082-112788<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 825<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6480020&amp;loc=d3e61044-112788<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for determining the fair value of financial instruments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35750535&amp;loc=d3e13279-108611<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 60<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 730<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Research and Development<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6523717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b),(f)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6143-108592<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6132-108592<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6061-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>LEGAL PROCEEDINGS<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAbstract', window );"><strong>LEGAL PROCEEDINGS [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDisclosures', window );">LEGAL PROCEEDINGS</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><br/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><b><font style="text-decoration: underline;">NOTE 6. LEGAL PROCEEDINGS</font></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">On April 23, 2014, the Company received a subpoena from the Securities Exchange Commission (the &#147;SEC&#148;) that stated that the staff of the SEC is conducting an investigation <i><font style="text-decoration: underline;">In the Matter of Galena Biopharma, Inc. File No. HO 12356</font></i> <i>(now known as &#147;<font style="text-decoration: underline;">In the Matter of Certain Stock Promotions</font>&#148;) </i>and that the subpoena was issued to the Company as part of the foregoing investigation. The SEC's subpoena and accompanying letter do not indicate whether the Company is, or is not, under investigation. We have fully cooperated with the SEC and as of November 2014, we had completed production of documents in response to the subpoena. To date, The SEC has not requested any further action from the Company.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The subpoena requires the Company to give the SEC, among other materials, all communications between anyone at the Company and certain persons and entities (which include investor-relations firms and persons associated with the investor-relations firms), all documents related to the listed persons and entities, all articles regarding the Company posted on certain equity research or other financial websites, and documents and communications related to individuals who post or have posted articles regarding the Company on equity research or other financial websites.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">There are no other pending legal proceedings to which the Company is a party or of which its property is the subject.</p>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_LossContingencyAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDisclosures">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 450<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 450<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 450<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14453-108349<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 450<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14394-108349<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 450<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14472-108349<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 460<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6851643&amp;loc=d3e12021-110248<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 450<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14557-108349<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 460<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6851643&amp;loc=d3e12053-110248<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 450<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14615-108349<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_LossContingencyDisclosures</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0ELE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>SUBSEQUENT EVENTS [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="margin: 0pt; font-family: 'times new roman';"><br/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b><font style="text-decoration: underline;">NOTE 7. SUBSEQUENT EVENTS</font></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b><i>Share Issuances</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">In the second quarter of 2015, the Company has received $<font>394,510</font> in cash from the exercise of warrants for the purchase of <font>157,804</font> shares of its common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">On May 6, 2015, certain stockholders of the Company, including certain members of Board of Directors of the Company and their affiliates, sold <font>4,750,000</font> shares of the Company's common stock in an underwritten secondary offering at a price of $<font>10.00</font> per share. The Company did not sell any shares in the offering and will not receive any of the proceeds from the offering.</p> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>STOCKHOLDERS' EQUITY [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Activity</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"><p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; font-size-adjust: none; font-stretch: normal;">
</p><p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; font-size-adjust: none; font-stretch: normal;">&#160;</p>
<table align="center" style="font: 10pt/normal Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;" cellspacing="0" cellpadding="0">

<tr style="vertical-align: bottom;">
<td nowrap="nowrap">&#160;</td>
<td nowrap="nowrap" style="padding-bottom: 1pt; font-weight: bold;">&#160;</td>
<td nowrap="nowrap" style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2">Number&#160;of<br/> Shares</td>
<td nowrap="nowrap" style="padding-bottom: 1pt; font-weight: bold;">&#160;</td>
<td nowrap="nowrap" style="padding-bottom: 1pt; font-weight: bold;">&#160;</td>
<td nowrap="nowrap" style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2">Weighted<br/> Average<br/> Grant&#160;Date<br/> Fair&#160;Value</td>
<td nowrap="nowrap" style="padding-bottom: 1pt; font-weight: bold;">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: #cceeff;">
<td style="width: 74%;">Non-vested shares, January 1, 2015</td>
<td style="width: 1%;">&#160;</td>
<td style="width: 1%; text-align: left;">&#160;</td>
<td style="width: 10%; text-align: right;"><font>579,764</font></td>
<td style="width: 1%; text-align: left;">&#160;</td>
<td style="width: 1%;">&#160;</td>
<td style="width: 1%; text-align: left;">&#160;</td>
<td style="width: 10%; text-align: right;"><font>6.20</font></td>
<td style="width: 1%; text-align: left;">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="padding-left: 0.125in;">Granted</td>
<td>&#160;</td>
<td style="text-align: left;">&#160;</td>
<td style="text-align: right;"><font>-</font></td>
<td style="text-align: left;">&#160;</td>
<td>&#160;</td>
<td style="text-align: left;">&#160;</td>
<td style="text-align: right;"><font>-</font></td>
<td style="text-align: left;">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: #cceeff;">
<td style="padding-left: 0.125in;">Vested</td>
<td>&#160;</td>
<td style="text-align: left;">&#160;</td>
<td style="text-align: right;"><font>(72,651</font></td>
<td style="text-align: left;">)</td>
<td>&#160;</td>
<td style="text-align: left;">&#160;</td>
<td style="text-align: right;"><font>6.20</font></td>
<td style="text-align: left;">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="padding-left: 0.125in;">Forfeited</td>
<td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td>
<td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">&#160;</td>
<td style="text-align: right; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"><font>-</font></td>
<td style="text-align: left; padding-bottom: 1pt; font-weight: bold;">&#160;</td>
<td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td>
<td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">&#160;</td>
<td style="text-align: right; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"><font>-</font></td>
<td style="text-align: left; padding-bottom: 1pt; font-weight: bold;">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: #cceeff;">
<td style="padding-bottom: 2.5pt;">Non-vested shares, March 31, 2015</td>
<td style="padding-bottom: 2.5pt;">&#160;</td>
<td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">&#160;</td>
<td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"><font>507,113</font></td>
<td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td>
<td style="padding-bottom: 2.5pt;">&#160;</td>
<td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">$</td>
<td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"><font>6.20</font></td>
<td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td>
</tr>

</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; text-indent: 0.5in; font-size-adjust: none; font-stretch: normal;">&#160;</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0E3LAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCKHOLDER'S EQUITY (Schedule of Restricted Stock Activity) (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-vested shares, January 1, 2015</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" onclick="toggleNextSibling(this);">579,764</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested</a></td>
        <td class="num"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" onclick="toggleNextSibling(this);">(72,651)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-vested shares, March 31, 2015</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" onclick="toggleNextSibling(this);">507,113</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Non-vested shares, January 1, 2015</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" onclick="toggleNextSibling(this);">$ 6.20</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" onclick="toggleNextSibling(this);">$ 6.20</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Non-vested shares, March 31, 2015</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" onclick="toggleNextSibling(this);">$ 6.20</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</span><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EMHAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2014</div>
        </th>
        <th class="th">
          <div>May 11, 2015</div>
        </th>
        <th class="th">
          <div>May 06, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from warrant exercises</a></td>
        <td class="nump"><a title="us-gaap_ProceedsFromWarrantExercises" onclick="toggleNextSibling(this);">$ 2,304,250</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProceedsFromWarrantExercises</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued during period</a></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodSharesNewIssues" onclick="toggleNextSibling(this);">9,200,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</span><span></span></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodSharesNewIssues" onclick="toggleNextSibling(this);">6,000,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Purchase of common stock</a></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised[us-gaap_AwardTypeAxis=us-gaap_WarrantMember]" onclick="toggleNextSibling(this);">921,700</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_WarrantMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from warrant exercises</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ProceedsFromWarrantExercises[us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember]" onclick="toggleNextSibling(this);">$ 394,510</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProceedsFromWarrantExercises<br>/ us-gaap_SubsequentEventTypeAxis<br>= us-gaap_SubsequentEventMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued during period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodSharesNewIssues[us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember]" onclick="toggleNextSibling(this);">4,750,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodSharesNewIssues<br>/ us-gaap_SubsequentEventTypeAxis<br>= us-gaap_SubsequentEventMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_SaleOfStockPricePerShare[us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember]" onclick="toggleNextSibling(this);">$ 10.00</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SaleOfStockPricePerShare<br>/ us-gaap_SubsequentEventTypeAxis<br>= us-gaap_SubsequentEventMember</span><span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Warrant [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Purchase of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised[us-gaap_AwardTypeAxis=us-gaap_WarrantMember;us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember]" onclick="toggleNextSibling(this);">157,804</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_WarrantMember<br>/ us-gaap_SubsequentEventTypeAxis<br>= us-gaap_SubsequentEventMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of share options (or share units) exercised during the current period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_WarrantMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EGH">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Condensed Statements of Operations (Parenthetical) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Condensed Statements of Operations [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Compensation</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensation" onclick="toggleNextSibling(this);">$ 1,467,753</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensation</span><span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensation" onclick="toggleNextSibling(this);">$ 919,350</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensation</span><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0ELE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>STOCKHOLDERS' EQUITY [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">
<p style="margin: 0pt; font-family: 'times new roman';"><br/></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b><font style="text-decoration: underline;">NOTE 3. STOCKHOLDERS' EQUITY</font></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b><i>Public offering</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">On March 3, 2015, the Company completed an underwritten public offering of <font>9,200,000</font> shares of its common stock at a price of $<font>8.00</font> per share of common stock. The net proceeds to the Company from the offering were $<font>68.3</font> million, after deducting underwriting discounts and commissions and offering expenses. The offering was made pursuant to the Company's existing shelf registration statement on Form S-3, including a base prospectus, which was filed with the SEC on November 20, 2014 and declared effective on December 10, 2014, a preliminary prospectus supplement thereunder, and a registration statement on Form S-3 filed with the SEC on February 26, 2015.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><b><i>Issuance of common stock upon conversion of preferred stock</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">During the three months ended March 31, 2015, the Company issued <font>1,000,000</font> shares of common stock upon the conversion of <font>2,000</font> shares of Series A Convertible Preferred Stock. The number conversion shares issued was determined on a formula basis of <font>500</font> common shares for each Series A Convertible Preferred Stock held.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><br/></p>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"><b><i>Common stock with vesting terms</i></b></p>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;">&#160;</p>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;">During 2014, the Company granted <font>782,500</font> shares of its restricted common stock to nine of its employees in accordance with the terms of their employment agreements. The 782,500 shares vest over a period of <font>three</font> years. As these shares were granted to employees, the Company calculated the aggregate fair value of the 782,500 shares based on the trading prices of the Company's stock at their grant dates and determined it to be $<font>4,851,590</font>, of which $<font>1,256,985</font> was expensed in 2014. The allocable portion of the fair value of the stock that vested during the three months ended March 31, 2015 amounted to $<font>450,445</font> and was recognized as expense in the accompanying statements of operations. As of March 31, 2015, the amount of unvested compensation related to all issuances of restricted common stock was $<font>3,144,160</font>, which will be recorded as expense in future periods as the shares vest.</p>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; font-size-adjust: none; font-stretch: normal;">&#160;</p>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;">When calculating basic net income (loss) per share, these shares are included in basic weighted average common shares outstanding from the time they vest. When calculating diluted net income (loss) per share, these shares are included in diluted weighted average common shares outstanding from the time they are granted, unless they are antidilutive. Shares of restricted stock granted above are subject to forfeiture to the Company or other restrictions that will lapse in accordance with a vesting schedule determined by our Board.</p>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"><b>&#160;</b></p>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; font-size-adjust: none; font-stretch: normal;">The following table summarizes restricted common stock activity:</p><div><p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; font-size-adjust: none; font-stretch: normal;">
</p><p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; font-size-adjust: none; font-stretch: normal;">&#160;</p>
<table align="center" style="font: 10pt/normal Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;" cellspacing="0" cellpadding="0">

<tr style="vertical-align: bottom;">
<td nowrap="nowrap">&#160;</td>
<td nowrap="nowrap" style="padding-bottom: 1pt; font-weight: bold;">&#160;</td>
<td nowrap="nowrap" style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2">Number&#160;of<br/> Shares</td>
<td nowrap="nowrap" style="padding-bottom: 1pt; font-weight: bold;">&#160;</td>
<td nowrap="nowrap" style="padding-bottom: 1pt; font-weight: bold;">&#160;</td>
<td nowrap="nowrap" style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2">Weighted<br/> Average<br/> Grant&#160;Date<br/> Fair&#160;Value</td>
<td nowrap="nowrap" style="padding-bottom: 1pt; font-weight: bold;">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: #cceeff;">
<td style="width: 74%;">Non-vested shares, January 1, 2015</td>
<td style="width: 1%;">&#160;</td>
<td style="width: 1%; text-align: left;">&#160;</td>
<td style="width: 10%; text-align: right;"><font>579,764</font></td>
<td style="width: 1%; text-align: left;">&#160;</td>
<td style="width: 1%;">&#160;</td>
<td style="width: 1%; text-align: left;">&#160;</td>
<td style="width: 10%; text-align: right;"><font>6.20</font></td>
<td style="width: 1%; text-align: left;">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="padding-left: 0.125in;">Granted</td>
<td>&#160;</td>
<td style="text-align: left;">&#160;</td>
<td style="text-align: right;"><font>-</font></td>
<td style="text-align: left;">&#160;</td>
<td>&#160;</td>
<td style="text-align: left;">&#160;</td>
<td style="text-align: right;"><font>-</font></td>
<td style="text-align: left;">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: #cceeff;">
<td style="padding-left: 0.125in;">Vested</td>
<td>&#160;</td>
<td style="text-align: left;">&#160;</td>
<td style="text-align: right;"><font>(72,651</font></td>
<td style="text-align: left;">)</td>
<td>&#160;</td>
<td style="text-align: left;">&#160;</td>
<td style="text-align: right;"><font>6.20</font></td>
<td style="text-align: left;">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: white;">
<td style="padding-left: 0.125in;">Forfeited</td>
<td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td>
<td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">&#160;</td>
<td style="text-align: right; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"><font>-</font></td>
<td style="text-align: left; padding-bottom: 1pt; font-weight: bold;">&#160;</td>
<td style="padding-bottom: 1pt; font-weight: bold;">&#160;</td>
<td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">&#160;</td>
<td style="text-align: right; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"><font>-</font></td>
<td style="text-align: left; padding-bottom: 1pt; font-weight: bold;">&#160;</td>
</tr>
<tr style="vertical-align: bottom; background-color: #cceeff;">
<td style="padding-bottom: 2.5pt;">Non-vested shares, March 31, 2015</td>
<td style="padding-bottom: 2.5pt;">&#160;</td>
<td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">&#160;</td>
<td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"><font>507,113</font></td>
<td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td>
<td style="padding-bottom: 2.5pt;">&#160;</td>
<td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">$</td>
<td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"><font>6.20</font></td>
<td style="text-align: left; padding-bottom: 2.5pt;">&#160;</td>
</tr>

</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0px; text-align: justify; text-indent: 0.5in; font-size-adjust: none; font-stretch: normal;">&#160;</p></div>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(d),(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -Subparagraph (SAB TOPIC 4.C)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section C<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Article 4<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Preferred Stock<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br><br><br>Reference 17: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br><br><br>Reference 18: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph d<br><br> -Article 4<br><br><br><br>Reference 19: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<FilingSummary xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <Version>2.4.1.9</Version>
  <ProcessingTime />
  <ReportFormat>Html</ReportFormat>
  <ContextCount>78</ContextCount>
  <ElementCount>136</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>32</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>001 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Ibio-dei</Role>
      <ShortName>Document And Entity Information</ShortName>
    </Report>
    <Report>
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>002 - Statement - Condensed Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Ibio-cbs</Role>
      <ShortName>Condensed Balance Sheets</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>003 - Statement - Condensed Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Ibio-cbsp</Role>
      <ShortName>Condensed Balance Sheets (Parenthetical)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>004 - Statement - Condensed Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Ibio-csoo</Role>
      <ShortName>Condensed Statements of Operations</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>005 - Statement - Condensed Statements of Operations (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Statement-CondensedStatementsofOperationsParenthetical</Role>
      <ShortName>Condensed Statements of Operations (Parenthetical)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>006 - Statement - Condensed Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Ibio-csose</Role>
      <ShortName>Condensed Statements of Stockholders' Equity</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>008 - Statement - Condensed Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Ibio-csocf</Role>
      <ShortName>Condensed Statements of Cash Flows</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>101 - Disclosure - GENERAL ORGANIZATION AND BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Ibio-goab</Role>
      <ShortName>GENERAL ORGANIZATION AND BUSINESS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Ibio-sosap</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>103 - Statement - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Ibio-se</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>104 - Disclosure - STOCK OPTIONS AND WARRANTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Ibio-soaw</Role>
      <ShortName>STOCK OPTIONS AND WARRANTS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>105 - Disclosure - LICENSE AND COMMITMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Disclosure-LICENSEANDCOMMITMENTS</Role>
      <ShortName>LICENSE AND COMMITMENTS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>106 - Disclosure - LEGAL PROCEEDINGS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Disclosure-LEGALPROCEEDINGS</Role>
      <ShortName>LEGAL PROCEEDINGS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>107 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Ibio-se1</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Ibio-sosapp</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES (Policies)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>303 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Disclosure-STOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>304 - Disclosure - STOCK OPTIONS AND WARRANTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Ibio-soawt</Role>
      <ShortName>STOCK OPTIONS AND WARRANTS (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>40101 - Disclosure - GENERAL ORGANIZATION AND BUSINESS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Ibio-goabd</Role>
      <ShortName>GENERAL ORGANIZATION AND BUSINESS (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>40201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Ibio-sosapd</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>40301 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Disclosure-STOCKHOLDERSEQUITYNarrativeDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Narrative) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>40302 - Disclosure - STOCKHOLDER'S EQUITY (Schedule of Restricted Stock Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Disclosure-STOCKHOLDERSEQUITYScheduleofRestrictedStockActivityDetails</Role>
      <ShortName>STOCKHOLDER'S EQUITY (Schedule of Restricted Stock Activity) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>40401 - Disclosure - STOCK OPTIONS AND WARRANTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Ibio-soawnd</Role>
      <ShortName>STOCK OPTIONS AND WARRANTS (Narrative) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>40402 - Disclosure - STOCK OPTIONS AND WARRANTS (Schedule of Status of Stock Options) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Ibio-soawsososod</Role>
      <ShortName>STOCK OPTIONS AND WARRANTS (Schedule of Status of Stock Options) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>40403 - Disclosure - STOCK OPTIONS AND WARRANTS (Schedule of Status of Stock Warrants) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Disclosure-STOCKOPTIONSANDWARRANTSScheduleofStatusofStockWarrantsDetails</Role>
      <ShortName>STOCK OPTIONS AND WARRANTS (Schedule of Status of Stock Warrants) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>40501 - Disclosure - LICENSE AND COMMITMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Disclosure-LICENSEANDCOMMITMENTSDetails</Role>
      <ShortName>LICENSE AND COMMITMENTS (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>40801 - Disclosure - SUBSEQUENT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lbio.com/role/Disclosure-SUBSEQUENTEVENTSDetails</Role>
      <ShortName>SUBSEQUENT EVENTS (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">Element us-gaap_LongTermPurchaseCommitmentAmount had a mix of decimals attribute values: -6 0.</Log>
    <Log type="Info">Element us-gaap_ProceedsFromIssuanceOfCommonStock had a mix of decimals attribute values: -5 0.</Log>
    <Log type="Info">Columns in Cash Flows statement 'Condensed Statements of Cash Flows (USD $)' have maximum duration 364 days and at least 16 values. Shorter duration columns must have at least one fourth (4) as many values. Column '12/1/2014 - 12/31/2014' is shorter (30 days) and has only 2 values, so it is being removed.</Log>
    <Log type="Info">Process Flow-Through: 002 - Statement - Condensed Balance Sheets</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Mar. 31, 2014'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2013'</Log>
    <Log type="Info">Process Flow-Through: 003 - Statement - Condensed Balance Sheets (Parenthetical)</Log>
    <Log type="Info">Process Flow-Through: 004 - Statement - Condensed Statements of Operations</Log>
    <Log type="Info">Process Flow-Through: 005 - Statement - Condensed Statements of Operations (Parenthetical)</Log>
    <Log type="Info">Process Flow-Through: 008 - Statement - Condensed Statements of Cash Flows</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2014'</Log>
    <Log type="Info">Process Flow-Through: 103 - Statement - STOCKHOLDERS' EQUITY</Log>
  </Logs>
  <InputFiles>
    <File>lbio-20150331.xml</File>
    <File>lbio-20150331.xsd</File>
    <File>lbio-20150331_cal.xml</File>
    <File>lbio-20150331_def.xml</File>
    <File>lbio-20150331_lab.xml</File>
    <File>lbio-20150331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles />
  <BaseTaxonomies />
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0E6VAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Narrative) (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued during period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodSharesNewIssues" onclick="toggleNextSibling(this);">9,200,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodSharesNewIssues" onclick="toggleNextSibling(this);">6,000,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
        <td class="nump"><a title="us-gaap_SharePrice" onclick="toggleNextSibling(this);">$ 5.75</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharePrice</span><span></span></td>
        <td class="nump"><a title="us-gaap_SharePrice" onclick="toggleNextSibling(this);">$ 8.00</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharePrice</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_SharePrice" onclick="toggleNextSibling(this);">$ 5.75</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharePrice</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from the issuance of common stock, net</a></td>
        <td class="nump"><a title="us-gaap_ProceedsFromIssuanceOfCommonStock" onclick="toggleNextSibling(this);">$ 32,200,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProceedsFromIssuanceOfCommonStock</span><span></span></td>
        <td class="nump"><a title="us-gaap_ProceedsFromIssuanceOfCommonStock" onclick="toggleNextSibling(this);">$ 68,307,838</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProceedsFromIssuanceOfCommonStock</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ProceedsFromIssuanceOfCommonStock" onclick="toggleNextSibling(this);">$ 68,300,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProceedsFromIssuanceOfCommonStock</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of Stock, Shares Issued</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ConversionOfStockSharesIssued1" onclick="toggleNextSibling(this);">1,000,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ConversionOfStockSharesIssued1</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of Stock, Shares Converted</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ConversionOfStockSharesConverted1" onclick="toggleNextSibling(this);">2,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ConversionOfStockSharesConverted1</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_AllocatedShareBasedCompensationExpense" onclick="toggleNextSibling(this);">1,017,308</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AllocatedShareBasedCompensationExpense</span><span></span></td>
        <td class="nump"><a title="us-gaap_AllocatedShareBasedCompensationExpense" onclick="toggleNextSibling(this);">901,650</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AllocatedShareBasedCompensationExpense</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember]" onclick="toggleNextSibling(this);">782,500</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockMember</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">3 years<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested', window );">Nonvested, fair value</a></td>
        <td class="nump"><a title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember]" onclick="toggleNextSibling(this);">4,851,590</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember]" onclick="toggleNextSibling(this);">4,851,590</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockMember</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_AllocatedShareBasedCompensationExpense[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember]" onclick="toggleNextSibling(this);">1,256,985</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AllocatedShareBasedCompensationExpense<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockMember</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Vested, fair value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember]" onclick="toggleNextSibling(this);">450,445</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation cost</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember]" onclick="toggleNextSibling(this);">$ 3,144,160</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=lbio_SeriesConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of Stock, Shares Converted</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ConversionOfStockSharesConverted1[us-gaap_StatementClassOfStockAxis=lbio_SeriesConvertiblePreferredStockMember]" onclick="toggleNextSibling(this);">500</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ConversionOfStockSharesConverted1<br>/ us-gaap_StatementClassOfStockAxis<br>= lbio_SeriesConvertiblePreferredStockMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.F)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section F<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Unrecognized cost of unvested share-based awards, other than options, awarded to employees as compensation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Intrinsic value of equity-based compensation awards not vested. Excludes stock and unit options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (d)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Price of a single share of a number of saleable stocks of a company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SharePrice</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=lbio_SeriesConvertiblePreferredStockMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=lbio_SeriesConvertiblePreferredStockMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
